<SUBMISSION>
<ACCESSION-NUMBER>0001903596-22-000530
<TYPE>10-Q
<PUBLIC-DOCUMENT-COUNT>56
<PERIOD>20220630
<FILING-DATE>20220815
<DATE-OF-FILING-DATE-CHANGE>20220815
<FILER>
<COMPANY-DATA>
<CONFORMED-NAME>ALR TECHNOLOGIES INC.
<CIK>0001087022
<ASSIGNED-SIC>3669
<IRS-NUMBER>880225807
<STATE-OF-INCORPORATION>NV
<FISCAL-YEAR-END>1231
</COMPANY-DATA>
<FILING-VALUES>
<FORM-TYPE>10-Q
<ACT>34
<FILE-NUMBER>000-30414
<FILM-NUMBER>221164919
</FILING-VALUES>
<BUSINESS-ADDRESS>
<STREET1>7400 BEAUFONT SPRINGS DRIVE
<STREET2>SUITE 300
<CITY>RICHMOND
<STATE>VA
<ZIP>23225
<PHONE>(804) 554-3500
</BUSINESS-ADDRESS>
<MAIL-ADDRESS>
<STREET1>7400 BEAUFONT SPRINGS DRIVE
<STREET2>SUITE 300
<CITY>RICHMOND
<STATE>VA
<ZIP>23225
</MAIL-ADDRESS>
<FORMER-COMPANY>
<FORMER-CONFORMED-NAME>ALR TECHNOLOGIES INC
<DATE-CHANGED>19990524
</FORMER-COMPANY>
</FILER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>sfsalr10q081122.htm
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:us-roles="http://fasb.org/us-roles/2022" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:country="http://xbrl.sec.gov/country/2022" xmlns:srt="http://fasb.org/srt/2022" xmlns:ALRT="http://alrt.com/20220630">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02B_US%2DGAAP%2D2022 -->
<!-- Field: Set; Name: xdx; ID: xdx_033_ALRT_alrt.com_20220630 -->
<!-- Field: Set; Name: xdx; ID: xdx_04A_20220101_20220630 -->
<!-- Field: Set; Name: xdx; ID: xdx_055_edei%2D%2DEntityCentralIndexKey_0001087022 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_051_edei%2D%2DCurrentFiscalYearEndDate_%2D%2DLS0xMi0zMQ== -->
<!-- Field: Set; Name: xdx; ID: xdx_050_edei%2D%2DDocumentFiscalYearFocus_2022 -->
<!-- Field: Set; Name: xdx; ID: xdx_058_edei%2D%2DDocumentFiscalPeriodFocus_Q2 -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_069_Pure_4_xbrli%2D%2Dpure -->
<body>
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="From2022-01-01to2022-06-30" name="dei:EntityCentralIndexKey">0001087022</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2022-01-01to2022-06-30" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2022-01-01to2022-06-30" name="dei:CurrentFiscalYearEndDate">--12-31</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2022-01-01to2022-06-30" name="dei:DocumentFiscalYearFocus">2022</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2022-01-01to2022-06-30" name="dei:DocumentFiscalPeriodFocus">Q2</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2022-01-01to2022-06-30" id="xdx2ixbrl0030" name="dei:EntityCurrentReportingStatus">Yes</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2022-01-01to2022-06-30" id="xdx2ixbrl0031" name="dei:EntityInteractiveDataCurrent">Yes</ix:nonNumeric>
  <ix:nonFraction name="us-gaap:PreferredStockValue" contextRef="AsOf2022-06-30" id="xdx2ixbrl0097" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:PreferredStockValue" contextRef="AsOf2021-12-31" id="xdx2ixbrl0099" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:Revenues" contextRef="From2021-04-012021-06-30" id="xdx2ixbrl0137" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:Revenues" contextRef="From2021-01-012021-06-30" id="xdx2ixbrl0139" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:CostOfRevenue" contextRef="From2021-04-012021-06-30" id="xdx2ixbrl0142" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:CostOfRevenue" contextRef="From2021-01-012021-06-30" id="xdx2ixbrl0144" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:GrossProfit" contextRef="From2021-04-012021-06-30" id="xdx2ixbrl0147" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:GrossProfit" contextRef="From2021-01-012021-06-30" id="xdx2ixbrl0149" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:GainsLossesOnExtinguishmentOfDebt" contextRef="From2022-04-012022-06-30" id="xdx2ixbrl0191" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:GainsLossesOnExtinguishmentOfDebt" contextRef="From2022-01-01to2022-06-30" id="xdx2ixbrl0193" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax" contextRef="From2021-04-012021-06-30" id="xdx2ixbrl0212" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax" contextRef="From2021-01-012021-06-30" id="xdx2ixbrl0214" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ALRT:StockbasedCompensationgeneralSellingAndAdministration" contextRef="From2021-01-012021-06-30" id="xdx2ixbrl0241" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ALRT:StockbasedCompensationinterest" contextRef="From2022-01-01to2022-06-30" id="xdx2ixbrl0246" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ALRT:BonusesSettledByIssuanceOfShares" contextRef="From2021-01-012021-06-30" id="xdx2ixbrl0256" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ALRT:LossOnSettlementOfDebt" contextRef="From2022-01-01to2022-06-30" id="xdx2ixbrl0258" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ProceedsFromConvertibleDebt" contextRef="From2021-01-012021-06-30" id="xdx2ixbrl0283" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="From2021-01-012021-06-30" id="xdx2ixbrl0295" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ALRT:UnsecuredPromissoryNotesPayableToRelativesOfChairmanWithFixedAmountsOfInterestDueAugust312022" contextRef="AsOf2021-12-31" id="xdx2ixbrl0399" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ALRT:UnsecuredPromissoryNotesPayableToUnrelatedLendersWithFixedAmountsOfInterestDue" contextRef="AsOf2021-12-31" id="xdx2ixbrl0451" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" contextRef="From2022-01-01to2022-06-30" id="xdx2ixbrl0655" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" contextRef="From2022-01-01to2022-06-30" id="xdx2ixbrl0657" unitRef="USDPShares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" contextRef="From2022-01-01to2022-06-30" id="xdx2ixbrl0663" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" contextRef="From2022-01-01to2022-06-30" id="xdx2ixbrl0665" unitRef="USDPShares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ALRT:OpenOptionContractsWrittenNumbersOfShare" contextRef="From2022-01-012022-06-30_custom_Options11Member" id="xdx2ixbrl0854" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ALRT:ExercisePrices" contextRef="From2022-01-012022-06-30_custom_Options11Member" id="xdx2ixbrl0856" unitRef="USDPShares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ALRT:IntrinsicValue" contextRef="From2022-01-012022-06-30_custom_Options11Member" id="xdx2ixbrl0858" unitRef="USDPShares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ALRT:OpenOptionContractsWrittenNumbersOfShare" contextRef="From2022-01-012022-06-30_custom_Options12Member" id="xdx2ixbrl0866" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ALRT:ExercisePrices" contextRef="From2022-01-012022-06-30_custom_Options12Member" id="xdx2ixbrl0868" unitRef="USDPShares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ALRT:IntrinsicValue" contextRef="From2022-01-012022-06-30_custom_Options12Member" id="xdx2ixbrl0870" unitRef="USDPShares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ALRT:OpenOptionContractsWrittenNumbersOfShare" contextRef="From2022-01-012022-06-30_custom_Options13Member" id="xdx2ixbrl0878" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ALRT:ExercisePrices" contextRef="From2022-01-012022-06-30_custom_Options13Member" id="xdx2ixbrl0880" unitRef="USDPShares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ALRT:IntrinsicValue" contextRef="From2022-01-012022-06-30_custom_Options13Member" id="xdx2ixbrl0882" unitRef="USDPShares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:InterestExpenseDebt" contextRef="From2022-04-012022-06-30" id="xdx2ixbrl1039" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:InterestExpenseDebt" contextRef="From2022-01-01to2022-06-30" id="xdx2ixbrl1041" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OtherSellingGeneralAndAdministrativeExpense" contextRef="From2021-04-012021-06-30" id="xdx2ixbrl1055" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OtherSellingGeneralAndAdministrativeExpense" contextRef="From2021-01-012021-06-30" id="xdx2ixbrl1057" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ALRT:InterestExpenseRelatedToModificationOfStockOptionsHeldByChairmanAndChiefExecutiveOfficerOfCompanyAndHisSpouseRelatedToFinancingProvided" contextRef="From2022-04-012022-06-30" id="xdx2ixbrl1105" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ALRT:InterestExpenseRelatedToModificationOfStockOptionsHeldByChairmanAndChiefExecutiveOfficerOfCompanyAndHisSpouseRelatedToFinancingProvided" contextRef="From2022-01-01to2022-06-30" id="xdx2ixbrl1107" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ALRT:ConsultingFeesToDirectorOfCompanySettledWithIssuanceOfCommonStock" contextRef="From2021-04-012021-06-30" id="xdx2ixbrl1121" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ALRT:ConsultingFeesToDirectorOfCompanySettledWithIssuanceOfCommonStock" contextRef="From2021-01-012021-06-30" id="xdx2ixbrl1123" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ALRT:LossOnSettlementOfDebtToRelativeOfChairmanAndChiefExecutiveOfficerOfCompany" contextRef="From2022-04-012022-06-30" id="xdx2ixbrl1130" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ALRT:LossOnSettlementOfDebtToRelativeOfChairmanAndChiefExecutiveOfficerOfCompany" contextRef="From2022-01-01to2022-06-30" id="xdx2ixbrl1132" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ALRT:RentPaidToCompanyControlledBySpouseOfChairmanAndImmediateFamilyMembers" contextRef="From2021-04-012021-06-30" id="xdx2ixbrl1136" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ALRT:RentPaidToCompanyControlledBySpouseOfChairmanAndImmediateFamilyMembers" contextRef="From2021-01-012021-06-30" id="xdx2ixbrl1138" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:Revenues" contextRef="From2022-01-012022-06-30_custom_OtherMember" id="xdx2ixbrl1191" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:Revenues" contextRef="From2021-01-012021-06-30_custom_OtherMember" id="xdx2ixbrl1193" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:Revenues" contextRef="From2021-01-012021-06-30_country_SG" id="xdx2ixbrl1197" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:Revenues" contextRef="From2022-01-012022-06-30_country_US" id="xdx2ixbrl1199" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:Revenues" contextRef="From2021-01-012021-06-30_country_US" id="xdx2ixbrl1201" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:Revenues" contextRef="From2021-01-012021-06-30" id="xdx2ixbrl1205" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-01-012021-06-30_custom_OtherMember" id="xdx2ixbrl1209" unitRef="USD" xs:nil="true"></ix:nonFraction>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="alrt-20220630.xsd" xlink:type="simple" />
  </ix:references>
 <ix:resources>
    <xbrli:context id="From2022-01-01to2022-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001087022</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-08-15">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001087022</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-08-15</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001087022</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001087022</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-04-012022-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001087022</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-04-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-04-012021-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001087022</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-04-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001087022</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001087022</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001087022</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_RelatedPartyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001087022</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ALRT:RelatedPartyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_RelatedPartyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001087022</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ALRT:RelatedPartyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_RelatedPartyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001087022</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ALRT:RelatedPartyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-06-30_custom_RelatedPartyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001087022</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ALRT:RelatedPartyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_custom_RelatedPartyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001087022</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ALRT:RelatedPartyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_UnRelatedPartyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001087022</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ALRT:UnRelatedPartyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_UnRelatedPartyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001087022</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ALRT:UnRelatedPartyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_UnRelatedPartyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001087022</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ALRT:UnRelatedPartyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-06-30_custom_UnRelatedPartyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001087022</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ALRT:UnRelatedPartyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_custom_UnRelatedPartyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001087022</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ALRT:UnRelatedPartyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001087022</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-06-30_custom_ChairmanAndCEOMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001087022</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">ALRT:ChairmanAndCEOMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_custom_ChairmanAndCEOMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001087022</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">ALRT:ChairmanAndCEOMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-06-30_custom_WifeOfChairmanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001087022</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">ALRT:WifeOfChairmanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_custom_WifeOfChairmanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001087022</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">ALRT:WifeOfChairmanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_ChairmanAndCEOMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001087022</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">ALRT:ChairmanAndCEOMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_ChairmanAndCEOMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001087022</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">ALRT:ChairmanAndCEOMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_WifeOfChairmanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001087022</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">ALRT:WifeOfChairmanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_WifeOfChairmanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001087022</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">ALRT:WifeOfChairmanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-06-30_custom_Options1Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001087022</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options1Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_Options1Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001087022</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options1Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-06-30_custom_Options2Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001087022</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options2Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_Options2Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001087022</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options2Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-06-30_custom_Options3Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001087022</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options3Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_Options3Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001087022</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options3Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-06-30_custom_Options4Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001087022</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options4Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_Options4Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001087022</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options4Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-06-30_custom_Options5Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001087022</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options5Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_Options5Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001087022</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options5Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-06-30_custom_Options6Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001087022</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options6Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_Options6Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001087022</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options6Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-06-30_custom_Options7Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001087022</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options7Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_Options7Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001087022</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options7Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-06-30_custom_Options8Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001087022</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options8Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_Options8Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001087022</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options8Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-06-30_custom_Options9Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001087022</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options9Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_Options9Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001087022</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options9Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-06-30_custom_Options10Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001087022</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options10Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_Options10Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001087022</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options10Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-06-30_custom_Options11Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001087022</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options11Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_Options11Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001087022</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options11Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-06-30_custom_Options12Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001087022</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options12Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_Options12Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001087022</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options12Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-06-30_custom_Options13Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001087022</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options13Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_Options13Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001087022</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options13Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-06-30_custom_Options14Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001087022</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options14Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_Options14Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001087022</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options14Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-06-30_custom_Options15Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001087022</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options15Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_Options15Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001087022</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options15Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-06-30_custom_Options16Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001087022</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options16Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_Options16Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001087022</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options16Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-06-30_custom_Options17Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001087022</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options17Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_Options17Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001087022</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options17Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-06-30_custom_Options18Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001087022</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options18Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_Options18Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001087022</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options18Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-06-30_custom_Options19Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001087022</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options19Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_Options19Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001087022</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options19Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-06-30_custom_Options20Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001087022</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options20Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_Options20Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001087022</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options20Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-06-30_custom_Options21Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001087022</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options21Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_Options21Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001087022</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options21Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-06-30_custom_Options22Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001087022</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options22Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_Options22Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001087022</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options22Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-06-30_custom_Options23Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001087022</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options23Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_Options23Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001087022</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options23Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_custom_OtherMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001087022</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">ALRT:OtherMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_OtherMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001087022</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">ALRT:OtherMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_country_SG">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001087022</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:SG</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_country_SG">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001087022</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:SG</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_country_US">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001087022</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_country_US">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001087022</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-06-30_custom_OtherMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001087022</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">ALRT:OtherMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-06-30_custom_OtherMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001087022</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">ALRT:OtherMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-06-30_country_SG">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001087022</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:SG</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-06-30_country_SG">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001087022</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:SG</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-06-30_country_US">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001087022</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-06-30_country_US">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001087022</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
    <xbrli:unit id="Pure">
      <xbrli:measure>xbrli:pure</xbrli:measure>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<!-- Field: Rule-Page --><div style="margin-top: 1pt; margin-bottom: 1pt; width: 100%"><div style="border-top: Black 3.5pt solid; border-bottom: Black 1pt solid; font-size: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></div></div><!-- Field: /Rule-Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>UNITED
STATES</b></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SECURITIES
AND EXCHANGE COMMISSION</b></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Washington,
D.C. 20549</b></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 16pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FORM
<span id="xdx_900_edei--DocumentType_c20220101__20220630_zcJT4lqI4w2k"><ix:nonNumeric contextRef="From2022-01-01to2022-06-30" name="dei:DocumentType">10-Q</ix:nonNumeric></span></b></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_907_edei--DocumentQuarterlyReport_c20220101__20220630" title="Document Quarterly Report"><ix:nonNumeric contextRef="From2022-01-01to2022-06-30" format="ixt:booleantrue" name="dei:DocumentQuarterlyReport">[X]</ix:nonNumeric></span></b></span></td>
    <td style="width: 97%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>QUARTERLY REPORT UNDER TO SECTION
    13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED <span id="xdx_903_edei--DocumentPeriodEndDate_c20220101__20220630" title="Document Period End Date"><ix:nonNumeric contextRef="From2022-01-01to2022-06-30" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate">JUNE 30, 2022</ix:nonNumeric></span></b></span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>OR</i></b></span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>[&#160;&#160;&#160;]<span id="xdx_90C_edei--DocumentTransitionReport_c20220101__20220630_zS7ms1vP3wJj" style="display: none"><ix:nonNumeric contextRef="From2022-01-01to2022-06-30" format="ixt:booleanfalse" name="dei:DocumentTransitionReport">&#9744;</ix:nonNumeric></span></b></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d)
    OF THE SECURITIES EXCHANGE ACT OF 1934</b></span></td></tr>
  </table>
<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Commission
file number <span id="xdx_90A_edei--EntityFileNumber_c20220101__20220630_zkaxkDx0J3d"><ix:nonNumeric contextRef="From2022-01-01to2022-06-30" name="dei:EntityFileNumber">000-30414</ix:nonNumeric></span></b></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 20pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_900_edei--EntityRegistrantName_c20220101__20220630_zaUtfwuWRo3k"><ix:nonNumeric contextRef="From2022-01-01to2022-06-30" name="dei:EntityRegistrantName">ALR TECHNOLOGIES INC.</ix:nonNumeric></span></b></span></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>(Exact
name of registrant as specified in its charter)</i></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_908_edei--EntityIncorporationStateCountryCode_c20220101__20220630_zxnNiixoMzc5" style="text-transform: uppercase"><ix:nonNumeric contextRef="From2022-01-01to2022-06-30" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode">nevada</ix:nonNumeric></span></b></span></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>(State
or other jurisdiction of incorporation or organization)</i></span></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_905_edei--EntityTaxIdentificationNumber_c20220101__20220630_z5uEavtTqfr1"><ix:nonNumeric contextRef="From2022-01-01to2022-06-30" name="dei:EntityTaxIdentificationNumber">88-0225807</ix:nonNumeric></span></b></span></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>(I.R.S.
Employer Identification No.)</i></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_906_edei--EntityAddressAddressLine1_c20220101__20220630_z5wRPcLEdjYi"><ix:nonNumeric contextRef="From2022-01-01to2022-06-30" name="dei:EntityAddressAddressLine1">7400 Beaufont Springs Drive</ix:nonNumeric></span> <span id="xdx_90C_edei--EntityAddressAddressLine2_c20220101__20220630_zC0IhsfDrWei"><ix:nonNumeric contextRef="From2022-01-01to2022-06-30" name="dei:EntityAddressAddressLine2">Suite 300</ix:nonNumeric></span></b></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_905_edei--EntityAddressCityOrTown_c20220101__20220630_z0w3mYhT2bn"><ix:nonNumeric contextRef="From2022-01-01to2022-06-30" name="dei:EntityAddressCityOrTown">Richmond</ix:nonNumeric></span>,
<span id="xdx_906_edei--EntityAddressStateOrProvince_c20220101__20220630_zdQOeIkAYBh7"><ix:nonNumeric contextRef="From2022-01-01to2022-06-30" name="dei:EntityAddressStateOrProvince">VA</ix:nonNumeric></span> <span id="xdx_909_edei--EntityAddressPostalZipCode_c20220101__20220630_zyGHVmDzbtCl"><ix:nonNumeric contextRef="From2022-01-01to2022-06-30" name="dei:EntityAddressPostalZipCode">23225</ix:nonNumeric></span></b></span></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>(Address
of principal executive offices, including zip code.)</i></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_900_edei--CityAreaCode_c20220101__20220630_zrIhtWT3aKNb"><ix:nonNumeric contextRef="From2022-01-01to2022-06-30" name="dei:CityAreaCode">(804)</ix:nonNumeric></span>
<span id="xdx_900_edei--LocalPhoneNumber_c20220101__20220630_zsbTt3ElKNKe"><ix:nonNumeric contextRef="From2022-01-01to2022-06-30" name="dei:LocalPhoneNumber">554-3500</ix:nonNumeric></span></b></span></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>(Telephone
number, including area code)</i></span></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the issuer (1) has filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act during the
preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such
filing requirements for the last 90 days. <b><span id="xdx_900_edei--EntityCurrentReportingStatus_c20220101__20220630_zXGb1gSb4BY7"><span style="-sec-ix-hidden: xdx2ixbrl0030">YES</span></span> [ X ] NO [ ]</b></span></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data
File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (SS 232.405 of this chapter) during the preceding 12
months (or for such shorter period that the registrant was required to submit and post such files). <b><span id="xdx_90F_edei--EntityInteractiveDataCurrent_c20220101__20220630_zgtDSSTbS35"><span style="-sec-ix-hidden: xdx2ixbrl0031">YES</span></span> [X] NO [ ]</b></span></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting
company. See the definitions of &#8220;large accelerated filer, &#8220;accelerated filer,&#8221; &#8220;non-accelerated filer,&#8221;
and &#8220;smaller reporting company&#8221; in Rule 12b-2 of the Exchange Act. (Check one):</span></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 42%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Large Accelerated Filer</b></span></td>
    <td style="width: 4%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>[&#160;&#160;&#160;]</b></span></td>
    <td style="width: 6%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 38%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Accelerated Filer</b></span></td>
    <td style="width: 7%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>[&#160;&#160;&#160;]</b></span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90C_edei--EntityFilerCategory_c20220101__20220630" title="Entity Filer Category"><ix:nonNumeric contextRef="From2022-01-01to2022-06-30" format="ixt-sec:entityfilercategoryen" name="dei:EntityFilerCategory">Non-accelerated Filer</ix:nonNumeric></span></b></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>[&#160;&#160;&#160;]</b></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Smaller Reporting Company</b></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_909_edei--EntitySmallBusiness_c20220101__20220630_zm9ZstNethJ2"><ix:nonNumeric contextRef="From2022-01-01to2022-06-30" format="ixt:booleantrue" name="dei:EntitySmallBusiness">[X]</ix:nonNumeric></span></b></span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>(Do not check if smaller reporting company)</i></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>
<p style="font: 9pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><i><span><span id="xdx_902_edei--EntityEmergingGrowthCompany_c20220101__20220630_zBzFmdZ4RQ57" style="display: none"><ix:nonNumeric contextRef="From2022-01-01to2022-06-30" format="ixt:booleanfalse" name="dei:EntityEmergingGrowthCompany">&#9744;</ix:nonNumeric></span></span></i></i></span></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><i><span></span></i></i></span></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). <b>YES [ ] <span id="xdx_901_edei--EntityShellCompany_c20220101__20220630_zNYsWLwSQ5Ig"><ix:nonNumeric contextRef="From2022-01-01to2022-06-30" format="ixt:booleanfalse" name="dei:EntityShellCompany">NO</ix:nonNumeric></span> [ X ]</b></span></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>APPLICABLE
ONLY TO CORPORATE ISSUERS:</b></span></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">State
the number of shares outstanding of each of the issuer&#8217;s classes of common equity, as of the latest practicable date: <span id="xdx_90E_edei--EntityCommonStockSharesOutstanding_iI_c20220815_zbUsDDFrDxF9"><b><ix:nonFraction name="dei:EntityCommonStockSharesOutstanding" contextRef="AsOf2022-08-15" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">551,966,844</ix:nonFraction>
</b></span></span><b><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">as of August 15, 2022.</span></b></p>

<!-- Field: Rule-Page --><div style="margin-top: 1pt; margin-bottom: 1pt; width: 100%"><div style="border-top: Black 1pt solid; border-bottom: Black 3.5pt solid; font-size: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></div></div><!-- Field: /Rule-Page -->

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 1 -->
    <div style="margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ALR
TECHNOLOGIES INC.</b></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>TABLE
OF CONTENTS</b></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>PART I.
    FINANCIAL INFORMATION</i></b></span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: top">
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: top">
    <td style="width: 9%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item 1.</span></td>
    <td style="width: 84%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Condensed Consolidated Financial
    Statements.</span></td>
    <td style="width: 7%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Condensed Consolidated Balance Sheets (unaudited)</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4</span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Condensed Consolidated Statements of Operations (unaudited)</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5</span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Condensed Consolidated Statements of Cash Flows (unaudited)</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6</span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notes to Condensed Consolidated Financial Statements
    (unaudited)</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7</span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item 2.</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management&#8217;s Discussion and Analysis of Financial
    Condition and Results of Operations.</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">26</span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item 3.</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Quantitative and Qualitative Disclosures About Market
    Risk.</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">38</span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item 4.</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Controls and Procedures.</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">38</span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>PART II. OTHER INFORMATION</i></b></span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item 1.</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Legal Proceedings.</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">39</span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item 1A.</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risk Factors.</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">39</span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item 2</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unregistered Sales of Equity Securities</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">39</span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item 3.</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Defaults Upon Senior Securities.</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">39</span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item 5.</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other Information.</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">39</span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item 6.</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exhibits.</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">40</span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: top">
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Signatures</i></span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">41</span></td></tr>
  </table>
<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 2 -->
    <div style="margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>PART
I. FINANCIAL INFORMATION</i></b></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM 1.</b></span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CONDENSED
                                            CONSOLIDATED FINANCIAL STATEMENTS.</b></span></td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><img src="image_001.jpg" alt="" style="height: 79px; width: 236px" /></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ALR
TECHNOLOGIES INC.</b></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Condensed
Consolidated Financial Statements</b></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>June&#160;30,
2022 and 2021 </b></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(unaudited)</b></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top; background-color: #CCCCCC">
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: 12pt Times New Roman, Times, Serif; width: 84%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>Index</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: 12pt Times New Roman, Times, Serif; width: 16%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>Page</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="font: 12pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&#160;</span></td>
    <td style="font: 12pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&#160;</span></td></tr>
  <tr style="vertical-align: top">
    <td style="font: 12pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">Condensed
    Consolidated Balance Sheets</span></td>
    <td style="font: 12pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">4</span></td></tr>
  <tr style="vertical-align: top">
    <td style="font: 12pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&#160;</span></td>
    <td style="font: 12pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&#160;</span></td></tr>
  <tr style="vertical-align: top">
    <td style="font: 12pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">Condensed
    Consolidated Statements of Operations</span></td>
    <td style="font: 12pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">5</span></td></tr>
  <tr style="vertical-align: top">
    <td style="font: 12pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&#160;</span></td>
    <td style="font: 12pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&#160;</span></td></tr>
  <tr style="vertical-align: top">
    <td style="font: 12pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">Condensed
    Consolidated Statements of Cash Flows</span></td>
    <td style="font: 12pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">6</span></td></tr>
  <tr style="vertical-align: top">
    <td style="font: 12pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&#160;</span></td>
    <td style="font: 12pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">&#160;</span></td></tr>
  <tr style="vertical-align: top">
    <td style="font: 12pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">Notes
    to Condensed Consolidated Financial Statements</span></td>
    <td style="font: 12pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7
    &#8211; 25</span></td></tr>
  </table>
<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 3 -->
    <div style="margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ALR
TECHNOLOGIES INC.</b></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Condensed
Consolidated Balance Sheets</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">($
United States)</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_300_111_zfRRSr8PKcRc" summary="xdx: Statement - Condensed Consolidated Balance Sheets (Unaudited)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-size: 12pt; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" id="xdx_49C_20220630_zMuRjGEuJCnb" style="border-bottom: Black 1pt solid; font-size: 12pt; text-align: center"><p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>June 30,</b></span></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2022</b></span></p></td><td style="font-size: 12pt; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" id="xdx_49B_20211231_zI0aXRdgZtc1" style="border-bottom: Black 1pt solid; font-size: 12pt; text-align: center"><p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31,</b></span></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2021</b></span></p></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -7.6pt; padding-left: 7.6pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Unaudited)</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--AssetsAbstract_iB_zml9kNx4r2qk" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-indent: -7.6pt; padding-left: 7.6pt">Assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--AssetsCurrentAbstract_iB_zDZm1BI4Awoc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -7.6pt; padding-left: 7.6pt">Current assets:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--Cash_i01I_maCzVFV_zuo5LxMkM2Ye" style="vertical-align: bottom; background-color: White">
    <td style="width: 56%; text-indent: -7.6pt; padding-left: 7.6pt">Cash</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:Cash" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">8,996</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:Cash" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">115,922</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--PrepaidExpenseCurrent_i01I_maCzVFV_zn4SsGMvIwuk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: -7.6pt; padding-left: 7.6pt">Prepaid expenses</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:PrepaidExpenseCurrent" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">87,331</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:PrepaidExpenseCurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">77,295</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--Assets_i01TI_mtCzVFV_z73fzBsUNJVe" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: -7.6pt; padding-left: 7.6pt">Total assets</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">96,327</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">193,217</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -7.6pt; padding-left: 7.6pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--LiabilitiesAndStockholdersEquityAbstract_iB" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; text-indent: -7.6pt; padding-left: 7.6pt">Liabilities and Stockholders&#8217; Deficit</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--LiabilitiesCurrentAbstract_iB_zQsUeOKGuiye" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -7.6pt; padding-left: 7.6pt">Current liabilities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--AccountsPayableAndAccruedLiabilitiesCurrent_i01I_maCzHyF_zthzBB2apCq2" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -7.6pt; padding-left: 7.6pt">Accounts payable and accrued liabilities</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,330,196</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,130,546</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_ecustom--PromissoryNotesPayableToRelatedParties_i01I_maCzHyF_z7UcCF5NDj1a" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -7.6pt; padding-left: 7.6pt">Promissory notes payable to related parties</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ALRT:PromissoryNotesPayableToRelatedParties" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,091,966</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ALRT:PromissoryNotesPayableToRelatedParties" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,041,966</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_ecustom--PromissoryNotesPayableUnrelatedLender_i01I_maCzHyF_znm6BTALP22g" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -7.6pt; padding-left: 7.6pt">Promissory notes payable to unrelated parties</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ALRT:PromissoryNotesPayableUnrelatedLender" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,457,726</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ALRT:PromissoryNotesPayableUnrelatedLender" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,213,368</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--InterestPayableCurrent_i01I_maCzHyF_zoMY8o5ww5Jh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -7.6pt; padding-left: 7.6pt">Interest payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:InterestPayableCurrent" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,388,068</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:InterestPayableCurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,110,647</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_ecustom--LinesOfCreditFromRelatedParties_i01I_maCzHyF_zrAJJ4KQwPt6" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: -7.6pt; padding-left: 7.6pt">Lines of credit from related parties</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ALRT:LinesOfCreditFromRelatedParties" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">15,087,038</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ALRT:LinesOfCreditFromRelatedParties" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">14,008,833</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--Liabilities_i01TI_mtCzHyF_maCzDHN_zgMejYohGn9a" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: -7.6pt; padding-left: 7.6pt">Total liabilities</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:Liabilities" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">26,354,994</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:Liabilities" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">24,505,360</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -7.6pt; padding-left: 7.6pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--StockholdersEquityAbstract_iB" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; text-indent: -7.6pt; padding-left: 7.6pt">Stockholders&#8217; Deficit</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -7.6pt; padding-left: 7.6pt">Preferred stock:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -7.6pt; padding-left: 7.6pt">Authorized: <span id="xdx_906_eus-gaap--PreferredStockSharesAuthorized_c20220630_pdd" title="Preferred shares, authorized"><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">500,000,000</ix:nonFraction></span> shares of preferred stock (December&#160;31, 2021&#160;&#8211; <span id="xdx_903_eus-gaap--PreferredStockSharesAuthorized_c20211231_pdd" title="Preferred shares, authorized"><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">500,000,000</ix:nonFraction></span>) with a par value of $<span id="xdx_90C_eus-gaap--PreferredStockParOrStatedValuePerShare_c20220630_pdd" title="Preferred shares, par value"><span id="xdx_902_eus-gaap--PreferredStockParOrStatedValuePerShare_c20211231_pdd" title="Preferred shares, par value"><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares"><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.001</ix:nonFraction></ix:nonFraction></span></span> per share</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -7.6pt; padding-left: 7.6pt">Shares issued and outstanding: Nil <span id="xdx_90D_eus-gaap--PreferredStockSharesIssued_c20220630_pdd" title="Preferred shares, issued"><span id="xdx_90E_eus-gaap--PreferredStockSharesOutstanding_c20220630_pdd" title="Preferred shares, outstanding" style="display: none"><ix:nonFraction name="us-gaap:PreferredStockSharesIssued" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">0</ix:nonFraction></ix:nonFraction></span></span> shares of preferred
    stock (December&#160;31, 2021&#160;&#8211; Nil <span id="xdx_908_eus-gaap--PreferredStockSharesIssued_c20211231_pdd" title="Preferred shares, issued"><span id="xdx_90D_eus-gaap--PreferredStockSharesOutstanding_c20211231_pdd" title="Preferred shares, outstanding" style="display: none"><ix:nonFraction name="us-gaap:PreferredStockSharesIssued" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">0</ix:nonFraction></ix:nonFraction></span></span>) were issued and outstanding</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--PreferredStockValue_i01I_pp0p0_maCz89E_c20220630_zAZc5reb23qa" title="Preferred Stock, Value" style="color: White; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0097">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--PreferredStockValue_pp0p0_maCz89E_c20211231_znHTAglMTu0g" title="Preferred Stock, Value" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0099">&#8212;</span>&#160;&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -7.6pt; padding-left: 7.6pt">Common stock:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -7.6pt; padding-left: 7.6pt">Authorized: <span id="xdx_900_eus-gaap--CommonStockSharesAuthorized_c20220630_pdd" title="Common shares, authorized"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">10,000,000,000</ix:nonFraction></span> shares of common stock (December&#160;31, 2021&#160;&#8211; <span id="xdx_90A_eus-gaap--CommonStockSharesAuthorized_c20211231_pdd" title="Common shares, authorized"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">10,000,000,000</ix:nonFraction></span>) with a par value of $<span id="xdx_903_eus-gaap--CommonStockParOrStatedValuePerShare_c20220630_pdd" title="Common shares, par value"><span id="xdx_900_eus-gaap--CommonStockParOrStatedValuePerShare_c20211231_pdd" title="Common shares, par value"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.001</ix:nonFraction></ix:nonFraction></span></span> per share</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -7.6pt; padding-left: 7.6pt">Shares issued and outstanding: <span id="xdx_904_eus-gaap--CommonStockSharesIssued_c20220630_pdd" title="Common shares, Issued"><span id="xdx_90E_eus-gaap--CommonStockSharesOutstanding_c20220630_pdd" title="Common shares, outstanding"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">551,966,844</ix:nonFraction></ix:nonFraction></span></span> shares of common stock (December&#160;31, 2021&#160;&#8211; <span id="xdx_901_eus-gaap--CommonStockSharesIssued_c20211231_pdd" title="Common shares, Issued"><span id="xdx_900_eus-gaap--CommonStockSharesOutstanding_c20211231_pdd" title="Common shares, outstanding"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">542,716,344</ix:nonFraction></ix:nonFraction></span></span>)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--CommonStockValue_i01I_pp0p0_maCz89E_c20220630_z2f9p53mrv2j" title="Common Stock, Value" style="text-align: right"><ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">551,966</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--CommonStockValue_iI_pp0p0_maCz89E_c20211231_zHh2e92v2Awc" title="Common Stock, Value" style="text-align: right"><ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">542,716</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--AdditionalPaidInCapital_i01I_maCz89E_z3itig5NSF0i" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -7.6pt; padding-left: 7.6pt">Additional paid-in capital</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AdditionalPaidInCapital" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">78,103,332</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AdditionalPaidInCapital" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">77,171,627</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--AccumulatedOtherComprehensiveIncomeLossNetOfTax_i01I_pp0p0_maCz89E_z2zjAnpMjhBi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -7.6pt; padding-left: 7.6pt">Accumulated other comprehensive loss&#160;&#8211; cumulative translation differences</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">6,273</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">11,409</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_40C_eus-gaap--RetainedEarningsAccumulatedDeficit_i01I_maCz89E_zI66EzNgQKmf" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: -7.6pt; padding-left: 7.6pt">Accumulated deficit</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">104,907,692</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">102,015,077</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_40A_eus-gaap--StockholdersEquity_iTI_pp0p0_mtCz89E_maCzDHN_zHb01lbs7mza" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: -7.6pt; padding-left: 7.6pt">Total stockholders&#8217; deficit </td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">26,258,667</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">24,312,143</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_40B_eus-gaap--LiabilitiesAndStockholdersEquity_iTI_pp0p0_mtCzDHN_zZQFEHvOWcNb" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: -7.6pt; padding-left: 7.6pt">Total liabilities and stockholders&#8217; deficit</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">96,327</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">193,217</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -7.6pt; padding-left: 7.6pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Basis
of presentation, nature of operations and going concern</b> (note 1)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Subsequent
events</b> (note 11)</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">See
accompanying notes to the condensed consolidated financial statements.</span></p>

<!-- Field: Page; Sequence: 4; Options: NewSection; Value: 4 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ALR
TECHNOLOGIES INC.</b></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Condensed
Consolidated Statements of Operations</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">($
United States)</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Unaudited)</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_301_113_zO0LgbueK4y2" summary="xdx: Statement - Condensed Consolidated Statements of Operations (Unaudited)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -6.25pt; padding-left: 6.25pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_497_20220401__20220630_z0R5nJxC0Us" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_499_20210401__20210630_zH528NoC10p6" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_49D_20220101__20220630_zd8mOtMOGcvl" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_499_20210101__20210630_zjek7VXHe6U1" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-size: 12pt">&#160;</td>
    <td colspan="7" style="font-size: 12pt; text-align: center"><p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Three Months Ended</b></span></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>June 30,</b></span></p></td><td style="font-size: 12pt">&#160;</td>
    <td colspan="7" style="font-size: 12pt; text-align: center"><p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Six Months Ended</b></span></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>June 30,</b></span></p></td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="3" style="text-align: right">&#160;</td><td>&#160;</td>
    <td colspan="3" style="text-align: right">&#160;</td><td>&#160;</td>
    <td colspan="3" style="text-align: right">&#160;</td><td>&#160;</td>
    <td colspan="3" style="text-align: right">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--Revenues_maCzDLj_ze15rZwg195c" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%; font-weight: bold; text-indent: -6.25pt; padding-left: 6.25pt">Revenue</td><td style="width: 3%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2022-04-012022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">980</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 3%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0137">&#8212;</span>&#160;&#160;</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 3%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2022-01-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,023</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 3%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0139">&#8212;</span>&#160;&#160;</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--CostOfRevenue_iN_di_msCzDLj_zqq34lgSn6Xh" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; padding-bottom: 1pt; text-indent: -6.25pt; padding-left: 6.25pt">Cost of revenue</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:CostOfRevenue" contextRef="From2022-04-012022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">444</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0142">&#8212;</span>&#160;&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:CostOfRevenue" contextRef="From2022-01-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,038</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0144">&#8212;</span>&#160;&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--GrossProfit_iT_mtCzDLj_maCz4DC_z3uusGBhtTK2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1pt; text-indent: -6.25pt; padding-left: 6.25pt">Gross margin</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:GrossProfit" contextRef="From2022-04-012022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">536</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0147">&#8212;</span>&#160;&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:GrossProfit" contextRef="From2022-01-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">985</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0149">&#8212;</span>&#160;&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -6.25pt; padding-left: 6.25pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--OperatingExpensesAbstract_iB_zJvIDDzp7rbd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; text-indent: -6.25pt; padding-left: 6.25pt">Operating Expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--ResearchAndDevelopmentExpense_i01_msCzKZl_zoEB1UVrPp48" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -7.6pt; padding-left: 17.05pt">Product development costs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ResearchAndDevelopmentExpense" contextRef="From2022-04-012022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">121,551</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ResearchAndDevelopmentExpense" contextRef="From2021-04-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">128,157</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ResearchAndDevelopmentExpense" contextRef="From2022-01-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">249,771</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ResearchAndDevelopmentExpense" contextRef="From2021-01-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">240,199</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--ProfessionalFees_i01_msCzKZl_zgkGc04foIod" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -7.6pt; padding-left: 17.05pt">Professional fees</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProfessionalFees" contextRef="From2022-04-012022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">352,943</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProfessionalFees" contextRef="From2021-04-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">138,890</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProfessionalFees" contextRef="From2022-01-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">524,560</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProfessionalFees" contextRef="From2021-01-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">356,118</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--SellingGeneralAndAdministrativeExpense_i01_msCzKZl_zyxWq7fqq5b9" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: -7.6pt; padding-left: 17.05pt">Selling, general and administrative expenses</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:SellingGeneralAndAdministrativeExpense" contextRef="From2022-04-012022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">454,680</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:SellingGeneralAndAdministrativeExpense" contextRef="From2021-04-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">215,466</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:SellingGeneralAndAdministrativeExpense" contextRef="From2022-01-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,009,505</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:SellingGeneralAndAdministrativeExpense" contextRef="From2021-01-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">423,752</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--OperatingIncomeLoss_i01NT_di_mtCzKZl_maCz4DC_zTVxATZCHLic" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1pt; text-indent: -6.25pt; padding-left: 6.25pt">Operating Loss</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:OperatingIncomeLoss" contextRef="From2022-04-012022-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">929,174</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:OperatingIncomeLoss" contextRef="From2021-04-012021-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">482,513</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:OperatingIncomeLoss" contextRef="From2022-01-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,783,836</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:OperatingIncomeLoss" contextRef="From2021-01-012021-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,020,069</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -6.25pt; padding-left: 6.25pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_i01T_mtCz4DC_maCzLG6_zxpBaKvURzq2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1pt; text-indent: -6.25pt; padding-left: 6.25pt">Loss before other items</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="From2022-04-012022-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">928,638</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="From2021-04-012021-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">482,513</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="From2022-01-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,782,851</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="From2021-01-012021-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,020,069</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -6.25pt; padding-left: 6.25pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--NonoperatingIncomeExpenseAbstract_iB_zJD2DUjbK2jb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; text-indent: -6.25pt; padding-left: 6.25pt">Other Items</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--InterestExpense_i01N_di_msCzoWm_zTeRYDZUjVib" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -7.6pt; padding-left: 17.05pt">Interest expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:InterestExpense" contextRef="From2022-04-012022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">559,128</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:InterestExpense" contextRef="From2021-04-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,804,403</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:InterestExpense" contextRef="From2022-01-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,109,764</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:InterestExpense" contextRef="From2021-01-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,283,770</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_409_eus-gaap--GainsLossesOnExtinguishmentOfDebt_i01_maCzoWm_zJTVSmi0xIv7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: -7.6pt; padding-left: 17.05pt">Loss on settlement of debt</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0191">&#8212;</span>&#160;&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:GainsLossesOnExtinguishmentOfDebt" contextRef="From2021-04-012021-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">33,614</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0193">&#8212;</span>&#160;&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:GainsLossesOnExtinguishmentOfDebt" contextRef="From2021-01-012021-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">33,614</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_409_eus-gaap--NonoperatingIncomeExpense_i01T_mtCzoWm_maCzLG6_z0fwo1qHjSY6" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1pt; text-indent: -6.25pt; padding-left: 6.25pt">Total Other Items</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NonoperatingIncomeExpense" contextRef="From2022-04-012022-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">559,128</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NonoperatingIncomeExpense" contextRef="From2021-04-012021-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,838,017</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NonoperatingIncomeExpense" contextRef="From2022-01-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,109,764</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NonoperatingIncomeExpense" contextRef="From2021-01-012021-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">2,317,384</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -6.25pt; padding-left: 6.25pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--NetIncomeLoss_i01T_mtCzLG6_maCzC5y_zFGYpN4INhef" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; text-indent: -6.25pt; padding-left: 6.25pt">Net Loss</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-04-012022-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,487,766</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-04-012021-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">2,320,530</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-01-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">2,892,615</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-01-012021-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">3,337,453</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -7.6pt; padding-left: 7.6pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--OtherComprehensiveIncomeLossNetOfTaxAttributableToParentAbstract_iB_z5HPSBDXEJK1" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; text-indent: -6.25pt; padding-left: 6.25pt">Other comprehensive loss</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax_i01N_di_msCzC5y_zIzozX3WPJxi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: -7.6pt; padding-left: 17.05pt">Exchange difference on translating foreign operations</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax" contextRef="From2022-04-012022-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">6,067</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0212">&#8212;</span>&#160;&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax" contextRef="From2022-01-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">5,136</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0214">&#8212;</span>&#160;&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -6.25pt; padding-left: 6.25pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--ComprehensiveIncomeNetOfTax_iT_mtCzC5y_zI43Ke6YU8pg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1pt; text-indent: -6.25pt; padding-left: 6.25pt">Comprehensive loss for the period</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:ComprehensiveIncomeNetOfTax" contextRef="From2022-04-012022-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,481,699</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:ComprehensiveIncomeNetOfTax" contextRef="From2021-04-012021-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">2,320,530</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:ComprehensiveIncomeNetOfTax" contextRef="From2022-01-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">2,887,479</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:ComprehensiveIncomeNetOfTax" contextRef="From2021-01-012021-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">3,337,453</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -6.25pt; padding-left: 6.25pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_408_ecustom--WeightedAverageNumberOfSharesOfCommonStockOutstandingBasicAndDiluted_znUvZpf1wCmd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1pt; text-indent: -7.6pt; padding-left: 7.6pt">Weighted average number of shares of common stock outstanding, basic and diluted</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ALRT:WeightedAverageNumberOfSharesOfCommonStockOutstandingBasicAndDiluted" contextRef="From2022-04-012022-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">545,491,844</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ALRT:WeightedAverageNumberOfSharesOfCommonStockOutstandingBasicAndDiluted" contextRef="From2021-04-012021-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">532,676,344</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ALRT:WeightedAverageNumberOfSharesOfCommonStockOutstandingBasicAndDiluted" contextRef="From2022-01-01to2022-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">544,104,125</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ALRT:WeightedAverageNumberOfSharesOfCommonStockOutstandingBasicAndDiluted" contextRef="From2021-01-012021-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">527,072,440</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -7.6pt; padding-left: 7.6pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_ecustom--LossPerShareBasicAndDiluted_z1JUkQ7ZsBr4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1pt; text-indent: -7.6pt; padding-left: 7.6pt">Loss per share, basic and diluted</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="ALRT:LossPerShareBasicAndDiluted" contextRef="From2022-04-012022-06-30" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">0.00</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="ALRT:LossPerShareBasicAndDiluted" contextRef="From2021-04-012021-06-30" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">0.00</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="ALRT:LossPerShareBasicAndDiluted" contextRef="From2022-01-01to2022-06-30" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">0.01</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="ALRT:LossPerShareBasicAndDiluted" contextRef="From2021-01-012021-06-30" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">0.01</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -7.6pt; padding-left: 7.6pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  </table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">See
accompanying notes to the condensed consolidated financial statements.</span></p>


<!-- Field: Page; Sequence: 5 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ALR
TECHNOLOGIES INC.</b></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Condensed
Consolidated Statements of Cash Flows</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">($
United States)</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Unaudited)</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_30C_112_zQVd6yukeix3" summary="xdx: Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -7.6pt; padding-left: 17.05pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_498_20220101__20220630_zzE6zR5WIuHg" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_492_20210101__20210630_zy8NtfgEFa3g" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-size: 12pt">&#160;</td>
    <td colspan="7" style="font-size: 12pt; text-align: center"><p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Six Months Ended</b></span></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>June&#160;30,</b></span></p></td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="3" style="text-align: right">&#160;</td><td>&#160;</td>
    <td colspan="3" style="text-align: right">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--NetCashProvidedByUsedInOperatingActivitiesAbstract_iB_zyLNp5uAczhe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; text-indent: -7.6pt; padding-left: 7.6pt">OPERATING ACTIVITIES</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_i01N_di_msCzcqa_zEyW9I10qvdg" style="vertical-align: bottom; background-color: White">
    <td style="width: 56%; text-align: left; text-indent: -7.6pt; padding-left: 7.6pt">Net loss</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" contextRef="From2022-01-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,892,615</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" contextRef="From2021-01-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,337,453</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td></tr>
  <tr id="xdx_403_ecustom--StockbasedCompensationproductDevelopmentCosts_i01N_di_msCzcqa_z5PXUB6rNrkl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -7.6pt; padding-left: 17.05pt">Stock-based compensation-product development costs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ALRT:StockbasedCompensationproductDevelopmentCosts" contextRef="From2022-01-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">118,586</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ALRT:StockbasedCompensationproductDevelopmentCosts" contextRef="From2021-01-012021-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">97,842</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_ecustom--StockbasedCompensationgeneralSellingAndAdministration_i01_maCzcqa_zFMq1XUL34pk" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -7.6pt; padding-left: 17.05pt">Stock-based compensation-selling, general and administrative</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ALRT:StockbasedCompensationgeneralSellingAndAdministration" contextRef="From2022-01-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">382,157</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0241">&#8212;</span>&#160;&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_ecustom--StockbasedCompensationProfessionalFees_i01_maCzcqa_zmQGJhbR1h5d" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -7.6pt; padding-left: 17.05pt">Stock-based compensation-professional fees</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ALRT:StockbasedCompensationProfessionalFees" contextRef="From2022-01-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">17,916</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ALRT:StockbasedCompensationProfessionalFees" contextRef="From2021-01-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">43,295</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_ecustom--StockbasedCompensationinterest_i01_maCzcqa_zMU2NOnm2Jdf" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -7.6pt; padding-left: 17.05pt">Stock-based compensation-interest</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0246">&#8212;</span>&#160;&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ALRT:StockbasedCompensationinterest" contextRef="From2021-01-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,287,834</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_ecustom--InterestExpenseOnLinesOfCredit_i01_maCzcqa_zwzAExHJ9NQa" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -7.6pt; padding-left: 17.05pt">Interest expense on lines of credit</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ALRT:InterestExpenseOnLinesOfCredit" contextRef="From2022-01-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">777,515</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ALRT:InterestExpenseOnLinesOfCredit" contextRef="From2021-01-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">670,452</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_ecustom--NoncashImputedInterestExpenses_i01_pp0p0_maCzcqa_zsL6GIQn2Wu6" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -7.6pt; padding-left: 17.05pt">Non-cash imputed interest expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ALRT:NoncashImputedInterestExpenses" contextRef="From2022-01-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">52,271</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ALRT:NoncashImputedInterestExpenses" contextRef="From2021-01-012021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">60,059</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_ecustom--BonusesSettledByIssuanceOfShares_i01_pp0p0_maCzcqa_zhgLDKXOuLsi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -7.6pt; padding-left: 17.05pt">Bonuses settled by issuance of shares</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ALRT:BonusesSettledByIssuanceOfShares" contextRef="From2022-01-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">245,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0256">&#8212;</span>&#160;&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_ecustom--LossOnSettlementOfDebt_i01N_pp0p0_di_msCzcqa_zm5BrrHm4mJk" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -7.6pt; padding-left: 17.05pt">Loss on settlement of debt</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0258">&#8212;</span>&#160;&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ALRT:LossOnSettlementOfDebt" contextRef="From2021-01-012021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">33,614</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--IncreaseDecreaseInOperatingCapitalAbstract_i01B" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -7.6pt; padding-left: 7.6pt">Changes in operating assets and liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--IncreaseDecreaseInPrepaidExpense_i01N_di_msCzcqa_zn8J9ZQkmOM7" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -7.6pt; padding-left: 17.05pt">Decrease (increase) in prepaid expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInPrepaidExpense" contextRef="From2022-01-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">10,036</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInPrepaidExpense" contextRef="From2021-01-012021-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">5,103</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_i01_maCzcqa_z3qf0P84UHo5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -7.6pt; padding-left: 17.05pt">Increase in accounts payable and accrued liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" contextRef="From2022-01-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">324,650</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" contextRef="From2021-01-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">17,736</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--IncreaseDecreaseInInterestPayableNet_i01_maCzcqa_zbR2OUQF1tS7" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: -7.6pt; padding-left: 17.05pt">Increase in interest payable</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInInterestPayableNet" contextRef="From2022-01-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">277,421</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInInterestPayableNet" contextRef="From2021-01-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">264,100</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -7.6pt; padding-left: 7.6pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--NetCashProvidedByUsedInOperatingActivities_i01T_mtCzcqa_maCzMfS_zhFzSmrWi3wl" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: -7.6pt; padding-left: 7.6pt">Net cash used in operating activities</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="From2022-01-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">707,135</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="From2021-01-012021-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">857,418</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -7.6pt; padding-left: 7.6pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--NetCashProvidedByUsedInFinancingActivitiesAbstract_iB_zdUcy4TiMpzk" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; text-indent: -7.6pt; padding-left: 7.6pt">FINANCING ACTIVITIES</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--ProceedsFromLinesOfCredit_i01_maCztoz_zDd9tO2GP0pi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -7.6pt; padding-left: 7.6pt">Proceeds from lines of credit</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromLinesOfCredit" contextRef="From2022-01-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">438,165</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromLinesOfCredit" contextRef="From2021-01-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">401,758</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--ProceedsFromConvertibleDebt_i01_maCztoz_zcMniXpr7wej" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -7.6pt; padding-left: 7.6pt">Proceeds from promissory notes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromConvertibleDebt" contextRef="From2022-01-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">294,358</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0283">&#8212;</span>&#160;&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_ecustom--RepaymentOfLinesOfCreditInterest_i01N_di_msCztoz_zEEtuZZJRDF" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -7.6pt; padding-left: 7.6pt">Repayment of lines of credit interest</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="ALRT:RepaymentOfLinesOfCreditInterest" contextRef="From2022-01-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">137,475</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="ALRT:RepaymentOfLinesOfCreditInterest" contextRef="From2021-01-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">370,723</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_401_eus-gaap--ProceedsFromIssuanceOfCommonStock_i01_maCztoz_z0uXNNzDg4P6" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: -7.6pt; padding-left: 7.6pt">Proceeds from sales of shares of common stock</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfCommonStock" contextRef="From2022-01-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">25</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfCommonStock" contextRef="From2021-01-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,136,832</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -7.6pt; padding-left: 7.6pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--NetCashProvidedByUsedInFinancingActivities_i01T_mtCztoz_maCzMfS_zakLIN6EPEE7" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: -7.6pt; padding-left: 7.6pt">Net cash provided by financing activities</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="From2022-01-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">595,073</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="From2021-01-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,167,867</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -7.6pt; padding-left: 7.6pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_i01_maCzMfS_zei8fPb5jBaa" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: -7.6pt; padding-left: 7.6pt">Effect of foreign exchange on cash</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="From2022-01-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,136</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0295">&#8212;</span>&#160;&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -7.6pt; padding-left: 7.6pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_i01T_mtCzMfS_zC2VxPDhITj5" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -7.6pt; padding-left: 7.6pt">Change in cash</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" contextRef="From2022-01-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">106,926</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" contextRef="From2021-01-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">310,449</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_i01S_zXaysTR7z7S2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt; text-indent: -7.6pt; padding-left: 7.6pt">Cash, beginning of period</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">115,922</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">66,190</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_i01E_zw83vXd6mQpa" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt; text-indent: -7.6pt; padding-left: 7.6pt">Cash, end of period</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">8,996</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">376,639</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">See
accompanying notes to the condensed consolidated financial statements.</span></p>


<!-- Field: Page; Sequence: 6 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ALR
TECHNOLOGIES INC.</b></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notes
to Condensed Consolidated Financial Statements</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the Six Months Ended June&#160;30, 2022</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">($
United States)</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Unaudited)</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2022-01-01to2022-06-30" escape="true" name="us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock"><p id="xdx_80D_eus-gaap--BusinessDescriptionAndBasisOfPresentationTextBlock_zSW4x2kpNIM3" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>1.&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span id="xdx_827_zpX6MzaLLNo3">Basis
of presentation, nature of operations and going concern</span></b></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ALR
Technologies Inc. (the &#8220;<b>Company</b>&#8221;) was incorporated under the laws of the state of Nevada on March&#160;24, 1987. On
May&#160;16, 2020, the Company incorporated a wholly owned subsidiary, ALR Technologies Sg Pte. Ltd. (&#8220;<b>ALR Singapore</b>&#8221;),
under the <i>Companies Act</i> of Singapore. On June&#160;9, 2021, the Company incorporated a wholly owned subsidiary, Canada Diabetes
Solution Centre, Inc., under the <i>Business Corporations Act </i>of Alberta.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
May 17, 2022, the Company entered into an Agreement and Plan of Merger and Reorganization (the &#8220;<b>Redomicile Merger Agreement</b>&#8221;)
with ALR Technologies SG Pte. Ltd., a Singapore company limited by shares, and its wholly-owned subsidiary, ALRT Delaware, Inc., a Delaware
corporation (&#8220;<b>ALR Delaware</b>&#8221;), relating to a proposed merger transaction for the sole purpose of changing the Company&#8217;s
jurisdiction of incorporation from Nevada to Singapore. The Redomicile Merger Agreement provides that, upon the terms and subject to
the conditions set forth therein, ALR Delaware will merge with and into the Company (the &#8220;<b>Redomicile Merger</b>&#8221;), and
the Company will be the surviving entity and a wholly-owned subsidiary of ALR Singapore. ALR Delaware will cease to exist. At the closing
of the Redomicile Merger, the stockholders of the Company will exchange their shares of common stock, and any options or warrants to
purchase shares of common stock which they might hold, on a one-for-one basis, for ordinary shares (&#8220;<b>ALR Singapore Ordinary
Shares</b>&#8221;) and options or warrants to subscribe for ALR Singapore Ordinary Shares, as applicable. This Agreement contains customary
closing conditions, including, among others, approval of the Redomicile Merger by the Company&#8217;s stockholders, the effectiveness
of the registration statement on Form F-4 filed by ALR Singapore related to the Redomicile Merger, and receipt of required regulatory
approvals.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has developed its &#8220;<b>Diabetes Solution</b>&#8221;, which is a comprehensive approach to diabetes care consisting of data
collection, predictive A1C, insulin dosage adjustment suggestions, performance tracking, remote monitoring and diabetes test supplies.
The Company is seeking commercial opportunities to deploy the Diabetes Solution and GluCurve Pet CGM.</span></p>

<p style="font: 11pt/12pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt/12pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles
in the United States of America (&#8220;<b>U.S. GAAP</b>&#8221;) in U.S. dollars and on a going concern basis, which presumes the realization
of assets and the discharge of liabilities and commitments in the normal course of operations for the foreseeable future. Several adverse
conditions cast substantial doubt on the validity of this assumption. The Company has incurred significant losses over the six-month
periods ended June&#160;30, 2022 and 2021 of $<span id="xdx_907_eus-gaap--ProfitLoss_iN_pp0p0_di_c20220101__20220630_zsqT71PrnD37" title="Net loss"><ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2022-01-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">2,892,615</ix:nonFraction></span> and $<span id="xdx_90A_eus-gaap--ProfitLoss_iN_pp0p0_di_c20210101__20210630_zUBZpjQFoi4j" title="Net loss"><ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2021-01-012021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">3,337,453</ix:nonFraction></span>, respectively. As of June&#160;30, 2022, the Company is unable
to self-finance its operations, has a working capital deficit of $<span id="xdx_908_ecustom--WorkingCapitalDeficit_c20220630_pp0p0" title="Working capital deficit"><ix:nonFraction name="ALRT:WorkingCapitalDeficit" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">26,258,667</ix:nonFraction></span> (December&#160;31, 2021&#160;- $<span id="xdx_905_ecustom--WorkingCapitalDeficit_c20211231_pp0p0" title="Working capital deficit"><ix:nonFraction name="ALRT:WorkingCapitalDeficit" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">24,312,143</ix:nonFraction></span>), accumulated
deficit of $<span id="xdx_901_eus-gaap--RetainedEarningsAccumulatedDeficit_iNI_pp0p0_di_c20220630_zoR93beFpJL1" title="Accumulated deficit"><ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">104,907,692</ix:nonFraction></span> (December&#160;31, 2021&#160;- $<span id="xdx_908_eus-gaap--RetainedEarningsAccumulatedDeficit_iNI_pp0p0_di_c20211231_zuDMIrhN9v23" title="Accumulated deficit"><ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">102,015,077</ix:nonFraction></span>), limited resources, no source of operating cash flow and no assurance
that sufficient funding will be available to conduct continued product development activities. If the Company is able to finance its
required product development activities, there is no assurance the Company&#8217;s current projects will be commercially viable or profitable.
The Company has debts comprised of accounts payable and accrued liabilities, interest payable, lines of credit and promissory notes payable
totaling $26,354,994 currently due, due on demand or considered delinquent. There is no assurance that the Company will not face additional
legal action from creditors regarding delinquent accounts payable, promissory notes payable and interest payable. Any one or a combination
of these above conditions could result in the failure of the business and cause the Company to cease operations.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 7 -->
    <div id="xdx_235_zJYVxtK36Dw9" style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" id="xdx_23F_zao1WjrkoBw8" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div id="xdx_230_zYAEMMDeN5u4" style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p id="xdx_235_zDF9hLiHAOpk" style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_238_zAJ3tkI0PKq1" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ALR
TECHNOLOGIES INC.</b></span></p></ix:exclude>

<ix:exclude><p id="xdx_23D_zZxbXUMc9rkg" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notes
to Condensed Consolidated Financial Statements</span></p></ix:exclude>

<ix:exclude><p id="xdx_23E_zmG3at6oD7Eg" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the Six Months Ended June&#160;30, 2022</span></p></ix:exclude>

<ix:exclude><p id="xdx_23D_zi2wZehDUEud" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">($
United States)</span></p></ix:exclude>

<ix:exclude><p id="xdx_232_zVrB8zaZc7Af" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Unaudited)</span></p></ix:exclude>

<ix:exclude><p id="xdx_232_zgOJNJJwAUl1" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_231_zrNlIYw4LmXg" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_230_zhBso7h3Cp4b" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>1.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Basis
of presentation, nature of operations and going concern (continued)</b></span></p></ix:exclude>

<ix:exclude><p id="xdx_235_zMU2r3GtHjvf" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:exclude>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s ability to continue as a going concern is dependent upon the continued financial support of its creditors and its ability
to obtain financing to fund working capital and overhead requirements, fund the development of the Company&#8217;s product line, and
ultimately, the Company&#8217;s ability to achieve profitable operations and repay overdue obligations. Management has obtained short-term
financing from related parties through line of credit facilities with available borrowing in principal up to $14,300,000. As of June&#160;30,
2022, the total principal balance outstanding was $<span id="xdx_900_ecustom--PrincipalBorrowed_c20220630_pp0p0" title="Principal Borrowed"><ix:nonFraction name="ALRT:PrincipalBorrowed" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">13,126,570</ix:nonFraction></span>. The resolution of whether the Company is able to continue as a going concern
is dependent upon the realization of management&#8217;s plans. There can be no assurance that the Company will be able to raise any additional
debt or equity capital from the sources described above or that the lenders in the line of credit arrangements will maintain the availability
of borrowing from the line. If management is unsuccessful in obtaining short-term financing or achieving long-term profitable operations,
the Company will be required to cease operations.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
March 2020, the World Health Organization declared coronavirus, COVID-19, a global pandemic. This contagious disease outbreak, which
has continued to spread, and any related adverse public health developments, has adversely affected workforces, economies and financial
markets globally, potentially leading to an economic downturn. Management does not expect that COVID-19 will have a significant impact
on the Company; however, it could have a potential impact on the Company&#8217;s ability to raise money, market its products to attract
customers or procure equipment and parts for its glucose monitoring system.</span></p>

<p style="font: 11pt/12pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt/12pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
of the Company&#8217;s debt is either due on demand or is in default, while continuing to accrue interest at its stated rate. The Company
will seek to obtain creditors&#8217; consents to delay repayment of the outstanding promissory notes payable and related interest thereto,
until it is able to replace this financing with funds generated by operations, recapitalization with replacement debt or from equity
financings through private placements. While some of the Company&#8217;s creditors have agreed to extend repayment deadlines in the past,
there is no assurance that they will continue to do so in the future. In the past, creditors have successfully commenced legal action
against the Company to recover debts outstanding. In those instances, the Company was able to obtain financing from related parties to
cover the verdict or settlement; however, there is no assurance that the Company would be able to obtain the same financing in the future.
If the Company is unsuccessful in obtaining financing to cover any potential verdicts or settlements, the Company will be required to
cease operations.</span></p>

<p style="font: 11pt/12pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s activities will necessitate significant uses of working capital beyond 2022. Additionally, the Company&#8217;s capital
requirements will depend on many factors, including the success of the Company&#8217;s continued product development and distribution
efforts. The Company plans to continue financing its operations with the lines of credit it has available and other sources of financing.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-01to2022-06-30" escape="true" name="us-gaap:SignificantAccountingPoliciesTextBlock"><p id="xdx_80C_eus-gaap--SignificantAccountingPoliciesTextBlock_zyJxA7JjDiDk" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2.&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span id="xdx_82C_zu1sAKqAVhmh">Significant
accounting policies</span></b></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
unaudited condensed consolidated financial statements include the accounts of the Company and its wholly owned subsidiary, ALR Singapore,
which was incorporated on May&#160;16, 2020 in Singapore, and Canada Diabetes Solution Centre, Inc., which was incorporated on June&#160;9,
2021 in Alberta, Canada. The Canadian subsidiary is currently inactive. All significant intercompany balances and transactions have been
eliminated on consolidation.</span></p>


<ix:exclude><!-- Field: Page; Sequence: 8 -->
    <div id="xdx_23E_zj4ThZcDixI7" style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" id="xdx_23C_zlgUBfPhtlAk" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div id="xdx_231_zrc4k2A1uL7j" style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p id="xdx_234_z3qtcUVJq28g" style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_230_zHNjP8V6yx16" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ALR
TECHNOLOGIES INC.</b></span></p></ix:exclude>

<ix:exclude><p id="xdx_233_zdR2zpxPrJf7" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notes
to Condensed Consolidated Financial Statements</span></p></ix:exclude>

<ix:exclude><p id="xdx_23B_z61hLg4MUVl8" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the Six Months Ended June&#160;30, 2022</span></p></ix:exclude>

<ix:exclude><p id="xdx_232_zf6QzztMXGsj" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">($
United States)</span></p></ix:exclude>

<ix:exclude><p id="xdx_23C_z3YhIrAgWjoh" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Unaudited)</span></p></ix:exclude>

<ix:exclude><p id="xdx_23D_zdlSB8EYMktc" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_23E_zRLPQj0Pi2Hk" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_230_zWNmfR96Lv8e" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Significant
accounting policies (continued)</b></span></p></ix:exclude>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
unaudited condensed consolidated financial statements as of June&#160;30, 2022 and for the period then ended have been prepared pursuant
to the rules and regulations of the Securities and Exchange Commission. Certain information and note disclosures normally included in
annual consolidated financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to those rules
and regulations, although the Company believes that the disclosures made are adequate to make the information not misleading.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the opinion of management, all adjustments necessary to present fairly the financial position as of June&#160;30, 2022 and December&#160;31,
2021 and the results of operations and cash flows as of June&#160;30, 2022 and 2021, and for the periods then ended, have been made.
Those adjustments consist of normal and recurring adjustments.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
unaudited condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes
thereto included in the Annual Report on Form 10-K for the fiscal year ended December&#160;31, 2021.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
results of operations for the six months ended June&#160;30, 2022 are not necessarily indicative of the results to be expected for the
full year.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-01to2022-06-30" escape="true" name="us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock"><p id="xdx_80C_eus-gaap--AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_zZ4oF8qnvL1h" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>3.&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span id="xdx_82E_zGWscJVie4F9">Accounts
payable and accrued liabilities</span></b></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
summary of the accounts payable and accrued liabilities is as follows:</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2022-01-01to2022-06-30" escape="true" name="us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_882_eus-gaap--ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_zIAYmb31SlCl" summary="xdx: Disclosure - Accounts payable and accrued liabilities (Details)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -6.25pt; padding-left: 6.25pt"><span id="xdx_8B3_zMgg2L6UhlIa" style="display: none">Schedule of accounts payable and accrued liabilities</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_49A_20220630_zQWFngjJz4U" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_49A_20211231_zCItUCjUFYCb" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>June 30,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2022</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2021</b></span></p></td></tr>
  <tr id="xdx_407_eus-gaap--AccountsPayableCurrent_iI_pp0p0_maAPAALzyUX_zMouvasbIQD6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; text-align: left; text-indent: -6.25pt; padding-left: 6.25pt">Accounts payable</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:AccountsPayableCurrent" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,074,813</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:AccountsPayableCurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">806,059</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--AccruedLiabilitiesCurrent_iI_pp0p0_maAPAALzyUX_zwThB4GEHg7l" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -6.25pt; padding-left: 6.25pt">Accrued liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccruedLiabilitiesCurrent" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">255,039</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccruedLiabilitiesCurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">322,087</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--DeferredRevenueCurrent_iI_pp0p0_maAPAALzyUX_z6HUqeJsjan9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: -6.25pt; padding-left: 6.25pt">Deferred revenue</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:DeferredRevenueCurrent" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">344</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:DeferredRevenueCurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,400</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--AccountsPayableAndAccruedLiabilitiesCurrent_iTI_pp0p0_mtAPAALzyUX_zqkcBR7wzwS1" style="vertical-align: bottom; background-color: White">
    <td style="color: White; padding-bottom: 1pt; text-indent: -6.25pt; padding-left: 6.25pt">Accounts payable and accrued liabilities</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,330,196</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,130,546</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  </table></ix:nonNumeric>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-01to2022-06-30" escape="true" name="ALRT:InterestAdvancesAndPromissoryNotesPayableTextBlock"><p id="xdx_800_ecustom--InterestAdvancesAndPromissoryNotesPayableTextBlock_zUYaTr9Iwxv2" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>4.
&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span id="xdx_824_z1Vnv4uahTTl">Interest, advances and promissory notes payable</span></b></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;Promissory
notes payable to related parties</span></p>

<p style="font: 11pt/12pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt/12pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
summary of activities of promissory notes payable to related parties is as follows:</span></p>

<p style="font: 11pt/12pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2022-01-01to2022-06-30" escape="true" name="ALRT:SummaryOfActivitiesOfPromissoryNotesPayableTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_89A_ecustom--SummaryOfActivitiesOfPromissoryNotesPayableTableTextBlock_z0bGHDOg43o5" summary="xdx: Disclosure - Interest, advances and promissory notes payable (Details)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -7.6pt; padding-left: 17.05pt"><span id="xdx_8BF_zx6hRVjkN568" style="display: none">Summary of activities of promissory notes payable</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td title="Transferred from promissory notes payable pursuant to private transaction" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: -7.6pt; padding-left: 17.05pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold">Promissory Notes Payable to Related Parties</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Carrying Value</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 70%; text-indent: -6.25pt; padding-left: 6.25pt">Balance, December&#160;31, 2020</td><td style="width: 10%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--NotesPayableRelatedPartiesClassifiedCurrent_iS_pp0p0_c20210101__20211231__us-gaap--DebtInstrumentAxis__custom--RelatedPartyMember_zhNUeKEsqmka" title="Carrying value at beginning" style="width: 18%; text-align: right"><ix:nonFraction name="us-gaap:NotesPayableRelatedPartiesClassifiedCurrent" contextRef="AsOf2020-12-31_custom_RelatedPartyMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,031,966</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: -7.6pt; padding-left: 17.05pt">Transferred from promissory notes payable pursuant to private transaction</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_980_ecustom--TransferredFromPromissoryNotesPayablePursuantToPrivateTransaction._c20210101__20211231__us-gaap--DebtInstrumentAxis__custom--RelatedPartyMember_pp0p0" title="Transferred from promissory notes payable pursuant to private transaction" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ALRT:TransferredFromPromissoryNotesPayablePursuantToPrivateTransaction." contextRef="From2021-01-012021-12-31_custom_RelatedPartyMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">10,000</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -6.25pt; padding-left: 6.25pt">Balance, December&#160;31, 2021</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--NotesPayableRelatedPartiesClassifiedCurrent_iS_pp0p0_c20220101__20220630__us-gaap--DebtInstrumentAxis__custom--RelatedPartyMember_zQhzLi4n7Tvk" title="Carrying value at beginning" style="text-align: right"><ix:nonFraction name="us-gaap:NotesPayableRelatedPartiesClassifiedCurrent" contextRef="AsOf2021-12-31_custom_RelatedPartyMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,041,966</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: -7.6pt; padding-left: 17.05pt">Promissory notes received</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_987_ecustom--TransferredFromPromissoryNotesPayablePursuantToPrivateTransaction._pp0p0_c20220101__20220630__us-gaap--DebtInstrumentAxis__custom--RelatedPartyMember_zmUCm4bELTR2" title="Transferred from promissory notes payable pursuant to private transaction" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ALRT:TransferredFromPromissoryNotesPayablePursuantToPrivateTransaction." contextRef="From2022-01-012022-06-30_custom_RelatedPartyMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">50,000</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt; text-indent: -6.25pt; padding-left: 6.25pt">Balance, June&#160;30, 2022</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_98E_eus-gaap--NotesPayableRelatedPartiesClassifiedCurrent_iE_pp0p0_c20220101__20220630__us-gaap--DebtInstrumentAxis__custom--RelatedPartyMember_zswjKOZmFJuf" title="Carrying value at ending" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:NotesPayableRelatedPartiesClassifiedCurrent" contextRef="AsOf2022-06-30_custom_RelatedPartyMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,091,966</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8AB_zpYstANSzQ9k" style="font: 11pt/12pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 9 -->
    <div id="xdx_232_z82BUakJGaEf" style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" id="xdx_23E_zRAdPDTUJxqd" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div id="xdx_23F_zwcIma8v8mxf" style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p id="xdx_237_zKDan90aLdRg" style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_234_zM6k3YoZxMh3" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ALR
TECHNOLOGIES INC.</b></span></p></ix:exclude>

<ix:exclude><p id="xdx_23B_zNbgJmIIWuAl" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notes
to Condensed Consolidated Financial Statements</span></p></ix:exclude>

<ix:exclude><p id="xdx_234_zHuaRgRip3Ba" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the Six Months Ended June&#160;30, 2022</span></p></ix:exclude>

<ix:exclude><p id="xdx_23D_z5ZCxzkOgeo7" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">($
United States)</span></p></ix:exclude>

<ix:exclude><p id="xdx_237_zGL09XquVYqj" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Unaudited)</span></p></ix:exclude>

<ix:exclude><p id="xdx_232_zX61Qk8rI1Vd" style="font: 11pt/12pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_233_zZF4qz1G9Sp6" style="font: 11pt/12pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_239_zAuFPor2S6Q9" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>4.
&#160;&#160;&#160;&#160;&#160;&#160;&#160;Interest, advances and promissory notes payable (continued)</b></span></p></ix:exclude>

<ix:exclude><p id="xdx_23D_zrMVQ0jaOeT2" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_239_zaRkY82GY5h6" style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;Promissory
notes payable to related parties (continued)</span></p></ix:exclude>

<p style="font: 11pt/12pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt/12pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
summary of the promissory notes payable to related parties is as follows:</span></p>

<p style="font: 11pt/12pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2022-01-01to2022-06-30" escape="true" name="ALRT:ScheduleofPromissoryNotesPayableRelativesofBoardofDirectorsTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_89D_ecustom--ScheduleofPromissoryNotesPayableRelativesofBoardofDirectorsTableTextBlock_zTluJknl4cpc" summary="xdx: Disclosure - Interest, advances and promissory notes payable (Details 1)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -0.25in; padding-left: 0.5in"><span id="xdx_8BF_zMWtijPXKJMd" style="display: none">Schedule of activity of promissory notes payable to related parties</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_490_20220630" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_495_20211231" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold">Promissory Notes Payable to Related Parties</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>June 30,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2022</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December&#160;31, </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2021</b></span></p></td></tr>
  <tr id="xdx_40C_ecustom--PromissoryNotesPayableToRelativesOfDirectorsCollateralizedByAGeneralSecurityAgreementOnAllTheAssetsOfTheCompanyDueOnDemandAbstract_iB" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -6.25pt; padding-left: 6.25pt">Promissory notes payable to relatives of directors collateralized by a general security agreement over all the assets of the Company, past maturity:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_ecustom--NotePayablewithInterestat1PercentInterestperMonth_i01I_pp0p0_maPNRPzSkp_zCZEXHsG2SA5" style="vertical-align: bottom; background-color: White">
    <td style="width: 56%; text-indent: -0.25in; padding-left: 0.5in">i.&#160;&#160;&#160;&#160;&#160;&#160;&#160; Interest at 1% per month</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right"><ix:nonFraction name="ALRT:NotePayablewithInterestat1PercentInterestperMonth" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">720,619</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right"><ix:nonFraction name="ALRT:NotePayablewithInterestat1PercentInterestperMonth" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">720,619</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_ecustom--InterestAt1.25PerMonth_i01I_pp0p0_maPNRPzSkp_zajCDc37Ikzf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.25in; padding-left: 0.5in">ii.&#160;&#160;&#160;&#160;&#160; Interest at 1.25% per month</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ALRT:InterestAt1.25PerMonth" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">51,347</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ALRT:InterestAt1.25PerMonth" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">51,347</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_ecustom--NotePayableInterestattheUSBankPrimeRatePlus1PercentperMonth_i01I_pp0p0_maPNRPzSkp_zfFK5Ko0ayAi" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -0.25in; padding-left: 0.5in">iii.&#160;&#160;&#160; Interest at the U.S. bank prime rate plus 1%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ALRT:NotePayableInterestattheUSBankPrimeRatePlus1PercentperMonth" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">100,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ALRT:NotePayableInterestattheUSBankPrimeRatePlus1PercentperMonth" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">100,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_ecustom--Iv.InterestAt0.5PerMonth_i01I_pp0p0_maPNRPzSkp_zNojSE3AprF7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.25in; padding-left: 0.5in">iv.&#160;&#160;&#160;&#160; Interest at 0.5% per month</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ALRT:Iv.InterestAt0.5PerMonth" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">695,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ALRT:Iv.InterestAt0.5PerMonth" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">695,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.5in">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_ecustom--UnsecuredPromissoryNotesPayableToRelativesOfChairmanWithFixedAmountsOfInterestDueAugust312022_i01I_maPNRPzSkp_znx5gB0wWObk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Unsecured promissory notes payable to relatives of the Chairman with fixed amounts of interest due August 31, 2022</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ALRT:UnsecuredPromissoryNotesPayableToRelativesOfChairmanWithFixedAmountsOfInterestDueAugust312022" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">50,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0399">&#8212;</span>&#160;&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -6.25pt; padding-left: 6.25pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_ecustom--PromissoryNotesPayableUnsecuredtoRelativesofaDirectorBearingInterestat1PercentperMonth_i01I_pp0p0_maPNRPzSkp_zvNAesXXE3fh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: -6.25pt; padding-left: 6.25pt">Promissory notes payable, unsecured, to relatives of a director, bearing interest at 1% per month, past maturity</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ALRT:PromissoryNotesPayableUnsecuredtoRelativesofaDirectorBearingInterestat1PercentperMonth" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,475,000</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ALRT:PromissoryNotesPayableUnsecuredtoRelativesofaDirectorBearingInterestat1PercentperMonth" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,475,000</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_ecustom--PromissoryNotesRelatedParty_iTI_pp0p0_mtPNRPzSkp_zhyRf1a5jknj" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1pt; text-indent: -6.25pt; padding-left: 6.25pt">Total Promissory Notes Payable to Related Parties</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ALRT:PromissoryNotesRelatedParty" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,091,966</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ALRT:PromissoryNotesRelatedParty" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,041,966</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A6_zszEiwL350Oj" style="font: 11pt/12pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt/12pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company received advances from relatives of the Chairman aggregating $50,000, with a fixed interest amount of $4,000, which will mature
and be repayable on August&#160;31, 2022.</span></p>

<p style="font: 11pt/12pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt/12pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
amounts past maturity continue to accrue interest at their stated rates and are considered due on demand.</span></p>

<p style="font: 11pt/12pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;Promissory
notes payable to unrelated parties</span></p>

<p style="font: 11pt/12pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt/12pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
summary of activities of promissory notes payable to unrelated parties is as follows:</span></p>

<p style="font: 11pt/12pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2022-01-01to2022-06-30" escape="true" name="ALRT:ScheduleofPromissoryNotesPayableToUnrelatedPartiesTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_89F_ecustom--ScheduleofPromissoryNotesPayableToUnrelatedPartiesTableTextBlock_zTAUjvgmfGn3" summary="xdx: Disclosure - Interest, advances and promissory notes payable (Details 2)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -7.6pt; padding-left: 17.05pt"><span id="xdx_8BD_ztKTvFkvLtyj" style="display: none">Schedule of Promissory Notes Payable to Unrelated Parties</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold">Promissory Notes Payable to Unrelated Parties</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Carrying Value</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 70%; padding-left: 5.4pt">Balance, December&#160;31, 2020</td><td style="width: 10%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--NotesPayable_iS_pp0p0_c20210101__20211231__us-gaap--DebtInstrumentAxis__custom--UnRelatedPartyMember_zwr4roHuHQZc" title="Balance at beginning" style="width: 18%; text-align: right"><ix:nonFraction name="us-gaap:NotesPayable" contextRef="AsOf2020-12-31_custom_UnRelatedPartyMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,254,353</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -7.6pt; padding-left: 17.05pt">Reclassified to interest payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--IncreaseDecreaseInInterestPayableNet_c20210101__20211231__us-gaap--DebtInstrumentAxis__custom--UnRelatedPartyMember_pp0p0" title="Reclassified to interest payable" style="text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInInterestPayableNet" contextRef="From2021-01-012021-12-31_custom_UnRelatedPartyMember" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">10,985</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -7.6pt; padding-left: 17.05pt">Extinguished through issuance of shares of common stock (note&#160;6)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_ecustom--ExtinguishedThroughIssuanceOfSharesOfCommonStock_c20210101__20211231__us-gaap--DebtInstrumentAxis__custom--UnRelatedPartyMember_pp0p0" title="Extinguished through issuance of shares of common stock (note 6)" style="text-align: right">(<ix:nonFraction name="ALRT:ExtinguishedThroughIssuanceOfSharesOfCommonStock" contextRef="From2021-01-012021-12-31_custom_UnRelatedPartyMember" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">20,000</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: -7.6pt; padding-left: 17.05pt">Transferred to promissory notes payable pursuant to private transaction</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_989_ecustom--TransferredFromPromissoryNotesPayablePursuantToPrivateTransaction._pp0p0_c20210101__20211231__us-gaap--DebtInstrumentAxis__custom--UnRelatedPartyMember_z66pY7kqzp3" title="Transferred from promissory notes payable pursuant to private transaction" style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="ALRT:TransferredFromPromissoryNotesPayablePursuantToPrivateTransaction." contextRef="From2021-01-012021-12-31_custom_UnRelatedPartyMember" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">10,000</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -6.25pt; padding-left: 6.25pt">Balance, December&#160;31, 2021</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--NotesPayable_iS_pp0p0_c20220101__20220630__us-gaap--DebtInstrumentAxis__custom--UnRelatedPartyMember_zw4v8aOJCWI3" title="Balance at beginning" style="text-align: right"><ix:nonFraction name="us-gaap:NotesPayable" contextRef="AsOf2021-12-31_custom_UnRelatedPartyMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,213,368</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: -7.6pt; padding-left: 17.05pt">Promissory notes received</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98A_ecustom--PromissoryNoteReceived_iP3custom--TransferredFromPromissoryNotesPayablePursuantToPrivateTransaction._pp0p0_c20220101__20220630__us-gaap--DebtInstrumentAxis__custom--UnRelatedPartyMember_zxxX2DUkuGd4" title="Promissory note received" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ALRT:PromissoryNoteReceived" contextRef="From2022-01-012022-06-30_custom_UnRelatedPartyMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">244,358</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt; text-indent: -6.25pt; padding-left: 6.25pt">Balance, June&#160;30, 2022</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_987_eus-gaap--NotesPayable_iE_pp0p0_c20220101__20220630__us-gaap--DebtInstrumentAxis__custom--UnRelatedPartyMember_zItqds7dEKT" title="Balance at ending" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:NotesPayable" contextRef="AsOf2022-06-30_custom_UnRelatedPartyMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,457,726</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A0_zZEYFIlQGRn9" style="font: 11pt/12pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 10 -->
    <div id="xdx_23A_zhFIWayzkESf" style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" id="xdx_23A_zjg695XBiBe2" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></td><td id="xdx_233_zmV2S2vFhDx1" style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div id="xdx_23B_zn9amNZoLGKf" style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p id="xdx_23D_zLUFQ9CPv22c" style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_237_zNxvbEJAe2i4" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ALR
TECHNOLOGIES INC.</b></span></p></ix:exclude>

<ix:exclude><p id="xdx_23F_z9iZUUoLl7d1" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notes
to Condensed Consolidated Financial Statements</span></p></ix:exclude>

<ix:exclude><p id="xdx_239_zDbZyP870rqe" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the Six Months Ended June&#160;30, 2022</span></p></ix:exclude>

<ix:exclude><p id="xdx_23B_z4cuHPbPhaVd" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">($
United States)</span></p></ix:exclude>

<ix:exclude><p id="xdx_23F_zqAsjuLSdX4l" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Unaudited)</span></p></ix:exclude>

<ix:exclude><p id="xdx_236_zR6WCDwlNhb1" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_23C_zEzDYGq1AZb3" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_237_zsA8D0cTUTvl" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>4.</b>&#160;&#160;&#160;&#160;&#160;&#160;&#160;<b>Interest,
advances and promissory notes payable (continued)</b></span></p></ix:exclude>

<ix:exclude><p id="xdx_238_zdLH0wLIKNAc" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_23E_z07HPHJLe8e2" style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;Promissory
notes payable to unrelated parties (continued)</span></p></ix:exclude>

<p style="font: 11pt/12pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt/12pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
summary of the promissory notes payable to unrelated parties is as follows:</span></p>

<p style="font: 11pt/12pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2022-01-01to2022-06-30" escape="true" name="ALRT:ScheduleofActivityofPromissoryNotestoUnrelatedPatiesTableTextBlock"><table cellspacing="0" cellpadding="0" id="xdx_89A_ecustom--ScheduleofActivityofPromissoryNotestoUnrelatedPatiesTableTextBlock_z6rmCLNEuxL9" summary="xdx: Disclosure - Interest, advances and promissory notes payable (Details 3)" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 0.5in; text-indent: -0.25in"><span id="xdx_8B0_zY97BBiURzFf" style="display: none">Schedule of activity of promissory notes payable to unrelated parties</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td colspan="3" id="xdx_496_20220630_zUco1HS3wWD6" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td id="xdx_496_20211231_zd759ABF6vac" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
<tr>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Promissory
    Notes Payable to Unrelated Parties</b></span></td>
    <td colspan="4" style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>June
                                            30,</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2022</b></span></p></td>
    <td colspan="3" style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December&#160;31,
    2021</b></span></td></tr>
  <tr id="xdx_404_ecustom--UnsecuredPromissoryNotesPayableToUnrelatedLendersAbstract_iB" style="vertical-align: bottom">
    <td style="padding-right: 5.4pt; padding-left: 6.25pt; text-indent: -6.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unsecured
    promissory notes payable to unrelated lenders, past maturity:</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_408_ecustom--I.InterestAt1PerMonthRepayableOnMarch312009DueOnDemand_i01I_pp0p0_maTPNPTzcOO_zEaEjMBpyNl7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 5.4pt; padding-left: 0.5in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.&#160;&#160;&#160;&#160;&#160;&#160;&#160;
    Interest at 1% per month</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td colspan="3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:I.InterestAt1PerMonthRepayableOnMarch312009DueOnDemand" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,317,456</ix:nonFraction></span></td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:I.InterestAt1PerMonthRepayableOnMarch312009DueOnDemand" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,317,456</ix:nonFraction></span></td></tr>
  <tr id="xdx_404_ecustom--Iii.InterestAt0.625PerMonthWith50000RepayableOnOctober5200440000RepayableOnDecember312004And60000RepayableOnJuly282006AllDueOnDemand_i01I_pp0p0_maTPNPTzcOO_z5LfbogWX5Hl" style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 0.5in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii.&#160;&#160;&#160;&#160;&#160;
    Interest at 0.667% per month </span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:Iii.InterestAt0.625PerMonthWith50000RepayableOnOctober5200440000RepayableOnDecember312004And60000RepayableOnJuly282006AllDueOnDemand" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">425,000</ix:nonFraction></span></td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:Iii.InterestAt0.625PerMonthWith50000RepayableOnOctober5200440000RepayableOnDecember312004And60000RepayableOnJuly282006AllDueOnDemand" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">425,000</ix:nonFraction></span></td></tr>
  <tr id="xdx_402_ecustom--Vi.InterestAt0.667PerMonthWith125000DueJanuary152011_i01I_pp0p0_maTPNPTzcOO_z3d511g0sYNg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 5.4pt; padding-left: 0.5in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">iii.&#160;&#160;&#160;
    Interest at 0.625% per month</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:Vi.InterestAt0.667PerMonthWith125000DueJanuary152011" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">150,000</ix:nonFraction></span></td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:Vi.InterestAt0.667PerMonthWith125000DueJanuary152011" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">150,000</ix:nonFraction></span></td></tr>
  <tr id="xdx_405_ecustom--Noninterestbearing_i01I_pp0p0_maTPNPTzcOO_zG27jbeoNRs8" style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 0.5in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">iv.&#160;&#160;&#160;&#160;
    Non-interest-bearing</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:Noninterestbearing" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">270,912</ix:nonFraction></span></td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:Noninterestbearing" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">270,912</ix:nonFraction></span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 5.4pt; padding-left: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_404_ecustom--UnsecuredPromissoryNotesPayableToUnrelatedLendersWithFixedAmountsOfInterestDue_i01I_maTPNPTzcOO_zLP3ahPwzV3h" style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unsecured promissory notes
    payable to unrelated lenders with fixed amounts of interest due August 31, 2022</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:UnsecuredPromissoryNotesPayableToUnrelatedLendersWithFixedAmountsOfInterestDue" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">244,358</ix:nonFraction></span></td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0451">-</span></span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 5.4pt; padding-left: 6.25pt; text-indent: -6.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_406_ecustom--PromissoryNotesPayableSecuredByGuaranteeFromChiefExecutiveOfficerBearingInterestAt1PerMonth_i01I_pp0p0_maTPNPTzcOO_zbSX8UJ9bRP2" style="vertical-align: bottom; background-color: White">
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 6.25pt; text-indent: -6.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Promissory
    notes payable, secured by a guarantee from the Chief Executive Officer, bearing interest at 1% per month, past maturity</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:PromissoryNotesPayableSecuredByGuaranteeFromChiefExecutiveOfficerBearingInterestAt1PerMonth" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">50,000</ix:nonFraction></span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:PromissoryNotesPayableSecuredByGuaranteeFromChiefExecutiveOfficerBearingInterestAt1PerMonth" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">50,000</ix:nonFraction></span></td></tr>
  <tr id="xdx_40B_ecustom--TotalPromissoryNotesPayableToUnrelatedParties_i01TI_pp0p0_mtTPNPTzcOO_zdMBflbeIQUb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 6.25pt; text-indent: -6.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Total
    Promissory Notes Payable to Unrelated Parties</b></span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:TotalPromissoryNotesPayableToUnrelatedParties" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,457,726</ix:nonFraction></span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:TotalPromissoryNotesPayableToUnrelatedParties" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,213,368</ix:nonFraction></span></td></tr>
  <tr style="background-color: White">
    <td style="width: 61%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 15%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 15%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>
</ix:nonNumeric><p id="xdx_8A0_zkIEwTOU9r7g" style="font: 11pt/12pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt/12pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company received advances from two shareholders aggregating SGD$340,000 ($244,358), with a fixed interest amount of $10,000, which will
mature and be repayable on August&#160;31, 2022. The principal amount of SGD$150,000 was repaid to one shareholder in July 2022.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt/12pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
amounts past maturity continue to accrue interest at their stated rates and are considered due on demand.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;Interest
payable</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
summary of the interest payable activity is as follows:</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2022-01-01to2022-06-30" escape="true" name="us-gaap:InterestAndOtherIncomeTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_894_eus-gaap--InterestAndOtherIncomeTableTextBlock_zJtNkPyGnT2a" summary="xdx: Disclosure - Interest, advances and promissory notes payable (Details 4)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -7.6pt; padding-left: 17.05pt"><span id="xdx_8BB_z47PrD5aVv5f" style="display: none">Schedule of interest payable activity</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td title="Reclassified from promissory notes payable" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold">Interest Payable</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Carrying Value</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 70%; padding-left: 5.4pt">Balance, December&#160;31, 2020</td><td style="width: 10%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--InterestPayableCurrentAndNoncurrent_iS_pp0p0_c20210101__20211231_z4V37YcUr9g" title="Beginning Balance" style="width: 18%; text-align: right"><ix:nonFraction name="us-gaap:InterestPayableCurrentAndNoncurrent" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,575,326</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -7.6pt; padding-left: 17.05pt">Reclassified from promissory notes payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_ecustom--ReclassifiedFromPromissoryNotesPayable_c20210101__20211231_pp0p0" title="Reclassified from promissory notes payable" style="text-align: right"><ix:nonFraction name="ALRT:ReclassifiedFromPromissoryNotesPayable" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">10,985</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -7.6pt; padding-left: 17.05pt">Interest incurred on promissory notes payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_ecustom--InterestExpenseIncurredonPromissoryNotesandOtherPayables_c20210101__20211231_pp0p0" title="Interest incurred on promissory notes payable" style="text-align: right"><ix:nonFraction name="ALRT:InterestExpenseIncurredonPromissoryNotesandOtherPayables" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">527,336</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: -7.6pt; padding-left: 17.05pt">Interest payable retired through issuance of shares</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_981_ecustom--InterestPayableRetiredThroughIssuanceOfShares_c20210101__20211231_pp0p0" title="Interest payable retired through issuance of shares" style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="ALRT:InterestPayableRetiredThroughIssuanceOfShares" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">3,000</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 5.4pt">Balance, December&#160;31, 2021</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--InterestPayableCurrentAndNoncurrent_iS_pp0p0_c20220101__20220630_z2CXzlH0iwCj" title="Beginning Balance" style="text-align: right"><ix:nonFraction name="us-gaap:InterestPayableCurrentAndNoncurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,110,647</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: -7.6pt; padding-left: 17.05pt">Interest incurred on promissory notes payable</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_988_ecustom--InterestExpenseIncurredonPromissoryNotesandOtherPayables_c20220101__20220630_pp0p0" title="Interest incurred on promissory notes payable" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ALRT:InterestExpenseIncurredonPromissoryNotesandOtherPayables" contextRef="From2022-01-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">277,421</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt; padding-left: 5.4pt">Balance, June&#160;30, 2022</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_985_eus-gaap--InterestPayableCurrentAndNoncurrent_iE_pp0p0_c20220101__20220630_zhd73XLCKBj2" title="Ending Balance" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:InterestPayableCurrentAndNoncurrent" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,388,068</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8AD_zi6IDnsQJlR2" style="margin-top: 0; margin-bottom: 0">&#160;</p>


<ix:exclude><!-- Field: Page; Sequence: 11 -->
    <div id="xdx_23F_zdUzJOqtP3ti" style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" id="xdx_23D_zTi9uEbWhhof" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></td><td id="xdx_238_zBlsw8CZCl2a" style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div id="xdx_23E_zwRIzNV7pWk2" style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p id="xdx_233_zbWL3KMmUhoh" style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_23A_zVYsucOUDG6a" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ALR
TECHNOLOGIES INC.</b></span></p></ix:exclude>

<ix:exclude><p id="xdx_238_zCU3MBBEmlFd" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notes
to Condensed Consolidated Financial Statements</span></p></ix:exclude>

<ix:exclude><p id="xdx_23E_zEFA9u0p8fXg" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the Six Months Ended June&#160;30, 2022</span></p></ix:exclude>

<ix:exclude><p id="xdx_23E_zHZmLVYywpt" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">($
United States)</span></p></ix:exclude>

<ix:exclude><p id="xdx_237_zlCArS2sWE4e" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Unaudited)</span></p></ix:exclude>

<ix:exclude><p id="xdx_23E_zKx7VhNx4xkk" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_23A_zJTPmuuy7eO1" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_235_zRY8KwsHI1S3" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>4.</b>&#160;&#160;&#160;&#160;&#160;&#160;&#160;<b>Interest,
advances and promissory notes payable (continued)</b></span></p></ix:exclude>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:exclude><p id="xdx_233_z7IZKf5PNKm9" style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;Interest
payable (continued)</span></p></ix:exclude>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interest
payable is due to related and non-related parties as follows:</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2022-01-01to2022-06-30" escape="true" name="ALRT:ScheduledOfInterestPayableDueToRelatedTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_896_ecustom--ScheduledOfInterestPayableDueToRelatedTableTextBlock_zorClcnrgGJj" summary="xdx: Disclosure - Interest, advances and promissory notes payable (Details 5)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: -6.25pt; padding-left: 6.25pt"><span id="xdx_8B2_zMsjrkxgS7F8" style="display: none">Schedule of Interest payable due to related and non-related parties</span></td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_49A_20220630_zUOrm8c1Q5J5" style="text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_499_20211231_zxtrdp7LXJ0l" style="text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold">Interest Payable</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>June 30,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2022</b></span></p></td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December&#160;31, 2021</td></tr>
  <tr id="xdx_403_ecustom--InterestPayableRelativesOfDirectors_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; text-align: left; text-indent: -6.25pt; padding-left: 6.25pt">Related parties</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right"><ix:nonFraction name="ALRT:InterestPayableRelativesOfDirectors" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,362,918</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right"><ix:nonFraction name="ALRT:InterestPayableRelativesOfDirectors" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,200,170</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_403_ecustom--InterestPayabletoNonrelatedParties_iI_pp0p0" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: -6.25pt; padding-left: 6.25pt">Unrelated parties</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ALRT:InterestPayabletoNonrelatedParties" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,025,150</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ALRT:InterestPayabletoNonrelatedParties" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,910,477</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_ecustom--InterestPayableCurrentAndNoncurrents_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="color: rgb(204,238,255); padding-bottom: 1pt; text-indent: -6.25pt; padding-left: 6.25pt">Interest payable</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ALRT:InterestPayableCurrentAndNoncurrents" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,388,068</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ALRT:InterestPayableCurrentAndNoncurrents" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,110,647</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A9_zllxSpCtTLSd" style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
payment terms, security and any interest payable are based on the underlying promissory notes payable that the Company has outstanding.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;Interest
expense</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the period ended June&#160;30, 2022, the Company incurred interest expense of $<span id="xdx_903_eus-gaap--InterestExpense_c20220101__20220630_pp0p0" title="Interest expense"><ix:nonFraction name="us-gaap:InterestExpense" contextRef="From2022-01-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,109,764</ix:nonFraction></span> (2021&#160;- $<span id="xdx_901_eus-gaap--InterestExpense_c20210101__20210630_pp0p0" title="Interest expense"><ix:nonFraction name="us-gaap:InterestExpense" contextRef="From2021-01-012021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,283,770</ix:nonFraction></span>) as follows:</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 53.3pt"></td><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#183;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$Nil
                                            (2021&#160;- $1,287,834) incurred related to the modification of options held by the Chairman
                                            and his spouse that were granted in connection with financing provided to the Company;</span></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 53.3pt"></td><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#183;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$777,515
                                            (2021&#160;- $670,452) incurred on lines of credit payable as shown in note&#160;5; </span></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 53.3pt"></td><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#183;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$277,421
                                            (2021&#160;- $264,100) incurred on promissory notes (notes&#160;4(a) and 4(b));</span></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 53.3pt"></td><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#183;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$52,271
                                            (2021&#160;- $60,059) incurred from the calculation of imputed interest on accounts payable
                                            outstanding for longer than one year, advances payable and promissory notes payable, which
                                            had no stated interest rate; and</span></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 53.3pt"></td><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#183;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$<span id="xdx_90A_eus-gaap--InterestExpenseRelatedParty_c20220101__20220630_pp0p0" title="Interest on other"><ix:nonFraction name="us-gaap:InterestExpenseRelatedParty" contextRef="From2022-01-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,557</ix:nonFraction></span>
                                            (2021&#160;- $<span id="xdx_908_eus-gaap--InterestExpenseRelatedParty_c20210101__20210630_pp0p0" title="Interest on other"><ix:nonFraction name="us-gaap:InterestExpenseRelatedParty" contextRef="From2021-01-012021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,325</ix:nonFraction></span>) interest on other items.</span></td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:exclude><p id="xdx_231_zXaGhrbJAmP1" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:exclude>


<ix:exclude><!-- Field: Page; Sequence: 12 -->
    <div id="xdx_239_zQKgiy6FN3f9" style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" id="xdx_235_zzGBRluKJWij" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></td><td id="xdx_236_zT6XbjNQ7LE7" style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div id="xdx_233_zID650zdC8jd" style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p id="xdx_23E_zm35xlKedP8" style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_232_zdDZxPG0Sili" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ALR
TECHNOLOGIES INC.</b></span></p></ix:exclude>

<ix:exclude><p id="xdx_238_zCgtQhVwDjKl" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notes
to Condensed Consolidated Financial Statements</span></p></ix:exclude>

<ix:exclude><p id="xdx_231_zHaSC7ZKzDXf" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the Six Months Ended June&#160;30, 2022</span></p></ix:exclude>

<ix:exclude><p id="xdx_23E_zPsSKyVJWBB" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">($
United States)</span></p></ix:exclude>

<ix:exclude><p id="xdx_23B_z8lJmrWV9ezi" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Unaudited)</span></p></ix:exclude>

<ix:exclude><p id="xdx_233_zO2Jh75wQyf6" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_23B_zmfyNVFLnsQa" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:exclude>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-01to2022-06-30" escape="true" name="ALRT:LineOfCreditTextBlock"><p id="xdx_803_ecustom--LineOfCreditTextBlock_zJUquDrdaD5f" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>5.
&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span id="xdx_82E_zNAtBJWpzqYa">Lines of credit</span></b></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
summary of lines of credit activity is as follows:</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2022-01-01to2022-06-30" escape="true" name="us-gaap:ScheduleOfLineOfCreditFacilitiesTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_89D_eus-gaap--ScheduleOfLineOfCreditFacilitiesTextBlock_zKMNFGvRVN99" summary="xdx: Disclosure - Lines of credit (Details)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -7.6pt; padding-left: 17.05pt"><span id="xdx_8B1_zATBTdZKmVW4" style="display: none">Schedule of lines of credit activity</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td title="Advances received on lines of credit" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold">Lines of Credit</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Total</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 70%; padding-left: 5.4pt">Balance, December&#160;31, 2020</td><td style="width: 10%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98B_eus-gaap--LongTermLineOfCredit_iS_pp0p0_c20210101__20211231_zRhtx1Ez1L94" title="Balance at beginning" style="width: 18%; text-align: right"><ix:nonFraction name="us-gaap:LongTermLineOfCredit" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">11,914,092</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -7.6pt; padding-left: 17.05pt">Advances received on lines of credit</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--LineOfCreditFacilityPeriodicPaymentPrincipal_c20210101__20211231_pp0p0" title="Advances received on lines of credit" style="text-align: right"><ix:nonFraction name="us-gaap:LineOfCreditFacilityPeriodicPaymentPrincipal" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,149,279</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -7.6pt; padding-left: 17.05pt">Interest incurred on lines of credit</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--LineOfCreditFacilityPeriodicPaymentInterest_c20210101__20211231_pp0p0" title="Interest incurred on lines of credit" style="text-align: right"><ix:nonFraction name="us-gaap:LineOfCreditFacilityPeriodicPaymentInterest" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,402,187</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: -7.6pt; padding-left: 17.05pt">Repayment of interest on lines of credit</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_981_ecustom--RepaymentOfInterestOnLinesOfCredit_c20210101__20211231_pp0p0" title="Repayment of interest on lines of credit" style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="ALRT:RepaymentOfInterestOnLinesOfCredit" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">456,725</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 5.4pt">Balance, December&#160;31, 2021</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--LongTermLineOfCredit_iS_pp0p0_c20220101__20220630_ziT29OeiKi7k" title="Balance at beginning" style="text-align: right"><ix:nonFraction name="us-gaap:LongTermLineOfCredit" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">14,008,833</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -7.6pt; padding-left: 17.05pt">Advances received on lines of credit</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--LineOfCreditFacilityPeriodicPaymentPrincipal_c20220101__20220630_pp0p0" title="Advances received on lines of credit" style="text-align: right"><ix:nonFraction name="us-gaap:LineOfCreditFacilityPeriodicPaymentPrincipal" contextRef="From2022-01-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">438,165</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -7.6pt; padding-left: 17.05pt">Interest incurred on lines of credit</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_eus-gaap--LineOfCreditFacilityPeriodicPaymentInterest_c20220101__20220630_pp0p0" title="Interest incurred on lines of credit" style="text-align: right"><ix:nonFraction name="us-gaap:LineOfCreditFacilityPeriodicPaymentInterest" contextRef="From2022-01-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">777,515</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: -7.6pt; padding-left: 17.05pt">Repayment of interest on lines of credit</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_982_ecustom--RepaymentOfInterestOnLinesOfCredit_c20220101__20220630_pp0p0" title="Repayment of interest on lines of credit" style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="ALRT:RepaymentOfInterestOnLinesOfCredit" contextRef="From2022-01-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">137,475</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt; padding-left: 5.4pt">Balance, June&#160;30, 2022</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_982_eus-gaap--LongTermLineOfCredit_iE_pp0p0_c20220101__20220630_zBhbtCvA0bAh" title="Balance at ending" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:LongTermLineOfCredit" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">15,087,038</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A8_zJpnoRNamLr2" style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 10, 2021, the Company and the spouse of the Chairman entered into an amendment agreement to increase the borrowing limit on
the line of credit provided by the spouse of the Chairman to the Company from $2,000,000 to $4,000,000. The terms of amounts to be advanced
under the amendment are consistent with the line of credit. In connection with the line of credit, the Company granted the spouse of
the Chairman the option to acquire 40,000,000 shares of common stock of the Company at a price of $0.05 per share until December&#160;31,
2026 (note&#160;7).</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of June&#160;30, 2022, the Company had two lines of credit as follows:</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2022-01-01to2022-06-30" escape="true" name="ALRT:ScheduledOfLineOfCreditTableTextBlock"><table cellspacing="0" cellpadding="0" id="xdx_89B_ecustom--ScheduledOfLineOfCreditTableTextBlock_zRahJRFE61N8" summary="xdx: Disclosure - Lines of credit (Details 1)" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span id="xdx_8BF_zBK8AxfWWqua" style="display: none">Schedule of lines of credit</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: -2.8pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: -2.8pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: -2.8pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: -2.8pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td></tr>
<tr>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Creditor</span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 8%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interest
    Rate</span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Borrowing
    Limit</span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Repayment
    Terms</span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Principal
    Borrowed</span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accrued
    Interest</span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    Outstanding</span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Security</span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 15%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Purpose</span></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chairman
    and CEO </span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_ecustom--InterestRate_c20220101__20220630__us-gaap--LineOfCreditFacilityAxis__custom--ChairmanAndCEOMember" title="Interest Rate"><ix:nonNumeric contextRef="From2022-01-012022-06-30_custom_ChairmanAndCEOMember" name="ALRT:InterestRate">1%
    per Month</ix:nonNumeric></span> </span></td>
    <td style="padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$
    <span id="xdx_90B_ecustom--BorrowingLimit_c20220630__us-gaap--LineOfCreditFacilityAxis__custom--ChairmanAndCEOMember_pp0p0" title="Borrowing Limit"><ix:nonFraction name="ALRT:BorrowingLimit" contextRef="AsOf2022-06-30_custom_ChairmanAndCEOMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">10,300,000</ix:nonFraction></span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_ecustom--RepaymentTerms1_c20220101__20220630__us-gaap--LineOfCreditFacilityAxis__custom--ChairmanAndCEOMember" title="Repayment Terms"><ix:nonNumeric contextRef="From2022-01-012022-06-30_custom_ChairmanAndCEOMember" name="ALRT:RepaymentTerms1">Due
    on Demand</ix:nonNumeric></span></span></td>
    <td style="padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$
    <span id="xdx_90F_ecustom--PrincipalBorrowed_c20220630__us-gaap--LineOfCreditFacilityAxis__custom--ChairmanAndCEOMember_pp0p0" title="Principal Borrowed"><ix:nonFraction name="ALRT:PrincipalBorrowed" contextRef="AsOf2022-06-30_custom_ChairmanAndCEOMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">10,300,000</ix:nonFraction></span></span></td>
    <td style="padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$
    <span id="xdx_90D_ecustom--AccruedInterest_c20220630__us-gaap--LineOfCreditFacilityAxis__custom--ChairmanAndCEOMember_pp0p0" title="Accrued Interest"><ix:nonFraction name="ALRT:AccruedInterest" contextRef="AsOf2022-06-30_custom_ChairmanAndCEOMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,763,048</ix:nonFraction></span></span></td>
    <td style="padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$
    <span id="xdx_904_ecustom--TotalOutstanding_c20220630__us-gaap--LineOfCreditFacilityAxis__custom--ChairmanAndCEOMember_pp0p0" title="Total Outstanding"><ix:nonFraction name="ALRT:TotalOutstanding" contextRef="AsOf2022-06-30_custom_ChairmanAndCEOMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">12,063,048</ix:nonFraction></span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_ecustom--Security1_c20220101__20220630__us-gaap--LineOfCreditFacilityAxis__custom--ChairmanAndCEOMember" title="Security"><ix:nonNumeric contextRef="From2022-01-012022-06-30_custom_ChairmanAndCEOMember" name="ALRT:Security1">General
    Security over Assets</ix:nonNumeric></span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_ecustom--Purpose1_c20220101__20220630__us-gaap--LineOfCreditFacilityAxis__custom--ChairmanAndCEOMember" title="Purpose"><ix:nonNumeric contextRef="From2022-01-012022-06-30_custom_ChairmanAndCEOMember" name="ALRT:Purpose1">General
    Corporate Requirements</ix:nonNumeric></span></span></td></tr>
  <tr style="background-color: White">
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Wife
    of Chairman</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_ecustom--InterestRate_c20220101__20220630__us-gaap--LineOfCreditFacilityAxis__custom--WifeOfChairmanMember" title="Interest Rate"><ix:nonNumeric contextRef="From2022-01-012022-06-30_custom_WifeOfChairmanMember" name="ALRT:InterestRate">1%
    per Month</ix:nonNumeric></span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_ecustom--BorrowingLimit_c20220630__us-gaap--LineOfCreditFacilityAxis__custom--WifeOfChairmanMember_pp0p0" title="Borrowing Limit"><ix:nonFraction name="ALRT:BorrowingLimit" contextRef="AsOf2022-06-30_custom_WifeOfChairmanMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,000,000</ix:nonFraction></span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_ecustom--RepaymentTerms1_c20220101__20220630__us-gaap--LineOfCreditFacilityAxis__custom--WifeOfChairmanMember" title="Repayment Terms"><ix:nonNumeric contextRef="From2022-01-012022-06-30_custom_WifeOfChairmanMember" name="ALRT:RepaymentTerms1">Due
    on Demand</ix:nonNumeric></span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_ecustom--PrincipalBorrowed_c20220630__us-gaap--LineOfCreditFacilityAxis__custom--WifeOfChairmanMember_pp0p0" title="Principal Borrowed"><ix:nonFraction name="ALRT:PrincipalBorrowed" contextRef="AsOf2022-06-30_custom_WifeOfChairmanMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,826,570</ix:nonFraction></span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_ecustom--AccruedInterest_c20220630__us-gaap--LineOfCreditFacilityAxis__custom--WifeOfChairmanMember_pp0p0" title="Accrued Interest"><ix:nonFraction name="ALRT:AccruedInterest" contextRef="AsOf2022-06-30_custom_WifeOfChairmanMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">197,420</ix:nonFraction></span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_ecustom--TotalOutstanding_c20220630__us-gaap--LineOfCreditFacilityAxis__custom--WifeOfChairmanMember_pp0p0" title="Total Outstanding"><ix:nonFraction name="ALRT:TotalOutstanding" contextRef="AsOf2022-06-30_custom_WifeOfChairmanMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,023,990</ix:nonFraction></span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_ecustom--Security1_c20220101__20220630__us-gaap--LineOfCreditFacilityAxis__custom--WifeOfChairmanMember" title="Security"><ix:nonNumeric contextRef="From2022-01-012022-06-30_custom_WifeOfChairmanMember" name="ALRT:Security1">General
    Security over Assets</ix:nonNumeric></span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_ecustom--Purpose1_c20220101__20220630__us-gaap--LineOfCreditFacilityAxis__custom--WifeOfChairmanMember" title="Purpose"><ix:nonNumeric contextRef="From2022-01-012022-06-30_custom_WifeOfChairmanMember" name="ALRT:Purpose1">General
    Corporate Requirements</ix:nonNumeric></span></span></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$
    <span id="xdx_90C_ecustom--BorrowingLimit_c20220630_pp0p0" title="Borrowing Limit"><ix:nonFraction name="ALRT:BorrowingLimit" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">14,300,000</ix:nonFraction></span></span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$
    <span id="xdx_902_ecustom--PrincipalBorrowed_iI_pp0p0_c20220630_z2E6OXZMPoqg" title="Principal Borrowed"><ix:nonFraction name="ALRT:PrincipalBorrowed" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">13,126,570</ix:nonFraction></span></span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$
    <span id="xdx_902_ecustom--AccruedInterest_c20220630_pp0p0" title="Accrued Interest"><ix:nonFraction name="ALRT:AccruedInterest" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,960,468</ix:nonFraction></span></span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$
    <span id="xdx_903_ecustom--TotalOutstanding_c20220630_pp0p0" title="Total Outstanding"><ix:nonFraction name="ALRT:TotalOutstanding" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">15,087,038</ix:nonFraction></span></span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>
<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December&#160;31, 2021, the Company had two lines of credit as follows:</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Creditor</span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 8%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interest
    Rate</span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Borrowing
    Limit</span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Repayment
    Terms</span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Principal
    Borrowed</span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accrued
    Interest</span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    Outstanding</span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Security</span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 15%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Purpose</span></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chairman
    and CEO </span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_ecustom--InterestRate_c20210101__20211231__us-gaap--LineOfCreditFacilityAxis__custom--ChairmanAndCEOMember" title="Interest Rate"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_ChairmanAndCEOMember" name="ALRT:InterestRate">1%
    per Month</ix:nonNumeric></span> </span></td>
    <td style="padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$
    <span id="xdx_908_ecustom--BorrowingLimit_c20211231__us-gaap--LineOfCreditFacilityAxis__custom--ChairmanAndCEOMember_pp0p0" title="Borrowing Limit"><ix:nonFraction name="ALRT:BorrowingLimit" contextRef="AsOf2021-12-31_custom_ChairmanAndCEOMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">10,300,000</ix:nonFraction></span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_ecustom--RepaymentTerms1_c20210101__20211231__us-gaap--LineOfCreditFacilityAxis__custom--ChairmanAndCEOMember" title="Repayment Terms"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_ChairmanAndCEOMember" name="ALRT:RepaymentTerms1">Due
    on Demand</ix:nonNumeric></span></span></td>
    <td style="padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$
    <span id="xdx_900_ecustom--PrincipalBorrowed_c20211231__us-gaap--LineOfCreditFacilityAxis__custom--ChairmanAndCEOMember_pp0p0" title="Principal Borrowed"><ix:nonFraction name="ALRT:PrincipalBorrowed" contextRef="AsOf2021-12-31_custom_ChairmanAndCEOMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">10,220,700</ix:nonFraction></span></span></td>
    <td style="padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$
    <span id="xdx_900_ecustom--AccruedInterest_c20211231__us-gaap--LineOfCreditFacilityAxis__custom--ChairmanAndCEOMember_pp0p0" title="Accrued Interest"><ix:nonFraction name="ALRT:AccruedInterest" contextRef="AsOf2021-12-31_custom_ChairmanAndCEOMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,208,582</ix:nonFraction></span></span></td>
    <td style="padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$
    <span id="xdx_907_ecustom--TotalOutstanding_c20211231__us-gaap--LineOfCreditFacilityAxis__custom--ChairmanAndCEOMember_pp0p0" title="Total Outstanding"><ix:nonFraction name="ALRT:TotalOutstanding" contextRef="AsOf2021-12-31_custom_ChairmanAndCEOMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">11,429,282</ix:nonFraction></span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_ecustom--Security1_c20210101__20211231__us-gaap--LineOfCreditFacilityAxis__custom--ChairmanAndCEOMember" title="Security"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_ChairmanAndCEOMember" name="ALRT:Security1">General
    Security over Assets</ix:nonNumeric></span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_ecustom--Purpose1_c20210101__20211231__us-gaap--LineOfCreditFacilityAxis__custom--ChairmanAndCEOMember" title="Purpose"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_ChairmanAndCEOMember" name="ALRT:Purpose1">General
    Corporate Requirements</ix:nonNumeric></span></span></td></tr>
  <tr style="background-color: White">
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Wife
    of Chairman</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_ecustom--InterestRate_c20210101__20211231__us-gaap--LineOfCreditFacilityAxis__custom--WifeOfChairmanMember" title="Interest Rate"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_WifeOfChairmanMember" name="ALRT:InterestRate">1%
    per Month</ix:nonNumeric></span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_ecustom--BorrowingLimit_c20211231__us-gaap--LineOfCreditFacilityAxis__custom--WifeOfChairmanMember_pp0p0" title="Borrowing Limit"><ix:nonFraction name="ALRT:BorrowingLimit" contextRef="AsOf2021-12-31_custom_WifeOfChairmanMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,000,000</ix:nonFraction></span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_ecustom--RepaymentTerms1_c20210101__20211231__us-gaap--LineOfCreditFacilityAxis__custom--WifeOfChairmanMember" title="Repayment Terms"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_WifeOfChairmanMember" name="ALRT:RepaymentTerms1">Due
    on Demand</ix:nonNumeric></span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_ecustom--PrincipalBorrowed_c20211231__us-gaap--LineOfCreditFacilityAxis__custom--WifeOfChairmanMember_pp0p0" title="Principal Borrowed"><ix:nonFraction name="ALRT:PrincipalBorrowed" contextRef="AsOf2021-12-31_custom_WifeOfChairmanMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,467,705</ix:nonFraction></span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_904_ecustom--AccruedInterest_c20211231__us-gaap--LineOfCreditFacilityAxis__custom--WifeOfChairmanMember_pp0p0" title="Accrued Interest"><ix:nonFraction name="ALRT:AccruedInterest" contextRef="AsOf2021-12-31_custom_WifeOfChairmanMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">111,846</ix:nonFraction></span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_ecustom--TotalOutstanding_c20211231__us-gaap--LineOfCreditFacilityAxis__custom--WifeOfChairmanMember_pp0p0" title="Total Outstanding"><ix:nonFraction name="ALRT:TotalOutstanding" contextRef="AsOf2021-12-31_custom_WifeOfChairmanMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,579,551</ix:nonFraction></span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_ecustom--Security1_c20210101__20211231__us-gaap--LineOfCreditFacilityAxis__custom--WifeOfChairmanMember" title="Security"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_WifeOfChairmanMember" name="ALRT:Security1">General
    Security over Assets</ix:nonNumeric></span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_ecustom--Purpose1_c20210101__20211231__us-gaap--LineOfCreditFacilityAxis__custom--WifeOfChairmanMember" title="Purpose"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_WifeOfChairmanMember" name="ALRT:Purpose1">General
    Corporate Requirements</ix:nonNumeric></span></span></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$
    <span id="xdx_90F_ecustom--BorrowingLimit_c20211231_pp0p0" title="Borrowing Limit"><ix:nonFraction name="ALRT:BorrowingLimit" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">14,300,000</ix:nonFraction></span></span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$
    <span id="xdx_90F_ecustom--PrincipalBorrowed_c20211231_pp0p0" title="Principal Borrowed"><ix:nonFraction name="ALRT:PrincipalBorrowed" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">12,688,405</ix:nonFraction></span></span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$<span id="xdx_90F_ecustom--AccruedInterest_c20211231_pp0p0" title="Accrued Interest">
    <ix:nonFraction name="ALRT:AccruedInterest" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,320,428</ix:nonFraction></span></span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$
    <span id="xdx_900_ecustom--TotalOutstanding_c20211231_pp0p0" title="Total Outstanding"><ix:nonFraction name="ALRT:TotalOutstanding" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">14,008,833</ix:nonFraction></span></span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>
</ix:nonNumeric><p id="xdx_8A2_zUIZZ25eBE04" style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 13 -->
    <div id="xdx_230_zJNUOUaRAFh9" style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" id="xdx_239_z8KVnAJYzEOf" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></td><td id="xdx_23B_zpxIQwxKYMf3" style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div id="xdx_236_ztZGuy2VtbO5" style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p id="xdx_238_zYh8WRJRgjyc" style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_232_ztItCA15FeLi" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ALR
TECHNOLOGIES INC.</b></span></p></ix:exclude>

<ix:exclude><p id="xdx_239_zacBZ1ki6yZ1" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notes
to Condensed Consolidated Financial Statements</span></p></ix:exclude>

<ix:exclude><p id="xdx_234_zaR6v68mrpP7" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the Six Months Ended June&#160;30, 2022</span></p></ix:exclude>

<ix:exclude><p id="xdx_233_ztMiOqWg7B73" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">($
United States)</span></p></ix:exclude>

<ix:exclude><p id="xdx_238_zOamivoN4Uu4" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Unaudited)</span></p></ix:exclude>

<ix:exclude><p id="xdx_23A_zD1DQUmoxTRg" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_234_zSnshZALzShd" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:exclude>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-01to2022-06-30" escape="true" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock"><p id="xdx_80C_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_zWejA8MeCBsl" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>6.&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span id="xdx_823_z5o6392NDyMk">Capital
stock</span></b></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 17.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Authorized
                                            capital stock</span></td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify; text-indent: -0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white"><tr style="vertical-align: top">
<td style="width: 35.45pt"></td><td style="width: 18.55pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">i)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common
                                            Stock</span></td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,000,000,000
shares of common stock with a par value of $0.001 per share.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white"><tr style="vertical-align: top">
<td style="width: 35.45pt"></td><td style="width: 18.55pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Preferred
                                            Stock </span></td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">500,000,000
shares of preferred stock with a par value of $0.001 per share.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;Issued
capital stock</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>During
the period ended June&#160;30, 2022:</b></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white"><tr style="vertical-align: top">
<td style="width: 35.3pt"></td><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">i)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
                                            January 18, 2022, the Company issued a prospectus whereby it distributed 101,025,592 subscription
                                            rights to its shareholders to purchase shares of common stock of the Company at a price of
                                            $0.05 per share. The rights were set to expire on February 18, 2022, subsequently extended
                                            to March&#160;15, 2022. On such case-by-case basis, the Company allowed for the exercise
                                            of any such shares until April&#160;1, 2022. Management may, at its discretion, allocate
                                            unexercised subscription rights to non-shareholders within 150 days (August&#160;12, 2022)
                                            following the expiration date of March&#160;15, 2022. On March&#160;21, 2022, the Company
                                            recognized share subscriptions receivable of $25 pursuant to its registration statement and
                                            issued a total of 500 shares of common stock for gross proceeds of $25. The subscription
                                            rights were cancelled on July 7, 2022 (note 11(a)).</span></td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white"><tr style="vertical-align: top">
<td style="width: 35.45pt"></td><td style="width: 18.55pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            Company issued four parties an aggregate 9,250,000 shares of common stock at a fair value
                                            of $0.04 per share for a total of $370,000 in exchange for the retirement of $125,000 of
                                            accounts payable and $245,000 for bonuses issued.</span></td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:exclude><p id="xdx_237_zy50uxOPuo4d" style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:exclude>


<ix:exclude><!-- Field: Page; Sequence: 14 -->
    <div id="xdx_239_zBrfjDU0aFr9" style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" id="xdx_232_ze8Kav0djO3f" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></td><td id="xdx_237_zDobZIz5NUFc" style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div id="xdx_23D_zbk6dDBeNRr7" style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p id="xdx_237_zxidNCaXNqT3" style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_23E_ziAptnaenUT6" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ALR
TECHNOLOGIES INC.</b></span></p></ix:exclude>

<ix:exclude><p id="xdx_23F_zPnTavG9LNcf" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notes
to Condensed Consolidated Financial Statements</span></p></ix:exclude>

<ix:exclude><p id="xdx_23D_z8OX5mHyvH61" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the Six Months Ended June&#160;30, 2022</span></p></ix:exclude>

<ix:exclude><p id="xdx_239_zlXLTpPBZrf6" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">($
United States)</span></p></ix:exclude>

<ix:exclude><p id="xdx_231_zP5PXc6mLqOi" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Unaudited)</span></p></ix:exclude>

<ix:exclude><p id="xdx_238_zUtT6zqzK0Wa" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_23C_zO7zqJJ06QBj" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_234_zXx2AQBP3QJ8" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>6.</b>&#160;&#160;&#160;&#160;&#160;&#160;&#160;<b>Capital
stock (continued)</b></span></p></ix:exclude>

<ix:exclude><p id="xdx_23B_zClw3dmgNIFb" style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_237_zXuHdP4MrmQ9" style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;Issued
capital stock (continued)</span></p></ix:exclude>

<ix:exclude><p id="xdx_234_zAgAui7EwkPc" style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:exclude>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>During
the year ended December&#160;31, 2021:</b></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 35.45pt"></td><td style="width: 18.55pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">iii)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
                                            January 4, 2021, 1,000 shares of common stock were cancelled by a shareholder; no consideration
                                            was exchanged.</span></td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify; text-indent: -18.55pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 35.45pt"></td><td style="width: 18.55pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">iv)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
                                            April 12, 2021, the Company elected to extend the initial 90-day period (April&#160;22, 2021)
                                            by an additional 100-day period related to the closing of the rights offering. The Company
                                            had until July&#160;31, 2021 to sell the remaining 113,025,592 shares of common stock. The
                                            Company further extended the offering period to October 29, 2021. The Company filed a post-effective
                                            amendment to further extend the rights offering from October 29, 2021 to March 15, 2022.
                                            On such case-by-case basis, the Company allowed for the exercise of any such shares until
                                            April&#160;1, 2022. Management may, at its discretion, allocate unexercised subscription
                                            rights to non-shareholders within 150 days (August 12, 2022) following the expiration date
                                            of March&#160;15, 2022. The subscription rights were cancelled on July 7, 2022 (note 11(a)).</span></td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify; text-indent: -18.55pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 35.45pt"></td><td style="width: 18.55pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">v)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            Company collected subscriptions of $1,124,832 pursuant to its registration statement and
                                            issued a total of 26,496,635 shares of common stock for gross proceeds of $1,324,832; $200,000
                                            of the proceeds had been collected during the year ended December&#160;31, 2020 and recognized
                                            as obligation to issue shares.</span></td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify; text-indent: -18.55pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 35.45pt"></td><td style="width: 18.55pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">vi)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            Company received proceeds of $12,000 pursuant to the exercise of options to acquire 800,000
                                            shares of common stock at a price of $0.015 per share.</span></td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-indent: -18.55pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 35.45pt"></td><td style="width: 18.55pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">vii)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            Company entered into two shares for debt agreements with two creditors to issue an aggregate
                                            4,400,000 shares of common stock at a fair value of $0.057 per share for a purchase price
                                            of $250,800 in exchange for the retirement of $217,186 of liabilities comprised of: </span></td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 71.45pt"></td><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#183;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounts
                                            payable&#9;-&#9;$ 194,186</span></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 71.45pt"></td><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#183;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Promissory
                                            notes &#8211; Principal &#9;-&#9;$ 20,000</span></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 71.45pt"></td><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#183;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Line
                                            of credit &#8211; Accrued interest&#9;-&#9;$ 3,000</span></td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify; text-indent: 13.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company recognized loss on debt settlement of $33,614. The Company also issued commitment letters to two creditors offering them an aggregate
20,000,000 shares of common stock in exchange for the extinguishment of $1,511,377 in promissory notes and interest payable prior to
December&#160;31, 2021 (note&#160;8). These offer letters expired on December&#160;31, 2021 without the parties executing any settlements.
On March&#160;18, 2022, the Company extended the offer letters from December&#160;31, 2021 to December&#160;31, 2022 for the settlement
of $1,541,000 in promissory notes and interest payable. As of the date of these condensed consolidated financial statements, the offer
letters have not been executed.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 15 -->
    <div id="xdx_236_z3QgP4bNs4Ud" style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" id="xdx_23A_zOUN1u2U2He9" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></td><td id="xdx_237_zs2g3o56dIed" style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div id="xdx_231_zy2y2KN6v38e" style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p id="xdx_23E_zLnDimx3pHse" style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_238_zKw6BMDX7DLi" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ALR
TECHNOLOGIES INC.</b></span></p></ix:exclude>

<ix:exclude><p id="xdx_238_zpEoxqbpAeO5" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notes
to Condensed Consolidated Financial Statements</span></p></ix:exclude>

<ix:exclude><p id="xdx_23F_zOzFJe12xHya" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the Six Months Ended June&#160;30, 2022</span></p></ix:exclude>

<ix:exclude><p id="xdx_233_zSfufm6o8Ho" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">($
United States)</span></p></ix:exclude>

<ix:exclude><p id="xdx_23D_zr4lEhWGDn25" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Unaudited)</span></p></ix:exclude>

<ix:exclude><p id="xdx_234_z8I4uDOeBKuj" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_232_zF7M2O03eHhk" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:exclude>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-01to2022-06-30" escape="true" name="ALRT:AdditionalPaidInCapitalTextBlock"><p id="xdx_802_ecustom--AdditionalPaidInCapitalTextBlock_znlk1pU4dip9" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>7.
&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span id="xdx_823_zUDSEonENrri">Additional paid-in capital</span></b></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stock
options</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
summary of stock option activity is as follows:</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2022-01-01to2022-06-30" escape="true" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"><table cellspacing="0" cellpadding="0" id="xdx_892_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_zUoiYiGi2vq5" summary="xdx: Disclosure - Additional paid-in capital (Details)" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span id="xdx_8B1_zKthe3E0mds9" style="display: none">Schedule of share-based compensation, stock options, activity</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Six
                                            Months Ended</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>June&#160;30,
    2022</b></span></p></td>
    <td colspan="3" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Year
                                            Ended</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December&#160;31,
    2021</b></span></p></td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number
    of Options</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Weighted
    Average Exercise Price</span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number
    of Options</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Weighted
    Average Exercise Price</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 45%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding,
    beginning of period</span></td>
    <td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20220101__20220630_zV1DYlxCfDN8" title="Outstanding, beginning of period" style="width: 16%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">5,497,001,500</ix:nonFraction></span></td>
    <td style="width: 3%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20220101__20220630_zQXpNrvOIiRh" title="Average Exercise Price, beginning" style="width: 8%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.006</ix:nonFraction></span></td>
    <td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20210101__20211231_zAwiiG38tZ2b" title="Outstanding, beginning of period" style="width: 16%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">5,362,701,500</ix:nonFraction></span></td>
    <td style="width: 3%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20210101__20211231_zO1LKcElzOu7" title="Average Exercise Price, beginning" style="width: 9%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.004</ix:nonFraction></span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</span></td>
    <td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_c20220101__20220630_pdd" title="Granted" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0655">-</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20220101__20220630_pdd" title="Granted, per share" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0657">-</span></span></td>
    <td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_c20210101__20211231_pdd" title="Granted" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">165,000,000</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20210101__20211231_pdd" title="Granted, per share" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.050</ix:nonFraction></span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercised
    </span></td>
    <td id="xdx_98C_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_di_c20220101__20220630_zrvMVZcthA6b" title="Exercised" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0663">-</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_iN_di_c20220101__20220630_zxzdztcQw2U7" title="Exercised per share" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0665">-</span></span></td>
    <td id="xdx_98C_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_di_c20210101__20211231_z3u32gzrfZC7" title="Exercised" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">800,000</ix:nonFraction>)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_iN_di_c20210101__20211231_zi9SZEmKkBQk" title="Exercised per share" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.015</ix:nonFraction>)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cancelled</span></td>
    <td id="xdx_980_ecustom--ShareBasedCompensationArrangementbyShareBasedPaymentAwardOptionsCancelations_iN_di_c20220101__20220630_zhCh96P9e14d" title="Cancelled" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="ALRT:ShareBasedCompensationArrangementbyShareBasedPaymentAwardOptionsCancelations" contextRef="From2022-01-01to2022-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">90,000,000</ix:nonFraction>)</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98C_ecustom--CancelledPerShares_iN_di_c20220101__20220630_zjhNUX9qAFAj" title="Cancelled per share" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="ALRT:CancelledPerShares" contextRef="From2022-01-01to2022-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.041</ix:nonFraction>)</span></td>
    <td id="xdx_98E_ecustom--ShareBasedCompensationArrangementbyShareBasedPaymentAwardOptionsCancelations_iN_di_c20210101__20211231_znFABDdf4dOh" title="Cancelled" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="ALRT:ShareBasedCompensationArrangementbyShareBasedPaymentAwardOptionsCancelations" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">29,900,000</ix:nonFraction>)</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98E_ecustom--CancelledPerShares_iN_di_c20210101__20211231_zFFfX3awkha1" title="Cancelled per share" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="ALRT:CancelledPerShares" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.034</ix:nonFraction>)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding,
    end of period</span></td>
    <td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20220101__20220630_zbKFTwrihlcl" title="Outstanding, end of period" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">5,407,001,500</ix:nonFraction></span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20220101__20220630_zc8T3dYSe4N4" title="Average Exercise price, ending" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.005</ix:nonFraction></span></td>
    <td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20210101__20211231_zbgPrtK7TVQf" title="Outstanding, end of period" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">5,497,001,500</ix:nonFraction></span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20210101__20211231_zgkryhDzsGA6" title="Average Exercise price, ending" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.006</ix:nonFraction></span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercisable,
    end of period</span></td>
    <td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_c20220630_pdd" title="Exercisable, end of period" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">5,223,701,500</ix:nonFraction></span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_c20220630_pdd" title="Exercisable, end of period" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.004</ix:nonFraction></span></td>
    <td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_c20211231_pdd" title="Exercisable, end of period" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">5,221,701,500</ix:nonFraction></span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_c20211231_pdd" title="Exercisable, end of period" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.004</ix:nonFraction></span></td></tr>
  </table>
</ix:nonNumeric><p id="xdx_8AF_z8qgwZeEZTPb" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>During
the period ended June&#160;30, 2022:</b></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">On
March 18, 2022, the Company modified 70,000,000 options previously granted to a number of advisors and independent contractors by extending
the vesting period under vesting terms, which have not been met, from September&#160;30, 2021 and December&#160;31, 2021 to December&#160;31,
2022, and from June&#160;30, 2022 to June&#160;30, 2023.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">On
March 18, 2022, the Company amended 2,500,000 options previously granted to an individual on October&#160;4, 2021 by vesting 1,000,000
options with performance conditions and cancelling the remaining 1,500,000 options. During the period ended June&#160;30, 2022, $59,639
related to the 1,000,000 options that vested immediately was recorded.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Effective
March 18, 2022, the Company cancelled 20,000,000 stock options exercisable at $0.015, 10,000,000 stock options exercisable at $0.035
and 28,500,000 exercisable at $0.05 related to the termination of certain contractors.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">On
April 27, 2022, the Company provided termination notice to a contractor. As a result, the contractor&#8217;s 30,000,000 stock options
exercisable at $0.05 were cancelled, unvested, effective June&#160;30, 2022.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">During
the period ended June&#160;30, 2022, the Company recorded a total of $518,659 in compensation expense related to the vesting of stock
options granted in 2021, including the $59,639 from the modification of vesting terms of 1,000,000 options.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 16 -->
    <div id="xdx_23B_zoR7hUf6Wd7k" style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" id="xdx_23B_zO17J90EEod5" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></td><td id="xdx_23A_z57RZhWd7sJ3" style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div id="xdx_239_zykTexCARYPe" style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p id="xdx_238_zLi4q3Pziua7" style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_238_zHTPWMf8ybIl" style="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_239_zKNAHmR5CRDe" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ALR
TECHNOLOGIES INC.</b></span></p></ix:exclude>

<ix:exclude><p id="xdx_236_zwGOm9Lu2Ymj" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notes
to Condensed Consolidated Financial Statements</span></p></ix:exclude>

<ix:exclude><p id="xdx_239_zc11lKIq4U0e" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the Six Months Ended June&#160;30, 2022</span></p></ix:exclude>

<ix:exclude><p id="xdx_232_zo7Emm7XuqJ4" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">($
United States)</span></p></ix:exclude>

<ix:exclude><p id="xdx_233_zwFnDieB7vqg" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Unaudited)</span></p></ix:exclude>

<ix:exclude><p id="xdx_23D_zPNLvB3dMTf6" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_23A_zGGEPqF4qwD9" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_235_zoRkQdDOuA7a" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>7.
&#160;&#160;&#160;&#160;&#160;&#160;&#160;Additional paid-in capital (continued)</b></span></p></ix:exclude>

<ix:exclude><p id="xdx_23C_zfVDygrAc1i9" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_239_zq3fIg6APsCh" style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Stock
options (continued)</span></p></ix:exclude>

<ix:exclude><p id="xdx_234_zufrgMPeXIyj" style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span> </p></ix:exclude>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><b>During
the year ended December&#160;31, 2021:</b></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">On
January 28, 2021, the Company granted the option to acquire an aggregate 32,000,000 shares of common stock at a price of $0.05 per share
to six individuals. All of the options will vest according to performance or time-based conditions. Options to acquire 22,000,000 shares
of common stock will expire December&#160;31, 2025, and options to acquire 10,000,000 shares of common stock will expire May&#160;17,
2024. As at June&#160;30, 2022, 2,000,000 (December&#160;31, 2021&#160;- 1,000,000) options have vested to date. The fair value of the
options granted totals $1,706,244, of which $573,292 relates to stock options that have time-based vesting conditions and $1,132,952
relates to stock options that have performance vesting conditions. During the period ended June&#160;30, 2022, $98,726 (December&#160;31,
2021 - $248,189) related to stock options with time-based vesting conditions and $56,648 (December&#160;31, 2021 - $nil) related to stock
options with performance-based vesting conditions was recognized. The remaining fair value of $1,302,681 has not been recorded.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">On
February 22, 2021, the Company granted the option to acquire an aggregate 5,000,000 shares of common stock at a price of $0.05 per share.
These options were granted to three individuals and have an expiry date of May 17, 2024. None of these options have vested to date. The
fair value of the options granted totaled $225,141. During the period ended June&#160;30, 2022, $34,638 (December&#160;31, 2021 - $57,730)
related to stock options with time-based vesting conditions was recognized. The remaining fair value of $132,773 has not been recorded.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">On
April 14, 2021, the Company&#8217;s Board of Directors approved the grant of the option to acquire an aggregate 28,500,000 shares of
common stock at a price of $0.05 per share until December&#160;31, 2025 to five individuals. All of the options will vest according to
performance or time-based conditions; 200,000 options have vested to date. The fair value of the options granted totaled $1,565,812,
of which $351,621 related to stock options that have time-based vesting conditions and $1,214,191 related to stock options that have
performance vesting conditions. During the period ended June&#160;30, 2022, $54,558 (December&#160;31, 2021 - $88,540) related to the
stock options with time-based vesting conditions was recognized. The remaining fair value of $1,422,714 has not been recorded.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">On
May 12, 2021, the Company&#8217;s Board of Directors amended the option to acquire 2,000,000 shares, previously granted on January 28,
2021 to a consultant, to increase the option by 1,000,000 to provide the optionee the option to acquire an aggregate 3,000,000 shares
of common stock at a price of $0.05 per share until December&#160;31, 2025. All other terms of the January 28, 2021 grant remain the
same and the options are subject to performance vesting conditions. The fair value of the additional 1,000,000 amended options granted
totaled $54,940 was not recorded, as it cannot be determined that it is more likely than not that the performance condition will be met.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">On
May 31, 2021, the Company granted one consultant the option to acquire 5,000,000 shares of common stock of the Company at a price of
$0.05 per share until December&#160;31, 2025 subject to performance vesting conditions. The fair value of the options granted totaled
$254,708 was not recorded, as it cannot be determined that it is more likely than not that the performance condition will be met.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 17 -->
    <div id="xdx_23E_z3tKkqnmNLA8" style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" id="xdx_23D_zujuAYIvagT4" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></td><td id="xdx_233_zwKCWNl0SQV" style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div id="xdx_231_zlEmYZpYrQgl" style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p id="xdx_23E_zFV3TCTPQlj5" style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_230_zFHWH0rcTl18" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ALR
TECHNOLOGIES INC.</b></span></p></ix:exclude>

<ix:exclude><p id="xdx_234_z76zLxy0rLl4" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notes
to Condensed Consolidated Financial Statements</span></p></ix:exclude>

<ix:exclude><p id="xdx_230_zE6UpyaErVja" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the Six Months Ended June&#160;30, 2022</span></p></ix:exclude>

<ix:exclude><p id="xdx_239_zGSt9urqdpPe" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">($
United States)</span></p></ix:exclude>

<ix:exclude><p id="xdx_23A_zEtG6EtVpszi" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Unaudited)</span></p></ix:exclude>

<ix:exclude><p id="xdx_23D_zQa9jgV6qGgc" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_23F_zH3N06QWaFX9" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_234_zU9VREiPjhnd" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>7.
&#160;&#160;&#160;&#160;&#160;&#160;&#160;Additional paid-in capital (continued)</b></span></p></ix:exclude>

<ix:exclude><p id="xdx_231_zthhNTdzGa07" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_23D_zYacJWOI0715" style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Stock
options (continued)</span></p></ix:exclude>

<ix:exclude><p id="xdx_239_z2M0kpItGkqd" style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_234_z3ZYKqbfSHB6" style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><b>During
the year ended December&#160;31, 2021: (continued)</b></span></p></ix:exclude>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">On
June 27, 2021, the Company cancelled 7,400,000 stock options with an average exercise price of $0.033.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">On
June 27, 2021, the Company&#8217;s Board of Directors approved the grant of the option to acquire an aggregate 21,000,000 shares of common
stock at a price of $0.05 per share until June&#160;30, 2026 to four individuals. All of the options will vest according to performance
or time-based conditions. The fair value of the options granted totaled $1,374,208, of which $26,175 related to stock options with time-based
vesting conditions and $1,348,033 related to stock options with performance vesting conditions. During the period ended June&#160;30,
2022, $9,812 (December&#160;31, 2021 - $9,816) related to the stock options with time-based vesting conditions was recognized. The remaining
fair value of $1,354,580 has not been recorded.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">On
June&#160;30, 2021, the Company amended the option to acquire 4,365,001,300 shares of common stock granted on July&#160;1, 2016 by extending
the expiry date from July&#160;1, 2021 to April&#160;12, 2024. The options were granted in connection with lines of credit provided by
the Chairman and his spouse, which are currently outstanding (note&#160;5). All of the options had vested in previous years. The fair
value of the amendments totaled $1,287,834 and was recorded during the year ended December&#160;31, 2021 in interest expense.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Effective
July 22, 2021, the Company cancelled 22,500,000 stock options exercisable at $0.035 related to the termination of certain contractors
and advisors.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">On
August 27, 2021, the Company granted a member of the Board of Directors the option to acquire 5,000,000 shares of common stock at a price
of $0.05 per share until June&#160;30, 2026. The fair value of the options granted totaling $304,692 was fully recorded at grant.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">On
October 4, 2021, the Company granted two individuals the option to acquire an aggregate 17,500,000 options at an exercise price of $0.05
per share until September&#160;30, 2026; 15,000,000 of the options will vest according to time-based conditions and 2,500,000 will vest
according to performance conditions. </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On March 18, 2022,
the Company cancelled 1,500,000 options and vested 1,000,000 options with performance vesting conditions. <span style="background-color: white">As
at June&#160;30, 2022, 1,000,000 (December&#160;31, 2021&#160;- nil) options have vested to date. The fair value of the options granted
totaled $1,043,690, of which $894,592 related to stock options that have time-based vesting conditions and $149,098 related to stock
options that have performance vesting conditions. During the period ended June&#160;30, 2022, $204,638 (December&#160;31, 2021 - $101,758)
related to stock options with time-based vesting conditions and $59,639 (December&#160;31, 2021 - $nil) related to stock options with
performance-based vesting conditions was recognized. The remaining fair value of $677,655 has not been recorded.</span></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">On
December 10, 2021, the Company granted one creditor the option to acquire 40,000,000 shares of common stock of the Company at a price
of $0.05 per share until December&#160;31, 2026 in connection with receiving line of credit financing (note&#160;5). The fair value of
the options granted totaled $2,137,286 and was fully recorded upon the Company entering into the financing agreement with the creditor.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 18 -->
    <div id="xdx_232_zKG2NSyFl6Sb" style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" id="xdx_237_zGKvXV9YDnS3" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></td><td id="xdx_23A_zXAAmrTK2rxf" style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div id="xdx_234_zt49yMIc1dUf" style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p id="xdx_239_zGh4aGa4xVa2" style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_239_z5SxSPlLfGkh" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ALR
TECHNOLOGIES INC.</b></span></p></ix:exclude>

<ix:exclude><p id="xdx_230_zWh1ZKEz2o7l" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notes
to Condensed Consolidated Financial Statements</span></p></ix:exclude>

<ix:exclude><p id="xdx_23D_zdPXfnTOxp8k" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the Six Months Ended June&#160;30, 2022</span></p></ix:exclude>

<ix:exclude><p id="xdx_235_zucM7ypIsHi6" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">($
United States)</span></p></ix:exclude>

<ix:exclude><p id="xdx_23B_zdN1tZQgyMFd" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Unaudited)</span></p></ix:exclude>

<ix:exclude><p id="xdx_236_zttcKKRzJyGc" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_230_z2bOj9mdhFx9" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_231_zediJ8WAEbi" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>7.
&#160;&#160;&#160;&#160;&#160;&#160;&#160;Additional paid-in capital (continued)</b></span></p></ix:exclude>

<ix:exclude><p id="xdx_23E_zyFPN7w1WnSh" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_23C_zwrYfwKn5yU2" style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stock
options (continued)</span></p></ix:exclude>

<ix:exclude><p id="xdx_23C_zAGwzSqitYjd" style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_232_zDBxXjL0UXM4" style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>During
the year ended December&#160;31, 2021: (continued)</b></span></p></ix:exclude>

<ix:exclude><p id="xdx_238_zNo2MSAjWAz6" style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:exclude>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">On
December 10, 2021, the Company granted one consultant the option to acquire 10,000,000 shares of common stock of the Company at a price
of $0.05 per share until December&#160;31, 2026 subject to performance vesting conditions. The fair value of the options granted totaled
$534,321 was not recorded, as it cannot be determined that it is more likely than not that the performance condition will be met.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">During
the year ended December&#160;31, 2021, the Company recorded a further $167,373 in compensation expense related to the vesting of stock
options granted in previous years.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Outstanding:</b></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The
options outstanding at June&#160;30, 2022 and December&#160;31, 2021 were as follows:</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2022-01-01to2022-06-30" escape="true" name="ALRT:ScheduleofOptionsOutstandingTableTextBlock"><table cellspacing="0" cellpadding="0" id="xdx_894_ecustom--ScheduleofOptionsOutstandingTableTextBlock_z6jbF1ydVQfd" summary="xdx: Disclosure - Additional paid-in capital (Details 1)" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span id="xdx_8B7_zW1FlOVS0Zvl" style="display: none">Schedule of Options Outstanding</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="5" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>June&#160;30,
    2022</b></span></td>
    <td colspan="5" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December&#160;31,
    2021</b></span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expiry
    Date</span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Options</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercise
    Price</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intrinsic
    Value</span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Options</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercise
    Price</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intrinsic
    Value</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="width: 34%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 13%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 3%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 7%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 3%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 7%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 13%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 3%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 7%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 3%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 7%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">November
    27, 2022</span></td>
    <td id="xdx_989_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options1Member_pdd" title="Options" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:OpenOptionContractsWrittenNumbersOfShare" contextRef="From2022-01-012022-06-30_custom_Options1Member" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">5,600,000</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98F_ecustom--ExercisePrices_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options1Member_pdd" title="Exercise Price" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:ExercisePrices" contextRef="From2022-01-012022-06-30_custom_Options1Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.015</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_983_ecustom--IntrinsicValue_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options1Member_pdd" title="Intrinsic Value" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:IntrinsicValue" contextRef="From2022-01-012022-06-30_custom_Options1Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.044</ix:nonFraction></span></td>
    <td id="xdx_98D_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options1Member_pdd" title="Options" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:OpenOptionContractsWrittenNumbersOfShare" contextRef="From2021-01-012021-12-31_custom_Options1Member" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">5,600,000</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98B_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options1Member_pdd" title="Exercise Price" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:ExercisePrices" contextRef="From2021-01-012021-12-31_custom_Options1Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.015</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98C_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options1Member_pdd" title="Intrinsic Value" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:IntrinsicValue" contextRef="From2021-01-012021-12-31_custom_Options1Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.045</ix:nonFraction></span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">January
    31, 2023</span></td>
    <td id="xdx_988_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options2Member_pdd" title="Options" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:OpenOptionContractsWrittenNumbersOfShare" contextRef="From2022-01-012022-06-30_custom_Options2Member" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">20,500,000</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_981_ecustom--ExercisePrices_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options2Member_pdd" title="Exercise Price" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:ExercisePrices" contextRef="From2022-01-012022-06-30_custom_Options2Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.015</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_980_ecustom--IntrinsicValue_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options2Member_pdd" title="Intrinsic Value" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:IntrinsicValue" contextRef="From2022-01-012022-06-30_custom_Options2Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.044</ix:nonFraction></span></td>
    <td id="xdx_98C_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options2Member_pdd" title="Options" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:OpenOptionContractsWrittenNumbersOfShare" contextRef="From2021-01-012021-12-31_custom_Options2Member" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">40,500,000</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98C_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options2Member_pdd" title="Exercise Price" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:ExercisePrices" contextRef="From2021-01-012021-12-31_custom_Options2Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.015</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98F_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options2Member_pdd" title="Intrinsic Value" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:IntrinsicValue" contextRef="From2021-01-012021-12-31_custom_Options2Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.045</ix:nonFraction></span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">June
    13, 2023</span></td>
    <td id="xdx_984_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options3Member_pdd" title="Options" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:OpenOptionContractsWrittenNumbersOfShare" contextRef="From2022-01-012022-06-30_custom_Options3Member" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">5,000,000</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_980_ecustom--ExercisePrices_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options3Member_pdd" title="Exercise Price" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:ExercisePrices" contextRef="From2022-01-012022-06-30_custom_Options3Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.015</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_981_ecustom--IntrinsicValue_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options3Member_pdd" title="Intrinsic Value" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:IntrinsicValue" contextRef="From2022-01-012022-06-30_custom_Options3Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.044</ix:nonFraction></span></td>
    <td id="xdx_98B_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options3Member_pdd" title="Options" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:OpenOptionContractsWrittenNumbersOfShare" contextRef="From2021-01-012021-12-31_custom_Options3Member" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">5,000,000</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98D_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options3Member_pdd" title="Exercise Price" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:ExercisePrices" contextRef="From2021-01-012021-12-31_custom_Options3Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.015</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98E_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options3Member_pdd" title="Intrinsic Value" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:IntrinsicValue" contextRef="From2021-01-012021-12-31_custom_Options3Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.045</ix:nonFraction></span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">March
    14, 2024</span></td>
    <td id="xdx_985_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options4Member_pdd" title="Options" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:OpenOptionContractsWrittenNumbersOfShare" contextRef="From2022-01-012022-06-30_custom_Options4Member" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,650,000</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_983_ecustom--ExercisePrices_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options4Member_pdd" title="Exercise Price" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:ExercisePrices" contextRef="From2022-01-012022-06-30_custom_Options4Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.035</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_986_ecustom--IntrinsicValue_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options4Member_pdd" title="Intrinsic Value" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:IntrinsicValue" contextRef="From2022-01-012022-06-30_custom_Options4Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.024</ix:nonFraction></span></td>
    <td id="xdx_98A_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options4Member_pdd" title="Options" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:OpenOptionContractsWrittenNumbersOfShare" contextRef="From2021-01-012021-12-31_custom_Options4Member" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,650,000</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98E_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options4Member_pdd" title="Exercise Price" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:ExercisePrices" contextRef="From2021-01-012021-12-31_custom_Options4Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.035</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_982_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options4Member_pdd" title="Intrinsic Value" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:IntrinsicValue" contextRef="From2021-01-012021-12-31_custom_Options4Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.025</ix:nonFraction></span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">April
    12, 2024</span></td>
    <td id="xdx_986_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options5Member_pdd" title="Options" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:OpenOptionContractsWrittenNumbersOfShare" contextRef="From2022-01-012022-06-30_custom_Options5Member" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">4,925,001,500</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_982_ecustom--ExercisePrices_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options5Member_pdd" title="Exercise Price" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:ExercisePrices" contextRef="From2022-01-012022-06-30_custom_Options5Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.002</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_987_ecustom--IntrinsicValue_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options5Member_pdd" title="Intrinsic Value" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:IntrinsicValue" contextRef="From2022-01-012022-06-30_custom_Options5Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.057</ix:nonFraction></span></td>
    <td id="xdx_989_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options5Member_pdd" title="Options" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:OpenOptionContractsWrittenNumbersOfShare" contextRef="From2021-01-012021-12-31_custom_Options5Member" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">4,925,001,500</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98F_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options5Member_pdd" title="Exercise Price" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:ExercisePrices" contextRef="From2021-01-012021-12-31_custom_Options5Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.002</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_983_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options5Member_pdd" title="Intrinsic Value" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:IntrinsicValue" contextRef="From2021-01-012021-12-31_custom_Options5Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.058</ix:nonFraction></span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">April
    12, 2024</span></td>
    <td id="xdx_987_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options6Member_pdd" title="Options" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:OpenOptionContractsWrittenNumbersOfShare" contextRef="From2022-01-012022-06-30_custom_Options6Member" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,350,000</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_985_ecustom--ExercisePrices_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options6Member_pdd" title="Exercise Price" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:ExercisePrices" contextRef="From2022-01-012022-06-30_custom_Options6Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.015</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_984_ecustom--IntrinsicValue_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options6Member_pdd" title="Intrinsic Value" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:IntrinsicValue" contextRef="From2022-01-012022-06-30_custom_Options6Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.044</ix:nonFraction></span></td>
    <td id="xdx_988_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options6Member_pdd" title="Options" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:OpenOptionContractsWrittenNumbersOfShare" contextRef="From2021-01-012021-12-31_custom_Options6Member" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,350,000</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_981_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options6Member_pdd" title="Exercise Price" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:ExercisePrices" contextRef="From2021-01-012021-12-31_custom_Options6Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.015</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_980_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options6Member_pdd" title="Intrinsic Value" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:IntrinsicValue" contextRef="From2021-01-012021-12-31_custom_Options6Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.045</ix:nonFraction></span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">April
    12, 2024</span></td>
    <td id="xdx_980_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options7Member_pdd" title="Options" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:OpenOptionContractsWrittenNumbersOfShare" contextRef="From2022-01-012022-06-30_custom_Options7Member" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">200,000</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_984_ecustom--ExercisePrices_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options7Member_pdd" title="Exercise Price" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:ExercisePrices" contextRef="From2022-01-012022-06-30_custom_Options7Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.030</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_985_ecustom--IntrinsicValue_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options7Member_pdd" title="Intrinsic Value" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:IntrinsicValue" contextRef="From2022-01-012022-06-30_custom_Options7Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.029</ix:nonFraction></span></td>
    <td id="xdx_984_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options7Member_pdd" title="Options" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:OpenOptionContractsWrittenNumbersOfShare" contextRef="From2021-01-012021-12-31_custom_Options7Member" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">200,000</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_980_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options7Member_pdd" title="Exercise Price" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:ExercisePrices" contextRef="From2021-01-012021-12-31_custom_Options7Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.030</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_981_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options7Member_pdd" title="Intrinsic Value" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:IntrinsicValue" contextRef="From2021-01-012021-12-31_custom_Options7Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.030</ix:nonFraction></span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">May
    6, 2024</span></td>
    <td id="xdx_981_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options8Member_pdd" title="Options" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:OpenOptionContractsWrittenNumbersOfShare" contextRef="From2022-01-012022-06-30_custom_Options8Member" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">13,000,000</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_987_ecustom--ExercisePrices_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options8Member_pdd" title="Exercise Price" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:ExercisePrices" contextRef="From2022-01-012022-06-30_custom_Options8Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.035</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98A_ecustom--IntrinsicValue_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options8Member_pdd" title="Intrinsic Value" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:IntrinsicValue" contextRef="From2022-01-012022-06-30_custom_Options8Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.024</ix:nonFraction></span></td>
    <td id="xdx_985_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options8Member_pdd" title="Options" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:OpenOptionContractsWrittenNumbersOfShare" contextRef="From2021-01-012021-12-31_custom_Options8Member" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">13,000,000</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_983_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options8Member_pdd" title="Exercise Price" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:ExercisePrices" contextRef="From2021-01-012021-12-31_custom_Options8Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.035</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_986_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options8Member_pdd" title="Intrinsic Value" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:IntrinsicValue" contextRef="From2021-01-012021-12-31_custom_Options8Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.025</ix:nonFraction></span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">May
    17, 2024</span></td>
    <td id="xdx_982_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options9Member_pdd" title="Options" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:OpenOptionContractsWrittenNumbersOfShare" contextRef="From2022-01-012022-06-30_custom_Options9Member" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">57,000,000</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_986_ecustom--ExercisePrices_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options9Member_pdd" title="Exercise Price" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:ExercisePrices" contextRef="From2022-01-012022-06-30_custom_Options9Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.050</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98B_ecustom--IntrinsicValue_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options9Member_pdd" title="Intrinsic Value" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:IntrinsicValue" contextRef="From2022-01-012022-06-30_custom_Options9Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.009</ix:nonFraction></span></td>
    <td id="xdx_986_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options9Member_pdd" title="Options" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:OpenOptionContractsWrittenNumbersOfShare" contextRef="From2021-01-012021-12-31_custom_Options9Member" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">77,000,000</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_982_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options9Member_pdd" title="Exercise Price" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:ExercisePrices" contextRef="From2021-01-012021-12-31_custom_Options9Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.050</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_987_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options9Member_pdd" title="Intrinsic Value" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:IntrinsicValue" contextRef="From2021-01-012021-12-31_custom_Options9Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.010</ix:nonFraction></span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">May
    17, 2024</span></td>
    <td id="xdx_98C_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options10Member_pdd" title="Options" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:OpenOptionContractsWrittenNumbersOfShare" contextRef="From2022-01-012022-06-30_custom_Options10Member" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">19,400,000</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98C_ecustom--ExercisePrices_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options10Member_pdd" title="Exercise Price" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:ExercisePrices" contextRef="From2022-01-012022-06-30_custom_Options10Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.035</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_984_ecustom--IntrinsicValue_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options10Member_pdd" title="Intrinsic Value" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:IntrinsicValue" contextRef="From2022-01-012022-06-30_custom_Options10Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.024</ix:nonFraction></span></td>
    <td id="xdx_988_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options10Member_pdd" title="Options" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:OpenOptionContractsWrittenNumbersOfShare" contextRef="From2021-01-012021-12-31_custom_Options10Member" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">19,400,000</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_988_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options10Member_pdd" title="Exercise Price" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:ExercisePrices" contextRef="From2021-01-012021-12-31_custom_Options10Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.035</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_989_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options10Member_pdd" title="Intrinsic Value" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:IntrinsicValue" contextRef="From2021-01-012021-12-31_custom_Options10Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.025</ix:nonFraction></span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">June
    17, 2024</span></td>
    <td id="xdx_98D_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options11Member_pdd" title="Options" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0854">-</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_984_ecustom--ExercisePrices_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options11Member_pdd" title="Exercise Price" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0856">-</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_987_ecustom--IntrinsicValue_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options11Member_pdd" title="Intrinsic Value" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0858">-</span></span></td>
    <td id="xdx_989_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options11Member_pdd" title="Options" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:OpenOptionContractsWrittenNumbersOfShare" contextRef="From2021-01-012021-12-31_custom_Options11Member" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">5,000,000</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98F_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options11Member_pdd" title="Exercise Price" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:ExercisePrices" contextRef="From2021-01-012021-12-31_custom_Options11Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.050</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98A_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options11Member_pdd" title="Intrinsic Value" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:IntrinsicValue" contextRef="From2021-01-012021-12-31_custom_Options11Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.010</ix:nonFraction></span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">August
    16, 2024</span></td>
    <td id="xdx_983_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options12Member_pdd" title="Options" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0866">-</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_985_ecustom--ExercisePrices_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options12Member_pdd" title="Exercise Price" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0868">-</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_986_ecustom--IntrinsicValue_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options12Member_pdd" title="Intrinsic Value" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0870">-</span></span></td>
    <td id="xdx_98E_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options12Member_pdd" title="Options" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:OpenOptionContractsWrittenNumbersOfShare" contextRef="From2021-01-012021-12-31_custom_Options12Member" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,500,000</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98E_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options12Member_pdd" title="Exercise Price" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:ExercisePrices" contextRef="From2021-01-012021-12-31_custom_Options12Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.050</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98B_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options12Member_pdd" title="Intrinsic Value" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:IntrinsicValue" contextRef="From2021-01-012021-12-31_custom_Options12Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.010</ix:nonFraction></span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">September
    6, 2024</span></td>
    <td id="xdx_982_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options13Member_pdd" title="Options" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0878">-</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_986_ecustom--ExercisePrices_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options13Member_pdd" title="Exercise Price" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0880">-</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_981_ecustom--IntrinsicValue_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options13Member_pdd" title="Intrinsic Value" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0882">-</span></span></td>
    <td id="xdx_98F_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options13Member_pdd" title="Options" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:OpenOptionContractsWrittenNumbersOfShare" contextRef="From2021-01-012021-12-31_custom_Options13Member" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,000,000</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98D_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options13Member_pdd" title="Exercise Price" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:ExercisePrices" contextRef="From2021-01-012021-12-31_custom_Options13Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.050</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_985_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options13Member_pdd" title="Intrinsic Value" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:IntrinsicValue" contextRef="From2021-01-012021-12-31_custom_Options13Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.010</ix:nonFraction></span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">October
    3, 2024</span></td>
    <td id="xdx_981_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options14Member_pdd" title="Options" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:OpenOptionContractsWrittenNumbersOfShare" contextRef="From2022-01-012022-06-30_custom_Options14Member" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,500,000</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_987_ecustom--ExercisePrices_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options14Member_pdd" title="Exercise Price" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:ExercisePrices" contextRef="From2022-01-012022-06-30_custom_Options14Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.035</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_980_ecustom--IntrinsicValue_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options14Member_pdd" title="Intrinsic Value" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:IntrinsicValue" contextRef="From2022-01-012022-06-30_custom_Options14Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.024</ix:nonFraction></span></td>
    <td id="xdx_98C_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options14Member_pdd" title="Options" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:OpenOptionContractsWrittenNumbersOfShare" contextRef="From2021-01-012021-12-31_custom_Options14Member" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,500,000</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98C_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options14Member_pdd" title="Exercise Price" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:ExercisePrices" contextRef="From2021-01-012021-12-31_custom_Options14Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.035</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_984_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options14Member_pdd" title="Intrinsic Value" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:IntrinsicValue" contextRef="From2021-01-012021-12-31_custom_Options14Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.025</ix:nonFraction></span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">October
    24, 2024</span></td>
    <td id="xdx_980_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options15Member_pdd" title="Options" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:OpenOptionContractsWrittenNumbersOfShare" contextRef="From2022-01-012022-06-30_custom_Options15Member" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,000,000</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_980_ecustom--ExercisePrices_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options15Member_pdd" title="Exercise Price" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:ExercisePrices" contextRef="From2022-01-012022-06-30_custom_Options15Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.035</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_983_ecustom--IntrinsicValue_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options15Member_pdd" title="Intrinsic Value" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:IntrinsicValue" contextRef="From2022-01-012022-06-30_custom_Options15Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.024</ix:nonFraction></span></td>
    <td id="xdx_98D_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options15Member_pdd" title="Options" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:OpenOptionContractsWrittenNumbersOfShare" contextRef="From2021-01-012021-12-31_custom_Options15Member" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,000,000</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_984_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options15Member_pdd" title="Exercise Price" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:ExercisePrices" contextRef="From2021-01-012021-12-31_custom_Options15Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.035</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_987_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options15Member_pdd" title="Intrinsic Value" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:IntrinsicValue" contextRef="From2021-01-012021-12-31_custom_Options15Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.025</ix:nonFraction></span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December
    11, 2024</span></td>
    <td id="xdx_987_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options16Member_pdd" title="Options" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:OpenOptionContractsWrittenNumbersOfShare" contextRef="From2022-01-012022-06-30_custom_Options16Member" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">120,000,000</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_981_ecustom--ExercisePrices_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options16Member_pdd" title="Exercise Price" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:ExercisePrices" contextRef="From2022-01-012022-06-30_custom_Options16Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.015</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_982_ecustom--IntrinsicValue_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options16Member_pdd" title="Intrinsic Value" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:IntrinsicValue" contextRef="From2022-01-012022-06-30_custom_Options16Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.044</ix:nonFraction></span></td>
    <td id="xdx_983_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options16Member_pdd" title="Options" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:OpenOptionContractsWrittenNumbersOfShare" contextRef="From2021-01-012021-12-31_custom_Options16Member" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">120,000,000</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_985_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options16Member_pdd" title="Exercise Price" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:ExercisePrices" contextRef="From2021-01-012021-12-31_custom_Options16Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.015</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_986_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options16Member_pdd" title="Intrinsic Value" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:IntrinsicValue" contextRef="From2021-01-012021-12-31_custom_Options16Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.045</ix:nonFraction></span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">April
    1, 2025</span></td>
    <td id="xdx_986_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options17Member_pdd" title="Options" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:OpenOptionContractsWrittenNumbersOfShare" contextRef="From2022-01-012022-06-30_custom_Options17Member" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">10,000,000</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_982_ecustom--ExercisePrices_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options17Member_pdd" title="Exercise Price" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:ExercisePrices" contextRef="From2022-01-012022-06-30_custom_Options17Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.035</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98D_ecustom--IntrinsicValue_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options17Member_pdd" title="Intrinsic Value" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:IntrinsicValue" contextRef="From2022-01-012022-06-30_custom_Options17Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.024</ix:nonFraction></span></td>
    <td id="xdx_982_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options17Member_pdd" title="Options" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:OpenOptionContractsWrittenNumbersOfShare" contextRef="From2021-01-012021-12-31_custom_Options17Member" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">10,000,000</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_986_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options17Member_pdd" title="Exercise Price" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:ExercisePrices" contextRef="From2021-01-012021-12-31_custom_Options17Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.035</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_981_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options17Member_pdd" title="Intrinsic Value" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:IntrinsicValue" contextRef="From2021-01-012021-12-31_custom_Options17Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.025</ix:nonFraction></span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">May
    31, 2025</span></td>
    <td id="xdx_985_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options18Member_pdd" title="Options" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:OpenOptionContractsWrittenNumbersOfShare" contextRef="From2022-01-012022-06-30_custom_Options18Member" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">10,000,000</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_983_ecustom--ExercisePrices_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options18Member_pdd" title="Exercise Price" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:ExercisePrices" contextRef="From2022-01-012022-06-30_custom_Options18Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.035</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98C_ecustom--IntrinsicValue_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options18Member_pdd" title="Intrinsic Value" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:IntrinsicValue" contextRef="From2022-01-012022-06-30_custom_Options18Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.024</ix:nonFraction></span></td>
    <td id="xdx_981_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options18Member_pdd" title="Options" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:OpenOptionContractsWrittenNumbersOfShare" contextRef="From2021-01-012021-12-31_custom_Options18Member" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">20,000,000</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_987_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options18Member_pdd" title="Exercise Price" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:ExercisePrices" contextRef="From2021-01-012021-12-31_custom_Options18Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.035</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_980_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options18Member_pdd" title="Intrinsic Value" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:IntrinsicValue" contextRef="From2021-01-012021-12-31_custom_Options18Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.025</ix:nonFraction></span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">May
    31, 2025</span></td>
    <td id="xdx_984_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options19Member_pdd" title="Options" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:OpenOptionContractsWrittenNumbersOfShare" contextRef="From2022-01-012022-06-30_custom_Options19Member" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">57,300,000</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98C_ecustom--ExercisePrices_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options19Member_pdd" title="Exercise Price" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:ExercisePrices" contextRef="From2022-01-012022-06-30_custom_Options19Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.050</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98F_ecustom--IntrinsicValue_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options19Member_pdd" title="Intrinsic Value" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:IntrinsicValue" contextRef="From2022-01-012022-06-30_custom_Options19Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.009</ix:nonFraction></span></td>
    <td id="xdx_980_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options19Member_pdd" title="Options" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:OpenOptionContractsWrittenNumbersOfShare" contextRef="From2021-01-012021-12-31_custom_Options19Member" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">87,300,000</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_980_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options19Member_pdd" title="Exercise Price" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:ExercisePrices" contextRef="From2021-01-012021-12-31_custom_Options19Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.050</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_983_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options19Member_pdd" title="Intrinsic Value" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:IntrinsicValue" contextRef="From2021-01-012021-12-31_custom_Options19Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.010</ix:nonFraction></span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December&#160;31,
    2025</span></td>
    <td id="xdx_98D_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options20Member_pdd" title="Options" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:OpenOptionContractsWrittenNumbersOfShare" contextRef="From2022-01-012022-06-30_custom_Options20Member" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">56,500,000</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_984_ecustom--ExercisePrices_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options20Member_pdd" title="Exercise Price" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:ExercisePrices" contextRef="From2022-01-012022-06-30_custom_Options20Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.050</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_987_ecustom--IntrinsicValue_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options20Member_pdd" title="Intrinsic Value" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:IntrinsicValue" contextRef="From2022-01-012022-06-30_custom_Options20Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.009</ix:nonFraction></span></td>
    <td id="xdx_989_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options20Member_pdd" title="Options" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:OpenOptionContractsWrittenNumbersOfShare" contextRef="From2021-01-012021-12-31_custom_Options20Member" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">56,500,000</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98F_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options20Member_pdd" title="Exercise Price" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:ExercisePrices" contextRef="From2021-01-012021-12-31_custom_Options20Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.050</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98A_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options20Member_pdd" title="Intrinsic Value" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:IntrinsicValue" contextRef="From2021-01-012021-12-31_custom_Options20Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.010</ix:nonFraction></span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">June&#160;30,
    2026</span></td>
    <td id="xdx_983_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options21Member_pdd" title="Options" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:OpenOptionContractsWrittenNumbersOfShare" contextRef="From2022-01-012022-06-30_custom_Options21Member" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">26,000,000</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_985_ecustom--ExercisePrices_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options21Member_pdd" title="Exercise Price" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:ExercisePrices" contextRef="From2022-01-012022-06-30_custom_Options21Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.050</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_986_ecustom--IntrinsicValue_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options21Member_pdd" title="Intrinsic Value" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:IntrinsicValue" contextRef="From2022-01-012022-06-30_custom_Options21Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.009</ix:nonFraction></span></td>
    <td id="xdx_98E_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options21Member_pdd" title="Options" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:OpenOptionContractsWrittenNumbersOfShare" contextRef="From2021-01-012021-12-31_custom_Options21Member" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">26,000,000</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98E_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options21Member_pdd" title="Exercise Price" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:ExercisePrices" contextRef="From2021-01-012021-12-31_custom_Options21Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.050</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98B_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options21Member_pdd" title="Intrinsic Value" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:IntrinsicValue" contextRef="From2021-01-012021-12-31_custom_Options21Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.010</ix:nonFraction></span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">September
    30, 2026</span></td>
    <td id="xdx_982_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options22Member_pdd" title="Options" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:OpenOptionContractsWrittenNumbersOfShare" contextRef="From2022-01-012022-06-30_custom_Options22Member" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">16,000,000</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_986_ecustom--ExercisePrices_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options22Member_pdd" title="Exercise Price" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:ExercisePrices" contextRef="From2022-01-012022-06-30_custom_Options22Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.050</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_981_ecustom--IntrinsicValue_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options22Member_pdd" title="Intrinsic Value" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:IntrinsicValue" contextRef="From2022-01-012022-06-30_custom_Options22Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.009</ix:nonFraction></span></td>
    <td id="xdx_98F_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options22Member_pdd" title="Options" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:OpenOptionContractsWrittenNumbersOfShare" contextRef="From2021-01-012021-12-31_custom_Options22Member" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">17,500,000</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98D_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options22Member_pdd" title="Exercise Price" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:ExercisePrices" contextRef="From2021-01-012021-12-31_custom_Options22Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.050</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_985_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options22Member_pdd" title="Intrinsic Value" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:IntrinsicValue" contextRef="From2021-01-012021-12-31_custom_Options22Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.010</ix:nonFraction></span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December&#160;31,
    2026</span></td>
    <td id="xdx_981_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options23Member_pdd" title="Options" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:OpenOptionContractsWrittenNumbersOfShare" contextRef="From2022-01-012022-06-30_custom_Options23Member" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">50,000,000</ix:nonFraction></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_987_ecustom--ExercisePrices_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options23Member_pdd" title="Exercise Price" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:ExercisePrices" contextRef="From2022-01-012022-06-30_custom_Options23Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.050</ix:nonFraction></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_980_ecustom--IntrinsicValue_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options23Member_pdd" title="Intrinsic Value" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:IntrinsicValue" contextRef="From2022-01-012022-06-30_custom_Options23Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.009</ix:nonFraction></span></td>
    <td id="xdx_98C_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options23Member_pdd" title="Options" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:OpenOptionContractsWrittenNumbersOfShare" contextRef="From2021-01-012021-12-31_custom_Options23Member" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">50,000,000</ix:nonFraction></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98C_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options23Member_pdd" title="Exercise Price" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:ExercisePrices" contextRef="From2021-01-012021-12-31_custom_Options23Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.050</ix:nonFraction></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_984_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options23Member_pdd" title="Intrinsic Value" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:IntrinsicValue" contextRef="From2021-01-012021-12-31_custom_Options23Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.010</ix:nonFraction></span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td>
    <td id="xdx_980_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220630_pdd" title="Options" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:OpenOptionContractsWrittenNumbersOfShare" contextRef="From2022-01-01to2022-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">5,407,001,500</ix:nonFraction></span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_986_ecustom--ExercisePrices_c20220101__20220630_pdd" title="Exercise Price" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:ExercisePrices" contextRef="From2022-01-01to2022-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.005</ix:nonFraction></span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_989_ecustom--IntrinsicValue_c20220101__20220630_pdd" title="Intrinsic Value" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:IntrinsicValue" contextRef="From2022-01-01to2022-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.053</ix:nonFraction></span></td>
    <td id="xdx_984_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231_pdd" title="Options" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:OpenOptionContractsWrittenNumbersOfShare" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">5,497,001,500</ix:nonFraction></span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_982_ecustom--ExercisePrices_c20210101__20211231_pdd" title="Exercise Price" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:ExercisePrices" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.006</ix:nonFraction></span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_985_ecustom--IntrinsicValue_c20210101__20211231_pdd" title="Intrinsic Value" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ALRT:IntrinsicValue" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.054</ix:nonFraction></span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Weighted
    Average Remaining Contractual Life</span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20220101__20220630_zWiLVbV9cCZ4" title="Weighted Average Remaining Contractual Life"><ix:nonNumeric contextRef="From2022-01-01to2022-06-30" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">1.87</ix:nonNumeric></span></span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20210101__20211231_zlPBtc7FoC4l" title="Weighted Average Remaining Contractual Life"><ix:nonNumeric contextRef="From2021-01-012021-12-31" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">2.37</ix:nonNumeric></span></span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>
<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><p id="xdx_8AD_z30Vgv9DjIIb" style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 19 -->
    <div id="xdx_23A_zL2DrWjcXxsa" style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" id="xdx_23C_zO594kmE7Dr6" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></td><td id="xdx_231_z1cuQMQQF6Xl" style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div id="xdx_23A_zNaEv4Sj6q89" style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p id="xdx_230_zMxI9DuwoUT6" style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_235_zhOUpRsEqxF3" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ALR
TECHNOLOGIES INC.</b></span></p></ix:exclude>

<ix:exclude><p id="xdx_239_zvIluP4CdgS8" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notes
to Condensed Consolidated Financial Statements</span></p></ix:exclude>

<ix:exclude><p id="xdx_236_zSnJRQMmfju8" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the Six Months Ended June&#160;30, 2022</span></p></ix:exclude>

<ix:exclude><p id="xdx_23A_zezXKyJRqrf6" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">($
United States)</span></p></ix:exclude>

<ix:exclude><p id="xdx_232_zgCEVXOEAxl6" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Unaudited)</span></p></ix:exclude>

<ix:exclude><p id="xdx_235_zUwe9PoSX8A1" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_233_zBAdFeeApuC5" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_23D_zk6aff6HpLn" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>7.
&#160;&#160;&#160;&#160;&#160;&#160;&#160;Additional paid-in capital (continued)</b></span></p></ix:exclude>

<ix:exclude><p id="xdx_23F_zv8s48fS6fwb" style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_235_zHGcvYBKU796" style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stock
options (continued)</span></p></ix:exclude>

<ix:exclude><p id="xdx_236_zt3hyn50if08" style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:exclude>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
fair value of the stock options granted and vested was allocated as follows:</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2022-01-01to2022-06-30" escape="true" name="us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_897_eus-gaap--ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_zAieNWJFwSL5" summary="xdx: Disclosure - Additional paid-in capital (Details 2)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -7.1pt; padding-left: 14.2pt"><span id="xdx_8BF_zkr2h51EzkZg" style="display: none">Schedule of Fair Value of Stock Options Granted-Allocation</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_49A_20220401__20220630_zqv7fsuHb40a" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_497_20210401__20210630_z53lf9cfitN5" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_49F_20220101__20220630_zkOtOGVIv4O9" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_49F_20210101__20210630_zsj8W9Hjt4Ok" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Three Months Ended</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>June&#160;30, 2022</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Three Months Ended</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>June&#160;30, 2021</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Six Months Ended</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>June&#160;30, 2022</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Six Months Ended</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>June&#160;30, 2021</b></span></p></td></tr>
  <tr id="xdx_40D_eus-gaap--InterestExpenseDebt_maTz8pZ_zawqV4y5I0T2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%; text-align: left; text-indent: -7.1pt; padding-left: 14.2pt">Interest expense</td><td style="width: 3%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1039">&#8212;</span>&#160;&#160;</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 3%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:InterestExpenseDebt" contextRef="From2021-04-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,287,834</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 3%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1041">&#8212;</span>&#160;&#160;</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 3%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:InterestExpenseDebt" contextRef="From2021-01-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,287,834</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_maTz8pZ_ztudKj64f4a1" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -7.1pt; padding-left: 14.2pt">Product development expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" contextRef="From2022-04-012022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">56,418</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" contextRef="From2021-04-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">61,697</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" contextRef="From2022-01-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">118,586</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" contextRef="From2021-01-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">97,842</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--ProfessionalAndContractServicesExpense_maTz8pZ_zmwPAzZlOCmb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -7.1pt; padding-left: 14.2pt">Professional expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProfessionalAndContractServicesExpense" contextRef="From2022-04-012022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">8,957</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProfessionalAndContractServicesExpense" contextRef="From2021-04-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">28,070</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProfessionalAndContractServicesExpense" contextRef="From2022-01-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">17,916</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProfessionalAndContractServicesExpense" contextRef="From2021-01-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">43,295</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--OtherSellingGeneralAndAdministrativeExpense_maTz8pZ_zQ9KPUtr4fm9" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: -7.1pt; padding-left: 14.2pt">Selling, general and administrative expenses</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:OtherSellingGeneralAndAdministrativeExpense" contextRef="From2022-04-012022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">133,495</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1055">&#8212;</span>&#160;&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:OtherSellingGeneralAndAdministrativeExpense" contextRef="From2022-01-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">382,157</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1057">&#8212;</span>&#160;&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -13.5pt; padding-left: 0.25in">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_ecustom--Total_iT_pp0p0_mtTz8pZ_zfGCw9vnMgVd" style="vertical-align: bottom; background-color: White">
    <td style="display: none; padding-bottom: 1pt; text-indent: -7.1pt; padding-left: 14.2pt">&#160;Fair value of the stock options granted</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ALRT:Total" contextRef="From2022-04-012022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">198,870</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ALRT:Total" contextRef="From2021-04-012021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,377,601</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ALRT:Total" contextRef="From2022-01-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">518,659</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ALRT:Total" contextRef="From2021-01-012021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,428,971</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A8_zzuQzAPfNN7b" style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company uses the fair value method for determining stock-based compensation for all options granted during the fiscal periods. The fair
value was determined using the Black-Scholes option pricing model based on the following weighted average assumptions:</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2022-01-01to2022-06-30" escape="true" name="us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_895_eus-gaap--ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_zR1Dx1NDg6Dg" summary="xdx: Disclosure - Additional paid-in capital (Details 3)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -6.25pt; padding-left: 6.25pt"><span id="xdx_8BD_zcSjjppCVuK6" style="display: none">Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-size: 12pt; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 12pt; text-align: center"><p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>June&#160;30,</b></span></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2022</b></span></p></td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">December&#160;31,</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">2021</p></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; text-align: left; text-indent: -6.25pt; padding-left: 6.25pt">Risk-free interest rate</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right"><span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_c20210101__20211231_zYqUjZP2qKDk" title="Risk-free interest rate"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.87</ix:nonFraction></span></td><td style="width: 1%; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -6.25pt; padding-left: 6.25pt">Expected life</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20210101__20211231_zhNNsFBDHCw7" title="Expected life"><ix:nonNumeric contextRef="From2021-01-012021-12-31" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">4.8</ix:nonNumeric></span> years</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -6.25pt; padding-left: 6.25pt">Expected dividends</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend_pp0p0_dp_c20210101__20211231_zeoyAzkgLNxk" title="Expected dividends"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="0" scale="-2" unitRef="USD">0</ix:nonFraction></span></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -6.25pt; padding-left: 6.25pt">Expected volatility</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp_c20210101__20211231_z8ssnjE7yBK7" title="Expected volatility"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">278</ix:nonFraction></span></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: -6.25pt; padding-left: 6.25pt">Forfeiture rate</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageIntrinsicValue_dp_c20210101__20211231_zGhyd9Bp1Apf" title="Forfeiture rate"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageIntrinsicValue" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="USDPShares">0</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left">%</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8AF_zL5lfXIuQ7Bc" style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">There
were no options granted during the six months ended June&#160;30, 2022. The weighted average fair value for the options granted during
the year ended December&#160;31, 2021 was </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$<span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20210101__20211231_zHfs39Bauv87" title="Weighted average fair value options granted"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.06</ix:nonFraction></span><span style="background-color: white">.</span></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:exclude><p id="xdx_238_zAQFsilldSY1" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:exclude>


<ix:exclude><!-- Field: Page; Sequence: 20 -->
    <div id="xdx_23F_zq8fDEiS9zY9" style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" id="xdx_23D_zJPd0T22smJ1" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></td><td id="xdx_238_z97PIvdtBLP" style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div id="xdx_236_zJot6tFXPq29" style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p id="xdx_230_zkkbN6f0lOL1" style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_23A_zspoq3GAjgeb" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ALR
TECHNOLOGIES INC.</b></span></p></ix:exclude>

<ix:exclude><p id="xdx_230_zwo178YsrLXl" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notes
to Condensed Consolidated Financial Statements</span></p></ix:exclude>

<ix:exclude><p id="xdx_232_ztPr8xCc8Dhb" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the Six Months Ended June&#160;30, 2022</span></p></ix:exclude>

<ix:exclude><p id="xdx_239_zsjMjtrdktb4" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">($
United States)</span></p></ix:exclude>

<ix:exclude><p id="xdx_23A_zNSYlVIJ9Oua" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Unaudited)</span></p></ix:exclude>

<ix:exclude><p id="xdx_235_zYQC0n4boPt9" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_239_z2fs6joD912" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:exclude>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-01to2022-06-30" escape="true" name="us-gaap:RelatedPartyTransactionsDisclosureTextBlock"><p id="xdx_800_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_zPp4n3aZk1B9" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>8.</b>&#160;&#160;&#160;&#160;&#160;&#160;&#160;<b><span id="xdx_829_zExiT1eJebji">Related
party transactions and balances</span></b></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2022-01-01to2022-06-30" escape="true" name="us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_882_eus-gaap--ScheduleOfRelatedPartyTransactionsTableTextBlock_zfWfVwVtCy5e" summary="xdx: Disclosure - Related party transactions and balances (Details)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -7.1pt; padding-left: 14.2pt"><span id="xdx_8BE_zR7Yvg3k2MDe" style="display: none">Schedule of related party transactions</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_491_20220401__20220630_zn6ultEjUn36" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_49B_20210401__20210630_zdsHow6FYqQb" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_492_20220101__20220630_z9fB57JuG5Mf" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_490_20210101__20210630_z0WMvSSbdky9" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Three Months Ended</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>June&#160;30, 2022</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Three Months Ended</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>June&#160;30, 2021</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Six Months Ended</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>June&#160;30, 2022</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Six Months Ended</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>June&#160;30, 2021</b></span></p></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_ecustom--RelatedPartyTransactionIncludedWithinInterestExpense_iB" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Related party transactions included within interest expense:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_ecustom--InterestExpenseOnPromissoryNotesIssuedToRelativesOfChairmanAndChiefExecutiveOfficerOfCompany_i_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%; text-align: left; text-indent: -7.1pt; padding-left: 14.2pt">Interest expenses on promissory notes issued to relatives of the Chairman and Chief Executive Officer of the Company</td><td style="width: 3%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 10%; text-align: right"><ix:nonFraction name="ALRT:InterestExpenseOnPromissoryNotesIssuedToRelativesOfChairmanAndChiefExecutiveOfficerOfCompany" contextRef="From2022-04-012022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">83,457</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 3%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 10%; text-align: right"><ix:nonFraction name="ALRT:InterestExpenseOnPromissoryNotesIssuedToRelativesOfChairmanAndChiefExecutiveOfficerOfCompany" contextRef="From2021-04-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">78,981</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 3%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 10%; text-align: right"><ix:nonFraction name="ALRT:InterestExpenseOnPromissoryNotesIssuedToRelativesOfChairmanAndChiefExecutiveOfficerOfCompany" contextRef="From2022-01-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">162,749</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 3%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 10%; text-align: right"><ix:nonFraction name="ALRT:InterestExpenseOnPromissoryNotesIssuedToRelativesOfChairmanAndChiefExecutiveOfficerOfCompany" contextRef="From2021-01-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">157,963</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_ecustom--InterestExpenseOnLinesOfCreditPayableToChairmanAndChiefExecutiveOfficerOfCompanyAndHisSpouse_i_pp0p0" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -7.1pt; padding-left: 14.2pt">Interest expense on lines of credit payable to the Chairman and Chief Executive Officer of the Company and his spouse</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ALRT:InterestExpenseOnLinesOfCreditPayableToChairmanAndChiefExecutiveOfficerOfCompanyAndHisSpouse" contextRef="From2022-04-012022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">392,593</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ALRT:InterestExpenseOnLinesOfCreditPayableToChairmanAndChiefExecutiveOfficerOfCompanyAndHisSpouse" contextRef="From2021-04-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">355,715</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ALRT:InterestExpenseOnLinesOfCreditPayableToChairmanAndChiefExecutiveOfficerOfCompanyAndHisSpouse" contextRef="From2022-01-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">777,515</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ALRT:InterestExpenseOnLinesOfCreditPayableToChairmanAndChiefExecutiveOfficerOfCompanyAndHisSpouse" contextRef="From2021-01-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">670,452</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_ecustom--InterestExpenseRelatedToModificationOfStockOptionsHeldByChairmanAndChiefExecutiveOfficerOfCompanyAndHisSpouseRelatedToFinancingProvided_zKTIh7876p1i" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: -7.1pt; padding-left: 14.2pt">Interest expense related to the modification of stock options held by the Chairman and Chief Executive Officer of the Company and his spouse related to financing provided</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1105">&#8212;</span>&#160;&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ALRT:InterestExpenseRelatedToModificationOfStockOptionsHeldByChairmanAndChiefExecutiveOfficerOfCompanyAndHisSpouseRelatedToFinancingProvided" contextRef="From2021-04-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,287,834</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1107">&#8212;</span>&#160;&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ALRT:InterestExpenseRelatedToModificationOfStockOptionsHeldByChairmanAndChiefExecutiveOfficerOfCompanyAndHisSpouseRelatedToFinancingProvided" contextRef="From2021-01-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,287,834</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_408_ecustom--RelatedPartyTransactionsIncludingWithinSellingGeneralAndAdministrationExpenses_iB" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Related party transactions including within selling, general and administrative expenses:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_ecustom--ConsultingFeesToChairmanAndChiefExecutiveOfficerOfCompanyAccruedOnLineOfCreditAvailableToCompany_z2C54136v8zh" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -7.1pt; padding-left: 14.2pt">Consulting fees to the Chairman and Chief Executive Officer of the Company accrued on the line of credit available to the Company</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ALRT:ConsultingFeesToChairmanAndChiefExecutiveOfficerOfCompanyAccruedOnLineOfCreditAvailableToCompany" contextRef="From2022-04-012022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">62,400</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ALRT:ConsultingFeesToChairmanAndChiefExecutiveOfficerOfCompanyAccruedOnLineOfCreditAvailableToCompany" contextRef="From2021-04-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">62,400</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ALRT:ConsultingFeesToChairmanAndChiefExecutiveOfficerOfCompanyAccruedOnLineOfCreditAvailableToCompany" contextRef="From2022-01-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">124,800</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ALRT:ConsultingFeesToChairmanAndChiefExecutiveOfficerOfCompanyAccruedOnLineOfCreditAvailableToCompany" contextRef="From2021-01-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">124,800</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_ecustom--ConsultingFeesToDirectorOfCompanySettledWithIssuanceOfCommonStock_ztxkHOeK1iGi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -7.1pt; padding-left: 14.2pt">Consulting fees to a director of the Company settled with issuance of common stock</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ALRT:ConsultingFeesToDirectorOfCompanySettledWithIssuanceOfCommonStock" contextRef="From2022-04-012022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">40,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1121">&#8212;</span>&#160;&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ALRT:ConsultingFeesToDirectorOfCompanySettledWithIssuanceOfCommonStock" contextRef="From2022-01-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">40,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1123">&#8212;</span>&#160;&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_ecustom--SalaryForServicesAsVpCorporateAndDirectorOfSingaporeSubsidiaryToSpouseOfChairmanAndChiefExecutiveOfficerOfCompany_i_pp0p0" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -7.1pt; padding-left: 14.2pt">Salary for services as VP Corporate and director of the Singapore subsidiary to the spouse of the Chairman and Chief Executive Officer of the Company</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ALRT:SalaryForServicesAsVpCorporateAndDirectorOfSingaporeSubsidiaryToSpouseOfChairmanAndChiefExecutiveOfficerOfCompany" contextRef="From2022-04-012022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">10,890</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ALRT:SalaryForServicesAsVpCorporateAndDirectorOfSingaporeSubsidiaryToSpouseOfChairmanAndChiefExecutiveOfficerOfCompany" contextRef="From2021-04-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">11,254</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ALRT:SalaryForServicesAsVpCorporateAndDirectorOfSingaporeSubsidiaryToSpouseOfChairmanAndChiefExecutiveOfficerOfCompany" contextRef="From2022-01-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">21,981</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ALRT:SalaryForServicesAsVpCorporateAndDirectorOfSingaporeSubsidiaryToSpouseOfChairmanAndChiefExecutiveOfficerOfCompany" contextRef="From2021-01-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">11,254</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_ecustom--LossOnSettlementOfDebtToRelativeOfChairmanAndChiefExecutiveOfficerOfCompany_zKseanDzvHkb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -7.1pt; padding-left: 14.2pt">Loss on settlement of debt to a relative of the Chairman and Chief Executive Officer of the Company</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1130">&#8212;</span>&#160;&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ALRT:LossOnSettlementOfDebtToRelativeOfChairmanAndChiefExecutiveOfficerOfCompany" contextRef="From2021-04-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">16,800</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1132">&#8212;</span>&#160;&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ALRT:LossOnSettlementOfDebtToRelativeOfChairmanAndChiefExecutiveOfficerOfCompany" contextRef="From2021-01-012021-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">16,800</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_ecustom--RentPaidToCompanyControlledBySpouseOfChairmanAndImmediateFamilyMembers_i_pp0p0" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: -7.1pt; padding-left: 14.2pt">Rent paid to a company controlled by the spouse of the Chairman and immediate family members</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ALRT:RentPaidToCompanyControlledBySpouseOfChairmanAndImmediateFamilyMembers" contextRef="From2022-04-012022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">8,006</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1136">&#8212;</span>&#160;&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ALRT:RentPaidToCompanyControlledBySpouseOfChairmanAndImmediateFamilyMembers" contextRef="From2022-01-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">20,206</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1138">&#8212;</span>&#160;&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  </table></ix:nonNumeric>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Interest
on promissory notes payable to related parties, management compensation and compensation paid to a relative of a director have been recorded
at the exchange amount, which is the amount agreed to by the parties. </span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The
Company also issued commitment letters to two creditors who are relatives of the Chairman and Chief Executive Officer of the Company
offering them an aggregate 20,000,000 shares of common stock in exchange for the extinguishment of $1,511,377 in promissory notes and
interest payable prior to December&#160;31, 2021 (note&#160;6(b)(vii)). These offer letters expired on December&#160;31, 2021 without
the parties executing any settlements. On March 18, 2022, the Company extended the offer letters from December&#160;31, 2021 to December&#160;31,
2022 for the settlement of $1,541,000 in promissory notes and interest payable. </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of the date of these condensed consolidated financial statements, the offer letters have not been executed.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 21 -->
    <div id="xdx_23D_zVsj3RyCk3b8" style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" id="xdx_234_zH553boQgvlb" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></td><td id="xdx_23F_zkqAo75MypT9" style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div id="xdx_238_ztTzlQlKiTr3" style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p id="xdx_23C_zcvsLaWkzZGk" style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_23F_z4BI1vExcQ75" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ALR
TECHNOLOGIES INC.</b></span></p></ix:exclude>

<ix:exclude><p id="xdx_235_zgphSpMnlV5g" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notes
to Condensed Consolidated Financial Statements</span></p></ix:exclude>

<ix:exclude><p id="xdx_23A_z04LeoCpryR9" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the Six Months Ended June&#160;30, 2022</span></p></ix:exclude>

<ix:exclude><p id="xdx_237_z6VLJJ5eE7v" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">($
United States)</span></p></ix:exclude>

<ix:exclude><p id="xdx_238_zeFoOrtW2w7e" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Unaudited)</span></p></ix:exclude>

<ix:exclude><p id="xdx_230_zYVUdbs8No51" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_230_zduYqmS0tWo4" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_23E_zuMnbtRNuJgh" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>8.
&#160;&#160;&#160;&#160;&#160;&#160;&#160;Related party transactions and balances (continued)</b></span></p></ix:exclude>

<ix:exclude><p id="xdx_237_zM2i94ilsW0k" style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:exclude>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
June 3, 2022, the Company issued an aggregate of 1,000,000 shares of common stock at a fair value of $0.04 per share for the settlement
of $40,000 for a bonus issued and recognized in consulting fees <span style="background-color: white">(note&#160;6(b)(ii))</span>.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
July 7, 2022, the Company granted the Chairman and Chief Executive Officer the option to acquire 115,500,000 shares of common stock of
the Company at a price of $0.05 per share until December&#160;31, <span style="background-color: white">2026 </span>(note 11(a)).</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-01to2022-06-30" escape="true" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock"><p id="xdx_80B_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_z9RkJqzrBGYf" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>9.</b>&#160;&#160;&#160;&#160;&#160;&#160;&#160;<b><span id="xdx_828_zh4z5znECrec">Commitments
and contingencies</span></b></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 18.9pt"></td><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Contingencies
                                            </span></td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 36.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has had three judgments against it relating to overdue promissory notes and accrued interest, and a fourth creditor has demanded
repayment of an overdue promissory note and accrued interest. To date, the Company has not repaid any of these promissory notes and related
accrued interest and could be subject to further action. The legal liability, totaling $1,271,981, of these promissory notes and related
accrued interest have been fully recognized and recorded by the Company. The Company has accrued interest of $291,457 related to one
of these promissory notes.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 22, 2020, a default judgment was entered against the Company in regard to one of the above noted judgments totaling $551,576,
consisting of the principal amount of $300,000 and accrued interest of $251,576, as of the date of the Civil Summons.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Commitments
                                            </span></td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">i)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management
                                            contract</span></td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has a consulting arrangement with Mr. Sidney Chan, Chief Executive Officer and Chairman of the Board of Directors of the Company.
Under the terms of the contract, Mr. Chan will be paid $240,000 per annum for services as Chief Executive Officer. The contract can be
terminated at any time with thirty days&#8217; notice and the payment of two years&#8217; annual salary. Should the contract be terminated,
all debts owed to Mr. Chan and his spouse must be immediately repaid. The initial term of the contract is for one year and automatically
renews for continuous one-year terms. Also, under the terms of the contract are the following:</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0.75in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Incentive
                                            revenue bonus</span></td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
Chan will be entitled to a 1% net sales commission from the sales of any of the Company&#8217;s products at any time during his life,
regardless if Mr. Chan is still under contract with the Company.</span></p>


<ix:exclude><!-- Field: Page; Sequence: 22 -->
    <div id="xdx_237_zs4a3vYMTlzf" style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" id="xdx_23A_z4Awn9Trfnz3" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></td><td id="xdx_230_zT4X59acL5s7" style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div id="xdx_237_zt8XwOW44hG5" style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p id="xdx_237_zjyACHoJDsK8" style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_23E_zYwTZvwWFZkg" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ALR
TECHNOLOGIES INC.</b></span></p></ix:exclude>

<ix:exclude><p id="xdx_23E_zmlmD0CcML9h" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notes
to Condensed Consolidated Financial Statements</span></p></ix:exclude>

<ix:exclude><p id="xdx_232_z4xLc3uNYYT5" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the Six Months Ended June&#160;30, 2022</span></p></ix:exclude>

<ix:exclude><p id="xdx_236_zquyVKmEzVd4" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">($
United States)</span></p></ix:exclude>

<ix:exclude><p id="xdx_234_zYiMeF7aXhEj" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Unaudited)</span></p></ix:exclude>

<ix:exclude><p id="xdx_239_ziyp6sSrvhR8" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_231_z1wIlAYE2OEi" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_230_z8ql9xpad45a" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>9.</b>&#160;&#160;&#160;&#160;&#160;&#160;&#160;<b>Commitments
and contingencies (continued)</b></span></p></ix:exclude>

<ix:exclude><p id="xdx_23C_zMOmUdAiHOMj" style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_23A_zuJXq3Ea5WIh" style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)
Commitments (continued)</span></p></ix:exclude>

<ix:exclude><p id="xdx_232_zO3eZQLT5Pg2" style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:exclude>

<ix:exclude><table cellpadding="0" cellspacing="0" id="xdx_23B_znDQywJWtoQ3" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">i)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management
                                            contract (continued)</span></td></tr></table></ix:exclude>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0.75in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sale
                                            of business</span></td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
more than 50% of the Company&#8217;s stock or assets are sold, Mr. Chan will be compensated for entering into non-compete agreements
based on the selling price of the Company or its assets as follows:</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 1in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2%
                                            of sales price up to $24,999,999 plus</span></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 1in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3%
                                            of sales price between $25,000,000 and $49,999,999 plus</span></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 1in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">iii.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4%
                                            of sales price between $50,000,000 and $199,999,999 plus</span></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 1in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">iv.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5%
                                            of sales price in excess of $200,000,000.</span></td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
August 4, 2022, ALR Singapore entered into an Employment Agreement with the Chairman and Chief Executive Officer (the &#8220;Employment
Agreement&#8221;) with an effective date of July 1, 2022 (note 11(c)).</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Manufacturing
                                            and Supply Agreement</span></td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
June&#160;28, 2022, ALR Singapore entered into a Manufacturing and Supply Agreement (the &#8220;<b>Supply Agreement</b>&#8221;) with
Infinovo Medical Co., Ltd. (&#8220;<b>Infinovo</b>&#8221;). Pursuant to the Supply Agreement, Infinovo will manufacture and supply certain
continuous glucose monitoring components necessary to the Company&#8217;s diabetes management platform for animal health, known as &#8220;<b>GluCurve</b>&#8221;.
The term of the Supply Agreement continues for three years from August&#160;1, 2022, unless earlier terminated in accordance with the
terms of the Supply Agreement. The Supply Agreement, however, will not become effective unless (i) ALR Singapore enters into a binding
distribution agreement for the sale and distribution of GluCurve by July&#160;31, 2022, and (ii) ALR Singapore and Infinovo enter into
a quality agreement by July&#160;31, 2022. There can be no assurance that the two conditions to effectiveness of the Supply Agreement
will be satisfied. If the conditions are met and the agreement becomes effective, the Supply Agreement will automatically renew for additional
one year terms unless ALR Singapore or Infinovo provides written notice of its intent to terminate the Supply Agreement. The Supply Agreement
provides for customary reasons to terminate the Supply Agreement for cause with immediate effect.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
closing conditions for the Supply Agreement between ALR Singapore and Infinovo were not met and the Supply Agreement has now terminated
(note 11(d)).</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 23 -->
    <div id="xdx_23A_zPxAsNtiNF99" style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" id="xdx_234_znFeCWCjI8md" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></td><td id="xdx_239_zVaH6b0DQsM8" style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div id="xdx_23F_zm9PiI9MtX83" style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p id="xdx_23D_zlLckhKhKjve" style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_23F_zYumKLX9CVw7" style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_235_zuw3rRd2QrN8" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ALR
TECHNOLOGIES INC.</b></span></p></ix:exclude>

<ix:exclude><p id="xdx_237_zkSNLXrQ91H9" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notes
to Condensed Consolidated Financial Statements</span></p></ix:exclude>

<ix:exclude><p id="xdx_236_zfBR49tc32th" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the Six Months Ended June&#160;30, 2022</span></p></ix:exclude>

<ix:exclude><p id="xdx_23D_zigs1xPrqhHb" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">($
United States)</span></p></ix:exclude>

<ix:exclude><p id="xdx_23D_zSPxfTpkI6D9" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Unaudited)</span></p></ix:exclude>

<ix:exclude><p id="xdx_236_z8TDCFTUC4Gj" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_23A_zPmYHwxXKXJj" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:exclude>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-01to2022-06-30" escape="true" name="us-gaap:SegmentReportingDisclosureTextBlock"><p id="xdx_808_eus-gaap--SegmentReportingDisclosureTextBlock_zrJlnRpXAbuj" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>10.</b>&#160;&#160;&#160;&#160;&#160;&#160;&#160;<b><span id="xdx_82D_zd8aEXD4TcMj">Operating
segments</span></b></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has one operating segment, development of diabetes hardware and software. The Company&#8217;s geographical segments are summarized
as follows:</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2022-01-01to2022-06-30" escape="true" name="us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_898_eus-gaap--ScheduleOfSegmentReportingInformationBySegmentTextBlock_z19IF7i0tr1f" summary="xdx: Disclosure - Operating segments (Details)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10.05pt"><span id="xdx_8B5_zSQc2FjcK0qd" style="display: none">Schedule of Operating Segments</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>June 30,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2022</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December&#160;31,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2021</b></span></p></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-left: 5.4pt">Current and Total Assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 56%; padding-left: 10.05pt">Other</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_980_eus-gaap--Assets_c20220630__srt--StatementGeographicalAxis__custom--OtherMember_pp0p0" title="Current and Total Assets" style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2022-06-30_custom_OtherMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">15,327</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_983_eus-gaap--Assets_c20211231__srt--StatementGeographicalAxis__custom--OtherMember_pp0p0" title="Current and Total Assets" style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2021-12-31_custom_OtherMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">9,547</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10.05pt">Singapore</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--Assets_c20220630__srt--StatementGeographicalAxis__country--SG_pp0p0" title="Current and Total Assets" style="text-align: right"><ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2022-06-30_country_SG" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,777</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--Assets_c20211231__srt--StatementGeographicalAxis__country--SG_pp0p0" title="Current and Total Assets" style="text-align: right"><ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2021-12-31_country_SG" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">110,527</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 10.05pt">United States</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--Assets_c20220630__srt--StatementGeographicalAxis__country--US_pp0p0" title="Current and Total Assets" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2022-06-30_country_US" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">77,223</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--Assets_c20211231__srt--StatementGeographicalAxis__country--US_pp0p0" title="Current and Total Assets" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2021-12-31_country_US" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">73,143</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt; text-indent: -6.25pt; padding-left: 6.25pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_988_eus-gaap--Assets_c20220630_pp0p0" title="Current and Total Assets" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">96,327</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_980_eus-gaap--Assets_c20211231_pp0p0" title="Current and Total Assets" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">193,217</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Six Months </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Ended June&#160;30, 2022</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Six Months </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Ended June&#160;30, 2021</b></span></p></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-indent: -6.25pt; padding-left: 6.25pt">Revenue</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10.05pt">Other</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_987_eus-gaap--Revenues_c20220101__20220630__srt--StatementGeographicalAxis__custom--OtherMember_pp0p0" title="Revenue" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1191">&#8212;</span>&#160;&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--Revenues_c20210101__20210630__srt--StatementGeographicalAxis__custom--OtherMember_pp0p0" title="Revenue" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1193">&#8212;</span>&#160;&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; padding-left: 10.05pt">Singapore</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--Revenues_c20220101__20220630__srt--StatementGeographicalAxis__country--SG_pp0p0" title="Revenue" style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2022-01-012022-06-30_country_SG" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,023</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--Revenues_c20210101__20210630__srt--StatementGeographicalAxis__country--SG_pp0p0" title="Revenue" style="width: 12%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1197">&#8212;</span>&#160;&#160;</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 10.05pt">United States</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--Revenues_c20220101__20220630__srt--StatementGeographicalAxis__country--US_pp0p0" title="Revenue" style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1199">&#8212;</span>&#160;&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--Revenues_c20210101__20210630__srt--StatementGeographicalAxis__country--US_pp0p0" title="Revenue" style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1201">&#8212;</span>&#160;&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt; text-indent: -6.25pt; padding-left: 6.25pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_986_eus-gaap--Revenues_c20220101__20220630_pp0p0" title="Revenue" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2022-01-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,023</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_98B_eus-gaap--Revenues_c20210101__20210630_pp0p0" title="Revenue" style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1205">&#8212;</span>&#160;&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -6.25pt; padding-left: 6.25pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; text-indent: -6.25pt; padding-left: 6.25pt">Net Loss</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10.05pt">Other</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98D_eus-gaap--NetIncomeLoss_c20220101__20220630__srt--StatementGeographicalAxis__custom--OtherMember_pp0p0" title="Net Loss" style="text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-01-012022-06-30_custom_OtherMember" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">1,457</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98B_eus-gaap--NetIncomeLoss_c20210101__20210630__srt--StatementGeographicalAxis__custom--OtherMember_pp0p0" title="Net Loss" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1209">&#8212;</span>&#160;&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10.05pt">Singapore</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--NetIncomeLoss_c20220101__20220630__srt--StatementGeographicalAxis__country--SG_pp0p0" title="Net Loss" style="text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-01-012022-06-30_country_SG" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">141,861</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--NetIncomeLoss_c20210101__20210630__srt--StatementGeographicalAxis__country--SG_pp0p0" title="Net Loss" style="text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-01-012021-06-30_country_SG" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">77,666</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 10.05pt">United States</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--NetIncomeLoss_c20220101__20220630__srt--StatementGeographicalAxis__country--US_pp0p0" title="Net Loss" style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-01-012022-06-30_country_US" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">2,749,297</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--NetIncomeLoss_c20210101__20210630__srt--StatementGeographicalAxis__country--US_pp0p0" title="Net Loss" style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-01-012021-06-30_country_US" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">3,259,787</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt; text-indent: -6.25pt; padding-left: 6.25pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_987_eus-gaap--NetIncomeLoss_c20220101__20220630_pp0p0" title="Net Loss" style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-01-01to2022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">2,892,615</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_985_eus-gaap--NetIncomeLoss_c20210101__20210630_pp0p0" title="Net Loss" style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-01-012021-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">3,337,453</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A0_zkH6IA2PGSQg" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-01to2022-06-30" escape="true" name="us-gaap:SubsequentEventsTextBlock"><p id="xdx_806_eus-gaap--SubsequentEventsTextBlock_zStQ919zb3lk" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>11.</b>&#160;&#160;&#160;&#160;&#160;&#160;&#160;<b><span id="xdx_828_zEfaV68VRSG">Subsequent
events</span></b></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
                                            July 7, 2022, the Company granted the Chairman and Chief Executive Officer the option to
                                            acquire 115,500,000 shares of common stock of the Company at a price of $0.05 per share until
                                            December&#160;31, <span style="background-color: white">2026. The Company canceled the </span>subscription
                                            rights to distribute 101,025,092 shares of common stock at a price of $0.05 pursuant to the
                                            prospectus (note 6(b)(i)).</span></td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt/12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
                                            July 12, 2022, ALR Singapore received advances from a relative of the Chairman aggregating
                                            SGD$500,000, with interest of $150 per day outstanding payable upon maturity or early payment,
                                            which will mature and be repayable on August&#160;31, 2022. The principal amount of SGD$500,000
                                            was repaid on July 18, 2022.</span></td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
                                            August 4, 2022, ALR Singapore entered into an Employment Agreement with the Chairman and
                                            Chief Executive Officer with an effective date of July 1, 2022 (note 9(b)(i)). The terms
                                            of the Employment Agreement were materially the same as the Services Agreement between the
                                            Company and the Chief Executive Officer, except as follows: </span></td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:exclude><p id="xdx_23E_zzJfosUoIa3e" style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:exclude>


<ix:exclude><!-- Field: Page; Sequence: 24 -->
    <div id="xdx_23A_ztLRynGdLxz4" style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" id="xdx_23E_zG8YjqpeSVU6" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></td><td id="xdx_232_zUztClcENVcb" style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div id="xdx_239_zlacAfVT76mb" style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p id="xdx_237_z6wwbQ6Vin44" style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_235_zkdU0juLe0M2" style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_237_zNo086eyhh04" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ALR
TECHNOLOGIES INC.</b></span></p></ix:exclude>

<ix:exclude><p id="xdx_23E_zvQGngaImfIf" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notes
to Condensed Consolidated Financial Statements</span></p></ix:exclude>

<ix:exclude><p id="xdx_23C_zxflmefUCEij" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the Six Months Ended June&#160;30, 2022</span></p></ix:exclude>

<ix:exclude><p id="xdx_237_zqZiR6C9ATI5" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">($
United States)</span></p></ix:exclude>

<ix:exclude><p id="xdx_232_zyNJI33z6iz9" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Unaudited)</span></p></ix:exclude>

<ix:exclude><p id="xdx_23D_zglwwp2hGcj4" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_23A_zljynysxs5Ja" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_23C_zofBaj2GNgg4" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>11.</b>&#160;&#160;&#160;&#160;&#160;&#160;&#160;<b>Subsequent
events (continued)</b></span></p></ix:exclude>

<ix:exclude><p id="xdx_232_zm9h2quISc98" style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:exclude>

<ix:exclude><table cellpadding="0" cellspacing="0" id="xdx_23D_z2PVUelCCJt4" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Employment
                                            Agreement (continued)</span></td></tr></table></ix:exclude>

<ix:exclude><p id="xdx_233_zemYnRVdaCUf" style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:exclude>

<table cellpadding="0" cellspacing="0" style="font: 12pt/13.7pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#183;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            incentive compensation whereby Mr. Chan will earn a 1% commission from the sale of Company
                                            products has been amended to be in perpetuity and assignable. Previously, the commission
                                            was based on the lifetime of Mr. Chan, and</span></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 12pt/13.7pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#183;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
                                            Chan has relinquished his right to certain compensation on the sale of the business or assets
                                            of the Company or its affiliates. </span></td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt/13.7pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with entering into the Employment Agreement with ALR Singapore:</span></p>

<p style="font: 11pt/13.7pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt/13.7pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
                                            Chan has been issued a bonus of $150,000 as consideration for the advancements to the GluCurve
                                            business unit;</span></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 12pt/13.7pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            services agreement between the Company and Mr. Chan has terminated, and</span></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 12pt/13.7pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
                                            Chan will continue to act as Chief Executive Officer, Chief Financial Officer, Chief Accounting
                                            Officer and Treasurer of the Company.</span></td></tr></table>

<p style="font: 11pt/13.7pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt/13.7pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Employment Agreement is executed and the Services Agreement is being terminated in connection with the Redomicile Agreement.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            closing conditions for the Supply Agreement between ALR Singapore and Infinovo were not met
                                            and the Supply Agreement has now terminated. The parties are now working on completing a
                                            new agreement whereby the closing condition for ALR Singapore to enter into a binding sales
                                            and distribution agreement for the GluCurve would be August 31, 2022. Should the parties
                                            enter into a new manufacturing and supply agreement, it will not become effective unless
                                            ALR Singapore enters into a binding distribution agreement for the sale and distribution
                                            of GluCurve by August 31, 2022. There can be no assurance that the parties will enter in
                                            such new agreement or that this condition to effectiveness of the new agreement will be satisfied
                                            (note 9(b)(ii)).</span></td></tr></table>

</ix:nonNumeric><p id="xdx_811_zMMwJmM4QDF4" style="margin-top: 0; margin-bottom: 0">&#160;</p>


<!-- Field: Page; Sequence: 25 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM
                          2.</b></span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>MANAGEMENT&#8217;S
                                            DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.</b></span></td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management&#8217;s
Discussion and Analysis of Financial Condition and Results of Operations (&#8220;<b>MD&amp;A</b>&#8221;) is designed to provide a reader
of our Unaudited Condensed Consolidated Financial Statements and Notes thereto that are contained in this quarterly report, with a narrative
from the perspective of management. You should also consider this information with the information included in our Annual Report on Form
10-K for the year ended December 31, 2021, and our other filings with the SEC, including our quarterly and current reports that we have
filed since December 31, 2021 through the date of this report. This report covers the three and six months ended June 30, 2022.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Forward-Looking
Statements</b></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following information must be read in conjunction with the unaudited Condensed Consolidated Financial Statements and Notes thereto included
in Item 1 of this Quarterly Report, and the audited Consolidated Financial Statements and Notes thereto and Management&#8217;s Discussion
and Analysis or Plan of Operations contained in the Company&#8217;s Annual Report on Form 10-K for the year ended December&#160;31, 2021.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Form 10-Q includes &#8220;forward-looking statements&#8221;, as such term is used within the meaning of the <i>Private Securities Litigation
Reform Act of 1995</i>. These &#8220;forward-looking statements&#8221; are not based on historical fact and involve assessments of certain
risks, developments and uncertainties in our business looking to the future. Such forward-looking statements can be identified by the
use of terminology such as &#8220;may&#8221;, &#8220;will&#8221;, &#8220;should&#8221;, &#8220;expect&#8221;, &#8220;anticipate&#8221;,
&#8220;estimate&#8221;, &#8220;intend&#8221;, &#8220;continue&#8221;, &#8220;believe&#8221;, or the negatives or other variations of
these terms or comparable terminology. Forward-looking statements may include projections, forecasts or estimates of future performance
and developments. Forward-looking statements contained in this Form 10-Q are based upon assumptions and assessments that we believe to
be reasonable as of the date of this report. Whether those assumptions and assessments will be realized will be determined by future
factors, developments and events, which are difficult to predict and may be beyond our control. Actual results, factors, developments
and events may differ materially from those we assumed and assessed. Risks, uncertainties, contingencies and developments, including
those identified in the <i>Risk Factors </i>section of filings we make with the Securities and Exchange Commission (the &#8220;SEC&#8221;)
pursuant to Sections 13(a), 13(c), 14 or 15(d) <span style="letter-spacing: -0.3pt">of </span>the <i>Securities Exchange Act of 1934</i>,
as amended (the &#8220;Exchange Act&#8221;), incorporated by reference herein, could cause our future operating results to differ materially
from those set forth in any forward-looking statement. There can be no assurance that any such forward-looking statement, projection,
forecast or estimate contained can be realized, or that actual returns, results or business prospects will not differ materially from
those set forth in any forward-looking statement. Given these uncertainties, readers are cautioned not to place undue reliance on such
forward-looking statements. <span style="letter-spacing: -0.4pt">We </span>disclaim any obligation to update any such factors or to publicly
announce the results of any revisions to any of the forward-looking statements contained herein to reflect future results, events or
developments.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
for the description of historical facts contained herein, this Form 10-Q contains certain forward-looking statements concerning future
applications of the Company&#8217;s technologies and the Company&#8217;s proposed services and future prospects, that involve risk and
uncertainties, including the possibility that the Company will: (i) be unable to commercialize services based on its technology, (ii)
be unable to achieve profitable operations, or (iii) not receive additional financing as required to support future operations, as detailed
herein and from time to time in the Company&#8217;s future filings with the SEC and elsewhere. Such statements are based on management&#8217;s
current expectations and are subject to a number of factors and uncertainties that could cause actual results to differ materially from
those described in the forward-looking statements.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
consolidated financial statements are stated in United States dollars and are prepared in accordance with U.S. GAAP.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
this quarterly report, unless otherwise specified, all references to &#8220;common shares&#8221; refer to the common shares in our capital
stock.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 26 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
used in this quarterly report, the terms &#8220;we&#8221;, &#8220;us&#8221;, &#8220;our&#8221;, the &#8220;Company&#8221; and &#8220;ALRT&#8221;
mean ALR Technologies Inc., unless otherwise indicated.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Overview</b></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 34.95pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">ALRT
is a data management company that developed a comprehensive approach to diabetes care that includes: (i) a Food and Drug Administration
(&#8220;<b>FDA</b>&#8221;) cleared and <i>Health Insurance Portability and Accountability Act of 1996</i> (&#8220;<b>HIPAA</b>&#8221;)
compliant diabetes management system (as previously defined, the &#8220;<b>Diabetes Solution</b>&#8221;) that collects data directly
from blood glucose meters (&#8220;<b>BGM</b>&#8221;) (and which was subsequently modified to integrate with continuous glucose monitoring
(&#8220;<b>CGM</b>&#8221;) devices), (ii) a patent pending Predictive A1C algorithm to track treatment success between lab reports, and
(iii) an FDA-cleared Insulin Dosing Adjustment program. From this technology portfolio, the Company has developed the Diabetes Solution
for human health, and the GluCurve, a modified version of the Diabetes Solution, for animal health (&#8220;<b>GluCurve</b>&#8221;).</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Recent
Developments &#8211; Proposed Migration to Singapore</b></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 34.95pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
reported in the Company&#8217;s Current Report on Form 8-K dated May 20, 2022 (the &#8220;<b>May 20, 2022 Form 8-K</b>&#8221;), on May
17, 2022, the Company entered into an Agreement and Plan of Merger and Reorganization with ALR Singapore and its wholly-owned subsidiary,
ALR Delaware, relating to a proposed merger transaction for the sole purpose of changing the Company&#8217;s jurisdiction of incorporation
from Nevada to Singapore.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 34.95pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Redomicile Merger Agreement provides that, upon the terms and subject to the conditions set forth therein, ALR Delaware will merge with
and into the Company, and the Company will be the surviving entity and a wholly-owned subsidiary of ALR Singapore. ALR Delaware will
cease to exist. At the closing of the Redomicile Merger, the stockholders of the Company will exchange their shares of common stock,
and any options or warrants to purchase shares of common stock which they might hold, on a one-for-one basis, for ordinary shares and
options or warrants to subscribe for ALR Singapore Ordinary Shares, as applicable.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 34.95pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
order to facilitate the Redomicile Merger and to comply with Singapore law, (i) ownership of ALR Singapore, which was previously a wholly-owned
subsidiary of the Company, was transferred to KAD, a Singapore private company owned by trust entities controlled by the Company&#8217;s
CEO, Sidney Chan, and (ii) ALR Singapore formed ALR Delaware as a new subsidiary corporation.</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 34.95pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
the effective time of the Redomicile Merger (the &#8220;<b>Effective Time</b>&#8221;) ALR Singapore, together with the Company as its
subsidiary, will own and continue to conduct the Company&#8217;s business in substantially the same manner as is currently being conducted
by the Company and its subsidiaries. Accordingly, for holders of Company common stock, much will remain unchanged following the Redomicile
Merger. There will be some differences in stockholder rights, given the differences between the laws of Nevada and Singapore as they
relate to companies incorporated in those jurisdictions. The ALR Singapore Ordinary Shares are expected to trade on the OTCQB, either
under a new or the same ticker symbol under which the Company&#8217;s shares of common stock are currently traded, and are expected to
begin trading on the OTCQB as soon as possible following the Effective Time.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 27 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 34.95pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Redomicile Merger Agreement contains customary closing conditions, including, among others, approval of the Redomicile Merger by the
Company&#8217;s stockholders, the effectiveness of the registration statement on Form F-4 filed by ALR Singapore related to the Redomicile
Merger, and receipt of required regulatory approvals. The consent of the holders of a majority of the outstanding shares of the Company&#8217;s
common stock entitled to vote is required to approve and adopt the Redomicile Merger Agreement. The Board of Directors of the Company
believes that the Redomicile Merger is advisable and in the best interests of the Company and its stockholders.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 34.95pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the Redomicile Merger Agreement, the Board of Directors of the Company may exercise its discretion to terminate the agreement, and
therefore abandon the Redomicile Merger, at any time prior to the Effective Time, including after the adoption of the Redomicile Merger
Agreement by the Company&#8217;s stockholders.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 34.95pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
consolidated assets and liabilities of ALR Singapore and the Company, as its wholly-owned subsidiary, immediately after the Redomicile
Merger and at the Effective Time, will be identical to the assets and liabilities of the Company immediately prior to the Redomicile
Merger. The officers and directors of the Company immediately before the Redomicile Merger becomes effective will also serve as officers
and directors of ALR Singapore at the Effective Time. In addition, pursuant to Singapore law, ALR Singapore is required to appoint certain
officers and to have at least one director who is ordinarily resident in Singapore. Therefore, prior to the Redomicile Merger, and continuing
upon effectiveness of the Redomicile Merger, ALR Singapore will appoint Benjamin Szeto, as Secretary and Chief Legal Counsel, and Christine
Kan, the spouse of CEO Sidney Chan, as Vice President. Mr. Szeto and Ms. Kan are both residents of Singapore. Additionally, Ms. Kan,
who is currently serving as a director of ALR Singapore, will continue to serve as a locally resident director following the Redomicile
Merger. After the Redomicile Merger, it is also anticipated that at least initially, the officers and directors of the Company, as the
wholly-owned subsidiary of ALR Singapore, will remain the same as prior to the Redomicile Merger. The Redomicile Merger will not result
in any material change to the Company&#8217;s business and will not have any effect on the relative equity interests of the Company&#8217;s
stockholders.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 34.95pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The
</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Redomicile Merger Agreement has been approved by the
Boards of Directors of each of the Company, ALR Singapore, and ALR Delaware. Subject to the required approval of the Company&#8217;s
stockholders, requisite regulatory approvals, the effectiveness of the registration statement on Form F-4 filed by ALR Singapore related
to the Redomicile Merger, and other customary closing conditions, the Redomicile Merger is expected to be completed during the third
quarter of 2022.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 34.95pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
foregoing summary of the Redomicile Merger Agreement does not purport to be complete and is qualified in its entirety by reference to
the complete text of the Redomicile Merger Agreement, which is an exhibit to the May 20, 2022 Form 8-K.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 34.95pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additional
information about the Redomicile Merger and where to find it: In connection with the proposed Redomicile Merger, ALR Singapore has filed
with the United States Securities and Exchange Commission (the &#8220;<b>SEC</b>&#8221;) a registration statement on Form F-4 for the
purpose of registering the ordinary shares of ALR Singapore to be issued to the stockholders of the Company. The registration statement,
if and when declared effective, will include a prospectus/information statement of the Company which will be sent to the stockholders
of the Company in connection with approval of the Redomicile Merger and related matters by the stockholders of the Company, in addition
to other matters. In addition, the Company may file other relevant documents concerning the proposed Redomicile Merger with the SEC.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 34.95pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
communication does not constitute an offer to sell or the solicitation of an offer to buy any securities or a solicitation of any vote
or approval. Stockholders of the Company are urged to read the registration statement on Form F-4 and the prospectus/information statement
to be included within the registration statement, and any other relevant documents to be filed with the SEC in connection with the proposed
Redomicile Merger, because they will contain important information about the Company, ALR Singapore, and the proposed transaction.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 28 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Other
Recent Developments&#8212;January 1, 2022 through June 30, 2022</b></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 18, 2022, the Company issued a prospectus whereby it distributed 101,025,592 subscription rights to its shareholders to purchase
shares of common stock of the Company at a price of $0.05 per share. The rights were set to expire on February&#160;18, 2022, and subsequently
extended to March&#160;15, 2022. Management had until August 12, 2022 to place the rights that were unexercised. The Company recognized
share subscriptions receivable of $25 pursuant to its registration statement and issued a total of 500 shares of common stock for gross
proceeds of $25. The subscription rights were cancelled on July 7, 2022.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 18, 2022, the Company extended the commitment letters previously issued to two creditors who are relatives of the Chairman and
Chief Executive Officer of the Company, offering them an aggregate 20,000,000 shares of common stock in exchange for the extinguishment
of $1,541,000 in promissory notes and interest payable from December&#160;31, 2021 to December&#160;31, 2022. As the date of this Report,
the offer letters have not been executed.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">On
March 18, 2022, the Company modified 70,000,000 options previously granted to a number of advisors and independent contractors by extending
the vesting period under vesting terms, which have not been met, from September&#160;30, 2021 and December&#160;31, 2021 to December&#160;31,
2022, and from June&#160;30, 2022 to June&#160;30, 2023.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">On
March 18, 2022, the Company amended 2,500,000 options previously granted to an individual on October&#160;4, 2021 by vesting 1,000,000
options and cancelling the remaining 1,500,000 options with performance conditions. During the period ended June&#160;30, 2022, $59,639
related to the 1,000,000 options that vested immediately was recorded.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Effective
March 18, 2022, the Company cancelled 20,000,000 stock options exercisable at $0.015, 10,000,000 stock options exercisable at $0.035
and 28,500,000 exercisable at $0.05 related to the termination of certain contractors.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">On
April 27, 2022, the Company provided termination notice to a contractor. As a result, the contractor&#8217;s 30,000,000 stock options
exercisable at $0.05 was cancelled, unvested, effective June&#160;30, 2022.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
June 28, 2022, ALR Singapore entered into a Supply Agreement with Infinovo. Pursuant to the Supply Agreement, Infinovo will manufacture
and supply certain continuous glucose monitoring components necessary to the Company&#8217;s diabetes management platform for animal
health, known as GluCurve. The term of the Supply Agreement continues for three years from August&#160;1, 2022, unless earlier terminated
in accordance with the terms of the Supply Agreement. The Supply Agreement, however, will not become effective unless (i) ALR Singapore
enters into a binding distribution agreement for the sale and distribution of GluCurve by July&#160;31, 2022, and (ii) ALR Singapore
and Infinovo enter into a quality agreement by July&#160;31, 2022. There can be no assurance that the two conditions to effectiveness
of the Supply Agreement will be satisfied. If the conditions are met and the agreement becomes effective, the Supply Agreement will automatically
renew for additional one year terms unless ALRT Singapore or Infinovo provides written notice of its intent to terminate the Supply Agreement.
The Supply Agreement provides for customary reasons to terminate the Supply Agreement for cause with immediate effect.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
closing conditions for the Supply Agreement between ALR Singapore and Infinovo were not met and the Supply Agreement has now terminated.
The parties are now working on completing a new agreement whereby the closing condition for ALR Singapore to enter into a binding sales
and distribution agreement for the GluCurve would be August 31, 2022. Should the parties enter into a new manufacturing and supply agreement,
it will not become effective unless ALR Singapore enters into a binding distribution agreement for the sale and distribution of GluCurve
by August 31, 2022. There can be no assurance that the parties will enter in such new agreement or that this condition to effectiveness
of the new agreement will be satisfied.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 29 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Recent
Developments &#8211; Subsequent to June&#160;30, 2022</b></span></p>

<p style="font: 11pt/13.7pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">On
July 7, 2022, the Company granted the Chairman and Chief Executive Officer the option to acquire 115,500,000 shares of common stock of
the Company at a price of $0.05 per share until December&#160;31, 2026.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt/13.7pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
August 4, 2022, ALR Singapore entered into an Employment Agreement with the Chairman and Chief Executive Officer with an effective date
of July 1, 2022. The terms of the Employment Agreement with ALR Singapore are materially similar to the existing services arrangement
between ALRT except as follows:</span></p>

<p style="font: 11pt/13.7pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt/13.7pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#183;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            incentive compensation whereby Mr. Chan will earn a 1% commission from the sale of Company
                                            products has been amended to be in perpetuity and assignable. Previously, the commission
                                            was based on the lifetime of Mr. Chan, and</span></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 12pt/13.7pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#183;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
                                            Chan has relinquished his right to certain compensation on the sale of the business or assets
                                            of ALRT or its affiliates. </span></td></tr></table>

<p style="font: 11pt/13.7pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt/13.7pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with entering into the Employment Agreement with ALR Singapore:</span></p>

<p style="font: 11pt/13.7pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 12pt/13.7pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1)&#160;&#160;&#160;&#160;&#160;
Mr. Chan has been issued a bonus of $150,000 as consideration for the advancements to the GluCurve business unit;</span></p>

<p style="font: 12pt/13.7pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2)&#160;&#160;&#160;&#160;&#160;
the services agreement between ALRT and Mr. Chan has terminated, and</span></p>

<p style="font: 12pt/13.7pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3)&#160;&#160;&#160;&#160;&#160;
Mr. Chan will continue to act as Chief Executive Officer, Chief Financial Officer, Chief Accounting Officer and Treasurer of ALRT.</span></p>

<p style="font: 11pt/13.7pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Employment Agreement is executed and the Services Agreement is being terminated in connection with the Redomicile Agreement.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Additional
Financing</b></span></p>

<p style="font: 11pt/13.7pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Promissory
Notes </span></i></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">In
March 2022, the Company received an advance from a shareholder for SGD$270,000 ($194,049), with a fixed interest amount of $8,000, which
will mature and be repayable on August&#160;31, 2022. The principal amount of SGD$150,000 was repaid in July 2022.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">In
May 2022, the Company received an advance from a shareholder for SGD$70,000 ($50,309), with a fixed interest amount of $2,000, which
will mature and be repayable on August&#160;31, 2022. </span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
May 2022, the Company received an advance from a related party for $25,000, with a fixed interest amount of $2,000, which will mature
and be repayable on <span style="background-color: white">August&#160;31, 2022.</span></span></p>

<p style="font: 11pt/13.7pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
June 2022, the Company received an advance from a related party for $25,000, with a fixed interest amount of $2,000, which will mature
and be repayable on <span style="background-color: white">August&#160;31, 2022.</span></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">In
July 2022, the Company received an advance from a related party for SGD$500,000, with a fixed interest amount of $150 per day, which
will mature and be repayable on August 31, 2022. The Company may repay the promissory note at any time prior to the maturity date. The
principal amount of SGD$500,000 was repaid on July 18, 2022.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Rights
Offering </span></i></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 4, 2020, the Company filed a Form S-1 Registration Statement to distribute subscription rights to purchase up to an aggregate
127,522,227 shares of our common stock at a price of $0.05 per share. As at December&#160;31, 2021, the Company issued 26,496,635 unrestricted
shares of common stock related to proceeds received of $1,324,832. The Company had until October&#160;29, 2021 to sell the remaining
101,025,592 shares of common stock for total proceeds of $5,051,280, if exercised. On December&#160;14, 2021, the Company filed a post-effective
amendment to distribute subscription rights to purchase up to an aggregate 101,025,592 shares of our common stock at a price of $0.05
per share. Each stockholder as of the record date of the December&#160;4, 2020 Form S-1 Registration Statement who received rights and
had not previously exercised those subscription rights as of the expiration date of January&#160;22, 2021, received one subscription
right for each previous subscription right held as at such time. The rights expired March&#160;15, 2022. Pursuant to the terms of the
offering, management may, in its discretion, allocate unexercised subscription rights to non-shareholders within 150 days (until August&#160;12,
2022) following the expiration date of March&#160;15, 2022. In March 2022, the Company recognized share subscription receivable of $25
pursuant to its registration statement and issued an additional 500 shares of common stock for gross proceeds of $25. The subscription
rights were cancelled on July 7, 2022.</span></p>

<!-- Field: Page; Sequence: 30 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Results
of Operations</b></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Six
months ended June&#160;30, 2022 compared to Six months ended June&#160;30, 2021</i></b></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Six Months Ended <br />June&#160;30, <br />2022</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Six Months Ended <br />June&#160;30, <br />2021</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Amount ($) <br />Increase / <br />(Decrease)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Percentage (%) Increase / (Decrease)</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="3" style="text-align: right">&#160;</td><td>&#160;</td>
    <td colspan="3" style="text-align: right">&#160;</td><td>&#160;</td>
    <td colspan="3" style="text-align: right">&#160;</td><td>&#160;</td>
    <td colspan="3" style="text-align: right">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%; text-indent: -12.15pt; padding-left: 12.15pt">Revenue</td><td style="width: 3%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">2,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 3%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;$</td><td style="width: 10%; text-align: right">&#8212;&#160;&#160;</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 3%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 10%; text-align: right">2,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 3%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 10%; text-align: right">100</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt; text-indent: -12.15pt; padding-left: 12.15pt">Cost of revenue</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(1,000</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8212;&#160;&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(1,000</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">100</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: -12.15pt; padding-left: 12.15pt">Gross margin</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">1,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8212;&#160;&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">1,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">100</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -12.15pt; padding-left: 12.15pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -12.15pt; padding-left: 12.15pt">Operating Expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -12.15pt; padding-left: 12.15pt">&#160;&#160;Product development costs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">250,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">240,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -12.15pt; padding-left: 12.15pt">&#160;&#160;Professional fees</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">525,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">356,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">169,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">47</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: -12.15pt; padding-left: 12.15pt">&#160;&#160;Selling, general and administrative</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">1,009,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">424,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">585,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">138</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: -12.15pt; padding-left: 12.15pt">Operating loss</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">1,784,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">1,020,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">764,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">75</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -12.15pt; padding-left: 12.15pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: -12.15pt; padding-left: 12.15pt">Loss before other items</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">1,783,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">1,020,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">763,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">75</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -12.15pt; padding-left: 12.15pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -12.15pt; padding-left: 12.15pt">Other Items</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -12.15pt; padding-left: 12.15pt">&#160;&#160;Interest expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,110,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,284,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,174,000</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(51</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: -12.15pt; padding-left: 12.15pt">&#160;&#160;Loss on settlement of debt</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8212;&#160;&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">33,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(33,000</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(100</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: -12.15pt; padding-left: 12.15pt">Total other items</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">1,110,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">2,317,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(1,207,000</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(52</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt; text-indent: -12.15pt; padding-left: 12.15pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: -12.15pt; padding-left: 12.15pt">Net Loss</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">2,893,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;$</td><td style="border-bottom: Black 1pt solid; text-align: right">3,337,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(444,000</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(13</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  </table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 31 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
net loss for the six months ended June&#160;30, 2022 was 13% ($444,000) lower than the net loss at June&#160;30, 2021. Loss before other
items and stock-based compensation was $385,000 (44%) higher during the six months ended June&#160;30, 2022, as compared to the six months
ended June&#160;30, 2021. We highlight that <b><i>loss before other items and stock-based compensation </i></b>is a &#8220;non-GAAP financial
measure&#8221;. This measure is calculated by removing those items from the net loss presented on our unaudited condensed consolidated
statements of operations. This measure does not have a standardized meaning under U.S. GAAP. Management uses this measure internally
to evaluate its results of operations as it removes the impact of stock-based compensation, non-operational losses and interest accretion.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Six Months Ended <br />June&#160;30, <br />2022</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Six Months Ended <br />June&#160;30, <br />2021</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Amount ($) <br />Increase / <br />(Decrease)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Percentage (%) Increase / (Decrease)</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="3" style="text-align: right">&#160;</td><td>&#160;</td>
    <td colspan="3" style="text-align: right">&#160;</td><td>&#160;</td>
    <td colspan="3" style="text-align: right">&#160;</td><td>&#160;</td>
    <td colspan="3" style="text-align: right">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%; text-align: left; padding-left: 5.4pt">Loss Before Other Items</td><td style="width: 3%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">1,783,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 3%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;$</td><td style="width: 10%; text-align: right">1,020,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 3%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 10%; text-align: right">763,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 3%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 10%; text-align: right">75</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: -9pt; padding-left: 9pt">Stock-based compensation included in selling, general and administrative expenses, professional fees and product development costs</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">519,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">141,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">378,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">268</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: -9pt; padding-left: 9pt">Loss Before Other Items and Stock-based Compensation</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">1,264,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;$</td><td style="border-bottom: Black 1pt solid; text-align: right">879,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">385,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">44</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -9pt; padding-left: 9pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  </table>

<p style="font: 11pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
net loss before interest and stock-based compensation for the Company&#8217;s six months ended June&#160;30, 2022 increased by $385,000
due primarily to increased selling, general and administrative expenses as a result of costs incurred in relation to ALR Singapore and
in relation to the rights offering.</span></p>

<p style="font: 11pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Selling,
General and Administrative</span></span></p>

<p style="font: 11pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Selling,
general and administrative costs incurred consist of salaries and consulting fees of management personnel, stock-based compensation for
options vested to management personnel, travel and trade show costs, rent of the Company&#8217;s corporate office, website development
costs and general costs incurred through day-to-day operations.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the period, the Company had increased selling, general and administrative operating expenses, as compared to the same period in 2021.
The selling, general and administrative expenses, excluding stock-based compensation, increased by $203,000 during 2022, as compared
to 2021, primarily driven by an increase in salaries, payroll expenses and consulting fees paid to personnel related to GluCurve Pet
CGM, mailing and printing of materials related to the rights offering in the current period offset by fees paid to a market research
firm related to commercialization plans for the Company&#8217;s GluCurve Pet CGM in the comparative period of the prior year. The components
of selling, general and administrative expenses and the changes therein can be seen as follows:</span></p>

<p style="font: 11pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid">Selling, General and Administrative:</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Six Months Ended <br />June&#160;30, <br />2022</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Six Months Ended <br />June&#160;30, <br />2021</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Amount ($) <br />Increase / <br />(Decrease)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 46%; text-align: left; padding-left: 5.4pt">Salaries and consulting fees</td><td style="width: 5%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">479,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 5%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;$</td><td style="width: 11%; text-align: right">305,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 5%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 11%; text-align: right">174,000</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 5.4pt">Travel and trade shows</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">6,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(4,000</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 5.4pt">Website and information technology</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">13,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">9,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 5.4pt">Transfer agent, filing fees and quotation costs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">15,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">8,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">7,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 5.4pt">Market research consulting fees</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">44,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(34,000</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 5.4pt">Payroll expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">39,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">9,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">30,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 5.4pt">License and permits</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(9,000</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 5.4pt">Shareholder communications</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">28,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">23,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 5.4pt">Foreign exchange</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">8,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">7,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">Other general and administrative costs</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">28,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">17,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">11,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 5.4pt">Subtotal</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">627,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">424,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">203,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">Stock-based compensation</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">382,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8212;&#160;&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">382,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt; padding-left: 5.4pt">Total</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">1,009,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;$</td><td style="border-bottom: Black 1pt solid; text-align: right">424,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">585,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  </table>


<!-- Field: Page; Sequence: 32 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Product
development costs</span></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Substantially
all of the product development costs incurred related to a) services provided by contractors of the Company, and b) expenses incurred
for product development. The Company incurred stock-based compensation expense of $119,000 during Q2 2022 related to the grant and vesting
of options to its product development team compared to $98,000 during Q2 2021.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Professional
fees</span></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Professional
fees incurred consists of consulting and advisory fees of certain professionals retained, audit fees, tax consultant fees, recruiter
fees, legal fees and stock-based compensation for options granted to professionals. Excluding the difference in net loss attributed to
the vesting of stock options granted in the prior year, professional fees increased by $194,000 from the comparative period of the prior
year. The increase in professional fees was mainly due to accounting and legal fees in the current period offset by recruiter fees paid
in the comparative period of the prior year. During the period, the increase in accounting and legal fees related to:</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#183;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Assessing
                                            business structure alternatives, including evaluating and forming the animal health division;</span></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#183;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Evaluating
                                            retaining additional personnel to support commercialization strategies in Singapore and the
                                            United States;</span></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#183;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Increased
                                            compensation paid to certain accounting professionals retained; </span></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#183;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Its
                                            proposed migration to Singapore and preparation of the Form F-4 filed on May 24, 2022; and</span></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#183;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Completing
                                            the rights offering financing, preparing subsequent amendments to extend the rights offering
                                            and issuing the post-effective amendment to the rights offering.</span></td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By
type of professional cost, the variance can be seen as follows:</span></p>

<p style="font: 11pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid">Professional fees:</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Six Months Ended <br />June&#160;30, <br />2022</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Six Months Ended <br />June&#160;30, <br />2021</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Amount ($) <br />Increase / <br />(Decrease)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 46%; text-align: left; padding-left: 5.4pt">Corporate auditor</td><td style="width: 5%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">29,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 5%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;$</td><td style="width: 11%; text-align: right">14,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 5%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 11%; text-align: right">15,000</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 5.4pt">Accounting fees</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">203,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">76,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">127,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 5.4pt">Tax consultant fees</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">14,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">40,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(26,000</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 5.4pt">Legal fees</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">260,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">90,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">170,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 5.4pt">Recruiter fees</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;&#160;&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">48,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(48,000</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">Market consultants and outreach</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">1,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">45,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(44,000</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 5.4pt">Subtotal</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">507,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">313,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">194,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">Stock-based compensation</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">18,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">43,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(25,000</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt; padding-left: 5.4pt">Total</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">525,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;$</td><td style="border-bottom: Black 1pt solid; text-align: right">356,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">169,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Interest
expense</span></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interest
expense was from the following sources for the six months ended June&#160;30, 2022 and 2021:</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid">Interest expense:</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Six Months Ended <br />June&#160;30, <br />2022</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Six Months Ended <br />June&#160;30, <br />2021</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Amount ($) <br />Increase / <br />(Decrease)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 46%; text-align: left; padding-left: 5.4pt">Interest expense incurred on promissory notes</td><td style="width: 5%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">277,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 5%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;$</td><td style="width: 11%; text-align: right">264,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 5%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 11%; text-align: right">13,000</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 5.4pt">Interest expense incurred on lines of credit</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">778,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">671,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">107,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 5.4pt">Imputed interest on zero interest loans</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">52,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">60,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(8,000</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">Other interest</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">3,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">1,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">2,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 5.4pt">Subtotal</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,110,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">996,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">114,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">Interest expense incurred on stock options modified</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8212;&#160;&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">1,288,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(1,288,000</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt; padding-left: 5.4pt">Total</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">1,110,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;$</td><td style="border-bottom: Black 1pt solid; text-align: right">2,284,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(1,174,000</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  </table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 33 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Interest
on Promissory Notes </i></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company received an advance from two shareholders for an aggregate SGD$340,000 ($244,000), with a fixed interest amount of $10,000, during
the six months ended June&#160;30, 2022. The Company also received an advance from two related parties for an aggregate $50,000, with
a fixed interest amount of $4,000, during the six months ended June&#160;30, 2022. There were no other significant changes in the amount
of promissory notes outstanding as at June&#160;30, 2022 and 2021. The interest incurred on promissory notes was consistent during the
six months ended June&#160;30, 2022 and 2021.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Interest
on Lines of Credit </i></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has two line of credit facilities with balances as follows:</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid">Lines of credit:</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Six Months Ended <br />June&#160;30, <br />2022</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Six Months Ended <br />June&#160;30, <br />2021</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Amount ($) <br />Increase / <br />(Decrease)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 46%; text-align: left; padding-left: 5.4pt">Line of credit provided by Sidney Chan</td><td style="width: 5%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">10,300,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 5%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;$</td><td style="width: 11%; text-align: right">9,941,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 5%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 11%; text-align: right">359,000</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">Line of credit provided by Christine Kan</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">2,827,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">2,000,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">827,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt; padding-left: 5.4pt">Total</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">13,127,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;$</td><td style="border-bottom: Black 1pt solid; text-align: right">11,941,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">1,186,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
principal balance of the lines of credit due to Mr. Sidney Chan and Ms. Christine Kan increased due to advances from Mr. Chan and Ms.
Kan under the lines of credit to finance the operations of the Company.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company incurred interest on the lines of credit as follows:</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid">Interest expense on lines of credit:</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Six Months Ended <br />June&#160;30, <br />2022</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Six Months Ended <br />June&#160;30, <br />2021</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Amount ($) <br />Increase / <br />(Decrease)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 46%; text-align: left; text-indent: -10.35pt; padding-left: 10.35pt">Interest expense incurred on the line of credit from Sidney Chan during the period</td><td style="width: 5%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">617,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 5%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;$</td><td style="width: 11%; text-align: right">551,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 5%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 11%; text-align: right">66,000</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: -10.35pt; padding-left: 10.35pt">Interest expense incurred on the line of credit from Christine Kan during the period</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">161,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">120,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">41,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt; text-indent: -10.35pt; padding-left: 10.35pt">Total</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">778,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;$</td><td style="border-bottom: Black 1pt solid; text-align: right">671,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">107,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Imputed
Interest </i></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the 2022 and 2021 periods, the Company had certain zero interest promissory notes and accounts payable in excess of one year. Pursuant
to the Company&#8217;s accounting policy, these zero interest amounts are considered to be financing items in nature and are assigned
a deemed interest rate (1% per month). The interest incurred on these is expensed as imputed interest and instead of increasing the liabilities
of the Company, it is allocated to equity under the financial statement line item <i>additional paid-in capital</i>. The change from
the prior period is related to the discussion included under <i>Interest on Promissory Notes</i> above.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Liquidity
and Capital Resources</b></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid">Working Capital</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">As At <br />June&#160;30, <br />2022</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">As At <br />December&#160;31, 2021</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Amount ($) <br />Increase / <br />(Decrease)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Percentage (%) Increase / (Decrease)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%; text-align: left; padding-left: 5.4pt">Current Assets</td><td style="width: 3%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">96,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 3%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;$</td><td style="width: 10%; text-align: right">193,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 3%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 10%; text-align: right">(97,000</td><td style="width: 1%; text-align: left">)</td><td style="width: 3%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 10%; text-align: right">(50</td><td style="width: 1%; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">Current Liabilities</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">26,355,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">24,505,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">1,850,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">8</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">Working Capital Deficiency</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">(26,259,000</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;$</td><td style="border-bottom: Black 1pt solid; text-align: right">(24,312,000</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(1,947,000</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">8</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 5.4pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  </table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 34 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has a severe working capital deficiency. It does not have the ability to service its current liabilities for the next twelve
months and is reliant on its line of credit facilities to meet its ongoing operations. Until the Company has revenue-producing activities
that exceed its operating requirements, it will be unable to service its current liabilities and the working capital deficit will continue
to increase. As of the date of this report, the Company has not commenced commercial revenue-generating activities. The Company is expected
to continue generating revenues in Singapore during the 2022 fiscal year; however, the amount and timing are uncertain. The revenues
generated in 2021 and 2022 are not expected to be sufficient to finance the ongoing operations of the business and repay the current
liabilities. The Company is also evaluating opportunities for its GluCurve product, the timing and amount of revenues from which are
uncertain. There is substantial doubt about the Company&#8217;s ability to repay its current liabilities in the near term or any time
in the future, which could ultimately lead to business failure.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Current
Assets </i></b></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s nominal current assets as at June&#160;30, 2022 and December&#160;31, 2021 consist of cash and prepaid expenses.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Current
Liabilities</i></b></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has current liabilities of $26,355,000 at June&#160;30, 2022, as compared to $24,505,000 at December&#160;31, 2021. Current liabilities
are as follows:</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">June&#160;30, <br />2022</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">December&#160;31, 2021</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Change <br />($)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Change <br />(%)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%; text-align: left; text-indent: -6.25pt; padding-left: 6.25pt">Accounts payable and accrued liabilities</td><td style="width: 3%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">1,330,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 3%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;$</td><td style="width: 10%; text-align: right">1,130,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 3%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 10%; text-align: right">200,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 3%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 10%; text-align: right">18</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -6.25pt; padding-left: 6.25pt">Promissory notes to related parties</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,092,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,042,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">50,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -6.25pt; padding-left: 6.25pt">Promissory notes to arm&#8217;s length parties</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,458,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,213,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">245,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">11</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -6.25pt; padding-left: 6.25pt">Interest payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,388,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,111,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">277,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">7</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: -6.25pt; padding-left: 6.25pt">Lines of credit from related parties</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">15,087,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">14,009,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">1,078,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">8</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: -6.25pt; padding-left: 6.25pt">Total current liabilities</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">26,355,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;$</td><td style="border-bottom: Black 1pt solid; text-align: right">24,505,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">1,850,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">8</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Accounts
payable and accrued liabilities</span></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounts
payable and accrued liabilities consists of trade payables and accrued liabilities of the Company. Accounts payable totaling approximately
$1,075,000 and accrued liabilities totaling approximately $255,000. Approximately $600,000 of accounts payable is more than one year
old with the majority of these being more than ten years old.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
fluctuations in accounts payable occurred in the regular course of business.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Promissory
notes to related parties and promissory notes payable to arm&#8217;s length parties </span></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has promissory notes with 24 individuals or corporations that relate to historical amounts borrowed. With the exception of the
SGD$340,000 advance received from arm&#8217;s length parties and $50,000 received from related parties during the six month period ended
June&#160;30, 2022, there has been no new activity for several years. All of the promissory notes, other than the SGD$340,000 and $50,000
loan received during the current period, are past due and continue to accrue interest at their respective legal rates of interest (mostly
1% per month). During the six months ended June&#160;30, 2022, the Company received an advance from two shareholders for SGD$340,000
($244,000), with a fixed interest amount of $10,000, due August 31, 2022, and from two related parties for $50,000, with a fixed interest
amount of $4,000, due August 31, 2022.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Interest
payable&#9;</span></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interest
payable relates to the unpaid interest expense incurred on the promissory notes to related parties and promissory notes to arm&#8217;s
length parties. The change from December&#160;31, 2021 to June&#160;30, 2022 relates to $277,000 of accrued interest incurred on promissory
notes at their stated rates of interest.</span></p>


<!-- Field: Page; Sequence: 35 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
of the promissory notes, except for the promissory notes received during the most recent six month period, and related interest payable,
are overdue.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Cash
Flows</i></b></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid">Cash Flows</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Six Months Ended <br />June&#160;30, 2022</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Six Months Ended <br />June&#160;30, 2021</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; text-align: left; padding-left: 5.4pt">Cash flows used in Operating Activities</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">(707,000</td><td style="width: 1%; text-align: left">)</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">(857,000</td><td style="width: 1%; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 5.4pt">Cash flows provided by Financing Activities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">595,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,167,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">Effect of foreign exchange on cash</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">5,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8212;&#160;&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">Net Increase (Decrease) in Cash During Period</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">(107,000</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">310,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Cash
Balances and Working Capital</i></b></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of June&#160;30, 2022, the Company&#8217;s cash balance was $9,000 compared to $116,000 as of December&#160;31, 2021. The Company does
not have sufficient cash on hand to fund its requirements for the 2022 fiscal year and will need to secure additional financing.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Cash
Used in Operating Activities</i></b></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash
used by the Company in operating activities during the six months ended June&#160;30, 2022 was $707,000 in comparison with $857,000 used
during the same period last year. The Company&#8217;s expenditures from operations were used as follows (approximate amounts):</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid">Cash Used in Operating Activities Reconciliation</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Six Months Ended <br />June&#160;30, <br />2022</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Six Months Ended <br />June&#160;30, <br />2021</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; text-align: left; text-indent: -6.25pt; padding-left: 6.25pt">Net loss</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">(2,893,000</td><td style="width: 1%; text-align: left">)</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">(3,337,000</td><td style="width: 1%; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -6.25pt; padding-left: 6.25pt">Stock-based compensation incurred for product development, professional fees and interest expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">519,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,429,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -6.25pt; padding-left: 6.25pt">Non-cash imputed interest expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">52,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">60,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -6.25pt; padding-left: 6.25pt">Loss on debt settlement</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;&#160;&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">33,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -6.25pt; padding-left: 6.25pt">Bonuses settled by issuance of shares</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">245,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;&#160;&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -6.25pt; padding-left: 6.25pt">Net purchases with balances owing in accounts payable and accrued liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">325,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">18,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -6.25pt; padding-left: 6.25pt">Retainers and prepaid services</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(10,000</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -6.25pt; padding-left: 6.25pt">Accrued interest on lines of credit</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">778,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">671,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: -6.25pt; padding-left: 6.25pt">Accrued interest from promissory notes</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">277,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">264,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: -6.25pt; padding-left: 6.25pt">Cash used in operating activities</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">(707,000</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">(857,000</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -6.25pt; padding-left: 6.25pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  </table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
expenditures incurred were to fund the operating activities of the business.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 36 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Cash
Proceeds from Financing Activities</i></b></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash
sourced by the Company from financing activities during the six months ended June&#160;30, 2022 was $595,000 in comparison with $1,167,000
sourced during the same period last year. The funds were sourced as follows:</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid">Cash from Financing Activities Reconciliation</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Six Months Ended <br />June&#160;30, <br />2022</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Six Months Ended <br />June&#160;30, <br />2021</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; text-align: left; padding-left: 5.4pt">Proceeds from rights offering</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">&#8212;&#160;&#160;</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">1,125,000</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 5.4pt">Proceeds from exercise of options</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;&#160;&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">12,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 5.4pt">Proceeds from promissory notes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">294,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;&#160;&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">Net proceeds from line of credit from Mr. Sidney Chan</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">301,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">30,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">Cash provided by financing activities</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">595,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">1,167,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Short-
and Long-term Liquidity</i></b></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of June&#160;30, 2022, the Company does not have the current financial resources and committed financing to enable it to meet its administrative
overhead, product development budgeted costs and debt obligations over the next twelve months.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
majority of the Company&#8217;s debt financing is due on demand or overdue. The Company will seek to obtain creditors&#8217; consents
to delay repayment of these loans until it is able to replace these financings with funds generated by operations, replacement debt,
or from equity financings through private placements or the exercise of options and warrants. While the Company&#8217;s creditors have
agreed to extend repayment deadlines in the past, there is no assurance that they will continue to do so in the future. The Company has
faced litigation from creditors in the past and is currently being sued by one creditor. There is no assurance that additional creditors
will not make claims against the Company in the future. Failure to obtain either replacement financing or creditor consent to delay the
repayment of existing financing could result in the Company having to cease operations.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Tabular
Disclosure of Contractual Obligations:</i></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="19" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Payments Due by Period</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Less</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Than 1</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Year</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>1-3</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Years</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>3-5</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Years</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>More</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Than 5</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Years</b></span></p></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 35%; text-align: left; text-indent: -6.25pt; padding-left: 6.25pt">Accounts payable and accrued liabilities</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">1,330,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">1,330,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">&#8212;&#160;&#160;</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">&#8212;&#160;&#160;</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">&#8212;&#160;&#160;</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -6.25pt; padding-left: 6.25pt">Promissory notes to related parties</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,092,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,092,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;&#160;&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;&#160;&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;&#160;&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -6.25pt; padding-left: 6.25pt">Promissory notes to arm&#8217;s length parties</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,458,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,458,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;&#160;&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;&#160;&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;&#160;&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -6.25pt; padding-left: 6.25pt">Interest payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,388,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,388,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;&#160;&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;&#160;&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;&#160;&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt; text-indent: -6.25pt; padding-left: 6.25pt">Lines of credit</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">15,087,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">15,087,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8212;&#160;&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8212;&#160;&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8212;&#160;&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt; text-indent: -6.25pt; padding-left: 6.25pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">26,355,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">26,355,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8212;&#160;&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8212;&#160;&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8212;&#160;&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -6.25pt; padding-left: 6.25pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  </table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company will continue to use the funds available from the lines of credit to cover administrative overhead and product development requirements
until such time as it can establish cash flows from operations. In the next year, the Company anticipates the amount borrowed under the
lines of credit to increase, as it expects to commercially launch its GluCurve before December&#160;31, 2022 and proceed with activities
to launch the Diabetes Solution with CGM for Human Health during 2023.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 37 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Critical
Accounting Policies and Going Concern</i></b></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
discussion and analysis of our results of operations and liquidity and capital resources are based on our unaudited condensed consolidated
financial statements for the three and six months ended June&#160;30, 2022 and 2021, which have been prepared in accordance with U.S.
GAAP.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
preparation of these condensed consolidated financial statements requires us to make estimates and judgments that affect the reported
amounts of assets, liabilities, revenues and expenses, and disclosure of contingent assets and liabilities. We base our estimates on
historical and anticipated results, trends and various other assumptions that we believe are reasonable under the circumstances, including
assumptions as to future events. These estimates form the basis for making judgments about the carrying values of assets and liabilities
that are not readily apparent from other sources. By their nature, estimates are subject to an inherent degree of uncertainty. Actual
results may differ materially from our estimates.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s condensed consolidated financial statements have been prepared on a going concern basis, which presumes the realization
of assets and the discharge of liabilities and commitments in the normal course of operations for the foreseeable future. See note 1
of the unaudited condensed consolidated financial statements.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Due
to our being a development stage company and not having generated significant revenues, in the notes to our condensed consolidated financial
statements, we have included disclosure regarding concerns about our ability to continue as a going concern.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Off-Balance
Sheet Arrangements</i></b></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has no off-balance sheet financing arrangements that have or are reasonably likely to have a current or future effect on the
Company&#8217;s financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital
expenditures or capital resources, that is material to investors.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM
                          3.</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>QUANTITATIVE
                                            AND QUALITATIVE DISCLOSURE ABOUT MARKET RISK.</b></span></td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
applicable. The Company is a smaller reporting company as defined in Rule 12b-2 of the <i>Securities Exchange Act of 1934</i>.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM
                          4.</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CONTROLS
                                            AND PROCEDURES.</b></span></td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the supervision and with the participation of our management, including the Principal Executive Officer and Principal Financial Officer,
we have evaluated the effectiveness of our disclosure controls and procedures as required by Exchange Act Rules 13a-15(b) as of the end
of the period covered by this report. Based on this assessment, we found our disclosure controls and procedures to be not effective due
to insufficient written policies and procedures for reporting requirements and accounting and financial reporting with respect to the
requirements and application of U.S. GAAP and SEC disclosure requirements.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
assessment is consistent with the evaluation by Company management of our internal controls over financial reporting, as set forth in
Item 9A of the Company&#8217;s Annual Report on Form 10-K for the fiscal year ended December&#160;31, 2021.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">While
the Company is working to remedy these deficiencies as its business activities evolve, there were no changes in our internal controls
over financial reporting during the quarter ended June&#160;30, 2022 that have materially affected, or are reasonably likely to materially
affect, our internal control over financial reporting.</span></p>


<!-- Field: Page; Sequence: 38 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>PART
II. OTHER INFORMATION</i></b></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM
                          1.</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>LEGAL
                                            PROCEEDINGS.</b></span></td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
were no changes during the period beginning April&#160;1, 2022 to the date of this Form 10-Q, with respect to pending legal proceedings
previously reported by the Company.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM
                          1A.</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>RISK
                                            FACTORS.</b></span></td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are a smaller reporting company as defined by Rule 12b-2 of the <i>Securities Exchange Act of 1934</i> and are not required to provide
the information under this item.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM
                          2.</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>UNREGISTERED
                                            SALES OF EQUITY SECURITIES</b></span></td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
June 3, 2022, the Company issued 9,250,000 restricted shares of common stock to four creditors of the Company in consideration of shares
for debt and bonuses issued. The offers and sales of these securities were made pursuant to private placement exemptions from the registration
requirements of the Securities Act, including exemptions under Section 4(a)(2) of the Securities Act and Regulation D, and/or pursuant
to sales to Non-US purchasers pursuant to Regulation S, to a limited number of sophisticated investors with full access to material information
about the Company.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM
                          3.</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>DEFAULTS
                                            UPON SENIOR SECURITIES.</b></span></td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
at June&#160;30, 2022, the Company had promissory notes payable and related interest payable, totalling $9,938,000 in default.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM
                          5.</b></span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>OTHER
                                            INFORMATION.</b></span></td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">None.</span></p>


<!-- Field: Page; Sequence: 39 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<p style="margin: 0"></p><table cellpadding="0" cellspacing="0" style="width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"><td style="width: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM
                                            6. EXHIBITS.</b></span></td></tr></table>





<p style="margin: 0"></p><p style="margin: 0; text-align: justify; text-indent: 0.25in"></p>


<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top; background-color: #BFBFBF">
    <td style="border-top: Black 3pt double; line-height: 12pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exhibit</b></span></td>
    <td colspan="2" style="border-top: Black 3pt double; line-height: 12pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="border-top: Black 3pt double; border-bottom: Black 1pt solid; text-align: center; line-height: 12pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Incorporated
    by reference</b></span></td>
    <td style="border-top: Black 3pt double; text-align: center; line-height: 12pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Filed</b></span></td></tr>
  <tr style="vertical-align: top; background-color: #BFBFBF">
    <td style="border-bottom: Black 1pt solid; line-height: 12pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>No.</b></span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; line-height: 12pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Document
    Description</b></span></td>
    <td style="border-bottom: Black 1pt solid; text-align: center; line-height: 12pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Form</b></span></td>
    <td style="border-bottom: Black 1pt solid; text-align: center; line-height: 12pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Date</b></span></td>
    <td style="border-bottom: Black 1pt solid; text-align: center; line-height: 12pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Number</b></span></td>
    <td style="border-bottom: Black 1pt solid; text-align: center; line-height: 12pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>herewith</b></span></td></tr>
  <tr style="vertical-align: top">
    <td colspan="2" style="line-height: 12pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1</span></td>
    <td style="line-height: 12pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="sfsalr10q081122ex3_1.htm">Restated Articles of Incorporation.</a></span></td>
    <td style="text-align: center; line-height: 12pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center; line-height: 12pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center; line-height: 12pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1</span></td>
    <td style="text-align: center; line-height: 12pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">X</span></td></tr>
  <tr style="vertical-align: top">
    <td colspan="2" style="line-height: 12pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.2</span></td>
    <td style="line-height: 12pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1087022/000108702299000004/0001087022-99-000004.txt">Bylaws.</a></span></td>
    <td style="text-align: center; line-height: 12pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10-SB</span></td>
    <td style="text-align: center; line-height: 12pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12/10/99</span></td>
    <td style="text-align: center; line-height: 12pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.2</span></td>
    <td style="text-align: center; line-height: 12pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: top">
    <td colspan="2" style="line-height: 12pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.6</span></td>
    <td style="line-height: 12pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1087022/000100201411000486/exh32.htm">Amendment
    to Bylaws, dated October 13, 2011.</a></span></td>
    <td style="text-align: center; line-height: 12pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</span></td>
    <td style="text-align: center; line-height: 12pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10/17/11</span></td>
    <td style="text-align: center; line-height: 12pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center; line-height: 12pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: top">
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.7</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1087022/000100201412000228/exh3-6.htm">Amendment
    to Bylaws, dated April 10, 2012.</a></span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4/16/12</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: top">
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1087022/000190359622000416/f2salr8k070522ex10_1.htm">Manufacturing
    and Supply Agreement with Infinovo Medical Co., Ltd.</a></span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7/5/22</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: top">
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.2</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1087022/000190359622000343/f2salr8k031522ex2_1.htm">Agreement
    and Plan of Merger and Reorganization dated May 17, 2022 by and among ALR Singapore, ALR Delaware, and the Company</a></span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5/17/22</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: top">
    <td colspan="2" style="line-height: 12pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">14.1</span></td>
    <td style="line-height: 12pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1087022/000172186818000148/f2alrt10q022018ex14_1.htm">Code
    of Ethics.</a></span></td>
    <td style="text-align: center; line-height: 12pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10-KSB</span></td>
    <td style="text-align: center; line-height: 12pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4/14/04</span></td>
    <td style="text-align: center; line-height: 12pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">14.1</span></td>
    <td style="text-align: center; line-height: 12pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: top">
    <td colspan="2" style="line-height: 12pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">31.1</span></td>
    <td style="line-height: 12pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="sfsalr10q081122ex31_1.htm">Certification
    of Principal Executive Officer and Principal Financial Officer pursuant to Section 302 of the <i>Sarbanes-Oxley Act of 2002</i>.</a></span></td>
    <td style="text-align: center; line-height: 12pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center; line-height: 12pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center; line-height: 12pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center; line-height: 12pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">X</span></td></tr>
  <tr style="vertical-align: top">
    <td colspan="2" style="line-height: 12pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">32.1</span></td>
    <td style="line-height: 12pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="sfsalr10q081122ex32_1.htm">Certification of Chief Executive Officer and Chief Financial Officer pursuant to Section 906 of the <i>Sarbanes-Oxley Act of 2002</i>.</a></span></td>
    <td style="text-align: center; line-height: 12pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center; line-height: 12pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center; line-height: 12pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center; line-height: 12pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">X</span></td></tr>
  <tr style="vertical-align: top">
    <td colspan="2" style="line-height: 12pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.10</span></td>
    <td style="line-height: 12pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">L<a href="http://www.sec.gov/Archives/edgar/data/1087022/000190359622000108/sfsalr10k032222ex99_10.htm">ine of Credit Agreement with Sidney Chan.</a></span></td>
    <td style="text-align: center; line-height: 12pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10-KB</span></td>
    <td style="text-align: center; line-height: 12pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3/30/22</span></td>
    <td style="text-align: center; line-height: 12pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.10</span></td>
    <td style="text-align: center; line-height: 12pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: top">
    <td colspan="2" style="line-height: 12pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.11</span></td>
    <td style="line-height: 12pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1087022/000172186821000901/f2salr8k121421ex99_1.htm">Line of Credit Agreement with Christine Kan.</a></span></td>
    <td style="text-align: center; line-height: 12pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</span></td>
    <td style="text-align: center; line-height: 12pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12/10/21</span></td>
    <td style="text-align: center; line-height: 12pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.1</span></td>
    <td style="text-align: center; line-height: 12pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: top">
    <td colspan="2" style="line-height: 12pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.13</span></td>
    <td style="line-height: 12pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1087022/000190359622000108/sfsalr10k032222ex99_13.htm">Employment Agreement between the Company and Christine Kan.</a></span></td>
    <td style="text-align: center; line-height: 12pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10-KB</span></td>
    <td style="text-align: center; line-height: 12pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3/30/22</span></td>
    <td style="text-align: center; line-height: 12pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.13</span></td>
    <td style="text-align: center; line-height: 12pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: top">
    <td colspan="2" style="line-height: 12pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.14</span></td>
    <td style="line-height: 12pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/0001087022/000190359622000520/0001903596-22-000520-index.htm">Employment Agreement between Sidney Chan and ALR Technologies SG Pte. Ltd.</a></span></td>
    <td style="text-align: center; line-height: 12pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</span></td>
    <td style="text-align: center; line-height: 12pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8/12/22</span></td>
    <td style="text-align: center; line-height: 12pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.10</span></td>
    <td style="text-align: center; line-height: 12pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: top">
    <td colspan="2" style="line-height: 12pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.19</span></td>
    <td style="line-height: 12pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1087022/000172186818000148/f2alrt10q022018ex99_19.htm">Audit Committee Charter.</a></span></td>
    <td style="text-align: center; line-height: 12pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10-KB</span></td>
    <td style="text-align: center; line-height: 12pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3/31/14</span></td>
    <td style="text-align: center; line-height: 12pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.19</span></td>
    <td style="text-align: center; line-height: 12pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: top">
    <td colspan="2" style="line-height: 12pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.20</span></td>
    <td style="line-height: 12pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1087022/000172186818000148/f2alrt10q022018ex99_20.htm">Disclosure Committee Charter.</a></span></td>
    <td style="text-align: center; line-height: 12pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10-KSB</span></td>
    <td style="text-align: center; line-height: 12pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4/14/04</span></td>
    <td style="text-align: center; line-height: 12pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.20</span></td>
    <td style="text-align: center; line-height: 12pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: top">
    <td colspan="2" style="line-height: 12pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.30</span></td>
    <td style="line-height: 12pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1087022/000100201413000341/exh99-8.htm">Nomination Committee Charter.</a></span></td>
    <td style="text-align: center; line-height: 12pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10-KB</span></td>
    <td style="text-align: center; line-height: 12pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3/31/14</span></td>
    <td style="text-align: center; line-height: 12pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.30</span></td>
    <td style="text-align: center; line-height: 12pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: top">
    <td colspan="2" style="line-height: 12pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.40</span></td>
    <td style="line-height: 12pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1087022/000172186818000148/f2alrt10q022018ex99_40.htm">Compensation Committee Charter.</a></span></td>
    <td style="text-align: center; line-height: 12pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10-KB</span></td>
    <td style="text-align: center; line-height: 12pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3/31/14</span></td>
    <td style="text-align: center; line-height: 12pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.40</span></td>
    <td style="text-align: center; line-height: 12pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr>
    <td style="width: 7%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 62%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 7%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 8%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 7%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 8%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>

<!-- Field: Page; Sequence: 40 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>SIGNATURES</i></b></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the requirements of Sections 13 or 15(d) of the <i>Securities Exchange Act of 1934</i>, the Registrant has duly caused this amended
report to be signed on its behalf by the undersigned, thereunto duly authorized, on this 15th day of August 2022.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ALR TECHNOLOGIES, INC.</b></span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Registrant)</span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: top">
    <td style="width: 50%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 5%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">BY:</span></td>
    <td style="width: 45%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">SIDNEY CHAN</span></span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sidney Chan</span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Principal Executive Officer, Principal Accounting Officer,
    Principal Financial Officer, Secretary/Treasurer and Director</span></td></tr>
  </table>
<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"></p>

<!-- Field: Page; Sequence: 41; Options: Last -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


</body>
</html>
<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- 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 -->
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>2
<FILENAME>sfsalr10q081122ex31_1.htm
<DESCRIPTION>CERTIFICATION
<TEXT>
<HTML>
<HEAD>
<TITLE></TITLE>
</HEAD>
<BODY>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>EXHIBIT
31.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CERTIFICATION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PURSUANT
TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I,
Sidney Chan, certify that:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 20px; font: 12pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</FONT></TD>
    <TD STYLE="width: 7px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 12pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I
    have reviewed this Form 10-Q for the quarter ended June 30, 2022, of ALR Technologies, Inc.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 20px; font: 12pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</FONT></TD>
    <TD STYLE="width: 7px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 12pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
    on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary
    to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to
    the period covered by this report;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 20px; font: 12pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</FONT></TD>
    <TD STYLE="width: 7px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 12pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
    on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material
    respects the financial condition, results of operations and cash flows of the Company as of, and for, the periods presented in this
    report;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 20px; font: 12pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</FONT></TD>
    <TD STYLE="width: 7px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 12pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Company's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as
    defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act
    Rules 13a-15(f) and 15d-15(f)) for the Company and have</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 47px; font: 12pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a.</FONT></TD>
    <TD STYLE="width: 7px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 12pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Designed
    such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision,
    to ensure that material information relating to the Company, including its consolidated subsidiaries, is made known to us by others
    within those entities, particularly during the period in which this report is being prepared</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 47px; font: 12pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b.</FONT></TD>
    <TD STYLE="width: 7px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 12pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Designed
    such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our
    supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements
    for external purposes in accordance with generally accepted accounting principles;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 47px; font: 12pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c.</FONT></TD>
    <TD STYLE="width: 7px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 12pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Evaluated
    the effectiveness of the Company's disclosure controls and procedures and presented in this report our conclusions about the effectiveness
    of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 47px; font: 12pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d.</FONT></TD>
    <TD STYLE="width: 7px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 12pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Disclosed
    in this report any change in the Company's internal control over financial reporting that occurred during the Company's most recent
    fiscal quarter (the Company's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably
    likely to materially affect, the Company's internal control over financial reporting; and</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 20px; font: 12pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.</FONT></TD>
    <TD STYLE="width: 7px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 12pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Company's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial
    reporting, to the Company's auditors and the audit committee of the Company's board of directors (or persons performing the equivalent
    functions):</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 47px; font: 12pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a.</FONT></TD>
    <TD STYLE="width: 7px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 12pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
    significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are
    reasonably likely to adversely affect the Company's ability to record, process, summarize and report financial information; and</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 47px; font: 12pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b.</FONT></TD>
    <TD STYLE="width: 7px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 12pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
    fraud, whether or not material, that involves management or other employees who have a significant role in the Company's internal
    control over financial reporting.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
<U>August 15, 2022</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:&nbsp;<U>/s/
Sidney Chan</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sidney
Chan</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
Executive Officer and Chief Financial Officer</FONT></P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>3
<FILENAME>sfsalr10q081122ex32_1.htm
<DESCRIPTION>CERTIFICATION
<TEXT>
<HTML>
<HEAD>
<TITLE></TITLE>
</HEAD>
<BODY>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>EXHIBIT
32.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CERTIFICATION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PURSUANT
TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (18 U.S.C SECTION 1350)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the Quarterly Report of ALR Technologies Inc. (the &#8220;Company&#8221;) on Form 10-Q for the period ended June 30,
2022, as filed with the Securities and Exchange Commission (the &#8220;Report&#8221;), I, Sidney Chan, Chief Executive Officer of the
Company, hereby certify as of the date hereof, solely for purposes of Title 18, Chapter&nbsp;63, Section&nbsp;1350 of the United States
Code, that to my knowledge:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 20px; font: 12pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</FONT></TD>
    <TD STYLE="width: 7px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 12pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Report fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934, and</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 20px; font: 12pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</FONT></TD>
    <TD STYLE="width: 7px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 12pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    information contained in the Report fairly presents, in all material respects, the financial condition and results of operations
    of the Company at the dates and for the periods indicated.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
signed original of this written statement required by Section&nbsp;906, or other document authenticating, acknowledging, or otherwise
adopting the signature that appears in typed form within the electronic version of this written statement required by Section&nbsp;906,
has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff
upon request.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Certification has not been, and shall not be deemed, &#8220;filed&#8221; with the Securities and Exchange Commission.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
<U>August 15, 2022</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:
<U>/s/ Sidney Chan</U>&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sidney
Chan</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
Executive Officer and Chief Financial Officer</FONT></P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>image_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  H'!P@'!@H(" @+"@H+#A@0#@T-
M#AT5%A$8(Q\E)"(?(B$F*S<O)BDT*2$B,$$Q-#D[/CX^)2Y$24,\2#<]/CO_
MVP!# 0H+"PX-#AP0$!P[*"(H.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SL[
M.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SO_P  1" !/ .P# 2(  A$! Q$!_\0
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M3<PQ@QR;0=IW =#QWKQ3_A9WC+_H--_WXC_^)KW'Q7H\OB+PO>Z7;S)%)=(
MLC@E1\P/;Z5Y=_PI#6?^@O8_]\/6=-P2]X#G_P#A9WC+_H--_P!^(_\ XFC_
M (6=XR_Z#3?]^(__ (FKWB#X5ZGX=T2XU6XU&TFCMP"R1JP)R<<9^M</6Z4)
M;(#K8OB3XVGE2&'5I)))&"HBV\9+$] !MKU72[_6/#F@?;/%6I&\U"X&8[54
M11'[?*!D^IZ5B_"CP?9V^BP^)) L]]<JWD;Q\L(!(X]SCK6MJ/@[6=4O'NKK
M4+=G;H,-A1Z#VKBQ,VERTT=>$IT9S_?2M%?B7M'T32];TU-3OK)'N;EF>1@[
M 9W'MFL?Q7:Q^';FU.CF2R,R-YABD;+8(QW]ZL67BJ'P[;_V/-:2326C,C2(
MP"L<D\9^M5M0GF\<742:?;^2UJA+^<X&02.F/I7!)P<+1^(]>E"O#$.=1OV6
MN[TMTT^XQ%UW5]R_\32[ZC_EJ:];'05YP/ NM!@?]&X/_/4_X5Z..E:8=35^
M8YLUJ4)\GLFNNWR%HHHKJ/%.9^(.O_\ "/>$;NX1MMQ./(@_WF[_ (#)_"OG
M'H*]"^,.O_VCXDCTJ)\PZ<OSX/!D;D_D,"N?\":%_P )#XNLK1UW01MYT_\
MN+SC\3@?C7737+"[&=5KG@0V7PHLKQ8O].MF^U7''.U\9'X#;^1KS6.1XI$E
MB8JZ,&5AV(Y!KZLNK6*\M);69 T4R&-U/<$8-?+^MZ5+HFMWFF3 [K:4H"?X
ME['\1BE2G>Z8(^C_  KK:>(O#=EJ:D;I8QY@'\+CAA^8K7KQ[X*Z_P"5=W>@
M3/\ +,//@!_O#AA^6#^%>PUA./+*PC"\;?\ (E:Q_P!>C_RKYH'05]+^-O\
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M,\7_ +5U+_H(W?\ W_;_ !JO+-+/(9)I'E<]6=B2?Q->X_\ "F/"_P#SUO\
M_O\ C_"JVH_!G0ETZX:PEO/M8C8P^9,"I;' (QTJ%5@!Y#HVJ3:)K%IJ<'W[
M:4/C^\.X_$9%?4%G=PW]E!>6[;HIXQ(A]01D5\ILK(Q1U*LIPP/8]Z]M^#>O
M_;O#\NCROF;3VR@/>-N1^1R/RI5HW5P9U/C;_D2M8_Z]'_E7S0.@KZ7\;?\
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;&#Q2KM9?G8\BNDHHJ&[NX@HHHI %%%% '__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>5
<FILENAME>alrt-20220630.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.15b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: 96sps7xRiXgOn8uFZn9MSaaMObOdx5Z7melBtmV5bUlKbyooZGzxwSklDr7m8aYL -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:srt="http://fasb.org/srt/2022" xmlns:srt-types="http://fasb.org/srt-types/2022" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:ALRT="http://alrt.com/20220630" elementFormDefault="qualified" targetNamespace="http://alrt.com/20220630">
    <annotation>
      <appinfo>
	<link:roleType roleURI="http://alrt.com/role/Cover" id="Cover">
	  <link:definition>00000001 - Document - Cover</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://alrt.com/role/BalanceSheets" id="BalanceSheets">
	  <link:definition>00000002 - Statement - Condensed Consolidated Balance Sheets (Unaudited)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://alrt.com/role/BalanceSheetsParenthetical" id="BalanceSheetsParenthetical">
	  <link:definition>00000003 - Statement - Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://alrt.com/role/StatementsOfOperations" id="StatementsOfOperations">
	  <link:definition>00000004 - Statement - Condensed Consolidated Statements of Operations (Unaudited)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://alrt.com/role/StatementsOfCashFlows" id="StatementsOfCashFlows">
	  <link:definition>00000005 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://alrt.com/role/BasisOfPresentationNatureOfOperationsAndGoingConcern" id="BasisOfPresentationNatureOfOperationsAndGoingConcern">
	  <link:definition>00000006 - Disclosure - Basis of presentation, nature of operations and going concern</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://alrt.com/role/SignificantAccountingPolicies" id="SignificantAccountingPolicies">
	  <link:definition>00000007 - Disclosure - Significant accounting policies</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://alrt.com/role/AccountsPayableAndAccruedLiabilities" id="AccountsPayableAndAccruedLiabilities">
	  <link:definition>00000008 - Disclosure - Accounts payable and accrued liabilities</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayable" id="InterestAdvancesAndPromissoryNotesPayable">
	  <link:definition>00000009 - Disclosure - Interest, advances and promissory notes payable</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://alrt.com/role/LinesOfCredit" id="LinesOfCredit">
	  <link:definition>00000010 - Disclosure - Lines of credit</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://alrt.com/role/CapitalStock" id="CapitalStock">
	  <link:definition>00000011 - Disclosure - Capital stock</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://alrt.com/role/AdditionalPaid-inCapital" id="AdditionalPaid-inCapital">
	  <link:definition>00000012 - Disclosure - Additional paid-in capital</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://alrt.com/role/RelatedPartyTransactionsAndBalances" id="RelatedPartyTransactionsAndBalances">
	  <link:definition>00000013 - Disclosure - Related party transactions and balances</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://alrt.com/role/CommitmentsAndContingencies" id="CommitmentsAndContingencies">
	  <link:definition>00000014 - Disclosure - Commitments and contingencies</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://alrt.com/role/OperatingSegments" id="OperatingSegments">
	  <link:definition>00000015 - Disclosure - Operating segments</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://alrt.com/role/SubsequentEvents" id="SubsequentEvents">
	  <link:definition>00000016 - Disclosure - Subsequent events</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://alrt.com/role/AccountsPayableAndAccruedLiabilitiesTables" id="AccountsPayableAndAccruedLiabilitiesTables">
	  <link:definition>00000017 - Disclosure - Accounts payable and accrued liabilities (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableTables" id="InterestAdvancesAndPromissoryNotesPayableTables">
	  <link:definition>00000018 - Disclosure - Interest, advances and promissory notes payable (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://alrt.com/role/LinesOfCreditTables" id="LinesOfCreditTables">
	  <link:definition>00000019 - Disclosure - Lines of credit (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://alrt.com/role/AdditionalPaid-inCapitalTables" id="AdditionalPaid-inCapitalTables">
	  <link:definition>00000020 - Disclosure - Additional paid-in capital (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://alrt.com/role/RelatedPartyTransactionsAndBalancesTables" id="RelatedPartyTransactionsAndBalancesTables">
	  <link:definition>00000021 - Disclosure - Related party transactions and balances (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://alrt.com/role/OperatingSegmentsTables" id="OperatingSegmentsTables">
	  <link:definition>00000022 - Disclosure - Operating segments (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://alrt.com/role/BasisOfPresentationNatureOfOperationsAndGoingConcernDetailsNarrative" id="BasisOfPresentationNatureOfOperationsAndGoingConcernDetailsNarrative">
	  <link:definition>00000023 - Disclosure - Basis of presentation, nature of operations and going concern (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://alrt.com/role/AccountsPayableAndAccruedLiabilitiesDetails" id="AccountsPayableAndAccruedLiabilitiesDetails">
	  <link:definition>00000024 - Disclosure - Accounts payable and accrued liabilities (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails" id="InterestAdvancesAndPromissoryNotesPayableDetails">
	  <link:definition>00000025 - Disclosure - Interest, advances and promissory notes payable (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails1" id="InterestAdvancesAndPromissoryNotesPayableDetails1">
	  <link:definition>00000026 - Disclosure - Interest, advances and promissory notes payable (Details 1)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails2" id="InterestAdvancesAndPromissoryNotesPayableDetails2">
	  <link:definition>00000027 - Disclosure - Interest, advances and promissory notes payable (Details 2)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails3" id="InterestAdvancesAndPromissoryNotesPayableDetails3">
	  <link:definition>00000028 - Disclosure - Interest, advances and promissory notes payable (Details 3)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails4" id="InterestAdvancesAndPromissoryNotesPayableDetails4">
	  <link:definition>00000029 - Disclosure - Interest, advances and promissory notes payable (Details 4)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails5" id="InterestAdvancesAndPromissoryNotesPayableDetails5">
	  <link:definition>00000030 - Disclosure - Interest, advances and promissory notes payable (Details 5)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetailsNarrative" id="InterestAdvancesAndPromissoryNotesPayableDetailsNarrative">
	  <link:definition>00000031 - Disclosure - Interest, advances and promissory notes payable (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://alrt.com/role/LinesOfCreditDetails" id="LinesOfCreditDetails">
	  <link:definition>00000032 - Disclosure - Lines of credit (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://alrt.com/role/LinesOfCreditDetails1" id="LinesOfCreditDetails1">
	  <link:definition>00000033 - Disclosure - Lines of credit (Details 1)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://alrt.com/role/AdditionalPaid-inCapitalDetails" id="AdditionalPaid-inCapitalDetails">
	  <link:definition>00000034 - Disclosure - Additional paid-in capital (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://alrt.com/role/AdditionalPaid-inCapitalDetails1" id="AdditionalPaid-inCapitalDetails1">
	  <link:definition>00000035 - Disclosure - Additional paid-in capital (Details 1)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://alrt.com/role/AdditionalPaid-inCapitalDetails2" id="AdditionalPaid-inCapitalDetails2">
	  <link:definition>00000036 - Disclosure - Additional paid-in capital (Details 2)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://alrt.com/role/AdditionalPaid-inCapitalDetails3" id="AdditionalPaid-inCapitalDetails3">
	  <link:definition>00000037 - Disclosure - Additional paid-in capital (Details 3)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://alrt.com/role/AdditionalPaid-inCapitalDetailsNarrative" id="AdditionalPaid-inCapitalDetailsNarrative">
	  <link:definition>00000038 - Disclosure - Additional paid-in capital (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://alrt.com/role/RelatedPartyTransactionsAndBalancesDetails" id="RelatedPartyTransactionsAndBalancesDetails">
	  <link:definition>00000039 - Disclosure - Related party transactions and balances (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://alrt.com/role/OperatingSegmentsDetails" id="OperatingSegmentsDetails">
	  <link:definition>00000040 - Disclosure - Operating segments (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:linkbaseRef xlink:type="simple" xlink:href="alrt-20220630_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="alrt-20220630_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="alrt-20220630_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Calculation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="alrt-20220630_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Definition Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2022" schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd" />
    <import namespace="http://fasb.org/us-gaap/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd" />
    <import namespace="http://fasb.org/us-types/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2022" schemaLocation="https://xbrl.sec.gov/country/2022/country-2022.xsd" />
    <import namespace="http://fasb.org/srt/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd" />
    <import namespace="http://fasb.org/srt-types/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd" />
    <element id="ALRT_RelatedPartyMember" name="RelatedPartyMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ALRT_UnRelatedPartyMember" name="UnRelatedPartyMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ALRT_ChairmanAndCEOMember" name="ChairmanAndCEOMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ALRT_WifeOfChairmanMember" name="WifeOfChairmanMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ALRT_Options1Member" name="Options1Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ALRT_Options2Member" name="Options2Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ALRT_Options3Member" name="Options3Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ALRT_Options4Member" name="Options4Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ALRT_Options5Member" name="Options5Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ALRT_Options6Member" name="Options6Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ALRT_Options7Member" name="Options7Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ALRT_Options8Member" name="Options8Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ALRT_Options9Member" name="Options9Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ALRT_Options10Member" name="Options10Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ALRT_Options11Member" name="Options11Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ALRT_Options12Member" name="Options12Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ALRT_Options13Member" name="Options13Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ALRT_Options14Member" name="Options14Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ALRT_Options15Member" name="Options15Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ALRT_Options16Member" name="Options16Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ALRT_Options17Member" name="Options17Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ALRT_Options18Member" name="Options18Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ALRT_Options19Member" name="Options19Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ALRT_Options20Member" name="Options20Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ALRT_Options21Member" name="Options21Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ALRT_Options22Member" name="Options22Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ALRT_Options23Member" name="Options23Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ALRT_OtherMember" name="OtherMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ALRT_PromissoryNotesPayableToRelatedParties" name="PromissoryNotesPayableToRelatedParties" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ALRT_PromissoryNotesPayableUnrelatedLender" name="PromissoryNotesPayableUnrelatedLender" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ALRT_LinesOfCreditFromRelatedParties" name="LinesOfCreditFromRelatedParties" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ALRT_WeightedAverageNumberOfSharesOfCommonStockOutstandingBasicAndDiluted" name="WeightedAverageNumberOfSharesOfCommonStockOutstandingBasicAndDiluted" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="ALRT_LossPerShareBasicAndDiluted" name="LossPerShareBasicAndDiluted" nillable="true" xbrli:periodType="duration" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="ALRT_StockbasedCompensationproductDevelopmentCosts" name="StockbasedCompensationproductDevelopmentCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ALRT_StockbasedCompensationgeneralSellingAndAdministration" name="StockbasedCompensationgeneralSellingAndAdministration" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ALRT_StockbasedCompensationProfessionalFees" name="StockbasedCompensationProfessionalFees" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ALRT_StockbasedCompensationinterest" name="StockbasedCompensationinterest" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ALRT_InterestExpenseOnLinesOfCredit" name="InterestExpenseOnLinesOfCredit" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ALRT_NoncashImputedInterestExpenses" name="NoncashImputedInterestExpenses" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ALRT_BonusesSettledByIssuanceOfShares" name="BonusesSettledByIssuanceOfShares" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ALRT_LossOnSettlementOfDebt" name="LossOnSettlementOfDebt" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ALRT_RepaymentOfLinesOfCreditInterest" name="RepaymentOfLinesOfCreditInterest" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ALRT_DisclosureInterestAdvancesAndPromissoryNotesPayableAbstract" name="DisclosureInterestAdvancesAndPromissoryNotesPayableAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="ALRT_InterestAdvancesAndPromissoryNotesPayableTextBlock" name="InterestAdvancesAndPromissoryNotesPayableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="ALRT_DisclosureLinesOfCreditAbstract" name="DisclosureLinesOfCreditAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="ALRT_LineOfCreditTextBlock" name="LineOfCreditTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="ALRT_DisclosureAdditionalPaidinCapitalAbstract" name="DisclosureAdditionalPaidinCapitalAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="ALRT_AdditionalPaidInCapitalTextBlock" name="AdditionalPaidInCapitalTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="ALRT_SummaryOfActivitiesOfPromissoryNotesPayableTableTextBlock" name="SummaryOfActivitiesOfPromissoryNotesPayableTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="ALRT_ScheduleofPromissoryNotesPayableRelativesofBoardofDirectorsTableTextBlock" name="ScheduleofPromissoryNotesPayableRelativesofBoardofDirectorsTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="ALRT_ScheduleofPromissoryNotesPayableToUnrelatedPartiesTableTextBlock" name="ScheduleofPromissoryNotesPayableToUnrelatedPartiesTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="ALRT_ScheduleofActivityofPromissoryNotestoUnrelatedPatiesTableTextBlock" name="ScheduleofActivityofPromissoryNotestoUnrelatedPatiesTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="ALRT_ScheduledOfInterestPayableDueToRelatedTableTextBlock" name="ScheduledOfInterestPayableDueToRelatedTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="ALRT_ScheduledOfLineOfCreditTableTextBlock" name="ScheduledOfLineOfCreditTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="ALRT_ScheduleofOptionsOutstandingTableTextBlock" name="ScheduleofOptionsOutstandingTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="ALRT_WorkingCapitalDeficit" name="WorkingCapitalDeficit" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ALRT_PrincipalBorrowed" name="PrincipalBorrowed" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ALRT_TransferredFromPromissoryNotesPayablePursuantToPrivateTransaction." name="TransferredFromPromissoryNotesPayablePursuantToPrivateTransaction." nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ALRT_PromissoryNotesPayableToRelativesOfDirectorsCollateralizedByAGeneralSecurityAgreementOnAllTheAssetsOfTheCompanyDueOnDemandAbstract" name="PromissoryNotesPayableToRelativesOfDirectorsCollateralizedByAGeneralSecurityAgreementOnAllTheAssetsOfTheCompanyDueOnDemandAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="ALRT_NotePayablewithInterestat1PercentInterestperMonth" name="NotePayablewithInterestat1PercentInterestperMonth" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ALRT_InterestAt1.25PerMonth" name="InterestAt1.25PerMonth" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ALRT_NotePayableInterestattheUSBankPrimeRatePlus1PercentperMonth" name="NotePayableInterestattheUSBankPrimeRatePlus1PercentperMonth" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ALRT_Iv.InterestAt0.5PerMonth" name="Iv.InterestAt0.5PerMonth" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ALRT_UnsecuredPromissoryNotesPayableToRelativesOfChairmanWithFixedAmountsOfInterestDueAugust312022" name="UnsecuredPromissoryNotesPayableToRelativesOfChairmanWithFixedAmountsOfInterestDueAugust312022" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ALRT_PromissoryNotesPayableUnsecuredtoRelativesofaDirectorBearingInterestat1PercentperMonth" name="PromissoryNotesPayableUnsecuredtoRelativesofaDirectorBearingInterestat1PercentperMonth" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ALRT_PromissoryNotesRelatedParty" name="PromissoryNotesRelatedParty" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ALRT_ExtinguishedThroughIssuanceOfSharesOfCommonStock" name="ExtinguishedThroughIssuanceOfSharesOfCommonStock" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ALRT_PromissoryNoteReceived" name="PromissoryNoteReceived" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ALRT_UnsecuredPromissoryNotesPayableToUnrelatedLendersAbstract" name="UnsecuredPromissoryNotesPayableToUnrelatedLendersAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="ALRT_I.InterestAt1PerMonthRepayableOnMarch312009DueOnDemand" name="I.InterestAt1PerMonthRepayableOnMarch312009DueOnDemand" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ALRT_Iii.InterestAt0.625PerMonthWith50000RepayableOnOctober5200440000RepayableOnDecember312004And60000RepayableOnJuly282006AllDueOnDemand" name="Iii.InterestAt0.625PerMonthWith50000RepayableOnOctober5200440000RepayableOnDecember312004And60000RepayableOnJuly282006AllDueOnDemand" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ALRT_Vi.InterestAt0.667PerMonthWith125000DueJanuary152011" name="Vi.InterestAt0.667PerMonthWith125000DueJanuary152011" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ALRT_Noninterestbearing" name="Noninterestbearing" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ALRT_UnsecuredPromissoryNotesPayableToUnrelatedLendersWithFixedAmountsOfInterestDue" name="UnsecuredPromissoryNotesPayableToUnrelatedLendersWithFixedAmountsOfInterestDue" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ALRT_PromissoryNotesPayableSecuredByGuaranteeFromChiefExecutiveOfficerBearingInterestAt1PerMonth" name="PromissoryNotesPayableSecuredByGuaranteeFromChiefExecutiveOfficerBearingInterestAt1PerMonth" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ALRT_TotalPromissoryNotesPayableToUnrelatedParties" name="TotalPromissoryNotesPayableToUnrelatedParties" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ALRT_ReclassifiedFromPromissoryNotesPayable" name="ReclassifiedFromPromissoryNotesPayable" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ALRT_InterestExpenseIncurredonPromissoryNotesandOtherPayables" name="InterestExpenseIncurredonPromissoryNotesandOtherPayables" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ALRT_InterestPayableRetiredThroughIssuanceOfShares" name="InterestPayableRetiredThroughIssuanceOfShares" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ALRT_InterestPayableRelativesOfDirectors" name="InterestPayableRelativesOfDirectors" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ALRT_InterestPayabletoNonrelatedParties" name="InterestPayabletoNonrelatedParties" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ALRT_InterestPayableCurrentAndNoncurrents" name="InterestPayableCurrentAndNoncurrents" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ALRT_RepaymentOfInterestOnLinesOfCredit" name="RepaymentOfInterestOnLinesOfCredit" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ALRT_InterestRate" name="InterestRate" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="ALRT_BorrowingLimit" name="BorrowingLimit" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ALRT_RepaymentTerms1" name="RepaymentTerms1" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="ALRT_AccruedInterest" name="AccruedInterest" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ALRT_TotalOutstanding" name="TotalOutstanding" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ALRT_Security1" name="Security1" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="ALRT_Purpose1" name="Purpose1" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="ALRT_ShareBasedCompensationArrangementbyShareBasedPaymentAwardOptionsCancelations" name="ShareBasedCompensationArrangementbyShareBasedPaymentAwardOptionsCancelations" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="ALRT_CancelledPerShares" name="CancelledPerShares" nillable="true" xbrli:periodType="duration" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="ALRT_OpenOptionContractsWrittenNumbersOfShare" name="OpenOptionContractsWrittenNumbersOfShare" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="ALRT_ExercisePrices" name="ExercisePrices" nillable="true" xbrli:periodType="duration" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="ALRT_IntrinsicValue" name="IntrinsicValue" nillable="true" xbrli:periodType="duration" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="ALRT_Total" name="Total" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ALRT_RelatedPartyTransactionIncludedWithinInterestExpense" name="RelatedPartyTransactionIncludedWithinInterestExpense" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="ALRT_InterestExpenseOnPromissoryNotesIssuedToRelativesOfChairmanAndChiefExecutiveOfficerOfCompany" name="InterestExpenseOnPromissoryNotesIssuedToRelativesOfChairmanAndChiefExecutiveOfficerOfCompany" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ALRT_InterestExpenseOnLinesOfCreditPayableToChairmanAndChiefExecutiveOfficerOfCompanyAndHisSpouse" name="InterestExpenseOnLinesOfCreditPayableToChairmanAndChiefExecutiveOfficerOfCompanyAndHisSpouse" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ALRT_InterestExpenseRelatedToModificationOfStockOptionsHeldByChairmanAndChiefExecutiveOfficerOfCompanyAndHisSpouseRelatedToFinancingProvided" name="InterestExpenseRelatedToModificationOfStockOptionsHeldByChairmanAndChiefExecutiveOfficerOfCompanyAndHisSpouseRelatedToFinancingProvided" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ALRT_RelatedPartyTransactionsIncludingWithinSellingGeneralAndAdministrationExpenses" name="RelatedPartyTransactionsIncludingWithinSellingGeneralAndAdministrationExpenses" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="ALRT_ConsultingFeesToChairmanAndChiefExecutiveOfficerOfCompanyAccruedOnLineOfCreditAvailableToCompany" name="ConsultingFeesToChairmanAndChiefExecutiveOfficerOfCompanyAccruedOnLineOfCreditAvailableToCompany" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ALRT_ConsultingFeesToDirectorOfCompanySettledWithIssuanceOfCommonStock" name="ConsultingFeesToDirectorOfCompanySettledWithIssuanceOfCommonStock" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ALRT_SalaryForServicesAsVpCorporateAndDirectorOfSingaporeSubsidiaryToSpouseOfChairmanAndChiefExecutiveOfficerOfCompany" name="SalaryForServicesAsVpCorporateAndDirectorOfSingaporeSubsidiaryToSpouseOfChairmanAndChiefExecutiveOfficerOfCompany" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ALRT_LossOnSettlementOfDebtToRelativeOfChairmanAndChiefExecutiveOfficerOfCompany" name="LossOnSettlementOfDebtToRelativeOfChairmanAndChiefExecutiveOfficerOfCompany" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ALRT_RentPaidToCompanyControlledBySpouseOfChairmanAndImmediateFamilyMembers" name="RentPaidToCompanyControlledBySpouseOfChairmanAndImmediateFamilyMembers" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>6
<FILENAME>alrt-20220630_cal.xml
<DESCRIPTION>XBRL CALCULATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.15b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://alrt.com/role/Cover" xlink:href="alrt-20220630.xsd#Cover" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/BalanceSheets" xlink:href="alrt-20220630.xsd#BalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/BalanceSheetsParenthetical" xlink:href="alrt-20220630.xsd#BalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/StatementsOfOperations" xlink:href="alrt-20220630.xsd#StatementsOfOperations" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/StatementsOfCashFlows" xlink:href="alrt-20220630.xsd#StatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/BasisOfPresentationNatureOfOperationsAndGoingConcern" xlink:href="alrt-20220630.xsd#BasisOfPresentationNatureOfOperationsAndGoingConcern" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/SignificantAccountingPolicies" xlink:href="alrt-20220630.xsd#SignificantAccountingPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/AccountsPayableAndAccruedLiabilities" xlink:href="alrt-20220630.xsd#AccountsPayableAndAccruedLiabilities" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayable" xlink:href="alrt-20220630.xsd#InterestAdvancesAndPromissoryNotesPayable" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/LinesOfCredit" xlink:href="alrt-20220630.xsd#LinesOfCredit" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/CapitalStock" xlink:href="alrt-20220630.xsd#CapitalStock" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/AdditionalPaid-inCapital" xlink:href="alrt-20220630.xsd#AdditionalPaid-inCapital" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/RelatedPartyTransactionsAndBalances" xlink:href="alrt-20220630.xsd#RelatedPartyTransactionsAndBalances" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/CommitmentsAndContingencies" xlink:href="alrt-20220630.xsd#CommitmentsAndContingencies" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/OperatingSegments" xlink:href="alrt-20220630.xsd#OperatingSegments" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/SubsequentEvents" xlink:href="alrt-20220630.xsd#SubsequentEvents" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/AccountsPayableAndAccruedLiabilitiesTables" xlink:href="alrt-20220630.xsd#AccountsPayableAndAccruedLiabilitiesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableTables" xlink:href="alrt-20220630.xsd#InterestAdvancesAndPromissoryNotesPayableTables" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/LinesOfCreditTables" xlink:href="alrt-20220630.xsd#LinesOfCreditTables" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/AdditionalPaid-inCapitalTables" xlink:href="alrt-20220630.xsd#AdditionalPaid-inCapitalTables" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/RelatedPartyTransactionsAndBalancesTables" xlink:href="alrt-20220630.xsd#RelatedPartyTransactionsAndBalancesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/OperatingSegmentsTables" xlink:href="alrt-20220630.xsd#OperatingSegmentsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/BasisOfPresentationNatureOfOperationsAndGoingConcernDetailsNarrative" xlink:href="alrt-20220630.xsd#BasisOfPresentationNatureOfOperationsAndGoingConcernDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/AccountsPayableAndAccruedLiabilitiesDetails" xlink:href="alrt-20220630.xsd#AccountsPayableAndAccruedLiabilitiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails" xlink:href="alrt-20220630.xsd#InterestAdvancesAndPromissoryNotesPayableDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails1" xlink:href="alrt-20220630.xsd#InterestAdvancesAndPromissoryNotesPayableDetails1" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails2" xlink:href="alrt-20220630.xsd#InterestAdvancesAndPromissoryNotesPayableDetails2" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails3" xlink:href="alrt-20220630.xsd#InterestAdvancesAndPromissoryNotesPayableDetails3" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails4" xlink:href="alrt-20220630.xsd#InterestAdvancesAndPromissoryNotesPayableDetails4" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails5" xlink:href="alrt-20220630.xsd#InterestAdvancesAndPromissoryNotesPayableDetails5" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetailsNarrative" xlink:href="alrt-20220630.xsd#InterestAdvancesAndPromissoryNotesPayableDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/LinesOfCreditDetails" xlink:href="alrt-20220630.xsd#LinesOfCreditDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/LinesOfCreditDetails1" xlink:href="alrt-20220630.xsd#LinesOfCreditDetails1" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/AdditionalPaid-inCapitalDetails" xlink:href="alrt-20220630.xsd#AdditionalPaid-inCapitalDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/AdditionalPaid-inCapitalDetails1" xlink:href="alrt-20220630.xsd#AdditionalPaid-inCapitalDetails1" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/AdditionalPaid-inCapitalDetails2" xlink:href="alrt-20220630.xsd#AdditionalPaid-inCapitalDetails2" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/AdditionalPaid-inCapitalDetails3" xlink:href="alrt-20220630.xsd#AdditionalPaid-inCapitalDetails3" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/AdditionalPaid-inCapitalDetailsNarrative" xlink:href="alrt-20220630.xsd#AdditionalPaid-inCapitalDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/RelatedPartyTransactionsAndBalancesDetails" xlink:href="alrt-20220630.xsd#RelatedPartyTransactionsAndBalancesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/OperatingSegmentsDetails" xlink:href="alrt-20220630.xsd#OperatingSegmentsDetails" xlink:type="simple" />
    <link:calculationLink xlink:type="extended" xlink:role="http://alrt.com/role/Cover" xlink:title="00000001 - Document - Cover" />
    <link:calculationLink xlink:type="extended" xlink:role="http://alrt.com/role/BalanceSheets" xlink:title="00000002 - Statement - Condensed Consolidated Balance Sheets (Unaudited)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Cash" xlink:label="loc_us-gaapCash" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapCash" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseCurrent" xlink:label="loc_us-gaapPrepaidExpenseCurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapPrepaidExpenseCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_PromissoryNotesPayableToRelatedParties" xlink:label="loc_ALRTPromissoryNotesPayableToRelatedParties" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_ALRTPromissoryNotesPayableToRelatedParties" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_PromissoryNotesPayableUnrelatedLender" xlink:label="loc_ALRTPromissoryNotesPayableUnrelatedLender" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_ALRTPromissoryNotesPayableUnrelatedLender" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPayableCurrent" xlink:label="loc_us-gaapInterestPayableCurrent" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapInterestPayableCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_LinesOfCreditFromRelatedParties" xlink:label="loc_ALRTLinesOfCreditFromRelatedParties" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_ALRTLinesOfCreditFromRelatedParties" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaapPreferredStockValue" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapPreferredStockValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapCommonStockValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapAdditionalPaidInCapital" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossNetOfTax" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapLiabilities" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://alrt.com/role/BalanceSheetsParenthetical" xlink:title="00000003 - Statement - Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://alrt.com/role/StatementsOfOperations" xlink:title="00000004 - Statement - Condensed Consolidated Statements of Operations (Unaudited)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit" xlink:label="loc_us-gaapGrossProfit" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues" xlink:label="loc_us-gaapRevenues" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapGrossProfit" xlink:to="loc_us-gaapRevenues" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfRevenue" xlink:label="loc_us-gaapCostOfRevenue" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapGrossProfit" xlink:to="loc_us-gaapCostOfRevenue" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaapOperatingIncomeLoss" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaapResearchAndDevelopmentExpense" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingIncomeLoss" xlink:to="loc_us-gaapResearchAndDevelopmentExpense" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfessionalFees" xlink:label="loc_us-gaapProfessionalFees" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingIncomeLoss" xlink:to="loc_us-gaapProfessionalFees" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="loc_us-gaapSellingGeneralAndAdministrativeExpense" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingIncomeLoss" xlink:to="loc_us-gaapSellingGeneralAndAdministrativeExpense" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="loc_us-gaapGrossProfit" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="loc_us-gaapOperatingIncomeLoss" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaapNonoperatingIncomeExpense" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense" xlink:label="loc_us-gaapInterestExpense" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapInterestExpense" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="loc_us-gaapGainsLossesOnExtinguishmentOfDebt" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapGainsLossesOnExtinguishmentOfDebt" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-gaapNonoperatingIncomeExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="loc_us-gaapComprehensiveIncomeNetOfTax" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapComprehensiveIncomeNetOfTax" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax" xlink:label="loc_us-gaapOtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapComprehensiveIncomeNetOfTax" xlink:to="loc_us-gaapOtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax" xlink:type="arc" weight="-1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://alrt.com/role/StatementsOfCashFlows" xlink:title="00000005 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="loc_us-gaapNetIncomeLossAvailableToCommonStockholdersBasic" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapNetIncomeLossAvailableToCommonStockholdersBasic" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_StockbasedCompensationproductDevelopmentCosts" xlink:label="loc_ALRTStockbasedCompensationproductDevelopmentCosts" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_ALRTStockbasedCompensationproductDevelopmentCosts" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_StockbasedCompensationgeneralSellingAndAdministration" xlink:label="loc_ALRTStockbasedCompensationgeneralSellingAndAdministration" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_ALRTStockbasedCompensationgeneralSellingAndAdministration" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_StockbasedCompensationProfessionalFees" xlink:label="loc_ALRTStockbasedCompensationProfessionalFees" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_ALRTStockbasedCompensationProfessionalFees" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_StockbasedCompensationinterest" xlink:label="loc_ALRTStockbasedCompensationinterest" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_ALRTStockbasedCompensationinterest" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_InterestExpenseOnLinesOfCredit" xlink:label="loc_ALRTInterestExpenseOnLinesOfCredit" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_ALRTInterestExpenseOnLinesOfCredit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_NoncashImputedInterestExpenses" xlink:label="loc_ALRTNoncashImputedInterestExpenses" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_ALRTNoncashImputedInterestExpenses" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_BonusesSettledByIssuanceOfShares" xlink:label="loc_ALRTBonusesSettledByIssuanceOfShares" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_ALRTBonusesSettledByIssuanceOfShares" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_LossOnSettlementOfDebt" xlink:label="loc_ALRTLossOnSettlementOfDebt" />
      <link:calculationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_ALRTLossOnSettlementOfDebt" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:label="loc_us-gaapIncreaseDecreaseInPrepaidExpense" />
      <link:calculationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInPrepaidExpense" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities" />
      <link:calculationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInterestPayableNet" xlink:label="loc_us-gaapIncreaseDecreaseInInterestPayableNet" />
      <link:calculationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInInterestPayableNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromLinesOfCredit" xlink:label="loc_us-gaapProceedsFromLinesOfCredit" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromLinesOfCredit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromConvertibleDebt" xlink:label="loc_us-gaapProceedsFromConvertibleDebt" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromConvertibleDebt" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_RepaymentOfLinesOfCreditInterest" xlink:label="loc_ALRTRepaymentOfLinesOfCreditInterest" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_ALRTRepaymentOfLinesOfCreditInterest" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="loc_us-gaapProceedsFromIssuanceOfCommonStock" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromIssuanceOfCommonStock" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaapEffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="loc_us-gaapEffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://alrt.com/role/BasisOfPresentationNatureOfOperationsAndGoingConcern" xlink:title="00000006 - Disclosure - Basis of presentation, nature of operations and going concern" />
    <link:calculationLink xlink:type="extended" xlink:role="http://alrt.com/role/SignificantAccountingPolicies" xlink:title="00000007 - Disclosure - Significant accounting policies" />
    <link:calculationLink xlink:type="extended" xlink:role="http://alrt.com/role/AccountsPayableAndAccruedLiabilities" xlink:title="00000008 - Disclosure - Accounts payable and accrued liabilities" />
    <link:calculationLink xlink:type="extended" xlink:role="http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayable" xlink:title="00000009 - Disclosure - Interest, advances and promissory notes payable" />
    <link:calculationLink xlink:type="extended" xlink:role="http://alrt.com/role/LinesOfCredit" xlink:title="00000010 - Disclosure - Lines of credit" />
    <link:calculationLink xlink:type="extended" xlink:role="http://alrt.com/role/CapitalStock" xlink:title="00000011 - Disclosure - Capital stock" />
    <link:calculationLink xlink:type="extended" xlink:role="http://alrt.com/role/AdditionalPaid-inCapital" xlink:title="00000012 - Disclosure - Additional paid-in capital" />
    <link:calculationLink xlink:type="extended" xlink:role="http://alrt.com/role/RelatedPartyTransactionsAndBalances" xlink:title="00000013 - Disclosure - Related party transactions and balances" />
    <link:calculationLink xlink:type="extended" xlink:role="http://alrt.com/role/CommitmentsAndContingencies" xlink:title="00000014 - Disclosure - Commitments and contingencies" />
    <link:calculationLink xlink:type="extended" xlink:role="http://alrt.com/role/OperatingSegments" xlink:title="00000015 - Disclosure - Operating segments" />
    <link:calculationLink xlink:type="extended" xlink:role="http://alrt.com/role/SubsequentEvents" xlink:title="00000016 - Disclosure - Subsequent events" />
    <link:calculationLink xlink:type="extended" xlink:role="http://alrt.com/role/AccountsPayableAndAccruedLiabilitiesTables" xlink:title="00000017 - Disclosure - Accounts payable and accrued liabilities (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableTables" xlink:title="00000018 - Disclosure - Interest, advances and promissory notes payable (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://alrt.com/role/LinesOfCreditTables" xlink:title="00000019 - Disclosure - Lines of credit (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://alrt.com/role/AdditionalPaid-inCapitalTables" xlink:title="00000020 - Disclosure - Additional paid-in capital (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://alrt.com/role/RelatedPartyTransactionsAndBalancesTables" xlink:title="00000021 - Disclosure - Related party transactions and balances (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://alrt.com/role/OperatingSegmentsTables" xlink:title="00000022 - Disclosure - Operating segments (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://alrt.com/role/BasisOfPresentationNatureOfOperationsAndGoingConcernDetailsNarrative" xlink:title="00000023 - Disclosure - Basis of presentation, nature of operations and going concern (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://alrt.com/role/AccountsPayableAndAccruedLiabilitiesDetails" xlink:title="00000024 - Disclosure - Accounts payable and accrued liabilities (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaapAccountsPayableCurrent" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent" xlink:to="loc_us-gaapAccountsPayableCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccruedLiabilitiesCurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent" xlink:to="loc_us-gaapAccruedLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredRevenueCurrent" xlink:label="loc_us-gaapDeferredRevenueCurrent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent" xlink:to="loc_us-gaapDeferredRevenueCurrent" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails" xlink:title="00000025 - Disclosure - Interest, advances and promissory notes payable (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails1" xlink:title="00000026 - Disclosure - Interest, advances and promissory notes payable (Details 1)">
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_PromissoryNotesRelatedParty" xlink:label="loc_ALRTPromissoryNotesRelatedParty" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_NotePayablewithInterestat1PercentInterestperMonth" xlink:label="loc_ALRTNotePayablewithInterestat1PercentInterestperMonth" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ALRTPromissoryNotesRelatedParty" xlink:to="loc_ALRTNotePayablewithInterestat1PercentInterestperMonth" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_InterestAt1.25PerMonth" xlink:label="loc_ALRTInterestAt1.25PerMonth" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ALRTPromissoryNotesRelatedParty" xlink:to="loc_ALRTInterestAt1.25PerMonth" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_NotePayableInterestattheUSBankPrimeRatePlus1PercentperMonth" xlink:label="loc_ALRTNotePayableInterestattheUSBankPrimeRatePlus1PercentperMonth" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ALRTPromissoryNotesRelatedParty" xlink:to="loc_ALRTNotePayableInterestattheUSBankPrimeRatePlus1PercentperMonth" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_Iv.InterestAt0.5PerMonth" xlink:label="loc_ALRTIv.InterestAt0.5PerMonth" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ALRTPromissoryNotesRelatedParty" xlink:to="loc_ALRTIv.InterestAt0.5PerMonth" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_UnsecuredPromissoryNotesPayableToRelativesOfChairmanWithFixedAmountsOfInterestDueAugust312022" xlink:label="loc_ALRTUnsecuredPromissoryNotesPayableToRelativesOfChairmanWithFixedAmountsOfInterestDueAugust312022" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ALRTPromissoryNotesRelatedParty" xlink:to="loc_ALRTUnsecuredPromissoryNotesPayableToRelativesOfChairmanWithFixedAmountsOfInterestDueAugust312022" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_PromissoryNotesPayableUnsecuredtoRelativesofaDirectorBearingInterestat1PercentperMonth" xlink:label="loc_ALRTPromissoryNotesPayableUnsecuredtoRelativesofaDirectorBearingInterestat1PercentperMonth" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ALRTPromissoryNotesRelatedParty" xlink:to="loc_ALRTPromissoryNotesPayableUnsecuredtoRelativesofaDirectorBearingInterestat1PercentperMonth" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails2" xlink:title="00000027 - Disclosure - Interest, advances and promissory notes payable (Details 2)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails3" xlink:title="00000028 - Disclosure - Interest, advances and promissory notes payable (Details 3)">
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_TotalPromissoryNotesPayableToUnrelatedParties" xlink:label="loc_ALRTTotalPromissoryNotesPayableToUnrelatedParties" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_I.InterestAt1PerMonthRepayableOnMarch312009DueOnDemand" xlink:label="loc_ALRTI.InterestAt1PerMonthRepayableOnMarch312009DueOnDemand" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ALRTTotalPromissoryNotesPayableToUnrelatedParties" xlink:to="loc_ALRTI.InterestAt1PerMonthRepayableOnMarch312009DueOnDemand" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_Iii.InterestAt0.625PerMonthWith50000RepayableOnOctober5200440000RepayableOnDecember312004And60000RepayableOnJuly282006AllDueOnDemand" xlink:label="loc_ALRTIii.InterestAt0.625PerMonthWith50000RepayableOnOctober5200440000RepayableOnDecember312004And60000RepayableOnJuly282006AllDueOnDemand" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ALRTTotalPromissoryNotesPayableToUnrelatedParties" xlink:to="loc_ALRTIii.InterestAt0.625PerMonthWith50000RepayableOnOctober5200440000RepayableOnDecember312004And60000RepayableOnJuly282006AllDueOnDemand" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_Vi.InterestAt0.667PerMonthWith125000DueJanuary152011" xlink:label="loc_ALRTVi.InterestAt0.667PerMonthWith125000DueJanuary152011" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ALRTTotalPromissoryNotesPayableToUnrelatedParties" xlink:to="loc_ALRTVi.InterestAt0.667PerMonthWith125000DueJanuary152011" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_Noninterestbearing" xlink:label="loc_ALRTNoninterestbearing" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ALRTTotalPromissoryNotesPayableToUnrelatedParties" xlink:to="loc_ALRTNoninterestbearing" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_UnsecuredPromissoryNotesPayableToUnrelatedLendersWithFixedAmountsOfInterestDue" xlink:label="loc_ALRTUnsecuredPromissoryNotesPayableToUnrelatedLendersWithFixedAmountsOfInterestDue" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ALRTTotalPromissoryNotesPayableToUnrelatedParties" xlink:to="loc_ALRTUnsecuredPromissoryNotesPayableToUnrelatedLendersWithFixedAmountsOfInterestDue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_PromissoryNotesPayableSecuredByGuaranteeFromChiefExecutiveOfficerBearingInterestAt1PerMonth" xlink:label="loc_ALRTPromissoryNotesPayableSecuredByGuaranteeFromChiefExecutiveOfficerBearingInterestAt1PerMonth" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ALRTTotalPromissoryNotesPayableToUnrelatedParties" xlink:to="loc_ALRTPromissoryNotesPayableSecuredByGuaranteeFromChiefExecutiveOfficerBearingInterestAt1PerMonth" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails4" xlink:title="00000029 - Disclosure - Interest, advances and promissory notes payable (Details 4)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails5" xlink:title="00000030 - Disclosure - Interest, advances and promissory notes payable (Details 5)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetailsNarrative" xlink:title="00000031 - Disclosure - Interest, advances and promissory notes payable (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://alrt.com/role/LinesOfCreditDetails" xlink:title="00000032 - Disclosure - Lines of credit (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://alrt.com/role/LinesOfCreditDetails1" xlink:title="00000033 - Disclosure - Lines of credit (Details 1)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://alrt.com/role/AdditionalPaid-inCapitalDetails" xlink:title="00000034 - Disclosure - Additional paid-in capital (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://alrt.com/role/AdditionalPaid-inCapitalDetails1" xlink:title="00000035 - Disclosure - Additional paid-in capital (Details 1)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://alrt.com/role/AdditionalPaid-inCapitalDetails2" xlink:title="00000036 - Disclosure - Additional paid-in capital (Details 2)">
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_Total" xlink:label="loc_ALRTTotal" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseDebt" xlink:label="loc_us-gaapInterestExpenseDebt" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ALRTTotal" xlink:to="loc_us-gaapInterestExpenseDebt" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" xlink:label="loc_us-gaapResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ALRTTotal" xlink:to="loc_us-gaapResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfessionalAndContractServicesExpense" xlink:label="loc_us-gaapProfessionalAndContractServicesExpense" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ALRTTotal" xlink:to="loc_us-gaapProfessionalAndContractServicesExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherSellingGeneralAndAdministrativeExpense" xlink:label="loc_us-gaapOtherSellingGeneralAndAdministrativeExpense" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ALRTTotal" xlink:to="loc_us-gaapOtherSellingGeneralAndAdministrativeExpense" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://alrt.com/role/AdditionalPaid-inCapitalDetails3" xlink:title="00000037 - Disclosure - Additional paid-in capital (Details 3)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://alrt.com/role/AdditionalPaid-inCapitalDetailsNarrative" xlink:title="00000038 - Disclosure - Additional paid-in capital (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://alrt.com/role/RelatedPartyTransactionsAndBalancesDetails" xlink:title="00000039 - Disclosure - Related party transactions and balances (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://alrt.com/role/OperatingSegmentsDetails" xlink:title="00000040 - Disclosure - Operating segments (Details)" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>7
<FILENAME>alrt-20220630_def.xml
<DESCRIPTION>XBRL DEFINITION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.15b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://alrt.com/role/Cover" xlink:href="alrt-20220630.xsd#Cover" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/BalanceSheets" xlink:href="alrt-20220630.xsd#BalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/BalanceSheetsParenthetical" xlink:href="alrt-20220630.xsd#BalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/StatementsOfOperations" xlink:href="alrt-20220630.xsd#StatementsOfOperations" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/StatementsOfCashFlows" xlink:href="alrt-20220630.xsd#StatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/BasisOfPresentationNatureOfOperationsAndGoingConcern" xlink:href="alrt-20220630.xsd#BasisOfPresentationNatureOfOperationsAndGoingConcern" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/SignificantAccountingPolicies" xlink:href="alrt-20220630.xsd#SignificantAccountingPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/AccountsPayableAndAccruedLiabilities" xlink:href="alrt-20220630.xsd#AccountsPayableAndAccruedLiabilities" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayable" xlink:href="alrt-20220630.xsd#InterestAdvancesAndPromissoryNotesPayable" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/LinesOfCredit" xlink:href="alrt-20220630.xsd#LinesOfCredit" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/CapitalStock" xlink:href="alrt-20220630.xsd#CapitalStock" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/AdditionalPaid-inCapital" xlink:href="alrt-20220630.xsd#AdditionalPaid-inCapital" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/RelatedPartyTransactionsAndBalances" xlink:href="alrt-20220630.xsd#RelatedPartyTransactionsAndBalances" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/CommitmentsAndContingencies" xlink:href="alrt-20220630.xsd#CommitmentsAndContingencies" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/OperatingSegments" xlink:href="alrt-20220630.xsd#OperatingSegments" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/SubsequentEvents" xlink:href="alrt-20220630.xsd#SubsequentEvents" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/AccountsPayableAndAccruedLiabilitiesTables" xlink:href="alrt-20220630.xsd#AccountsPayableAndAccruedLiabilitiesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableTables" xlink:href="alrt-20220630.xsd#InterestAdvancesAndPromissoryNotesPayableTables" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/LinesOfCreditTables" xlink:href="alrt-20220630.xsd#LinesOfCreditTables" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/AdditionalPaid-inCapitalTables" xlink:href="alrt-20220630.xsd#AdditionalPaid-inCapitalTables" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/RelatedPartyTransactionsAndBalancesTables" xlink:href="alrt-20220630.xsd#RelatedPartyTransactionsAndBalancesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/OperatingSegmentsTables" xlink:href="alrt-20220630.xsd#OperatingSegmentsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/BasisOfPresentationNatureOfOperationsAndGoingConcernDetailsNarrative" xlink:href="alrt-20220630.xsd#BasisOfPresentationNatureOfOperationsAndGoingConcernDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/AccountsPayableAndAccruedLiabilitiesDetails" xlink:href="alrt-20220630.xsd#AccountsPayableAndAccruedLiabilitiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails" xlink:href="alrt-20220630.xsd#InterestAdvancesAndPromissoryNotesPayableDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails1" xlink:href="alrt-20220630.xsd#InterestAdvancesAndPromissoryNotesPayableDetails1" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails2" xlink:href="alrt-20220630.xsd#InterestAdvancesAndPromissoryNotesPayableDetails2" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails3" xlink:href="alrt-20220630.xsd#InterestAdvancesAndPromissoryNotesPayableDetails3" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails4" xlink:href="alrt-20220630.xsd#InterestAdvancesAndPromissoryNotesPayableDetails4" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails5" xlink:href="alrt-20220630.xsd#InterestAdvancesAndPromissoryNotesPayableDetails5" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetailsNarrative" xlink:href="alrt-20220630.xsd#InterestAdvancesAndPromissoryNotesPayableDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/LinesOfCreditDetails" xlink:href="alrt-20220630.xsd#LinesOfCreditDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/LinesOfCreditDetails1" xlink:href="alrt-20220630.xsd#LinesOfCreditDetails1" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/AdditionalPaid-inCapitalDetails" xlink:href="alrt-20220630.xsd#AdditionalPaid-inCapitalDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/AdditionalPaid-inCapitalDetails1" xlink:href="alrt-20220630.xsd#AdditionalPaid-inCapitalDetails1" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/AdditionalPaid-inCapitalDetails2" xlink:href="alrt-20220630.xsd#AdditionalPaid-inCapitalDetails2" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/AdditionalPaid-inCapitalDetails3" xlink:href="alrt-20220630.xsd#AdditionalPaid-inCapitalDetails3" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/AdditionalPaid-inCapitalDetailsNarrative" xlink:href="alrt-20220630.xsd#AdditionalPaid-inCapitalDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/RelatedPartyTransactionsAndBalancesDetails" xlink:href="alrt-20220630.xsd#RelatedPartyTransactionsAndBalancesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/OperatingSegmentsDetails" xlink:href="alrt-20220630.xsd#OperatingSegmentsDetails" xlink:type="simple" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll" arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
    <link:definitionLink xlink:type="extended" xlink:role="http://alrt.com/role/Cover" xlink:title="00000001 - Document - Cover" />
    <link:definitionLink xlink:type="extended" xlink:role="http://alrt.com/role/BalanceSheets" xlink:title="00000002 - Statement - Condensed Consolidated Balance Sheets (Unaudited)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://alrt.com/role/BalanceSheetsParenthetical" xlink:title="00000003 - Statement - Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://alrt.com/role/StatementsOfOperations" xlink:title="00000004 - Statement - Condensed Consolidated Statements of Operations (Unaudited)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://alrt.com/role/StatementsOfCashFlows" xlink:title="00000005 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://alrt.com/role/BasisOfPresentationNatureOfOperationsAndGoingConcern" xlink:title="00000006 - Disclosure - Basis of presentation, nature of operations and going concern" />
    <link:definitionLink xlink:type="extended" xlink:role="http://alrt.com/role/SignificantAccountingPolicies" xlink:title="00000007 - Disclosure - Significant accounting policies" />
    <link:definitionLink xlink:type="extended" xlink:role="http://alrt.com/role/AccountsPayableAndAccruedLiabilities" xlink:title="00000008 - Disclosure - Accounts payable and accrued liabilities" />
    <link:definitionLink xlink:type="extended" xlink:role="http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayable" xlink:title="00000009 - Disclosure - Interest, advances and promissory notes payable" />
    <link:definitionLink xlink:type="extended" xlink:role="http://alrt.com/role/LinesOfCredit" xlink:title="00000010 - Disclosure - Lines of credit" />
    <link:definitionLink xlink:type="extended" xlink:role="http://alrt.com/role/CapitalStock" xlink:title="00000011 - Disclosure - Capital stock" />
    <link:definitionLink xlink:type="extended" xlink:role="http://alrt.com/role/AdditionalPaid-inCapital" xlink:title="00000012 - Disclosure - Additional paid-in capital" />
    <link:definitionLink xlink:type="extended" xlink:role="http://alrt.com/role/RelatedPartyTransactionsAndBalances" xlink:title="00000013 - Disclosure - Related party transactions and balances" />
    <link:definitionLink xlink:type="extended" xlink:role="http://alrt.com/role/CommitmentsAndContingencies" xlink:title="00000014 - Disclosure - Commitments and contingencies" />
    <link:definitionLink xlink:type="extended" xlink:role="http://alrt.com/role/OperatingSegments" xlink:title="00000015 - Disclosure - Operating segments" />
    <link:definitionLink xlink:type="extended" xlink:role="http://alrt.com/role/SubsequentEvents" xlink:title="00000016 - Disclosure - Subsequent events" />
    <link:definitionLink xlink:type="extended" xlink:role="http://alrt.com/role/AccountsPayableAndAccruedLiabilitiesTables" xlink:title="00000017 - Disclosure - Accounts payable and accrued liabilities (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableTables" xlink:title="00000018 - Disclosure - Interest, advances and promissory notes payable (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://alrt.com/role/LinesOfCreditTables" xlink:title="00000019 - Disclosure - Lines of credit (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://alrt.com/role/AdditionalPaid-inCapitalTables" xlink:title="00000020 - Disclosure - Additional paid-in capital (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://alrt.com/role/RelatedPartyTransactionsAndBalancesTables" xlink:title="00000021 - Disclosure - Related party transactions and balances (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://alrt.com/role/OperatingSegmentsTables" xlink:title="00000022 - Disclosure - Operating segments (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://alrt.com/role/BasisOfPresentationNatureOfOperationsAndGoingConcernDetailsNarrative" xlink:title="00000023 - Disclosure - Basis of presentation, nature of operations and going concern (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://alrt.com/role/AccountsPayableAndAccruedLiabilitiesDetails" xlink:title="00000024 - Disclosure - Accounts payable and accrued liabilities (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails" xlink:title="00000025 - Disclosure - Interest, advances and promissory notes payable (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtLineItems" xlink:label="loc_us-gaapShortTermDebtLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShortTermDebtTable" xlink:label="loc_us-gaapScheduleOfShortTermDebtTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapScheduleOfShortTermDebtTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaapDebtInstrumentAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShortTermDebtTable" xlink:to="loc_us-gaapDebtInstrumentAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_RelatedPartyMember" xlink:label="loc_ALRTRelatedPartyMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_ALRTRelatedPartyMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NotesPayableRelatedPartiesClassifiedCurrent" xlink:label="loc_us-gaapNotesPayableRelatedPartiesClassifiedCurrent_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapNotesPayableRelatedPartiesClassifiedCurrent_60" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_TransferredFromPromissoryNotesPayablePursuantToPrivateTransaction." xlink:label="loc_ALRTTransferredFromPromissoryNotesPayablePursuantToPrivateTransaction._60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_ALRTTransferredFromPromissoryNotesPayablePursuantToPrivateTransaction._60" xlink:type="arc" order="1" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails1" xlink:title="00000026 - Disclosure - Interest, advances and promissory notes payable (Details 1)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails2" xlink:title="00000027 - Disclosure - Interest, advances and promissory notes payable (Details 2)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtLineItems" xlink:label="loc_us-gaapShortTermDebtLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShortTermDebtTable" xlink:label="loc_us-gaapScheduleOfShortTermDebtTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapScheduleOfShortTermDebtTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaapDebtInstrumentAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShortTermDebtTable" xlink:to="loc_us-gaapDebtInstrumentAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_UnRelatedPartyMember" xlink:label="loc_ALRTUnRelatedPartyMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_ALRTUnRelatedPartyMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NotesPayable" xlink:label="loc_us-gaapNotesPayable_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapNotesPayable_60" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInterestPayableNet" xlink:label="loc_us-gaapIncreaseDecreaseInInterestPayableNet_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapIncreaseDecreaseInInterestPayableNet_60" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_ExtinguishedThroughIssuanceOfSharesOfCommonStock" xlink:label="loc_ALRTExtinguishedThroughIssuanceOfSharesOfCommonStock_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_ALRTExtinguishedThroughIssuanceOfSharesOfCommonStock_60" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_TransferredFromPromissoryNotesPayablePursuantToPrivateTransaction." xlink:label="loc_ALRTTransferredFromPromissoryNotesPayablePursuantToPrivateTransaction._60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_ALRTTransferredFromPromissoryNotesPayablePursuantToPrivateTransaction._60" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_PromissoryNoteReceived" xlink:label="loc_ALRTPromissoryNoteReceived_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_ALRTPromissoryNoteReceived_60" xlink:type="arc" order="4" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails3" xlink:title="00000028 - Disclosure - Interest, advances and promissory notes payable (Details 3)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails4" xlink:title="00000029 - Disclosure - Interest, advances and promissory notes payable (Details 4)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails5" xlink:title="00000030 - Disclosure - Interest, advances and promissory notes payable (Details 5)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetailsNarrative" xlink:title="00000031 - Disclosure - Interest, advances and promissory notes payable (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://alrt.com/role/LinesOfCreditDetails" xlink:title="00000032 - Disclosure - Lines of credit (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://alrt.com/role/LinesOfCreditDetails1" xlink:title="00000033 - Disclosure - Lines of credit (Details 1)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityLineItems" xlink:label="loc_us-gaapLineOfCreditFacilityLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityTable" xlink:label="loc_us-gaapLineOfCreditFacilityTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapLineOfCreditFacilityLineItems" xlink:to="loc_us-gaapLineOfCreditFacilityTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityAxis" xlink:label="loc_us-gaapLineOfCreditFacilityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapLineOfCreditFacilityTable" xlink:to="loc_us-gaapLineOfCreditFacilityAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityLenderDomain" xlink:label="loc_us-gaapLineOfCreditFacilityLenderDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapLineOfCreditFacilityAxis" xlink:to="loc_us-gaapLineOfCreditFacilityLenderDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityLenderDomain" xlink:label="loc_us-gaapLineOfCreditFacilityLenderDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapLineOfCreditFacilityAxis" xlink:to="loc_us-gaapLineOfCreditFacilityLenderDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_ChairmanAndCEOMember" xlink:label="loc_ALRTChairmanAndCEOMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLineOfCreditFacilityLenderDomain" xlink:to="loc_ALRTChairmanAndCEOMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_WifeOfChairmanMember" xlink:label="loc_ALRTWifeOfChairmanMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLineOfCreditFacilityLenderDomain" xlink:to="loc_ALRTWifeOfChairmanMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_InterestRate" xlink:label="loc_ALRTInterestRate_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLineOfCreditFacilityLineItems" xlink:to="loc_ALRTInterestRate_110" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_BorrowingLimit" xlink:label="loc_ALRTBorrowingLimit_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLineOfCreditFacilityLineItems" xlink:to="loc_ALRTBorrowingLimit_110" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_RepaymentTerms1" xlink:label="loc_ALRTRepaymentTerms1_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLineOfCreditFacilityLineItems" xlink:to="loc_ALRTRepaymentTerms1_110" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_PrincipalBorrowed" xlink:label="loc_ALRTPrincipalBorrowed_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLineOfCreditFacilityLineItems" xlink:to="loc_ALRTPrincipalBorrowed_110" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_AccruedInterest" xlink:label="loc_ALRTAccruedInterest_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLineOfCreditFacilityLineItems" xlink:to="loc_ALRTAccruedInterest_110" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_TotalOutstanding" xlink:label="loc_ALRTTotalOutstanding_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLineOfCreditFacilityLineItems" xlink:to="loc_ALRTTotalOutstanding_110" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_Security1" xlink:label="loc_ALRTSecurity1_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLineOfCreditFacilityLineItems" xlink:to="loc_ALRTSecurity1_110" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_Purpose1" xlink:label="loc_ALRTPurpose1_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLineOfCreditFacilityLineItems" xlink:to="loc_ALRTPurpose1_110" xlink:type="arc" order="7" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://alrt.com/role/AdditionalPaid-inCapitalDetails" xlink:title="00000034 - Disclosure - Additional paid-in capital (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://alrt.com/role/AdditionalPaid-inCapitalDetails1" xlink:title="00000035 - Disclosure - Additional paid-in capital (Details 1)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OffsettingAssetsLineItems" xlink:label="loc_us-gaapOffsettingAssetsLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OffsettingAssetsTable" xlink:label="loc_us-gaapOffsettingAssetsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapOffsettingAssetsLineItems" xlink:to="loc_us-gaapOffsettingAssetsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis" xlink:label="loc_us-gaapDerivativeInstrumentRiskAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapOffsettingAssetsTable" xlink:to="loc_us-gaapDerivativeInstrumentRiskAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="loc_us-gaapDerivativeContractTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapDerivativeInstrumentRiskAxis" xlink:to="loc_us-gaapDerivativeContractTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="loc_us-gaapDerivativeContractTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDerivativeInstrumentRiskAxis" xlink:to="loc_us-gaapDerivativeContractTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_Options1Member" xlink:label="loc_ALRTOptions1Member_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDerivativeContractTypeDomain" xlink:to="loc_ALRTOptions1Member_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_Options2Member" xlink:label="loc_ALRTOptions2Member_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDerivativeContractTypeDomain" xlink:to="loc_ALRTOptions2Member_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_Options3Member" xlink:label="loc_ALRTOptions3Member_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDerivativeContractTypeDomain" xlink:to="loc_ALRTOptions3Member_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_Options4Member" xlink:label="loc_ALRTOptions4Member_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDerivativeContractTypeDomain" xlink:to="loc_ALRTOptions4Member_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_Options5Member" xlink:label="loc_ALRTOptions5Member_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDerivativeContractTypeDomain" xlink:to="loc_ALRTOptions5Member_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_Options6Member" xlink:label="loc_ALRTOptions6Member_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDerivativeContractTypeDomain" xlink:to="loc_ALRTOptions6Member_100" xlink:type="arc" order="101" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_Options7Member" xlink:label="loc_ALRTOptions7Member_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDerivativeContractTypeDomain" xlink:to="loc_ALRTOptions7Member_120" xlink:type="arc" order="121" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_Options8Member" xlink:label="loc_ALRTOptions8Member_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDerivativeContractTypeDomain" xlink:to="loc_ALRTOptions8Member_140" xlink:type="arc" order="141" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_Options9Member" xlink:label="loc_ALRTOptions9Member_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDerivativeContractTypeDomain" xlink:to="loc_ALRTOptions9Member_160" xlink:type="arc" order="161" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_Options10Member" xlink:label="loc_ALRTOptions10Member_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDerivativeContractTypeDomain" xlink:to="loc_ALRTOptions10Member_180" xlink:type="arc" order="181" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_Options11Member" xlink:label="loc_ALRTOptions11Member_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDerivativeContractTypeDomain" xlink:to="loc_ALRTOptions11Member_200" xlink:type="arc" order="201" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_Options12Member" xlink:label="loc_ALRTOptions12Member_220" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDerivativeContractTypeDomain" xlink:to="loc_ALRTOptions12Member_220" xlink:type="arc" order="221" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_Options13Member" xlink:label="loc_ALRTOptions13Member_240" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDerivativeContractTypeDomain" xlink:to="loc_ALRTOptions13Member_240" xlink:type="arc" order="241" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_Options14Member" xlink:label="loc_ALRTOptions14Member_260" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDerivativeContractTypeDomain" xlink:to="loc_ALRTOptions14Member_260" xlink:type="arc" order="261" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_Options15Member" xlink:label="loc_ALRTOptions15Member_280" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDerivativeContractTypeDomain" xlink:to="loc_ALRTOptions15Member_280" xlink:type="arc" order="281" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_Options16Member" xlink:label="loc_ALRTOptions16Member_300" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDerivativeContractTypeDomain" xlink:to="loc_ALRTOptions16Member_300" xlink:type="arc" order="301" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_Options17Member" xlink:label="loc_ALRTOptions17Member_320" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDerivativeContractTypeDomain" xlink:to="loc_ALRTOptions17Member_320" xlink:type="arc" order="321" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_Options18Member" xlink:label="loc_ALRTOptions18Member_340" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDerivativeContractTypeDomain" xlink:to="loc_ALRTOptions18Member_340" xlink:type="arc" order="341" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_Options19Member" xlink:label="loc_ALRTOptions19Member_360" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDerivativeContractTypeDomain" xlink:to="loc_ALRTOptions19Member_360" xlink:type="arc" order="361" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_Options20Member" xlink:label="loc_ALRTOptions20Member_380" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDerivativeContractTypeDomain" xlink:to="loc_ALRTOptions20Member_380" xlink:type="arc" order="381" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_Options21Member" xlink:label="loc_ALRTOptions21Member_400" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDerivativeContractTypeDomain" xlink:to="loc_ALRTOptions21Member_400" xlink:type="arc" order="401" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_Options22Member" xlink:label="loc_ALRTOptions22Member_420" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDerivativeContractTypeDomain" xlink:to="loc_ALRTOptions22Member_420" xlink:type="arc" order="421" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_Options23Member" xlink:label="loc_ALRTOptions23Member_440" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDerivativeContractTypeDomain" xlink:to="loc_ALRTOptions23Member_440" xlink:type="arc" order="441" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_OpenOptionContractsWrittenNumbersOfShare" xlink:label="loc_ALRTOpenOptionContractsWrittenNumbersOfShare_490" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOffsettingAssetsLineItems" xlink:to="loc_ALRTOpenOptionContractsWrittenNumbersOfShare_490" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_ExercisePrices" xlink:label="loc_ALRTExercisePrices_490" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOffsettingAssetsLineItems" xlink:to="loc_ALRTExercisePrices_490" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_IntrinsicValue" xlink:label="loc_ALRTIntrinsicValue_490" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOffsettingAssetsLineItems" xlink:to="loc_ALRTIntrinsicValue_490" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_490" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOffsettingAssetsLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_490" xlink:type="arc" order="3" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://alrt.com/role/AdditionalPaid-inCapitalDetails2" xlink:title="00000036 - Disclosure - Additional paid-in capital (Details 2)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://alrt.com/role/AdditionalPaid-inCapitalDetails3" xlink:title="00000037 - Disclosure - Additional paid-in capital (Details 3)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://alrt.com/role/AdditionalPaid-inCapitalDetailsNarrative" xlink:title="00000038 - Disclosure - Additional paid-in capital (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://alrt.com/role/RelatedPartyTransactionsAndBalancesDetails" xlink:title="00000039 - Disclosure - Related party transactions and balances (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://alrt.com/role/OperatingSegmentsDetails" xlink:title="00000040 - Disclosure - Operating segments (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:label="loc_us-gaapRevenuesFromExternalCustomersAndLongLivedAssetsLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:label="loc_us-gaapScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:to="loc_us-gaapScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis" xlink:label="loc_srtStatementGeographicalAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:to="loc_srtStatementGeographicalAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srtSegmentGeographicalDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtStatementGeographicalAxis" xlink:to="loc_srtSegmentGeographicalDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srtSegmentGeographicalDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtStatementGeographicalAxis" xlink:to="loc_srtSegmentGeographicalDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_OtherMember" xlink:label="loc_ALRTOtherMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_ALRTOtherMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_SG" xlink:label="loc_countrySG_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countrySG_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US" xlink:label="loc_countryUS_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryUS_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:to="loc_us-gaapAssets_170" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues" xlink:label="loc_us-gaapRevenues_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:to="loc_us-gaapRevenues_170" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:to="loc_us-gaapNetIncomeLoss_170" xlink:type="arc" order="2" />
    </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>8
<FILENAME>alrt-20220630_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.15b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis" xlink:label="us-gaap_DebtInstrumentAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentAxis_lbl" xml:lang="en-US">Debt Instrument [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_RelatedPartyMember" xlink:label="ALRT_RelatedPartyMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_RelatedPartyMember" xlink:to="ALRT_RelatedPartyMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ALRT_RelatedPartyMember_lbl" xml:lang="en-US">Related Party [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_UnRelatedPartyMember" xlink:label="ALRT_UnRelatedPartyMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_UnRelatedPartyMember" xlink:to="ALRT_UnRelatedPartyMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ALRT_UnRelatedPartyMember_lbl" xml:lang="en-US">Un Related Party [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityAxis" xlink:label="us-gaap_LineOfCreditFacilityAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCreditFacilityAxis" xlink:to="us-gaap_LineOfCreditFacilityAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LineOfCreditFacilityAxis_lbl" xml:lang="en-US">Lender Name [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_ChairmanAndCEOMember" xlink:label="ALRT_ChairmanAndCEOMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_ChairmanAndCEOMember" xlink:to="ALRT_ChairmanAndCEOMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ALRT_ChairmanAndCEOMember_lbl" xml:lang="en-US">Chairman And C E O [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_WifeOfChairmanMember" xlink:label="ALRT_WifeOfChairmanMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_WifeOfChairmanMember" xlink:to="ALRT_WifeOfChairmanMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ALRT_WifeOfChairmanMember_lbl" xml:lang="en-US">Wife Of Chairman [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis" xlink:label="us-gaap_DerivativeInstrumentRiskAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeInstrumentRiskAxis" xlink:to="us-gaap_DerivativeInstrumentRiskAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DerivativeInstrumentRiskAxis_lbl" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_Options1Member" xlink:label="ALRT_Options1Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_Options1Member" xlink:to="ALRT_Options1Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ALRT_Options1Member_lbl" xml:lang="en-US">Options 1 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_Options2Member" xlink:label="ALRT_Options2Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_Options2Member" xlink:to="ALRT_Options2Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ALRT_Options2Member_lbl" xml:lang="en-US">Options 2 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_Options3Member" xlink:label="ALRT_Options3Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_Options3Member" xlink:to="ALRT_Options3Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ALRT_Options3Member_lbl" xml:lang="en-US">Options 3 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_Options4Member" xlink:label="ALRT_Options4Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_Options4Member" xlink:to="ALRT_Options4Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ALRT_Options4Member_lbl" xml:lang="en-US">Options 4 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_Options5Member" xlink:label="ALRT_Options5Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_Options5Member" xlink:to="ALRT_Options5Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ALRT_Options5Member_lbl" xml:lang="en-US">Options 5 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_Options6Member" xlink:label="ALRT_Options6Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_Options6Member" xlink:to="ALRT_Options6Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ALRT_Options6Member_lbl" xml:lang="en-US">Options 6 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_Options7Member" xlink:label="ALRT_Options7Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_Options7Member" xlink:to="ALRT_Options7Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ALRT_Options7Member_lbl" xml:lang="en-US">Options 7 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_Options8Member" xlink:label="ALRT_Options8Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_Options8Member" xlink:to="ALRT_Options8Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ALRT_Options8Member_lbl" xml:lang="en-US">Options 8 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_Options9Member" xlink:label="ALRT_Options9Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_Options9Member" xlink:to="ALRT_Options9Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ALRT_Options9Member_lbl" xml:lang="en-US">Options 9 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_Options10Member" xlink:label="ALRT_Options10Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_Options10Member" xlink:to="ALRT_Options10Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ALRT_Options10Member_lbl" xml:lang="en-US">Options 10 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_Options11Member" xlink:label="ALRT_Options11Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_Options11Member" xlink:to="ALRT_Options11Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ALRT_Options11Member_lbl" xml:lang="en-US">Options 11 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_Options12Member" xlink:label="ALRT_Options12Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_Options12Member" xlink:to="ALRT_Options12Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ALRT_Options12Member_lbl" xml:lang="en-US">Options 12 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_Options13Member" xlink:label="ALRT_Options13Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_Options13Member" xlink:to="ALRT_Options13Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ALRT_Options13Member_lbl" xml:lang="en-US">Options 13 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_Options14Member" xlink:label="ALRT_Options14Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_Options14Member" xlink:to="ALRT_Options14Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ALRT_Options14Member_lbl" xml:lang="en-US">Options 14 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_Options15Member" xlink:label="ALRT_Options15Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_Options15Member" xlink:to="ALRT_Options15Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ALRT_Options15Member_lbl" xml:lang="en-US">Options 15 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_Options16Member" xlink:label="ALRT_Options16Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_Options16Member" xlink:to="ALRT_Options16Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ALRT_Options16Member_lbl" xml:lang="en-US">Options 16 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_Options17Member" xlink:label="ALRT_Options17Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_Options17Member" xlink:to="ALRT_Options17Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ALRT_Options17Member_lbl" xml:lang="en-US">Options 17 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_Options18Member" xlink:label="ALRT_Options18Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_Options18Member" xlink:to="ALRT_Options18Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ALRT_Options18Member_lbl" xml:lang="en-US">Options 18 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_Options19Member" xlink:label="ALRT_Options19Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_Options19Member" xlink:to="ALRT_Options19Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ALRT_Options19Member_lbl" xml:lang="en-US">Options 19 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_Options20Member" xlink:label="ALRT_Options20Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_Options20Member" xlink:to="ALRT_Options20Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ALRT_Options20Member_lbl" xml:lang="en-US">Options 20 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_Options21Member" xlink:label="ALRT_Options21Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_Options21Member" xlink:to="ALRT_Options21Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ALRT_Options21Member_lbl" xml:lang="en-US">Options 21 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_Options22Member" xlink:label="ALRT_Options22Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_Options22Member" xlink:to="ALRT_Options22Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ALRT_Options22Member_lbl" xml:lang="en-US">Options 22 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_Options23Member" xlink:label="ALRT_Options23Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_Options23Member" xlink:to="ALRT_Options23Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ALRT_Options23Member_lbl" xml:lang="en-US">Options 23 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis" xlink:label="srt_StatementGeographicalAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_StatementGeographicalAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_StatementGeographicalAxis_lbl" xml:lang="en-US">Geographical [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_OtherMember" xlink:label="ALRT_OtherMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_OtherMember" xlink:to="ALRT_OtherMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ALRT_OtherMember_lbl" xml:lang="en-US">Other [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_SG" xlink:label="country_SG" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="country_SG" xlink:to="country_SG_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="country_SG_lbl" xml:lang="en-US">SINGAPORE</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US" xlink:label="country_US" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="country_US" xlink:to="country_US_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="country_US_lbl" xml:lang="en-US">UNITED STATES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementOfFinancialPositionAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfFinancialPositionAbstract_lbl" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract" xlink:label="us-gaap_AssetsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsAbstract_lbl" xml:lang="en-US">Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="us-gaap_AssetsCurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrentAbstract_lbl" xml:lang="en-US">Current assets:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Cash" xlink:label="us-gaap_Cash" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Cash" xlink:to="us-gaap_Cash_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Cash_lbl" xml:lang="en-US">Cash</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseCurrent" xlink:label="us-gaap_PrepaidExpenseCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseCurrent" xlink:to="us-gaap_PrepaidExpenseCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PrepaidExpenseCurrent_lbl" xml:lang="en-US">Prepaid expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Assets_lbl" xml:lang="en-US">Total assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xml:lang="en-US">Liabilities and Stockholders&#8217; Deficit</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="us-gaap_LiabilitiesCurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl" xml:lang="en-US">Current liabilities:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_lbl" xml:lang="en-US">Accounts payable and accrued liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_PromissoryNotesPayableToRelatedParties" xlink:label="ALRT_PromissoryNotesPayableToRelatedParties" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_PromissoryNotesPayableToRelatedParties" xlink:to="ALRT_PromissoryNotesPayableToRelatedParties_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ALRT_PromissoryNotesPayableToRelatedParties_lbl" xml:lang="en-US">Promissory notes payable to related parties</link:label>
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_PromissoryNotesPayableUnrelatedLender" xlink:label="ALRT_PromissoryNotesPayableUnrelatedLender" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_PromissoryNotesPayableUnrelatedLender" xlink:to="ALRT_PromissoryNotesPayableUnrelatedLender_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ALRT_PromissoryNotesPayableUnrelatedLender_lbl" xml:lang="en-US">Promissory notes payable to unrelated parties</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPayableCurrent" xlink:label="us-gaap_InterestPayableCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestPayableCurrent" xlink:to="us-gaap_InterestPayableCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestPayableCurrent_lbl" xml:lang="en-US">Interest payable</link:label>
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_LinesOfCreditFromRelatedParties" xlink:label="ALRT_LinesOfCreditFromRelatedParties" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_LinesOfCreditFromRelatedParties" xlink:to="ALRT_LinesOfCreditFromRelatedParties_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ALRT_LinesOfCreditFromRelatedParties_lbl" xml:lang="en-US">Lines of credit from related parties</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Liabilities_lbl" xml:lang="en-US">Total liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="us-gaap_StockholdersEquityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityAbstract_lbl" xml:lang="en-US">Stockholders&#8217; Deficit</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue" xlink:label="us-gaap_PreferredStockValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockValue" xlink:to="us-gaap_PreferredStockValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockValue_lbl" xml:lang="en-US">Preferred Stock, Value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockValue" xlink:to="us-gaap_CommonStockValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockValue_lbl" xml:lang="en-US">Common Stock, Value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="us-gaap_AdditionalPaidInCapital" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapital" xlink:to="us-gaap_AdditionalPaidInCapital_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapital_lbl" xml:lang="en-US">Additional paid-in capital</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_lbl" xml:lang="en-US">Accumulated other comprehensive loss&#160;&#8211; cumulative translation differences</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xml:lang="en-US">Accumulated deficit</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_StockholdersEquity_lbl" xml:lang="en-US">Total stockholders&#8217; deficit</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xml:lang="en-US">Total liabilities and stockholders&#8217; deficit</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesAuthorized" xlink:to="us-gaap_PreferredStockSharesAuthorized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesAuthorized_lbl" xml:lang="en-US">Preferred shares, authorized</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xml:lang="en-US">Preferred shares, par value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="us-gaap_PreferredStockSharesIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesIssued" xlink:to="us-gaap_PreferredStockSharesIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesIssued_lbl" xml:lang="en-US">Preferred shares, issued</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="us-gaap_PreferredStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesOutstanding" xlink:to="us-gaap_PreferredStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl" xml:lang="en-US">Preferred shares, outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl" xml:lang="en-US">Common shares, authorized</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xml:lang="en-US">Common shares, par value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xml:lang="en-US">Common shares, Issued</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xml:lang="en-US">Common shares, outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract" xlink:label="us-gaap_IncomeStatementAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_IncomeStatementAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeStatementAbstract_lbl" xml:lang="en-US">Income Statement [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues" xlink:label="us-gaap_Revenues" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Revenues" xlink:to="us-gaap_Revenues_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Revenues_lbl" xml:lang="en-US">Revenue</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfRevenue" xlink:label="us-gaap_CostOfRevenue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostOfRevenue" xlink:to="us-gaap_CostOfRevenue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_CostOfRevenue_lbl" xml:lang="en-US">Cost of revenue</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit" xlink:label="us-gaap_GrossProfit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GrossProfit" xlink:to="us-gaap_GrossProfit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_GrossProfit_lbl" xml:lang="en-US">Gross margin</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="us-gaap_OperatingExpensesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_OperatingExpensesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingExpensesAbstract_lbl" xml:lang="en-US">Operating Expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="us-gaap_ResearchAndDevelopmentExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpense" xlink:to="us-gaap_ResearchAndDevelopmentExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ResearchAndDevelopmentExpense_lbl" xml:lang="en-US">Product development costs</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfessionalFees" xlink:label="us-gaap_ProfessionalFees" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProfessionalFees" xlink:to="us-gaap_ProfessionalFees_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProfessionalFees_lbl" xml:lang="en-US">Professional fees</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="us-gaap_SellingGeneralAndAdministrativeExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpense_lbl" xml:lang="en-US">Selling, general and administrative expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:label="us-gaap_OperatingIncomeLoss_lbl" xml:lang="en-US">Operating Loss</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" xml:lang="en-US">Loss before other items</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpenseAbstract" xlink:label="us-gaap_NonoperatingIncomeExpenseAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_NonoperatingIncomeExpenseAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NonoperatingIncomeExpenseAbstract_lbl" xml:lang="en-US">Other Items</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense" xlink:label="us-gaap_InterestExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpense" xlink:to="us-gaap_InterestExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_InterestExpense_lbl" xml:lang="en-US">Interest expense</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="us-gaap_GainsLossesOnExtinguishmentOfDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:to="us-gaap_GainsLossesOnExtinguishmentOfDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GainsLossesOnExtinguishmentOfDebt_lbl" xml:lang="en-US">Loss on settlement of debt</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="us-gaap_NonoperatingIncomeExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_NonoperatingIncomeExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NonoperatingIncomeExpense_lbl" xml:lang="en-US">Total Other Items</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetIncomeLoss_lbl" xml:lang="en-US">Net Loss</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxAttributableToParentAbstract" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxAttributableToParentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeLossNetOfTaxAttributableToParentAbstract" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTaxAttributableToParentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxAttributableToParentAbstract_lbl" xml:lang="en-US">Other comprehensive loss</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax" xlink:label="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax" xlink:to="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax_lbl" xml:lang="en-US">Exchange difference on translating foreign operations</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="us-gaap_ComprehensiveIncomeNetOfTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax_lbl" xml:lang="en-US">Comprehensive loss for the period</link:label>
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_WeightedAverageNumberOfSharesOfCommonStockOutstandingBasicAndDiluted" xlink:label="ALRT_WeightedAverageNumberOfSharesOfCommonStockOutstandingBasicAndDiluted" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_WeightedAverageNumberOfSharesOfCommonStockOutstandingBasicAndDiluted" xlink:to="ALRT_WeightedAverageNumberOfSharesOfCommonStockOutstandingBasicAndDiluted_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ALRT_WeightedAverageNumberOfSharesOfCommonStockOutstandingBasicAndDiluted_lbl" xml:lang="en-US">Weighted average number of shares of common stock outstanding, basic and diluted</link:label>
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_LossPerShareBasicAndDiluted" xlink:label="ALRT_LossPerShareBasicAndDiluted" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_LossPerShareBasicAndDiluted" xlink:to="ALRT_LossPerShareBasicAndDiluted_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ALRT_LossPerShareBasicAndDiluted_lbl" xml:lang="en-US">Loss per share, basic and diluted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="us-gaap_StatementOfCashFlowsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_StatementOfCashFlowsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfCashFlowsAbstract_lbl" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">OPERATING ACTIVITIES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_lbl" xml:lang="en-US">Net loss</link:label>
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_StockbasedCompensationproductDevelopmentCosts" xlink:label="ALRT_StockbasedCompensationproductDevelopmentCosts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_StockbasedCompensationproductDevelopmentCosts" xlink:to="ALRT_StockbasedCompensationproductDevelopmentCosts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ALRT_StockbasedCompensationproductDevelopmentCosts_lbl" xml:lang="en-US">Stock-based compensation-product development costs</link:label>
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_StockbasedCompensationgeneralSellingAndAdministration" xlink:label="ALRT_StockbasedCompensationgeneralSellingAndAdministration" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_StockbasedCompensationgeneralSellingAndAdministration" xlink:to="ALRT_StockbasedCompensationgeneralSellingAndAdministration_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ALRT_StockbasedCompensationgeneralSellingAndAdministration_lbl" xml:lang="en-US">Stock-based compensation-selling, general and administrative</link:label>
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_StockbasedCompensationProfessionalFees" xlink:label="ALRT_StockbasedCompensationProfessionalFees" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_StockbasedCompensationProfessionalFees" xlink:to="ALRT_StockbasedCompensationProfessionalFees_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ALRT_StockbasedCompensationProfessionalFees_lbl" xml:lang="en-US">Stock-based compensation-professional fees</link:label>
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_StockbasedCompensationinterest" xlink:label="ALRT_StockbasedCompensationinterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_StockbasedCompensationinterest" xlink:to="ALRT_StockbasedCompensationinterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ALRT_StockbasedCompensationinterest_lbl" xml:lang="en-US">Stock-based compensation-interest</link:label>
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_InterestExpenseOnLinesOfCredit" xlink:label="ALRT_InterestExpenseOnLinesOfCredit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_InterestExpenseOnLinesOfCredit" xlink:to="ALRT_InterestExpenseOnLinesOfCredit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ALRT_InterestExpenseOnLinesOfCredit_lbl" xml:lang="en-US">Interest expense on lines of credit</link:label>
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_NoncashImputedInterestExpenses" xlink:label="ALRT_NoncashImputedInterestExpenses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_NoncashImputedInterestExpenses" xlink:to="ALRT_NoncashImputedInterestExpenses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ALRT_NoncashImputedInterestExpenses_lbl" xml:lang="en-US">Non-cash imputed interest expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_BonusesSettledByIssuanceOfShares" xlink:label="ALRT_BonusesSettledByIssuanceOfShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_BonusesSettledByIssuanceOfShares" xlink:to="ALRT_BonusesSettledByIssuanceOfShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ALRT_BonusesSettledByIssuanceOfShares_lbl" xml:lang="en-US">Bonuses settled by issuance of shares</link:label>
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_LossOnSettlementOfDebt" xlink:label="ALRT_LossOnSettlementOfDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_LossOnSettlementOfDebt" xlink:to="ALRT_LossOnSettlementOfDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ALRT_LossOnSettlementOfDebt_lbl" xml:lang="en-US">Loss on settlement of debt</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xml:lang="en-US">Changes in operating assets and liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:label="us-gaap_IncreaseDecreaseInPrepaidExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:to="us-gaap_IncreaseDecreaseInPrepaidExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInPrepaidExpense_lbl" xml:lang="en-US">Decrease (increase) in prepaid expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl" xml:lang="en-US">Increase in accounts payable and accrued liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInterestPayableNet" xlink:label="us-gaap_IncreaseDecreaseInInterestPayableNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInInterestPayableNet" xlink:to="us-gaap_IncreaseDecreaseInInterestPayableNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInInterestPayableNet_lbl" xml:lang="en-US">Increase in interest payable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xml:lang="en-US">Net cash used in operating activities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xml:lang="en-US">FINANCING ACTIVITIES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromLinesOfCredit" xlink:label="us-gaap_ProceedsFromLinesOfCredit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromLinesOfCredit" xlink:to="us-gaap_ProceedsFromLinesOfCredit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromLinesOfCredit_lbl" xml:lang="en-US">Proceeds from lines of credit</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromConvertibleDebt" xlink:label="us-gaap_ProceedsFromConvertibleDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromConvertibleDebt" xlink:to="us-gaap_ProceedsFromConvertibleDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromConvertibleDebt_lbl" xml:lang="en-US">Proceeds from promissory notes</link:label>
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_RepaymentOfLinesOfCreditInterest" xlink:label="ALRT_RepaymentOfLinesOfCreditInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_RepaymentOfLinesOfCreditInterest" xlink:to="ALRT_RepaymentOfLinesOfCreditInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ALRT_RepaymentOfLinesOfCreditInterest_lbl" xml:lang="en-US">Repayment of lines of credit interest</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" xml:lang="en-US">Proceeds from sales of shares of common stock</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xml:lang="en-US">Net cash provided by financing activities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xml:lang="en-US">Effect of foreign exchange on cash</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl" xml:lang="en-US">Change in cash</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xml:lang="en-US">Cash, beginning of period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_lbl" xml:lang="en-US">Cash, end of period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_AccountingPoliciesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountingPoliciesAbstract_lbl" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:label="us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:to="us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_lbl" xml:lang="en-US">Basis of presentation, nature of operations and going concern</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xml:lang="en-US">Significant accounting policies</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="us-gaap_PayablesAndAccrualsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="us-gaap_PayablesAndAccrualsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PayablesAndAccrualsAbstract_lbl" xml:lang="en-US">Payables and Accruals [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl" xml:lang="en-US">Accounts payable and accrued liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_DisclosureInterestAdvancesAndPromissoryNotesPayableAbstract" xlink:label="ALRT_DisclosureInterestAdvancesAndPromissoryNotesPayableAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_DisclosureInterestAdvancesAndPromissoryNotesPayableAbstract" xlink:to="ALRT_DisclosureInterestAdvancesAndPromissoryNotesPayableAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ALRT_DisclosureInterestAdvancesAndPromissoryNotesPayableAbstract_lbl" xml:lang="en-US">Interest Advances And Promissory Notes Payable</link:label>
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_InterestAdvancesAndPromissoryNotesPayableTextBlock" xlink:label="ALRT_InterestAdvancesAndPromissoryNotesPayableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_InterestAdvancesAndPromissoryNotesPayableTextBlock" xlink:to="ALRT_InterestAdvancesAndPromissoryNotesPayableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ALRT_InterestAdvancesAndPromissoryNotesPayableTextBlock_lbl" xml:lang="en-US">Interest, advances and promissory notes payable</link:label>
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_DisclosureLinesOfCreditAbstract" xlink:label="ALRT_DisclosureLinesOfCreditAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_DisclosureLinesOfCreditAbstract" xlink:to="ALRT_DisclosureLinesOfCreditAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ALRT_DisclosureLinesOfCreditAbstract_lbl" xml:lang="en-US">Lines Of Credit</link:label>
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_LineOfCreditTextBlock" xlink:label="ALRT_LineOfCreditTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_LineOfCreditTextBlock" xlink:to="ALRT_LineOfCreditTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ALRT_LineOfCreditTextBlock_lbl" xml:lang="en-US">Lines of credit</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract" xlink:label="us-gaap_EquityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_EquityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityAbstract_lbl" xml:lang="en-US">Equity [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xml:lang="en-US">Capital stock</link:label>
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_DisclosureAdditionalPaidinCapitalAbstract" xlink:label="ALRT_DisclosureAdditionalPaidinCapitalAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_DisclosureAdditionalPaidinCapitalAbstract" xlink:to="ALRT_DisclosureAdditionalPaidinCapitalAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ALRT_DisclosureAdditionalPaidinCapitalAbstract_lbl" xml:lang="en-US">Additional Paid-in Capital</link:label>
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_AdditionalPaidInCapitalTextBlock" xlink:label="ALRT_AdditionalPaidInCapitalTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_AdditionalPaidInCapitalTextBlock" xlink:to="ALRT_AdditionalPaidInCapitalTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ALRT_AdditionalPaidInCapitalTextBlock_lbl" xml:lang="en-US">Additional paid-in capital</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="us-gaap_RelatedPartyTransactionsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsAbstract" xlink:to="us-gaap_RelatedPartyTransactionsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsAbstract_lbl" xml:lang="en-US">Related Party Transactions [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:to="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl" xml:lang="en-US">Related party transactions and balances</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xml:lang="en-US">Commitments and contingencies</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract" xlink:label="us-gaap_SegmentReportingAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingAbstract" xlink:to="us-gaap_SegmentReportingAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SegmentReportingAbstract_lbl" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingDisclosureTextBlock" xlink:label="us-gaap_SegmentReportingDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="us-gaap_SegmentReportingDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SegmentReportingDisclosureTextBlock_lbl" xml:lang="en-US">Operating segments</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="us-gaap_SubsequentEventsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventsAbstract_lbl" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="us-gaap_SubsequentEventsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsTextBlock" xlink:to="us-gaap_SubsequentEventsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventsTextBlock_lbl" xml:lang="en-US">Subsequent events</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:label="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_lbl" xml:lang="en-US">Schedule of accounts payable and accrued liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_SummaryOfActivitiesOfPromissoryNotesPayableTableTextBlock" xlink:label="ALRT_SummaryOfActivitiesOfPromissoryNotesPayableTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_SummaryOfActivitiesOfPromissoryNotesPayableTableTextBlock" xlink:to="ALRT_SummaryOfActivitiesOfPromissoryNotesPayableTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ALRT_SummaryOfActivitiesOfPromissoryNotesPayableTableTextBlock_lbl" xml:lang="en-US">Summary of activities of promissory notes payable</link:label>
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_ScheduleofPromissoryNotesPayableRelativesofBoardofDirectorsTableTextBlock" xlink:label="ALRT_ScheduleofPromissoryNotesPayableRelativesofBoardofDirectorsTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_ScheduleofPromissoryNotesPayableRelativesofBoardofDirectorsTableTextBlock" xlink:to="ALRT_ScheduleofPromissoryNotesPayableRelativesofBoardofDirectorsTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ALRT_ScheduleofPromissoryNotesPayableRelativesofBoardofDirectorsTableTextBlock_lbl" xml:lang="en-US">Schedule of activity of promissory notes payable to related parties</link:label>
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_ScheduleofPromissoryNotesPayableToUnrelatedPartiesTableTextBlock" xlink:label="ALRT_ScheduleofPromissoryNotesPayableToUnrelatedPartiesTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_ScheduleofPromissoryNotesPayableToUnrelatedPartiesTableTextBlock" xlink:to="ALRT_ScheduleofPromissoryNotesPayableToUnrelatedPartiesTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ALRT_ScheduleofPromissoryNotesPayableToUnrelatedPartiesTableTextBlock_lbl" xml:lang="en-US">Schedule of Promissory Notes Payable to Unrelated Parties</link:label>
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_ScheduleofActivityofPromissoryNotestoUnrelatedPatiesTableTextBlock" xlink:label="ALRT_ScheduleofActivityofPromissoryNotestoUnrelatedPatiesTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_ScheduleofActivityofPromissoryNotestoUnrelatedPatiesTableTextBlock" xlink:to="ALRT_ScheduleofActivityofPromissoryNotestoUnrelatedPatiesTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ALRT_ScheduleofActivityofPromissoryNotestoUnrelatedPatiesTableTextBlock_lbl" xml:lang="en-US">Schedule of activity of promissory notes payable to unrelated parties</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestAndOtherIncomeTableTextBlock" xlink:label="us-gaap_InterestAndOtherIncomeTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestAndOtherIncomeTableTextBlock" xlink:to="us-gaap_InterestAndOtherIncomeTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestAndOtherIncomeTableTextBlock_lbl" xml:lang="en-US">Schedule of interest payable activity</link:label>
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_ScheduledOfInterestPayableDueToRelatedTableTextBlock" xlink:label="ALRT_ScheduledOfInterestPayableDueToRelatedTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_ScheduledOfInterestPayableDueToRelatedTableTextBlock" xlink:to="ALRT_ScheduledOfInterestPayableDueToRelatedTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ALRT_ScheduledOfInterestPayableDueToRelatedTableTextBlock_lbl" xml:lang="en-US">Schedule of Interest payable due to related and non-related parties</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock" xlink:label="us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock" xlink:to="us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock_lbl" xml:lang="en-US">Schedule of lines of credit activity</link:label>
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_ScheduledOfLineOfCreditTableTextBlock" xlink:label="ALRT_ScheduledOfLineOfCreditTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_ScheduledOfLineOfCreditTableTextBlock" xlink:to="ALRT_ScheduledOfLineOfCreditTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ALRT_ScheduledOfLineOfCreditTableTextBlock_lbl" xml:lang="en-US">Schedule of lines of credit</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl" xml:lang="en-US">Schedule of share-based compensation, stock options, activity</link:label>
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_ScheduleofOptionsOutstandingTableTextBlock" xlink:label="ALRT_ScheduleofOptionsOutstandingTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_ScheduleofOptionsOutstandingTableTextBlock" xlink:to="ALRT_ScheduleofOptionsOutstandingTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ALRT_ScheduleofOptionsOutstandingTableTextBlock_lbl" xml:lang="en-US">Schedule of Options Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_lbl" xml:lang="en-US">Schedule of Fair Value of Stock Options Granted-Allocation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl" xml:lang="en-US">Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock" xlink:label="us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock" xlink:to="us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock_lbl" xml:lang="en-US">Schedule of related party transactions</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:label="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:to="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_lbl" xml:lang="en-US">Schedule of Operating Segments</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss" xlink:label="us-gaap_ProfitLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProfitLoss" xlink:to="us-gaap_ProfitLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_ProfitLoss_lbl" xml:lang="en-US">Net loss</link:label>
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_WorkingCapitalDeficit" xlink:label="ALRT_WorkingCapitalDeficit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_WorkingCapitalDeficit" xlink:to="ALRT_WorkingCapitalDeficit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ALRT_WorkingCapitalDeficit_lbl" xml:lang="en-US">Working capital deficit</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_2_lbl" xml:lang="en-US">Accumulated deficit</link:label>
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_PrincipalBorrowed" xlink:label="ALRT_PrincipalBorrowed" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_PrincipalBorrowed" xlink:to="ALRT_PrincipalBorrowed_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ALRT_PrincipalBorrowed_lbl" xml:lang="en-US">Principal Borrowed</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent" xlink:label="us-gaap_AccountsPayableCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableCurrent" xlink:to="us-gaap_AccountsPayableCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableCurrent_lbl" xml:lang="en-US">Accounts payable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="us-gaap_AccruedLiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="us-gaap_AccruedLiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccruedLiabilitiesCurrent_lbl" xml:lang="en-US">Accrued liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredRevenueCurrent" xlink:label="us-gaap_DeferredRevenueCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredRevenueCurrent" xlink:to="us-gaap_DeferredRevenueCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredRevenueCurrent_lbl" xml:lang="en-US">Deferred revenue</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_2_lbl" xml:lang="en-US">Accounts payable and accrued liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShortTermDebtTable" xlink:label="us-gaap_ScheduleOfShortTermDebtTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShortTermDebtTable" xlink:to="us-gaap_ScheduleOfShortTermDebtTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShortTermDebtTable_lbl" xml:lang="en-US">Schedule of Short-Term Debt [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtLineItems" xlink:label="us-gaap_ShortTermDebtLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShortTermDebtLineItems" xlink:to="us-gaap_ShortTermDebtLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShortTermDebtLineItems_lbl" xml:lang="en-US">Short-Term Debt [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NotesPayableRelatedPartiesClassifiedCurrent" xlink:label="us-gaap_NotesPayableRelatedPartiesClassifiedCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NotesPayableRelatedPartiesClassifiedCurrent" xlink:to="us-gaap_NotesPayableRelatedPartiesClassifiedCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_NotesPayableRelatedPartiesClassifiedCurrent_lbl" xml:lang="en-US">Carrying value at beginning</link:label>
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_TransferredFromPromissoryNotesPayablePursuantToPrivateTransaction." xlink:label="ALRT_TransferredFromPromissoryNotesPayablePursuantToPrivateTransaction." />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_TransferredFromPromissoryNotesPayablePursuantToPrivateTransaction." xlink:to="ALRT_TransferredFromPromissoryNotesPayablePursuantToPrivateTransaction._lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ALRT_TransferredFromPromissoryNotesPayablePursuantToPrivateTransaction._lbl" xml:lang="en-US">Transferred from promissory notes payable pursuant to private transaction</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NotesPayableRelatedPartiesClassifiedCurrent" xlink:to="us-gaap_NotesPayableRelatedPartiesClassifiedCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_NotesPayableRelatedPartiesClassifiedCurrent_2_lbl" xml:lang="en-US">Carrying value at ending</link:label>
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_PromissoryNotesPayableToRelativesOfDirectorsCollateralizedByAGeneralSecurityAgreementOnAllTheAssetsOfTheCompanyDueOnDemandAbstract" xlink:label="ALRT_PromissoryNotesPayableToRelativesOfDirectorsCollateralizedByAGeneralSecurityAgreementOnAllTheAssetsOfTheCompanyDueOnDemandAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_PromissoryNotesPayableToRelativesOfDirectorsCollateralizedByAGeneralSecurityAgreementOnAllTheAssetsOfTheCompanyDueOnDemandAbstract" xlink:to="ALRT_PromissoryNotesPayableToRelativesOfDirectorsCollateralizedByAGeneralSecurityAgreementOnAllTheAssetsOfTheCompanyDueOnDemandAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ALRT_PromissoryNotesPayableToRelativesOfDirectorsCollateralizedByAGeneralSecurityAgreementOnAllTheAssetsOfTheCompanyDueOnDemandAbstract_lbl" xml:lang="en-US">Promissory notes payable to relatives of directors collateralized by a general security agreement over all the assets of the Company, past maturity:</link:label>
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_NotePayablewithInterestat1PercentInterestperMonth" xlink:label="ALRT_NotePayablewithInterestat1PercentInterestperMonth" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_NotePayablewithInterestat1PercentInterestperMonth" xlink:to="ALRT_NotePayablewithInterestat1PercentInterestperMonth_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ALRT_NotePayablewithInterestat1PercentInterestperMonth_lbl" xml:lang="en-US">i.&#160;&#160;&#160;&#160;&#160;&#160;&#160; Interest at 1% per month</link:label>
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_InterestAt1.25PerMonth" xlink:label="ALRT_InterestAt1.25PerMonth" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_InterestAt1.25PerMonth" xlink:to="ALRT_InterestAt1.25PerMonth_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ALRT_InterestAt1.25PerMonth_lbl" xml:lang="en-US">ii.&#160;&#160;&#160;&#160;&#160; Interest at 1.25% per month</link:label>
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_NotePayableInterestattheUSBankPrimeRatePlus1PercentperMonth" xlink:label="ALRT_NotePayableInterestattheUSBankPrimeRatePlus1PercentperMonth" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_NotePayableInterestattheUSBankPrimeRatePlus1PercentperMonth" xlink:to="ALRT_NotePayableInterestattheUSBankPrimeRatePlus1PercentperMonth_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ALRT_NotePayableInterestattheUSBankPrimeRatePlus1PercentperMonth_lbl" xml:lang="en-US">iii.&#160;&#160;&#160; Interest at the U.S. bank prime rate plus 1%</link:label>
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_Iv.InterestAt0.5PerMonth" xlink:label="ALRT_Iv.InterestAt0.5PerMonth" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_Iv.InterestAt0.5PerMonth" xlink:to="ALRT_Iv.InterestAt0.5PerMonth_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ALRT_Iv.InterestAt0.5PerMonth_lbl" xml:lang="en-US">iv.&#160;&#160;&#160;&#160; Interest at 0.5% per month</link:label>
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_UnsecuredPromissoryNotesPayableToRelativesOfChairmanWithFixedAmountsOfInterestDueAugust312022" xlink:label="ALRT_UnsecuredPromissoryNotesPayableToRelativesOfChairmanWithFixedAmountsOfInterestDueAugust312022" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_UnsecuredPromissoryNotesPayableToRelativesOfChairmanWithFixedAmountsOfInterestDueAugust312022" xlink:to="ALRT_UnsecuredPromissoryNotesPayableToRelativesOfChairmanWithFixedAmountsOfInterestDueAugust312022_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ALRT_UnsecuredPromissoryNotesPayableToRelativesOfChairmanWithFixedAmountsOfInterestDueAugust312022_lbl" xml:lang="en-US">Unsecured promissory notes payable to relatives of the Chairman with fixed amounts of interest due August 31, 2022</link:label>
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_PromissoryNotesPayableUnsecuredtoRelativesofaDirectorBearingInterestat1PercentperMonth" xlink:label="ALRT_PromissoryNotesPayableUnsecuredtoRelativesofaDirectorBearingInterestat1PercentperMonth" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_PromissoryNotesPayableUnsecuredtoRelativesofaDirectorBearingInterestat1PercentperMonth" xlink:to="ALRT_PromissoryNotesPayableUnsecuredtoRelativesofaDirectorBearingInterestat1PercentperMonth_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ALRT_PromissoryNotesPayableUnsecuredtoRelativesofaDirectorBearingInterestat1PercentperMonth_lbl" xml:lang="en-US">Promissory notes payable, unsecured, to relatives of a director, bearing interest at 1% per month, past maturity</link:label>
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_PromissoryNotesRelatedParty" xlink:label="ALRT_PromissoryNotesRelatedParty" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_PromissoryNotesRelatedParty" xlink:to="ALRT_PromissoryNotesRelatedParty_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ALRT_PromissoryNotesRelatedParty_lbl" xml:lang="en-US">Total Promissory Notes Payable to Related Parties</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NotesPayable" xlink:label="us-gaap_NotesPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NotesPayable" xlink:to="us-gaap_NotesPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_NotesPayable_lbl" xml:lang="en-US">Balance at beginning</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInInterestPayableNet" xlink:to="us-gaap_IncreaseDecreaseInInterestPayableNet_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncreaseDecreaseInInterestPayableNet_2_lbl" xml:lang="en-US">Reclassified to interest payable</link:label>
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_ExtinguishedThroughIssuanceOfSharesOfCommonStock" xlink:label="ALRT_ExtinguishedThroughIssuanceOfSharesOfCommonStock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_ExtinguishedThroughIssuanceOfSharesOfCommonStock" xlink:to="ALRT_ExtinguishedThroughIssuanceOfSharesOfCommonStock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ALRT_ExtinguishedThroughIssuanceOfSharesOfCommonStock_lbl" xml:lang="en-US">Extinguished through issuance of shares of common stock (note 6)</link:label>
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_PromissoryNoteReceived" xlink:label="ALRT_PromissoryNoteReceived" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_PromissoryNoteReceived" xlink:to="ALRT_PromissoryNoteReceived_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ALRT_PromissoryNoteReceived_lbl" xml:lang="en-US">Promissory note received</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NotesPayable" xlink:to="us-gaap_NotesPayable_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_NotesPayable_2_lbl" xml:lang="en-US">Balance at ending</link:label>
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_UnsecuredPromissoryNotesPayableToUnrelatedLendersAbstract" xlink:label="ALRT_UnsecuredPromissoryNotesPayableToUnrelatedLendersAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_UnsecuredPromissoryNotesPayableToUnrelatedLendersAbstract" xlink:to="ALRT_UnsecuredPromissoryNotesPayableToUnrelatedLendersAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ALRT_UnsecuredPromissoryNotesPayableToUnrelatedLendersAbstract_lbl" xml:lang="en-US">Unsecured promissory notes payable to unrelated lenders, past maturity:</link:label>
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_I.InterestAt1PerMonthRepayableOnMarch312009DueOnDemand" xlink:label="ALRT_I.InterestAt1PerMonthRepayableOnMarch312009DueOnDemand" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_I.InterestAt1PerMonthRepayableOnMarch312009DueOnDemand" xlink:to="ALRT_I.InterestAt1PerMonthRepayableOnMarch312009DueOnDemand_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ALRT_I.InterestAt1PerMonthRepayableOnMarch312009DueOnDemand_lbl" xml:lang="en-US">i.&#160;&#160;&#160;&#160;&#160;&#160;&#160; Interest at 1% per month</link:label>
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_Iii.InterestAt0.625PerMonthWith50000RepayableOnOctober5200440000RepayableOnDecember312004And60000RepayableOnJuly282006AllDueOnDemand" xlink:label="ALRT_Iii.InterestAt0.625PerMonthWith50000RepayableOnOctober5200440000RepayableOnDecember312004And60000RepayableOnJuly282006AllDueOnDemand" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_Iii.InterestAt0.625PerMonthWith50000RepayableOnOctober5200440000RepayableOnDecember312004And60000RepayableOnJuly282006AllDueOnDemand" xlink:to="ALRT_Iii.InterestAt0.625PerMonthWith50000RepayableOnOctober5200440000RepayableOnDecember312004And60000RepayableOnJuly282006AllDueOnDemand_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ALRT_Iii.InterestAt0.625PerMonthWith50000RepayableOnOctober5200440000RepayableOnDecember312004And60000RepayableOnJuly282006AllDueOnDemand_lbl" xml:lang="en-US">ii.&#160;&#160;&#160;&#160;&#160; Interest at 0.667% per month</link:label>
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_Vi.InterestAt0.667PerMonthWith125000DueJanuary152011" xlink:label="ALRT_Vi.InterestAt0.667PerMonthWith125000DueJanuary152011" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_Vi.InterestAt0.667PerMonthWith125000DueJanuary152011" xlink:to="ALRT_Vi.InterestAt0.667PerMonthWith125000DueJanuary152011_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ALRT_Vi.InterestAt0.667PerMonthWith125000DueJanuary152011_lbl" xml:lang="en-US">iii.&#160;&#160;&#160; Interest at 0.625% per month</link:label>
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_Noninterestbearing" xlink:label="ALRT_Noninterestbearing" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_Noninterestbearing" xlink:to="ALRT_Noninterestbearing_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ALRT_Noninterestbearing_lbl" xml:lang="en-US">iv.&#160;&#160;&#160;&#160; Non-interest-bearing</link:label>
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_UnsecuredPromissoryNotesPayableToUnrelatedLendersWithFixedAmountsOfInterestDue" xlink:label="ALRT_UnsecuredPromissoryNotesPayableToUnrelatedLendersWithFixedAmountsOfInterestDue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_UnsecuredPromissoryNotesPayableToUnrelatedLendersWithFixedAmountsOfInterestDue" xlink:to="ALRT_UnsecuredPromissoryNotesPayableToUnrelatedLendersWithFixedAmountsOfInterestDue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ALRT_UnsecuredPromissoryNotesPayableToUnrelatedLendersWithFixedAmountsOfInterestDue_lbl" xml:lang="en-US">Unsecured promissory notes payable to unrelated lenders with fixed amounts of interest due August 31, 2022</link:label>
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_PromissoryNotesPayableSecuredByGuaranteeFromChiefExecutiveOfficerBearingInterestAt1PerMonth" xlink:label="ALRT_PromissoryNotesPayableSecuredByGuaranteeFromChiefExecutiveOfficerBearingInterestAt1PerMonth" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_PromissoryNotesPayableSecuredByGuaranteeFromChiefExecutiveOfficerBearingInterestAt1PerMonth" xlink:to="ALRT_PromissoryNotesPayableSecuredByGuaranteeFromChiefExecutiveOfficerBearingInterestAt1PerMonth_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ALRT_PromissoryNotesPayableSecuredByGuaranteeFromChiefExecutiveOfficerBearingInterestAt1PerMonth_lbl" xml:lang="en-US">Promissory notes payable, secured by a guarantee from the Chief Executive Officer, bearing interest at 1% per month, past maturity</link:label>
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_TotalPromissoryNotesPayableToUnrelatedParties" xlink:label="ALRT_TotalPromissoryNotesPayableToUnrelatedParties" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_TotalPromissoryNotesPayableToUnrelatedParties" xlink:to="ALRT_TotalPromissoryNotesPayableToUnrelatedParties_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ALRT_TotalPromissoryNotesPayableToUnrelatedParties_lbl" xml:lang="en-US">Total Promissory Notes Payable to Unrelated Parties</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPayableCurrentAndNoncurrent" xlink:label="us-gaap_InterestPayableCurrentAndNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestPayableCurrentAndNoncurrent" xlink:to="us-gaap_InterestPayableCurrentAndNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_InterestPayableCurrentAndNoncurrent_lbl" xml:lang="en-US">Beginning Balance</link:label>
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_ReclassifiedFromPromissoryNotesPayable" xlink:label="ALRT_ReclassifiedFromPromissoryNotesPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_ReclassifiedFromPromissoryNotesPayable" xlink:to="ALRT_ReclassifiedFromPromissoryNotesPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ALRT_ReclassifiedFromPromissoryNotesPayable_lbl" xml:lang="en-US">Reclassified from promissory notes payable</link:label>
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_InterestExpenseIncurredonPromissoryNotesandOtherPayables" xlink:label="ALRT_InterestExpenseIncurredonPromissoryNotesandOtherPayables" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_InterestExpenseIncurredonPromissoryNotesandOtherPayables" xlink:to="ALRT_InterestExpenseIncurredonPromissoryNotesandOtherPayables_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ALRT_InterestExpenseIncurredonPromissoryNotesandOtherPayables_lbl" xml:lang="en-US">Interest incurred on promissory notes payable</link:label>
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_InterestPayableRetiredThroughIssuanceOfShares" xlink:label="ALRT_InterestPayableRetiredThroughIssuanceOfShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_InterestPayableRetiredThroughIssuanceOfShares" xlink:to="ALRT_InterestPayableRetiredThroughIssuanceOfShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ALRT_InterestPayableRetiredThroughIssuanceOfShares_lbl" xml:lang="en-US">Interest payable retired through issuance of shares</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestPayableCurrentAndNoncurrent" xlink:to="us-gaap_InterestPayableCurrentAndNoncurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_InterestPayableCurrentAndNoncurrent_2_lbl" xml:lang="en-US">Ending Balance</link:label>
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_InterestPayableRelativesOfDirectors" xlink:label="ALRT_InterestPayableRelativesOfDirectors" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_InterestPayableRelativesOfDirectors" xlink:to="ALRT_InterestPayableRelativesOfDirectors_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ALRT_InterestPayableRelativesOfDirectors_lbl" xml:lang="en-US">Related parties</link:label>
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_InterestPayabletoNonrelatedParties" xlink:label="ALRT_InterestPayabletoNonrelatedParties" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_InterestPayabletoNonrelatedParties" xlink:to="ALRT_InterestPayabletoNonrelatedParties_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ALRT_InterestPayabletoNonrelatedParties_lbl" xml:lang="en-US">Unrelated parties</link:label>
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_InterestPayableCurrentAndNoncurrents" xlink:label="ALRT_InterestPayableCurrentAndNoncurrents" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_InterestPayableCurrentAndNoncurrents" xlink:to="ALRT_InterestPayableCurrentAndNoncurrents_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ALRT_InterestPayableCurrentAndNoncurrents_lbl" xml:lang="en-US">Interest payable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpense" xlink:to="us-gaap_InterestExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestExpense_2_lbl" xml:lang="en-US">Interest expense</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseRelatedParty" xlink:label="us-gaap_InterestExpenseRelatedParty" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpenseRelatedParty" xlink:to="us-gaap_InterestExpenseRelatedParty_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestExpenseRelatedParty_lbl" xml:lang="en-US">Interest on other</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermLineOfCredit" xlink:label="us-gaap_LongTermLineOfCredit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermLineOfCredit" xlink:to="us-gaap_LongTermLineOfCredit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_LongTermLineOfCredit_lbl" xml:lang="en-US">Balance at beginning</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityPeriodicPaymentPrincipal" xlink:label="us-gaap_LineOfCreditFacilityPeriodicPaymentPrincipal" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCreditFacilityPeriodicPaymentPrincipal" xlink:to="us-gaap_LineOfCreditFacilityPeriodicPaymentPrincipal_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LineOfCreditFacilityPeriodicPaymentPrincipal_lbl" xml:lang="en-US">Advances received on lines of credit</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityPeriodicPaymentInterest" xlink:label="us-gaap_LineOfCreditFacilityPeriodicPaymentInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCreditFacilityPeriodicPaymentInterest" xlink:to="us-gaap_LineOfCreditFacilityPeriodicPaymentInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LineOfCreditFacilityPeriodicPaymentInterest_lbl" xml:lang="en-US">Interest incurred on lines of credit</link:label>
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_RepaymentOfInterestOnLinesOfCredit" xlink:label="ALRT_RepaymentOfInterestOnLinesOfCredit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_RepaymentOfInterestOnLinesOfCredit" xlink:to="ALRT_RepaymentOfInterestOnLinesOfCredit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ALRT_RepaymentOfInterestOnLinesOfCredit_lbl" xml:lang="en-US">Repayment of interest on lines of credit</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermLineOfCredit" xlink:to="us-gaap_LongTermLineOfCredit_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_LongTermLineOfCredit_2_lbl" xml:lang="en-US">Balance at ending</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityTable" xlink:label="us-gaap_LineOfCreditFacilityTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCreditFacilityTable" xlink:to="us-gaap_LineOfCreditFacilityTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LineOfCreditFacilityTable_lbl" xml:lang="en-US">Line of Credit Facility [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityLineItems" xlink:label="us-gaap_LineOfCreditFacilityLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCreditFacilityLineItems" xlink:to="us-gaap_LineOfCreditFacilityLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LineOfCreditFacilityLineItems_lbl" xml:lang="en-US">Line of Credit Facility [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_InterestRate" xlink:label="ALRT_InterestRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_InterestRate" xlink:to="ALRT_InterestRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ALRT_InterestRate_lbl" xml:lang="en-US">Interest Rate</link:label>
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_BorrowingLimit" xlink:label="ALRT_BorrowingLimit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_BorrowingLimit" xlink:to="ALRT_BorrowingLimit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ALRT_BorrowingLimit_lbl" xml:lang="en-US">Borrowing Limit</link:label>
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_RepaymentTerms1" xlink:label="ALRT_RepaymentTerms1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_RepaymentTerms1" xlink:to="ALRT_RepaymentTerms1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ALRT_RepaymentTerms1_lbl" xml:lang="en-US">Repayment Terms</link:label>
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_AccruedInterest" xlink:label="ALRT_AccruedInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_AccruedInterest" xlink:to="ALRT_AccruedInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ALRT_AccruedInterest_lbl" xml:lang="en-US">Accrued Interest</link:label>
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_TotalOutstanding" xlink:label="ALRT_TotalOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_TotalOutstanding" xlink:to="ALRT_TotalOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ALRT_TotalOutstanding_lbl" xml:lang="en-US">Total Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_Security1" xlink:label="ALRT_Security1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_Security1" xlink:to="ALRT_Security1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ALRT_Security1_lbl" xml:lang="en-US">Security</link:label>
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_Purpose1" xlink:label="ALRT_Purpose1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_Purpose1" xlink:to="ALRT_Purpose1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ALRT_Purpose1_lbl" xml:lang="en-US">Purpose</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xml:lang="en-US">Outstanding, beginning of period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xml:lang="en-US">Average Exercise Price, beginning</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_lbl" xml:lang="en-US">Granted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Granted, per share</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xml:lang="en-US">Exercised</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Exercised per share</link:label>
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_ShareBasedCompensationArrangementbyShareBasedPaymentAwardOptionsCancelations" xlink:label="ALRT_ShareBasedCompensationArrangementbyShareBasedPaymentAwardOptionsCancelations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_ShareBasedCompensationArrangementbyShareBasedPaymentAwardOptionsCancelations" xlink:to="ALRT_ShareBasedCompensationArrangementbyShareBasedPaymentAwardOptionsCancelations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ALRT_ShareBasedCompensationArrangementbyShareBasedPaymentAwardOptionsCancelations_lbl" xml:lang="en-US">Cancelled</link:label>
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_CancelledPerShares" xlink:label="ALRT_CancelledPerShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_CancelledPerShares" xlink:to="ALRT_CancelledPerShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ALRT_CancelledPerShares_lbl" xml:lang="en-US">Cancelled per share</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2_lbl" xml:lang="en-US">Outstanding, end of period</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2_lbl" xml:lang="en-US">Average Exercise price, ending</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl" xml:lang="en-US">Exercisable, end of period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_lbl" xml:lang="en-US">Exercisable, end of period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OffsettingAssetsTable" xlink:label="us-gaap_OffsettingAssetsTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OffsettingAssetsTable" xlink:to="us-gaap_OffsettingAssetsTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OffsettingAssetsTable_lbl" xml:lang="en-US">Offsetting Assets [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OffsettingAssetsLineItems" xlink:label="us-gaap_OffsettingAssetsLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OffsettingAssetsLineItems" xlink:to="us-gaap_OffsettingAssetsLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OffsettingAssetsLineItems_lbl" xml:lang="en-US">Offsetting Assets [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_OpenOptionContractsWrittenNumbersOfShare" xlink:label="ALRT_OpenOptionContractsWrittenNumbersOfShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_OpenOptionContractsWrittenNumbersOfShare" xlink:to="ALRT_OpenOptionContractsWrittenNumbersOfShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ALRT_OpenOptionContractsWrittenNumbersOfShare_lbl" xml:lang="en-US">Options</link:label>
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_ExercisePrices" xlink:label="ALRT_ExercisePrices" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_ExercisePrices" xlink:to="ALRT_ExercisePrices_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ALRT_ExercisePrices_lbl" xml:lang="en-US">Exercise Price</link:label>
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_IntrinsicValue" xlink:label="ALRT_IntrinsicValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_IntrinsicValue" xlink:to="ALRT_IntrinsicValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ALRT_IntrinsicValue_lbl" xml:lang="en-US">Intrinsic Value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl" xml:lang="en-US">Weighted Average Remaining Contractual Life</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseDebt" xlink:label="us-gaap_InterestExpenseDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpenseDebt" xlink:to="us-gaap_InterestExpenseDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_InterestExpenseDebt_lbl" xml:lang="en-US">Interest expense</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" xlink:label="us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" xlink:to="us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_lbl" xml:lang="en-US">Product development expense</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfessionalAndContractServicesExpense" xlink:label="us-gaap_ProfessionalAndContractServicesExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProfessionalAndContractServicesExpense" xlink:to="us-gaap_ProfessionalAndContractServicesExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProfessionalAndContractServicesExpense_lbl" xml:lang="en-US">Professional expense</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherSellingGeneralAndAdministrativeExpense" xlink:label="us-gaap_OtherSellingGeneralAndAdministrativeExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherSellingGeneralAndAdministrativeExpense" xlink:to="us-gaap_OtherSellingGeneralAndAdministrativeExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OtherSellingGeneralAndAdministrativeExpense_lbl" xml:lang="en-US">Selling, general and administrative expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_Total" xlink:label="ALRT_Total" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_Total" xlink:to="ALRT_Total_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ALRT_Total_lbl" xml:lang="en-US">&#160;Fair value of the stock options granted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl" xml:lang="en-US">Risk-free interest rate</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl" xml:lang="en-US">Expected life</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend_lbl" xml:lang="en-US">Expected dividends</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl" xml:lang="en-US">Expected volatility</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageIntrinsicValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageIntrinsicValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageIntrinsicValue_lbl" xml:lang="en-US">Forfeiture rate</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xml:lang="en-US">Weighted average fair value options granted</link:label>
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_RelatedPartyTransactionIncludedWithinInterestExpense" xlink:label="ALRT_RelatedPartyTransactionIncludedWithinInterestExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_RelatedPartyTransactionIncludedWithinInterestExpense" xlink:to="ALRT_RelatedPartyTransactionIncludedWithinInterestExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ALRT_RelatedPartyTransactionIncludedWithinInterestExpense_lbl" xml:lang="en-US">Related party transactions included within interest expense:</link:label>
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_InterestExpenseOnPromissoryNotesIssuedToRelativesOfChairmanAndChiefExecutiveOfficerOfCompany" xlink:label="ALRT_InterestExpenseOnPromissoryNotesIssuedToRelativesOfChairmanAndChiefExecutiveOfficerOfCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_InterestExpenseOnPromissoryNotesIssuedToRelativesOfChairmanAndChiefExecutiveOfficerOfCompany" xlink:to="ALRT_InterestExpenseOnPromissoryNotesIssuedToRelativesOfChairmanAndChiefExecutiveOfficerOfCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ALRT_InterestExpenseOnPromissoryNotesIssuedToRelativesOfChairmanAndChiefExecutiveOfficerOfCompany_lbl" xml:lang="en-US">Interest expenses on promissory notes issued to relatives of the Chairman and Chief Executive Officer of the Company</link:label>
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_InterestExpenseOnLinesOfCreditPayableToChairmanAndChiefExecutiveOfficerOfCompanyAndHisSpouse" xlink:label="ALRT_InterestExpenseOnLinesOfCreditPayableToChairmanAndChiefExecutiveOfficerOfCompanyAndHisSpouse" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_InterestExpenseOnLinesOfCreditPayableToChairmanAndChiefExecutiveOfficerOfCompanyAndHisSpouse" xlink:to="ALRT_InterestExpenseOnLinesOfCreditPayableToChairmanAndChiefExecutiveOfficerOfCompanyAndHisSpouse_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ALRT_InterestExpenseOnLinesOfCreditPayableToChairmanAndChiefExecutiveOfficerOfCompanyAndHisSpouse_lbl" xml:lang="en-US">Interest expense on lines of credit payable to the Chairman and Chief Executive Officer of the Company and his spouse</link:label>
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_InterestExpenseRelatedToModificationOfStockOptionsHeldByChairmanAndChiefExecutiveOfficerOfCompanyAndHisSpouseRelatedToFinancingProvided" xlink:label="ALRT_InterestExpenseRelatedToModificationOfStockOptionsHeldByChairmanAndChiefExecutiveOfficerOfCompanyAndHisSpouseRelatedToFinancingProvided" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_InterestExpenseRelatedToModificationOfStockOptionsHeldByChairmanAndChiefExecutiveOfficerOfCompanyAndHisSpouseRelatedToFinancingProvided" xlink:to="ALRT_InterestExpenseRelatedToModificationOfStockOptionsHeldByChairmanAndChiefExecutiveOfficerOfCompanyAndHisSpouseRelatedToFinancingProvided_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ALRT_InterestExpenseRelatedToModificationOfStockOptionsHeldByChairmanAndChiefExecutiveOfficerOfCompanyAndHisSpouseRelatedToFinancingProvided_lbl" xml:lang="en-US">Interest expense related to the modification of stock options held by the Chairman and Chief Executive Officer of the Company and his spouse related to financing provided</link:label>
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_RelatedPartyTransactionsIncludingWithinSellingGeneralAndAdministrationExpenses" xlink:label="ALRT_RelatedPartyTransactionsIncludingWithinSellingGeneralAndAdministrationExpenses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_RelatedPartyTransactionsIncludingWithinSellingGeneralAndAdministrationExpenses" xlink:to="ALRT_RelatedPartyTransactionsIncludingWithinSellingGeneralAndAdministrationExpenses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ALRT_RelatedPartyTransactionsIncludingWithinSellingGeneralAndAdministrationExpenses_lbl" xml:lang="en-US">Related party transactions including within selling, general and administrative expenses:</link:label>
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_ConsultingFeesToChairmanAndChiefExecutiveOfficerOfCompanyAccruedOnLineOfCreditAvailableToCompany" xlink:label="ALRT_ConsultingFeesToChairmanAndChiefExecutiveOfficerOfCompanyAccruedOnLineOfCreditAvailableToCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_ConsultingFeesToChairmanAndChiefExecutiveOfficerOfCompanyAccruedOnLineOfCreditAvailableToCompany" xlink:to="ALRT_ConsultingFeesToChairmanAndChiefExecutiveOfficerOfCompanyAccruedOnLineOfCreditAvailableToCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ALRT_ConsultingFeesToChairmanAndChiefExecutiveOfficerOfCompanyAccruedOnLineOfCreditAvailableToCompany_lbl" xml:lang="en-US">Consulting fees to the Chairman and Chief Executive Officer of the Company accrued on the line of credit available to the Company</link:label>
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_ConsultingFeesToDirectorOfCompanySettledWithIssuanceOfCommonStock" xlink:label="ALRT_ConsultingFeesToDirectorOfCompanySettledWithIssuanceOfCommonStock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_ConsultingFeesToDirectorOfCompanySettledWithIssuanceOfCommonStock" xlink:to="ALRT_ConsultingFeesToDirectorOfCompanySettledWithIssuanceOfCommonStock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ALRT_ConsultingFeesToDirectorOfCompanySettledWithIssuanceOfCommonStock_lbl" xml:lang="en-US">Consulting fees to a director of the Company settled with issuance of common stock</link:label>
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_SalaryForServicesAsVpCorporateAndDirectorOfSingaporeSubsidiaryToSpouseOfChairmanAndChiefExecutiveOfficerOfCompany" xlink:label="ALRT_SalaryForServicesAsVpCorporateAndDirectorOfSingaporeSubsidiaryToSpouseOfChairmanAndChiefExecutiveOfficerOfCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_SalaryForServicesAsVpCorporateAndDirectorOfSingaporeSubsidiaryToSpouseOfChairmanAndChiefExecutiveOfficerOfCompany" xlink:to="ALRT_SalaryForServicesAsVpCorporateAndDirectorOfSingaporeSubsidiaryToSpouseOfChairmanAndChiefExecutiveOfficerOfCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ALRT_SalaryForServicesAsVpCorporateAndDirectorOfSingaporeSubsidiaryToSpouseOfChairmanAndChiefExecutiveOfficerOfCompany_lbl" xml:lang="en-US">Salary for services as VP Corporate and director of the Singapore subsidiary to the spouse of the Chairman and Chief Executive Officer of the Company</link:label>
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_LossOnSettlementOfDebtToRelativeOfChairmanAndChiefExecutiveOfficerOfCompany" xlink:label="ALRT_LossOnSettlementOfDebtToRelativeOfChairmanAndChiefExecutiveOfficerOfCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_LossOnSettlementOfDebtToRelativeOfChairmanAndChiefExecutiveOfficerOfCompany" xlink:to="ALRT_LossOnSettlementOfDebtToRelativeOfChairmanAndChiefExecutiveOfficerOfCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ALRT_LossOnSettlementOfDebtToRelativeOfChairmanAndChiefExecutiveOfficerOfCompany_lbl" xml:lang="en-US">Loss on settlement of debt to a relative of the Chairman and Chief Executive Officer of the Company</link:label>
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_RentPaidToCompanyControlledBySpouseOfChairmanAndImmediateFamilyMembers" xlink:label="ALRT_RentPaidToCompanyControlledBySpouseOfChairmanAndImmediateFamilyMembers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_RentPaidToCompanyControlledBySpouseOfChairmanAndImmediateFamilyMembers" xlink:to="ALRT_RentPaidToCompanyControlledBySpouseOfChairmanAndImmediateFamilyMembers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ALRT_RentPaidToCompanyControlledBySpouseOfChairmanAndImmediateFamilyMembers_lbl" xml:lang="en-US">Rent paid to a company controlled by the spouse of the Chairman and immediate family members</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:label="us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:to="us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_lbl" xml:lang="en-US">Schedule of Revenues from External Customers and Long-Lived Assets [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:label="us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:to="us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_lbl" xml:lang="en-US">Revenues from External Customers and Long-Lived Assets [Line Items]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Assets_2_lbl" xml:lang="en-US">Current and Total Assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLoss_2_lbl" xml:lang="en-US">Net Loss</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_NotePayablewithInterestat1PercentInterestperMonth" xlink:to="ALRT_NotePayablewithInterestat1PercentInterestperMonth_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ALRT_NotePayablewithInterestat1PercentInterestperMonth_doc" xml:lang="en-US">Including the current and noncurrent portions, aggregate carrying amount of all types of notes payable, as of the balance sheet date, with initial maturities beyond one year or beyond the normal operating cycle, if longer</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_NotePayableInterestattheUSBankPrimeRatePlus1PercentperMonth" xlink:to="ALRT_NotePayableInterestattheUSBankPrimeRatePlus1PercentperMonth_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ALRT_NotePayableInterestattheUSBankPrimeRatePlus1PercentperMonth_doc" xml:lang="en-US">Including the current and noncurrent portions, aggregate carrying amount of all types of notes payable, as of the balance sheet date, with initial maturities beyond one year or beyond the normal operating cycle, if longer</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_PromissoryNotesPayableUnsecuredtoRelativesofaDirectorBearingInterestat1PercentperMonth" xlink:to="ALRT_PromissoryNotesPayableUnsecuredtoRelativesofaDirectorBearingInterestat1PercentperMonth_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ALRT_PromissoryNotesPayableUnsecuredtoRelativesofaDirectorBearingInterestat1PercentperMonth_doc" xml:lang="en-US">Including the current and noncurrent portions, aggregate carrying amount of all types of notes payable, as of the balance sheet date, with initial maturities beyond one year or beyond the normal operating cycle, if longer</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_PromissoryNotesRelatedParty" xlink:to="ALRT_PromissoryNotesRelatedParty_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ALRT_PromissoryNotesRelatedParty_doc" xml:lang="en-US">Including the current and noncurrent portions, aggregate carrying amount of all types of notes payable, as of the balance sheet date, with initial maturities beyond one year or beyond the normal operating cycle, if longer</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_InterestExpenseIncurredonPromissoryNotesandOtherPayables" xlink:to="ALRT_InterestExpenseIncurredonPromissoryNotesandOtherPayables_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ALRT_InterestExpenseIncurredonPromissoryNotesandOtherPayables_doc" xml:lang="en-US">The cost of borrowed funds accounted for as interest that was charged against earnings during the period.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_InterestPayableRelativesOfDirectors" xlink:to="ALRT_InterestPayableRelativesOfDirectors_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ALRT_InterestPayableRelativesOfDirectors_doc" xml:lang="en-US">Carrying value as of the balance sheet date of [accrued] interest payable to relatives of directors on all forms of debt, including trade payables, that has been incurred and is unpaid.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_InterestPayabletoNonrelatedParties" xlink:to="ALRT_InterestPayabletoNonrelatedParties_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ALRT_InterestPayabletoNonrelatedParties_doc" xml:lang="en-US">Carrying value as of the balance sheet date of [accrued] interest payable to non-related parties on all forms of debt, including trade payables, that has been incurred and is unpaid.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_ShareBasedCompensationArrangementbyShareBasedPaymentAwardOptionsCancelations" xlink:to="ALRT_ShareBasedCompensationArrangementbyShareBasedPaymentAwardOptionsCancelations_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ALRT_ShareBasedCompensationArrangementbyShareBasedPaymentAwardOptionsCancelations_doc" xml:lang="en-US">The number of shares under options that were cancelled during the reporting period.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Liabilities_2_lbl" xml:lang="en-US">Liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquity_2_lbl" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_2_lbl" xml:lang="en-US">Liabilities and Equity</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostOfRevenue" xlink:to="us-gaap_CostOfRevenue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CostOfRevenue_2_lbl" xml:lang="en-US">Cost of Revenue</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GrossProfit" xlink:to="us-gaap_GrossProfit_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GrossProfit_2_lbl" xml:lang="en-US">Gross Profit</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingIncomeLoss_2_lbl" xml:lang="en-US">Operating Income (Loss)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_lbl" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_NonoperatingIncomeExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NonoperatingIncomeExpense_2_lbl" xml:lang="en-US">Nonoperating Income (Expense)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax" xlink:to="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax_2_lbl" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Reclassification Adjustment from AOCI, Realized upon Sale or Liquidation, Net of Tax</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="us-gaap_ComprehensiveIncomeNetOfTax_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax_2_lbl" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_2_lbl" xml:lang="en-US">Net Income (Loss) Available to Common Stockholders, Basic</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_StockbasedCompensationproductDevelopmentCosts" xlink:to="ALRT_StockbasedCompensationproductDevelopmentCosts_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ALRT_StockbasedCompensationproductDevelopmentCosts_2_lbl" xml:lang="en-US">StockbasedCompensationproductDevelopmentCosts</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_LossOnSettlementOfDebt" xlink:to="ALRT_LossOnSettlementOfDebt_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ALRT_LossOnSettlementOfDebt_2_lbl" xml:lang="en-US">LossOnSettlementOfDebt</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:to="us-gaap_IncreaseDecreaseInPrepaidExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInPrepaidExpense_2_lbl" xml:lang="en-US">Increase (Decrease) in Prepaid Expense</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_RepaymentOfLinesOfCreditInterest" xlink:to="ALRT_RepaymentOfLinesOfCreditInterest_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ALRT_RepaymentOfLinesOfCreditInterest_2_lbl" xml:lang="en-US">RepaymentOfLinesOfCreditInterest</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_lbl" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2_lbl" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_2_lbl" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_2_lbl" xml:lang="en-US">Accounts Payable and Accrued Liabilities Disclosure [Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_AdditionalPaidInCapitalTextBlock" xlink:to="ALRT_AdditionalPaidInCapitalTextBlock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ALRT_AdditionalPaidInCapitalTextBlock_2_lbl" xml:lang="en-US">AdditionalPaidInCapitalTextBlock</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProfitLoss" xlink:to="us-gaap_ProfitLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProfitLoss_2_lbl" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NotesPayableRelatedPartiesClassifiedCurrent" xlink:to="us-gaap_NotesPayableRelatedPartiesClassifiedCurrent_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NotesPayableRelatedPartiesClassifiedCurrent_3_lbl" xml:lang="en-US">Notes Payable, Related Parties, Current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_PromissoryNotesRelatedParty" xlink:to="ALRT_PromissoryNotesRelatedParty_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ALRT_PromissoryNotesRelatedParty_3_lbl" xml:lang="en-US">PromissoryNotesRelatedParty</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NotesPayable" xlink:to="us-gaap_NotesPayable_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NotesPayable_3_lbl" xml:lang="en-US">Notes Payable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_I.InterestAt1PerMonthRepayableOnMarch312009DueOnDemand" xlink:to="ALRT_I.InterestAt1PerMonthRepayableOnMarch312009DueOnDemand_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ALRT_I.InterestAt1PerMonthRepayableOnMarch312009DueOnDemand_2_lbl" xml:lang="en-US">I.InterestAt1PerMonthRepayableOnMarch312009DueOnDemand</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_TotalPromissoryNotesPayableToUnrelatedParties" xlink:to="ALRT_TotalPromissoryNotesPayableToUnrelatedParties_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ALRT_TotalPromissoryNotesPayableToUnrelatedParties_2_lbl" xml:lang="en-US">TotalPromissoryNotesPayableToUnrelatedParties</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestPayableCurrentAndNoncurrent" xlink:to="us-gaap_InterestPayableCurrentAndNoncurrent_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestPayableCurrentAndNoncurrent_3_lbl" xml:lang="en-US">Interest Payable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_InterestPayableCurrentAndNoncurrents" xlink:to="ALRT_InterestPayableCurrentAndNoncurrents_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ALRT_InterestPayableCurrentAndNoncurrents_2_lbl" xml:lang="en-US">InterestPayableCurrentAndNoncurrents</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermLineOfCredit" xlink:to="us-gaap_LongTermLineOfCredit_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermLineOfCredit_3_lbl" xml:lang="en-US">Long-Term Line of Credit, Noncurrent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_3_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_3_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_2_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_2_lbl" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_ShareBasedCompensationArrangementbyShareBasedPaymentAwardOptionsCancelations" xlink:to="ALRT_ShareBasedCompensationArrangementbyShareBasedPaymentAwardOptionsCancelations_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ALRT_ShareBasedCompensationArrangementbyShareBasedPaymentAwardOptionsCancelations_3_lbl" xml:lang="en-US">ShareBasedCompensationArrangementbyShareBasedPaymentAwardOptionsCancelations</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_CancelledPerShares" xlink:to="ALRT_CancelledPerShares_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ALRT_CancelledPerShares_2_lbl" xml:lang="en-US">CancelledPerShares</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_2_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Exercise Price</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpenseDebt" xlink:to="us-gaap_InterestExpenseDebt_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestExpenseDebt_2_lbl" xml:lang="en-US">Interest Expense, Debt</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherSellingGeneralAndAdministrativeExpense" xlink:to="us-gaap_OtherSellingGeneralAndAdministrativeExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherSellingGeneralAndAdministrativeExpense_2_lbl" xml:lang="en-US">Other Selling, General and Administrative Expense</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ALRT_Total" xlink:to="ALRT_Total_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ALRT_Total_2_lbl" xml:lang="en-US">Total</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>9
<FILENAME>alrt-20220630_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.15b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://alrt.com/role/Cover" xlink:href="alrt-20220630.xsd#Cover" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/BalanceSheets" xlink:href="alrt-20220630.xsd#BalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/BalanceSheetsParenthetical" xlink:href="alrt-20220630.xsd#BalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/StatementsOfOperations" xlink:href="alrt-20220630.xsd#StatementsOfOperations" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/StatementsOfCashFlows" xlink:href="alrt-20220630.xsd#StatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/BasisOfPresentationNatureOfOperationsAndGoingConcern" xlink:href="alrt-20220630.xsd#BasisOfPresentationNatureOfOperationsAndGoingConcern" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/SignificantAccountingPolicies" xlink:href="alrt-20220630.xsd#SignificantAccountingPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/AccountsPayableAndAccruedLiabilities" xlink:href="alrt-20220630.xsd#AccountsPayableAndAccruedLiabilities" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayable" xlink:href="alrt-20220630.xsd#InterestAdvancesAndPromissoryNotesPayable" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/LinesOfCredit" xlink:href="alrt-20220630.xsd#LinesOfCredit" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/CapitalStock" xlink:href="alrt-20220630.xsd#CapitalStock" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/AdditionalPaid-inCapital" xlink:href="alrt-20220630.xsd#AdditionalPaid-inCapital" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/RelatedPartyTransactionsAndBalances" xlink:href="alrt-20220630.xsd#RelatedPartyTransactionsAndBalances" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/CommitmentsAndContingencies" xlink:href="alrt-20220630.xsd#CommitmentsAndContingencies" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/OperatingSegments" xlink:href="alrt-20220630.xsd#OperatingSegments" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/SubsequentEvents" xlink:href="alrt-20220630.xsd#SubsequentEvents" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/AccountsPayableAndAccruedLiabilitiesTables" xlink:href="alrt-20220630.xsd#AccountsPayableAndAccruedLiabilitiesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableTables" xlink:href="alrt-20220630.xsd#InterestAdvancesAndPromissoryNotesPayableTables" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/LinesOfCreditTables" xlink:href="alrt-20220630.xsd#LinesOfCreditTables" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/AdditionalPaid-inCapitalTables" xlink:href="alrt-20220630.xsd#AdditionalPaid-inCapitalTables" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/RelatedPartyTransactionsAndBalancesTables" xlink:href="alrt-20220630.xsd#RelatedPartyTransactionsAndBalancesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/OperatingSegmentsTables" xlink:href="alrt-20220630.xsd#OperatingSegmentsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/BasisOfPresentationNatureOfOperationsAndGoingConcernDetailsNarrative" xlink:href="alrt-20220630.xsd#BasisOfPresentationNatureOfOperationsAndGoingConcernDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/AccountsPayableAndAccruedLiabilitiesDetails" xlink:href="alrt-20220630.xsd#AccountsPayableAndAccruedLiabilitiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails" xlink:href="alrt-20220630.xsd#InterestAdvancesAndPromissoryNotesPayableDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails1" xlink:href="alrt-20220630.xsd#InterestAdvancesAndPromissoryNotesPayableDetails1" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails2" xlink:href="alrt-20220630.xsd#InterestAdvancesAndPromissoryNotesPayableDetails2" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails3" xlink:href="alrt-20220630.xsd#InterestAdvancesAndPromissoryNotesPayableDetails3" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails4" xlink:href="alrt-20220630.xsd#InterestAdvancesAndPromissoryNotesPayableDetails4" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails5" xlink:href="alrt-20220630.xsd#InterestAdvancesAndPromissoryNotesPayableDetails5" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetailsNarrative" xlink:href="alrt-20220630.xsd#InterestAdvancesAndPromissoryNotesPayableDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/LinesOfCreditDetails" xlink:href="alrt-20220630.xsd#LinesOfCreditDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/LinesOfCreditDetails1" xlink:href="alrt-20220630.xsd#LinesOfCreditDetails1" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/AdditionalPaid-inCapitalDetails" xlink:href="alrt-20220630.xsd#AdditionalPaid-inCapitalDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/AdditionalPaid-inCapitalDetails1" xlink:href="alrt-20220630.xsd#AdditionalPaid-inCapitalDetails1" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/AdditionalPaid-inCapitalDetails2" xlink:href="alrt-20220630.xsd#AdditionalPaid-inCapitalDetails2" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/AdditionalPaid-inCapitalDetails3" xlink:href="alrt-20220630.xsd#AdditionalPaid-inCapitalDetails3" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/AdditionalPaid-inCapitalDetailsNarrative" xlink:href="alrt-20220630.xsd#AdditionalPaid-inCapitalDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/RelatedPartyTransactionsAndBalancesDetails" xlink:href="alrt-20220630.xsd#RelatedPartyTransactionsAndBalancesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://alrt.com/role/OperatingSegmentsDetails" xlink:href="alrt-20220630.xsd#OperatingSegmentsDetails" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://alrt.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://alrt.com/role/BalanceSheets" xlink:title="00000002 - Statement - Condensed Consolidated Balance Sheets (Unaudited)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaapStatementOfFinancialPositionAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract" xlink:label="loc_us-gaapAssetsAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapAssetsAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_us-gaapAssetsCurrentAbstract" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapAssetsCurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Cash" xlink:label="loc_us-gaapCash" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapCash" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseCurrent" xlink:label="loc_us-gaapPrepaidExpenseCurrent" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapPrepaidExpenseCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_us-gaapLiabilitiesCurrentAbstract" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapLiabilitiesCurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_PromissoryNotesPayableToRelatedParties" xlink:label="loc_ALRTPromissoryNotesPayableToRelatedParties" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_ALRTPromissoryNotesPayableToRelatedParties" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_PromissoryNotesPayableUnrelatedLender" xlink:label="loc_ALRTPromissoryNotesPayableUnrelatedLender" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_ALRTPromissoryNotesPayableUnrelatedLender" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPayableCurrent" xlink:label="loc_us-gaapInterestPayableCurrent" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapInterestPayableCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_LinesOfCreditFromRelatedParties" xlink:label="loc_ALRTLinesOfCreditFromRelatedParties" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_ALRTLinesOfCreditFromRelatedParties" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="loc_us-gaapStockholdersEquityAbstract" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapStockholdersEquityAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaapPreferredStockValue" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapPreferredStockValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapCommonStockValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapAdditionalPaidInCapital" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossNetOfTax" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://alrt.com/role/BalanceSheetsParenthetical" xlink:title="00000003 - Statement - Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaapStatementOfFinancialPositionAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaapPreferredStockSharesAuthorized" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapPreferredStockSharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaapPreferredStockParOrStatedValuePerShare" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapPreferredStockParOrStatedValuePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="loc_us-gaapPreferredStockSharesIssued" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapPreferredStockSharesIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="loc_us-gaapPreferredStockSharesOutstanding" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapPreferredStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaapCommonStockSharesAuthorized" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapCommonStockSharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaapCommonStockSharesIssued" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapCommonStockSharesIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapCommonStockSharesOutstanding" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://alrt.com/role/StatementsOfOperations" xlink:title="00000004 - Statement - Condensed Consolidated Statements of Operations (Unaudited)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract" xlink:label="loc_us-gaapIncomeStatementAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues" xlink:label="loc_us-gaapRevenues" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapRevenues" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfRevenue" xlink:label="loc_us-gaapCostOfRevenue" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapCostOfRevenue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit" xlink:label="loc_us-gaapGrossProfit" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapGrossProfit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="loc_us-gaapOperatingExpensesAbstract" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapOperatingExpensesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaapResearchAndDevelopmentExpense" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_us-gaapResearchAndDevelopmentExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfessionalFees" xlink:label="loc_us-gaapProfessionalFees" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_us-gaapProfessionalFees" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="loc_us-gaapSellingGeneralAndAdministrativeExpense" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_us-gaapSellingGeneralAndAdministrativeExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaapOperatingIncomeLoss" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_us-gaapOperatingIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpenseAbstract" xlink:label="loc_us-gaapNonoperatingIncomeExpenseAbstract" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense" xlink:label="loc_us-gaapInterestExpense" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapInterestExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="loc_us-gaapGainsLossesOnExtinguishmentOfDebt" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapGainsLossesOnExtinguishmentOfDebt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaapNonoperatingIncomeExpense" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapNonoperatingIncomeExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxAttributableToParentAbstract" xlink:label="loc_us-gaapOtherComprehensiveIncomeLossNetOfTaxAttributableToParentAbstract" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapOtherComprehensiveIncomeLossNetOfTaxAttributableToParentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax" xlink:label="loc_us-gaapOtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherComprehensiveIncomeLossNetOfTaxAttributableToParentAbstract" xlink:to="loc_us-gaapOtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="loc_us-gaapComprehensiveIncomeNetOfTax" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapComprehensiveIncomeNetOfTax" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_WeightedAverageNumberOfSharesOfCommonStockOutstandingBasicAndDiluted" xlink:label="loc_ALRTWeightedAverageNumberOfSharesOfCommonStockOutstandingBasicAndDiluted" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_ALRTWeightedAverageNumberOfSharesOfCommonStockOutstandingBasicAndDiluted" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_LossPerShareBasicAndDiluted" xlink:label="loc_ALRTLossPerShareBasicAndDiluted" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_ALRTLossPerShareBasicAndDiluted" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://alrt.com/role/StatementsOfCashFlows" xlink:title="00000005 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="loc_us-gaapStatementOfCashFlowsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="loc_us-gaapNetIncomeLossAvailableToCommonStockholdersBasic" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapNetIncomeLossAvailableToCommonStockholdersBasic" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_StockbasedCompensationproductDevelopmentCosts" xlink:label="loc_ALRTStockbasedCompensationproductDevelopmentCosts" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_ALRTStockbasedCompensationproductDevelopmentCosts" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_StockbasedCompensationgeneralSellingAndAdministration" xlink:label="loc_ALRTStockbasedCompensationgeneralSellingAndAdministration" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_ALRTStockbasedCompensationgeneralSellingAndAdministration" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_StockbasedCompensationProfessionalFees" xlink:label="loc_ALRTStockbasedCompensationProfessionalFees" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_ALRTStockbasedCompensationProfessionalFees" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_StockbasedCompensationinterest" xlink:label="loc_ALRTStockbasedCompensationinterest" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_ALRTStockbasedCompensationinterest" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_InterestExpenseOnLinesOfCredit" xlink:label="loc_ALRTInterestExpenseOnLinesOfCredit" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_ALRTInterestExpenseOnLinesOfCredit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_NoncashImputedInterestExpenses" xlink:label="loc_ALRTNoncashImputedInterestExpenses" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_ALRTNoncashImputedInterestExpenses" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_BonusesSettledByIssuanceOfShares" xlink:label="loc_ALRTBonusesSettledByIssuanceOfShares" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_ALRTBonusesSettledByIssuanceOfShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_LossOnSettlementOfDebt" xlink:label="loc_ALRTLossOnSettlementOfDebt" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_ALRTLossOnSettlementOfDebt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:label="loc_us-gaapIncreaseDecreaseInPrepaidExpense" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInPrepaidExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInterestPayableNet" xlink:label="loc_us-gaapIncreaseDecreaseInInterestPayableNet" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInInterestPayableNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromLinesOfCredit" xlink:label="loc_us-gaapProceedsFromLinesOfCredit" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapProceedsFromLinesOfCredit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromConvertibleDebt" xlink:label="loc_us-gaapProceedsFromConvertibleDebt" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapProceedsFromConvertibleDebt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_RepaymentOfLinesOfCreditInterest" xlink:label="loc_ALRTRepaymentOfLinesOfCreditInterest" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_ALRTRepaymentOfLinesOfCreditInterest" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="loc_us-gaapProceedsFromIssuanceOfCommonStock" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapProceedsFromIssuanceOfCommonStock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaapEffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapEffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://alrt.com/role/BasisOfPresentationNatureOfOperationsAndGoingConcern" xlink:title="00000006 - Disclosure - Basis of presentation, nature of operations and going concern">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:label="loc_us-gaapBusinessDescriptionAndBasisOfPresentationTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapBusinessDescriptionAndBasisOfPresentationTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://alrt.com/role/SignificantAccountingPolicies" xlink:title="00000007 - Disclosure - Significant accounting policies">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="loc_us-gaapSignificantAccountingPoliciesTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapSignificantAccountingPoliciesTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://alrt.com/role/AccountsPayableAndAccruedLiabilities" xlink:title="00000008 - Disclosure - Accounts payable and accrued liabilities">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="loc_us-gaapPayablesAndAccrualsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:label="loc_us-gaapAccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapAccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayable" xlink:title="00000009 - Disclosure - Interest, advances and promissory notes payable">
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_DisclosureInterestAdvancesAndPromissoryNotesPayableAbstract" xlink:label="loc_ALRTDisclosureInterestAdvancesAndPromissoryNotesPayableAbstract" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_InterestAdvancesAndPromissoryNotesPayableTextBlock" xlink:label="loc_ALRTInterestAdvancesAndPromissoryNotesPayableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ALRTDisclosureInterestAdvancesAndPromissoryNotesPayableAbstract" xlink:to="loc_ALRTInterestAdvancesAndPromissoryNotesPayableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://alrt.com/role/LinesOfCredit" xlink:title="00000010 - Disclosure - Lines of credit">
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_DisclosureLinesOfCreditAbstract" xlink:label="loc_ALRTDisclosureLinesOfCreditAbstract" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_LineOfCreditTextBlock" xlink:label="loc_ALRTLineOfCreditTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ALRTDisclosureLinesOfCreditAbstract" xlink:to="loc_ALRTLineOfCreditTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://alrt.com/role/CapitalStock" xlink:title="00000011 - Disclosure - Capital stock">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="loc_us-gaapStockholdersEquityNoteDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapStockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://alrt.com/role/AdditionalPaid-inCapital" xlink:title="00000012 - Disclosure - Additional paid-in capital">
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_DisclosureAdditionalPaidinCapitalAbstract" xlink:label="loc_ALRTDisclosureAdditionalPaidinCapitalAbstract" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_AdditionalPaidInCapitalTextBlock" xlink:label="loc_ALRTAdditionalPaidInCapitalTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ALRTDisclosureAdditionalPaidinCapitalAbstract" xlink:to="loc_ALRTAdditionalPaidInCapitalTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://alrt.com/role/RelatedPartyTransactionsAndBalances" xlink:title="00000013 - Disclosure - Related party transactions and balances">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="loc_us-gaapRelatedPartyTransactionsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="loc_us-gaapRelatedPartyTransactionsDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsAbstract" xlink:to="loc_us-gaapRelatedPartyTransactionsDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://alrt.com/role/CommitmentsAndContingencies" xlink:title="00000014 - Disclosure - Commitments and contingencies">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapCommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://alrt.com/role/OperatingSegments" xlink:title="00000015 - Disclosure - Operating segments">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaapSegmentReportingAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingDisclosureTextBlock" xlink:label="loc_us-gaapSegmentReportingDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentReportingAbstract" xlink:to="loc_us-gaapSegmentReportingDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://alrt.com/role/SubsequentEvents" xlink:title="00000016 - Disclosure - Subsequent events">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="loc_us-gaapSubsequentEventsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="loc_us-gaapSubsequentEventsTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventsAbstract" xlink:to="loc_us-gaapSubsequentEventsTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://alrt.com/role/AccountsPayableAndAccruedLiabilitiesTables" xlink:title="00000017 - Disclosure - Accounts payable and accrued liabilities (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="loc_us-gaapPayablesAndAccrualsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:label="loc_us-gaapScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableTables" xlink:title="00000018 - Disclosure - Interest, advances and promissory notes payable (Tables)">
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_DisclosureInterestAdvancesAndPromissoryNotesPayableAbstract" xlink:label="loc_ALRTDisclosureInterestAdvancesAndPromissoryNotesPayableAbstract" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_SummaryOfActivitiesOfPromissoryNotesPayableTableTextBlock" xlink:label="loc_ALRTSummaryOfActivitiesOfPromissoryNotesPayableTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ALRTDisclosureInterestAdvancesAndPromissoryNotesPayableAbstract" xlink:to="loc_ALRTSummaryOfActivitiesOfPromissoryNotesPayableTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_ScheduleofPromissoryNotesPayableRelativesofBoardofDirectorsTableTextBlock" xlink:label="loc_ALRTScheduleofPromissoryNotesPayableRelativesofBoardofDirectorsTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ALRTDisclosureInterestAdvancesAndPromissoryNotesPayableAbstract" xlink:to="loc_ALRTScheduleofPromissoryNotesPayableRelativesofBoardofDirectorsTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_ScheduleofPromissoryNotesPayableToUnrelatedPartiesTableTextBlock" xlink:label="loc_ALRTScheduleofPromissoryNotesPayableToUnrelatedPartiesTableTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ALRTDisclosureInterestAdvancesAndPromissoryNotesPayableAbstract" xlink:to="loc_ALRTScheduleofPromissoryNotesPayableToUnrelatedPartiesTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_ScheduleofActivityofPromissoryNotestoUnrelatedPatiesTableTextBlock" xlink:label="loc_ALRTScheduleofActivityofPromissoryNotestoUnrelatedPatiesTableTextBlock" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ALRTDisclosureInterestAdvancesAndPromissoryNotesPayableAbstract" xlink:to="loc_ALRTScheduleofActivityofPromissoryNotestoUnrelatedPatiesTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestAndOtherIncomeTableTextBlock" xlink:label="loc_us-gaapInterestAndOtherIncomeTableTextBlock" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ALRTDisclosureInterestAdvancesAndPromissoryNotesPayableAbstract" xlink:to="loc_us-gaapInterestAndOtherIncomeTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_ScheduledOfInterestPayableDueToRelatedTableTextBlock" xlink:label="loc_ALRTScheduledOfInterestPayableDueToRelatedTableTextBlock" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ALRTDisclosureInterestAdvancesAndPromissoryNotesPayableAbstract" xlink:to="loc_ALRTScheduledOfInterestPayableDueToRelatedTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://alrt.com/role/LinesOfCreditTables" xlink:title="00000019 - Disclosure - Lines of credit (Tables)">
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_DisclosureLinesOfCreditAbstract" xlink:label="loc_ALRTDisclosureLinesOfCreditAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock" xlink:label="loc_us-gaapScheduleOfLineOfCreditFacilitiesTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ALRTDisclosureLinesOfCreditAbstract" xlink:to="loc_us-gaapScheduleOfLineOfCreditFacilitiesTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_ScheduledOfLineOfCreditTableTextBlock" xlink:label="loc_ALRTScheduledOfLineOfCreditTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ALRTDisclosureLinesOfCreditAbstract" xlink:to="loc_ALRTScheduledOfLineOfCreditTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://alrt.com/role/AdditionalPaid-inCapitalTables" xlink:title="00000020 - Disclosure - Additional paid-in capital (Tables)">
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_DisclosureAdditionalPaidinCapitalAbstract" xlink:label="loc_ALRTDisclosureAdditionalPaidinCapitalAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ALRTDisclosureAdditionalPaidinCapitalAbstract" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_ScheduleofOptionsOutstandingTableTextBlock" xlink:label="loc_ALRTScheduleofOptionsOutstandingTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ALRTDisclosureAdditionalPaidinCapitalAbstract" xlink:to="loc_ALRTScheduleofOptionsOutstandingTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:label="loc_us-gaapScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ALRTDisclosureAdditionalPaidinCapitalAbstract" xlink:to="loc_us-gaapScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:label="loc_us-gaapScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ALRTDisclosureAdditionalPaidinCapitalAbstract" xlink:to="loc_us-gaapScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://alrt.com/role/RelatedPartyTransactionsAndBalancesTables" xlink:title="00000021 - Disclosure - Related party transactions and balances (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="loc_us-gaapRelatedPartyTransactionsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock" xlink:label="loc_us-gaapScheduleOfRelatedPartyTransactionsTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsAbstract" xlink:to="loc_us-gaapScheduleOfRelatedPartyTransactionsTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://alrt.com/role/OperatingSegmentsTables" xlink:title="00000022 - Disclosure - Operating segments (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaapSegmentReportingAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:label="loc_us-gaapScheduleOfSegmentReportingInformationBySegmentTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentReportingAbstract" xlink:to="loc_us-gaapScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://alrt.com/role/BasisOfPresentationNatureOfOperationsAndGoingConcernDetailsNarrative" xlink:title="00000023 - Disclosure - Basis of presentation, nature of operations and going concern (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaapProfitLoss" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapProfitLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_WorkingCapitalDeficit" xlink:label="loc_ALRTWorkingCapitalDeficit" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_ALRTWorkingCapitalDeficit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_PrincipalBorrowed" xlink:label="loc_ALRTPrincipalBorrowed" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_ALRTPrincipalBorrowed" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://alrt.com/role/AccountsPayableAndAccruedLiabilitiesDetails" xlink:title="00000024 - Disclosure - Accounts payable and accrued liabilities (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="loc_us-gaapPayablesAndAccrualsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaapAccountsPayableCurrent" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapAccountsPayableCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccruedLiabilitiesCurrent" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapAccruedLiabilitiesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredRevenueCurrent" xlink:label="loc_us-gaapDeferredRevenueCurrent" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapDeferredRevenueCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails" xlink:title="00000025 - Disclosure - Interest, advances and promissory notes payable (Details)">
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_DisclosureInterestAdvancesAndPromissoryNotesPayableAbstract" xlink:label="loc_ALRTDisclosureInterestAdvancesAndPromissoryNotesPayableAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShortTermDebtTable" xlink:label="loc_us-gaapScheduleOfShortTermDebtTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ALRTDisclosureInterestAdvancesAndPromissoryNotesPayableAbstract" xlink:to="loc_us-gaapScheduleOfShortTermDebtTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtLineItems" xlink:label="loc_us-gaapShortTermDebtLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShortTermDebtTable" xlink:to="loc_us-gaapShortTermDebtLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaapDebtInstrumentAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShortTermDebtTable" xlink:to="loc_us-gaapDebtInstrumentAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_RelatedPartyMember" xlink:label="loc_ALRTRelatedPartyMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_ALRTRelatedPartyMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NotesPayableRelatedPartiesClassifiedCurrent" xlink:label="loc_us-gaapNotesPayableRelatedPartiesClassifiedCurrent" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapNotesPayableRelatedPartiesClassifiedCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_TransferredFromPromissoryNotesPayablePursuantToPrivateTransaction." xlink:label="loc_ALRTTransferredFromPromissoryNotesPayablePursuantToPrivateTransaction." />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_ALRTTransferredFromPromissoryNotesPayablePursuantToPrivateTransaction." xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NotesPayableRelatedPartiesClassifiedCurrent" xlink:label="loc_us-gaapNotesPayableRelatedPartiesClassifiedCurrent_2" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapNotesPayableRelatedPartiesClassifiedCurrent_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails1" xlink:title="00000026 - Disclosure - Interest, advances and promissory notes payable (Details 1)">
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_DisclosureInterestAdvancesAndPromissoryNotesPayableAbstract" xlink:label="loc_ALRTDisclosureInterestAdvancesAndPromissoryNotesPayableAbstract" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_PromissoryNotesPayableToRelativesOfDirectorsCollateralizedByAGeneralSecurityAgreementOnAllTheAssetsOfTheCompanyDueOnDemandAbstract" xlink:label="loc_ALRTPromissoryNotesPayableToRelativesOfDirectorsCollateralizedByAGeneralSecurityAgreementOnAllTheAssetsOfTheCompanyDueOnDemandAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ALRTDisclosureInterestAdvancesAndPromissoryNotesPayableAbstract" xlink:to="loc_ALRTPromissoryNotesPayableToRelativesOfDirectorsCollateralizedByAGeneralSecurityAgreementOnAllTheAssetsOfTheCompanyDueOnDemandAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_NotePayablewithInterestat1PercentInterestperMonth" xlink:label="loc_ALRTNotePayablewithInterestat1PercentInterestperMonth" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ALRTPromissoryNotesPayableToRelativesOfDirectorsCollateralizedByAGeneralSecurityAgreementOnAllTheAssetsOfTheCompanyDueOnDemandAbstract" xlink:to="loc_ALRTNotePayablewithInterestat1PercentInterestperMonth" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_InterestAt1.25PerMonth" xlink:label="loc_ALRTInterestAt1.25PerMonth" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ALRTPromissoryNotesPayableToRelativesOfDirectorsCollateralizedByAGeneralSecurityAgreementOnAllTheAssetsOfTheCompanyDueOnDemandAbstract" xlink:to="loc_ALRTInterestAt1.25PerMonth" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_NotePayableInterestattheUSBankPrimeRatePlus1PercentperMonth" xlink:label="loc_ALRTNotePayableInterestattheUSBankPrimeRatePlus1PercentperMonth" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ALRTPromissoryNotesPayableToRelativesOfDirectorsCollateralizedByAGeneralSecurityAgreementOnAllTheAssetsOfTheCompanyDueOnDemandAbstract" xlink:to="loc_ALRTNotePayableInterestattheUSBankPrimeRatePlus1PercentperMonth" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_Iv.InterestAt0.5PerMonth" xlink:label="loc_ALRTIv.InterestAt0.5PerMonth" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ALRTPromissoryNotesPayableToRelativesOfDirectorsCollateralizedByAGeneralSecurityAgreementOnAllTheAssetsOfTheCompanyDueOnDemandAbstract" xlink:to="loc_ALRTIv.InterestAt0.5PerMonth" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_UnsecuredPromissoryNotesPayableToRelativesOfChairmanWithFixedAmountsOfInterestDueAugust312022" xlink:label="loc_ALRTUnsecuredPromissoryNotesPayableToRelativesOfChairmanWithFixedAmountsOfInterestDueAugust312022" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ALRTPromissoryNotesPayableToRelativesOfDirectorsCollateralizedByAGeneralSecurityAgreementOnAllTheAssetsOfTheCompanyDueOnDemandAbstract" xlink:to="loc_ALRTUnsecuredPromissoryNotesPayableToRelativesOfChairmanWithFixedAmountsOfInterestDueAugust312022" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_PromissoryNotesPayableUnsecuredtoRelativesofaDirectorBearingInterestat1PercentperMonth" xlink:label="loc_ALRTPromissoryNotesPayableUnsecuredtoRelativesofaDirectorBearingInterestat1PercentperMonth" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ALRTPromissoryNotesPayableToRelativesOfDirectorsCollateralizedByAGeneralSecurityAgreementOnAllTheAssetsOfTheCompanyDueOnDemandAbstract" xlink:to="loc_ALRTPromissoryNotesPayableUnsecuredtoRelativesofaDirectorBearingInterestat1PercentperMonth" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_PromissoryNotesRelatedParty" xlink:label="loc_ALRTPromissoryNotesRelatedParty" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ALRTDisclosureInterestAdvancesAndPromissoryNotesPayableAbstract" xlink:to="loc_ALRTPromissoryNotesRelatedParty" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails2" xlink:title="00000027 - Disclosure - Interest, advances and promissory notes payable (Details 2)">
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_DisclosureInterestAdvancesAndPromissoryNotesPayableAbstract" xlink:label="loc_ALRTDisclosureInterestAdvancesAndPromissoryNotesPayableAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShortTermDebtTable" xlink:label="loc_us-gaapScheduleOfShortTermDebtTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ALRTDisclosureInterestAdvancesAndPromissoryNotesPayableAbstract" xlink:to="loc_us-gaapScheduleOfShortTermDebtTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtLineItems" xlink:label="loc_us-gaapShortTermDebtLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShortTermDebtTable" xlink:to="loc_us-gaapShortTermDebtLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaapDebtInstrumentAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShortTermDebtTable" xlink:to="loc_us-gaapDebtInstrumentAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_UnRelatedPartyMember" xlink:label="loc_ALRTUnRelatedPartyMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_ALRTUnRelatedPartyMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NotesPayable" xlink:label="loc_us-gaapNotesPayable" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapNotesPayable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInterestPayableNet" xlink:label="loc_us-gaapIncreaseDecreaseInInterestPayableNet" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapIncreaseDecreaseInInterestPayableNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_ExtinguishedThroughIssuanceOfSharesOfCommonStock" xlink:label="loc_ALRTExtinguishedThroughIssuanceOfSharesOfCommonStock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_ALRTExtinguishedThroughIssuanceOfSharesOfCommonStock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_TransferredFromPromissoryNotesPayablePursuantToPrivateTransaction." xlink:label="loc_ALRTTransferredFromPromissoryNotesPayablePursuantToPrivateTransaction." />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_ALRTTransferredFromPromissoryNotesPayablePursuantToPrivateTransaction." xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_PromissoryNoteReceived" xlink:label="loc_ALRTPromissoryNoteReceived" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_ALRTPromissoryNoteReceived" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NotesPayable" xlink:label="loc_us-gaapNotesPayable_2" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapNotesPayable_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails3" xlink:title="00000028 - Disclosure - Interest, advances and promissory notes payable (Details 3)">
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_DisclosureInterestAdvancesAndPromissoryNotesPayableAbstract" xlink:label="loc_ALRTDisclosureInterestAdvancesAndPromissoryNotesPayableAbstract" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_UnsecuredPromissoryNotesPayableToUnrelatedLendersAbstract" xlink:label="loc_ALRTUnsecuredPromissoryNotesPayableToUnrelatedLendersAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ALRTDisclosureInterestAdvancesAndPromissoryNotesPayableAbstract" xlink:to="loc_ALRTUnsecuredPromissoryNotesPayableToUnrelatedLendersAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_I.InterestAt1PerMonthRepayableOnMarch312009DueOnDemand" xlink:label="loc_ALRTI.InterestAt1PerMonthRepayableOnMarch312009DueOnDemand" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ALRTUnsecuredPromissoryNotesPayableToUnrelatedLendersAbstract" xlink:to="loc_ALRTI.InterestAt1PerMonthRepayableOnMarch312009DueOnDemand" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_Iii.InterestAt0.625PerMonthWith50000RepayableOnOctober5200440000RepayableOnDecember312004And60000RepayableOnJuly282006AllDueOnDemand" xlink:label="loc_ALRTIii.InterestAt0.625PerMonthWith50000RepayableOnOctober5200440000RepayableOnDecember312004And60000RepayableOnJuly282006AllDueOnDemand" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ALRTUnsecuredPromissoryNotesPayableToUnrelatedLendersAbstract" xlink:to="loc_ALRTIii.InterestAt0.625PerMonthWith50000RepayableOnOctober5200440000RepayableOnDecember312004And60000RepayableOnJuly282006AllDueOnDemand" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_Vi.InterestAt0.667PerMonthWith125000DueJanuary152011" xlink:label="loc_ALRTVi.InterestAt0.667PerMonthWith125000DueJanuary152011" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ALRTUnsecuredPromissoryNotesPayableToUnrelatedLendersAbstract" xlink:to="loc_ALRTVi.InterestAt0.667PerMonthWith125000DueJanuary152011" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_Noninterestbearing" xlink:label="loc_ALRTNoninterestbearing" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ALRTUnsecuredPromissoryNotesPayableToUnrelatedLendersAbstract" xlink:to="loc_ALRTNoninterestbearing" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_UnsecuredPromissoryNotesPayableToUnrelatedLendersWithFixedAmountsOfInterestDue" xlink:label="loc_ALRTUnsecuredPromissoryNotesPayableToUnrelatedLendersWithFixedAmountsOfInterestDue" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ALRTUnsecuredPromissoryNotesPayableToUnrelatedLendersAbstract" xlink:to="loc_ALRTUnsecuredPromissoryNotesPayableToUnrelatedLendersWithFixedAmountsOfInterestDue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_PromissoryNotesPayableSecuredByGuaranteeFromChiefExecutiveOfficerBearingInterestAt1PerMonth" xlink:label="loc_ALRTPromissoryNotesPayableSecuredByGuaranteeFromChiefExecutiveOfficerBearingInterestAt1PerMonth" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ALRTUnsecuredPromissoryNotesPayableToUnrelatedLendersAbstract" xlink:to="loc_ALRTPromissoryNotesPayableSecuredByGuaranteeFromChiefExecutiveOfficerBearingInterestAt1PerMonth" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_TotalPromissoryNotesPayableToUnrelatedParties" xlink:label="loc_ALRTTotalPromissoryNotesPayableToUnrelatedParties" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ALRTUnsecuredPromissoryNotesPayableToUnrelatedLendersAbstract" xlink:to="loc_ALRTTotalPromissoryNotesPayableToUnrelatedParties" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails4" xlink:title="00000029 - Disclosure - Interest, advances and promissory notes payable (Details 4)">
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_DisclosureInterestAdvancesAndPromissoryNotesPayableAbstract" xlink:label="loc_ALRTDisclosureInterestAdvancesAndPromissoryNotesPayableAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPayableCurrentAndNoncurrent" xlink:label="loc_us-gaapInterestPayableCurrentAndNoncurrent" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ALRTDisclosureInterestAdvancesAndPromissoryNotesPayableAbstract" xlink:to="loc_us-gaapInterestPayableCurrentAndNoncurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_ReclassifiedFromPromissoryNotesPayable" xlink:label="loc_ALRTReclassifiedFromPromissoryNotesPayable" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ALRTDisclosureInterestAdvancesAndPromissoryNotesPayableAbstract" xlink:to="loc_ALRTReclassifiedFromPromissoryNotesPayable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_InterestExpenseIncurredonPromissoryNotesandOtherPayables" xlink:label="loc_ALRTInterestExpenseIncurredonPromissoryNotesandOtherPayables" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ALRTDisclosureInterestAdvancesAndPromissoryNotesPayableAbstract" xlink:to="loc_ALRTInterestExpenseIncurredonPromissoryNotesandOtherPayables" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_InterestPayableRetiredThroughIssuanceOfShares" xlink:label="loc_ALRTInterestPayableRetiredThroughIssuanceOfShares" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ALRTDisclosureInterestAdvancesAndPromissoryNotesPayableAbstract" xlink:to="loc_ALRTInterestPayableRetiredThroughIssuanceOfShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPayableCurrentAndNoncurrent" xlink:label="loc_us-gaapInterestPayableCurrentAndNoncurrent_2" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ALRTDisclosureInterestAdvancesAndPromissoryNotesPayableAbstract" xlink:to="loc_us-gaapInterestPayableCurrentAndNoncurrent_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails5" xlink:title="00000030 - Disclosure - Interest, advances and promissory notes payable (Details 5)">
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_DisclosureInterestAdvancesAndPromissoryNotesPayableAbstract" xlink:label="loc_ALRTDisclosureInterestAdvancesAndPromissoryNotesPayableAbstract" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_InterestPayableRelativesOfDirectors" xlink:label="loc_ALRTInterestPayableRelativesOfDirectors" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ALRTDisclosureInterestAdvancesAndPromissoryNotesPayableAbstract" xlink:to="loc_ALRTInterestPayableRelativesOfDirectors" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_InterestPayabletoNonrelatedParties" xlink:label="loc_ALRTInterestPayabletoNonrelatedParties" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ALRTDisclosureInterestAdvancesAndPromissoryNotesPayableAbstract" xlink:to="loc_ALRTInterestPayabletoNonrelatedParties" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_InterestPayableCurrentAndNoncurrents" xlink:label="loc_ALRTInterestPayableCurrentAndNoncurrents" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ALRTDisclosureInterestAdvancesAndPromissoryNotesPayableAbstract" xlink:to="loc_ALRTInterestPayableCurrentAndNoncurrents" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetailsNarrative" xlink:title="00000031 - Disclosure - Interest, advances and promissory notes payable (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_DisclosureInterestAdvancesAndPromissoryNotesPayableAbstract" xlink:label="loc_ALRTDisclosureInterestAdvancesAndPromissoryNotesPayableAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense" xlink:label="loc_us-gaapInterestExpense" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ALRTDisclosureInterestAdvancesAndPromissoryNotesPayableAbstract" xlink:to="loc_us-gaapInterestExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseRelatedParty" xlink:label="loc_us-gaapInterestExpenseRelatedParty" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ALRTDisclosureInterestAdvancesAndPromissoryNotesPayableAbstract" xlink:to="loc_us-gaapInterestExpenseRelatedParty" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://alrt.com/role/LinesOfCreditDetails" xlink:title="00000032 - Disclosure - Lines of credit (Details)">
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_DisclosureLinesOfCreditAbstract" xlink:label="loc_ALRTDisclosureLinesOfCreditAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermLineOfCredit" xlink:label="loc_us-gaapLongTermLineOfCredit" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ALRTDisclosureLinesOfCreditAbstract" xlink:to="loc_us-gaapLongTermLineOfCredit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityPeriodicPaymentPrincipal" xlink:label="loc_us-gaapLineOfCreditFacilityPeriodicPaymentPrincipal" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ALRTDisclosureLinesOfCreditAbstract" xlink:to="loc_us-gaapLineOfCreditFacilityPeriodicPaymentPrincipal" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityPeriodicPaymentInterest" xlink:label="loc_us-gaapLineOfCreditFacilityPeriodicPaymentInterest" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ALRTDisclosureLinesOfCreditAbstract" xlink:to="loc_us-gaapLineOfCreditFacilityPeriodicPaymentInterest" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_RepaymentOfInterestOnLinesOfCredit" xlink:label="loc_ALRTRepaymentOfInterestOnLinesOfCredit" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ALRTDisclosureLinesOfCreditAbstract" xlink:to="loc_ALRTRepaymentOfInterestOnLinesOfCredit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermLineOfCredit" xlink:label="loc_us-gaapLongTermLineOfCredit_2" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ALRTDisclosureLinesOfCreditAbstract" xlink:to="loc_us-gaapLongTermLineOfCredit_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://alrt.com/role/LinesOfCreditDetails1" xlink:title="00000033 - Disclosure - Lines of credit (Details 1)">
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_DisclosureLinesOfCreditAbstract" xlink:label="loc_ALRTDisclosureLinesOfCreditAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityTable" xlink:label="loc_us-gaapLineOfCreditFacilityTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ALRTDisclosureLinesOfCreditAbstract" xlink:to="loc_us-gaapLineOfCreditFacilityTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityLineItems" xlink:label="loc_us-gaapLineOfCreditFacilityLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLineOfCreditFacilityTable" xlink:to="loc_us-gaapLineOfCreditFacilityLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityAxis" xlink:label="loc_us-gaapLineOfCreditFacilityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLineOfCreditFacilityTable" xlink:to="loc_us-gaapLineOfCreditFacilityAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityLenderDomain" xlink:label="loc_us-gaapLineOfCreditFacilityLenderDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLineOfCreditFacilityAxis" xlink:to="loc_us-gaapLineOfCreditFacilityLenderDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_ChairmanAndCEOMember" xlink:label="loc_ALRTChairmanAndCEOMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLineOfCreditFacilityLenderDomain" xlink:to="loc_ALRTChairmanAndCEOMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_WifeOfChairmanMember" xlink:label="loc_ALRTWifeOfChairmanMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLineOfCreditFacilityLenderDomain" xlink:to="loc_ALRTWifeOfChairmanMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_InterestRate" xlink:label="loc_ALRTInterestRate" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLineOfCreditFacilityLineItems" xlink:to="loc_ALRTInterestRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_BorrowingLimit" xlink:label="loc_ALRTBorrowingLimit" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLineOfCreditFacilityLineItems" xlink:to="loc_ALRTBorrowingLimit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_RepaymentTerms1" xlink:label="loc_ALRTRepaymentTerms1" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLineOfCreditFacilityLineItems" xlink:to="loc_ALRTRepaymentTerms1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_PrincipalBorrowed" xlink:label="loc_ALRTPrincipalBorrowed" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLineOfCreditFacilityLineItems" xlink:to="loc_ALRTPrincipalBorrowed" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_AccruedInterest" xlink:label="loc_ALRTAccruedInterest" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLineOfCreditFacilityLineItems" xlink:to="loc_ALRTAccruedInterest" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_TotalOutstanding" xlink:label="loc_ALRTTotalOutstanding" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLineOfCreditFacilityLineItems" xlink:to="loc_ALRTTotalOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_Security1" xlink:label="loc_ALRTSecurity1" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLineOfCreditFacilityLineItems" xlink:to="loc_ALRTSecurity1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_Purpose1" xlink:label="loc_ALRTPurpose1" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLineOfCreditFacilityLineItems" xlink:to="loc_ALRTPurpose1" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://alrt.com/role/AdditionalPaid-inCapitalDetails" xlink:title="00000034 - Disclosure - Additional paid-in capital (Details)">
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_DisclosureAdditionalPaidinCapitalAbstract" xlink:label="loc_ALRTDisclosureAdditionalPaidinCapitalAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ALRTDisclosureAdditionalPaidinCapitalAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ALRTDisclosureAdditionalPaidinCapitalAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ALRTDisclosureAdditionalPaidinCapitalAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ALRTDisclosureAdditionalPaidinCapitalAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ALRTDisclosureAdditionalPaidinCapitalAbstract" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ALRTDisclosureAdditionalPaidinCapitalAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_ShareBasedCompensationArrangementbyShareBasedPaymentAwardOptionsCancelations" xlink:label="loc_ALRTShareBasedCompensationArrangementbyShareBasedPaymentAwardOptionsCancelations" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ALRTDisclosureAdditionalPaidinCapitalAbstract" xlink:to="loc_ALRTShareBasedCompensationArrangementbyShareBasedPaymentAwardOptionsCancelations" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_CancelledPerShares" xlink:label="loc_ALRTCancelledPerShares" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ALRTDisclosureAdditionalPaidinCapitalAbstract" xlink:to="loc_ALRTCancelledPerShares" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ALRTDisclosureAdditionalPaidinCapitalAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ALRTDisclosureAdditionalPaidinCapitalAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ALRTDisclosureAdditionalPaidinCapitalAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ALRTDisclosureAdditionalPaidinCapitalAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://alrt.com/role/AdditionalPaid-inCapitalDetails1" xlink:title="00000035 - Disclosure - Additional paid-in capital (Details 1)">
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_DisclosureAdditionalPaidinCapitalAbstract" xlink:label="loc_ALRTDisclosureAdditionalPaidinCapitalAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OffsettingAssetsTable" xlink:label="loc_us-gaapOffsettingAssetsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ALRTDisclosureAdditionalPaidinCapitalAbstract" xlink:to="loc_us-gaapOffsettingAssetsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OffsettingAssetsLineItems" xlink:label="loc_us-gaapOffsettingAssetsLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOffsettingAssetsTable" xlink:to="loc_us-gaapOffsettingAssetsLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis" xlink:label="loc_us-gaapDerivativeInstrumentRiskAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOffsettingAssetsTable" xlink:to="loc_us-gaapDerivativeInstrumentRiskAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="loc_us-gaapDerivativeContractTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeInstrumentRiskAxis" xlink:to="loc_us-gaapDerivativeContractTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_Options1Member" xlink:label="loc_ALRTOptions1Member" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeContractTypeDomain" xlink:to="loc_ALRTOptions1Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_Options2Member" xlink:label="loc_ALRTOptions2Member" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeContractTypeDomain" xlink:to="loc_ALRTOptions2Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_Options3Member" xlink:label="loc_ALRTOptions3Member" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeContractTypeDomain" xlink:to="loc_ALRTOptions3Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_Options4Member" xlink:label="loc_ALRTOptions4Member" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeContractTypeDomain" xlink:to="loc_ALRTOptions4Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_Options5Member" xlink:label="loc_ALRTOptions5Member" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeContractTypeDomain" xlink:to="loc_ALRTOptions5Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_Options6Member" xlink:label="loc_ALRTOptions6Member" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeContractTypeDomain" xlink:to="loc_ALRTOptions6Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_Options7Member" xlink:label="loc_ALRTOptions7Member" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeContractTypeDomain" xlink:to="loc_ALRTOptions7Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_Options8Member" xlink:label="loc_ALRTOptions8Member" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeContractTypeDomain" xlink:to="loc_ALRTOptions8Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_Options9Member" xlink:label="loc_ALRTOptions9Member" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeContractTypeDomain" xlink:to="loc_ALRTOptions9Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_Options10Member" xlink:label="loc_ALRTOptions10Member" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeContractTypeDomain" xlink:to="loc_ALRTOptions10Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_Options11Member" xlink:label="loc_ALRTOptions11Member" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeContractTypeDomain" xlink:to="loc_ALRTOptions11Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_Options12Member" xlink:label="loc_ALRTOptions12Member" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeContractTypeDomain" xlink:to="loc_ALRTOptions12Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_Options13Member" xlink:label="loc_ALRTOptions13Member" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeContractTypeDomain" xlink:to="loc_ALRTOptions13Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_Options14Member" xlink:label="loc_ALRTOptions14Member" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeContractTypeDomain" xlink:to="loc_ALRTOptions14Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_Options15Member" xlink:label="loc_ALRTOptions15Member" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeContractTypeDomain" xlink:to="loc_ALRTOptions15Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_Options16Member" xlink:label="loc_ALRTOptions16Member" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeContractTypeDomain" xlink:to="loc_ALRTOptions16Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_Options17Member" xlink:label="loc_ALRTOptions17Member" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeContractTypeDomain" xlink:to="loc_ALRTOptions17Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_Options18Member" xlink:label="loc_ALRTOptions18Member" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeContractTypeDomain" xlink:to="loc_ALRTOptions18Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_Options19Member" xlink:label="loc_ALRTOptions19Member" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeContractTypeDomain" xlink:to="loc_ALRTOptions19Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_Options20Member" xlink:label="loc_ALRTOptions20Member" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeContractTypeDomain" xlink:to="loc_ALRTOptions20Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_Options21Member" xlink:label="loc_ALRTOptions21Member" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeContractTypeDomain" xlink:to="loc_ALRTOptions21Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_Options22Member" xlink:label="loc_ALRTOptions22Member" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeContractTypeDomain" xlink:to="loc_ALRTOptions22Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_Options23Member" xlink:label="loc_ALRTOptions23Member" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeContractTypeDomain" xlink:to="loc_ALRTOptions23Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_OpenOptionContractsWrittenNumbersOfShare" xlink:label="loc_ALRTOpenOptionContractsWrittenNumbersOfShare" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOffsettingAssetsLineItems" xlink:to="loc_ALRTOpenOptionContractsWrittenNumbersOfShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_ExercisePrices" xlink:label="loc_ALRTExercisePrices" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOffsettingAssetsLineItems" xlink:to="loc_ALRTExercisePrices" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_IntrinsicValue" xlink:label="loc_ALRTIntrinsicValue" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOffsettingAssetsLineItems" xlink:to="loc_ALRTIntrinsicValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOffsettingAssetsLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://alrt.com/role/AdditionalPaid-inCapitalDetails2" xlink:title="00000036 - Disclosure - Additional paid-in capital (Details 2)">
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_DisclosureAdditionalPaidinCapitalAbstract" xlink:label="loc_ALRTDisclosureAdditionalPaidinCapitalAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseDebt" xlink:label="loc_us-gaapInterestExpenseDebt" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ALRTDisclosureAdditionalPaidinCapitalAbstract" xlink:to="loc_us-gaapInterestExpenseDebt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" xlink:label="loc_us-gaapResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ALRTDisclosureAdditionalPaidinCapitalAbstract" xlink:to="loc_us-gaapResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfessionalAndContractServicesExpense" xlink:label="loc_us-gaapProfessionalAndContractServicesExpense" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ALRTDisclosureAdditionalPaidinCapitalAbstract" xlink:to="loc_us-gaapProfessionalAndContractServicesExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherSellingGeneralAndAdministrativeExpense" xlink:label="loc_us-gaapOtherSellingGeneralAndAdministrativeExpense" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ALRTDisclosureAdditionalPaidinCapitalAbstract" xlink:to="loc_us-gaapOtherSellingGeneralAndAdministrativeExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_Total" xlink:label="loc_ALRTTotal" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ALRTDisclosureAdditionalPaidinCapitalAbstract" xlink:to="loc_ALRTTotal" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://alrt.com/role/AdditionalPaid-inCapitalDetails3" xlink:title="00000037 - Disclosure - Additional paid-in capital (Details 3)">
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_DisclosureAdditionalPaidinCapitalAbstract" xlink:label="loc_ALRTDisclosureAdditionalPaidinCapitalAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ALRTDisclosureAdditionalPaidinCapitalAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ALRTDisclosureAdditionalPaidinCapitalAbstract" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ALRTDisclosureAdditionalPaidinCapitalAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ALRTDisclosureAdditionalPaidinCapitalAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageIntrinsicValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageIntrinsicValue" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ALRTDisclosureAdditionalPaidinCapitalAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageIntrinsicValue" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://alrt.com/role/AdditionalPaid-inCapitalDetailsNarrative" xlink:title="00000038 - Disclosure - Additional paid-in capital (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_DisclosureAdditionalPaidinCapitalAbstract" xlink:label="loc_ALRTDisclosureAdditionalPaidinCapitalAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ALRTDisclosureAdditionalPaidinCapitalAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://alrt.com/role/RelatedPartyTransactionsAndBalancesDetails" xlink:title="00000039 - Disclosure - Related party transactions and balances (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="loc_us-gaapRelatedPartyTransactionsAbstract" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_RelatedPartyTransactionIncludedWithinInterestExpense" xlink:label="loc_ALRTRelatedPartyTransactionIncludedWithinInterestExpense" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsAbstract" xlink:to="loc_ALRTRelatedPartyTransactionIncludedWithinInterestExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_InterestExpenseOnPromissoryNotesIssuedToRelativesOfChairmanAndChiefExecutiveOfficerOfCompany" xlink:label="loc_ALRTInterestExpenseOnPromissoryNotesIssuedToRelativesOfChairmanAndChiefExecutiveOfficerOfCompany" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsAbstract" xlink:to="loc_ALRTInterestExpenseOnPromissoryNotesIssuedToRelativesOfChairmanAndChiefExecutiveOfficerOfCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_InterestExpenseOnLinesOfCreditPayableToChairmanAndChiefExecutiveOfficerOfCompanyAndHisSpouse" xlink:label="loc_ALRTInterestExpenseOnLinesOfCreditPayableToChairmanAndChiefExecutiveOfficerOfCompanyAndHisSpouse" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsAbstract" xlink:to="loc_ALRTInterestExpenseOnLinesOfCreditPayableToChairmanAndChiefExecutiveOfficerOfCompanyAndHisSpouse" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_InterestExpenseRelatedToModificationOfStockOptionsHeldByChairmanAndChiefExecutiveOfficerOfCompanyAndHisSpouseRelatedToFinancingProvided" xlink:label="loc_ALRTInterestExpenseRelatedToModificationOfStockOptionsHeldByChairmanAndChiefExecutiveOfficerOfCompanyAndHisSpouseRelatedToFinancingProvided" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsAbstract" xlink:to="loc_ALRTInterestExpenseRelatedToModificationOfStockOptionsHeldByChairmanAndChiefExecutiveOfficerOfCompanyAndHisSpouseRelatedToFinancingProvided" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_RelatedPartyTransactionsIncludingWithinSellingGeneralAndAdministrationExpenses" xlink:label="loc_ALRTRelatedPartyTransactionsIncludingWithinSellingGeneralAndAdministrationExpenses" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsAbstract" xlink:to="loc_ALRTRelatedPartyTransactionsIncludingWithinSellingGeneralAndAdministrationExpenses" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_ConsultingFeesToChairmanAndChiefExecutiveOfficerOfCompanyAccruedOnLineOfCreditAvailableToCompany" xlink:label="loc_ALRTConsultingFeesToChairmanAndChiefExecutiveOfficerOfCompanyAccruedOnLineOfCreditAvailableToCompany" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsAbstract" xlink:to="loc_ALRTConsultingFeesToChairmanAndChiefExecutiveOfficerOfCompanyAccruedOnLineOfCreditAvailableToCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_ConsultingFeesToDirectorOfCompanySettledWithIssuanceOfCommonStock" xlink:label="loc_ALRTConsultingFeesToDirectorOfCompanySettledWithIssuanceOfCommonStock" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsAbstract" xlink:to="loc_ALRTConsultingFeesToDirectorOfCompanySettledWithIssuanceOfCommonStock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_SalaryForServicesAsVpCorporateAndDirectorOfSingaporeSubsidiaryToSpouseOfChairmanAndChiefExecutiveOfficerOfCompany" xlink:label="loc_ALRTSalaryForServicesAsVpCorporateAndDirectorOfSingaporeSubsidiaryToSpouseOfChairmanAndChiefExecutiveOfficerOfCompany" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsAbstract" xlink:to="loc_ALRTSalaryForServicesAsVpCorporateAndDirectorOfSingaporeSubsidiaryToSpouseOfChairmanAndChiefExecutiveOfficerOfCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_LossOnSettlementOfDebtToRelativeOfChairmanAndChiefExecutiveOfficerOfCompany" xlink:label="loc_ALRTLossOnSettlementOfDebtToRelativeOfChairmanAndChiefExecutiveOfficerOfCompany" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsAbstract" xlink:to="loc_ALRTLossOnSettlementOfDebtToRelativeOfChairmanAndChiefExecutiveOfficerOfCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_RentPaidToCompanyControlledBySpouseOfChairmanAndImmediateFamilyMembers" xlink:label="loc_ALRTRentPaidToCompanyControlledBySpouseOfChairmanAndImmediateFamilyMembers" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsAbstract" xlink:to="loc_ALRTRentPaidToCompanyControlledBySpouseOfChairmanAndImmediateFamilyMembers" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://alrt.com/role/OperatingSegmentsDetails" xlink:title="00000040 - Disclosure - Operating segments (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaapSegmentReportingAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:label="loc_us-gaapScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentReportingAbstract" xlink:to="loc_us-gaapScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:label="loc_us-gaapRevenuesFromExternalCustomersAndLongLivedAssetsLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:to="loc_us-gaapRevenuesFromExternalCustomersAndLongLivedAssetsLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis" xlink:label="loc_srtStatementGeographicalAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:to="loc_srtStatementGeographicalAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srtSegmentGeographicalDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtStatementGeographicalAxis" xlink:to="loc_srtSegmentGeographicalDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="alrt-20220630.xsd#ALRT_OtherMember" xlink:label="loc_ALRTOtherMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_ALRTOtherMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_SG" xlink:label="loc_countrySG" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countrySG" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US" xlink:label="loc_countryUS" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryUS" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:to="loc_us-gaapAssets" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues" xlink:label="loc_us-gaapRevenues" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:to="loc_us-gaapRevenues" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140629362859936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover - shares<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Aug. 15, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jun. 30,  2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">000-30414<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">ALR TECHNOLOGIES INC.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001087022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">88-0225807<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">NV<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">7400 Beaufont Springs Drive<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Richmond<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">VA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">23225<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(804)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">554-3500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Non-accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">551,966,844<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 308<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140629364621792">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets (Unaudited) - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Cash', window );">Cash</a></td>
<td class="nump">$ 8,996<span></span>
</td>
<td class="nump">$ 115,922<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseCurrent', window );">Prepaid expenses</a></td>
<td class="nump">87,331<span></span>
</td>
<td class="nump">77,295<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">96,327<span></span>
</td>
<td class="nump">193,217<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent', window );">Accounts payable and accrued liabilities</a></td>
<td class="nump">1,330,196<span></span>
</td>
<td class="nump">1,130,546<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ALRT_PromissoryNotesPayableToRelatedParties', window );">Promissory notes payable to related parties</a></td>
<td class="nump">3,091,966<span></span>
</td>
<td class="nump">3,041,966<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ALRT_PromissoryNotesPayableUnrelatedLender', window );">Promissory notes payable to unrelated parties</a></td>
<td class="nump">2,457,726<span></span>
</td>
<td class="nump">2,213,368<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPayableCurrent', window );">Interest payable</a></td>
<td class="nump">4,388,068<span></span>
</td>
<td class="nump">4,110,647<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ALRT_LinesOfCreditFromRelatedParties', window );">Lines of credit from related parties</a></td>
<td class="nump">15,087,038<span></span>
</td>
<td class="nump">14,008,833<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">26,354,994<span></span>
</td>
<td class="nump">24,505,360<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders&#8217; Deficit</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred Stock, Value</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common Stock, Value</a></td>
<td class="nump">551,966<span></span>
</td>
<td class="nump">542,716<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="nump">78,103,332<span></span>
</td>
<td class="nump">77,171,627<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss&#160;&#8211; cumulative translation differences</a></td>
<td class="num">(6,273)<span></span>
</td>
<td class="num">(11,409)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(104,907,692)<span></span>
</td>
<td class="num">(102,015,077)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders&#8217; deficit</a></td>
<td class="num">(26,258,667)<span></span>
</td>
<td class="num">(24,312,143)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and stockholders&#8217; deficit</a></td>
<td class="nump">$ 96,327<span></span>
</td>
<td class="nump">$ 193,217<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ALRT_LinesOfCreditFromRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ALRT_LinesOfCreditFromRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ALRT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ALRT_PromissoryNotesPayableToRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ALRT_PromissoryNotesPayableToRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ALRT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ALRT_PromissoryNotesPayableUnrelatedLender">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ALRT_PromissoryNotesPayableUnrelatedLender</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ALRT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Cash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=118262064&amp;loc=SL116631418-115840<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section 45<br> -Paragraph 21<br> -URI https://asc.fasb.org/extlink&amp;oid=118262064&amp;loc=SL116631419-115840<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Cash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of [accrued] interest payable on all forms of debt, including trade payables, that has been incurred and is unpaid. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6387103&amp;loc=d3e6435-108320<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 05<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126905020&amp;loc=d3e5879-108316<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140629364832208">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred shares, authorized</a></td>
<td class="nump">500,000,000<span></span>
</td>
<td class="nump">500,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred shares, par value</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred shares, issued</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred shares, outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common shares, authorized</a></td>
<td class="nump">10,000,000,000<span></span>
</td>
<td class="nump">10,000,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common shares, par value</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common shares, Issued</a></td>
<td class="nump">551,966,844<span></span>
</td>
<td class="nump">542,716,344<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common shares, outstanding</a></td>
<td class="nump">551,966,844<span></span>
</td>
<td class="nump">542,716,344<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140629364622544">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Operations (Unaudited) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenue</a></td>
<td class="nump">$ 980<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 2,023<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfRevenue', window );">Cost of revenue</a></td>
<td class="num">(444)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(1,038)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross margin</a></td>
<td class="nump">536<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">985<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating Expenses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Product development costs</a></td>
<td class="nump">121,551<span></span>
</td>
<td class="nump">128,157<span></span>
</td>
<td class="nump">249,771<span></span>
</td>
<td class="nump">240,199<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfessionalFees', window );">Professional fees</a></td>
<td class="nump">352,943<span></span>
</td>
<td class="nump">138,890<span></span>
</td>
<td class="nump">524,560<span></span>
</td>
<td class="nump">356,118<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, general and administrative expenses</a></td>
<td class="nump">454,680<span></span>
</td>
<td class="nump">215,466<span></span>
</td>
<td class="nump">1,009,505<span></span>
</td>
<td class="nump">423,752<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating Loss</a></td>
<td class="nump">929,174<span></span>
</td>
<td class="nump">482,513<span></span>
</td>
<td class="nump">1,783,836<span></span>
</td>
<td class="nump">1,020,069<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Loss before other items</a></td>
<td class="num">(928,638)<span></span>
</td>
<td class="num">(482,513)<span></span>
</td>
<td class="num">(1,782,851)<span></span>
</td>
<td class="num">(1,020,069)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpenseAbstract', window );"><strong>Other Items</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="num">(559,128)<span></span>
</td>
<td class="num">(1,804,403)<span></span>
</td>
<td class="num">(1,109,764)<span></span>
</td>
<td class="num">(2,283,770)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on settlement of debt</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(33,614)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(33,614)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Total Other Items</a></td>
<td class="num">(559,128)<span></span>
</td>
<td class="num">(1,838,017)<span></span>
</td>
<td class="num">(1,109,764)<span></span>
</td>
<td class="num">(2,317,384)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Loss</a></td>
<td class="num">(1,487,766)<span></span>
</td>
<td class="num">(2,320,530)<span></span>
</td>
<td class="num">(2,892,615)<span></span>
</td>
<td class="num">(3,337,453)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxAttributableToParentAbstract', window );"><strong>Other comprehensive loss</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax', window );">Exchange difference on translating foreign operations</a></td>
<td class="nump">6,067<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">5,136<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive loss for the period</a></td>
<td class="num">$ (1,481,699)<span></span>
</td>
<td class="num">$ (2,320,530)<span></span>
</td>
<td class="num">$ (2,887,479)<span></span>
</td>
<td class="num">$ (3,337,453)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ALRT_WeightedAverageNumberOfSharesOfCommonStockOutstandingBasicAndDiluted', window );">Weighted average number of shares of common stock outstanding, basic and diluted</a></td>
<td class="nump">545,491,844<span></span>
</td>
<td class="nump">532,676,344<span></span>
</td>
<td class="nump">544,104,125<span></span>
</td>
<td class="nump">527,072,440<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ALRT_LossPerShareBasicAndDiluted', window );">Loss per share, basic and diluted</a></td>
<td class="nump">$ (0.00)<span></span>
</td>
<td class="nump">$ (0.00)<span></span>
</td>
<td class="num">$ (0.01)<span></span>
</td>
<td class="num">$ (0.01)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ALRT_LossPerShareBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ALRT_LossPerShareBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ALRT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ALRT_WeightedAverageNumberOfSharesOfCommonStockOutstandingBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ALRT_WeightedAverageNumberOfSharesOfCommonStockOutstandingBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ALRT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate cost of goods produced and sold and services rendered during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126972273&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126972273&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 18: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126941158&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of reclassification adjustment from accumulated other comprehensive income for translation gain (loss) realized upon the sale or liquidation of an investment in a foreign entity and foreign currency hedges that are designated and qualified as hedging instruments for hedges of the foreign currency exposure of a net investment in a foreign operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL34724391-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e709-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 40<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=116633155&amp;loc=d3e31531-110899<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e689-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxAttributableToParentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxAttributableToParentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfessionalFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07.2(a),(b),(c),(d))<br> -URI https://asc.fasb.org/extlink&amp;oid=120401555&amp;loc=SL114874292-224272<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 220<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (k)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433917&amp;loc=SL114874205-224268<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfessionalFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 730<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6472174&amp;loc=d3e58812-109433<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140629362884480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>OPERATING ACTIVITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net loss</a></td>
<td class="num">$ (2,892,615)<span></span>
</td>
<td class="num">$ (3,337,453)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ALRT_StockbasedCompensationproductDevelopmentCosts', window );">Stock-based compensation-product development costs</a></td>
<td class="nump">118,586<span></span>
</td>
<td class="nump">97,842<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ALRT_StockbasedCompensationgeneralSellingAndAdministration', window );">Stock-based compensation-selling, general and administrative</a></td>
<td class="nump">382,157<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ALRT_StockbasedCompensationProfessionalFees', window );">Stock-based compensation-professional fees</a></td>
<td class="nump">17,916<span></span>
</td>
<td class="nump">43,295<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ALRT_StockbasedCompensationinterest', window );">Stock-based compensation-interest</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">1,287,834<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ALRT_InterestExpenseOnLinesOfCredit', window );">Interest expense on lines of credit</a></td>
<td class="nump">777,515<span></span>
</td>
<td class="nump">670,452<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ALRT_NoncashImputedInterestExpenses', window );">Non-cash imputed interest expenses</a></td>
<td class="nump">52,271<span></span>
</td>
<td class="nump">60,059<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ALRT_BonusesSettledByIssuanceOfShares', window );">Bonuses settled by issuance of shares</a></td>
<td class="nump">245,000<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ALRT_LossOnSettlementOfDebt', window );">Loss on settlement of debt</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">33,614<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidExpense', window );">Decrease (increase) in prepaid expenses</a></td>
<td class="num">(10,036)<span></span>
</td>
<td class="nump">5,103<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities', window );">Increase in accounts payable and accrued liabilities</a></td>
<td class="nump">324,650<span></span>
</td>
<td class="nump">17,736<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInterestPayableNet', window );">Increase in interest payable</a></td>
<td class="nump">277,421<span></span>
</td>
<td class="nump">264,100<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="num">(707,135)<span></span>
</td>
<td class="num">(857,418)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>FINANCING ACTIVITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromLinesOfCredit', window );">Proceeds from lines of credit</a></td>
<td class="nump">438,165<span></span>
</td>
<td class="nump">401,758<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromConvertibleDebt', window );">Proceeds from promissory notes</a></td>
<td class="nump">294,358<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ALRT_RepaymentOfLinesOfCreditInterest', window );">Repayment of lines of credit interest</a></td>
<td class="num">(137,475)<span></span>
</td>
<td class="num">(370,723)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from sales of shares of common stock</a></td>
<td class="nump">25<span></span>
</td>
<td class="nump">1,136,832<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by financing activities</a></td>
<td class="nump">595,073<span></span>
</td>
<td class="nump">1,167,867<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Effect of foreign exchange on cash</a></td>
<td class="nump">5,136<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Change in cash</a></td>
<td class="num">(106,926)<span></span>
</td>
<td class="nump">310,449<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, beginning of period</a></td>
<td class="nump">115,922<span></span>
</td>
<td class="nump">66,190<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations', window );">Cash, end of period</a></td>
<td class="nump">$ 8,996<span></span>
</td>
<td class="nump">$ 376,639<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ALRT_BonusesSettledByIssuanceOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ALRT_BonusesSettledByIssuanceOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ALRT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ALRT_InterestExpenseOnLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ALRT_InterestExpenseOnLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ALRT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ALRT_LossOnSettlementOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ALRT_LossOnSettlementOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ALRT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ALRT_NoncashImputedInterestExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ALRT_NoncashImputedInterestExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ALRT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ALRT_RepaymentOfLinesOfCreditInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ALRT_RepaymentOfLinesOfCreditInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ALRT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ALRT_StockbasedCompensationProfessionalFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ALRT_StockbasedCompensationProfessionalFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ALRT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ALRT_StockbasedCompensationgeneralSellingAndAdministration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ALRT_StockbasedCompensationgeneralSellingAndAdministration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ALRT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ALRT_StockbasedCompensationinterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ALRT_StockbasedCompensationinterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ALRT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ALRT_StockbasedCompensationproductDevelopmentCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ALRT_StockbasedCompensationproductDevelopmentCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ALRT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInterestPayableNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in interest payable, which represents the amount owed to note holders, bond holders, and other parties for interest earned on loans or credit extended to the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInterestPayableNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1377-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from contractual arrangement with the lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140629366176320">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of presentation, nature of operations and going concern<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock', window );">Basis of presentation, nature of operations and going concern</a></td>
<td class="text"><p id="xdx_80D_eus-gaap--BusinessDescriptionAndBasisOfPresentationTextBlock_zSW4x2kpNIM3" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>1.&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span id="xdx_827_zpX6MzaLLNo3">Basis
of presentation, nature of operations and going concern</span></b></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ALR
Technologies Inc. (the &#8220;<b>Company</b>&#8221;) was incorporated under the laws of the state of Nevada on March&#160;24, 1987. On
May&#160;16, 2020, the Company incorporated a wholly owned subsidiary, ALR Technologies Sg Pte. Ltd. (&#8220;<b>ALR Singapore</b>&#8221;),
under the <i>Companies Act</i> of Singapore. On June&#160;9, 2021, the Company incorporated a wholly owned subsidiary, Canada Diabetes
Solution Centre, Inc., under the <i>Business Corporations Act </i>of Alberta.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
May 17, 2022, the Company entered into an Agreement and Plan of Merger and Reorganization (the &#8220;<b>Redomicile Merger Agreement</b>&#8221;)
with ALR Technologies SG Pte. Ltd., a Singapore company limited by shares, and its wholly-owned subsidiary, ALRT Delaware, Inc., a Delaware
corporation (&#8220;<b>ALR Delaware</b>&#8221;), relating to a proposed merger transaction for the sole purpose of changing the Company&#8217;s
jurisdiction of incorporation from Nevada to Singapore. The Redomicile Merger Agreement provides that, upon the terms and subject to
the conditions set forth therein, ALR Delaware will merge with and into the Company (the &#8220;<b>Redomicile Merger</b>&#8221;), and
the Company will be the surviving entity and a wholly-owned subsidiary of ALR Singapore. ALR Delaware will cease to exist. At the closing
of the Redomicile Merger, the stockholders of the Company will exchange their shares of common stock, and any options or warrants to
purchase shares of common stock which they might hold, on a one-for-one basis, for ordinary shares (&#8220;<b>ALR Singapore Ordinary
Shares</b>&#8221;) and options or warrants to subscribe for ALR Singapore Ordinary Shares, as applicable. This Agreement contains customary
closing conditions, including, among others, approval of the Redomicile Merger by the Company&#8217;s stockholders, the effectiveness
of the registration statement on Form F-4 filed by ALR Singapore related to the Redomicile Merger, and receipt of required regulatory
approvals.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has developed its &#8220;<b>Diabetes Solution</b>&#8221;, which is a comprehensive approach to diabetes care consisting of data
collection, predictive A1C, insulin dosage adjustment suggestions, performance tracking, remote monitoring and diabetes test supplies.
The Company is seeking commercial opportunities to deploy the Diabetes Solution and GluCurve Pet CGM.</span></p>

<p style="font: 11pt/12pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt/12pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles
in the United States of America (&#8220;<b>U.S. GAAP</b>&#8221;) in U.S. dollars and on a going concern basis, which presumes the realization
of assets and the discharge of liabilities and commitments in the normal course of operations for the foreseeable future. Several adverse
conditions cast substantial doubt on the validity of this assumption. The Company has incurred significant losses over the six-month
periods ended June&#160;30, 2022 and 2021 of $<span id="xdx_907_eus-gaap--ProfitLoss_iN_pp0p0_di_c20220101__20220630_zsqT71PrnD37" title="Net loss">2,892,615</span> and $<span id="xdx_90A_eus-gaap--ProfitLoss_iN_pp0p0_di_c20210101__20210630_zUBZpjQFoi4j" title="Net loss">3,337,453</span>, respectively. As of June&#160;30, 2022, the Company is unable
to self-finance its operations, has a working capital deficit of $<span id="xdx_908_ecustom--WorkingCapitalDeficit_c20220630_pp0p0" title="Working capital deficit">26,258,667</span> (December&#160;31, 2021&#160;- $<span id="xdx_905_ecustom--WorkingCapitalDeficit_c20211231_pp0p0" title="Working capital deficit">24,312,143</span>), accumulated
deficit of $<span id="xdx_901_eus-gaap--RetainedEarningsAccumulatedDeficit_iNI_pp0p0_di_c20220630_zoR93beFpJL1" title="Accumulated deficit">104,907,692</span> (December&#160;31, 2021&#160;- $<span id="xdx_908_eus-gaap--RetainedEarningsAccumulatedDeficit_iNI_pp0p0_di_c20211231_zuDMIrhN9v23" title="Accumulated deficit">102,015,077</span>), limited resources, no source of operating cash flow and no assurance
that sufficient funding will be available to conduct continued product development activities. If the Company is able to finance its
required product development activities, there is no assurance the Company&#8217;s current projects will be commercially viable or profitable.
The Company has debts comprised of accounts payable and accrued liabilities, interest payable, lines of credit and promissory notes payable
totaling $26,354,994 currently due, due on demand or considered delinquent. There is no assurance that the Company will not face additional
legal action from creditors regarding delinquent accounts payable, promissory notes payable and interest payable. Any one or a combination
of these above conditions could result in the failure of the business and cause the Company to cease operations.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>






















<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s ability to continue as a going concern is dependent upon the continued financial support of its creditors and its ability
to obtain financing to fund working capital and overhead requirements, fund the development of the Company&#8217;s product line, and
ultimately, the Company&#8217;s ability to achieve profitable operations and repay overdue obligations. Management has obtained short-term
financing from related parties through line of credit facilities with available borrowing in principal up to $14,300,000. As of June&#160;30,
2022, the total principal balance outstanding was $<span id="xdx_900_ecustom--PrincipalBorrowed_c20220630_pp0p0" title="Principal Borrowed">13,126,570</span>. The resolution of whether the Company is able to continue as a going concern
is dependent upon the realization of management&#8217;s plans. There can be no assurance that the Company will be able to raise any additional
debt or equity capital from the sources described above or that the lenders in the line of credit arrangements will maintain the availability
of borrowing from the line. If management is unsuccessful in obtaining short-term financing or achieving long-term profitable operations,
the Company will be required to cease operations.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
March 2020, the World Health Organization declared coronavirus, COVID-19, a global pandemic. This contagious disease outbreak, which
has continued to spread, and any related adverse public health developments, has adversely affected workforces, economies and financial
markets globally, potentially leading to an economic downturn. Management does not expect that COVID-19 will have a significant impact
on the Company; however, it could have a potential impact on the Company&#8217;s ability to raise money, market its products to attract
customers or procure equipment and parts for its glucose monitoring system.</span></p>

<p style="font: 11pt/12pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt/12pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
of the Company&#8217;s debt is either due on demand or is in default, while continuing to accrue interest at its stated rate. The Company
will seek to obtain creditors&#8217; consents to delay repayment of the outstanding promissory notes payable and related interest thereto,
until it is able to replace this financing with funds generated by operations, recapitalization with replacement debt or from equity
financings through private placements. While some of the Company&#8217;s creditors have agreed to extend repayment deadlines in the past,
there is no assurance that they will continue to do so in the future. In the past, creditors have successfully commenced legal action
against the Company to recover debts outstanding. In those instances, the Company was able to obtain financing from related parties to
cover the verdict or settlement; however, there is no assurance that the Company would be able to obtain the same financing in the future.
If the Company is unsuccessful in obtaining financing to cover any potential verdicts or settlements, the Company will be required to
cease operations.</span></p>

<p style="font: 11pt/12pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s activities will necessitate significant uses of working capital beyond 2022. Additionally, the Company&#8217;s capital
requirements will depend on many factors, including the success of the Company&#8217;s continued product development and distribution
efforts. The Company plans to continue financing its operations with the lines of credit it has available and other sources of financing.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the business description and basis of presentation concepts. Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI https://asc.fasb.org/topic&amp;trid=2122369<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -URI https://asc.fasb.org/topic&amp;trid=2122149<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -URI https://asc.fasb.org/topic&amp;trid=2134479<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140629364829024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant accounting policies<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">Significant accounting policies</a></td>
<td class="text"><p id="xdx_80C_eus-gaap--SignificantAccountingPoliciesTextBlock_zyJxA7JjDiDk" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2.&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span id="xdx_82C_zu1sAKqAVhmh">Significant
accounting policies</span></b></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
unaudited condensed consolidated financial statements include the accounts of the Company and its wholly owned subsidiary, ALR Singapore,
which was incorporated on May&#160;16, 2020 in Singapore, and Canada Diabetes Solution Centre, Inc., which was incorporated on June&#160;9,
2021 in Alberta, Canada. The Canadian subsidiary is currently inactive. All significant intercompany balances and transactions have been
eliminated on consolidation.</span></p>




















<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
unaudited condensed consolidated financial statements as of June&#160;30, 2022 and for the period then ended have been prepared pursuant
to the rules and regulations of the Securities and Exchange Commission. Certain information and note disclosures normally included in
annual consolidated financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to those rules
and regulations, although the Company believes that the disclosures made are adequate to make the information not misleading.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the opinion of management, all adjustments necessary to present fairly the financial position as of June&#160;30, 2022 and December&#160;31,
2021 and the results of operations and cash flows as of June&#160;30, 2022 and 2021, and for the periods then ended, have been made.
Those adjustments consist of normal and recurring adjustments.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
unaudited condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes
thereto included in the Annual Report on Form 10-K for the fiscal year ended December&#160;31, 2021.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
results of operations for the six months ended June&#160;30, 2022 are not necessarily indicative of the results to be expected for the
full year.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18726-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI https://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140629362825984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accounts payable and accrued liabilities<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock', window );">Accounts payable and accrued liabilities</a></td>
<td class="text"><p id="xdx_80C_eus-gaap--AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_zZ4oF8qnvL1h" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>3.&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span id="xdx_82E_zGWscJVie4F9">Accounts
payable and accrued liabilities</span></b></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
summary of the accounts payable and accrued liabilities is as follows:</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_882_eus-gaap--ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_zIAYmb31SlCl" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Accounts payable and accrued liabilities (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -6.25pt; padding-left: 6.25pt"><span id="xdx_8B3_zMgg2L6UhlIa" style="display: none">Schedule of accounts payable and accrued liabilities</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_49A_20220630_zQWFngjJz4U" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_49A_20211231_zCItUCjUFYCb" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>June 30,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2022</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2021</b></span></p></td></tr>
  <tr id="xdx_407_eus-gaap--AccountsPayableCurrent_iI_pp0p0_maAPAALzyUX_zMouvasbIQD6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; text-align: left; text-indent: -6.25pt; padding-left: 6.25pt">Accounts payable</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">1,074,813</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">806,059</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--AccruedLiabilitiesCurrent_iI_pp0p0_maAPAALzyUX_zwThB4GEHg7l" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -6.25pt; padding-left: 6.25pt">Accrued liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">255,039</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">322,087</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--DeferredRevenueCurrent_iI_pp0p0_maAPAALzyUX_z6HUqeJsjan9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: -6.25pt; padding-left: 6.25pt">Deferred revenue</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">344</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">2,400</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--AccountsPayableAndAccruedLiabilitiesCurrent_iTI_pp0p0_mtAPAALzyUX_zqkcBR7wzwS1" style="vertical-align: bottom; background-color: White">
    <td style="color: White; padding-bottom: 1pt; text-indent: -6.25pt; padding-left: 6.25pt">Accounts payable and accrued liabilities</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">1,330,196</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">1,130,546</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a),20,24)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140629367898448">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Interest, advances and promissory notes payable<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ALRT_DisclosureInterestAdvancesAndPromissoryNotesPayableAbstract', window );"><strong>Interest Advances And Promissory Notes Payable</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ALRT_InterestAdvancesAndPromissoryNotesPayableTextBlock', window );">Interest, advances and promissory notes payable</a></td>
<td class="text"><p id="xdx_800_ecustom--InterestAdvancesAndPromissoryNotesPayableTextBlock_zUYaTr9Iwxv2" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>4.
&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span id="xdx_824_z1Vnv4uahTTl">Interest, advances and promissory notes payable</span></b></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;Promissory
notes payable to related parties</span></p>

<p style="font: 11pt/12pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt/12pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
summary of activities of promissory notes payable to related parties is as follows:</span></p>

<p style="font: 11pt/12pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_89A_ecustom--SummaryOfActivitiesOfPromissoryNotesPayableTableTextBlock_z0bGHDOg43o5" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Interest, advances and promissory notes payable (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -7.6pt; padding-left: 17.05pt"><span id="xdx_8BF_zx6hRVjkN568" style="display: none">Summary of activities of promissory notes payable</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right" title="Transferred from promissory notes payable pursuant to private transaction">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: -7.6pt; padding-left: 17.05pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold">Promissory Notes Payable to Related Parties</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Carrying Value</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 70%; text-indent: -6.25pt; padding-left: 6.25pt">Balance, December&#160;31, 2020</td><td style="width: 10%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--NotesPayableRelatedPartiesClassifiedCurrent_iS_pp0p0_c20210101__20211231__us-gaap--DebtInstrumentAxis__custom--RelatedPartyMember_zhNUeKEsqmka" style="width: 18%; text-align: right" title="Carrying value at beginning">3,031,966</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: -7.6pt; padding-left: 17.05pt">Transferred from promissory notes payable pursuant to private transaction</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_980_ecustom--TransferredFromPromissoryNotesPayablePursuantToPrivateTransaction._c20210101__20211231__us-gaap--DebtInstrumentAxis__custom--RelatedPartyMember_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Transferred from promissory notes payable pursuant to private transaction">10,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -6.25pt; padding-left: 6.25pt">Balance, December&#160;31, 2021</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--NotesPayableRelatedPartiesClassifiedCurrent_iS_pp0p0_c20220101__20220630__us-gaap--DebtInstrumentAxis__custom--RelatedPartyMember_zQhzLi4n7Tvk" style="text-align: right" title="Carrying value at beginning">3,041,966</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: -7.6pt; padding-left: 17.05pt">Promissory notes received</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_987_ecustom--TransferredFromPromissoryNotesPayablePursuantToPrivateTransaction._pp0p0_c20220101__20220630__us-gaap--DebtInstrumentAxis__custom--RelatedPartyMember_zmUCm4bELTR2" style="border-bottom: Black 1pt solid; text-align: right" title="Transferred from promissory notes payable pursuant to private transaction">50,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt; text-indent: -6.25pt; padding-left: 6.25pt">Balance, June&#160;30, 2022</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_98E_eus-gaap--NotesPayableRelatedPartiesClassifiedCurrent_iE_pp0p0_c20220101__20220630__us-gaap--DebtInstrumentAxis__custom--RelatedPartyMember_zswjKOZmFJuf" style="border-bottom: Black 1pt solid; text-align: right" title="Carrying value at ending">3,091,966</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8AB_zpYstANSzQ9k" style="font: 11pt/12pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
























<p style="font: 11pt/12pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt/12pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
summary of the promissory notes payable to related parties is as follows:</span></p>

<p style="font: 11pt/12pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_89D_ecustom--ScheduleofPromissoryNotesPayableRelativesofBoardofDirectorsTableTextBlock_zTluJknl4cpc" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Interest, advances and promissory notes payable (Details 1)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -0.25in; padding-left: 0.5in"><span id="xdx_8BF_zMWtijPXKJMd" style="display: none">Schedule of activity of promissory notes payable to related parties</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_490_20220630" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_495_20211231" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold">Promissory Notes Payable to Related Parties</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>June 30,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2022</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December&#160;31, </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2021</b></span></p></td></tr>
  <tr id="xdx_40C_ecustom--PromissoryNotesPayableToRelativesOfDirectorsCollateralizedByAGeneralSecurityAgreementOnAllTheAssetsOfTheCompanyDueOnDemandAbstract_iB" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -6.25pt; padding-left: 6.25pt">Promissory notes payable to relatives of directors collateralized by a general security agreement over all the assets of the Company, past maturity:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_ecustom--NotePayablewithInterestat1PercentInterestperMonth_i01I_pp0p0_maPNRPzSkp_zCZEXHsG2SA5" style="vertical-align: bottom; background-color: White">
    <td style="width: 56%; text-indent: -0.25in; padding-left: 0.5in">i.&#160;&#160;&#160;&#160;&#160;&#160;&#160; Interest at 1% per month</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">720,619</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">720,619</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_ecustom--InterestAt1.25PerMonth_i01I_pp0p0_maPNRPzSkp_zajCDc37Ikzf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.25in; padding-left: 0.5in">ii.&#160;&#160;&#160;&#160;&#160; Interest at 1.25% per month</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">51,347</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">51,347</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_ecustom--NotePayableInterestattheUSBankPrimeRatePlus1PercentperMonth_i01I_pp0p0_maPNRPzSkp_zfFK5Ko0ayAi" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -0.25in; padding-left: 0.5in">iii.&#160;&#160;&#160; Interest at the U.S. bank prime rate plus 1%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">100,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">100,000</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_ecustom--Iv.InterestAt0.5PerMonth_i01I_pp0p0_maPNRPzSkp_zNojSE3AprF7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.25in; padding-left: 0.5in">iv.&#160;&#160;&#160;&#160; Interest at 0.5% per month</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">695,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">695,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.5in">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_ecustom--UnsecuredPromissoryNotesPayableToRelativesOfChairmanWithFixedAmountsOfInterestDueAugust312022_i01I_maPNRPzSkp_znx5gB0wWObk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Unsecured promissory notes payable to relatives of the Chairman with fixed amounts of interest due August 31, 2022</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">50,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0399">&#8212;</span>&#160;&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -6.25pt; padding-left: 6.25pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_ecustom--PromissoryNotesPayableUnsecuredtoRelativesofaDirectorBearingInterestat1PercentperMonth_i01I_pp0p0_maPNRPzSkp_zvNAesXXE3fh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: -6.25pt; padding-left: 6.25pt">Promissory notes payable, unsecured, to relatives of a director, bearing interest at 1% per month, past maturity</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">1,475,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">1,475,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_ecustom--PromissoryNotesRelatedParty_iTI_pp0p0_mtPNRPzSkp_zhyRf1a5jknj" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1pt; text-indent: -6.25pt; padding-left: 6.25pt">Total Promissory Notes Payable to Related Parties</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">3,091,966</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">3,041,966</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8A6_zszEiwL350Oj" style="font: 11pt/12pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt/12pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company received advances from relatives of the Chairman aggregating $50,000, with a fixed interest amount of $4,000, which will mature
and be repayable on August&#160;31, 2022.</span></p>

<p style="font: 11pt/12pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt/12pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
amounts past maturity continue to accrue interest at their stated rates and are considered due on demand.</span></p>

<p style="font: 11pt/12pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;Promissory
notes payable to unrelated parties</span></p>

<p style="font: 11pt/12pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt/12pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
summary of activities of promissory notes payable to unrelated parties is as follows:</span></p>

<p style="font: 11pt/12pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_89F_ecustom--ScheduleofPromissoryNotesPayableToUnrelatedPartiesTableTextBlock_zTAUjvgmfGn3" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Interest, advances and promissory notes payable (Details 2)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -7.6pt; padding-left: 17.05pt"><span id="xdx_8BD_ztKTvFkvLtyj" style="display: none">Schedule of Promissory Notes Payable to Unrelated Parties</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold">Promissory Notes Payable to Unrelated Parties</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Carrying Value</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 70%; padding-left: 5.4pt">Balance, December&#160;31, 2020</td><td style="width: 10%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--NotesPayable_iS_pp0p0_c20210101__20211231__us-gaap--DebtInstrumentAxis__custom--UnRelatedPartyMember_zwr4roHuHQZc" style="width: 18%; text-align: right" title="Balance at beginning">2,254,353</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -7.6pt; padding-left: 17.05pt">Reclassified to interest payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--IncreaseDecreaseInInterestPayableNet_c20210101__20211231__us-gaap--DebtInstrumentAxis__custom--UnRelatedPartyMember_pp0p0" style="text-align: right" title="Reclassified to interest payable">(10,985</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -7.6pt; padding-left: 17.05pt">Extinguished through issuance of shares of common stock (note&#160;6)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_ecustom--ExtinguishedThroughIssuanceOfSharesOfCommonStock_c20210101__20211231__us-gaap--DebtInstrumentAxis__custom--UnRelatedPartyMember_pp0p0" style="text-align: right" title="Extinguished through issuance of shares of common stock (note 6)">(20,000</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: -7.6pt; padding-left: 17.05pt">Transferred to promissory notes payable pursuant to private transaction</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_989_ecustom--TransferredFromPromissoryNotesPayablePursuantToPrivateTransaction._pp0p0_c20210101__20211231__us-gaap--DebtInstrumentAxis__custom--UnRelatedPartyMember_z66pY7kqzp3" style="border-bottom: Black 1pt solid; text-align: right" title="Transferred from promissory notes payable pursuant to private transaction">(10,000</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -6.25pt; padding-left: 6.25pt">Balance, December&#160;31, 2021</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--NotesPayable_iS_pp0p0_c20220101__20220630__us-gaap--DebtInstrumentAxis__custom--UnRelatedPartyMember_zw4v8aOJCWI3" style="text-align: right" title="Balance at beginning">2,213,368</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: -7.6pt; padding-left: 17.05pt">Promissory notes received</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98A_ecustom--PromissoryNoteReceived_iP3custom--TransferredFromPromissoryNotesPayablePursuantToPrivateTransaction._pp0p0_c20220101__20220630__us-gaap--DebtInstrumentAxis__custom--UnRelatedPartyMember_zxxX2DUkuGd4" style="border-bottom: Black 1pt solid; text-align: right" title="Promissory note received">244,358</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt; text-indent: -6.25pt; padding-left: 6.25pt">Balance, June&#160;30, 2022</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_987_eus-gaap--NotesPayable_iE_pp0p0_c20220101__20220630__us-gaap--DebtInstrumentAxis__custom--UnRelatedPartyMember_zItqds7dEKT" style="border-bottom: Black 1pt solid; text-align: right" title="Balance at ending">2,457,726</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8A0_zZEYFIlQGRn9" style="font: 11pt/12pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
























<p style="font: 11pt/12pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt/12pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
summary of the promissory notes payable to unrelated parties is as follows:</span></p>

<p style="font: 11pt/12pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_89A_ecustom--ScheduleofActivityofPromissoryNotestoUnrelatedPatiesTableTextBlock_z6rmCLNEuxL9" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Interest, advances and promissory notes payable (Details 3)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 0.5in; text-indent: -0.25in"><span id="xdx_8B0_zY97BBiURzFf" style="display: none">Schedule of activity of promissory notes payable to unrelated parties</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td colspan="3" id="xdx_496_20220630_zUco1HS3wWD6" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td id="xdx_496_20211231_zd759ABF6vac" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
<tr>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Promissory
    Notes Payable to Unrelated Parties</b></span></td>
    <td colspan="4" style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>June
                                            30,</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2022</b></span></p></td>
    <td colspan="3" style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December&#160;31,
    2021</b></span></td></tr>
  <tr id="xdx_404_ecustom--UnsecuredPromissoryNotesPayableToUnrelatedLendersAbstract_iB" style="vertical-align: bottom">
    <td style="padding-right: 5.4pt; padding-left: 6.25pt; text-indent: -6.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unsecured
    promissory notes payable to unrelated lenders, past maturity:</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_408_ecustom--I.InterestAt1PerMonthRepayableOnMarch312009DueOnDemand_i01I_pp0p0_maTPNPTzcOO_zEaEjMBpyNl7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 5.4pt; padding-left: 0.5in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.&#160;&#160;&#160;&#160;&#160;&#160;&#160;
    Interest at 1% per month</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td colspan="3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,317,456</span></td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,317,456</span></td></tr>
  <tr id="xdx_404_ecustom--Iii.InterestAt0.625PerMonthWith50000RepayableOnOctober5200440000RepayableOnDecember312004And60000RepayableOnJuly282006AllDueOnDemand_i01I_pp0p0_maTPNPTzcOO_z5LfbogWX5Hl" style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 0.5in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii.&#160;&#160;&#160;&#160;&#160;
    Interest at 0.667% per month </span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">425,000</span></td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">425,000</span></td></tr>
  <tr id="xdx_402_ecustom--Vi.InterestAt0.667PerMonthWith125000DueJanuary152011_i01I_pp0p0_maTPNPTzcOO_z3d511g0sYNg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 5.4pt; padding-left: 0.5in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">iii.&#160;&#160;&#160;
    Interest at 0.625% per month</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">150,000</span></td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">150,000</span></td></tr>
  <tr id="xdx_405_ecustom--Noninterestbearing_i01I_pp0p0_maTPNPTzcOO_zG27jbeoNRs8" style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 0.5in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">iv.&#160;&#160;&#160;&#160;
    Non-interest-bearing</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">270,912</span></td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">270,912</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 5.4pt; padding-left: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_404_ecustom--UnsecuredPromissoryNotesPayableToUnrelatedLendersWithFixedAmountsOfInterestDue_i01I_maTPNPTzcOO_zLP3ahPwzV3h" style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unsecured promissory notes
    payable to unrelated lenders with fixed amounts of interest due August 31, 2022</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">244,358</span></td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0451">-</span></span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 5.4pt; padding-left: 6.25pt; text-indent: -6.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_406_ecustom--PromissoryNotesPayableSecuredByGuaranteeFromChiefExecutiveOfficerBearingInterestAt1PerMonth_i01I_pp0p0_maTPNPTzcOO_zbSX8UJ9bRP2" style="vertical-align: bottom; background-color: White">
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 6.25pt; text-indent: -6.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Promissory
    notes payable, secured by a guarantee from the Chief Executive Officer, bearing interest at 1% per month, past maturity</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">50,000</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">50,000</span></td></tr>
  <tr id="xdx_40B_ecustom--TotalPromissoryNotesPayableToUnrelatedParties_i01TI_pp0p0_mtTPNPTzcOO_zdMBflbeIQUb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 6.25pt; text-indent: -6.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Total
    Promissory Notes Payable to Unrelated Parties</b></span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,457,726</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,213,368</span></td></tr>
  <tr style="background-color: White">
    <td style="width: 61%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 15%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 15%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>
<p id="xdx_8A0_zkIEwTOU9r7g" style="font: 11pt/12pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt/12pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company received advances from two shareholders aggregating SGD$340,000 ($244,358), with a fixed interest amount of $10,000, which will
mature and be repayable on August&#160;31, 2022. The principal amount of SGD$150,000 was repaid to one shareholder in July 2022.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt/12pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
amounts past maturity continue to accrue interest at their stated rates and are considered due on demand.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;Interest
payable</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
summary of the interest payable activity is as follows:</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_894_eus-gaap--InterestAndOtherIncomeTableTextBlock_zJtNkPyGnT2a" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Interest, advances and promissory notes payable (Details 4)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -7.6pt; padding-left: 17.05pt"><span id="xdx_8BB_z47PrD5aVv5f" style="display: none">Schedule of interest payable activity</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right" title="Reclassified from promissory notes payable">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold">Interest Payable</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Carrying Value</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 70%; padding-left: 5.4pt">Balance, December&#160;31, 2020</td><td style="width: 10%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--InterestPayableCurrentAndNoncurrent_iS_pp0p0_c20210101__20211231_z4V37YcUr9g" style="width: 18%; text-align: right" title="Beginning Balance">3,575,326</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -7.6pt; padding-left: 17.05pt">Reclassified from promissory notes payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_ecustom--ReclassifiedFromPromissoryNotesPayable_c20210101__20211231_pp0p0" style="text-align: right" title="Reclassified from promissory notes payable">10,985</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -7.6pt; padding-left: 17.05pt">Interest incurred on promissory notes payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_ecustom--InterestExpenseIncurredonPromissoryNotesandOtherPayables_c20210101__20211231_pp0p0" style="text-align: right" title="Interest incurred on promissory notes payable">527,336</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: -7.6pt; padding-left: 17.05pt">Interest payable retired through issuance of shares</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_981_ecustom--InterestPayableRetiredThroughIssuanceOfShares_c20210101__20211231_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Interest payable retired through issuance of shares">(3,000</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 5.4pt">Balance, December&#160;31, 2021</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--InterestPayableCurrentAndNoncurrent_iS_pp0p0_c20220101__20220630_z2CXzlH0iwCj" style="text-align: right" title="Beginning Balance">4,110,647</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: -7.6pt; padding-left: 17.05pt">Interest incurred on promissory notes payable</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_988_ecustom--InterestExpenseIncurredonPromissoryNotesandOtherPayables_c20220101__20220630_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Interest incurred on promissory notes payable">277,421</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt; padding-left: 5.4pt">Balance, June&#160;30, 2022</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_985_eus-gaap--InterestPayableCurrentAndNoncurrent_iE_pp0p0_c20220101__20220630_zhd73XLCKBj2" style="border-bottom: Black 1pt solid; text-align: right" title="Ending Balance">4,388,068</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8AD_zi6IDnsQJlR2" style="margin-top: 0; margin-bottom: 0">&#160;</p>




















<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interest
payable is due to related and non-related parties as follows:</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_896_ecustom--ScheduledOfInterestPayableDueToRelatedTableTextBlock_zorClcnrgGJj" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Interest, advances and promissory notes payable (Details 5)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: -6.25pt; padding-left: 6.25pt"><span id="xdx_8B2_zMsjrkxgS7F8" style="display: none">Schedule of Interest payable due to related and non-related parties</span></td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_49A_20220630_zUOrm8c1Q5J5" style="text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_499_20211231_zxtrdp7LXJ0l" style="text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold">Interest Payable</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>June 30,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2022</b></span></p></td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December&#160;31, 2021</td></tr>
  <tr id="xdx_403_ecustom--InterestPayableRelativesOfDirectors_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; text-align: left; text-indent: -6.25pt; padding-left: 6.25pt">Related parties</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">1,362,918</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">1,200,170</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_403_ecustom--InterestPayabletoNonrelatedParties_iI_pp0p0" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: -6.25pt; padding-left: 6.25pt">Unrelated parties</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">3,025,150</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">2,910,477</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_ecustom--InterestPayableCurrentAndNoncurrents_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="color: rgb(204,238,255); padding-bottom: 1pt; text-indent: -6.25pt; padding-left: 6.25pt">Interest payable</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">4,388,068</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">4,110,647</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8A9_zllxSpCtTLSd" style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
payment terms, security and any interest payable are based on the underlying promissory notes payable that the Company has outstanding.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;Interest
expense</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the period ended June&#160;30, 2022, the Company incurred interest expense of $<span id="xdx_903_eus-gaap--InterestExpense_c20220101__20220630_pp0p0" title="Interest expense">1,109,764</span> (2021&#160;- $<span id="xdx_901_eus-gaap--InterestExpense_c20210101__20210630_pp0p0" title="Interest expense">2,283,770</span>) as follows:</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 53.3pt"/><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#183;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$Nil
                                            (2021&#160;- $1,287,834) incurred related to the modification of options held by the Chairman
                                            and his spouse that were granted in connection with financing provided to the Company;</span></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 53.3pt"/><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#183;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$777,515
                                            (2021&#160;- $670,452) incurred on lines of credit payable as shown in note&#160;5; </span></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 53.3pt"/><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#183;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$277,421
                                            (2021&#160;- $264,100) incurred on promissory notes (notes&#160;4(a) and 4(b));</span></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 53.3pt"/><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#183;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$52,271
                                            (2021&#160;- $60,059) incurred from the calculation of imputed interest on accounts payable
                                            outstanding for longer than one year, advances payable and promissory notes payable, which
                                            had no stated interest rate; and</span></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 53.3pt"/><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#183;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$<span id="xdx_90A_eus-gaap--InterestExpenseRelatedParty_c20220101__20220630_pp0p0" title="Interest on other">2,557</span>
                                            (2021&#160;- $<span id="xdx_908_eus-gaap--InterestExpenseRelatedParty_c20210101__20210630_pp0p0" title="Interest on other">1,325</span>) interest on other items.</span></td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




















<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ALRT_DisclosureInterestAdvancesAndPromissoryNotesPayableAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ALRT_DisclosureInterestAdvancesAndPromissoryNotesPayableAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ALRT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ALRT_InterestAdvancesAndPromissoryNotesPayableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ALRT_InterestAdvancesAndPromissoryNotesPayableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ALRT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140629450117776">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Lines of credit<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ALRT_DisclosureLinesOfCreditAbstract', window );"><strong>Lines Of Credit</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ALRT_LineOfCreditTextBlock', window );">Lines of credit</a></td>
<td class="text"><p id="xdx_803_ecustom--LineOfCreditTextBlock_zJUquDrdaD5f" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>5.
&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span id="xdx_82E_zNAtBJWpzqYa">Lines of credit</span></b></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
summary of lines of credit activity is as follows:</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_89D_eus-gaap--ScheduleOfLineOfCreditFacilitiesTextBlock_zKMNFGvRVN99" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Lines of credit (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -7.6pt; padding-left: 17.05pt"><span id="xdx_8B1_zATBTdZKmVW4" style="display: none">Schedule of lines of credit activity</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right" title="Advances received on lines of credit">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold">Lines of Credit</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Total</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 70%; padding-left: 5.4pt">Balance, December&#160;31, 2020</td><td style="width: 10%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98B_eus-gaap--LongTermLineOfCredit_iS_pp0p0_c20210101__20211231_zRhtx1Ez1L94" style="width: 18%; text-align: right" title="Balance at beginning">11,914,092</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -7.6pt; padding-left: 17.05pt">Advances received on lines of credit</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--LineOfCreditFacilityPeriodicPaymentPrincipal_c20210101__20211231_pp0p0" style="text-align: right" title="Advances received on lines of credit">1,149,279</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -7.6pt; padding-left: 17.05pt">Interest incurred on lines of credit</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--LineOfCreditFacilityPeriodicPaymentInterest_c20210101__20211231_pp0p0" style="text-align: right" title="Interest incurred on lines of credit">1,402,187</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: -7.6pt; padding-left: 17.05pt">Repayment of interest on lines of credit</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_981_ecustom--RepaymentOfInterestOnLinesOfCredit_c20210101__20211231_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Repayment of interest on lines of credit">(456,725</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 5.4pt">Balance, December&#160;31, 2021</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--LongTermLineOfCredit_iS_pp0p0_c20220101__20220630_ziT29OeiKi7k" style="text-align: right" title="Balance at beginning">14,008,833</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -7.6pt; padding-left: 17.05pt">Advances received on lines of credit</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--LineOfCreditFacilityPeriodicPaymentPrincipal_c20220101__20220630_pp0p0" style="text-align: right" title="Advances received on lines of credit">438,165</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -7.6pt; padding-left: 17.05pt">Interest incurred on lines of credit</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_eus-gaap--LineOfCreditFacilityPeriodicPaymentInterest_c20220101__20220630_pp0p0" style="text-align: right" title="Interest incurred on lines of credit">777,515</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: -7.6pt; padding-left: 17.05pt">Repayment of interest on lines of credit</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_982_ecustom--RepaymentOfInterestOnLinesOfCredit_c20220101__20220630_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Repayment of interest on lines of credit">(137,475</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt; padding-left: 5.4pt">Balance, June&#160;30, 2022</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_982_eus-gaap--LongTermLineOfCredit_iE_pp0p0_c20220101__20220630_zBhbtCvA0bAh" style="border-bottom: Black 1pt solid; text-align: right" title="Balance at ending">15,087,038</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8A8_zJpnoRNamLr2" style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 10, 2021, the Company and the spouse of the Chairman entered into an amendment agreement to increase the borrowing limit on
the line of credit provided by the spouse of the Chairman to the Company from $2,000,000 to $4,000,000. The terms of amounts to be advanced
under the amendment are consistent with the line of credit. In connection with the line of credit, the Company granted the spouse of
the Chairman the option to acquire 40,000,000 shares of common stock of the Company at a price of $0.05 per share until December&#160;31,
2026 (note&#160;7).</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of June&#160;30, 2022, the Company had two lines of credit as follows:</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_89B_ecustom--ScheduledOfLineOfCreditTableTextBlock_zRahJRFE61N8" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Lines of credit (Details 1)">
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span id="xdx_8BF_zBK8AxfWWqua" style="display: none">Schedule of lines of credit</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: -2.8pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: -2.8pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: -2.8pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: -2.8pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td></tr>
<tr>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Creditor</span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 8%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interest
    Rate</span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Borrowing
    Limit</span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Repayment
    Terms</span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Principal
    Borrowed</span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accrued
    Interest</span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    Outstanding</span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Security</span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 15%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Purpose</span></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chairman
    and CEO </span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_ecustom--InterestRate_c20220101__20220630__us-gaap--LineOfCreditFacilityAxis__custom--ChairmanAndCEOMember" title="Interest Rate">1%
    per Month</span> </span></td>
    <td style="padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$
    <span id="xdx_90B_ecustom--BorrowingLimit_c20220630__us-gaap--LineOfCreditFacilityAxis__custom--ChairmanAndCEOMember_pp0p0" title="Borrowing Limit">10,300,000</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_ecustom--RepaymentTerms1_c20220101__20220630__us-gaap--LineOfCreditFacilityAxis__custom--ChairmanAndCEOMember" title="Repayment Terms">Due
    on Demand</span></span></td>
    <td style="padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$
    <span id="xdx_90F_ecustom--PrincipalBorrowed_c20220630__us-gaap--LineOfCreditFacilityAxis__custom--ChairmanAndCEOMember_pp0p0" title="Principal Borrowed">10,300,000</span></span></td>
    <td style="padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$
    <span id="xdx_90D_ecustom--AccruedInterest_c20220630__us-gaap--LineOfCreditFacilityAxis__custom--ChairmanAndCEOMember_pp0p0" title="Accrued Interest">1,763,048</span></span></td>
    <td style="padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$
    <span id="xdx_904_ecustom--TotalOutstanding_c20220630__us-gaap--LineOfCreditFacilityAxis__custom--ChairmanAndCEOMember_pp0p0" title="Total Outstanding">12,063,048</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_ecustom--Security1_c20220101__20220630__us-gaap--LineOfCreditFacilityAxis__custom--ChairmanAndCEOMember" title="Security">General
    Security over Assets</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_ecustom--Purpose1_c20220101__20220630__us-gaap--LineOfCreditFacilityAxis__custom--ChairmanAndCEOMember" title="Purpose">General
    Corporate Requirements</span></span></td></tr>
  <tr style="background-color: White">
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Wife
    of Chairman</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_ecustom--InterestRate_c20220101__20220630__us-gaap--LineOfCreditFacilityAxis__custom--WifeOfChairmanMember" title="Interest Rate">1%
    per Month</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_ecustom--BorrowingLimit_c20220630__us-gaap--LineOfCreditFacilityAxis__custom--WifeOfChairmanMember_pp0p0" title="Borrowing Limit">4,000,000</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_ecustom--RepaymentTerms1_c20220101__20220630__us-gaap--LineOfCreditFacilityAxis__custom--WifeOfChairmanMember" title="Repayment Terms">Due
    on Demand</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_ecustom--PrincipalBorrowed_c20220630__us-gaap--LineOfCreditFacilityAxis__custom--WifeOfChairmanMember_pp0p0" title="Principal Borrowed">2,826,570</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_ecustom--AccruedInterest_c20220630__us-gaap--LineOfCreditFacilityAxis__custom--WifeOfChairmanMember_pp0p0" title="Accrued Interest">197,420</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_ecustom--TotalOutstanding_c20220630__us-gaap--LineOfCreditFacilityAxis__custom--WifeOfChairmanMember_pp0p0" title="Total Outstanding">3,023,990</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_ecustom--Security1_c20220101__20220630__us-gaap--LineOfCreditFacilityAxis__custom--WifeOfChairmanMember" title="Security">General
    Security over Assets</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_ecustom--Purpose1_c20220101__20220630__us-gaap--LineOfCreditFacilityAxis__custom--WifeOfChairmanMember" title="Purpose">General
    Corporate Requirements</span></span></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$
    <span id="xdx_90C_ecustom--BorrowingLimit_c20220630_pp0p0" title="Borrowing Limit">14,300,000</span></span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$
    <span id="xdx_902_ecustom--PrincipalBorrowed_iI_pp0p0_c20220630_z2E6OXZMPoqg" title="Principal Borrowed">13,126,570</span></span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$
    <span id="xdx_902_ecustom--AccruedInterest_c20220630_pp0p0" title="Accrued Interest">1,960,468</span></span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$
    <span id="xdx_903_ecustom--TotalOutstanding_c20220630_pp0p0" title="Total Outstanding">15,087,038</span></span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>
<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December&#160;31, 2021, the Company had two lines of credit as follows:</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Creditor</span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 8%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interest
    Rate</span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Borrowing
    Limit</span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Repayment
    Terms</span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Principal
    Borrowed</span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accrued
    Interest</span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    Outstanding</span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Security</span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 15%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Purpose</span></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chairman
    and CEO </span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_ecustom--InterestRate_c20210101__20211231__us-gaap--LineOfCreditFacilityAxis__custom--ChairmanAndCEOMember" title="Interest Rate">1%
    per Month</span> </span></td>
    <td style="padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$
    <span id="xdx_908_ecustom--BorrowingLimit_c20211231__us-gaap--LineOfCreditFacilityAxis__custom--ChairmanAndCEOMember_pp0p0" title="Borrowing Limit">10,300,000</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_ecustom--RepaymentTerms1_c20210101__20211231__us-gaap--LineOfCreditFacilityAxis__custom--ChairmanAndCEOMember" title="Repayment Terms">Due
    on Demand</span></span></td>
    <td style="padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$
    <span id="xdx_900_ecustom--PrincipalBorrowed_c20211231__us-gaap--LineOfCreditFacilityAxis__custom--ChairmanAndCEOMember_pp0p0" title="Principal Borrowed">10,220,700</span></span></td>
    <td style="padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$
    <span id="xdx_900_ecustom--AccruedInterest_c20211231__us-gaap--LineOfCreditFacilityAxis__custom--ChairmanAndCEOMember_pp0p0" title="Accrued Interest">1,208,582</span></span></td>
    <td style="padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$
    <span id="xdx_907_ecustom--TotalOutstanding_c20211231__us-gaap--LineOfCreditFacilityAxis__custom--ChairmanAndCEOMember_pp0p0" title="Total Outstanding">11,429,282</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_ecustom--Security1_c20210101__20211231__us-gaap--LineOfCreditFacilityAxis__custom--ChairmanAndCEOMember" title="Security">General
    Security over Assets</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_ecustom--Purpose1_c20210101__20211231__us-gaap--LineOfCreditFacilityAxis__custom--ChairmanAndCEOMember" title="Purpose">General
    Corporate Requirements</span></span></td></tr>
  <tr style="background-color: White">
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Wife
    of Chairman</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_ecustom--InterestRate_c20210101__20211231__us-gaap--LineOfCreditFacilityAxis__custom--WifeOfChairmanMember" title="Interest Rate">1%
    per Month</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_ecustom--BorrowingLimit_c20211231__us-gaap--LineOfCreditFacilityAxis__custom--WifeOfChairmanMember_pp0p0" title="Borrowing Limit">4,000,000</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_ecustom--RepaymentTerms1_c20210101__20211231__us-gaap--LineOfCreditFacilityAxis__custom--WifeOfChairmanMember" title="Repayment Terms">Due
    on Demand</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_ecustom--PrincipalBorrowed_c20211231__us-gaap--LineOfCreditFacilityAxis__custom--WifeOfChairmanMember_pp0p0" title="Principal Borrowed">2,467,705</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_904_ecustom--AccruedInterest_c20211231__us-gaap--LineOfCreditFacilityAxis__custom--WifeOfChairmanMember_pp0p0" title="Accrued Interest">111,846</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_ecustom--TotalOutstanding_c20211231__us-gaap--LineOfCreditFacilityAxis__custom--WifeOfChairmanMember_pp0p0" title="Total Outstanding">2,579,551</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_ecustom--Security1_c20210101__20211231__us-gaap--LineOfCreditFacilityAxis__custom--WifeOfChairmanMember" title="Security">General
    Security over Assets</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_ecustom--Purpose1_c20210101__20211231__us-gaap--LineOfCreditFacilityAxis__custom--WifeOfChairmanMember" title="Purpose">General
    Corporate Requirements</span></span></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$
    <span id="xdx_90F_ecustom--BorrowingLimit_c20211231_pp0p0" title="Borrowing Limit">14,300,000</span></span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$
    <span id="xdx_90F_ecustom--PrincipalBorrowed_c20211231_pp0p0" title="Principal Borrowed">12,688,405</span></span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$<span id="xdx_90F_ecustom--AccruedInterest_c20211231_pp0p0" title="Accrued Interest">
    1,320,428</span></span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$
    <span id="xdx_900_ecustom--TotalOutstanding_c20211231_pp0p0" title="Total Outstanding">14,008,833</span></span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>
<p id="xdx_8A2_zUIZZ25eBE04" style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


















<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ALRT_DisclosureLinesOfCreditAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ALRT_DisclosureLinesOfCreditAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ALRT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ALRT_LineOfCreditTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ALRT_LineOfCreditTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ALRT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140629450117776">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Capital stock<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Capital stock</a></td>
<td class="text"><p id="xdx_80C_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_zWejA8MeCBsl" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>6.&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span id="xdx_823_z5o6392NDyMk">Capital
stock</span></b></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 18pt"/><td style="width: 17.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Authorized
                                            capital stock</span></td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify; text-indent: -0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white"><tr style="vertical-align: top">
<td style="width: 35.45pt"/><td style="width: 18.55pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">i)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common
                                            Stock</span></td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,000,000,000
shares of common stock with a par value of $0.001 per share.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white"><tr style="vertical-align: top">
<td style="width: 35.45pt"/><td style="width: 18.55pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Preferred
                                            Stock </span></td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">500,000,000
shares of preferred stock with a par value of $0.001 per share.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;Issued
capital stock</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>During
the period ended June&#160;30, 2022:</b></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white"><tr style="vertical-align: top">
<td style="width: 35.3pt"/><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">i)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
                                            January 18, 2022, the Company issued a prospectus whereby it distributed 101,025,592 subscription
                                            rights to its shareholders to purchase shares of common stock of the Company at a price of
                                            $0.05 per share. The rights were set to expire on February 18, 2022, subsequently extended
                                            to March&#160;15, 2022. On such case-by-case basis, the Company allowed for the exercise
                                            of any such shares until April&#160;1, 2022. Management may, at its discretion, allocate
                                            unexercised subscription rights to non-shareholders within 150 days (August&#160;12, 2022)
                                            following the expiration date of March&#160;15, 2022. On March&#160;21, 2022, the Company
                                            recognized share subscriptions receivable of $25 pursuant to its registration statement and
                                            issued a total of 500 shares of common stock for gross proceeds of $25. The subscription
                                            rights were cancelled on July 7, 2022 (note 11(a)).</span></td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white"><tr style="vertical-align: top">
<td style="width: 35.45pt"/><td style="width: 18.55pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            Company issued four parties an aggregate 9,250,000 shares of common stock at a fair value
                                            of $0.04 per share for a total of $370,000 in exchange for the retirement of $125,000 of
                                            accounts payable and $245,000 for bonuses issued.</span></td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




























<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>During
the year ended December&#160;31, 2021:</b></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 35.45pt"/><td style="width: 18.55pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">iii)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
                                            January 4, 2021, 1,000 shares of common stock were cancelled by a shareholder; no consideration
                                            was exchanged.</span></td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify; text-indent: -18.55pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 35.45pt"/><td style="width: 18.55pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">iv)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
                                            April 12, 2021, the Company elected to extend the initial 90-day period (April&#160;22, 2021)
                                            by an additional 100-day period related to the closing of the rights offering. The Company
                                            had until July&#160;31, 2021 to sell the remaining 113,025,592 shares of common stock. The
                                            Company further extended the offering period to October 29, 2021. The Company filed a post-effective
                                            amendment to further extend the rights offering from October 29, 2021 to March 15, 2022.
                                            On such case-by-case basis, the Company allowed for the exercise of any such shares until
                                            April&#160;1, 2022. Management may, at its discretion, allocate unexercised subscription
                                            rights to non-shareholders within 150 days (August 12, 2022) following the expiration date
                                            of March&#160;15, 2022. The subscription rights were cancelled on July 7, 2022 (note 11(a)).</span></td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify; text-indent: -18.55pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 35.45pt"/><td style="width: 18.55pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">v)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            Company collected subscriptions of $1,124,832 pursuant to its registration statement and
                                            issued a total of 26,496,635 shares of common stock for gross proceeds of $1,324,832; $200,000
                                            of the proceeds had been collected during the year ended December&#160;31, 2020 and recognized
                                            as obligation to issue shares.</span></td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify; text-indent: -18.55pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 35.45pt"/><td style="width: 18.55pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">vi)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            Company received proceeds of $12,000 pursuant to the exercise of options to acquire 800,000
                                            shares of common stock at a price of $0.015 per share.</span></td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-indent: -18.55pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 35.45pt"/><td style="width: 18.55pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">vii)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            Company entered into two shares for debt agreements with two creditors to issue an aggregate
                                            4,400,000 shares of common stock at a fair value of $0.057 per share for a purchase price
                                            of $250,800 in exchange for the retirement of $217,186 of liabilities comprised of: </span></td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 71.45pt"/><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#183;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounts
                                            payable	-	$ 194,186</span></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 71.45pt"/><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#183;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Promissory
                                            notes &#8211; Principal 	-	$ 20,000</span></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 71.45pt"/><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#183;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Line
                                            of credit &#8211; Accrued interest	-	$ 3,000</span></td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify; text-indent: 13.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company recognized loss on debt settlement of $33,614. The Company also issued commitment letters to two creditors offering them an aggregate
20,000,000 shares of common stock in exchange for the extinguishment of $1,511,377 in promissory notes and interest payable prior to
December&#160;31, 2021 (note&#160;8). These offer letters expired on December&#160;31, 2021 without the parties executing any settlements.
On March&#160;18, 2022, the Company extended the offer letters from December&#160;31, 2021 to December&#160;31, 2022 for the settlement
of $1,541,000 in promissory notes and interest payable. As of the date of these condensed consolidated financial statements, the offer
letters have not been executed.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


















<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI https://asc.fasb.org/topic&amp;trid=2208762<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496180-112644<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126731327&amp;loc=SL126733271-114008<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140629450117776">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Additional paid-in capital<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ALRT_DisclosureAdditionalPaidinCapitalAbstract', window );"><strong>Additional Paid-in Capital</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ALRT_AdditionalPaidInCapitalTextBlock', window );">Additional paid-in capital</a></td>
<td class="text"><p id="xdx_802_ecustom--AdditionalPaidInCapitalTextBlock_znlk1pU4dip9" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>7.
&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span id="xdx_823_zUDSEonENrri">Additional paid-in capital</span></b></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stock
options</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
summary of stock option activity is as follows:</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_892_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_zUoiYiGi2vq5" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Additional paid-in capital (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span id="xdx_8B1_zKthe3E0mds9" style="display: none">Schedule of share-based compensation, stock options, activity</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Six
                                            Months Ended</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>June&#160;30,
    2022</b></span></p></td>
    <td colspan="3" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Year
                                            Ended</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December&#160;31,
    2021</b></span></p></td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number
    of Options</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Weighted
    Average Exercise Price</span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number
    of Options</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Weighted
    Average Exercise Price</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 45%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding,
    beginning of period</span></td>
    <td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20220101__20220630_zV1DYlxCfDN8" style="width: 16%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Outstanding, beginning of period"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,497,001,500</span></td>
    <td style="width: 3%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20220101__20220630_zQXpNrvOIiRh" style="width: 8%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Average Exercise Price, beginning"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.006</span></td>
    <td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20210101__20211231_zAwiiG38tZ2b" style="width: 16%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Outstanding, beginning of period"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,362,701,500</span></td>
    <td style="width: 3%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20210101__20211231_zO1LKcElzOu7" style="width: 9%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Average Exercise Price, beginning"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.004</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</span></td>
    <td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_c20220101__20220630_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Granted"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0655">-</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20220101__20220630_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Granted, per share"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0657">-</span></span></td>
    <td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_c20210101__20211231_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Granted"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">165,000,000</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20210101__20211231_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Granted, per share"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.050</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercised
    </span></td>
    <td id="xdx_98C_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_di_c20220101__20220630_zrvMVZcthA6b" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercised"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0663">-</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_iN_di_c20220101__20220630_zxzdztcQw2U7" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercised per share"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0665">-</span></span></td>
    <td id="xdx_98C_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_di_c20210101__20211231_z3u32gzrfZC7" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercised"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(800,000)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_iN_di_c20210101__20211231_zi9SZEmKkBQk" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercised per share"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(0.015)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cancelled</span></td>
    <td id="xdx_980_ecustom--ShareBasedCompensationArrangementbyShareBasedPaymentAwardOptionsCancelations_iN_di_c20220101__20220630_zhCh96P9e14d" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cancelled"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(90,000,000)</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98C_ecustom--CancelledPerShares_iN_di_c20220101__20220630_zjhNUX9qAFAj" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cancelled per share"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(0.041)</span></td>
    <td id="xdx_98E_ecustom--ShareBasedCompensationArrangementbyShareBasedPaymentAwardOptionsCancelations_iN_di_c20210101__20211231_znFABDdf4dOh" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cancelled"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(29,900,000)</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98E_ecustom--CancelledPerShares_iN_di_c20210101__20211231_zFFfX3awkha1" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cancelled per share"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(0.034)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding,
    end of period</span></td>
    <td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20220101__20220630_zbKFTwrihlcl" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Outstanding, end of period"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,407,001,500</span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20220101__20220630_zc8T3dYSe4N4" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Average Exercise price, ending"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.005</span></td>
    <td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20210101__20211231_zbgPrtK7TVQf" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Outstanding, end of period"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,497,001,500</span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20210101__20211231_zgkryhDzsGA6" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Average Exercise price, ending"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.006</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercisable,
    end of period</span></td>
    <td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_c20220630_pdd" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercisable, end of period"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,223,701,500</span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_c20220630_pdd" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercisable, end of period"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.004</span></td>
    <td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_c20211231_pdd" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercisable, end of period"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,221,701,500</span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_c20211231_pdd" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercisable, end of period"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.004</span></td></tr>
  </table>
<p id="xdx_8AF_z8qgwZeEZTPb" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>During
the period ended June&#160;30, 2022:</b></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">On
March 18, 2022, the Company modified 70,000,000 options previously granted to a number of advisors and independent contractors by extending
the vesting period under vesting terms, which have not been met, from September&#160;30, 2021 and December&#160;31, 2021 to December&#160;31,
2022, and from June&#160;30, 2022 to June&#160;30, 2023.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">On
March 18, 2022, the Company amended 2,500,000 options previously granted to an individual on October&#160;4, 2021 by vesting 1,000,000
options with performance conditions and cancelling the remaining 1,500,000 options. During the period ended June&#160;30, 2022, $59,639
related to the 1,000,000 options that vested immediately was recorded.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Effective
March 18, 2022, the Company cancelled 20,000,000 stock options exercisable at $0.015, 10,000,000 stock options exercisable at $0.035
and 28,500,000 exercisable at $0.05 related to the termination of certain contractors.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">On
April 27, 2022, the Company provided termination notice to a contractor. As a result, the contractor&#8217;s 30,000,000 stock options
exercisable at $0.05 were cancelled, unvested, effective June&#160;30, 2022.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">During
the period ended June&#160;30, 2022, the Company recorded a total of $518,659 in compensation expense related to the vesting of stock
options granted in 2021, including the $59,639 from the modification of vesting terms of 1,000,000 options.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




























<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><b>During
the year ended December&#160;31, 2021:</b></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">On
January 28, 2021, the Company granted the option to acquire an aggregate 32,000,000 shares of common stock at a price of $0.05 per share
to six individuals. All of the options will vest according to performance or time-based conditions. Options to acquire 22,000,000 shares
of common stock will expire December&#160;31, 2025, and options to acquire 10,000,000 shares of common stock will expire May&#160;17,
2024. As at June&#160;30, 2022, 2,000,000 (December&#160;31, 2021&#160;- 1,000,000) options have vested to date. The fair value of the
options granted totals $1,706,244, of which $573,292 relates to stock options that have time-based vesting conditions and $1,132,952
relates to stock options that have performance vesting conditions. During the period ended June&#160;30, 2022, $98,726 (December&#160;31,
2021 - $248,189) related to stock options with time-based vesting conditions and $56,648 (December&#160;31, 2021 - $nil) related to stock
options with performance-based vesting conditions was recognized. The remaining fair value of $1,302,681 has not been recorded.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">On
February 22, 2021, the Company granted the option to acquire an aggregate 5,000,000 shares of common stock at a price of $0.05 per share.
These options were granted to three individuals and have an expiry date of May 17, 2024. None of these options have vested to date. The
fair value of the options granted totaled $225,141. During the period ended June&#160;30, 2022, $34,638 (December&#160;31, 2021 - $57,730)
related to stock options with time-based vesting conditions was recognized. The remaining fair value of $132,773 has not been recorded.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">On
April 14, 2021, the Company&#8217;s Board of Directors approved the grant of the option to acquire an aggregate 28,500,000 shares of
common stock at a price of $0.05 per share until December&#160;31, 2025 to five individuals. All of the options will vest according to
performance or time-based conditions; 200,000 options have vested to date. The fair value of the options granted totaled $1,565,812,
of which $351,621 related to stock options that have time-based vesting conditions and $1,214,191 related to stock options that have
performance vesting conditions. During the period ended June&#160;30, 2022, $54,558 (December&#160;31, 2021 - $88,540) related to the
stock options with time-based vesting conditions was recognized. The remaining fair value of $1,422,714 has not been recorded.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">On
May 12, 2021, the Company&#8217;s Board of Directors amended the option to acquire 2,000,000 shares, previously granted on January 28,
2021 to a consultant, to increase the option by 1,000,000 to provide the optionee the option to acquire an aggregate 3,000,000 shares
of common stock at a price of $0.05 per share until December&#160;31, 2025. All other terms of the January 28, 2021 grant remain the
same and the options are subject to performance vesting conditions. The fair value of the additional 1,000,000 amended options granted
totaled $54,940 was not recorded, as it cannot be determined that it is more likely than not that the performance condition will be met.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">On
May 31, 2021, the Company granted one consultant the option to acquire 5,000,000 shares of common stock of the Company at a price of
$0.05 per share until December&#160;31, 2025 subject to performance vesting conditions. The fair value of the options granted totaled
$254,708 was not recorded, as it cannot be determined that it is more likely than not that the performance condition will be met.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




























<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">On
June 27, 2021, the Company cancelled 7,400,000 stock options with an average exercise price of $0.033.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">On
June 27, 2021, the Company&#8217;s Board of Directors approved the grant of the option to acquire an aggregate 21,000,000 shares of common
stock at a price of $0.05 per share until June&#160;30, 2026 to four individuals. All of the options will vest according to performance
or time-based conditions. The fair value of the options granted totaled $1,374,208, of which $26,175 related to stock options with time-based
vesting conditions and $1,348,033 related to stock options with performance vesting conditions. During the period ended June&#160;30,
2022, $9,812 (December&#160;31, 2021 - $9,816) related to the stock options with time-based vesting conditions was recognized. The remaining
fair value of $1,354,580 has not been recorded.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">On
June&#160;30, 2021, the Company amended the option to acquire 4,365,001,300 shares of common stock granted on July&#160;1, 2016 by extending
the expiry date from July&#160;1, 2021 to April&#160;12, 2024. The options were granted in connection with lines of credit provided by
the Chairman and his spouse, which are currently outstanding (note&#160;5). All of the options had vested in previous years. The fair
value of the amendments totaled $1,287,834 and was recorded during the year ended December&#160;31, 2021 in interest expense.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Effective
July 22, 2021, the Company cancelled 22,500,000 stock options exercisable at $0.035 related to the termination of certain contractors
and advisors.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">On
August 27, 2021, the Company granted a member of the Board of Directors the option to acquire 5,000,000 shares of common stock at a price
of $0.05 per share until June&#160;30, 2026. The fair value of the options granted totaling $304,692 was fully recorded at grant.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">On
October 4, 2021, the Company granted two individuals the option to acquire an aggregate 17,500,000 options at an exercise price of $0.05
per share until September&#160;30, 2026; 15,000,000 of the options will vest according to time-based conditions and 2,500,000 will vest
according to performance conditions. </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On March 18, 2022,
the Company cancelled 1,500,000 options and vested 1,000,000 options with performance vesting conditions. <span style="background-color: white">As
at June&#160;30, 2022, 1,000,000 (December&#160;31, 2021&#160;- nil) options have vested to date. The fair value of the options granted
totaled $1,043,690, of which $894,592 related to stock options that have time-based vesting conditions and $149,098 related to stock
options that have performance vesting conditions. During the period ended June&#160;30, 2022, $204,638 (December&#160;31, 2021 - $101,758)
related to stock options with time-based vesting conditions and $59,639 (December&#160;31, 2021 - $nil) related to stock options with
performance-based vesting conditions was recognized. The remaining fair value of $677,655 has not been recorded.</span></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">On
December 10, 2021, the Company granted one creditor the option to acquire 40,000,000 shares of common stock of the Company at a price
of $0.05 per share until December&#160;31, 2026 in connection with receiving line of credit financing (note&#160;5). The fair value of
the options granted totaled $2,137,286 and was fully recorded upon the Company entering into the financing agreement with the creditor.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>






























<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">On
December 10, 2021, the Company granted one consultant the option to acquire 10,000,000 shares of common stock of the Company at a price
of $0.05 per share until December&#160;31, 2026 subject to performance vesting conditions. The fair value of the options granted totaled
$534,321 was not recorded, as it cannot be determined that it is more likely than not that the performance condition will be met.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">During
the year ended December&#160;31, 2021, the Company recorded a further $167,373 in compensation expense related to the vesting of stock
options granted in previous years.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Outstanding:</b></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The
options outstanding at June&#160;30, 2022 and December&#160;31, 2021 were as follows:</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_894_ecustom--ScheduleofOptionsOutstandingTableTextBlock_z6jbF1ydVQfd" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Additional paid-in capital (Details 1)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span id="xdx_8B7_zW1FlOVS0Zvl" style="display: none">Schedule of Options Outstanding</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="5" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>June&#160;30,
    2022</b></span></td>
    <td colspan="5" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December&#160;31,
    2021</b></span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expiry
    Date</span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Options</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercise
    Price</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intrinsic
    Value</span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Options</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercise
    Price</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intrinsic
    Value</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="width: 34%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 13%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 3%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 7%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 3%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 7%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 13%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 3%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 7%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 3%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 7%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">November
    27, 2022</span></td>
    <td id="xdx_989_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options1Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,600,000</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98F_ecustom--ExercisePrices_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options1Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.015</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_983_ecustom--IntrinsicValue_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options1Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.044</span></td>
    <td id="xdx_98D_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options1Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,600,000</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98B_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options1Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.015</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98C_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options1Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.045</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">January
    31, 2023</span></td>
    <td id="xdx_988_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options2Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">20,500,000</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_981_ecustom--ExercisePrices_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options2Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.015</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_980_ecustom--IntrinsicValue_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options2Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.044</span></td>
    <td id="xdx_98C_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options2Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">40,500,000</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98C_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options2Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.015</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98F_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options2Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.045</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">June
    13, 2023</span></td>
    <td id="xdx_984_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options3Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,000,000</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_980_ecustom--ExercisePrices_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options3Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.015</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_981_ecustom--IntrinsicValue_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options3Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.044</span></td>
    <td id="xdx_98B_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options3Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,000,000</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98D_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options3Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.015</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98E_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options3Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.045</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">March
    14, 2024</span></td>
    <td id="xdx_985_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options4Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,650,000</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_983_ecustom--ExercisePrices_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options4Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.035</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_986_ecustom--IntrinsicValue_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options4Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.024</span></td>
    <td id="xdx_98A_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options4Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,650,000</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98E_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options4Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.035</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_982_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options4Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.025</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">April
    12, 2024</span></td>
    <td id="xdx_986_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options5Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,925,001,500</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_982_ecustom--ExercisePrices_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options5Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.002</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_987_ecustom--IntrinsicValue_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options5Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.057</span></td>
    <td id="xdx_989_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options5Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,925,001,500</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98F_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options5Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.002</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_983_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options5Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.058</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">April
    12, 2024</span></td>
    <td id="xdx_987_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options6Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,350,000</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_985_ecustom--ExercisePrices_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options6Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.015</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_984_ecustom--IntrinsicValue_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options6Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.044</span></td>
    <td id="xdx_988_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options6Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,350,000</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_981_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options6Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.015</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_980_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options6Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.045</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">April
    12, 2024</span></td>
    <td id="xdx_980_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options7Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">200,000</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_984_ecustom--ExercisePrices_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options7Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.030</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_985_ecustom--IntrinsicValue_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options7Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.029</span></td>
    <td id="xdx_984_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options7Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">200,000</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_980_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options7Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.030</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_981_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options7Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.030</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">May
    6, 2024</span></td>
    <td id="xdx_981_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options8Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">13,000,000</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_987_ecustom--ExercisePrices_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options8Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.035</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98A_ecustom--IntrinsicValue_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options8Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.024</span></td>
    <td id="xdx_985_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options8Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">13,000,000</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_983_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options8Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.035</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_986_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options8Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.025</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">May
    17, 2024</span></td>
    <td id="xdx_982_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options9Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">57,000,000</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_986_ecustom--ExercisePrices_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options9Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.050</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98B_ecustom--IntrinsicValue_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options9Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.009</span></td>
    <td id="xdx_986_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options9Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">77,000,000</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_982_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options9Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.050</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_987_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options9Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.010</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">May
    17, 2024</span></td>
    <td id="xdx_98C_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options10Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">19,400,000</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98C_ecustom--ExercisePrices_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options10Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.035</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_984_ecustom--IntrinsicValue_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options10Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.024</span></td>
    <td id="xdx_988_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options10Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">19,400,000</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_988_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options10Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.035</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_989_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options10Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.025</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">June
    17, 2024</span></td>
    <td id="xdx_98D_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options11Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0854">-</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_984_ecustom--ExercisePrices_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options11Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0856">-</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_987_ecustom--IntrinsicValue_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options11Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0858">-</span></span></td>
    <td id="xdx_989_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options11Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,000,000</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98F_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options11Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.050</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98A_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options11Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.010</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">August
    16, 2024</span></td>
    <td id="xdx_983_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options12Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0866">-</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_985_ecustom--ExercisePrices_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options12Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0868">-</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_986_ecustom--IntrinsicValue_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options12Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0870">-</span></span></td>
    <td id="xdx_98E_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options12Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,500,000</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98E_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options12Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.050</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98B_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options12Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.010</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">September
    6, 2024</span></td>
    <td id="xdx_982_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options13Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0878">-</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_986_ecustom--ExercisePrices_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options13Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0880">-</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_981_ecustom--IntrinsicValue_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options13Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0882">-</span></span></td>
    <td id="xdx_98F_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options13Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,000,000</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98D_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options13Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.050</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_985_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options13Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.010</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">October
    3, 2024</span></td>
    <td id="xdx_981_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options14Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,500,000</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_987_ecustom--ExercisePrices_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options14Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.035</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_980_ecustom--IntrinsicValue_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options14Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.024</span></td>
    <td id="xdx_98C_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options14Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,500,000</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98C_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options14Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.035</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_984_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options14Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.025</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">October
    24, 2024</span></td>
    <td id="xdx_980_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options15Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,000,000</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_980_ecustom--ExercisePrices_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options15Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.035</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_983_ecustom--IntrinsicValue_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options15Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.024</span></td>
    <td id="xdx_98D_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options15Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,000,000</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_984_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options15Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.035</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_987_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options15Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.025</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December
    11, 2024</span></td>
    <td id="xdx_987_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options16Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">120,000,000</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_981_ecustom--ExercisePrices_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options16Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.015</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_982_ecustom--IntrinsicValue_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options16Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.044</span></td>
    <td id="xdx_983_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options16Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">120,000,000</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_985_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options16Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.015</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_986_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options16Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.045</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">April
    1, 2025</span></td>
    <td id="xdx_986_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options17Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,000,000</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_982_ecustom--ExercisePrices_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options17Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.035</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98D_ecustom--IntrinsicValue_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options17Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.024</span></td>
    <td id="xdx_982_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options17Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,000,000</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_986_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options17Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.035</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_981_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options17Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.025</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">May
    31, 2025</span></td>
    <td id="xdx_985_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options18Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,000,000</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_983_ecustom--ExercisePrices_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options18Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.035</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98C_ecustom--IntrinsicValue_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options18Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.024</span></td>
    <td id="xdx_981_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options18Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">20,000,000</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_987_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options18Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.035</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_980_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options18Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.025</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">May
    31, 2025</span></td>
    <td id="xdx_984_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options19Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">57,300,000</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98C_ecustom--ExercisePrices_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options19Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.050</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98F_ecustom--IntrinsicValue_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options19Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.009</span></td>
    <td id="xdx_980_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options19Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">87,300,000</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_980_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options19Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.050</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_983_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options19Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.010</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December&#160;31,
    2025</span></td>
    <td id="xdx_98D_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options20Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">56,500,000</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_984_ecustom--ExercisePrices_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options20Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.050</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_987_ecustom--IntrinsicValue_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options20Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.009</span></td>
    <td id="xdx_989_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options20Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">56,500,000</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98F_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options20Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.050</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98A_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options20Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.010</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">June&#160;30,
    2026</span></td>
    <td id="xdx_983_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options21Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">26,000,000</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_985_ecustom--ExercisePrices_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options21Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.050</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_986_ecustom--IntrinsicValue_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options21Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.009</span></td>
    <td id="xdx_98E_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options21Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">26,000,000</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98E_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options21Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.050</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98B_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options21Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.010</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">September
    30, 2026</span></td>
    <td id="xdx_982_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options22Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">16,000,000</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_986_ecustom--ExercisePrices_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options22Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.050</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_981_ecustom--IntrinsicValue_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options22Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.009</span></td>
    <td id="xdx_98F_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options22Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">17,500,000</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98D_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options22Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.050</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_985_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options22Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.010</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December&#160;31,
    2026</span></td>
    <td id="xdx_981_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options23Member_pdd" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">50,000,000</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_987_ecustom--ExercisePrices_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options23Member_pdd" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.050</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_980_ecustom--IntrinsicValue_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options23Member_pdd" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.009</span></td>
    <td id="xdx_98C_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options23Member_pdd" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">50,000,000</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98C_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options23Member_pdd" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.050</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_984_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options23Member_pdd" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.010</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td>
    <td id="xdx_980_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220630_pdd" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,407,001,500</span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_986_ecustom--ExercisePrices_c20220101__20220630_pdd" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.005</span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_989_ecustom--IntrinsicValue_c20220101__20220630_pdd" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.053</span></td>
    <td id="xdx_984_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231_pdd" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,497,001,500</span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_982_ecustom--ExercisePrices_c20210101__20211231_pdd" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.006</span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_985_ecustom--IntrinsicValue_c20210101__20211231_pdd" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.054</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Weighted
    Average Remaining Contractual Life</span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20220101__20220630_zWiLVbV9cCZ4" title="Weighted Average Remaining Contractual Life">1.87</span></span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20210101__20211231_zlPBtc7FoC4l" title="Weighted Average Remaining Contractual Life">2.37</span></span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>
<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_8AD_z30Vgv9DjIIb" style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


























<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
fair value of the stock options granted and vested was allocated as follows:</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_897_eus-gaap--ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_zAieNWJFwSL5" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Additional paid-in capital (Details 2)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -7.1pt; padding-left: 14.2pt"><span id="xdx_8BF_zkr2h51EzkZg" style="display: none">Schedule of Fair Value of Stock Options Granted-Allocation</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_49A_20220401__20220630_zqv7fsuHb40a" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_497_20210401__20210630_z53lf9cfitN5" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_49F_20220101__20220630_zkOtOGVIv4O9" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_49F_20210101__20210630_zsj8W9Hjt4Ok" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Three Months Ended</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>June&#160;30, 2022</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Three Months Ended</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>June&#160;30, 2021</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Six Months Ended</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>June&#160;30, 2022</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Six Months Ended</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>June&#160;30, 2021</b></span></p></td></tr>
  <tr id="xdx_40D_eus-gaap--InterestExpenseDebt_maTz8pZ_zawqV4y5I0T2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%; text-align: left; text-indent: -7.1pt; padding-left: 14.2pt">Interest expense</td><td style="width: 3%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1039">&#8212;</span>&#160;&#160;</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 3%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">1,287,834</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 3%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1041">&#8212;</span>&#160;&#160;</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 3%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">1,287,834</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_maTz8pZ_ztudKj64f4a1" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -7.1pt; padding-left: 14.2pt">Product development expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">56,418</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">61,697</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">118,586</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">97,842</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--ProfessionalAndContractServicesExpense_maTz8pZ_zmwPAzZlOCmb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -7.1pt; padding-left: 14.2pt">Professional expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">8,957</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">28,070</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">17,916</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">43,295</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--OtherSellingGeneralAndAdministrativeExpense_maTz8pZ_zQ9KPUtr4fm9" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: -7.1pt; padding-left: 14.2pt">Selling, general and administrative expenses</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">133,495</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1055">&#8212;</span>&#160;&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">382,157</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1057">&#8212;</span>&#160;&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -13.5pt; padding-left: 0.25in">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_ecustom--Total_iT_pp0p0_mtTz8pZ_zfGCw9vnMgVd" style="vertical-align: bottom; background-color: White">
    <td style="display: none; padding-bottom: 1pt; text-indent: -7.1pt; padding-left: 14.2pt">&#160;Fair value of the stock options granted</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">198,870</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">1,377,601</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">518,659</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">1,428,971</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8A8_zzuQzAPfNN7b" style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company uses the fair value method for determining stock-based compensation for all options granted during the fiscal periods. The fair
value was determined using the Black-Scholes option pricing model based on the following weighted average assumptions:</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_895_eus-gaap--ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_zR1Dx1NDg6Dg" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Additional paid-in capital (Details 3)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -6.25pt; padding-left: 6.25pt"><span id="xdx_8BD_zcSjjppCVuK6" style="display: none">Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-size: 12pt; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 12pt; text-align: center"><p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>June&#160;30,</b></span></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2022</b></span></p></td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">December&#160;31,</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">2021</p></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; text-align: left; text-indent: -6.25pt; padding-left: 6.25pt">Risk-free interest rate</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right"><span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_c20210101__20211231_zYqUjZP2qKDk" title="Risk-free interest rate">0.87</span></td><td style="width: 1%; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -6.25pt; padding-left: 6.25pt">Expected life</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20210101__20211231_zhNNsFBDHCw7" title="Expected life">4.8</span> years</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -6.25pt; padding-left: 6.25pt">Expected dividends</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend_pp0p0_dp_c20210101__20211231_zeoyAzkgLNxk" title="Expected dividends">0</span></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -6.25pt; padding-left: 6.25pt">Expected volatility</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp_c20210101__20211231_z8ssnjE7yBK7" title="Expected volatility">278</span></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: -6.25pt; padding-left: 6.25pt">Forfeiture rate</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageIntrinsicValue_dp_c20210101__20211231_zGhyd9Bp1Apf" title="Forfeiture rate">0</span></td><td style="padding-bottom: 1pt; text-align: left">%</td></tr>
  </table>

<p id="xdx_8AF_zL5lfXIuQ7Bc" style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">There
were no options granted during the six months ended June&#160;30, 2022. The weighted average fair value for the options granted during
the year ended December&#160;31, 2021 was </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$<span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20210101__20211231_zHfs39Bauv87" title="Weighted average fair value options granted">0.06</span><span style="background-color: white">.</span></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




















<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ALRT_AdditionalPaidInCapitalTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ALRT_AdditionalPaidInCapitalTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ALRT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ALRT_DisclosureAdditionalPaidinCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ALRT_DisclosureAdditionalPaidinCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ALRT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140629366433104">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related party transactions and balances<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsAbstract', window );"><strong>Related Party Transactions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock', window );">Related party transactions and balances</a></td>
<td class="text"><p id="xdx_800_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_zPp4n3aZk1B9" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>8.</b>&#160;&#160;&#160;&#160;&#160;&#160;&#160;<b><span id="xdx_829_zExiT1eJebji">Related
party transactions and balances</span></b></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_882_eus-gaap--ScheduleOfRelatedPartyTransactionsTableTextBlock_zfWfVwVtCy5e" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Related party transactions and balances (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -7.1pt; padding-left: 14.2pt"><span id="xdx_8BE_zR7Yvg3k2MDe" style="display: none">Schedule of related party transactions</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_491_20220401__20220630_zn6ultEjUn36" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_49B_20210401__20210630_zdsHow6FYqQb" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_492_20220101__20220630_z9fB57JuG5Mf" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_490_20210101__20210630_z0WMvSSbdky9" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Three Months Ended</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>June&#160;30, 2022</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Three Months Ended</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>June&#160;30, 2021</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Six Months Ended</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>June&#160;30, 2022</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Six Months Ended</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>June&#160;30, 2021</b></span></p></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_ecustom--RelatedPartyTransactionIncludedWithinInterestExpense_iB" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Related party transactions included within interest expense:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_ecustom--InterestExpenseOnPromissoryNotesIssuedToRelativesOfChairmanAndChiefExecutiveOfficerOfCompany_i_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%; text-align: left; text-indent: -7.1pt; padding-left: 14.2pt">Interest expenses on promissory notes issued to relatives of the Chairman and Chief Executive Officer of the Company</td><td style="width: 3%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 10%; text-align: right">83,457</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 3%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 10%; text-align: right">78,981</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 3%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 10%; text-align: right">162,749</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 3%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 10%; text-align: right">157,963</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_ecustom--InterestExpenseOnLinesOfCreditPayableToChairmanAndChiefExecutiveOfficerOfCompanyAndHisSpouse_i_pp0p0" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -7.1pt; padding-left: 14.2pt">Interest expense on lines of credit payable to the Chairman and Chief Executive Officer of the Company and his spouse</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">392,593</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">355,715</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">777,515</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">670,452</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_ecustom--InterestExpenseRelatedToModificationOfStockOptionsHeldByChairmanAndChiefExecutiveOfficerOfCompanyAndHisSpouseRelatedToFinancingProvided_zKTIh7876p1i" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: -7.1pt; padding-left: 14.2pt">Interest expense related to the modification of stock options held by the Chairman and Chief Executive Officer of the Company and his spouse related to financing provided</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1105">&#8212;</span>&#160;&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">1,287,834</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1107">&#8212;</span>&#160;&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">1,287,834</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_408_ecustom--RelatedPartyTransactionsIncludingWithinSellingGeneralAndAdministrationExpenses_iB" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Related party transactions including within selling, general and administrative expenses:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_ecustom--ConsultingFeesToChairmanAndChiefExecutiveOfficerOfCompanyAccruedOnLineOfCreditAvailableToCompany_z2C54136v8zh" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -7.1pt; padding-left: 14.2pt">Consulting fees to the Chairman and Chief Executive Officer of the Company accrued on the line of credit available to the Company</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">62,400</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">62,400</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">124,800</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">124,800</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_ecustom--ConsultingFeesToDirectorOfCompanySettledWithIssuanceOfCommonStock_ztxkHOeK1iGi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -7.1pt; padding-left: 14.2pt">Consulting fees to a director of the Company settled with issuance of common stock</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">40,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1121">&#8212;</span>&#160;&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">40,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1123">&#8212;</span>&#160;&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_ecustom--SalaryForServicesAsVpCorporateAndDirectorOfSingaporeSubsidiaryToSpouseOfChairmanAndChiefExecutiveOfficerOfCompany_i_pp0p0" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -7.1pt; padding-left: 14.2pt">Salary for services as VP Corporate and director of the Singapore subsidiary to the spouse of the Chairman and Chief Executive Officer of the Company</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10,890</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">11,254</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">21,981</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">11,254</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_ecustom--LossOnSettlementOfDebtToRelativeOfChairmanAndChiefExecutiveOfficerOfCompany_zKseanDzvHkb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -7.1pt; padding-left: 14.2pt">Loss on settlement of debt to a relative of the Chairman and Chief Executive Officer of the Company</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1130">&#8212;</span>&#160;&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">16,800</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1132">&#8212;</span>&#160;&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">16,800</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_ecustom--RentPaidToCompanyControlledBySpouseOfChairmanAndImmediateFamilyMembers_i_pp0p0" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: -7.1pt; padding-left: 14.2pt">Rent paid to a company controlled by the spouse of the Chairman and immediate family members</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">8,006</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1136">&#8212;</span>&#160;&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">20,206</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1138">&#8212;</span>&#160;&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Interest
on promissory notes payable to related parties, management compensation and compensation paid to a relative of a director have been recorded
at the exchange amount, which is the amount agreed to by the parties. </span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The
Company also issued commitment letters to two creditors who are relatives of the Chairman and Chief Executive Officer of the Company
offering them an aggregate 20,000,000 shares of common stock in exchange for the extinguishment of $1,511,377 in promissory notes and
interest payable prior to December&#160;31, 2021 (note&#160;6(b)(vii)). These offer letters expired on December&#160;31, 2021 without
the parties executing any settlements. On March 18, 2022, the Company extended the offer letters from December&#160;31, 2021 to December&#160;31,
2022 for the settlement of $1,541,000 in promissory notes and interest payable. </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of the date of these condensed consolidated financial statements, the offer letters have not been executed.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>






















<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
June 3, 2022, the Company issued an aggregate of 1,000,000 shares of common stock at a fair value of $0.04 per share for the settlement
of $40,000 for a bonus issued and recognized in consulting fees <span style="background-color: white">(note&#160;6(b)(ii))</span>.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
July 7, 2022, the Company granted the Chairman and Chief Executive Officer the option to acquire 115,500,000 shares of common stock of
the Company at a price of $0.05 per share until December&#160;31, <span style="background-color: white">2026 </span>(note 11(a)).</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -URI https://asc.fasb.org/topic&amp;trid=2122745<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39691-107864<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140629450017120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and contingencies<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and contingencies</a></td>
<td class="text"><p id="xdx_80B_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_z9RkJqzrBGYf" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>9.</b>&#160;&#160;&#160;&#160;&#160;&#160;&#160;<b><span id="xdx_828_zh4z5znECrec">Commitments
and contingencies</span></b></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 18.9pt"/><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Contingencies
                                            </span></td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 36.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has had three judgments against it relating to overdue promissory notes and accrued interest, and a fourth creditor has demanded
repayment of an overdue promissory note and accrued interest. To date, the Company has not repaid any of these promissory notes and related
accrued interest and could be subject to further action. The legal liability, totaling $1,271,981, of these promissory notes and related
accrued interest have been fully recognized and recorded by the Company. The Company has accrued interest of $291,457 related to one
of these promissory notes.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 22, 2020, a default judgment was entered against the Company in regard to one of the above noted judgments totaling $551,576,
consisting of the principal amount of $300,000 and accrued interest of $251,576, as of the date of the Civil Summons.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Commitments
                                            </span></td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">i)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management
                                            contract</span></td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has a consulting arrangement with Mr. Sidney Chan, Chief Executive Officer and Chairman of the Board of Directors of the Company.
Under the terms of the contract, Mr. Chan will be paid $240,000 per annum for services as Chief Executive Officer. The contract can be
terminated at any time with thirty days&#8217; notice and the payment of two years&#8217; annual salary. Should the contract be terminated,
all debts owed to Mr. Chan and his spouse must be immediately repaid. The initial term of the contract is for one year and automatically
renews for continuous one-year terms. Also, under the terms of the contract are the following:</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0.75in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Incentive
                                            revenue bonus</span></td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
Chan will be entitled to a 1% net sales commission from the sales of any of the Company&#8217;s products at any time during his life,
regardless if Mr. Chan is still under contract with the Company.</span></p>




























<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0.75in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sale
                                            of business</span></td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
more than 50% of the Company&#8217;s stock or assets are sold, Mr. Chan will be compensated for entering into non-compete agreements
based on the selling price of the Company or its assets as follows:</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 1in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2%
                                            of sales price up to $24,999,999 plus</span></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 1in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3%
                                            of sales price between $25,000,000 and $49,999,999 plus</span></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 1in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">iii.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4%
                                            of sales price between $50,000,000 and $199,999,999 plus</span></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 1in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">iv.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5%
                                            of sales price in excess of $200,000,000.</span></td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
August 4, 2022, ALR Singapore entered into an Employment Agreement with the Chairman and Chief Executive Officer (the &#8220;Employment
Agreement&#8221;) with an effective date of July 1, 2022 (note 11(c)).</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Manufacturing
                                            and Supply Agreement</span></td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
June&#160;28, 2022, ALR Singapore entered into a Manufacturing and Supply Agreement (the &#8220;<b>Supply Agreement</b>&#8221;) with
Infinovo Medical Co., Ltd. (&#8220;<b>Infinovo</b>&#8221;). Pursuant to the Supply Agreement, Infinovo will manufacture and supply certain
continuous glucose monitoring components necessary to the Company&#8217;s diabetes management platform for animal health, known as &#8220;<b>GluCurve</b>&#8221;.
The term of the Supply Agreement continues for three years from August&#160;1, 2022, unless earlier terminated in accordance with the
terms of the Supply Agreement. The Supply Agreement, however, will not become effective unless (i) ALR Singapore enters into a binding
distribution agreement for the sale and distribution of GluCurve by July&#160;31, 2022, and (ii) ALR Singapore and Infinovo enter into
a quality agreement by July&#160;31, 2022. There can be no assurance that the two conditions to effectiveness of the Supply Agreement
will be satisfied. If the conditions are met and the agreement becomes effective, the Supply Agreement will automatically renew for additional
one year terms unless ALR Singapore or Infinovo provides written notice of its intent to terminate the Supply Agreement. The Supply Agreement
provides for customary reasons to terminate the Supply Agreement for cause with immediate effect.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
closing conditions for the Supply Agreement between ALR Singapore and Infinovo were not met and the Supply Agreement has now terminated
(note 11(d)).</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




















<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI https://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 440<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6491277&amp;loc=d3e6429-115629<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI https://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140629450068224">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Operating segments<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">Operating segments</a></td>
<td class="text"><p id="xdx_808_eus-gaap--SegmentReportingDisclosureTextBlock_zrJlnRpXAbuj" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>10.</b>&#160;&#160;&#160;&#160;&#160;&#160;&#160;<b><span id="xdx_82D_zd8aEXD4TcMj">Operating
segments</span></b></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has one operating segment, development of diabetes hardware and software. The Company&#8217;s geographical segments are summarized
as follows:</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_898_eus-gaap--ScheduleOfSegmentReportingInformationBySegmentTextBlock_z19IF7i0tr1f" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Operating segments (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10.05pt"><span id="xdx_8B5_zSQc2FjcK0qd" style="display: none">Schedule of Operating Segments</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>June 30,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2022</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December&#160;31,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2021</b></span></p></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-left: 5.4pt">Current and Total Assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 56%; padding-left: 10.05pt">Other</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_980_eus-gaap--Assets_c20220630__srt--StatementGeographicalAxis__custom--OtherMember_pp0p0" style="width: 12%; text-align: right" title="Current and Total Assets">15,327</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_983_eus-gaap--Assets_c20211231__srt--StatementGeographicalAxis__custom--OtherMember_pp0p0" style="width: 12%; text-align: right" title="Current and Total Assets">9,547</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10.05pt">Singapore</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--Assets_c20220630__srt--StatementGeographicalAxis__country--SG_pp0p0" style="text-align: right" title="Current and Total Assets">3,777</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--Assets_c20211231__srt--StatementGeographicalAxis__country--SG_pp0p0" style="text-align: right" title="Current and Total Assets">110,527</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 10.05pt">United States</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--Assets_c20220630__srt--StatementGeographicalAxis__country--US_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Current and Total Assets">77,223</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--Assets_c20211231__srt--StatementGeographicalAxis__country--US_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Current and Total Assets">73,143</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt; text-indent: -6.25pt; padding-left: 6.25pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_988_eus-gaap--Assets_c20220630_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Current and Total Assets">96,327</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_980_eus-gaap--Assets_c20211231_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Current and Total Assets">193,217</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Six Months </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Ended June&#160;30, 2022</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Six Months </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Ended June&#160;30, 2021</b></span></p></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-indent: -6.25pt; padding-left: 6.25pt">Revenue</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10.05pt">Other</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_987_eus-gaap--Revenues_c20220101__20220630__srt--StatementGeographicalAxis__custom--OtherMember_pp0p0" style="text-align: right" title="Revenue"><span style="-sec-ix-hidden: xdx2ixbrl1191">&#8212;</span>&#160;&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--Revenues_c20210101__20210630__srt--StatementGeographicalAxis__custom--OtherMember_pp0p0" style="text-align: right" title="Revenue"><span style="-sec-ix-hidden: xdx2ixbrl1193">&#8212;</span>&#160;&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; padding-left: 10.05pt">Singapore</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--Revenues_c20220101__20220630__srt--StatementGeographicalAxis__country--SG_pp0p0" style="width: 12%; text-align: right" title="Revenue">2,023</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--Revenues_c20210101__20210630__srt--StatementGeographicalAxis__country--SG_pp0p0" style="width: 12%; text-align: right" title="Revenue"><span style="-sec-ix-hidden: xdx2ixbrl1197">&#8212;</span>&#160;&#160;</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 10.05pt">United States</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--Revenues_c20220101__20220630__srt--StatementGeographicalAxis__country--US_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Revenue"><span style="-sec-ix-hidden: xdx2ixbrl1199">&#8212;</span>&#160;&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--Revenues_c20210101__20210630__srt--StatementGeographicalAxis__country--US_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Revenue"><span style="-sec-ix-hidden: xdx2ixbrl1201">&#8212;</span>&#160;&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt; text-indent: -6.25pt; padding-left: 6.25pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_986_eus-gaap--Revenues_c20220101__20220630_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Revenue">2,023</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_98B_eus-gaap--Revenues_c20210101__20210630_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Revenue"><span style="-sec-ix-hidden: xdx2ixbrl1205">&#8212;</span>&#160;&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -6.25pt; padding-left: 6.25pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; text-indent: -6.25pt; padding-left: 6.25pt">Net Loss</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10.05pt">Other</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98D_eus-gaap--NetIncomeLoss_c20220101__20220630__srt--StatementGeographicalAxis__custom--OtherMember_pp0p0" style="text-align: right" title="Net Loss">(1,457</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98B_eus-gaap--NetIncomeLoss_c20210101__20210630__srt--StatementGeographicalAxis__custom--OtherMember_pp0p0" style="text-align: right" title="Net Loss"><span style="-sec-ix-hidden: xdx2ixbrl1209">&#8212;</span>&#160;&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10.05pt">Singapore</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--NetIncomeLoss_c20220101__20220630__srt--StatementGeographicalAxis__country--SG_pp0p0" style="text-align: right" title="Net Loss">(141,861</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--NetIncomeLoss_c20210101__20210630__srt--StatementGeographicalAxis__country--SG_pp0p0" style="text-align: right" title="Net Loss">(77,666</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 10.05pt">United States</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--NetIncomeLoss_c20220101__20220630__srt--StatementGeographicalAxis__country--US_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Net Loss">(2,749,297</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--NetIncomeLoss_c20210101__20210630__srt--StatementGeographicalAxis__country--US_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Net Loss">(3,259,787</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt; text-indent: -6.25pt; padding-left: 6.25pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_987_eus-gaap--NetIncomeLoss_c20220101__20220630_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Net Loss">(2,892,615</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_985_eus-gaap--NetIncomeLoss_c20210101__20210630_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Net Loss">(3,337,453</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  </table>

<p id="xdx_8A0_zkH6IA2PGSQg" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 34<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8981-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8721-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 26<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8844-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8657-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8721-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -URI https://asc.fasb.org/topic&amp;trid=2134510<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140629450117776">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent events<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">Subsequent events</a></td>
<td class="text"><p id="xdx_806_eus-gaap--SubsequentEventsTextBlock_zStQ919zb3lk" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>11.</b>&#160;&#160;&#160;&#160;&#160;&#160;&#160;<b><span id="xdx_828_zEfaV68VRSG">Subsequent
events</span></b></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
                                            July 7, 2022, the Company granted the Chairman and Chief Executive Officer the option to
                                            acquire 115,500,000 shares of common stock of the Company at a price of $0.05 per share until
                                            December&#160;31, <span style="background-color: white">2026. The Company canceled the </span>subscription
                                            rights to distribute 101,025,092 shares of common stock at a price of $0.05 pursuant to the
                                            prospectus (note 6(b)(i)).</span></td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt/12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
                                            July 12, 2022, ALR Singapore received advances from a relative of the Chairman aggregating
                                            SGD$500,000, with interest of $150 per day outstanding payable upon maturity or early payment,
                                            which will mature and be repayable on August&#160;31, 2022. The principal amount of SGD$500,000
                                            was repaid on July 18, 2022.</span></td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
                                            August 4, 2022, ALR Singapore entered into an Employment Agreement with the Chairman and
                                            Chief Executive Officer with an effective date of July 1, 2022 (note 9(b)(i)). The terms
                                            of the Employment Agreement were materially the same as the Services Agreement between the
                                            Company and the Chief Executive Officer, except as follows: </span></td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>






























<table cellpadding="0" cellspacing="0" style="font: 12pt/13.7pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#183;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            incentive compensation whereby Mr. Chan will earn a 1% commission from the sale of Company
                                            products has been amended to be in perpetuity and assignable. Previously, the commission
                                            was based on the lifetime of Mr. Chan, and</span></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 12pt/13.7pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#183;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
                                            Chan has relinquished his right to certain compensation on the sale of the business or assets
                                            of the Company or its affiliates. </span></td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt/13.7pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with entering into the Employment Agreement with ALR Singapore:</span></p>

<p style="font: 11pt/13.7pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt/13.7pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
                                            Chan has been issued a bonus of $150,000 as consideration for the advancements to the GluCurve
                                            business unit;</span></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 12pt/13.7pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            services agreement between the Company and Mr. Chan has terminated, and</span></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 12pt/13.7pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
                                            Chan will continue to act as Chief Executive Officer, Chief Financial Officer, Chief Accounting
                                            Officer and Treasurer of the Company.</span></td></tr></table>

<p style="font: 11pt/13.7pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt/13.7pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Employment Agreement is executed and the Services Agreement is being terminated in connection with the Redomicile Agreement.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            closing conditions for the Supply Agreement between ALR Singapore and Infinovo were not met
                                            and the Supply Agreement has now terminated. The parties are now working on completing a
                                            new agreement whereby the closing condition for ALR Singapore to enter into a binding sales
                                            and distribution agreement for the GluCurve would be August 31, 2022. Should the parties
                                            enter into a new manufacturing and supply agreement, it will not become effective unless
                                            ALR Singapore enters into a binding distribution agreement for the sale and distribution
                                            of GluCurve by August 31, 2022. There can be no assurance that the parties will enter in
                                            such new agreement or that this condition to effectiveness of the new agreement will be satisfied
                                            (note 9(b)(ii)).</span></td></tr></table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -URI https://asc.fasb.org/topic&amp;trid=2122774<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6842918&amp;loc=SL6314017-165662<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140629366217600">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accounts payable and accrued liabilities (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock', window );">Schedule of accounts payable and accrued liabilities</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_882_eus-gaap--ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_zIAYmb31SlCl" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Accounts payable and accrued liabilities (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -6.25pt; padding-left: 6.25pt"><span id="xdx_8B3_zMgg2L6UhlIa" style="display: none">Schedule of accounts payable and accrued liabilities</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_49A_20220630_zQWFngjJz4U" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_49A_20211231_zCItUCjUFYCb" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>June 30,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2022</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2021</b></span></p></td></tr>
  <tr id="xdx_407_eus-gaap--AccountsPayableCurrent_iI_pp0p0_maAPAALzyUX_zMouvasbIQD6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; text-align: left; text-indent: -6.25pt; padding-left: 6.25pt">Accounts payable</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">1,074,813</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">806,059</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--AccruedLiabilitiesCurrent_iI_pp0p0_maAPAALzyUX_zwThB4GEHg7l" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -6.25pt; padding-left: 6.25pt">Accrued liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">255,039</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">322,087</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--DeferredRevenueCurrent_iI_pp0p0_maAPAALzyUX_z6HUqeJsjan9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: -6.25pt; padding-left: 6.25pt">Deferred revenue</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">344</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">2,400</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--AccountsPayableAndAccruedLiabilitiesCurrent_iTI_pp0p0_mtAPAALzyUX_zqkcBR7wzwS1" style="vertical-align: bottom; background-color: White">
    <td style="color: White; padding-bottom: 1pt; text-indent: -6.25pt; padding-left: 6.25pt">Accounts payable and accrued liabilities</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">1,330,196</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">1,130,546</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140629363038192">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Interest, advances and promissory notes payable (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ALRT_DisclosureInterestAdvancesAndPromissoryNotesPayableAbstract', window );"><strong>Interest Advances And Promissory Notes Payable</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ALRT_SummaryOfActivitiesOfPromissoryNotesPayableTableTextBlock', window );">Summary of activities of promissory notes payable</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_89A_ecustom--SummaryOfActivitiesOfPromissoryNotesPayableTableTextBlock_z0bGHDOg43o5" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Interest, advances and promissory notes payable (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -7.6pt; padding-left: 17.05pt"><span id="xdx_8BF_zx6hRVjkN568" style="display: none">Summary of activities of promissory notes payable</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right" title="Transferred from promissory notes payable pursuant to private transaction">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: -7.6pt; padding-left: 17.05pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold">Promissory Notes Payable to Related Parties</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Carrying Value</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 70%; text-indent: -6.25pt; padding-left: 6.25pt">Balance, December&#160;31, 2020</td><td style="width: 10%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--NotesPayableRelatedPartiesClassifiedCurrent_iS_pp0p0_c20210101__20211231__us-gaap--DebtInstrumentAxis__custom--RelatedPartyMember_zhNUeKEsqmka" style="width: 18%; text-align: right" title="Carrying value at beginning">3,031,966</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: -7.6pt; padding-left: 17.05pt">Transferred from promissory notes payable pursuant to private transaction</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_980_ecustom--TransferredFromPromissoryNotesPayablePursuantToPrivateTransaction._c20210101__20211231__us-gaap--DebtInstrumentAxis__custom--RelatedPartyMember_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Transferred from promissory notes payable pursuant to private transaction">10,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -6.25pt; padding-left: 6.25pt">Balance, December&#160;31, 2021</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--NotesPayableRelatedPartiesClassifiedCurrent_iS_pp0p0_c20220101__20220630__us-gaap--DebtInstrumentAxis__custom--RelatedPartyMember_zQhzLi4n7Tvk" style="text-align: right" title="Carrying value at beginning">3,041,966</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: -7.6pt; padding-left: 17.05pt">Promissory notes received</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_987_ecustom--TransferredFromPromissoryNotesPayablePursuantToPrivateTransaction._pp0p0_c20220101__20220630__us-gaap--DebtInstrumentAxis__custom--RelatedPartyMember_zmUCm4bELTR2" style="border-bottom: Black 1pt solid; text-align: right" title="Transferred from promissory notes payable pursuant to private transaction">50,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt; text-indent: -6.25pt; padding-left: 6.25pt">Balance, June&#160;30, 2022</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_98E_eus-gaap--NotesPayableRelatedPartiesClassifiedCurrent_iE_pp0p0_c20220101__20220630__us-gaap--DebtInstrumentAxis__custom--RelatedPartyMember_zswjKOZmFJuf" style="border-bottom: Black 1pt solid; text-align: right" title="Carrying value at ending">3,091,966</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ALRT_ScheduleofPromissoryNotesPayableRelativesofBoardofDirectorsTableTextBlock', window );">Schedule of activity of promissory notes payable to related parties</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_89D_ecustom--ScheduleofPromissoryNotesPayableRelativesofBoardofDirectorsTableTextBlock_zTluJknl4cpc" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Interest, advances and promissory notes payable (Details 1)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -0.25in; padding-left: 0.5in"><span id="xdx_8BF_zMWtijPXKJMd" style="display: none">Schedule of activity of promissory notes payable to related parties</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_490_20220630" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_495_20211231" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold">Promissory Notes Payable to Related Parties</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>June 30,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2022</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December&#160;31, </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2021</b></span></p></td></tr>
  <tr id="xdx_40C_ecustom--PromissoryNotesPayableToRelativesOfDirectorsCollateralizedByAGeneralSecurityAgreementOnAllTheAssetsOfTheCompanyDueOnDemandAbstract_iB" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -6.25pt; padding-left: 6.25pt">Promissory notes payable to relatives of directors collateralized by a general security agreement over all the assets of the Company, past maturity:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_ecustom--NotePayablewithInterestat1PercentInterestperMonth_i01I_pp0p0_maPNRPzSkp_zCZEXHsG2SA5" style="vertical-align: bottom; background-color: White">
    <td style="width: 56%; text-indent: -0.25in; padding-left: 0.5in">i.&#160;&#160;&#160;&#160;&#160;&#160;&#160; Interest at 1% per month</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">720,619</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">720,619</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_ecustom--InterestAt1.25PerMonth_i01I_pp0p0_maPNRPzSkp_zajCDc37Ikzf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.25in; padding-left: 0.5in">ii.&#160;&#160;&#160;&#160;&#160; Interest at 1.25% per month</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">51,347</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">51,347</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_ecustom--NotePayableInterestattheUSBankPrimeRatePlus1PercentperMonth_i01I_pp0p0_maPNRPzSkp_zfFK5Ko0ayAi" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -0.25in; padding-left: 0.5in">iii.&#160;&#160;&#160; Interest at the U.S. bank prime rate plus 1%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">100,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">100,000</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_ecustom--Iv.InterestAt0.5PerMonth_i01I_pp0p0_maPNRPzSkp_zNojSE3AprF7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.25in; padding-left: 0.5in">iv.&#160;&#160;&#160;&#160; Interest at 0.5% per month</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">695,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">695,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.5in">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_ecustom--UnsecuredPromissoryNotesPayableToRelativesOfChairmanWithFixedAmountsOfInterestDueAugust312022_i01I_maPNRPzSkp_znx5gB0wWObk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Unsecured promissory notes payable to relatives of the Chairman with fixed amounts of interest due August 31, 2022</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">50,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0399">&#8212;</span>&#160;&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -6.25pt; padding-left: 6.25pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_ecustom--PromissoryNotesPayableUnsecuredtoRelativesofaDirectorBearingInterestat1PercentperMonth_i01I_pp0p0_maPNRPzSkp_zvNAesXXE3fh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: -6.25pt; padding-left: 6.25pt">Promissory notes payable, unsecured, to relatives of a director, bearing interest at 1% per month, past maturity</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">1,475,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">1,475,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_ecustom--PromissoryNotesRelatedParty_iTI_pp0p0_mtPNRPzSkp_zhyRf1a5jknj" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1pt; text-indent: -6.25pt; padding-left: 6.25pt">Total Promissory Notes Payable to Related Parties</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">3,091,966</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">3,041,966</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ALRT_ScheduleofPromissoryNotesPayableToUnrelatedPartiesTableTextBlock', window );">Schedule of Promissory Notes Payable to Unrelated Parties</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_89F_ecustom--ScheduleofPromissoryNotesPayableToUnrelatedPartiesTableTextBlock_zTAUjvgmfGn3" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Interest, advances and promissory notes payable (Details 2)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -7.6pt; padding-left: 17.05pt"><span id="xdx_8BD_ztKTvFkvLtyj" style="display: none">Schedule of Promissory Notes Payable to Unrelated Parties</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold">Promissory Notes Payable to Unrelated Parties</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Carrying Value</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 70%; padding-left: 5.4pt">Balance, December&#160;31, 2020</td><td style="width: 10%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--NotesPayable_iS_pp0p0_c20210101__20211231__us-gaap--DebtInstrumentAxis__custom--UnRelatedPartyMember_zwr4roHuHQZc" style="width: 18%; text-align: right" title="Balance at beginning">2,254,353</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -7.6pt; padding-left: 17.05pt">Reclassified to interest payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--IncreaseDecreaseInInterestPayableNet_c20210101__20211231__us-gaap--DebtInstrumentAxis__custom--UnRelatedPartyMember_pp0p0" style="text-align: right" title="Reclassified to interest payable">(10,985</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -7.6pt; padding-left: 17.05pt">Extinguished through issuance of shares of common stock (note&#160;6)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_ecustom--ExtinguishedThroughIssuanceOfSharesOfCommonStock_c20210101__20211231__us-gaap--DebtInstrumentAxis__custom--UnRelatedPartyMember_pp0p0" style="text-align: right" title="Extinguished through issuance of shares of common stock (note 6)">(20,000</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: -7.6pt; padding-left: 17.05pt">Transferred to promissory notes payable pursuant to private transaction</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_989_ecustom--TransferredFromPromissoryNotesPayablePursuantToPrivateTransaction._pp0p0_c20210101__20211231__us-gaap--DebtInstrumentAxis__custom--UnRelatedPartyMember_z66pY7kqzp3" style="border-bottom: Black 1pt solid; text-align: right" title="Transferred from promissory notes payable pursuant to private transaction">(10,000</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -6.25pt; padding-left: 6.25pt">Balance, December&#160;31, 2021</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--NotesPayable_iS_pp0p0_c20220101__20220630__us-gaap--DebtInstrumentAxis__custom--UnRelatedPartyMember_zw4v8aOJCWI3" style="text-align: right" title="Balance at beginning">2,213,368</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: -7.6pt; padding-left: 17.05pt">Promissory notes received</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98A_ecustom--PromissoryNoteReceived_iP3custom--TransferredFromPromissoryNotesPayablePursuantToPrivateTransaction._pp0p0_c20220101__20220630__us-gaap--DebtInstrumentAxis__custom--UnRelatedPartyMember_zxxX2DUkuGd4" style="border-bottom: Black 1pt solid; text-align: right" title="Promissory note received">244,358</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt; text-indent: -6.25pt; padding-left: 6.25pt">Balance, June&#160;30, 2022</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_987_eus-gaap--NotesPayable_iE_pp0p0_c20220101__20220630__us-gaap--DebtInstrumentAxis__custom--UnRelatedPartyMember_zItqds7dEKT" style="border-bottom: Black 1pt solid; text-align: right" title="Balance at ending">2,457,726</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ALRT_ScheduleofActivityofPromissoryNotestoUnrelatedPatiesTableTextBlock', window );">Schedule of activity of promissory notes payable to unrelated parties</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_89A_ecustom--ScheduleofActivityofPromissoryNotestoUnrelatedPatiesTableTextBlock_z6rmCLNEuxL9" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Interest, advances and promissory notes payable (Details 3)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 0.5in; text-indent: -0.25in"><span id="xdx_8B0_zY97BBiURzFf" style="display: none">Schedule of activity of promissory notes payable to unrelated parties</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td colspan="3" id="xdx_496_20220630_zUco1HS3wWD6" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td id="xdx_496_20211231_zd759ABF6vac" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
<tr>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Promissory
    Notes Payable to Unrelated Parties</b></span></td>
    <td colspan="4" style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>June
                                            30,</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2022</b></span></p></td>
    <td colspan="3" style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December&#160;31,
    2021</b></span></td></tr>
  <tr id="xdx_404_ecustom--UnsecuredPromissoryNotesPayableToUnrelatedLendersAbstract_iB" style="vertical-align: bottom">
    <td style="padding-right: 5.4pt; padding-left: 6.25pt; text-indent: -6.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unsecured
    promissory notes payable to unrelated lenders, past maturity:</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_408_ecustom--I.InterestAt1PerMonthRepayableOnMarch312009DueOnDemand_i01I_pp0p0_maTPNPTzcOO_zEaEjMBpyNl7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 5.4pt; padding-left: 0.5in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.&#160;&#160;&#160;&#160;&#160;&#160;&#160;
    Interest at 1% per month</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td colspan="3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,317,456</span></td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,317,456</span></td></tr>
  <tr id="xdx_404_ecustom--Iii.InterestAt0.625PerMonthWith50000RepayableOnOctober5200440000RepayableOnDecember312004And60000RepayableOnJuly282006AllDueOnDemand_i01I_pp0p0_maTPNPTzcOO_z5LfbogWX5Hl" style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 0.5in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii.&#160;&#160;&#160;&#160;&#160;
    Interest at 0.667% per month </span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">425,000</span></td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">425,000</span></td></tr>
  <tr id="xdx_402_ecustom--Vi.InterestAt0.667PerMonthWith125000DueJanuary152011_i01I_pp0p0_maTPNPTzcOO_z3d511g0sYNg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 5.4pt; padding-left: 0.5in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">iii.&#160;&#160;&#160;
    Interest at 0.625% per month</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">150,000</span></td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">150,000</span></td></tr>
  <tr id="xdx_405_ecustom--Noninterestbearing_i01I_pp0p0_maTPNPTzcOO_zG27jbeoNRs8" style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 0.5in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">iv.&#160;&#160;&#160;&#160;
    Non-interest-bearing</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">270,912</span></td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">270,912</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 5.4pt; padding-left: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_404_ecustom--UnsecuredPromissoryNotesPayableToUnrelatedLendersWithFixedAmountsOfInterestDue_i01I_maTPNPTzcOO_zLP3ahPwzV3h" style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unsecured promissory notes
    payable to unrelated lenders with fixed amounts of interest due August 31, 2022</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">244,358</span></td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0451">-</span></span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 5.4pt; padding-left: 6.25pt; text-indent: -6.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_406_ecustom--PromissoryNotesPayableSecuredByGuaranteeFromChiefExecutiveOfficerBearingInterestAt1PerMonth_i01I_pp0p0_maTPNPTzcOO_zbSX8UJ9bRP2" style="vertical-align: bottom; background-color: White">
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 6.25pt; text-indent: -6.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Promissory
    notes payable, secured by a guarantee from the Chief Executive Officer, bearing interest at 1% per month, past maturity</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">50,000</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">50,000</span></td></tr>
  <tr id="xdx_40B_ecustom--TotalPromissoryNotesPayableToUnrelatedParties_i01TI_pp0p0_mtTPNPTzcOO_zdMBflbeIQUb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 6.25pt; text-indent: -6.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Total
    Promissory Notes Payable to Unrelated Parties</b></span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,457,726</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,213,368</span></td></tr>
  <tr style="background-color: White">
    <td style="width: 61%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 15%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 15%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>
<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestAndOtherIncomeTableTextBlock', window );">Schedule of interest payable activity</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_894_eus-gaap--InterestAndOtherIncomeTableTextBlock_zJtNkPyGnT2a" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Interest, advances and promissory notes payable (Details 4)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -7.6pt; padding-left: 17.05pt"><span id="xdx_8BB_z47PrD5aVv5f" style="display: none">Schedule of interest payable activity</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right" title="Reclassified from promissory notes payable">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold">Interest Payable</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Carrying Value</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 70%; padding-left: 5.4pt">Balance, December&#160;31, 2020</td><td style="width: 10%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--InterestPayableCurrentAndNoncurrent_iS_pp0p0_c20210101__20211231_z4V37YcUr9g" style="width: 18%; text-align: right" title="Beginning Balance">3,575,326</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -7.6pt; padding-left: 17.05pt">Reclassified from promissory notes payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_ecustom--ReclassifiedFromPromissoryNotesPayable_c20210101__20211231_pp0p0" style="text-align: right" title="Reclassified from promissory notes payable">10,985</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -7.6pt; padding-left: 17.05pt">Interest incurred on promissory notes payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_ecustom--InterestExpenseIncurredonPromissoryNotesandOtherPayables_c20210101__20211231_pp0p0" style="text-align: right" title="Interest incurred on promissory notes payable">527,336</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: -7.6pt; padding-left: 17.05pt">Interest payable retired through issuance of shares</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_981_ecustom--InterestPayableRetiredThroughIssuanceOfShares_c20210101__20211231_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Interest payable retired through issuance of shares">(3,000</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 5.4pt">Balance, December&#160;31, 2021</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--InterestPayableCurrentAndNoncurrent_iS_pp0p0_c20220101__20220630_z2CXzlH0iwCj" style="text-align: right" title="Beginning Balance">4,110,647</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: -7.6pt; padding-left: 17.05pt">Interest incurred on promissory notes payable</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_988_ecustom--InterestExpenseIncurredonPromissoryNotesandOtherPayables_c20220101__20220630_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Interest incurred on promissory notes payable">277,421</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt; padding-left: 5.4pt">Balance, June&#160;30, 2022</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_985_eus-gaap--InterestPayableCurrentAndNoncurrent_iE_pp0p0_c20220101__20220630_zhd73XLCKBj2" style="border-bottom: Black 1pt solid; text-align: right" title="Ending Balance">4,388,068</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ALRT_ScheduledOfInterestPayableDueToRelatedTableTextBlock', window );">Schedule of Interest payable due to related and non-related parties</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_896_ecustom--ScheduledOfInterestPayableDueToRelatedTableTextBlock_zorClcnrgGJj" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Interest, advances and promissory notes payable (Details 5)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: -6.25pt; padding-left: 6.25pt"><span id="xdx_8B2_zMsjrkxgS7F8" style="display: none">Schedule of Interest payable due to related and non-related parties</span></td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_49A_20220630_zUOrm8c1Q5J5" style="text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_499_20211231_zxtrdp7LXJ0l" style="text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold">Interest Payable</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>June 30,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2022</b></span></p></td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December&#160;31, 2021</td></tr>
  <tr id="xdx_403_ecustom--InterestPayableRelativesOfDirectors_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; text-align: left; text-indent: -6.25pt; padding-left: 6.25pt">Related parties</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">1,362,918</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">1,200,170</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_403_ecustom--InterestPayabletoNonrelatedParties_iI_pp0p0" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: -6.25pt; padding-left: 6.25pt">Unrelated parties</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">3,025,150</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">2,910,477</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_ecustom--InterestPayableCurrentAndNoncurrents_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="color: rgb(204,238,255); padding-bottom: 1pt; text-indent: -6.25pt; padding-left: 6.25pt">Interest payable</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">4,388,068</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">4,110,647</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ALRT_DisclosureInterestAdvancesAndPromissoryNotesPayableAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ALRT_DisclosureInterestAdvancesAndPromissoryNotesPayableAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ALRT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ALRT_ScheduledOfInterestPayableDueToRelatedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ALRT_ScheduledOfInterestPayableDueToRelatedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ALRT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ALRT_ScheduleofActivityofPromissoryNotestoUnrelatedPatiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ALRT_ScheduleofActivityofPromissoryNotestoUnrelatedPatiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ALRT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ALRT_ScheduleofPromissoryNotesPayableRelativesofBoardofDirectorsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ALRT_ScheduleofPromissoryNotesPayableRelativesofBoardofDirectorsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ALRT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ALRT_ScheduleofPromissoryNotesPayableToUnrelatedPartiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ALRT_ScheduleofPromissoryNotesPayableToUnrelatedPartiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ALRT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ALRT_SummaryOfActivitiesOfPromissoryNotesPayableTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ALRT_SummaryOfActivitiesOfPromissoryNotesPayableTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ALRT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestAndOtherIncomeTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of interest income and income classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestAndOtherIncomeTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140629367575696">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Lines of credit (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ALRT_DisclosureLinesOfCreditAbstract', window );"><strong>Lines Of Credit</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock', window );">Schedule of lines of credit activity</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_89D_eus-gaap--ScheduleOfLineOfCreditFacilitiesTextBlock_zKMNFGvRVN99" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Lines of credit (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -7.6pt; padding-left: 17.05pt"><span id="xdx_8B1_zATBTdZKmVW4" style="display: none">Schedule of lines of credit activity</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right" title="Advances received on lines of credit">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold">Lines of Credit</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Total</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 70%; padding-left: 5.4pt">Balance, December&#160;31, 2020</td><td style="width: 10%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98B_eus-gaap--LongTermLineOfCredit_iS_pp0p0_c20210101__20211231_zRhtx1Ez1L94" style="width: 18%; text-align: right" title="Balance at beginning">11,914,092</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -7.6pt; padding-left: 17.05pt">Advances received on lines of credit</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--LineOfCreditFacilityPeriodicPaymentPrincipal_c20210101__20211231_pp0p0" style="text-align: right" title="Advances received on lines of credit">1,149,279</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -7.6pt; padding-left: 17.05pt">Interest incurred on lines of credit</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--LineOfCreditFacilityPeriodicPaymentInterest_c20210101__20211231_pp0p0" style="text-align: right" title="Interest incurred on lines of credit">1,402,187</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: -7.6pt; padding-left: 17.05pt">Repayment of interest on lines of credit</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_981_ecustom--RepaymentOfInterestOnLinesOfCredit_c20210101__20211231_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Repayment of interest on lines of credit">(456,725</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 5.4pt">Balance, December&#160;31, 2021</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--LongTermLineOfCredit_iS_pp0p0_c20220101__20220630_ziT29OeiKi7k" style="text-align: right" title="Balance at beginning">14,008,833</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -7.6pt; padding-left: 17.05pt">Advances received on lines of credit</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--LineOfCreditFacilityPeriodicPaymentPrincipal_c20220101__20220630_pp0p0" style="text-align: right" title="Advances received on lines of credit">438,165</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -7.6pt; padding-left: 17.05pt">Interest incurred on lines of credit</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_eus-gaap--LineOfCreditFacilityPeriodicPaymentInterest_c20220101__20220630_pp0p0" style="text-align: right" title="Interest incurred on lines of credit">777,515</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: -7.6pt; padding-left: 17.05pt">Repayment of interest on lines of credit</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_982_ecustom--RepaymentOfInterestOnLinesOfCredit_c20220101__20220630_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Repayment of interest on lines of credit">(137,475</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt; padding-left: 5.4pt">Balance, June&#160;30, 2022</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_982_eus-gaap--LongTermLineOfCredit_iE_pp0p0_c20220101__20220630_zBhbtCvA0bAh" style="border-bottom: Black 1pt solid; text-align: right" title="Balance at ending">15,087,038</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ALRT_ScheduledOfLineOfCreditTableTextBlock', window );">Schedule of lines of credit</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_89B_ecustom--ScheduledOfLineOfCreditTableTextBlock_zRahJRFE61N8" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Lines of credit (Details 1)">
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span id="xdx_8BF_zBK8AxfWWqua" style="display: none">Schedule of lines of credit</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: -2.8pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: -2.8pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: -2.8pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: -2.8pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td></tr>
<tr>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Creditor</span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 8%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interest
    Rate</span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Borrowing
    Limit</span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Repayment
    Terms</span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Principal
    Borrowed</span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accrued
    Interest</span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    Outstanding</span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Security</span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 15%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Purpose</span></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chairman
    and CEO </span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_ecustom--InterestRate_c20220101__20220630__us-gaap--LineOfCreditFacilityAxis__custom--ChairmanAndCEOMember" title="Interest Rate">1%
    per Month</span> </span></td>
    <td style="padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$
    <span id="xdx_90B_ecustom--BorrowingLimit_c20220630__us-gaap--LineOfCreditFacilityAxis__custom--ChairmanAndCEOMember_pp0p0" title="Borrowing Limit">10,300,000</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_ecustom--RepaymentTerms1_c20220101__20220630__us-gaap--LineOfCreditFacilityAxis__custom--ChairmanAndCEOMember" title="Repayment Terms">Due
    on Demand</span></span></td>
    <td style="padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$
    <span id="xdx_90F_ecustom--PrincipalBorrowed_c20220630__us-gaap--LineOfCreditFacilityAxis__custom--ChairmanAndCEOMember_pp0p0" title="Principal Borrowed">10,300,000</span></span></td>
    <td style="padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$
    <span id="xdx_90D_ecustom--AccruedInterest_c20220630__us-gaap--LineOfCreditFacilityAxis__custom--ChairmanAndCEOMember_pp0p0" title="Accrued Interest">1,763,048</span></span></td>
    <td style="padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$
    <span id="xdx_904_ecustom--TotalOutstanding_c20220630__us-gaap--LineOfCreditFacilityAxis__custom--ChairmanAndCEOMember_pp0p0" title="Total Outstanding">12,063,048</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_ecustom--Security1_c20220101__20220630__us-gaap--LineOfCreditFacilityAxis__custom--ChairmanAndCEOMember" title="Security">General
    Security over Assets</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_ecustom--Purpose1_c20220101__20220630__us-gaap--LineOfCreditFacilityAxis__custom--ChairmanAndCEOMember" title="Purpose">General
    Corporate Requirements</span></span></td></tr>
  <tr style="background-color: White">
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Wife
    of Chairman</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_ecustom--InterestRate_c20220101__20220630__us-gaap--LineOfCreditFacilityAxis__custom--WifeOfChairmanMember" title="Interest Rate">1%
    per Month</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_ecustom--BorrowingLimit_c20220630__us-gaap--LineOfCreditFacilityAxis__custom--WifeOfChairmanMember_pp0p0" title="Borrowing Limit">4,000,000</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_ecustom--RepaymentTerms1_c20220101__20220630__us-gaap--LineOfCreditFacilityAxis__custom--WifeOfChairmanMember" title="Repayment Terms">Due
    on Demand</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_ecustom--PrincipalBorrowed_c20220630__us-gaap--LineOfCreditFacilityAxis__custom--WifeOfChairmanMember_pp0p0" title="Principal Borrowed">2,826,570</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_ecustom--AccruedInterest_c20220630__us-gaap--LineOfCreditFacilityAxis__custom--WifeOfChairmanMember_pp0p0" title="Accrued Interest">197,420</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_ecustom--TotalOutstanding_c20220630__us-gaap--LineOfCreditFacilityAxis__custom--WifeOfChairmanMember_pp0p0" title="Total Outstanding">3,023,990</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_ecustom--Security1_c20220101__20220630__us-gaap--LineOfCreditFacilityAxis__custom--WifeOfChairmanMember" title="Security">General
    Security over Assets</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_ecustom--Purpose1_c20220101__20220630__us-gaap--LineOfCreditFacilityAxis__custom--WifeOfChairmanMember" title="Purpose">General
    Corporate Requirements</span></span></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$
    <span id="xdx_90C_ecustom--BorrowingLimit_c20220630_pp0p0" title="Borrowing Limit">14,300,000</span></span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$
    <span id="xdx_902_ecustom--PrincipalBorrowed_iI_pp0p0_c20220630_z2E6OXZMPoqg" title="Principal Borrowed">13,126,570</span></span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$
    <span id="xdx_902_ecustom--AccruedInterest_c20220630_pp0p0" title="Accrued Interest">1,960,468</span></span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$
    <span id="xdx_903_ecustom--TotalOutstanding_c20220630_pp0p0" title="Total Outstanding">15,087,038</span></span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>
<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December&#160;31, 2021, the Company had two lines of credit as follows:</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Creditor</span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 8%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interest
    Rate</span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Borrowing
    Limit</span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Repayment
    Terms</span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Principal
    Borrowed</span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accrued
    Interest</span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    Outstanding</span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Security</span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 15%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Purpose</span></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chairman
    and CEO </span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_ecustom--InterestRate_c20210101__20211231__us-gaap--LineOfCreditFacilityAxis__custom--ChairmanAndCEOMember" title="Interest Rate">1%
    per Month</span> </span></td>
    <td style="padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$
    <span id="xdx_908_ecustom--BorrowingLimit_c20211231__us-gaap--LineOfCreditFacilityAxis__custom--ChairmanAndCEOMember_pp0p0" title="Borrowing Limit">10,300,000</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_ecustom--RepaymentTerms1_c20210101__20211231__us-gaap--LineOfCreditFacilityAxis__custom--ChairmanAndCEOMember" title="Repayment Terms">Due
    on Demand</span></span></td>
    <td style="padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$
    <span id="xdx_900_ecustom--PrincipalBorrowed_c20211231__us-gaap--LineOfCreditFacilityAxis__custom--ChairmanAndCEOMember_pp0p0" title="Principal Borrowed">10,220,700</span></span></td>
    <td style="padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$
    <span id="xdx_900_ecustom--AccruedInterest_c20211231__us-gaap--LineOfCreditFacilityAxis__custom--ChairmanAndCEOMember_pp0p0" title="Accrued Interest">1,208,582</span></span></td>
    <td style="padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$
    <span id="xdx_907_ecustom--TotalOutstanding_c20211231__us-gaap--LineOfCreditFacilityAxis__custom--ChairmanAndCEOMember_pp0p0" title="Total Outstanding">11,429,282</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_ecustom--Security1_c20210101__20211231__us-gaap--LineOfCreditFacilityAxis__custom--ChairmanAndCEOMember" title="Security">General
    Security over Assets</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_ecustom--Purpose1_c20210101__20211231__us-gaap--LineOfCreditFacilityAxis__custom--ChairmanAndCEOMember" title="Purpose">General
    Corporate Requirements</span></span></td></tr>
  <tr style="background-color: White">
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Wife
    of Chairman</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_ecustom--InterestRate_c20210101__20211231__us-gaap--LineOfCreditFacilityAxis__custom--WifeOfChairmanMember" title="Interest Rate">1%
    per Month</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_ecustom--BorrowingLimit_c20211231__us-gaap--LineOfCreditFacilityAxis__custom--WifeOfChairmanMember_pp0p0" title="Borrowing Limit">4,000,000</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_ecustom--RepaymentTerms1_c20210101__20211231__us-gaap--LineOfCreditFacilityAxis__custom--WifeOfChairmanMember" title="Repayment Terms">Due
    on Demand</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_ecustom--PrincipalBorrowed_c20211231__us-gaap--LineOfCreditFacilityAxis__custom--WifeOfChairmanMember_pp0p0" title="Principal Borrowed">2,467,705</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_904_ecustom--AccruedInterest_c20211231__us-gaap--LineOfCreditFacilityAxis__custom--WifeOfChairmanMember_pp0p0" title="Accrued Interest">111,846</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_ecustom--TotalOutstanding_c20211231__us-gaap--LineOfCreditFacilityAxis__custom--WifeOfChairmanMember_pp0p0" title="Total Outstanding">2,579,551</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_ecustom--Security1_c20210101__20211231__us-gaap--LineOfCreditFacilityAxis__custom--WifeOfChairmanMember" title="Security">General
    Security over Assets</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_ecustom--Purpose1_c20210101__20211231__us-gaap--LineOfCreditFacilityAxis__custom--WifeOfChairmanMember" title="Purpose">General
    Corporate Requirements</span></span></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$
    <span id="xdx_90F_ecustom--BorrowingLimit_c20211231_pp0p0" title="Borrowing Limit">14,300,000</span></span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$
    <span id="xdx_90F_ecustom--PrincipalBorrowed_c20211231_pp0p0" title="Principal Borrowed">12,688,405</span></span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$<span id="xdx_90F_ecustom--AccruedInterest_c20211231_pp0p0" title="Accrued Interest">
    1,320,428</span></span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$
    <span id="xdx_900_ecustom--TotalOutstanding_c20211231_pp0p0" title="Total Outstanding">14,008,833</span></span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ALRT_DisclosureLinesOfCreditAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ALRT_DisclosureLinesOfCreditAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ALRT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ALRT_ScheduledOfLineOfCreditTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ALRT_ScheduledOfLineOfCreditTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ALRT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of short-term or long-term contractual arrangements with lenders, including letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140629363225120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Additional paid-in capital (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ALRT_DisclosureAdditionalPaidinCapitalAbstract', window );"><strong>Additional Paid-in Capital</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Schedule of share-based compensation, stock options, activity</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_892_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_zUoiYiGi2vq5" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Additional paid-in capital (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span id="xdx_8B1_zKthe3E0mds9" style="display: none">Schedule of share-based compensation, stock options, activity</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Six
                                            Months Ended</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>June&#160;30,
    2022</b></span></p></td>
    <td colspan="3" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Year
                                            Ended</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December&#160;31,
    2021</b></span></p></td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number
    of Options</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Weighted
    Average Exercise Price</span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number
    of Options</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Weighted
    Average Exercise Price</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 45%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding,
    beginning of period</span></td>
    <td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20220101__20220630_zV1DYlxCfDN8" style="width: 16%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Outstanding, beginning of period"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,497,001,500</span></td>
    <td style="width: 3%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20220101__20220630_zQXpNrvOIiRh" style="width: 8%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Average Exercise Price, beginning"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.006</span></td>
    <td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20210101__20211231_zAwiiG38tZ2b" style="width: 16%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Outstanding, beginning of period"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,362,701,500</span></td>
    <td style="width: 3%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20210101__20211231_zO1LKcElzOu7" style="width: 9%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Average Exercise Price, beginning"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.004</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</span></td>
    <td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_c20220101__20220630_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Granted"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0655">-</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20220101__20220630_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Granted, per share"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0657">-</span></span></td>
    <td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_c20210101__20211231_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Granted"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">165,000,000</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20210101__20211231_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Granted, per share"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.050</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercised
    </span></td>
    <td id="xdx_98C_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_di_c20220101__20220630_zrvMVZcthA6b" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercised"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0663">-</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_iN_di_c20220101__20220630_zxzdztcQw2U7" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercised per share"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0665">-</span></span></td>
    <td id="xdx_98C_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_di_c20210101__20211231_z3u32gzrfZC7" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercised"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(800,000)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_iN_di_c20210101__20211231_zi9SZEmKkBQk" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercised per share"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(0.015)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cancelled</span></td>
    <td id="xdx_980_ecustom--ShareBasedCompensationArrangementbyShareBasedPaymentAwardOptionsCancelations_iN_di_c20220101__20220630_zhCh96P9e14d" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cancelled"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(90,000,000)</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98C_ecustom--CancelledPerShares_iN_di_c20220101__20220630_zjhNUX9qAFAj" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cancelled per share"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(0.041)</span></td>
    <td id="xdx_98E_ecustom--ShareBasedCompensationArrangementbyShareBasedPaymentAwardOptionsCancelations_iN_di_c20210101__20211231_znFABDdf4dOh" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cancelled"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(29,900,000)</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98E_ecustom--CancelledPerShares_iN_di_c20210101__20211231_zFFfX3awkha1" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cancelled per share"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(0.034)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding,
    end of period</span></td>
    <td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20220101__20220630_zbKFTwrihlcl" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Outstanding, end of period"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,407,001,500</span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20220101__20220630_zc8T3dYSe4N4" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Average Exercise price, ending"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.005</span></td>
    <td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20210101__20211231_zbgPrtK7TVQf" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Outstanding, end of period"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,497,001,500</span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20210101__20211231_zgkryhDzsGA6" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Average Exercise price, ending"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.006</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercisable,
    end of period</span></td>
    <td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_c20220630_pdd" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercisable, end of period"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,223,701,500</span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_c20220630_pdd" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercisable, end of period"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.004</span></td>
    <td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_c20211231_pdd" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercisable, end of period"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,221,701,500</span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_c20211231_pdd" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercisable, end of period"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.004</span></td></tr>
  </table>
<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ALRT_ScheduleofOptionsOutstandingTableTextBlock', window );">Schedule of Options Outstanding</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_894_ecustom--ScheduleofOptionsOutstandingTableTextBlock_z6jbF1ydVQfd" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Additional paid-in capital (Details 1)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span id="xdx_8B7_zW1FlOVS0Zvl" style="display: none">Schedule of Options Outstanding</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="5" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>June&#160;30,
    2022</b></span></td>
    <td colspan="5" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December&#160;31,
    2021</b></span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expiry
    Date</span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Options</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercise
    Price</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intrinsic
    Value</span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Options</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercise
    Price</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intrinsic
    Value</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="width: 34%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 13%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 3%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 7%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 3%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 7%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 13%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 3%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 7%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 3%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 7%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">November
    27, 2022</span></td>
    <td id="xdx_989_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options1Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,600,000</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98F_ecustom--ExercisePrices_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options1Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.015</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_983_ecustom--IntrinsicValue_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options1Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.044</span></td>
    <td id="xdx_98D_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options1Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,600,000</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98B_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options1Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.015</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98C_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options1Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.045</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">January
    31, 2023</span></td>
    <td id="xdx_988_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options2Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">20,500,000</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_981_ecustom--ExercisePrices_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options2Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.015</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_980_ecustom--IntrinsicValue_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options2Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.044</span></td>
    <td id="xdx_98C_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options2Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">40,500,000</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98C_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options2Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.015</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98F_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options2Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.045</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">June
    13, 2023</span></td>
    <td id="xdx_984_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options3Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,000,000</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_980_ecustom--ExercisePrices_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options3Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.015</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_981_ecustom--IntrinsicValue_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options3Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.044</span></td>
    <td id="xdx_98B_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options3Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,000,000</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98D_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options3Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.015</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98E_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options3Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.045</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">March
    14, 2024</span></td>
    <td id="xdx_985_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options4Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,650,000</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_983_ecustom--ExercisePrices_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options4Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.035</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_986_ecustom--IntrinsicValue_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options4Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.024</span></td>
    <td id="xdx_98A_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options4Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,650,000</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98E_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options4Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.035</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_982_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options4Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.025</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">April
    12, 2024</span></td>
    <td id="xdx_986_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options5Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,925,001,500</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_982_ecustom--ExercisePrices_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options5Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.002</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_987_ecustom--IntrinsicValue_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options5Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.057</span></td>
    <td id="xdx_989_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options5Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,925,001,500</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98F_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options5Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.002</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_983_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options5Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.058</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">April
    12, 2024</span></td>
    <td id="xdx_987_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options6Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,350,000</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_985_ecustom--ExercisePrices_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options6Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.015</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_984_ecustom--IntrinsicValue_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options6Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.044</span></td>
    <td id="xdx_988_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options6Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,350,000</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_981_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options6Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.015</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_980_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options6Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.045</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">April
    12, 2024</span></td>
    <td id="xdx_980_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options7Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">200,000</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_984_ecustom--ExercisePrices_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options7Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.030</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_985_ecustom--IntrinsicValue_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options7Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.029</span></td>
    <td id="xdx_984_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options7Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">200,000</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_980_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options7Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.030</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_981_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options7Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.030</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">May
    6, 2024</span></td>
    <td id="xdx_981_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options8Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">13,000,000</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_987_ecustom--ExercisePrices_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options8Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.035</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98A_ecustom--IntrinsicValue_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options8Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.024</span></td>
    <td id="xdx_985_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options8Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">13,000,000</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_983_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options8Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.035</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_986_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options8Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.025</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">May
    17, 2024</span></td>
    <td id="xdx_982_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options9Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">57,000,000</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_986_ecustom--ExercisePrices_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options9Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.050</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98B_ecustom--IntrinsicValue_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options9Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.009</span></td>
    <td id="xdx_986_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options9Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">77,000,000</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_982_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options9Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.050</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_987_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options9Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.010</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">May
    17, 2024</span></td>
    <td id="xdx_98C_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options10Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">19,400,000</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98C_ecustom--ExercisePrices_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options10Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.035</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_984_ecustom--IntrinsicValue_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options10Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.024</span></td>
    <td id="xdx_988_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options10Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">19,400,000</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_988_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options10Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.035</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_989_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options10Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.025</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">June
    17, 2024</span></td>
    <td id="xdx_98D_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options11Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0854">-</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_984_ecustom--ExercisePrices_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options11Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0856">-</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_987_ecustom--IntrinsicValue_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options11Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0858">-</span></span></td>
    <td id="xdx_989_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options11Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,000,000</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98F_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options11Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.050</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98A_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options11Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.010</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">August
    16, 2024</span></td>
    <td id="xdx_983_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options12Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0866">-</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_985_ecustom--ExercisePrices_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options12Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0868">-</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_986_ecustom--IntrinsicValue_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options12Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0870">-</span></span></td>
    <td id="xdx_98E_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options12Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,500,000</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98E_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options12Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.050</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98B_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options12Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.010</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">September
    6, 2024</span></td>
    <td id="xdx_982_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options13Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0878">-</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_986_ecustom--ExercisePrices_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options13Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0880">-</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_981_ecustom--IntrinsicValue_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options13Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0882">-</span></span></td>
    <td id="xdx_98F_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options13Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,000,000</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98D_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options13Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.050</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_985_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options13Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.010</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">October
    3, 2024</span></td>
    <td id="xdx_981_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options14Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,500,000</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_987_ecustom--ExercisePrices_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options14Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.035</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_980_ecustom--IntrinsicValue_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options14Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.024</span></td>
    <td id="xdx_98C_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options14Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,500,000</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98C_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options14Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.035</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_984_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options14Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.025</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">October
    24, 2024</span></td>
    <td id="xdx_980_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options15Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,000,000</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_980_ecustom--ExercisePrices_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options15Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.035</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_983_ecustom--IntrinsicValue_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options15Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.024</span></td>
    <td id="xdx_98D_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options15Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,000,000</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_984_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options15Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.035</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_987_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options15Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.025</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December
    11, 2024</span></td>
    <td id="xdx_987_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options16Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">120,000,000</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_981_ecustom--ExercisePrices_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options16Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.015</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_982_ecustom--IntrinsicValue_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options16Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.044</span></td>
    <td id="xdx_983_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options16Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">120,000,000</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_985_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options16Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.015</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_986_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options16Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.045</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">April
    1, 2025</span></td>
    <td id="xdx_986_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options17Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,000,000</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_982_ecustom--ExercisePrices_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options17Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.035</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98D_ecustom--IntrinsicValue_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options17Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.024</span></td>
    <td id="xdx_982_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options17Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,000,000</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_986_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options17Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.035</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_981_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options17Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.025</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">May
    31, 2025</span></td>
    <td id="xdx_985_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options18Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,000,000</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_983_ecustom--ExercisePrices_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options18Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.035</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98C_ecustom--IntrinsicValue_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options18Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.024</span></td>
    <td id="xdx_981_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options18Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">20,000,000</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_987_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options18Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.035</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_980_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options18Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.025</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">May
    31, 2025</span></td>
    <td id="xdx_984_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options19Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">57,300,000</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98C_ecustom--ExercisePrices_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options19Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.050</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98F_ecustom--IntrinsicValue_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options19Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.009</span></td>
    <td id="xdx_980_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options19Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">87,300,000</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_980_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options19Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.050</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_983_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options19Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.010</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December&#160;31,
    2025</span></td>
    <td id="xdx_98D_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options20Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">56,500,000</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_984_ecustom--ExercisePrices_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options20Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.050</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_987_ecustom--IntrinsicValue_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options20Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.009</span></td>
    <td id="xdx_989_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options20Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">56,500,000</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98F_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options20Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.050</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98A_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options20Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.010</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">June&#160;30,
    2026</span></td>
    <td id="xdx_983_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options21Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">26,000,000</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_985_ecustom--ExercisePrices_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options21Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.050</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_986_ecustom--IntrinsicValue_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options21Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.009</span></td>
    <td id="xdx_98E_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options21Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">26,000,000</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98E_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options21Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.050</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98B_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options21Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.010</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">September
    30, 2026</span></td>
    <td id="xdx_982_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options22Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">16,000,000</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_986_ecustom--ExercisePrices_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options22Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.050</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_981_ecustom--IntrinsicValue_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options22Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.009</span></td>
    <td id="xdx_98F_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options22Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">17,500,000</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98D_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options22Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.050</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_985_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options22Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.010</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December&#160;31,
    2026</span></td>
    <td id="xdx_981_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options23Member_pdd" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">50,000,000</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_987_ecustom--ExercisePrices_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options23Member_pdd" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.050</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_980_ecustom--IntrinsicValue_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options23Member_pdd" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.009</span></td>
    <td id="xdx_98C_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options23Member_pdd" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">50,000,000</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_98C_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options23Member_pdd" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.050</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_984_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options23Member_pdd" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.010</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td>
    <td id="xdx_980_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220630_pdd" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,407,001,500</span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_986_ecustom--ExercisePrices_c20220101__20220630_pdd" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.005</span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_989_ecustom--IntrinsicValue_c20220101__20220630_pdd" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.053</span></td>
    <td id="xdx_984_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231_pdd" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,497,001,500</span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_982_ecustom--ExercisePrices_c20210101__20211231_pdd" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.006</span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td id="xdx_985_ecustom--IntrinsicValue_c20210101__20211231_pdd" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.054</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Weighted
    Average Remaining Contractual Life</span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20220101__20220630_zWiLVbV9cCZ4" title="Weighted Average Remaining Contractual Life">1.87</span></span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20210101__20211231_zlPBtc7FoC4l" title="Weighted Average Remaining Contractual Life">2.37</span></span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>
<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock', window );">Schedule of Fair Value of Stock Options Granted-Allocation</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_897_eus-gaap--ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_zAieNWJFwSL5" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Additional paid-in capital (Details 2)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -7.1pt; padding-left: 14.2pt"><span id="xdx_8BF_zkr2h51EzkZg" style="display: none">Schedule of Fair Value of Stock Options Granted-Allocation</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_49A_20220401__20220630_zqv7fsuHb40a" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_497_20210401__20210630_z53lf9cfitN5" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_49F_20220101__20220630_zkOtOGVIv4O9" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_49F_20210101__20210630_zsj8W9Hjt4Ok" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Three Months Ended</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>June&#160;30, 2022</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Three Months Ended</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>June&#160;30, 2021</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Six Months Ended</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>June&#160;30, 2022</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Six Months Ended</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>June&#160;30, 2021</b></span></p></td></tr>
  <tr id="xdx_40D_eus-gaap--InterestExpenseDebt_maTz8pZ_zawqV4y5I0T2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%; text-align: left; text-indent: -7.1pt; padding-left: 14.2pt">Interest expense</td><td style="width: 3%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1039">&#8212;</span>&#160;&#160;</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 3%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">1,287,834</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 3%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1041">&#8212;</span>&#160;&#160;</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 3%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">1,287,834</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_maTz8pZ_ztudKj64f4a1" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -7.1pt; padding-left: 14.2pt">Product development expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">56,418</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">61,697</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">118,586</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">97,842</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--ProfessionalAndContractServicesExpense_maTz8pZ_zmwPAzZlOCmb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -7.1pt; padding-left: 14.2pt">Professional expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">8,957</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">28,070</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">17,916</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">43,295</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--OtherSellingGeneralAndAdministrativeExpense_maTz8pZ_zQ9KPUtr4fm9" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: -7.1pt; padding-left: 14.2pt">Selling, general and administrative expenses</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">133,495</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1055">&#8212;</span>&#160;&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">382,157</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1057">&#8212;</span>&#160;&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -13.5pt; padding-left: 0.25in">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_ecustom--Total_iT_pp0p0_mtTz8pZ_zfGCw9vnMgVd" style="vertical-align: bottom; background-color: White">
    <td style="display: none; padding-bottom: 1pt; text-indent: -7.1pt; padding-left: 14.2pt">&#160;Fair value of the stock options granted</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">198,870</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">1,377,601</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">518,659</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">1,428,971</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_895_eus-gaap--ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_zR1Dx1NDg6Dg" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Additional paid-in capital (Details 3)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -6.25pt; padding-left: 6.25pt"><span id="xdx_8BD_zcSjjppCVuK6" style="display: none">Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-size: 12pt; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 12pt; text-align: center"><p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>June&#160;30,</b></span></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2022</b></span></p></td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">December&#160;31,</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">2021</p></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; text-align: left; text-indent: -6.25pt; padding-left: 6.25pt">Risk-free interest rate</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right"><span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_c20210101__20211231_zYqUjZP2qKDk" title="Risk-free interest rate">0.87</span></td><td style="width: 1%; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -6.25pt; padding-left: 6.25pt">Expected life</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20210101__20211231_zhNNsFBDHCw7" title="Expected life">4.8</span> years</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -6.25pt; padding-left: 6.25pt">Expected dividends</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend_pp0p0_dp_c20210101__20211231_zeoyAzkgLNxk" title="Expected dividends">0</span></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -6.25pt; padding-left: 6.25pt">Expected volatility</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp_c20210101__20211231_z8ssnjE7yBK7" title="Expected volatility">278</span></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: -6.25pt; padding-left: 6.25pt">Forfeiture rate</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageIntrinsicValue_dp_c20210101__20211231_zGhyd9Bp1Apf" title="Forfeiture rate">0</span></td><td style="padding-bottom: 1pt; text-align: left">%</td></tr>
  </table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ALRT_DisclosureAdditionalPaidinCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ALRT_DisclosureAdditionalPaidinCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ALRT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ALRT_ScheduleofOptionsOutstandingTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ALRT_ScheduleofOptionsOutstandingTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ALRT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140629366204080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related party transactions and balances (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsAbstract', window );"><strong>Related Party Transactions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock', window );">Schedule of related party transactions</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_882_eus-gaap--ScheduleOfRelatedPartyTransactionsTableTextBlock_zfWfVwVtCy5e" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Related party transactions and balances (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -7.1pt; padding-left: 14.2pt"><span id="xdx_8BE_zR7Yvg3k2MDe" style="display: none">Schedule of related party transactions</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_491_20220401__20220630_zn6ultEjUn36" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_49B_20210401__20210630_zdsHow6FYqQb" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_492_20220101__20220630_z9fB57JuG5Mf" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_490_20210101__20210630_z0WMvSSbdky9" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Three Months Ended</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>June&#160;30, 2022</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Three Months Ended</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>June&#160;30, 2021</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Six Months Ended</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>June&#160;30, 2022</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Six Months Ended</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>June&#160;30, 2021</b></span></p></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_ecustom--RelatedPartyTransactionIncludedWithinInterestExpense_iB" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Related party transactions included within interest expense:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_ecustom--InterestExpenseOnPromissoryNotesIssuedToRelativesOfChairmanAndChiefExecutiveOfficerOfCompany_i_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%; text-align: left; text-indent: -7.1pt; padding-left: 14.2pt">Interest expenses on promissory notes issued to relatives of the Chairman and Chief Executive Officer of the Company</td><td style="width: 3%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 10%; text-align: right">83,457</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 3%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 10%; text-align: right">78,981</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 3%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 10%; text-align: right">162,749</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 3%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 10%; text-align: right">157,963</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_ecustom--InterestExpenseOnLinesOfCreditPayableToChairmanAndChiefExecutiveOfficerOfCompanyAndHisSpouse_i_pp0p0" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -7.1pt; padding-left: 14.2pt">Interest expense on lines of credit payable to the Chairman and Chief Executive Officer of the Company and his spouse</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">392,593</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">355,715</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">777,515</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">670,452</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_ecustom--InterestExpenseRelatedToModificationOfStockOptionsHeldByChairmanAndChiefExecutiveOfficerOfCompanyAndHisSpouseRelatedToFinancingProvided_zKTIh7876p1i" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: -7.1pt; padding-left: 14.2pt">Interest expense related to the modification of stock options held by the Chairman and Chief Executive Officer of the Company and his spouse related to financing provided</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1105">&#8212;</span>&#160;&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">1,287,834</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1107">&#8212;</span>&#160;&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">1,287,834</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_408_ecustom--RelatedPartyTransactionsIncludingWithinSellingGeneralAndAdministrationExpenses_iB" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Related party transactions including within selling, general and administrative expenses:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_ecustom--ConsultingFeesToChairmanAndChiefExecutiveOfficerOfCompanyAccruedOnLineOfCreditAvailableToCompany_z2C54136v8zh" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -7.1pt; padding-left: 14.2pt">Consulting fees to the Chairman and Chief Executive Officer of the Company accrued on the line of credit available to the Company</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">62,400</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">62,400</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">124,800</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">124,800</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_ecustom--ConsultingFeesToDirectorOfCompanySettledWithIssuanceOfCommonStock_ztxkHOeK1iGi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -7.1pt; padding-left: 14.2pt">Consulting fees to a director of the Company settled with issuance of common stock</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">40,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1121">&#8212;</span>&#160;&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">40,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1123">&#8212;</span>&#160;&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_ecustom--SalaryForServicesAsVpCorporateAndDirectorOfSingaporeSubsidiaryToSpouseOfChairmanAndChiefExecutiveOfficerOfCompany_i_pp0p0" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -7.1pt; padding-left: 14.2pt">Salary for services as VP Corporate and director of the Singapore subsidiary to the spouse of the Chairman and Chief Executive Officer of the Company</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10,890</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">11,254</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">21,981</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">11,254</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_ecustom--LossOnSettlementOfDebtToRelativeOfChairmanAndChiefExecutiveOfficerOfCompany_zKseanDzvHkb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -7.1pt; padding-left: 14.2pt">Loss on settlement of debt to a relative of the Chairman and Chief Executive Officer of the Company</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1130">&#8212;</span>&#160;&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">16,800</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1132">&#8212;</span>&#160;&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">16,800</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_ecustom--RentPaidToCompanyControlledBySpouseOfChairmanAndImmediateFamilyMembers_i_pp0p0" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: -7.1pt; padding-left: 14.2pt">Rent paid to a company controlled by the spouse of the Chairman and immediate family members</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">8,006</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1136">&#8212;</span>&#160;&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">20,206</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1138">&#8212;</span>&#160;&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of related party transactions. Examples of related party transactions include, but are not limited to, transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners and (d) affiliates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140629368708864">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Operating segments (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock', window );">Schedule of Operating Segments</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_898_eus-gaap--ScheduleOfSegmentReportingInformationBySegmentTextBlock_z19IF7i0tr1f" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Operating segments (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10.05pt"><span id="xdx_8B5_zSQc2FjcK0qd" style="display: none">Schedule of Operating Segments</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>June 30,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2022</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December&#160;31,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2021</b></span></p></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-left: 5.4pt">Current and Total Assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 56%; padding-left: 10.05pt">Other</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_980_eus-gaap--Assets_c20220630__srt--StatementGeographicalAxis__custom--OtherMember_pp0p0" style="width: 12%; text-align: right" title="Current and Total Assets">15,327</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_983_eus-gaap--Assets_c20211231__srt--StatementGeographicalAxis__custom--OtherMember_pp0p0" style="width: 12%; text-align: right" title="Current and Total Assets">9,547</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10.05pt">Singapore</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--Assets_c20220630__srt--StatementGeographicalAxis__country--SG_pp0p0" style="text-align: right" title="Current and Total Assets">3,777</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--Assets_c20211231__srt--StatementGeographicalAxis__country--SG_pp0p0" style="text-align: right" title="Current and Total Assets">110,527</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 10.05pt">United States</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--Assets_c20220630__srt--StatementGeographicalAxis__country--US_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Current and Total Assets">77,223</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--Assets_c20211231__srt--StatementGeographicalAxis__country--US_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Current and Total Assets">73,143</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt; text-indent: -6.25pt; padding-left: 6.25pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_988_eus-gaap--Assets_c20220630_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Current and Total Assets">96,327</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_980_eus-gaap--Assets_c20211231_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Current and Total Assets">193,217</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Six Months </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Ended June&#160;30, 2022</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Six Months </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Ended June&#160;30, 2021</b></span></p></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-indent: -6.25pt; padding-left: 6.25pt">Revenue</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10.05pt">Other</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_987_eus-gaap--Revenues_c20220101__20220630__srt--StatementGeographicalAxis__custom--OtherMember_pp0p0" style="text-align: right" title="Revenue"><span style="-sec-ix-hidden: xdx2ixbrl1191">&#8212;</span>&#160;&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--Revenues_c20210101__20210630__srt--StatementGeographicalAxis__custom--OtherMember_pp0p0" style="text-align: right" title="Revenue"><span style="-sec-ix-hidden: xdx2ixbrl1193">&#8212;</span>&#160;&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; padding-left: 10.05pt">Singapore</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--Revenues_c20220101__20220630__srt--StatementGeographicalAxis__country--SG_pp0p0" style="width: 12%; text-align: right" title="Revenue">2,023</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--Revenues_c20210101__20210630__srt--StatementGeographicalAxis__country--SG_pp0p0" style="width: 12%; text-align: right" title="Revenue"><span style="-sec-ix-hidden: xdx2ixbrl1197">&#8212;</span>&#160;&#160;</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 10.05pt">United States</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--Revenues_c20220101__20220630__srt--StatementGeographicalAxis__country--US_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Revenue"><span style="-sec-ix-hidden: xdx2ixbrl1199">&#8212;</span>&#160;&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--Revenues_c20210101__20210630__srt--StatementGeographicalAxis__country--US_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Revenue"><span style="-sec-ix-hidden: xdx2ixbrl1201">&#8212;</span>&#160;&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt; text-indent: -6.25pt; padding-left: 6.25pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_986_eus-gaap--Revenues_c20220101__20220630_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Revenue">2,023</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_98B_eus-gaap--Revenues_c20210101__20210630_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Revenue"><span style="-sec-ix-hidden: xdx2ixbrl1205">&#8212;</span>&#160;&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -6.25pt; padding-left: 6.25pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; text-indent: -6.25pt; padding-left: 6.25pt">Net Loss</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10.05pt">Other</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98D_eus-gaap--NetIncomeLoss_c20220101__20220630__srt--StatementGeographicalAxis__custom--OtherMember_pp0p0" style="text-align: right" title="Net Loss">(1,457</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98B_eus-gaap--NetIncomeLoss_c20210101__20210630__srt--StatementGeographicalAxis__custom--OtherMember_pp0p0" style="text-align: right" title="Net Loss"><span style="-sec-ix-hidden: xdx2ixbrl1209">&#8212;</span>&#160;&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10.05pt">Singapore</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--NetIncomeLoss_c20220101__20220630__srt--StatementGeographicalAxis__country--SG_pp0p0" style="text-align: right" title="Net Loss">(141,861</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--NetIncomeLoss_c20210101__20210630__srt--StatementGeographicalAxis__country--SG_pp0p0" style="text-align: right" title="Net Loss">(77,666</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 10.05pt">United States</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--NetIncomeLoss_c20220101__20220630__srt--StatementGeographicalAxis__country--US_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Net Loss">(2,749,297</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--NetIncomeLoss_c20210101__20210630__srt--StatementGeographicalAxis__country--US_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Net Loss">(3,259,787</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt; text-indent: -6.25pt; padding-left: 6.25pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_987_eus-gaap--NetIncomeLoss_c20220101__20220630_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Net Loss">(2,892,615</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_985_eus-gaap--NetIncomeLoss_c20210101__20210630_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Net Loss">(3,337,453</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  </table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8813-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140629363899568">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of presentation, nature of operations and going concern (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net loss</a></td>
<td class="nump">$ 2,892,615<span></span>
</td>
<td class="nump">$ 3,337,453<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ALRT_WorkingCapitalDeficit', window );">Working capital deficit</a></td>
<td class="nump">26,258,667<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 24,312,143<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="nump">104,907,692<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">102,015,077<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ALRT_PrincipalBorrowed', window );">Principal Borrowed</a></td>
<td class="nump">$ 13,126,570<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12,688,405<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ALRT_PrincipalBorrowed">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ALRT_PrincipalBorrowed</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ALRT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ALRT_WorkingCapitalDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ALRT_WorkingCapitalDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ALRT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140629364627232">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Accounts payable and accrued liabilities (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">$ 1,074,813<span></span>
</td>
<td class="nump">$ 806,059<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued liabilities</a></td>
<td class="nump">255,039<span></span>
</td>
<td class="nump">322,087<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredRevenueCurrent', window );">Deferred revenue</a></td>
<td class="nump">344<span></span>
</td>
<td class="nump">2,400<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent', window );">Accounts payable and accrued liabilities</a></td>
<td class="nump">$ 1,330,196<span></span>
</td>
<td class="nump">$ 1,130,546<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenueCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenueCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140629362977648">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Interest, advances and promissory notes payable (Details) - Related Party [Member] - USD ($)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-Term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesPayableRelatedPartiesClassifiedCurrent', window );">Carrying value at beginning</a></td>
<td class="nump">$ 3,041,966<span></span>
</td>
<td class="nump">$ 3,031,966<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ALRT_TransferredFromPromissoryNotesPayablePursuantToPrivateTransaction.', window );">Transferred from promissory notes payable pursuant to private transaction</a></td>
<td class="nump">50,000<span></span>
</td>
<td class="nump">10,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesPayableRelatedPartiesClassifiedCurrent', window );">Carrying value at ending</a></td>
<td class="nump">$ 3,091,966<span></span>
</td>
<td class="nump">$ 3,041,966<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ALRT_TransferredFromPromissoryNotesPayablePursuantToPrivateTransaction.">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ALRT_TransferredFromPromissoryNotesPayablePursuantToPrivateTransaction.</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ALRT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesPayableRelatedPartiesClassifiedCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount for notes payable (written promise to pay), due to related parties. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesPayableRelatedPartiesClassifiedCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ALRT_RelatedPartyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ALRT_RelatedPartyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140629364759760">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Interest, advances and promissory notes payable (Details 1) - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ALRT_PromissoryNotesPayableToRelativesOfDirectorsCollateralizedByAGeneralSecurityAgreementOnAllTheAssetsOfTheCompanyDueOnDemandAbstract', window );"><strong>Promissory notes payable to relatives of directors collateralized by a general security agreement over all the assets of the Company, past maturity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ALRT_NotePayablewithInterestat1PercentInterestperMonth', window );">i.&#160;&#160;&#160;&#160;&#160;&#160;&#160; Interest at 1% per month</a></td>
<td class="nump">$ 720,619<span></span>
</td>
<td class="nump">$ 720,619<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ALRT_InterestAt1.25PerMonth', window );">ii.&#160;&#160;&#160;&#160;&#160; Interest at 1.25% per month</a></td>
<td class="nump">51,347<span></span>
</td>
<td class="nump">51,347<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ALRT_NotePayableInterestattheUSBankPrimeRatePlus1PercentperMonth', window );">iii.&#160;&#160;&#160; Interest at the U.S. bank prime rate plus 1%</a></td>
<td class="nump">100,000<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ALRT_Iv.InterestAt0.5PerMonth', window );">iv.&#160;&#160;&#160;&#160; Interest at 0.5% per month</a></td>
<td class="nump">695,000<span></span>
</td>
<td class="nump">695,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ALRT_UnsecuredPromissoryNotesPayableToRelativesOfChairmanWithFixedAmountsOfInterestDueAugust312022', window );">Unsecured promissory notes payable to relatives of the Chairman with fixed amounts of interest due August 31, 2022</a></td>
<td class="nump">50,000<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ALRT_PromissoryNotesPayableUnsecuredtoRelativesofaDirectorBearingInterestat1PercentperMonth', window );">Promissory notes payable, unsecured, to relatives of a director, bearing interest at 1% per month, past maturity</a></td>
<td class="nump">1,475,000<span></span>
</td>
<td class="nump">1,475,000<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ALRT_PromissoryNotesRelatedParty', window );">Total Promissory Notes Payable to Related Parties</a></td>
<td class="nump">$ 3,091,966<span></span>
</td>
<td class="nump">$ 3,041,966<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ALRT_InterestAt1.25PerMonth">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ALRT_InterestAt1.25PerMonth</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ALRT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ALRT_Iv.InterestAt0.5PerMonth">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ALRT_Iv.InterestAt0.5PerMonth</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ALRT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ALRT_NotePayableInterestattheUSBankPrimeRatePlus1PercentperMonth">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Including the current and noncurrent portions, aggregate carrying amount of all types of notes payable, as of the balance sheet date, with initial maturities beyond one year or beyond the normal operating cycle, if longer</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ALRT_NotePayableInterestattheUSBankPrimeRatePlus1PercentperMonth</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ALRT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ALRT_NotePayablewithInterestat1PercentInterestperMonth">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Including the current and noncurrent portions, aggregate carrying amount of all types of notes payable, as of the balance sheet date, with initial maturities beyond one year or beyond the normal operating cycle, if longer</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ALRT_NotePayablewithInterestat1PercentInterestperMonth</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ALRT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ALRT_PromissoryNotesPayableToRelativesOfDirectorsCollateralizedByAGeneralSecurityAgreementOnAllTheAssetsOfTheCompanyDueOnDemandAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ALRT_PromissoryNotesPayableToRelativesOfDirectorsCollateralizedByAGeneralSecurityAgreementOnAllTheAssetsOfTheCompanyDueOnDemandAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ALRT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ALRT_PromissoryNotesPayableUnsecuredtoRelativesofaDirectorBearingInterestat1PercentperMonth">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Including the current and noncurrent portions, aggregate carrying amount of all types of notes payable, as of the balance sheet date, with initial maturities beyond one year or beyond the normal operating cycle, if longer</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ALRT_PromissoryNotesPayableUnsecuredtoRelativesofaDirectorBearingInterestat1PercentperMonth</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ALRT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ALRT_PromissoryNotesRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Including the current and noncurrent portions, aggregate carrying amount of all types of notes payable, as of the balance sheet date, with initial maturities beyond one year or beyond the normal operating cycle, if longer</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ALRT_PromissoryNotesRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ALRT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ALRT_UnsecuredPromissoryNotesPayableToRelativesOfChairmanWithFixedAmountsOfInterestDueAugust312022">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ALRT_UnsecuredPromissoryNotesPayableToRelativesOfChairmanWithFixedAmountsOfInterestDueAugust312022</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ALRT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140629364711024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Interest, advances and promissory notes payable (Details 2) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-Term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInterestPayableNet', window );">Reclassified to interest payable</a></td>
<td class="nump">$ 277,421<span></span>
</td>
<td class="nump">$ 264,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ALRT_UnRelatedPartyMember', window );">Un Related Party [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-Term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesPayable', window );">Balance at beginning</a></td>
<td class="nump">2,213,368<span></span>
</td>
<td class="nump">$ 2,254,353<span></span>
</td>
<td class="nump">$ 2,254,353<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInterestPayableNet', window );">Reclassified to interest payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(10,985)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ALRT_ExtinguishedThroughIssuanceOfSharesOfCommonStock', window );">Extinguished through issuance of shares of common stock (note 6)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(20,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ALRT_TransferredFromPromissoryNotesPayablePursuantToPrivateTransaction.', window );">Transferred from promissory notes payable pursuant to private transaction</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(10,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ALRT_PromissoryNoteReceived', window );">Promissory note received</a></td>
<td class="nump">244,358<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesPayable', window );">Balance at ending</a></td>
<td class="nump">$ 2,457,726<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,213,368<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ALRT_ExtinguishedThroughIssuanceOfSharesOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ALRT_ExtinguishedThroughIssuanceOfSharesOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ALRT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ALRT_PromissoryNoteReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ALRT_PromissoryNoteReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ALRT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ALRT_TransferredFromPromissoryNotesPayablePursuantToPrivateTransaction.">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ALRT_TransferredFromPromissoryNotesPayablePursuantToPrivateTransaction.</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ALRT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInterestPayableNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in interest payable, which represents the amount owed to note holders, bond holders, and other parties for interest earned on loans or credit extended to the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInterestPayableNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Including the current and noncurrent portions, aggregate carrying amount of all types of notes payable, as of the balance sheet date, with initial maturities beyond one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ALRT_UnRelatedPartyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ALRT_UnRelatedPartyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140629364703408">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Interest, advances and promissory notes payable (Details 3) - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ALRT_UnsecuredPromissoryNotesPayableToUnrelatedLendersAbstract', window );"><strong>Unsecured promissory notes payable to unrelated lenders, past maturity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ALRT_I.InterestAt1PerMonthRepayableOnMarch312009DueOnDemand', window );">i.&#160;&#160;&#160;&#160;&#160;&#160;&#160; Interest at 1% per month</a></td>
<td class="nump">$ 1,317,456<span></span>
</td>
<td class="nump">$ 1,317,456<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ALRT_Iii.InterestAt0.625PerMonthWith50000RepayableOnOctober5200440000RepayableOnDecember312004And60000RepayableOnJuly282006AllDueOnDemand', window );">ii.&#160;&#160;&#160;&#160;&#160; Interest at 0.667% per month</a></td>
<td class="nump">425,000<span></span>
</td>
<td class="nump">425,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ALRT_Vi.InterestAt0.667PerMonthWith125000DueJanuary152011', window );">iii.&#160;&#160;&#160; Interest at 0.625% per month</a></td>
<td class="nump">150,000<span></span>
</td>
<td class="nump">150,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ALRT_Noninterestbearing', window );">iv.&#160;&#160;&#160;&#160; Non-interest-bearing</a></td>
<td class="nump">270,912<span></span>
</td>
<td class="nump">270,912<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ALRT_UnsecuredPromissoryNotesPayableToUnrelatedLendersWithFixedAmountsOfInterestDue', window );">Unsecured promissory notes payable to unrelated lenders with fixed amounts of interest due August 31, 2022</a></td>
<td class="nump">244,358<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ALRT_PromissoryNotesPayableSecuredByGuaranteeFromChiefExecutiveOfficerBearingInterestAt1PerMonth', window );">Promissory notes payable, secured by a guarantee from the Chief Executive Officer, bearing interest at 1% per month, past maturity</a></td>
<td class="nump">50,000<span></span>
</td>
<td class="nump">50,000<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ALRT_TotalPromissoryNotesPayableToUnrelatedParties', window );">Total Promissory Notes Payable to Unrelated Parties</a></td>
<td class="nump">$ 2,457,726<span></span>
</td>
<td class="nump">$ 2,213,368<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ALRT_I.InterestAt1PerMonthRepayableOnMarch312009DueOnDemand">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ALRT_I.InterestAt1PerMonthRepayableOnMarch312009DueOnDemand</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ALRT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ALRT_Iii.InterestAt0.625PerMonthWith50000RepayableOnOctober5200440000RepayableOnDecember312004And60000RepayableOnJuly282006AllDueOnDemand">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ALRT_Iii.InterestAt0.625PerMonthWith50000RepayableOnOctober5200440000RepayableOnDecember312004And60000RepayableOnJuly282006AllDueOnDemand</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ALRT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ALRT_Noninterestbearing">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ALRT_Noninterestbearing</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ALRT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ALRT_PromissoryNotesPayableSecuredByGuaranteeFromChiefExecutiveOfficerBearingInterestAt1PerMonth">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ALRT_PromissoryNotesPayableSecuredByGuaranteeFromChiefExecutiveOfficerBearingInterestAt1PerMonth</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ALRT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ALRT_TotalPromissoryNotesPayableToUnrelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ALRT_TotalPromissoryNotesPayableToUnrelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ALRT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ALRT_UnsecuredPromissoryNotesPayableToUnrelatedLendersAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ALRT_UnsecuredPromissoryNotesPayableToUnrelatedLendersAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ALRT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ALRT_UnsecuredPromissoryNotesPayableToUnrelatedLendersWithFixedAmountsOfInterestDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ALRT_UnsecuredPromissoryNotesPayableToUnrelatedLendersWithFixedAmountsOfInterestDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ALRT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ALRT_Vi.InterestAt0.667PerMonthWith125000DueJanuary152011">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ALRT_Vi.InterestAt0.667PerMonthWith125000DueJanuary152011</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ALRT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140629364717776">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Interest, advances and promissory notes payable (Details 4) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ALRT_DisclosureInterestAdvancesAndPromissoryNotesPayableAbstract', window );"><strong>Interest Advances And Promissory Notes Payable</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPayableCurrentAndNoncurrent', window );">Beginning Balance</a></td>
<td class="nump">$ 4,110,647<span></span>
</td>
<td class="nump">$ 3,575,326<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ALRT_ReclassifiedFromPromissoryNotesPayable', window );">Reclassified from promissory notes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,985<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ALRT_InterestExpenseIncurredonPromissoryNotesandOtherPayables', window );">Interest incurred on promissory notes payable</a></td>
<td class="nump">277,421<span></span>
</td>
<td class="nump">527,336<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ALRT_InterestPayableRetiredThroughIssuanceOfShares', window );">Interest payable retired through issuance of shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPayableCurrentAndNoncurrent', window );">Ending Balance</a></td>
<td class="nump">$ 4,388,068<span></span>
</td>
<td class="nump">$ 4,110,647<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ALRT_DisclosureInterestAdvancesAndPromissoryNotesPayableAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ALRT_DisclosureInterestAdvancesAndPromissoryNotesPayableAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ALRT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ALRT_InterestExpenseIncurredonPromissoryNotesandOtherPayables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cost of borrowed funds accounted for as interest that was charged against earnings during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ALRT_InterestExpenseIncurredonPromissoryNotesandOtherPayables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ALRT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ALRT_InterestPayableRetiredThroughIssuanceOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ALRT_InterestPayableRetiredThroughIssuanceOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ALRT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ALRT_ReclassifiedFromPromissoryNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ALRT_ReclassifiedFromPromissoryNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ALRT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPayableCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest payable on debt, including, but not limited to, trade payables.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.15(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPayableCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140629364687232">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Interest, advances and promissory notes payable (Details 5) - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ALRT_DisclosureInterestAdvancesAndPromissoryNotesPayableAbstract', window );"><strong>Interest Advances And Promissory Notes Payable</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ALRT_InterestPayableRelativesOfDirectors', window );">Related parties</a></td>
<td class="nump">$ 1,362,918<span></span>
</td>
<td class="nump">$ 1,200,170<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ALRT_InterestPayabletoNonrelatedParties', window );">Unrelated parties</a></td>
<td class="nump">3,025,150<span></span>
</td>
<td class="nump">2,910,477<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ALRT_InterestPayableCurrentAndNoncurrents', window );">Interest payable</a></td>
<td class="nump">$ 4,388,068<span></span>
</td>
<td class="nump">$ 4,110,647<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ALRT_DisclosureInterestAdvancesAndPromissoryNotesPayableAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ALRT_DisclosureInterestAdvancesAndPromissoryNotesPayableAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ALRT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ALRT_InterestPayableCurrentAndNoncurrents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ALRT_InterestPayableCurrentAndNoncurrents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ALRT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ALRT_InterestPayableRelativesOfDirectors">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of [accrued] interest payable to relatives of directors on all forms of debt, including trade payables, that has been incurred and is unpaid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ALRT_InterestPayableRelativesOfDirectors</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ALRT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ALRT_InterestPayabletoNonrelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of [accrued] interest payable to non-related parties on all forms of debt, including trade payables, that has been incurred and is unpaid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ALRT_InterestPayabletoNonrelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ALRT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140629363233696">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Interest, advances and promissory notes payable (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ALRT_DisclosureInterestAdvancesAndPromissoryNotesPayableAbstract', window );"><strong>Interest Advances And Promissory Notes Payable</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="nump">$ 559,128<span></span>
</td>
<td class="nump">$ 1,804,403<span></span>
</td>
<td class="nump">$ 1,109,764<span></span>
</td>
<td class="nump">$ 2,283,770<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpenseRelatedParty', window );">Interest on other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,557<span></span>
</td>
<td class="nump">$ 1,325<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ALRT_DisclosureInterestAdvancesAndPromissoryNotesPayableAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ALRT_DisclosureInterestAdvancesAndPromissoryNotesPayableAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ALRT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest expense incurred on a debt or other obligation to related party.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140629364759376">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Lines of credit (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ALRT_DisclosureLinesOfCreditAbstract', window );"><strong>Lines Of Credit</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermLineOfCredit', window );">Balance at beginning</a></td>
<td class="nump">$ 14,008,833<span></span>
</td>
<td class="nump">$ 11,914,092<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityPeriodicPaymentPrincipal', window );">Advances received on lines of credit</a></td>
<td class="nump">438,165<span></span>
</td>
<td class="nump">1,149,279<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityPeriodicPaymentInterest', window );">Interest incurred on lines of credit</a></td>
<td class="nump">777,515<span></span>
</td>
<td class="nump">1,402,187<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ALRT_RepaymentOfInterestOnLinesOfCredit', window );">Repayment of interest on lines of credit</a></td>
<td class="num">(137,475)<span></span>
</td>
<td class="num">(456,725)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermLineOfCredit', window );">Balance at ending</a></td>
<td class="nump">$ 15,087,038<span></span>
</td>
<td class="nump">$ 14,008,833<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ALRT_DisclosureLinesOfCreditAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ALRT_DisclosureLinesOfCreditAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ALRT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ALRT_RepaymentOfInterestOnLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ALRT_RepaymentOfInterestOnLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ALRT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityPeriodicPaymentInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the required periodic payment applied to interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityPeriodicPaymentInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityPeriodicPaymentPrincipal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the required periodic payment applied to principal.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityPeriodicPaymentPrincipal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermLineOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the noncurrent portion of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=99376301&amp;loc=d3e1336-112600<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=99376301&amp;loc=d3e1314-112600<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermLineOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140629358449520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Lines of credit (Details 1) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ALRT_BorrowingLimit', window );">Borrowing Limit</a></td>
<td class="nump">$ 14,300,000<span></span>
</td>
<td class="nump">$ 14,300,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ALRT_PrincipalBorrowed', window );">Principal Borrowed</a></td>
<td class="nump">13,126,570<span></span>
</td>
<td class="nump">12,688,405<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ALRT_AccruedInterest', window );">Accrued Interest</a></td>
<td class="nump">1,960,468<span></span>
</td>
<td class="nump">1,320,428<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ALRT_TotalOutstanding', window );">Total Outstanding</a></td>
<td class="nump">$ 15,087,038<span></span>
</td>
<td class="nump">$ 14,008,833<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityAxis=ALRT_ChairmanAndCEOMember', window );">Chairman And C E O [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ALRT_InterestRate', window );">Interest Rate</a></td>
<td class="text">1%
    per Month<span></span>
</td>
<td class="text">1%
    per Month<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ALRT_BorrowingLimit', window );">Borrowing Limit</a></td>
<td class="nump">$ 10,300,000<span></span>
</td>
<td class="nump">$ 10,300,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ALRT_RepaymentTerms1', window );">Repayment Terms</a></td>
<td class="text">Due
    on Demand<span></span>
</td>
<td class="text">Due
    on Demand<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ALRT_PrincipalBorrowed', window );">Principal Borrowed</a></td>
<td class="nump">$ 10,300,000<span></span>
</td>
<td class="nump">$ 10,220,700<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ALRT_AccruedInterest', window );">Accrued Interest</a></td>
<td class="nump">1,763,048<span></span>
</td>
<td class="nump">1,208,582<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ALRT_TotalOutstanding', window );">Total Outstanding</a></td>
<td class="nump">$ 12,063,048<span></span>
</td>
<td class="nump">$ 11,429,282<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ALRT_Security1', window );">Security</a></td>
<td class="text">General
    Security over Assets<span></span>
</td>
<td class="text">General
    Security over Assets<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ALRT_Purpose1', window );">Purpose</a></td>
<td class="text">General
    Corporate Requirements<span></span>
</td>
<td class="text">General
    Corporate Requirements<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityAxis=ALRT_WifeOfChairmanMember', window );">Wife Of Chairman [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ALRT_InterestRate', window );">Interest Rate</a></td>
<td class="text">1%
    per Month<span></span>
</td>
<td class="text">1%
    per Month<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ALRT_BorrowingLimit', window );">Borrowing Limit</a></td>
<td class="nump">$ 4,000,000<span></span>
</td>
<td class="nump">$ 4,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ALRT_RepaymentTerms1', window );">Repayment Terms</a></td>
<td class="text">Due
    on Demand<span></span>
</td>
<td class="text">Due
    on Demand<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ALRT_PrincipalBorrowed', window );">Principal Borrowed</a></td>
<td class="nump">$ 2,826,570<span></span>
</td>
<td class="nump">$ 2,467,705<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ALRT_AccruedInterest', window );">Accrued Interest</a></td>
<td class="nump">197,420<span></span>
</td>
<td class="nump">111,846<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ALRT_TotalOutstanding', window );">Total Outstanding</a></td>
<td class="nump">$ 3,023,990<span></span>
</td>
<td class="nump">$ 2,579,551<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ALRT_Security1', window );">Security</a></td>
<td class="text">General
    Security over Assets<span></span>
</td>
<td class="text">General
    Security over Assets<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ALRT_Purpose1', window );">Purpose</a></td>
<td class="text">General
    Corporate Requirements<span></span>
</td>
<td class="text">General
    Corporate Requirements<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ALRT_AccruedInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ALRT_AccruedInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ALRT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ALRT_BorrowingLimit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ALRT_BorrowingLimit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ALRT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ALRT_InterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ALRT_InterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ALRT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ALRT_PrincipalBorrowed">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ALRT_PrincipalBorrowed</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ALRT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ALRT_Purpose1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ALRT_Purpose1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ALRT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ALRT_RepaymentTerms1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ALRT_RepaymentTerms1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ALRT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ALRT_Security1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ALRT_Security1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ALRT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ALRT_TotalOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ALRT_TotalOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ALRT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityAxis=ALRT_ChairmanAndCEOMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityAxis=ALRT_ChairmanAndCEOMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityAxis=ALRT_WifeOfChairmanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityAxis=ALRT_WifeOfChairmanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140629358363536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Additional paid-in capital (Details) - $ / shares<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ALRT_DisclosureAdditionalPaidinCapitalAbstract', window );"><strong>Additional Paid-in Capital</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding, beginning of period</a></td>
<td class="nump">5,497,001,500<span></span>
</td>
<td class="nump">5,362,701,500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Average Exercise Price, beginning</a></td>
<td class="nump">$ 0.006<span></span>
</td>
<td class="nump">$ 0.004<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod', window );">Granted</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">165,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Granted, per share</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 0.050<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercised</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(800,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Exercised per share</a></td>
<td class="text"> <span></span>
</td>
<td class="num">$ (0.015)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ALRT_ShareBasedCompensationArrangementbyShareBasedPaymentAwardOptionsCancelations', window );">Cancelled</a></td>
<td class="num">(90,000,000)<span></span>
</td>
<td class="num">(29,900,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ALRT_CancelledPerShares', window );">Cancelled per share</a></td>
<td class="num">$ (0.041)<span></span>
</td>
<td class="num">$ (0.034)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding, end of period</a></td>
<td class="nump">5,407,001,500<span></span>
</td>
<td class="nump">5,497,001,500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Average Exercise price, ending</a></td>
<td class="nump">$ 0.005<span></span>
</td>
<td class="nump">$ 0.006<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Exercisable, end of period</a></td>
<td class="nump">5,223,701,500<span></span>
</td>
<td class="nump">5,221,701,500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice', window );">Exercisable, end of period</a></td>
<td class="nump">$ 0.004<span></span>
</td>
<td class="nump">$ 0.004<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ALRT_CancelledPerShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ALRT_CancelledPerShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ALRT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ALRT_DisclosureAdditionalPaidinCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ALRT_DisclosureAdditionalPaidinCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ALRT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ALRT_ShareBasedCompensationArrangementbyShareBasedPaymentAwardOptionsCancelations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ALRT_ShareBasedCompensationArrangementbyShareBasedPaymentAwardOptionsCancelations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ALRT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Agreed-upon price for the exchange of the underlying asset relating to the share-based payment award.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140629358662768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Additional paid-in capital (Details 1) - $ / shares<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OffsettingAssetsLineItems', window );"><strong>Offsetting Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ALRT_OpenOptionContractsWrittenNumbersOfShare', window );">Options</a></td>
<td class="nump">5,407,001,500<span></span>
</td>
<td class="nump">5,497,001,500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ALRT_ExercisePrices', window );">Exercise Price</a></td>
<td class="nump">$ 0.005<span></span>
</td>
<td class="nump">$ 0.006<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ALRT_IntrinsicValue', window );">Intrinsic Value</a></td>
<td class="nump">$ 0.053<span></span>
</td>
<td class="nump">$ 0.054<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Weighted Average Remaining Contractual Life</a></td>
<td class="text">1 year 10 months 13 days<span></span>
</td>
<td class="text">2 years 4 months 13 days<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=ALRT_Options1Member', window );">Options 1 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OffsettingAssetsLineItems', window );"><strong>Offsetting Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ALRT_OpenOptionContractsWrittenNumbersOfShare', window );">Options</a></td>
<td class="nump">5,600,000<span></span>
</td>
<td class="nump">5,600,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ALRT_ExercisePrices', window );">Exercise Price</a></td>
<td class="nump">$ 0.015<span></span>
</td>
<td class="nump">$ 0.015<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ALRT_IntrinsicValue', window );">Intrinsic Value</a></td>
<td class="nump">$ 0.044<span></span>
</td>
<td class="nump">$ 0.045<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=ALRT_Options2Member', window );">Options 2 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OffsettingAssetsLineItems', window );"><strong>Offsetting Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ALRT_OpenOptionContractsWrittenNumbersOfShare', window );">Options</a></td>
<td class="nump">20,500,000<span></span>
</td>
<td class="nump">40,500,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ALRT_ExercisePrices', window );">Exercise Price</a></td>
<td class="nump">$ 0.015<span></span>
</td>
<td class="nump">$ 0.015<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ALRT_IntrinsicValue', window );">Intrinsic Value</a></td>
<td class="nump">$ 0.044<span></span>
</td>
<td class="nump">$ 0.045<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=ALRT_Options3Member', window );">Options 3 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OffsettingAssetsLineItems', window );"><strong>Offsetting Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ALRT_OpenOptionContractsWrittenNumbersOfShare', window );">Options</a></td>
<td class="nump">5,000,000<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ALRT_ExercisePrices', window );">Exercise Price</a></td>
<td class="nump">$ 0.015<span></span>
</td>
<td class="nump">$ 0.015<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ALRT_IntrinsicValue', window );">Intrinsic Value</a></td>
<td class="nump">$ 0.044<span></span>
</td>
<td class="nump">$ 0.045<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=ALRT_Options4Member', window );">Options 4 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OffsettingAssetsLineItems', window );"><strong>Offsetting Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ALRT_OpenOptionContractsWrittenNumbersOfShare', window );">Options</a></td>
<td class="nump">6,650,000<span></span>
</td>
<td class="nump">6,650,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ALRT_ExercisePrices', window );">Exercise Price</a></td>
<td class="nump">$ 0.035<span></span>
</td>
<td class="nump">$ 0.035<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ALRT_IntrinsicValue', window );">Intrinsic Value</a></td>
<td class="nump">$ 0.024<span></span>
</td>
<td class="nump">$ 0.025<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=ALRT_Options5Member', window );">Options 5 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OffsettingAssetsLineItems', window );"><strong>Offsetting Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ALRT_OpenOptionContractsWrittenNumbersOfShare', window );">Options</a></td>
<td class="nump">4,925,001,500<span></span>
</td>
<td class="nump">4,925,001,500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ALRT_ExercisePrices', window );">Exercise Price</a></td>
<td class="nump">$ 0.002<span></span>
</td>
<td class="nump">$ 0.002<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ALRT_IntrinsicValue', window );">Intrinsic Value</a></td>
<td class="nump">$ 0.057<span></span>
</td>
<td class="nump">$ 0.058<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=ALRT_Options6Member', window );">Options 6 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OffsettingAssetsLineItems', window );"><strong>Offsetting Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ALRT_OpenOptionContractsWrittenNumbersOfShare', window );">Options</a></td>
<td class="nump">3,350,000<span></span>
</td>
<td class="nump">3,350,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ALRT_ExercisePrices', window );">Exercise Price</a></td>
<td class="nump">$ 0.015<span></span>
</td>
<td class="nump">$ 0.015<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ALRT_IntrinsicValue', window );">Intrinsic Value</a></td>
<td class="nump">$ 0.044<span></span>
</td>
<td class="nump">$ 0.045<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=ALRT_Options7Member', window );">Options 7 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OffsettingAssetsLineItems', window );"><strong>Offsetting Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ALRT_OpenOptionContractsWrittenNumbersOfShare', window );">Options</a></td>
<td class="nump">200,000<span></span>
</td>
<td class="nump">200,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ALRT_ExercisePrices', window );">Exercise Price</a></td>
<td class="nump">$ 0.030<span></span>
</td>
<td class="nump">$ 0.030<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ALRT_IntrinsicValue', window );">Intrinsic Value</a></td>
<td class="nump">$ 0.029<span></span>
</td>
<td class="nump">$ 0.030<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=ALRT_Options8Member', window );">Options 8 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OffsettingAssetsLineItems', window );"><strong>Offsetting Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ALRT_OpenOptionContractsWrittenNumbersOfShare', window );">Options</a></td>
<td class="nump">13,000,000<span></span>
</td>
<td class="nump">13,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ALRT_ExercisePrices', window );">Exercise Price</a></td>
<td class="nump">$ 0.035<span></span>
</td>
<td class="nump">$ 0.035<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ALRT_IntrinsicValue', window );">Intrinsic Value</a></td>
<td class="nump">$ 0.024<span></span>
</td>
<td class="nump">$ 0.025<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=ALRT_Options9Member', window );">Options 9 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OffsettingAssetsLineItems', window );"><strong>Offsetting Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ALRT_OpenOptionContractsWrittenNumbersOfShare', window );">Options</a></td>
<td class="nump">57,000,000<span></span>
</td>
<td class="nump">77,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ALRT_ExercisePrices', window );">Exercise Price</a></td>
<td class="nump">$ 0.050<span></span>
</td>
<td class="nump">$ 0.050<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ALRT_IntrinsicValue', window );">Intrinsic Value</a></td>
<td class="nump">$ 0.009<span></span>
</td>
<td class="nump">$ 0.010<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=ALRT_Options10Member', window );">Options 10 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OffsettingAssetsLineItems', window );"><strong>Offsetting Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ALRT_OpenOptionContractsWrittenNumbersOfShare', window );">Options</a></td>
<td class="nump">19,400,000<span></span>
</td>
<td class="nump">19,400,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ALRT_ExercisePrices', window );">Exercise Price</a></td>
<td class="nump">$ 0.035<span></span>
</td>
<td class="nump">$ 0.035<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ALRT_IntrinsicValue', window );">Intrinsic Value</a></td>
<td class="nump">$ 0.024<span></span>
</td>
<td class="nump">$ 0.025<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=ALRT_Options11Member', window );">Options 11 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OffsettingAssetsLineItems', window );"><strong>Offsetting Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ALRT_OpenOptionContractsWrittenNumbersOfShare', window );">Options</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ALRT_ExercisePrices', window );">Exercise Price</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 0.050<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ALRT_IntrinsicValue', window );">Intrinsic Value</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 0.010<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=ALRT_Options12Member', window );">Options 12 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OffsettingAssetsLineItems', window );"><strong>Offsetting Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ALRT_OpenOptionContractsWrittenNumbersOfShare', window );">Options</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">2,500,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ALRT_ExercisePrices', window );">Exercise Price</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 0.050<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ALRT_IntrinsicValue', window );">Intrinsic Value</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 0.010<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=ALRT_Options13Member', window );">Options 13 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OffsettingAssetsLineItems', window );"><strong>Offsetting Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ALRT_OpenOptionContractsWrittenNumbersOfShare', window );">Options</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ALRT_ExercisePrices', window );">Exercise Price</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 0.050<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ALRT_IntrinsicValue', window );">Intrinsic Value</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 0.010<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=ALRT_Options14Member', window );">Options 14 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OffsettingAssetsLineItems', window );"><strong>Offsetting Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ALRT_OpenOptionContractsWrittenNumbersOfShare', window );">Options</a></td>
<td class="nump">3,500,000<span></span>
</td>
<td class="nump">3,500,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ALRT_ExercisePrices', window );">Exercise Price</a></td>
<td class="nump">$ 0.035<span></span>
</td>
<td class="nump">$ 0.035<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ALRT_IntrinsicValue', window );">Intrinsic Value</a></td>
<td class="nump">$ 0.024<span></span>
</td>
<td class="nump">$ 0.025<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=ALRT_Options15Member', window );">Options 15 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OffsettingAssetsLineItems', window );"><strong>Offsetting Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ALRT_OpenOptionContractsWrittenNumbersOfShare', window );">Options</a></td>
<td class="nump">2,000,000<span></span>
</td>
<td class="nump">2,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ALRT_ExercisePrices', window );">Exercise Price</a></td>
<td class="nump">$ 0.035<span></span>
</td>
<td class="nump">$ 0.035<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ALRT_IntrinsicValue', window );">Intrinsic Value</a></td>
<td class="nump">$ 0.024<span></span>
</td>
<td class="nump">$ 0.025<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=ALRT_Options16Member', window );">Options 16 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OffsettingAssetsLineItems', window );"><strong>Offsetting Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ALRT_OpenOptionContractsWrittenNumbersOfShare', window );">Options</a></td>
<td class="nump">120,000,000<span></span>
</td>
<td class="nump">120,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ALRT_ExercisePrices', window );">Exercise Price</a></td>
<td class="nump">$ 0.015<span></span>
</td>
<td class="nump">$ 0.015<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ALRT_IntrinsicValue', window );">Intrinsic Value</a></td>
<td class="nump">$ 0.044<span></span>
</td>
<td class="nump">$ 0.045<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=ALRT_Options17Member', window );">Options 17 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OffsettingAssetsLineItems', window );"><strong>Offsetting Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ALRT_OpenOptionContractsWrittenNumbersOfShare', window );">Options</a></td>
<td class="nump">10,000,000<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ALRT_ExercisePrices', window );">Exercise Price</a></td>
<td class="nump">$ 0.035<span></span>
</td>
<td class="nump">$ 0.035<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ALRT_IntrinsicValue', window );">Intrinsic Value</a></td>
<td class="nump">$ 0.024<span></span>
</td>
<td class="nump">$ 0.025<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=ALRT_Options18Member', window );">Options 18 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OffsettingAssetsLineItems', window );"><strong>Offsetting Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ALRT_OpenOptionContractsWrittenNumbersOfShare', window );">Options</a></td>
<td class="nump">10,000,000<span></span>
</td>
<td class="nump">20,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ALRT_ExercisePrices', window );">Exercise Price</a></td>
<td class="nump">$ 0.035<span></span>
</td>
<td class="nump">$ 0.035<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ALRT_IntrinsicValue', window );">Intrinsic Value</a></td>
<td class="nump">$ 0.024<span></span>
</td>
<td class="nump">$ 0.025<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=ALRT_Options19Member', window );">Options 19 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OffsettingAssetsLineItems', window );"><strong>Offsetting Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ALRT_OpenOptionContractsWrittenNumbersOfShare', window );">Options</a></td>
<td class="nump">57,300,000<span></span>
</td>
<td class="nump">87,300,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ALRT_ExercisePrices', window );">Exercise Price</a></td>
<td class="nump">$ 0.050<span></span>
</td>
<td class="nump">$ 0.050<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ALRT_IntrinsicValue', window );">Intrinsic Value</a></td>
<td class="nump">$ 0.009<span></span>
</td>
<td class="nump">$ 0.010<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=ALRT_Options20Member', window );">Options 20 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OffsettingAssetsLineItems', window );"><strong>Offsetting Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ALRT_OpenOptionContractsWrittenNumbersOfShare', window );">Options</a></td>
<td class="nump">56,500,000<span></span>
</td>
<td class="nump">56,500,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ALRT_ExercisePrices', window );">Exercise Price</a></td>
<td class="nump">$ 0.050<span></span>
</td>
<td class="nump">$ 0.050<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ALRT_IntrinsicValue', window );">Intrinsic Value</a></td>
<td class="nump">$ 0.009<span></span>
</td>
<td class="nump">$ 0.010<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=ALRT_Options21Member', window );">Options 21 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OffsettingAssetsLineItems', window );"><strong>Offsetting Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ALRT_OpenOptionContractsWrittenNumbersOfShare', window );">Options</a></td>
<td class="nump">26,000,000<span></span>
</td>
<td class="nump">26,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ALRT_ExercisePrices', window );">Exercise Price</a></td>
<td class="nump">$ 0.050<span></span>
</td>
<td class="nump">$ 0.050<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ALRT_IntrinsicValue', window );">Intrinsic Value</a></td>
<td class="nump">$ 0.009<span></span>
</td>
<td class="nump">$ 0.010<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=ALRT_Options22Member', window );">Options 22 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OffsettingAssetsLineItems', window );"><strong>Offsetting Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ALRT_OpenOptionContractsWrittenNumbersOfShare', window );">Options</a></td>
<td class="nump">16,000,000<span></span>
</td>
<td class="nump">17,500,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ALRT_ExercisePrices', window );">Exercise Price</a></td>
<td class="nump">$ 0.050<span></span>
</td>
<td class="nump">$ 0.050<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ALRT_IntrinsicValue', window );">Intrinsic Value</a></td>
<td class="nump">$ 0.009<span></span>
</td>
<td class="nump">$ 0.010<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=ALRT_Options23Member', window );">Options 23 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OffsettingAssetsLineItems', window );"><strong>Offsetting Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ALRT_OpenOptionContractsWrittenNumbersOfShare', window );">Options</a></td>
<td class="nump">50,000,000<span></span>
</td>
<td class="nump">50,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ALRT_ExercisePrices', window );">Exercise Price</a></td>
<td class="nump">$ 0.050<span></span>
</td>
<td class="nump">$ 0.050<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ALRT_IntrinsicValue', window );">Intrinsic Value</a></td>
<td class="nump">$ 0.009<span></span>
</td>
<td class="nump">$ 0.010<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ALRT_ExercisePrices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ALRT_ExercisePrices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ALRT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ALRT_IntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ALRT_IntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ALRT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ALRT_OpenOptionContractsWrittenNumbersOfShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ALRT_OpenOptionContractsWrittenNumbersOfShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ALRT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OffsettingAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OffsettingAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=ALRT_Options1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=ALRT_Options1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=ALRT_Options2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=ALRT_Options2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=ALRT_Options3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=ALRT_Options3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=ALRT_Options4Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=ALRT_Options4Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=ALRT_Options5Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=ALRT_Options5Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=ALRT_Options6Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=ALRT_Options6Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=ALRT_Options7Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=ALRT_Options7Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=ALRT_Options8Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=ALRT_Options8Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=ALRT_Options9Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=ALRT_Options9Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=ALRT_Options10Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=ALRT_Options10Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=ALRT_Options11Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=ALRT_Options11Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=ALRT_Options12Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=ALRT_Options12Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=ALRT_Options13Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=ALRT_Options13Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=ALRT_Options14Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=ALRT_Options14Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=ALRT_Options15Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=ALRT_Options15Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=ALRT_Options16Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=ALRT_Options16Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=ALRT_Options17Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=ALRT_Options17Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=ALRT_Options18Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=ALRT_Options18Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=ALRT_Options19Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=ALRT_Options19Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=ALRT_Options20Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=ALRT_Options20Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=ALRT_Options21Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=ALRT_Options21Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=ALRT_Options22Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=ALRT_Options22Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=ALRT_Options23Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=ALRT_Options23Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140629358365968">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Additional paid-in capital (Details 2) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ALRT_DisclosureAdditionalPaidinCapitalAbstract', window );"><strong>Additional Paid-in Capital</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpenseDebt', window );">Interest expense</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 1,287,834<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 1,287,834<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost', window );">Product development expense</a></td>
<td class="nump">56,418<span></span>
</td>
<td class="nump">61,697<span></span>
</td>
<td class="nump">118,586<span></span>
</td>
<td class="nump">97,842<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfessionalAndContractServicesExpense', window );">Professional expense</a></td>
<td class="nump">8,957<span></span>
</td>
<td class="nump">28,070<span></span>
</td>
<td class="nump">17,916<span></span>
</td>
<td class="nump">43,295<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherSellingGeneralAndAdministrativeExpense', window );">Selling, general and administrative expenses</a></td>
<td class="nump">133,495<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">382,157<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ALRT_Total', window );">&#160;Fair value of the stock options granted</a></td>
<td class="nump">$ 198,870<span></span>
</td>
<td class="nump">$ 1,377,601<span></span>
</td>
<td class="nump">$ 518,659<span></span>
</td>
<td class="nump">$ 1,428,971<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ALRT_DisclosureAdditionalPaidinCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ALRT_DisclosureAdditionalPaidinCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ALRT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ALRT_Total">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ALRT_Total</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ALRT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense for debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6036836-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69F<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495745-112612<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69E<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495743-112612<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherSellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of selling, general and administrative expense classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherSellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfessionalAndContractServicesExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Professional and contract service expense includes cost reimbursements for support services related to contracted projects, outsourced management, technical and staff support.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfessionalAndContractServicesExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The costs incurred in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, excluding in-process research and development acquired in a business combination consummated during the period. Excludes software research and development, which has a separate concept.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140629367846016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Additional paid-in capital (Details 3)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ALRT_DisclosureAdditionalPaidinCapitalAbstract', window );"><strong>Additional Paid-in Capital</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest rate</a></td>
<td class="nump">0.87%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected life</a></td>
<td class="text">4 years 9 months 18 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend', window );">Expected dividends | $</a></td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected volatility</a></td>
<td class="nump">278.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageIntrinsicValue', window );">Forfeiture rate | $ / shares</a></td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ALRT_DisclosureAdditionalPaidinCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ALRT_DisclosureAdditionalPaidinCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ALRT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of the weighted average expected dividend for an entity using a valuation technique with different dividend rates during the contractual term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The combined weighted average of the accumulated differences between the fair values on underlying shares and exercises prices to acquire such shares as of the grant date on options that were either forfeited or lapsed.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140629368708864">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Additional paid-in capital (Details Narrative)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2021 </div>
<div>$ / shares</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ALRT_DisclosureAdditionalPaidinCapitalAbstract', window );"><strong>Additional Paid-in Capital</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted average fair value options granted</a></td>
<td class="nump">$ 0.06<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ALRT_DisclosureAdditionalPaidinCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ALRT_DisclosureAdditionalPaidinCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ALRT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140629364730448">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related party transactions and balances (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ALRT_RelatedPartyTransactionIncludedWithinInterestExpense', window );"><strong>Related party transactions included within interest expense:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ALRT_InterestExpenseOnPromissoryNotesIssuedToRelativesOfChairmanAndChiefExecutiveOfficerOfCompany', window );">Interest expenses on promissory notes issued to relatives of the Chairman and Chief Executive Officer of the Company</a></td>
<td class="nump">$ 83,457<span></span>
</td>
<td class="nump">$ 78,981<span></span>
</td>
<td class="nump">$ 162,749<span></span>
</td>
<td class="nump">$ 157,963<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ALRT_InterestExpenseOnLinesOfCreditPayableToChairmanAndChiefExecutiveOfficerOfCompanyAndHisSpouse', window );">Interest expense on lines of credit payable to the Chairman and Chief Executive Officer of the Company and his spouse</a></td>
<td class="nump">392,593<span></span>
</td>
<td class="nump">355,715<span></span>
</td>
<td class="nump">777,515<span></span>
</td>
<td class="nump">670,452<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ALRT_InterestExpenseRelatedToModificationOfStockOptionsHeldByChairmanAndChiefExecutiveOfficerOfCompanyAndHisSpouseRelatedToFinancingProvided', window );">Interest expense related to the modification of stock options held by the Chairman and Chief Executive Officer of the Company and his spouse related to financing provided</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">1,287,834<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">1,287,834<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ALRT_RelatedPartyTransactionsIncludingWithinSellingGeneralAndAdministrationExpenses', window );"><strong>Related party transactions including within selling, general and administrative expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ALRT_ConsultingFeesToChairmanAndChiefExecutiveOfficerOfCompanyAccruedOnLineOfCreditAvailableToCompany', window );">Consulting fees to the Chairman and Chief Executive Officer of the Company accrued on the line of credit available to the Company</a></td>
<td class="nump">62,400<span></span>
</td>
<td class="nump">62,400<span></span>
</td>
<td class="nump">124,800<span></span>
</td>
<td class="nump">124,800<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ALRT_ConsultingFeesToDirectorOfCompanySettledWithIssuanceOfCommonStock', window );">Consulting fees to a director of the Company settled with issuance of common stock</a></td>
<td class="nump">40,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">40,000<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ALRT_SalaryForServicesAsVpCorporateAndDirectorOfSingaporeSubsidiaryToSpouseOfChairmanAndChiefExecutiveOfficerOfCompany', window );">Salary for services as VP Corporate and director of the Singapore subsidiary to the spouse of the Chairman and Chief Executive Officer of the Company</a></td>
<td class="nump">10,890<span></span>
</td>
<td class="nump">11,254<span></span>
</td>
<td class="nump">21,981<span></span>
</td>
<td class="nump">11,254<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ALRT_LossOnSettlementOfDebtToRelativeOfChairmanAndChiefExecutiveOfficerOfCompany', window );">Loss on settlement of debt to a relative of the Chairman and Chief Executive Officer of the Company</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">16,800<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">16,800<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ALRT_RentPaidToCompanyControlledBySpouseOfChairmanAndImmediateFamilyMembers', window );">Rent paid to a company controlled by the spouse of the Chairman and immediate family members</a></td>
<td class="nump">$ 8,006<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 20,206<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ALRT_ConsultingFeesToChairmanAndChiefExecutiveOfficerOfCompanyAccruedOnLineOfCreditAvailableToCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ALRT_ConsultingFeesToChairmanAndChiefExecutiveOfficerOfCompanyAccruedOnLineOfCreditAvailableToCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ALRT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ALRT_ConsultingFeesToDirectorOfCompanySettledWithIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ALRT_ConsultingFeesToDirectorOfCompanySettledWithIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ALRT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ALRT_InterestExpenseOnLinesOfCreditPayableToChairmanAndChiefExecutiveOfficerOfCompanyAndHisSpouse">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ALRT_InterestExpenseOnLinesOfCreditPayableToChairmanAndChiefExecutiveOfficerOfCompanyAndHisSpouse</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ALRT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ALRT_InterestExpenseOnPromissoryNotesIssuedToRelativesOfChairmanAndChiefExecutiveOfficerOfCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ALRT_InterestExpenseOnPromissoryNotesIssuedToRelativesOfChairmanAndChiefExecutiveOfficerOfCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ALRT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ALRT_InterestExpenseRelatedToModificationOfStockOptionsHeldByChairmanAndChiefExecutiveOfficerOfCompanyAndHisSpouseRelatedToFinancingProvided">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ALRT_InterestExpenseRelatedToModificationOfStockOptionsHeldByChairmanAndChiefExecutiveOfficerOfCompanyAndHisSpouseRelatedToFinancingProvided</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ALRT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ALRT_LossOnSettlementOfDebtToRelativeOfChairmanAndChiefExecutiveOfficerOfCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ALRT_LossOnSettlementOfDebtToRelativeOfChairmanAndChiefExecutiveOfficerOfCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ALRT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ALRT_RelatedPartyTransactionIncludedWithinInterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ALRT_RelatedPartyTransactionIncludedWithinInterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ALRT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ALRT_RelatedPartyTransactionsIncludingWithinSellingGeneralAndAdministrationExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ALRT_RelatedPartyTransactionsIncludingWithinSellingGeneralAndAdministrationExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ALRT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ALRT_RentPaidToCompanyControlledBySpouseOfChairmanAndImmediateFamilyMembers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ALRT_RentPaidToCompanyControlledBySpouseOfChairmanAndImmediateFamilyMembers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ALRT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ALRT_SalaryForServicesAsVpCorporateAndDirectorOfSingaporeSubsidiaryToSpouseOfChairmanAndChiefExecutiveOfficerOfCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ALRT_SalaryForServicesAsVpCorporateAndDirectorOfSingaporeSubsidiaryToSpouseOfChairmanAndChiefExecutiveOfficerOfCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ALRT_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140629362246992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Operating segments (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Current and Total Assets</a></td>
<td class="nump">$ 96,327<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 96,327<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 193,217<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenue</a></td>
<td class="nump">980<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">2,023<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Loss</a></td>
<td class="num">(1,487,766)<span></span>
</td>
<td class="num">$ (2,320,530)<span></span>
</td>
<td class="num">(2,892,615)<span></span>
</td>
<td class="num">(3,337,453)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=ALRT_OtherMember', window );">Other [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Current and Total Assets</a></td>
<td class="nump">15,327<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,327<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,547<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,457)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_SG', window );">SINGAPORE</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Current and Total Assets</a></td>
<td class="nump">3,777<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,777<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">110,527<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,023<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(141,861)<span></span>
</td>
<td class="num">(77,666)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">UNITED STATES</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Current and Total Assets</a></td>
<td class="nump">$ 77,223<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">77,223<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 73,143<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (2,749,297)<span></span>
</td>
<td class="num">$ (3,259,787)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=ALRT_OtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=ALRT_OtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_SG">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_SG</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>sfsalr10q081122_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:ALRT="http://alrt.com/20220630"
  xmlns:country="http://xbrl.sec.gov/country/2022"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2022"
  xmlns:us-gaap="http://fasb.org/us-gaap/2022"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="alrt-20220630.xsd" xlink:type="simple"/>
    <context id="From2022-01-01to2022-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2022-08-15">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
        </entity>
        <period>
            <instant>2022-08-15</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="From2022-04-012022-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2021-04-012021-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2020-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_RelatedPartyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ALRT:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_RelatedPartyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ALRT:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_RelatedPartyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ALRT:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="From2022-01-012022-06-30_custom_RelatedPartyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ALRT:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2022-06-30_custom_RelatedPartyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ALRT:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_UnRelatedPartyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ALRT:UnRelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_UnRelatedPartyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ALRT:UnRelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_UnRelatedPartyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ALRT:UnRelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="From2022-01-012022-06-30_custom_UnRelatedPartyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ALRT:UnRelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2022-06-30_custom_UnRelatedPartyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ALRT:UnRelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="From2021-01-012021-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-06-30_custom_ChairmanAndCEOMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">ALRT:ChairmanAndCEOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2022-06-30_custom_ChairmanAndCEOMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">ALRT:ChairmanAndCEOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="From2022-01-012022-06-30_custom_WifeOfChairmanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">ALRT:WifeOfChairmanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2022-06-30_custom_WifeOfChairmanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">ALRT:WifeOfChairmanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_ChairmanAndCEOMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">ALRT:ChairmanAndCEOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_ChairmanAndCEOMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">ALRT:ChairmanAndCEOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_WifeOfChairmanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">ALRT:WifeOfChairmanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_WifeOfChairmanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">ALRT:WifeOfChairmanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="From2022-01-012022-06-30_custom_Options1Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_Options1Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-06-30_custom_Options2Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_Options2Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-06-30_custom_Options3Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_Options3Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-06-30_custom_Options4Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options4Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_Options4Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options4Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-06-30_custom_Options5Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options5Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_Options5Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options5Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-06-30_custom_Options6Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options6Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_Options6Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options6Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-06-30_custom_Options7Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options7Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_Options7Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options7Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-06-30_custom_Options8Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options8Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_Options8Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options8Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-06-30_custom_Options9Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options9Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_Options9Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options9Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-06-30_custom_Options10Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options10Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_Options10Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options10Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-06-30_custom_Options11Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options11Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_Options11Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options11Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-06-30_custom_Options12Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options12Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_Options12Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options12Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-06-30_custom_Options13Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options13Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_Options13Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options13Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-06-30_custom_Options14Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options14Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_Options14Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options14Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-06-30_custom_Options15Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options15Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_Options15Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options15Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-06-30_custom_Options16Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options16Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_Options16Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options16Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-06-30_custom_Options17Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options17Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_Options17Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options17Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-06-30_custom_Options18Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options18Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_Options18Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options18Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-06-30_custom_Options19Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options19Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_Options19Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options19Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-06-30_custom_Options20Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options20Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_Options20Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options20Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-06-30_custom_Options21Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options21Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_Options21Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options21Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-06-30_custom_Options22Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options22Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_Options22Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options22Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-06-30_custom_Options23Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options23Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_Options23Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ALRT:Options23Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2022-06-30_custom_OtherMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">ALRT:OtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_OtherMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">ALRT:OtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_country_SG">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:SG</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_country_SG">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:SG</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_country_US">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_country_US">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="From2022-01-012022-06-30_custom_OtherMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">ALRT:OtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-06-30_custom_OtherMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">ALRT:OtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-06-30_country_SG">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:SG</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-06-30_country_SG">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:SG</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-06-30_country_US">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-06-30_country_US">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001087022</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="Pure">
        <measure>pure</measure>
    </unit>
    <dei:EntityCentralIndexKey contextRef="From2022-01-01to2022-06-30">0001087022</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="From2022-01-01to2022-06-30">false</dei:AmendmentFlag>
    <dei:CurrentFiscalYearEndDate contextRef="From2022-01-01to2022-06-30">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalYearFocus contextRef="From2022-01-01to2022-06-30">2022</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus contextRef="From2022-01-01to2022-06-30">Q2</dei:DocumentFiscalPeriodFocus>
    <dei:EntityCurrentReportingStatus contextRef="From2022-01-01to2022-06-30" id="xdx2ixbrl0030">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent contextRef="From2022-01-01to2022-06-30" id="xdx2ixbrl0031">Yes</dei:EntityInteractiveDataCurrent>
    <us-gaap:PreferredStockValue
      contextRef="AsOf2022-06-30"
      id="xdx2ixbrl0097"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="AsOf2021-12-31"
      id="xdx2ixbrl0099"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:Revenues
      contextRef="From2021-04-012021-06-30"
      id="xdx2ixbrl0137"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:Revenues
      contextRef="From2021-01-012021-06-30"
      id="xdx2ixbrl0139"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CostOfRevenue
      contextRef="From2021-04-012021-06-30"
      id="xdx2ixbrl0142"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CostOfRevenue
      contextRef="From2021-01-012021-06-30"
      id="xdx2ixbrl0144"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:GrossProfit
      contextRef="From2021-04-012021-06-30"
      id="xdx2ixbrl0147"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:GrossProfit
      contextRef="From2021-01-012021-06-30"
      id="xdx2ixbrl0149"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="From2022-04-012022-06-30"
      id="xdx2ixbrl0191"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="From2022-01-01to2022-06-30"
      id="xdx2ixbrl0193"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax
      contextRef="From2021-04-012021-06-30"
      id="xdx2ixbrl0212"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax
      contextRef="From2021-01-012021-06-30"
      id="xdx2ixbrl0214"
      unitRef="USD"
      xsi:nil="true"/>
    <ALRT:StockbasedCompensationgeneralSellingAndAdministration
      contextRef="From2021-01-012021-06-30"
      id="xdx2ixbrl0241"
      unitRef="USD"
      xsi:nil="true"/>
    <ALRT:StockbasedCompensationinterest
      contextRef="From2022-01-01to2022-06-30"
      id="xdx2ixbrl0246"
      unitRef="USD"
      xsi:nil="true"/>
    <ALRT:BonusesSettledByIssuanceOfShares
      contextRef="From2021-01-012021-06-30"
      id="xdx2ixbrl0256"
      unitRef="USD"
      xsi:nil="true"/>
    <ALRT:LossOnSettlementOfDebt
      contextRef="From2022-01-01to2022-06-30"
      id="xdx2ixbrl0258"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="From2021-01-012021-06-30"
      id="xdx2ixbrl0283"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="From2021-01-012021-06-30"
      id="xdx2ixbrl0295"
      unitRef="USD"
      xsi:nil="true"/>
    <ALRT:UnsecuredPromissoryNotesPayableToRelativesOfChairmanWithFixedAmountsOfInterestDueAugust312022
      contextRef="AsOf2021-12-31"
      id="xdx2ixbrl0399"
      unitRef="USD"
      xsi:nil="true"/>
    <ALRT:UnsecuredPromissoryNotesPayableToUnrelatedLendersWithFixedAmountsOfInterestDue
      contextRef="AsOf2021-12-31"
      id="xdx2ixbrl0451"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
      contextRef="From2022-01-01to2022-06-30"
      id="xdx2ixbrl0655"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="From2022-01-01to2022-06-30"
      id="xdx2ixbrl0657"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="From2022-01-01to2022-06-30"
      id="xdx2ixbrl0663"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="From2022-01-01to2022-06-30"
      id="xdx2ixbrl0665"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <ALRT:OpenOptionContractsWrittenNumbersOfShare
      contextRef="From2022-01-012022-06-30_custom_Options11Member"
      id="xdx2ixbrl0854"
      unitRef="Shares"
      xsi:nil="true"/>
    <ALRT:ExercisePrices
      contextRef="From2022-01-012022-06-30_custom_Options11Member"
      id="xdx2ixbrl0856"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <ALRT:IntrinsicValue
      contextRef="From2022-01-012022-06-30_custom_Options11Member"
      id="xdx2ixbrl0858"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <ALRT:OpenOptionContractsWrittenNumbersOfShare
      contextRef="From2022-01-012022-06-30_custom_Options12Member"
      id="xdx2ixbrl0866"
      unitRef="Shares"
      xsi:nil="true"/>
    <ALRT:ExercisePrices
      contextRef="From2022-01-012022-06-30_custom_Options12Member"
      id="xdx2ixbrl0868"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <ALRT:IntrinsicValue
      contextRef="From2022-01-012022-06-30_custom_Options12Member"
      id="xdx2ixbrl0870"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <ALRT:OpenOptionContractsWrittenNumbersOfShare
      contextRef="From2022-01-012022-06-30_custom_Options13Member"
      id="xdx2ixbrl0878"
      unitRef="Shares"
      xsi:nil="true"/>
    <ALRT:ExercisePrices
      contextRef="From2022-01-012022-06-30_custom_Options13Member"
      id="xdx2ixbrl0880"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <ALRT:IntrinsicValue
      contextRef="From2022-01-012022-06-30_custom_Options13Member"
      id="xdx2ixbrl0882"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <us-gaap:InterestExpenseDebt
      contextRef="From2022-04-012022-06-30"
      id="xdx2ixbrl1039"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:InterestExpenseDebt
      contextRef="From2022-01-01to2022-06-30"
      id="xdx2ixbrl1041"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherSellingGeneralAndAdministrativeExpense
      contextRef="From2021-04-012021-06-30"
      id="xdx2ixbrl1055"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherSellingGeneralAndAdministrativeExpense
      contextRef="From2021-01-012021-06-30"
      id="xdx2ixbrl1057"
      unitRef="USD"
      xsi:nil="true"/>
    <ALRT:InterestExpenseRelatedToModificationOfStockOptionsHeldByChairmanAndChiefExecutiveOfficerOfCompanyAndHisSpouseRelatedToFinancingProvided
      contextRef="From2022-04-012022-06-30"
      id="xdx2ixbrl1105"
      unitRef="USD"
      xsi:nil="true"/>
    <ALRT:InterestExpenseRelatedToModificationOfStockOptionsHeldByChairmanAndChiefExecutiveOfficerOfCompanyAndHisSpouseRelatedToFinancingProvided
      contextRef="From2022-01-01to2022-06-30"
      id="xdx2ixbrl1107"
      unitRef="USD"
      xsi:nil="true"/>
    <ALRT:ConsultingFeesToDirectorOfCompanySettledWithIssuanceOfCommonStock
      contextRef="From2021-04-012021-06-30"
      id="xdx2ixbrl1121"
      unitRef="USD"
      xsi:nil="true"/>
    <ALRT:ConsultingFeesToDirectorOfCompanySettledWithIssuanceOfCommonStock
      contextRef="From2021-01-012021-06-30"
      id="xdx2ixbrl1123"
      unitRef="USD"
      xsi:nil="true"/>
    <ALRT:LossOnSettlementOfDebtToRelativeOfChairmanAndChiefExecutiveOfficerOfCompany
      contextRef="From2022-04-012022-06-30"
      id="xdx2ixbrl1130"
      unitRef="USD"
      xsi:nil="true"/>
    <ALRT:LossOnSettlementOfDebtToRelativeOfChairmanAndChiefExecutiveOfficerOfCompany
      contextRef="From2022-01-01to2022-06-30"
      id="xdx2ixbrl1132"
      unitRef="USD"
      xsi:nil="true"/>
    <ALRT:RentPaidToCompanyControlledBySpouseOfChairmanAndImmediateFamilyMembers
      contextRef="From2021-04-012021-06-30"
      id="xdx2ixbrl1136"
      unitRef="USD"
      xsi:nil="true"/>
    <ALRT:RentPaidToCompanyControlledBySpouseOfChairmanAndImmediateFamilyMembers
      contextRef="From2021-01-012021-06-30"
      id="xdx2ixbrl1138"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:Revenues
      contextRef="From2022-01-012022-06-30_custom_OtherMember"
      id="xdx2ixbrl1191"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:Revenues
      contextRef="From2021-01-012021-06-30_custom_OtherMember"
      id="xdx2ixbrl1193"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:Revenues
      contextRef="From2021-01-012021-06-30_country_SG"
      id="xdx2ixbrl1197"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:Revenues
      contextRef="From2022-01-012022-06-30_country_US"
      id="xdx2ixbrl1199"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:Revenues
      contextRef="From2021-01-012021-06-30_country_US"
      id="xdx2ixbrl1201"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:Revenues
      contextRef="From2021-01-012021-06-30"
      id="xdx2ixbrl1205"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-01-012021-06-30_custom_OtherMember"
      id="xdx2ixbrl1209"
      unitRef="USD"
      xsi:nil="true"/>
    <dei:DocumentType contextRef="From2022-01-01to2022-06-30">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport contextRef="From2022-01-01to2022-06-30">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate contextRef="From2022-01-01to2022-06-30">2022-06-30</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport contextRef="From2022-01-01to2022-06-30">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber contextRef="From2022-01-01to2022-06-30">000-30414</dei:EntityFileNumber>
    <dei:EntityRegistrantName contextRef="From2022-01-01to2022-06-30">ALR TECHNOLOGIES INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="From2022-01-01to2022-06-30">NV</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber contextRef="From2022-01-01to2022-06-30">88-0225807</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="From2022-01-01to2022-06-30">7400 Beaufont Springs Drive</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="From2022-01-01to2022-06-30">Suite 300</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="From2022-01-01to2022-06-30">Richmond</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="From2022-01-01to2022-06-30">VA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="From2022-01-01to2022-06-30">23225</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="From2022-01-01to2022-06-30">(804)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="From2022-01-01to2022-06-30">554-3500</dei:LocalPhoneNumber>
    <dei:EntityFilerCategory contextRef="From2022-01-01to2022-06-30">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness contextRef="From2022-01-01to2022-06-30">true</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany contextRef="From2022-01-01to2022-06-30">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany contextRef="From2022-01-01to2022-06-30">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding contextRef="AsOf2022-08-15" decimals="INF" unitRef="Shares">551966844</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:Cash contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">8996</us-gaap:Cash>
    <us-gaap:Cash contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">115922</us-gaap:Cash>
    <us-gaap:PrepaidExpenseCurrent contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">87331</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:PrepaidExpenseCurrent contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">77295</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:Assets contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">96327</us-gaap:Assets>
    <us-gaap:Assets contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">193217</us-gaap:Assets>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">1330196</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">1130546</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <ALRT:PromissoryNotesPayableToRelatedParties contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">3091966</ALRT:PromissoryNotesPayableToRelatedParties>
    <ALRT:PromissoryNotesPayableToRelatedParties contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">3041966</ALRT:PromissoryNotesPayableToRelatedParties>
    <ALRT:PromissoryNotesPayableUnrelatedLender contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">2457726</ALRT:PromissoryNotesPayableUnrelatedLender>
    <ALRT:PromissoryNotesPayableUnrelatedLender contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">2213368</ALRT:PromissoryNotesPayableUnrelatedLender>
    <us-gaap:InterestPayableCurrent contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">4388068</us-gaap:InterestPayableCurrent>
    <us-gaap:InterestPayableCurrent contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">4110647</us-gaap:InterestPayableCurrent>
    <ALRT:LinesOfCreditFromRelatedParties contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">15087038</ALRT:LinesOfCreditFromRelatedParties>
    <ALRT:LinesOfCreditFromRelatedParties contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">14008833</ALRT:LinesOfCreditFromRelatedParties>
    <us-gaap:Liabilities contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">26354994</us-gaap:Liabilities>
    <us-gaap:Liabilities contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">24505360</us-gaap:Liabilities>
    <us-gaap:PreferredStockSharesAuthorized contextRef="AsOf2022-06-30" decimals="INF" unitRef="Shares">500000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized contextRef="AsOf2021-12-31" decimals="INF" unitRef="Shares">500000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2022-06-30"
      decimals="INF"
      unitRef="USDPShares">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2021-12-31"
      decimals="INF"
      unitRef="USDPShares">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesIssued contextRef="AsOf2022-06-30" decimals="INF" unitRef="Shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding contextRef="AsOf2022-06-30" decimals="INF" unitRef="Shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued contextRef="AsOf2021-12-31" decimals="INF" unitRef="Shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding contextRef="AsOf2021-12-31" decimals="INF" unitRef="Shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:CommonStockSharesAuthorized contextRef="AsOf2022-06-30" decimals="INF" unitRef="Shares">10000000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized contextRef="AsOf2021-12-31" decimals="INF" unitRef="Shares">10000000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2022-06-30"
      decimals="INF"
      unitRef="USDPShares">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2021-12-31"
      decimals="INF"
      unitRef="USDPShares">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesIssued contextRef="AsOf2022-06-30" decimals="INF" unitRef="Shares">551966844</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding contextRef="AsOf2022-06-30" decimals="INF" unitRef="Shares">551966844</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued contextRef="AsOf2021-12-31" decimals="INF" unitRef="Shares">542716344</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding contextRef="AsOf2021-12-31" decimals="INF" unitRef="Shares">542716344</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">551966</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">542716</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">78103332</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">77171627</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">-6273</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">-11409</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">-104907692</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">-102015077</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">-26258667</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">-24312143</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">96327</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">193217</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:Revenues
      contextRef="From2022-04-012022-06-30"
      decimals="0"
      unitRef="USD">980</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2022-01-01to2022-06-30"
      decimals="0"
      unitRef="USD">2023</us-gaap:Revenues>
    <us-gaap:CostOfRevenue
      contextRef="From2022-04-012022-06-30"
      decimals="0"
      unitRef="USD">444</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="From2022-01-01to2022-06-30"
      decimals="0"
      unitRef="USD">1038</us-gaap:CostOfRevenue>
    <us-gaap:GrossProfit
      contextRef="From2022-04-012022-06-30"
      decimals="0"
      unitRef="USD">536</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="From2022-01-01to2022-06-30"
      decimals="0"
      unitRef="USD">985</us-gaap:GrossProfit>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="From2022-04-012022-06-30"
      decimals="0"
      unitRef="USD">121551</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="From2021-04-012021-06-30"
      decimals="0"
      unitRef="USD">128157</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="From2022-01-01to2022-06-30"
      decimals="0"
      unitRef="USD">249771</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="From2021-01-012021-06-30"
      decimals="0"
      unitRef="USD">240199</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ProfessionalFees
      contextRef="From2022-04-012022-06-30"
      decimals="0"
      unitRef="USD">352943</us-gaap:ProfessionalFees>
    <us-gaap:ProfessionalFees
      contextRef="From2021-04-012021-06-30"
      decimals="0"
      unitRef="USD">138890</us-gaap:ProfessionalFees>
    <us-gaap:ProfessionalFees
      contextRef="From2022-01-01to2022-06-30"
      decimals="0"
      unitRef="USD">524560</us-gaap:ProfessionalFees>
    <us-gaap:ProfessionalFees
      contextRef="From2021-01-012021-06-30"
      decimals="0"
      unitRef="USD">356118</us-gaap:ProfessionalFees>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="From2022-04-012022-06-30"
      decimals="0"
      unitRef="USD">454680</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="From2021-04-012021-06-30"
      decimals="0"
      unitRef="USD">215466</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="From2022-01-01to2022-06-30"
      decimals="0"
      unitRef="USD">1009505</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="From2021-01-012021-06-30"
      decimals="0"
      unitRef="USD">423752</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2022-04-012022-06-30"
      decimals="0"
      unitRef="USD">-929174</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2021-04-012021-06-30"
      decimals="0"
      unitRef="USD">-482513</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2022-01-01to2022-06-30"
      decimals="0"
      unitRef="USD">-1783836</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2021-01-012021-06-30"
      decimals="0"
      unitRef="USD">-1020069</us-gaap:OperatingIncomeLoss>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2022-04-012022-06-30"
      decimals="0"
      unitRef="USD">-928638</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2021-04-012021-06-30"
      decimals="0"
      unitRef="USD">-482513</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2022-01-01to2022-06-30"
      decimals="0"
      unitRef="USD">-1782851</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2021-01-012021-06-30"
      decimals="0"
      unitRef="USD">-1020069</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:InterestExpense
      contextRef="From2022-04-012022-06-30"
      decimals="0"
      unitRef="USD">559128</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="From2021-04-012021-06-30"
      decimals="0"
      unitRef="USD">1804403</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="From2022-01-01to2022-06-30"
      decimals="0"
      unitRef="USD">1109764</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="From2021-01-012021-06-30"
      decimals="0"
      unitRef="USD">2283770</us-gaap:InterestExpense>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="From2021-04-012021-06-30"
      decimals="0"
      unitRef="USD">-33614</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="From2021-01-012021-06-30"
      decimals="0"
      unitRef="USD">-33614</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="From2022-04-012022-06-30"
      decimals="0"
      unitRef="USD">-559128</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="From2021-04-012021-06-30"
      decimals="0"
      unitRef="USD">-1838017</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="From2022-01-01to2022-06-30"
      decimals="0"
      unitRef="USD">-1109764</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="From2021-01-012021-06-30"
      decimals="0"
      unitRef="USD">-2317384</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-04-012022-06-30"
      decimals="0"
      unitRef="USD">-1487766</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-04-012021-06-30"
      decimals="0"
      unitRef="USD">-2320530</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-01-01to2022-06-30"
      decimals="0"
      unitRef="USD">-2892615</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-01-012021-06-30"
      decimals="0"
      unitRef="USD">-3337453</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax
      contextRef="From2022-04-012022-06-30"
      decimals="0"
      unitRef="USD">-6067</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax
      contextRef="From2022-01-01to2022-06-30"
      decimals="0"
      unitRef="USD">-5136</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="From2022-04-012022-06-30"
      decimals="0"
      unitRef="USD">-1481699</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="From2021-04-012021-06-30"
      decimals="0"
      unitRef="USD">-2320530</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="From2022-01-01to2022-06-30"
      decimals="0"
      unitRef="USD">-2887479</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="From2021-01-012021-06-30"
      decimals="0"
      unitRef="USD">-3337453</us-gaap:ComprehensiveIncomeNetOfTax>
    <ALRT:WeightedAverageNumberOfSharesOfCommonStockOutstandingBasicAndDiluted
      contextRef="From2022-04-012022-06-30"
      decimals="INF"
      unitRef="Shares">545491844</ALRT:WeightedAverageNumberOfSharesOfCommonStockOutstandingBasicAndDiluted>
    <ALRT:WeightedAverageNumberOfSharesOfCommonStockOutstandingBasicAndDiluted
      contextRef="From2021-04-012021-06-30"
      decimals="INF"
      unitRef="Shares">532676344</ALRT:WeightedAverageNumberOfSharesOfCommonStockOutstandingBasicAndDiluted>
    <ALRT:WeightedAverageNumberOfSharesOfCommonStockOutstandingBasicAndDiluted
      contextRef="From2022-01-01to2022-06-30"
      decimals="INF"
      unitRef="Shares">544104125</ALRT:WeightedAverageNumberOfSharesOfCommonStockOutstandingBasicAndDiluted>
    <ALRT:WeightedAverageNumberOfSharesOfCommonStockOutstandingBasicAndDiluted
      contextRef="From2021-01-012021-06-30"
      decimals="INF"
      unitRef="Shares">527072440</ALRT:WeightedAverageNumberOfSharesOfCommonStockOutstandingBasicAndDiluted>
    <ALRT:LossPerShareBasicAndDiluted
      contextRef="From2022-04-012022-06-30"
      decimals="INF"
      unitRef="USDPShares">-0.00</ALRT:LossPerShareBasicAndDiluted>
    <ALRT:LossPerShareBasicAndDiluted
      contextRef="From2021-04-012021-06-30"
      decimals="INF"
      unitRef="USDPShares">-0.00</ALRT:LossPerShareBasicAndDiluted>
    <ALRT:LossPerShareBasicAndDiluted
      contextRef="From2022-01-01to2022-06-30"
      decimals="INF"
      unitRef="USDPShares">-0.01</ALRT:LossPerShareBasicAndDiluted>
    <ALRT:LossPerShareBasicAndDiluted
      contextRef="From2021-01-012021-06-30"
      decimals="INF"
      unitRef="USDPShares">-0.01</ALRT:LossPerShareBasicAndDiluted>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="From2022-01-01to2022-06-30"
      decimals="0"
      unitRef="USD">2892615</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="From2021-01-012021-06-30"
      decimals="0"
      unitRef="USD">3337453</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <ALRT:StockbasedCompensationproductDevelopmentCosts
      contextRef="From2022-01-01to2022-06-30"
      decimals="0"
      unitRef="USD">-118586</ALRT:StockbasedCompensationproductDevelopmentCosts>
    <ALRT:StockbasedCompensationproductDevelopmentCosts
      contextRef="From2021-01-012021-06-30"
      decimals="0"
      unitRef="USD">-97842</ALRT:StockbasedCompensationproductDevelopmentCosts>
    <ALRT:StockbasedCompensationgeneralSellingAndAdministration
      contextRef="From2022-01-01to2022-06-30"
      decimals="0"
      unitRef="USD">382157</ALRT:StockbasedCompensationgeneralSellingAndAdministration>
    <ALRT:StockbasedCompensationProfessionalFees
      contextRef="From2022-01-01to2022-06-30"
      decimals="0"
      unitRef="USD">17916</ALRT:StockbasedCompensationProfessionalFees>
    <ALRT:StockbasedCompensationProfessionalFees
      contextRef="From2021-01-012021-06-30"
      decimals="0"
      unitRef="USD">43295</ALRT:StockbasedCompensationProfessionalFees>
    <ALRT:StockbasedCompensationinterest
      contextRef="From2021-01-012021-06-30"
      decimals="0"
      unitRef="USD">1287834</ALRT:StockbasedCompensationinterest>
    <ALRT:InterestExpenseOnLinesOfCredit
      contextRef="From2022-01-01to2022-06-30"
      decimals="0"
      unitRef="USD">777515</ALRT:InterestExpenseOnLinesOfCredit>
    <ALRT:InterestExpenseOnLinesOfCredit
      contextRef="From2021-01-012021-06-30"
      decimals="0"
      unitRef="USD">670452</ALRT:InterestExpenseOnLinesOfCredit>
    <ALRT:NoncashImputedInterestExpenses
      contextRef="From2022-01-01to2022-06-30"
      decimals="0"
      unitRef="USD">52271</ALRT:NoncashImputedInterestExpenses>
    <ALRT:NoncashImputedInterestExpenses
      contextRef="From2021-01-012021-06-30"
      decimals="0"
      unitRef="USD">60059</ALRT:NoncashImputedInterestExpenses>
    <ALRT:BonusesSettledByIssuanceOfShares
      contextRef="From2022-01-01to2022-06-30"
      decimals="0"
      unitRef="USD">245000</ALRT:BonusesSettledByIssuanceOfShares>
    <ALRT:LossOnSettlementOfDebt
      contextRef="From2021-01-012021-06-30"
      decimals="0"
      unitRef="USD">-33614</ALRT:LossOnSettlementOfDebt>
    <us-gaap:IncreaseDecreaseInPrepaidExpense
      contextRef="From2022-01-01to2022-06-30"
      decimals="0"
      unitRef="USD">10036</us-gaap:IncreaseDecreaseInPrepaidExpense>
    <us-gaap:IncreaseDecreaseInPrepaidExpense
      contextRef="From2021-01-012021-06-30"
      decimals="0"
      unitRef="USD">-5103</us-gaap:IncreaseDecreaseInPrepaidExpense>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="From2022-01-01to2022-06-30"
      decimals="0"
      unitRef="USD">324650</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="From2021-01-012021-06-30"
      decimals="0"
      unitRef="USD">17736</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInInterestPayableNet
      contextRef="From2022-01-01to2022-06-30"
      decimals="0"
      unitRef="USD">277421</us-gaap:IncreaseDecreaseInInterestPayableNet>
    <us-gaap:IncreaseDecreaseInInterestPayableNet
      contextRef="From2021-01-012021-06-30"
      decimals="0"
      unitRef="USD">264100</us-gaap:IncreaseDecreaseInInterestPayableNet>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="From2022-01-01to2022-06-30"
      decimals="0"
      unitRef="USD">-707135</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="From2021-01-012021-06-30"
      decimals="0"
      unitRef="USD">-857418</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:ProceedsFromLinesOfCredit
      contextRef="From2022-01-01to2022-06-30"
      decimals="0"
      unitRef="USD">438165</us-gaap:ProceedsFromLinesOfCredit>
    <us-gaap:ProceedsFromLinesOfCredit
      contextRef="From2021-01-012021-06-30"
      decimals="0"
      unitRef="USD">401758</us-gaap:ProceedsFromLinesOfCredit>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="From2022-01-01to2022-06-30"
      decimals="0"
      unitRef="USD">294358</us-gaap:ProceedsFromConvertibleDebt>
    <ALRT:RepaymentOfLinesOfCreditInterest
      contextRef="From2022-01-01to2022-06-30"
      decimals="0"
      unitRef="USD">137475</ALRT:RepaymentOfLinesOfCreditInterest>
    <ALRT:RepaymentOfLinesOfCreditInterest
      contextRef="From2021-01-012021-06-30"
      decimals="0"
      unitRef="USD">370723</ALRT:RepaymentOfLinesOfCreditInterest>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="From2022-01-01to2022-06-30"
      decimals="0"
      unitRef="USD">25</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="From2021-01-012021-06-30"
      decimals="0"
      unitRef="USD">1136832</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="From2022-01-01to2022-06-30"
      decimals="0"
      unitRef="USD">595073</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="From2021-01-012021-06-30"
      decimals="0"
      unitRef="USD">1167867</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="From2022-01-01to2022-06-30"
      decimals="0"
      unitRef="USD">5136</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="From2022-01-01to2022-06-30"
      decimals="0"
      unitRef="USD">-106926</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="From2021-01-012021-06-30"
      decimals="0"
      unitRef="USD">310449</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">115922</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">66190</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">8996</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations contextRef="AsOf2021-06-30" decimals="0" unitRef="USD">376639</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock contextRef="From2022-01-01to2022-06-30">&lt;p id="xdx_80D_eus-gaap--BusinessDescriptionAndBasisOfPresentationTextBlock_zSW4x2kpNIM3" style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;1.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;span id="xdx_827_zpX6MzaLLNo3"&gt;Basis
of presentation, nature of operations and going concern&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;ALR
Technologies Inc. (the &#x201c;&lt;b&gt;Company&lt;/b&gt;&#x201d;) was incorporated under the laws of the state of Nevada on March&#160;24, 1987. On
May&#160;16, 2020, the Company incorporated a wholly owned subsidiary, ALR Technologies Sg Pte. Ltd. (&#x201c;&lt;b&gt;ALR Singapore&lt;/b&gt;&#x201d;),
under the &lt;i&gt;Companies Act&lt;/i&gt; of Singapore. On June&#160;9, 2021, the Company incorporated a wholly owned subsidiary, Canada Diabetes
Solution Centre, Inc., under the &lt;i&gt;Business Corporations Act &lt;/i&gt;of Alberta.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
May 17, 2022, the Company entered into an Agreement and Plan of Merger and Reorganization (the &#x201c;&lt;b&gt;Redomicile Merger Agreement&lt;/b&gt;&#x201d;)
with ALR Technologies SG Pte. Ltd., a Singapore company limited by shares, and its wholly-owned subsidiary, ALRT Delaware, Inc., a Delaware
corporation (&#x201c;&lt;b&gt;ALR Delaware&lt;/b&gt;&#x201d;), relating to a proposed merger transaction for the sole purpose of changing the Company&#x2019;s
jurisdiction of incorporation from Nevada to Singapore. The Redomicile Merger Agreement provides that, upon the terms and subject to
the conditions set forth therein, ALR Delaware will merge with and into the Company (the &#x201c;&lt;b&gt;Redomicile Merger&lt;/b&gt;&#x201d;), and
the Company will be the surviving entity and a wholly-owned subsidiary of ALR Singapore. ALR Delaware will cease to exist. At the closing
of the Redomicile Merger, the stockholders of the Company will exchange their shares of common stock, and any options or warrants to
purchase shares of common stock which they might hold, on a one-for-one basis, for ordinary shares (&#x201c;&lt;b&gt;ALR Singapore Ordinary
Shares&lt;/b&gt;&#x201d;) and options or warrants to subscribe for ALR Singapore Ordinary Shares, as applicable. This Agreement contains customary
closing conditions, including, among others, approval of the Redomicile Merger by the Company&#x2019;s stockholders, the effectiveness
of the registration statement on Form F-4 filed by ALR Singapore related to the Redomicile Merger, and receipt of required regulatory
approvals.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company has developed its &#x201c;&lt;b&gt;Diabetes Solution&lt;/b&gt;&#x201d;, which is a comprehensive approach to diabetes care consisting of data
collection, predictive A1C, insulin dosage adjustment suggestions, performance tracking, remote monitoring and diabetes test supplies.
The Company is seeking commercial opportunities to deploy the Diabetes Solution and GluCurve Pet CGM.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/12pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/12pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;These
unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles
in the United States of America (&#x201c;&lt;b&gt;U.S. GAAP&lt;/b&gt;&#x201d;) in U.S. dollars and on a going concern basis, which presumes the realization
of assets and the discharge of liabilities and commitments in the normal course of operations for the foreseeable future. Several adverse
conditions cast substantial doubt on the validity of this assumption. The Company has incurred significant losses over the six-month
periods ended June&#160;30, 2022 and 2021 of $&lt;span id="xdx_907_eus-gaap--ProfitLoss_iN_pp0p0_di_c20220101__20220630_zsqT71PrnD37" title="Net loss"&gt;2,892,615&lt;/span&gt; and $&lt;span id="xdx_90A_eus-gaap--ProfitLoss_iN_pp0p0_di_c20210101__20210630_zUBZpjQFoi4j" title="Net loss"&gt;3,337,453&lt;/span&gt;, respectively. As of June&#160;30, 2022, the Company is unable
to self-finance its operations, has a working capital deficit of $&lt;span id="xdx_908_ecustom--WorkingCapitalDeficit_c20220630_pp0p0" title="Working capital deficit"&gt;26,258,667&lt;/span&gt; (December&#160;31, 2021&#160;- $&lt;span id="xdx_905_ecustom--WorkingCapitalDeficit_c20211231_pp0p0" title="Working capital deficit"&gt;24,312,143&lt;/span&gt;), accumulated
deficit of $&lt;span id="xdx_901_eus-gaap--RetainedEarningsAccumulatedDeficit_iNI_pp0p0_di_c20220630_zoR93beFpJL1" title="Accumulated deficit"&gt;104,907,692&lt;/span&gt; (December&#160;31, 2021&#160;- $&lt;span id="xdx_908_eus-gaap--RetainedEarningsAccumulatedDeficit_iNI_pp0p0_di_c20211231_zuDMIrhN9v23" title="Accumulated deficit"&gt;102,015,077&lt;/span&gt;), limited resources, no source of operating cash flow and no assurance
that sufficient funding will be available to conduct continued product development activities. If the Company is able to finance its
required product development activities, there is no assurance the Company&#x2019;s current projects will be commercially viable or profitable.
The Company has debts comprised of accounts payable and accrued liabilities, interest payable, lines of credit and promissory notes payable
totaling $26,354,994 currently due, due on demand or considered delinquent. There is no assurance that the Company will not face additional
legal action from creditors regarding delinquent accounts payable, promissory notes payable and interest payable. Any one or a combination
of these above conditions could result in the failure of the business and cause the Company to cease operations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;






















&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company&#x2019;s ability to continue as a going concern is dependent upon the continued financial support of its creditors and its ability
to obtain financing to fund working capital and overhead requirements, fund the development of the Company&#x2019;s product line, and
ultimately, the Company&#x2019;s ability to achieve profitable operations and repay overdue obligations. Management has obtained short-term
financing from related parties through line of credit facilities with available borrowing in principal up to $14,300,000. As of June&#160;30,
2022, the total principal balance outstanding was $&lt;span id="xdx_900_ecustom--PrincipalBorrowed_c20220630_pp0p0" title="Principal Borrowed"&gt;13,126,570&lt;/span&gt;. The resolution of whether the Company is able to continue as a going concern
is dependent upon the realization of management&#x2019;s plans. There can be no assurance that the Company will be able to raise any additional
debt or equity capital from the sources described above or that the lenders in the line of credit arrangements will maintain the availability
of borrowing from the line. If management is unsuccessful in obtaining short-term financing or achieving long-term profitable operations,
the Company will be required to cease operations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
March 2020, the World Health Organization declared coronavirus, COVID-19, a global pandemic. This contagious disease outbreak, which
has continued to spread, and any related adverse public health developments, has adversely affected workforces, economies and financial
markets globally, potentially leading to an economic downturn. Management does not expect that COVID-19 will have a significant impact
on the Company; however, it could have a potential impact on the Company&#x2019;s ability to raise money, market its products to attract
customers or procure equipment and parts for its glucose monitoring system.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/12pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/12pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;All
of the Company&#x2019;s debt is either due on demand or is in default, while continuing to accrue interest at its stated rate. The Company
will seek to obtain creditors&#x2019; consents to delay repayment of the outstanding promissory notes payable and related interest thereto,
until it is able to replace this financing with funds generated by operations, recapitalization with replacement debt or from equity
financings through private placements. While some of the Company&#x2019;s creditors have agreed to extend repayment deadlines in the past,
there is no assurance that they will continue to do so in the future. In the past, creditors have successfully commenced legal action
against the Company to recover debts outstanding. In those instances, the Company was able to obtain financing from related parties to
cover the verdict or settlement; however, there is no assurance that the Company would be able to obtain the same financing in the future.
If the Company is unsuccessful in obtaining financing to cover any potential verdicts or settlements, the Company will be required to
cease operations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/12pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company&#x2019;s activities will necessitate significant uses of working capital beyond 2022. Additionally, the Company&#x2019;s capital
requirements will depend on many factors, including the success of the Company&#x2019;s continued product development and distribution
efforts. The Company plans to continue financing its operations with the lines of credit it has available and other sources of financing.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock>
    <us-gaap:ProfitLoss
      contextRef="From2022-01-01to2022-06-30"
      decimals="0"
      unitRef="USD">-2892615</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="From2021-01-012021-06-30"
      decimals="0"
      unitRef="USD">-3337453</us-gaap:ProfitLoss>
    <ALRT:WorkingCapitalDeficit contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">26258667</ALRT:WorkingCapitalDeficit>
    <ALRT:WorkingCapitalDeficit contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">24312143</ALRT:WorkingCapitalDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">-104907692</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">-102015077</us-gaap:RetainedEarningsAccumulatedDeficit>
    <ALRT:PrincipalBorrowed contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">13126570</ALRT:PrincipalBorrowed>
    <us-gaap:SignificantAccountingPoliciesTextBlock contextRef="From2022-01-01to2022-06-30">&lt;p id="xdx_80C_eus-gaap--SignificantAccountingPoliciesTextBlock_zyJxA7JjDiDk" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;span id="xdx_82C_zu1sAKqAVhmh"&gt;Significant
accounting policies&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;These
unaudited condensed consolidated financial statements include the accounts of the Company and its wholly owned subsidiary, ALR Singapore,
which was incorporated on May&#160;16, 2020 in Singapore, and Canada Diabetes Solution Centre, Inc., which was incorporated on June&#160;9,
2021 in Alberta, Canada. The Canadian subsidiary is currently inactive. All significant intercompany balances and transactions have been
eliminated on consolidation.&lt;/span&gt;&lt;/p&gt;




















&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
unaudited condensed consolidated financial statements as of June&#160;30, 2022 and for the period then ended have been prepared pursuant
to the rules and regulations of the Securities and Exchange Commission. Certain information and note disclosures normally included in
annual consolidated financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to those rules
and regulations, although the Company believes that the disclosures made are adequate to make the information not misleading.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
the opinion of management, all adjustments necessary to present fairly the financial position as of June&#160;30, 2022 and December&#160;31,
2021 and the results of operations and cash flows as of June&#160;30, 2022 and 2021, and for the periods then ended, have been made.
Those adjustments consist of normal and recurring adjustments.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;These
unaudited condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes
thereto included in the Annual Report on Form 10-K for the fiscal year ended December&#160;31, 2021.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
results of operations for the six months ended June&#160;30, 2022 are not necessarily indicative of the results to be expected for the
full year.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock contextRef="From2022-01-01to2022-06-30">&lt;p id="xdx_80C_eus-gaap--AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_zZ4oF8qnvL1h" style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;3.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;span id="xdx_82E_zGWscJVie4F9"&gt;Accounts
payable and accrued liabilities&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;A
summary of the accounts payable and accrued liabilities is as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_882_eus-gaap--ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_zIAYmb31SlCl" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Accounts payable and accrued liabilities (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -6.25pt; padding-left: 6.25pt"&gt;&lt;span id="xdx_8B3_zMgg2L6UhlIa" style="display: none"&gt;Schedule of accounts payable and accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49A_20220630_zQWFngjJz4U" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49A_20211231_zCItUCjUFYCb" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;June 30,&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2022&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;December 31,&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2021&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--AccountsPayableCurrent_iI_pp0p0_maAPAALzyUX_zMouvasbIQD6" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 56%; text-align: left; text-indent: -6.25pt; padding-left: 6.25pt"&gt;Accounts payable&lt;/td&gt;&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;1,074,813&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;806,059&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--AccruedLiabilitiesCurrent_iI_pp0p0_maAPAALzyUX_zwThB4GEHg7l" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -6.25pt; padding-left: 6.25pt"&gt;Accrued liabilities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;255,039&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;322,087&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--DeferredRevenueCurrent_iI_pp0p0_maAPAALzyUX_z6HUqeJsjan9" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; text-indent: -6.25pt; padding-left: 6.25pt"&gt;Deferred revenue&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;344&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;2,400&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--AccountsPayableAndAccruedLiabilitiesCurrent_iTI_pp0p0_mtAPAALzyUX_zqkcBR7wzwS1" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="color: White; padding-bottom: 1pt; text-indent: -6.25pt; padding-left: 6.25pt"&gt;Accounts payable and accrued liabilities&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,330,196&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,130,546&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock>
    <us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock contextRef="From2022-01-01to2022-06-30">&lt;table cellpadding="0" cellspacing="0" id="xdx_882_eus-gaap--ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_zIAYmb31SlCl" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Accounts payable and accrued liabilities (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -6.25pt; padding-left: 6.25pt"&gt;&lt;span id="xdx_8B3_zMgg2L6UhlIa" style="display: none"&gt;Schedule of accounts payable and accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49A_20220630_zQWFngjJz4U" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49A_20211231_zCItUCjUFYCb" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;June 30,&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2022&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;December 31,&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2021&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--AccountsPayableCurrent_iI_pp0p0_maAPAALzyUX_zMouvasbIQD6" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 56%; text-align: left; text-indent: -6.25pt; padding-left: 6.25pt"&gt;Accounts payable&lt;/td&gt;&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;1,074,813&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;806,059&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--AccruedLiabilitiesCurrent_iI_pp0p0_maAPAALzyUX_zwThB4GEHg7l" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -6.25pt; padding-left: 6.25pt"&gt;Accrued liabilities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;255,039&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;322,087&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--DeferredRevenueCurrent_iI_pp0p0_maAPAALzyUX_z6HUqeJsjan9" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; text-indent: -6.25pt; padding-left: 6.25pt"&gt;Deferred revenue&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;344&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;2,400&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--AccountsPayableAndAccruedLiabilitiesCurrent_iTI_pp0p0_mtAPAALzyUX_zqkcBR7wzwS1" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="color: White; padding-bottom: 1pt; text-indent: -6.25pt; padding-left: 6.25pt"&gt;Accounts payable and accrued liabilities&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,330,196&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,130,546&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock>
    <us-gaap:AccountsPayableCurrent contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">1074813</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">806059</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccruedLiabilitiesCurrent contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">255039</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">322087</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:DeferredRevenueCurrent contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">344</us-gaap:DeferredRevenueCurrent>
    <us-gaap:DeferredRevenueCurrent contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">2400</us-gaap:DeferredRevenueCurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">1330196</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">1130546</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <ALRT:InterestAdvancesAndPromissoryNotesPayableTextBlock contextRef="From2022-01-01to2022-06-30">&lt;p id="xdx_800_ecustom--InterestAdvancesAndPromissoryNotesPayableTextBlock_zUYaTr9Iwxv2" style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;4.
&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;span id="xdx_824_z1Vnv4uahTTl"&gt;Interest, advances and promissory notes payable&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;Promissory
notes payable to related parties&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/12pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/12pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;A
summary of activities of promissory notes payable to related parties is as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/12pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89A_ecustom--SummaryOfActivitiesOfPromissoryNotesPayableTableTextBlock_z0bGHDOg43o5" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Interest, advances and promissory notes payable (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -7.6pt; padding-left: 17.05pt"&gt;&lt;span id="xdx_8BF_zx6hRVjkN568" style="display: none"&gt;Summary of activities of promissory notes payable&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right" title="Transferred from promissory notes payable pursuant to private transaction"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; text-indent: -7.6pt; padding-left: 17.05pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;Promissory Notes Payable to Related Parties&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Carrying Value&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 70%; text-indent: -6.25pt; padding-left: 6.25pt"&gt;Balance, December&#160;31, 2020&lt;/td&gt;&lt;td style="width: 10%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--NotesPayableRelatedPartiesClassifiedCurrent_iS_pp0p0_c20210101__20211231__us-gaap--DebtInstrumentAxis__custom--RelatedPartyMember_zhNUeKEsqmka" style="width: 18%; text-align: right" title="Carrying value at beginning"&gt;3,031,966&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; text-indent: -7.6pt; padding-left: 17.05pt"&gt;Transferred from promissory notes payable pursuant to private transaction&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_ecustom--TransferredFromPromissoryNotesPayablePursuantToPrivateTransaction._c20210101__20211231__us-gaap--DebtInstrumentAxis__custom--RelatedPartyMember_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Transferred from promissory notes payable pursuant to private transaction"&gt;10,000&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -6.25pt; padding-left: 6.25pt"&gt;Balance, December&#160;31, 2021&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--NotesPayableRelatedPartiesClassifiedCurrent_iS_pp0p0_c20220101__20220630__us-gaap--DebtInstrumentAxis__custom--RelatedPartyMember_zQhzLi4n7Tvk" style="text-align: right" title="Carrying value at beginning"&gt;3,041,966&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; text-indent: -7.6pt; padding-left: 17.05pt"&gt;Promissory notes received&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_ecustom--TransferredFromPromissoryNotesPayablePursuantToPrivateTransaction._pp0p0_c20220101__20220630__us-gaap--DebtInstrumentAxis__custom--RelatedPartyMember_zmUCm4bELTR2" style="border-bottom: Black 1pt solid; text-align: right" title="Transferred from promissory notes payable pursuant to private transaction"&gt;50,000&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt; text-indent: -6.25pt; padding-left: 6.25pt"&gt;Balance, June&#160;30, 2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--NotesPayableRelatedPartiesClassifiedCurrent_iE_pp0p0_c20220101__20220630__us-gaap--DebtInstrumentAxis__custom--RelatedPartyMember_zswjKOZmFJuf" style="border-bottom: Black 1pt solid; text-align: right" title="Carrying value at ending"&gt;3,091,966&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AB_zpYstANSzQ9k" style="font: 11pt/12pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
























&lt;p style="font: 11pt/12pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/12pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;A
summary of the promissory notes payable to related parties is as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/12pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89D_ecustom--ScheduleofPromissoryNotesPayableRelativesofBoardofDirectorsTableTextBlock_zTluJknl4cpc" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Interest, advances and promissory notes payable (Details 1)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -0.25in; padding-left: 0.5in"&gt;&lt;span id="xdx_8BF_zMWtijPXKJMd" style="display: none"&gt;Schedule of activity of promissory notes payable to related parties&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_490_20220630" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_495_20211231" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;Promissory Notes Payable to Related Parties&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;June 30,&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2022&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;December&#160;31, &lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2021&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_ecustom--PromissoryNotesPayableToRelativesOfDirectorsCollateralizedByAGeneralSecurityAgreementOnAllTheAssetsOfTheCompanyDueOnDemandAbstract_iB" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; text-indent: -6.25pt; padding-left: 6.25pt"&gt;Promissory notes payable to relatives of directors collateralized by a general security agreement over all the assets of the Company, past maturity:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--NotePayablewithInterestat1PercentInterestperMonth_i01I_pp0p0_maPNRPzSkp_zCZEXHsG2SA5" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 56%; text-indent: -0.25in; padding-left: 0.5in"&gt;i.&#160;&#160;&#160;&#160;&#160;&#160;&#160; Interest at 1% per month&lt;/td&gt;&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;720,619&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;720,619&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_ecustom--InterestAt1.25PerMonth_i01I_pp0p0_maPNRPzSkp_zajCDc37Ikzf" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.25in; padding-left: 0.5in"&gt;ii.&#160;&#160;&#160;&#160;&#160; Interest at 1.25% per month&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;51,347&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;51,347&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_ecustom--NotePayableInterestattheUSBankPrimeRatePlus1PercentperMonth_i01I_pp0p0_maPNRPzSkp_zfFK5Ko0ayAi" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -0.25in; padding-left: 0.5in"&gt;iii.&#160;&#160;&#160; Interest at the U.S. bank prime rate plus 1%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;100,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;100,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_ecustom--Iv.InterestAt0.5PerMonth_i01I_pp0p0_maPNRPzSkp_zNojSE3AprF7" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.25in; padding-left: 0.5in"&gt;iv.&#160;&#160;&#160;&#160; Interest at 0.5% per month&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;695,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;695,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.5in"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_ecustom--UnsecuredPromissoryNotesPayableToRelativesOfChairmanWithFixedAmountsOfInterestDueAugust312022_i01I_maPNRPzSkp_znx5gB0wWObk" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Unsecured promissory notes payable to relatives of the Chairman with fixed amounts of interest due August 31, 2022&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;50,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0399"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -6.25pt; padding-left: 6.25pt"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_ecustom--PromissoryNotesPayableUnsecuredtoRelativesofaDirectorBearingInterestat1PercentperMonth_i01I_pp0p0_maPNRPzSkp_zvNAesXXE3fh" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; text-indent: -6.25pt; padding-left: 6.25pt"&gt;Promissory notes payable, unsecured, to relatives of a director, bearing interest at 1% per month, past maturity&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,475,000&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,475,000&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_ecustom--PromissoryNotesRelatedParty_iTI_pp0p0_mtPNRPzSkp_zhyRf1a5jknj" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 1pt; text-indent: -6.25pt; padding-left: 6.25pt"&gt;Total Promissory Notes Payable to Related Parties&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;3,091,966&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;3,041,966&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A6_zszEiwL350Oj" style="font: 11pt/12pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/12pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company received advances from relatives of the Chairman aggregating $50,000, with a fixed interest amount of $4,000, which will mature
and be repayable on August&#160;31, 2022.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/12pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/12pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;All
amounts past maturity continue to accrue interest at their stated rates and are considered due on demand.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/12pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;Promissory
notes payable to unrelated parties&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/12pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/12pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;A
summary of activities of promissory notes payable to unrelated parties is as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/12pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89F_ecustom--ScheduleofPromissoryNotesPayableToUnrelatedPartiesTableTextBlock_zTAUjvgmfGn3" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Interest, advances and promissory notes payable (Details 2)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -7.6pt; padding-left: 17.05pt"&gt;&lt;span id="xdx_8BD_ztKTvFkvLtyj" style="display: none"&gt;Schedule of Promissory Notes Payable to Unrelated Parties&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;Promissory Notes Payable to Unrelated Parties&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Carrying Value&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 70%; padding-left: 5.4pt"&gt;Balance, December&#160;31, 2020&lt;/td&gt;&lt;td style="width: 10%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--NotesPayable_iS_pp0p0_c20210101__20211231__us-gaap--DebtInstrumentAxis__custom--UnRelatedPartyMember_zwr4roHuHQZc" style="width: 18%; text-align: right" title="Balance at beginning"&gt;2,254,353&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -7.6pt; padding-left: 17.05pt"&gt;Reclassified to interest payable&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--IncreaseDecreaseInInterestPayableNet_c20210101__20211231__us-gaap--DebtInstrumentAxis__custom--UnRelatedPartyMember_pp0p0" style="text-align: right" title="Reclassified to interest payable"&gt;(10,985&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; text-indent: -7.6pt; padding-left: 17.05pt"&gt;Extinguished through issuance of shares of common stock (note&#160;6)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_ecustom--ExtinguishedThroughIssuanceOfSharesOfCommonStock_c20210101__20211231__us-gaap--DebtInstrumentAxis__custom--UnRelatedPartyMember_pp0p0" style="text-align: right" title="Extinguished through issuance of shares of common stock (note 6)"&gt;(20,000&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; text-indent: -7.6pt; padding-left: 17.05pt"&gt;Transferred to promissory notes payable pursuant to private transaction&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_ecustom--TransferredFromPromissoryNotesPayablePursuantToPrivateTransaction._pp0p0_c20210101__20211231__us-gaap--DebtInstrumentAxis__custom--UnRelatedPartyMember_z66pY7kqzp3" style="border-bottom: Black 1pt solid; text-align: right" title="Transferred from promissory notes payable pursuant to private transaction"&gt;(10,000&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -6.25pt; padding-left: 6.25pt"&gt;Balance, December&#160;31, 2021&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--NotesPayable_iS_pp0p0_c20220101__20220630__us-gaap--DebtInstrumentAxis__custom--UnRelatedPartyMember_zw4v8aOJCWI3" style="text-align: right" title="Balance at beginning"&gt;2,213,368&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; text-indent: -7.6pt; padding-left: 17.05pt"&gt;Promissory notes received&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--PromissoryNoteReceived_iP3custom--TransferredFromPromissoryNotesPayablePursuantToPrivateTransaction._pp0p0_c20220101__20220630__us-gaap--DebtInstrumentAxis__custom--UnRelatedPartyMember_zxxX2DUkuGd4" style="border-bottom: Black 1pt solid; text-align: right" title="Promissory note received"&gt;244,358&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt; text-indent: -6.25pt; padding-left: 6.25pt"&gt;Balance, June&#160;30, 2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--NotesPayable_iE_pp0p0_c20220101__20220630__us-gaap--DebtInstrumentAxis__custom--UnRelatedPartyMember_zItqds7dEKT" style="border-bottom: Black 1pt solid; text-align: right" title="Balance at ending"&gt;2,457,726&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A0_zZEYFIlQGRn9" style="font: 11pt/12pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
























&lt;p style="font: 11pt/12pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/12pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;A
summary of the promissory notes payable to unrelated parties is as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/12pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89A_ecustom--ScheduleofActivityofPromissoryNotestoUnrelatedPatiesTableTextBlock_z6rmCLNEuxL9" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Interest, advances and promissory notes payable (Details 3)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 0.5in; text-indent: -0.25in"&gt;&lt;span id="xdx_8B0_zY97BBiURzFf" style="display: none"&gt;Schedule of activity of promissory notes payable to unrelated parties&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" id="xdx_496_20220630_zUco1HS3wWD6" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_496_20211231_zd759ABF6vac" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Promissory
    Notes Payable to Unrelated Parties&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="4" style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;June
                                            30,&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2022&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;December&#160;31,
    2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_ecustom--UnsecuredPromissoryNotesPayableToUnrelatedLendersAbstract_iB" style="vertical-align: bottom"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 6.25pt; text-indent: -6.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Unsecured
    promissory notes payable to unrelated lenders, past maturity:&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_ecustom--I.InterestAt1PerMonthRepayableOnMarch312009DueOnDemand_i01I_pp0p0_maTPNPTzcOO_zEaEjMBpyNl7" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 0.5in; text-indent: -0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;i.&#160;&#160;&#160;&#160;&#160;&#160;&#160;
    Interest at 1% per month&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,317,456&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,317,456&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_ecustom--Iii.InterestAt0.625PerMonthWith50000RepayableOnOctober5200440000RepayableOnDecember312004And60000RepayableOnJuly282006AllDueOnDemand_i01I_pp0p0_maTPNPTzcOO_z5LfbogWX5Hl" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 0.5in; text-indent: -0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;ii.&#160;&#160;&#160;&#160;&#160;
    Interest at 0.667% per month &lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;425,000&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;425,000&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_ecustom--Vi.InterestAt0.667PerMonthWith125000DueJanuary152011_i01I_pp0p0_maTPNPTzcOO_z3d511g0sYNg" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 0.5in; text-indent: -0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;iii.&#160;&#160;&#160;
    Interest at 0.625% per month&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;150,000&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;150,000&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_ecustom--Noninterestbearing_i01I_pp0p0_maTPNPTzcOO_zG27jbeoNRs8" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 0.5in; text-indent: -0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;iv.&#160;&#160;&#160;&#160;
    Non-interest-bearing&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;270,912&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;270,912&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_ecustom--UnsecuredPromissoryNotesPayableToUnrelatedLendersWithFixedAmountsOfInterestDue_i01I_maTPNPTzcOO_zLP3ahPwzV3h" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Unsecured promissory notes
    payable to unrelated lenders with fixed amounts of interest due August 31, 2022&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;244,358&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0451"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 6.25pt; text-indent: -6.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_ecustom--PromissoryNotesPayableSecuredByGuaranteeFromChiefExecutiveOfficerBearingInterestAt1PerMonth_i01I_pp0p0_maTPNPTzcOO_zbSX8UJ9bRP2" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 6.25pt; text-indent: -6.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Promissory
    notes payable, secured by a guarantee from the Chief Executive Officer, bearing interest at 1% per month, past maturity&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;50,000&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;50,000&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_ecustom--TotalPromissoryNotesPayableToUnrelatedParties_i01TI_pp0p0_mtTPNPTzcOO_zdMBflbeIQUb" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 6.25pt; text-indent: -6.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Total
    Promissory Notes Payable to Unrelated Parties&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,457,726&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,213,368&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="width: 61%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 3%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 15%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 3%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 15%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p id="xdx_8A0_zkIEwTOU9r7g" style="font: 11pt/12pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/12pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company received advances from two shareholders aggregating SGD$340,000 ($244,358), with a fixed interest amount of $10,000, which will
mature and be repayable on August&#160;31, 2022. The principal amount of SGD$150,000 was repaid to one shareholder in July 2022.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/12pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;All
amounts past maturity continue to accrue interest at their stated rates and are considered due on demand.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;Interest
payable&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;A
summary of the interest payable activity is as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_894_eus-gaap--InterestAndOtherIncomeTableTextBlock_zJtNkPyGnT2a" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Interest, advances and promissory notes payable (Details 4)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -7.6pt; padding-left: 17.05pt"&gt;&lt;span id="xdx_8BB_z47PrD5aVv5f" style="display: none"&gt;Schedule of interest payable activity&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right" title="Reclassified from promissory notes payable"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;Interest Payable&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Carrying Value&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 70%; padding-left: 5.4pt"&gt;Balance, December&#160;31, 2020&lt;/td&gt;&lt;td style="width: 10%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--InterestPayableCurrentAndNoncurrent_iS_pp0p0_c20210101__20211231_z4V37YcUr9g" style="width: 18%; text-align: right" title="Beginning Balance"&gt;3,575,326&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -7.6pt; padding-left: 17.05pt"&gt;Reclassified from promissory notes payable&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_ecustom--ReclassifiedFromPromissoryNotesPayable_c20210101__20211231_pp0p0" style="text-align: right" title="Reclassified from promissory notes payable"&gt;10,985&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; text-indent: -7.6pt; padding-left: 17.05pt"&gt;Interest incurred on promissory notes payable&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--InterestExpenseIncurredonPromissoryNotesandOtherPayables_c20210101__20211231_pp0p0" style="text-align: right" title="Interest incurred on promissory notes payable"&gt;527,336&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; text-indent: -7.6pt; padding-left: 17.05pt"&gt;Interest payable retired through issuance of shares&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_ecustom--InterestPayableRetiredThroughIssuanceOfShares_c20210101__20211231_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Interest payable retired through issuance of shares"&gt;(3,000&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 5.4pt"&gt;Balance, December&#160;31, 2021&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--InterestPayableCurrentAndNoncurrent_iS_pp0p0_c20220101__20220630_z2CXzlH0iwCj" style="text-align: right" title="Beginning Balance"&gt;4,110,647&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; text-indent: -7.6pt; padding-left: 17.05pt"&gt;Interest incurred on promissory notes payable&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_ecustom--InterestExpenseIncurredonPromissoryNotesandOtherPayables_c20220101__20220630_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Interest incurred on promissory notes payable"&gt;277,421&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt; padding-left: 5.4pt"&gt;Balance, June&#160;30, 2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--InterestPayableCurrentAndNoncurrent_iE_pp0p0_c20220101__20220630_zhd73XLCKBj2" style="border-bottom: Black 1pt solid; text-align: right" title="Ending Balance"&gt;4,388,068&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AD_zi6IDnsQJlR2" style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;




















&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Interest
payable is due to related and non-related parties as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_896_ecustom--ScheduledOfInterestPayableDueToRelatedTableTextBlock_zorClcnrgGJj" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Interest, advances and promissory notes payable (Details 5)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; text-indent: -6.25pt; padding-left: 6.25pt"&gt;&lt;span id="xdx_8B2_zMsjrkxgS7F8" style="display: none"&gt;Schedule of Interest payable due to related and non-related parties&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49A_20220630_zUOrm8c1Q5J5" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_499_20211231_zxtrdp7LXJ0l" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;Interest Payable&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;June 30,&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2022&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;December&#160;31, 2021&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_ecustom--InterestPayableRelativesOfDirectors_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 56%; text-align: left; text-indent: -6.25pt; padding-left: 6.25pt"&gt;Related parties&lt;/td&gt;&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;1,362,918&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;1,200,170&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_ecustom--InterestPayabletoNonrelatedParties_iI_pp0p0" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; text-indent: -6.25pt; padding-left: 6.25pt"&gt;Unrelated parties&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;3,025,150&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;2,910,477&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_ecustom--InterestPayableCurrentAndNoncurrents_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="color: rgb(204,238,255); padding-bottom: 1pt; text-indent: -6.25pt; padding-left: 6.25pt"&gt;Interest payable&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;4,388,068&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;4,110,647&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A9_zllxSpCtTLSd" style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
payment terms, security and any interest payable are based on the underlying promissory notes payable that the Company has outstanding.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;Interest
expense&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During
the period ended June&#160;30, 2022, the Company incurred interest expense of $&lt;span id="xdx_903_eus-gaap--InterestExpense_c20220101__20220630_pp0p0" title="Interest expense"&gt;1,109,764&lt;/span&gt; (2021&#160;- $&lt;span id="xdx_901_eus-gaap--InterestExpense_c20210101__20210630_pp0p0" title="Interest expense"&gt;2,283,770&lt;/span&gt;) as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 53.3pt"/&gt;&lt;td style="width: 18pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$Nil
                                            (2021&#160;- $1,287,834) incurred related to the modification of options held by the Chairman
                                            and his spouse that were granted in connection with financing provided to the Company;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 53.3pt"/&gt;&lt;td style="width: 18pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$777,515
                                            (2021&#160;- $670,452) incurred on lines of credit payable as shown in note&#160;5; &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 53.3pt"/&gt;&lt;td style="width: 18pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$277,421
                                            (2021&#160;- $264,100) incurred on promissory notes (notes&#160;4(a) and 4(b));&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 53.3pt"/&gt;&lt;td style="width: 18pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$52,271
                                            (2021&#160;- $60,059) incurred from the calculation of imputed interest on accounts payable
                                            outstanding for longer than one year, advances payable and promissory notes payable, which
                                            had no stated interest rate; and&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 53.3pt"/&gt;&lt;td style="width: 18pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;span id="xdx_90A_eus-gaap--InterestExpenseRelatedParty_c20220101__20220630_pp0p0" title="Interest on other"&gt;2,557&lt;/span&gt;
                                            (2021&#160;- $&lt;span id="xdx_908_eus-gaap--InterestExpenseRelatedParty_c20210101__20210630_pp0p0" title="Interest on other"&gt;1,325&lt;/span&gt;) interest on other items.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




















</ALRT:InterestAdvancesAndPromissoryNotesPayableTextBlock>
    <ALRT:SummaryOfActivitiesOfPromissoryNotesPayableTableTextBlock contextRef="From2022-01-01to2022-06-30">&lt;table cellpadding="0" cellspacing="0" id="xdx_89A_ecustom--SummaryOfActivitiesOfPromissoryNotesPayableTableTextBlock_z0bGHDOg43o5" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Interest, advances and promissory notes payable (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -7.6pt; padding-left: 17.05pt"&gt;&lt;span id="xdx_8BF_zx6hRVjkN568" style="display: none"&gt;Summary of activities of promissory notes payable&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right" title="Transferred from promissory notes payable pursuant to private transaction"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; text-indent: -7.6pt; padding-left: 17.05pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;Promissory Notes Payable to Related Parties&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Carrying Value&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 70%; text-indent: -6.25pt; padding-left: 6.25pt"&gt;Balance, December&#160;31, 2020&lt;/td&gt;&lt;td style="width: 10%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--NotesPayableRelatedPartiesClassifiedCurrent_iS_pp0p0_c20210101__20211231__us-gaap--DebtInstrumentAxis__custom--RelatedPartyMember_zhNUeKEsqmka" style="width: 18%; text-align: right" title="Carrying value at beginning"&gt;3,031,966&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; text-indent: -7.6pt; padding-left: 17.05pt"&gt;Transferred from promissory notes payable pursuant to private transaction&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_ecustom--TransferredFromPromissoryNotesPayablePursuantToPrivateTransaction._c20210101__20211231__us-gaap--DebtInstrumentAxis__custom--RelatedPartyMember_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Transferred from promissory notes payable pursuant to private transaction"&gt;10,000&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -6.25pt; padding-left: 6.25pt"&gt;Balance, December&#160;31, 2021&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--NotesPayableRelatedPartiesClassifiedCurrent_iS_pp0p0_c20220101__20220630__us-gaap--DebtInstrumentAxis__custom--RelatedPartyMember_zQhzLi4n7Tvk" style="text-align: right" title="Carrying value at beginning"&gt;3,041,966&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; text-indent: -7.6pt; padding-left: 17.05pt"&gt;Promissory notes received&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_ecustom--TransferredFromPromissoryNotesPayablePursuantToPrivateTransaction._pp0p0_c20220101__20220630__us-gaap--DebtInstrumentAxis__custom--RelatedPartyMember_zmUCm4bELTR2" style="border-bottom: Black 1pt solid; text-align: right" title="Transferred from promissory notes payable pursuant to private transaction"&gt;50,000&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt; text-indent: -6.25pt; padding-left: 6.25pt"&gt;Balance, June&#160;30, 2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--NotesPayableRelatedPartiesClassifiedCurrent_iE_pp0p0_c20220101__20220630__us-gaap--DebtInstrumentAxis__custom--RelatedPartyMember_zswjKOZmFJuf" style="border-bottom: Black 1pt solid; text-align: right" title="Carrying value at ending"&gt;3,091,966&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</ALRT:SummaryOfActivitiesOfPromissoryNotesPayableTableTextBlock>
    <us-gaap:NotesPayableRelatedPartiesClassifiedCurrent
      contextRef="AsOf2020-12-31_custom_RelatedPartyMember"
      decimals="0"
      unitRef="USD">3031966</us-gaap:NotesPayableRelatedPartiesClassifiedCurrent>
    <ALRT:TransferredFromPromissoryNotesPayablePursuantToPrivateTransaction.
      contextRef="From2021-01-012021-12-31_custom_RelatedPartyMember"
      decimals="0"
      unitRef="USD">10000</ALRT:TransferredFromPromissoryNotesPayablePursuantToPrivateTransaction.>
    <us-gaap:NotesPayableRelatedPartiesClassifiedCurrent
      contextRef="AsOf2021-12-31_custom_RelatedPartyMember"
      decimals="0"
      unitRef="USD">3041966</us-gaap:NotesPayableRelatedPartiesClassifiedCurrent>
    <ALRT:TransferredFromPromissoryNotesPayablePursuantToPrivateTransaction.
      contextRef="From2022-01-012022-06-30_custom_RelatedPartyMember"
      decimals="0"
      unitRef="USD">50000</ALRT:TransferredFromPromissoryNotesPayablePursuantToPrivateTransaction.>
    <us-gaap:NotesPayableRelatedPartiesClassifiedCurrent
      contextRef="AsOf2022-06-30_custom_RelatedPartyMember"
      decimals="0"
      unitRef="USD">3091966</us-gaap:NotesPayableRelatedPartiesClassifiedCurrent>
    <ALRT:ScheduleofPromissoryNotesPayableRelativesofBoardofDirectorsTableTextBlock contextRef="From2022-01-01to2022-06-30">&lt;table cellpadding="0" cellspacing="0" id="xdx_89D_ecustom--ScheduleofPromissoryNotesPayableRelativesofBoardofDirectorsTableTextBlock_zTluJknl4cpc" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Interest, advances and promissory notes payable (Details 1)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -0.25in; padding-left: 0.5in"&gt;&lt;span id="xdx_8BF_zMWtijPXKJMd" style="display: none"&gt;Schedule of activity of promissory notes payable to related parties&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_490_20220630" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_495_20211231" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;Promissory Notes Payable to Related Parties&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;June 30,&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2022&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;December&#160;31, &lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2021&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_ecustom--PromissoryNotesPayableToRelativesOfDirectorsCollateralizedByAGeneralSecurityAgreementOnAllTheAssetsOfTheCompanyDueOnDemandAbstract_iB" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; text-indent: -6.25pt; padding-left: 6.25pt"&gt;Promissory notes payable to relatives of directors collateralized by a general security agreement over all the assets of the Company, past maturity:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--NotePayablewithInterestat1PercentInterestperMonth_i01I_pp0p0_maPNRPzSkp_zCZEXHsG2SA5" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 56%; text-indent: -0.25in; padding-left: 0.5in"&gt;i.&#160;&#160;&#160;&#160;&#160;&#160;&#160; Interest at 1% per month&lt;/td&gt;&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;720,619&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;720,619&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_ecustom--InterestAt1.25PerMonth_i01I_pp0p0_maPNRPzSkp_zajCDc37Ikzf" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.25in; padding-left: 0.5in"&gt;ii.&#160;&#160;&#160;&#160;&#160; Interest at 1.25% per month&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;51,347&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;51,347&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_ecustom--NotePayableInterestattheUSBankPrimeRatePlus1PercentperMonth_i01I_pp0p0_maPNRPzSkp_zfFK5Ko0ayAi" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -0.25in; padding-left: 0.5in"&gt;iii.&#160;&#160;&#160; Interest at the U.S. bank prime rate plus 1%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;100,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;100,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_ecustom--Iv.InterestAt0.5PerMonth_i01I_pp0p0_maPNRPzSkp_zNojSE3AprF7" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.25in; padding-left: 0.5in"&gt;iv.&#160;&#160;&#160;&#160; Interest at 0.5% per month&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;695,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;695,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.5in"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_ecustom--UnsecuredPromissoryNotesPayableToRelativesOfChairmanWithFixedAmountsOfInterestDueAugust312022_i01I_maPNRPzSkp_znx5gB0wWObk" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Unsecured promissory notes payable to relatives of the Chairman with fixed amounts of interest due August 31, 2022&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;50,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0399"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -6.25pt; padding-left: 6.25pt"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_ecustom--PromissoryNotesPayableUnsecuredtoRelativesofaDirectorBearingInterestat1PercentperMonth_i01I_pp0p0_maPNRPzSkp_zvNAesXXE3fh" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; text-indent: -6.25pt; padding-left: 6.25pt"&gt;Promissory notes payable, unsecured, to relatives of a director, bearing interest at 1% per month, past maturity&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,475,000&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,475,000&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_ecustom--PromissoryNotesRelatedParty_iTI_pp0p0_mtPNRPzSkp_zhyRf1a5jknj" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 1pt; text-indent: -6.25pt; padding-left: 6.25pt"&gt;Total Promissory Notes Payable to Related Parties&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;3,091,966&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;3,041,966&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</ALRT:ScheduleofPromissoryNotesPayableRelativesofBoardofDirectorsTableTextBlock>
    <ALRT:NotePayablewithInterestat1PercentInterestperMonth contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">720619</ALRT:NotePayablewithInterestat1PercentInterestperMonth>
    <ALRT:NotePayablewithInterestat1PercentInterestperMonth contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">720619</ALRT:NotePayablewithInterestat1PercentInterestperMonth>
    <ALRT:InterestAt1.25PerMonth contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">51347</ALRT:InterestAt1.25PerMonth>
    <ALRT:InterestAt1.25PerMonth contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">51347</ALRT:InterestAt1.25PerMonth>
    <ALRT:NotePayableInterestattheUSBankPrimeRatePlus1PercentperMonth contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">100000</ALRT:NotePayableInterestattheUSBankPrimeRatePlus1PercentperMonth>
    <ALRT:NotePayableInterestattheUSBankPrimeRatePlus1PercentperMonth contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">100000</ALRT:NotePayableInterestattheUSBankPrimeRatePlus1PercentperMonth>
    <ALRT:Iv.InterestAt0.5PerMonth contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">695000</ALRT:Iv.InterestAt0.5PerMonth>
    <ALRT:Iv.InterestAt0.5PerMonth contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">695000</ALRT:Iv.InterestAt0.5PerMonth>
    <ALRT:UnsecuredPromissoryNotesPayableToRelativesOfChairmanWithFixedAmountsOfInterestDueAugust312022 contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">50000</ALRT:UnsecuredPromissoryNotesPayableToRelativesOfChairmanWithFixedAmountsOfInterestDueAugust312022>
    <ALRT:PromissoryNotesPayableUnsecuredtoRelativesofaDirectorBearingInterestat1PercentperMonth contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">1475000</ALRT:PromissoryNotesPayableUnsecuredtoRelativesofaDirectorBearingInterestat1PercentperMonth>
    <ALRT:PromissoryNotesPayableUnsecuredtoRelativesofaDirectorBearingInterestat1PercentperMonth contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">1475000</ALRT:PromissoryNotesPayableUnsecuredtoRelativesofaDirectorBearingInterestat1PercentperMonth>
    <ALRT:PromissoryNotesRelatedParty contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">3091966</ALRT:PromissoryNotesRelatedParty>
    <ALRT:PromissoryNotesRelatedParty contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">3041966</ALRT:PromissoryNotesRelatedParty>
    <ALRT:ScheduleofPromissoryNotesPayableToUnrelatedPartiesTableTextBlock contextRef="From2022-01-01to2022-06-30">&lt;table cellpadding="0" cellspacing="0" id="xdx_89F_ecustom--ScheduleofPromissoryNotesPayableToUnrelatedPartiesTableTextBlock_zTAUjvgmfGn3" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Interest, advances and promissory notes payable (Details 2)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -7.6pt; padding-left: 17.05pt"&gt;&lt;span id="xdx_8BD_ztKTvFkvLtyj" style="display: none"&gt;Schedule of Promissory Notes Payable to Unrelated Parties&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;Promissory Notes Payable to Unrelated Parties&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Carrying Value&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 70%; padding-left: 5.4pt"&gt;Balance, December&#160;31, 2020&lt;/td&gt;&lt;td style="width: 10%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--NotesPayable_iS_pp0p0_c20210101__20211231__us-gaap--DebtInstrumentAxis__custom--UnRelatedPartyMember_zwr4roHuHQZc" style="width: 18%; text-align: right" title="Balance at beginning"&gt;2,254,353&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -7.6pt; padding-left: 17.05pt"&gt;Reclassified to interest payable&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--IncreaseDecreaseInInterestPayableNet_c20210101__20211231__us-gaap--DebtInstrumentAxis__custom--UnRelatedPartyMember_pp0p0" style="text-align: right" title="Reclassified to interest payable"&gt;(10,985&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; text-indent: -7.6pt; padding-left: 17.05pt"&gt;Extinguished through issuance of shares of common stock (note&#160;6)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_ecustom--ExtinguishedThroughIssuanceOfSharesOfCommonStock_c20210101__20211231__us-gaap--DebtInstrumentAxis__custom--UnRelatedPartyMember_pp0p0" style="text-align: right" title="Extinguished through issuance of shares of common stock (note 6)"&gt;(20,000&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; text-indent: -7.6pt; padding-left: 17.05pt"&gt;Transferred to promissory notes payable pursuant to private transaction&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_ecustom--TransferredFromPromissoryNotesPayablePursuantToPrivateTransaction._pp0p0_c20210101__20211231__us-gaap--DebtInstrumentAxis__custom--UnRelatedPartyMember_z66pY7kqzp3" style="border-bottom: Black 1pt solid; text-align: right" title="Transferred from promissory notes payable pursuant to private transaction"&gt;(10,000&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -6.25pt; padding-left: 6.25pt"&gt;Balance, December&#160;31, 2021&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--NotesPayable_iS_pp0p0_c20220101__20220630__us-gaap--DebtInstrumentAxis__custom--UnRelatedPartyMember_zw4v8aOJCWI3" style="text-align: right" title="Balance at beginning"&gt;2,213,368&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; text-indent: -7.6pt; padding-left: 17.05pt"&gt;Promissory notes received&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--PromissoryNoteReceived_iP3custom--TransferredFromPromissoryNotesPayablePursuantToPrivateTransaction._pp0p0_c20220101__20220630__us-gaap--DebtInstrumentAxis__custom--UnRelatedPartyMember_zxxX2DUkuGd4" style="border-bottom: Black 1pt solid; text-align: right" title="Promissory note received"&gt;244,358&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt; text-indent: -6.25pt; padding-left: 6.25pt"&gt;Balance, June&#160;30, 2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--NotesPayable_iE_pp0p0_c20220101__20220630__us-gaap--DebtInstrumentAxis__custom--UnRelatedPartyMember_zItqds7dEKT" style="border-bottom: Black 1pt solid; text-align: right" title="Balance at ending"&gt;2,457,726&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</ALRT:ScheduleofPromissoryNotesPayableToUnrelatedPartiesTableTextBlock>
    <us-gaap:NotesPayable
      contextRef="AsOf2020-12-31_custom_UnRelatedPartyMember"
      decimals="0"
      unitRef="USD">2254353</us-gaap:NotesPayable>
    <us-gaap:IncreaseDecreaseInInterestPayableNet
      contextRef="From2021-01-012021-12-31_custom_UnRelatedPartyMember"
      decimals="0"
      unitRef="USD">-10985</us-gaap:IncreaseDecreaseInInterestPayableNet>
    <ALRT:ExtinguishedThroughIssuanceOfSharesOfCommonStock
      contextRef="From2021-01-012021-12-31_custom_UnRelatedPartyMember"
      decimals="0"
      unitRef="USD">-20000</ALRT:ExtinguishedThroughIssuanceOfSharesOfCommonStock>
    <ALRT:TransferredFromPromissoryNotesPayablePursuantToPrivateTransaction.
      contextRef="From2021-01-012021-12-31_custom_UnRelatedPartyMember"
      decimals="0"
      unitRef="USD">-10000</ALRT:TransferredFromPromissoryNotesPayablePursuantToPrivateTransaction.>
    <us-gaap:NotesPayable
      contextRef="AsOf2021-12-31_custom_UnRelatedPartyMember"
      decimals="0"
      unitRef="USD">2213368</us-gaap:NotesPayable>
    <ALRT:PromissoryNoteReceived
      contextRef="From2022-01-012022-06-30_custom_UnRelatedPartyMember"
      decimals="0"
      unitRef="USD">244358</ALRT:PromissoryNoteReceived>
    <us-gaap:NotesPayable
      contextRef="AsOf2022-06-30_custom_UnRelatedPartyMember"
      decimals="0"
      unitRef="USD">2457726</us-gaap:NotesPayable>
    <ALRT:ScheduleofActivityofPromissoryNotestoUnrelatedPatiesTableTextBlock contextRef="From2022-01-01to2022-06-30">&lt;table cellpadding="0" cellspacing="0" id="xdx_89A_ecustom--ScheduleofActivityofPromissoryNotestoUnrelatedPatiesTableTextBlock_z6rmCLNEuxL9" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Interest, advances and promissory notes payable (Details 3)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 0.5in; text-indent: -0.25in"&gt;&lt;span id="xdx_8B0_zY97BBiURzFf" style="display: none"&gt;Schedule of activity of promissory notes payable to unrelated parties&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" id="xdx_496_20220630_zUco1HS3wWD6" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_496_20211231_zd759ABF6vac" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Promissory
    Notes Payable to Unrelated Parties&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="4" style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;June
                                            30,&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2022&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;December&#160;31,
    2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_ecustom--UnsecuredPromissoryNotesPayableToUnrelatedLendersAbstract_iB" style="vertical-align: bottom"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 6.25pt; text-indent: -6.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Unsecured
    promissory notes payable to unrelated lenders, past maturity:&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_ecustom--I.InterestAt1PerMonthRepayableOnMarch312009DueOnDemand_i01I_pp0p0_maTPNPTzcOO_zEaEjMBpyNl7" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 0.5in; text-indent: -0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;i.&#160;&#160;&#160;&#160;&#160;&#160;&#160;
    Interest at 1% per month&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,317,456&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,317,456&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_ecustom--Iii.InterestAt0.625PerMonthWith50000RepayableOnOctober5200440000RepayableOnDecember312004And60000RepayableOnJuly282006AllDueOnDemand_i01I_pp0p0_maTPNPTzcOO_z5LfbogWX5Hl" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 0.5in; text-indent: -0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;ii.&#160;&#160;&#160;&#160;&#160;
    Interest at 0.667% per month &lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;425,000&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;425,000&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_ecustom--Vi.InterestAt0.667PerMonthWith125000DueJanuary152011_i01I_pp0p0_maTPNPTzcOO_z3d511g0sYNg" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 0.5in; text-indent: -0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;iii.&#160;&#160;&#160;
    Interest at 0.625% per month&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;150,000&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;150,000&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_ecustom--Noninterestbearing_i01I_pp0p0_maTPNPTzcOO_zG27jbeoNRs8" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 0.5in; text-indent: -0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;iv.&#160;&#160;&#160;&#160;
    Non-interest-bearing&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;270,912&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;270,912&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_ecustom--UnsecuredPromissoryNotesPayableToUnrelatedLendersWithFixedAmountsOfInterestDue_i01I_maTPNPTzcOO_zLP3ahPwzV3h" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Unsecured promissory notes
    payable to unrelated lenders with fixed amounts of interest due August 31, 2022&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;244,358&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0451"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 6.25pt; text-indent: -6.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_ecustom--PromissoryNotesPayableSecuredByGuaranteeFromChiefExecutiveOfficerBearingInterestAt1PerMonth_i01I_pp0p0_maTPNPTzcOO_zbSX8UJ9bRP2" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 6.25pt; text-indent: -6.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Promissory
    notes payable, secured by a guarantee from the Chief Executive Officer, bearing interest at 1% per month, past maturity&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;50,000&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;50,000&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_ecustom--TotalPromissoryNotesPayableToUnrelatedParties_i01TI_pp0p0_mtTPNPTzcOO_zdMBflbeIQUb" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 6.25pt; text-indent: -6.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Total
    Promissory Notes Payable to Unrelated Parties&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,457,726&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,213,368&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="width: 61%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 3%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 15%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 3%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 15%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
</ALRT:ScheduleofActivityofPromissoryNotestoUnrelatedPatiesTableTextBlock>
    <ALRT:I.InterestAt1PerMonthRepayableOnMarch312009DueOnDemand contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">1317456</ALRT:I.InterestAt1PerMonthRepayableOnMarch312009DueOnDemand>
    <ALRT:I.InterestAt1PerMonthRepayableOnMarch312009DueOnDemand contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">1317456</ALRT:I.InterestAt1PerMonthRepayableOnMarch312009DueOnDemand>
    <ALRT:Iii.InterestAt0.625PerMonthWith50000RepayableOnOctober5200440000RepayableOnDecember312004And60000RepayableOnJuly282006AllDueOnDemand contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">425000</ALRT:Iii.InterestAt0.625PerMonthWith50000RepayableOnOctober5200440000RepayableOnDecember312004And60000RepayableOnJuly282006AllDueOnDemand>
    <ALRT:Iii.InterestAt0.625PerMonthWith50000RepayableOnOctober5200440000RepayableOnDecember312004And60000RepayableOnJuly282006AllDueOnDemand contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">425000</ALRT:Iii.InterestAt0.625PerMonthWith50000RepayableOnOctober5200440000RepayableOnDecember312004And60000RepayableOnJuly282006AllDueOnDemand>
    <ALRT:Vi.InterestAt0.667PerMonthWith125000DueJanuary152011 contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">150000</ALRT:Vi.InterestAt0.667PerMonthWith125000DueJanuary152011>
    <ALRT:Vi.InterestAt0.667PerMonthWith125000DueJanuary152011 contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">150000</ALRT:Vi.InterestAt0.667PerMonthWith125000DueJanuary152011>
    <ALRT:Noninterestbearing contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">270912</ALRT:Noninterestbearing>
    <ALRT:Noninterestbearing contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">270912</ALRT:Noninterestbearing>
    <ALRT:UnsecuredPromissoryNotesPayableToUnrelatedLendersWithFixedAmountsOfInterestDue contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">244358</ALRT:UnsecuredPromissoryNotesPayableToUnrelatedLendersWithFixedAmountsOfInterestDue>
    <ALRT:PromissoryNotesPayableSecuredByGuaranteeFromChiefExecutiveOfficerBearingInterestAt1PerMonth contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">50000</ALRT:PromissoryNotesPayableSecuredByGuaranteeFromChiefExecutiveOfficerBearingInterestAt1PerMonth>
    <ALRT:PromissoryNotesPayableSecuredByGuaranteeFromChiefExecutiveOfficerBearingInterestAt1PerMonth contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">50000</ALRT:PromissoryNotesPayableSecuredByGuaranteeFromChiefExecutiveOfficerBearingInterestAt1PerMonth>
    <ALRT:TotalPromissoryNotesPayableToUnrelatedParties contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">2457726</ALRT:TotalPromissoryNotesPayableToUnrelatedParties>
    <ALRT:TotalPromissoryNotesPayableToUnrelatedParties contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">2213368</ALRT:TotalPromissoryNotesPayableToUnrelatedParties>
    <us-gaap:InterestAndOtherIncomeTableTextBlock contextRef="From2022-01-01to2022-06-30">&lt;table cellpadding="0" cellspacing="0" id="xdx_894_eus-gaap--InterestAndOtherIncomeTableTextBlock_zJtNkPyGnT2a" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Interest, advances and promissory notes payable (Details 4)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -7.6pt; padding-left: 17.05pt"&gt;&lt;span id="xdx_8BB_z47PrD5aVv5f" style="display: none"&gt;Schedule of interest payable activity&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right" title="Reclassified from promissory notes payable"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;Interest Payable&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Carrying Value&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 70%; padding-left: 5.4pt"&gt;Balance, December&#160;31, 2020&lt;/td&gt;&lt;td style="width: 10%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--InterestPayableCurrentAndNoncurrent_iS_pp0p0_c20210101__20211231_z4V37YcUr9g" style="width: 18%; text-align: right" title="Beginning Balance"&gt;3,575,326&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -7.6pt; padding-left: 17.05pt"&gt;Reclassified from promissory notes payable&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_ecustom--ReclassifiedFromPromissoryNotesPayable_c20210101__20211231_pp0p0" style="text-align: right" title="Reclassified from promissory notes payable"&gt;10,985&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; text-indent: -7.6pt; padding-left: 17.05pt"&gt;Interest incurred on promissory notes payable&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--InterestExpenseIncurredonPromissoryNotesandOtherPayables_c20210101__20211231_pp0p0" style="text-align: right" title="Interest incurred on promissory notes payable"&gt;527,336&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; text-indent: -7.6pt; padding-left: 17.05pt"&gt;Interest payable retired through issuance of shares&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_ecustom--InterestPayableRetiredThroughIssuanceOfShares_c20210101__20211231_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Interest payable retired through issuance of shares"&gt;(3,000&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 5.4pt"&gt;Balance, December&#160;31, 2021&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--InterestPayableCurrentAndNoncurrent_iS_pp0p0_c20220101__20220630_z2CXzlH0iwCj" style="text-align: right" title="Beginning Balance"&gt;4,110,647&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; text-indent: -7.6pt; padding-left: 17.05pt"&gt;Interest incurred on promissory notes payable&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_ecustom--InterestExpenseIncurredonPromissoryNotesandOtherPayables_c20220101__20220630_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Interest incurred on promissory notes payable"&gt;277,421&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt; padding-left: 5.4pt"&gt;Balance, June&#160;30, 2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--InterestPayableCurrentAndNoncurrent_iE_pp0p0_c20220101__20220630_zhd73XLCKBj2" style="border-bottom: Black 1pt solid; text-align: right" title="Ending Balance"&gt;4,388,068&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:InterestAndOtherIncomeTableTextBlock>
    <us-gaap:InterestPayableCurrentAndNoncurrent contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">3575326</us-gaap:InterestPayableCurrentAndNoncurrent>
    <ALRT:ReclassifiedFromPromissoryNotesPayable
      contextRef="From2021-01-012021-12-31"
      decimals="0"
      unitRef="USD">10985</ALRT:ReclassifiedFromPromissoryNotesPayable>
    <ALRT:InterestExpenseIncurredonPromissoryNotesandOtherPayables
      contextRef="From2021-01-012021-12-31"
      decimals="0"
      unitRef="USD">527336</ALRT:InterestExpenseIncurredonPromissoryNotesandOtherPayables>
    <ALRT:InterestPayableRetiredThroughIssuanceOfShares
      contextRef="From2021-01-012021-12-31"
      decimals="0"
      unitRef="USD">-3000</ALRT:InterestPayableRetiredThroughIssuanceOfShares>
    <us-gaap:InterestPayableCurrentAndNoncurrent contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">4110647</us-gaap:InterestPayableCurrentAndNoncurrent>
    <ALRT:InterestExpenseIncurredonPromissoryNotesandOtherPayables
      contextRef="From2022-01-01to2022-06-30"
      decimals="0"
      unitRef="USD">277421</ALRT:InterestExpenseIncurredonPromissoryNotesandOtherPayables>
    <us-gaap:InterestPayableCurrentAndNoncurrent contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">4388068</us-gaap:InterestPayableCurrentAndNoncurrent>
    <ALRT:ScheduledOfInterestPayableDueToRelatedTableTextBlock contextRef="From2022-01-01to2022-06-30">&lt;table cellpadding="0" cellspacing="0" id="xdx_896_ecustom--ScheduledOfInterestPayableDueToRelatedTableTextBlock_zorClcnrgGJj" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Interest, advances and promissory notes payable (Details 5)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; text-indent: -6.25pt; padding-left: 6.25pt"&gt;&lt;span id="xdx_8B2_zMsjrkxgS7F8" style="display: none"&gt;Schedule of Interest payable due to related and non-related parties&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49A_20220630_zUOrm8c1Q5J5" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_499_20211231_zxtrdp7LXJ0l" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;Interest Payable&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;June 30,&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2022&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;December&#160;31, 2021&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_ecustom--InterestPayableRelativesOfDirectors_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 56%; text-align: left; text-indent: -6.25pt; padding-left: 6.25pt"&gt;Related parties&lt;/td&gt;&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;1,362,918&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;1,200,170&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_ecustom--InterestPayabletoNonrelatedParties_iI_pp0p0" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; text-indent: -6.25pt; padding-left: 6.25pt"&gt;Unrelated parties&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;3,025,150&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;2,910,477&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_ecustom--InterestPayableCurrentAndNoncurrents_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="color: rgb(204,238,255); padding-bottom: 1pt; text-indent: -6.25pt; padding-left: 6.25pt"&gt;Interest payable&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;4,388,068&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;4,110,647&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</ALRT:ScheduledOfInterestPayableDueToRelatedTableTextBlock>
    <ALRT:InterestPayableRelativesOfDirectors contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">1362918</ALRT:InterestPayableRelativesOfDirectors>
    <ALRT:InterestPayableRelativesOfDirectors contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">1200170</ALRT:InterestPayableRelativesOfDirectors>
    <ALRT:InterestPayabletoNonrelatedParties contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">3025150</ALRT:InterestPayabletoNonrelatedParties>
    <ALRT:InterestPayabletoNonrelatedParties contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">2910477</ALRT:InterestPayabletoNonrelatedParties>
    <ALRT:InterestPayableCurrentAndNoncurrents contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">4388068</ALRT:InterestPayableCurrentAndNoncurrents>
    <ALRT:InterestPayableCurrentAndNoncurrents contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">4110647</ALRT:InterestPayableCurrentAndNoncurrents>
    <us-gaap:InterestExpense
      contextRef="From2022-01-01to2022-06-30"
      decimals="0"
      unitRef="USD">1109764</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="From2021-01-012021-06-30"
      decimals="0"
      unitRef="USD">2283770</us-gaap:InterestExpense>
    <us-gaap:InterestExpenseRelatedParty
      contextRef="From2022-01-01to2022-06-30"
      decimals="0"
      unitRef="USD">2557</us-gaap:InterestExpenseRelatedParty>
    <us-gaap:InterestExpenseRelatedParty
      contextRef="From2021-01-012021-06-30"
      decimals="0"
      unitRef="USD">1325</us-gaap:InterestExpenseRelatedParty>
    <ALRT:LineOfCreditTextBlock contextRef="From2022-01-01to2022-06-30">&lt;p id="xdx_803_ecustom--LineOfCreditTextBlock_zJUquDrdaD5f" style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;5.
&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;span id="xdx_82E_zNAtBJWpzqYa"&gt;Lines of credit&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;A
summary of lines of credit activity is as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89D_eus-gaap--ScheduleOfLineOfCreditFacilitiesTextBlock_zKMNFGvRVN99" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Lines of credit (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -7.6pt; padding-left: 17.05pt"&gt;&lt;span id="xdx_8B1_zATBTdZKmVW4" style="display: none"&gt;Schedule of lines of credit activity&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right" title="Advances received on lines of credit"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;Lines of Credit&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Total&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 70%; padding-left: 5.4pt"&gt;Balance, December&#160;31, 2020&lt;/td&gt;&lt;td style="width: 10%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--LongTermLineOfCredit_iS_pp0p0_c20210101__20211231_zRhtx1Ez1L94" style="width: 18%; text-align: right" title="Balance at beginning"&gt;11,914,092&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -7.6pt; padding-left: 17.05pt"&gt;Advances received on lines of credit&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--LineOfCreditFacilityPeriodicPaymentPrincipal_c20210101__20211231_pp0p0" style="text-align: right" title="Advances received on lines of credit"&gt;1,149,279&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; text-indent: -7.6pt; padding-left: 17.05pt"&gt;Interest incurred on lines of credit&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--LineOfCreditFacilityPeriodicPaymentInterest_c20210101__20211231_pp0p0" style="text-align: right" title="Interest incurred on lines of credit"&gt;1,402,187&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; text-indent: -7.6pt; padding-left: 17.05pt"&gt;Repayment of interest on lines of credit&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_ecustom--RepaymentOfInterestOnLinesOfCredit_c20210101__20211231_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Repayment of interest on lines of credit"&gt;(456,725&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 5.4pt"&gt;Balance, December&#160;31, 2021&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--LongTermLineOfCredit_iS_pp0p0_c20220101__20220630_ziT29OeiKi7k" style="text-align: right" title="Balance at beginning"&gt;14,008,833&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -7.6pt; padding-left: 17.05pt"&gt;Advances received on lines of credit&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--LineOfCreditFacilityPeriodicPaymentPrincipal_c20220101__20220630_pp0p0" style="text-align: right" title="Advances received on lines of credit"&gt;438,165&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; text-indent: -7.6pt; padding-left: 17.05pt"&gt;Interest incurred on lines of credit&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--LineOfCreditFacilityPeriodicPaymentInterest_c20220101__20220630_pp0p0" style="text-align: right" title="Interest incurred on lines of credit"&gt;777,515&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; text-indent: -7.6pt; padding-left: 17.05pt"&gt;Repayment of interest on lines of credit&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_ecustom--RepaymentOfInterestOnLinesOfCredit_c20220101__20220630_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Repayment of interest on lines of credit"&gt;(137,475&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt; padding-left: 5.4pt"&gt;Balance, June&#160;30, 2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--LongTermLineOfCredit_iE_pp0p0_c20220101__20220630_zBhbtCvA0bAh" style="border-bottom: Black 1pt solid; text-align: right" title="Balance at ending"&gt;15,087,038&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A8_zJpnoRNamLr2" style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
December 10, 2021, the Company and the spouse of the Chairman entered into an amendment agreement to increase the borrowing limit on
the line of credit provided by the spouse of the Chairman to the Company from $2,000,000 to $4,000,000. The terms of amounts to be advanced
under the amendment are consistent with the line of credit. In connection with the line of credit, the Company granted the spouse of
the Chairman the option to acquire 40,000,000 shares of common stock of the Company at a price of $0.05 per share until December&#160;31,
2026 (note&#160;7).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of June&#160;30, 2022, the Company had two lines of credit as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89B_ecustom--ScheduledOfLineOfCreditTableTextBlock_zRahJRFE61N8" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Lines of credit (Details 1)"&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span id="xdx_8BF_zBK8AxfWWqua" style="display: none"&gt;Schedule of lines of credit&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Creditor&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 8%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Interest
    Rate&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Borrowing
    Limit&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Repayment
    Terms&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Principal
    Borrowed&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Accrued
    Interest&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total
    Outstanding&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Security&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 15%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Purpose&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Chairman
    and CEO &lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90E_ecustom--InterestRate_c20220101__20220630__us-gaap--LineOfCreditFacilityAxis__custom--ChairmanAndCEOMember" title="Interest Rate"&gt;1%
    per Month&lt;/span&gt; &lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$
    &lt;span id="xdx_90B_ecustom--BorrowingLimit_c20220630__us-gaap--LineOfCreditFacilityAxis__custom--ChairmanAndCEOMember_pp0p0" title="Borrowing Limit"&gt;10,300,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_901_ecustom--RepaymentTerms1_c20220101__20220630__us-gaap--LineOfCreditFacilityAxis__custom--ChairmanAndCEOMember" title="Repayment Terms"&gt;Due
    on Demand&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$
    &lt;span id="xdx_90F_ecustom--PrincipalBorrowed_c20220630__us-gaap--LineOfCreditFacilityAxis__custom--ChairmanAndCEOMember_pp0p0" title="Principal Borrowed"&gt;10,300,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$
    &lt;span id="xdx_90D_ecustom--AccruedInterest_c20220630__us-gaap--LineOfCreditFacilityAxis__custom--ChairmanAndCEOMember_pp0p0" title="Accrued Interest"&gt;1,763,048&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$
    &lt;span id="xdx_904_ecustom--TotalOutstanding_c20220630__us-gaap--LineOfCreditFacilityAxis__custom--ChairmanAndCEOMember_pp0p0" title="Total Outstanding"&gt;12,063,048&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90C_ecustom--Security1_c20220101__20220630__us-gaap--LineOfCreditFacilityAxis__custom--ChairmanAndCEOMember" title="Security"&gt;General
    Security over Assets&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_909_ecustom--Purpose1_c20220101__20220630__us-gaap--LineOfCreditFacilityAxis__custom--ChairmanAndCEOMember" title="Purpose"&gt;General
    Corporate Requirements&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Wife
    of Chairman&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_905_ecustom--InterestRate_c20220101__20220630__us-gaap--LineOfCreditFacilityAxis__custom--WifeOfChairmanMember" title="Interest Rate"&gt;1%
    per Month&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90A_ecustom--BorrowingLimit_c20220630__us-gaap--LineOfCreditFacilityAxis__custom--WifeOfChairmanMember_pp0p0" title="Borrowing Limit"&gt;4,000,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90D_ecustom--RepaymentTerms1_c20220101__20220630__us-gaap--LineOfCreditFacilityAxis__custom--WifeOfChairmanMember" title="Repayment Terms"&gt;Due
    on Demand&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_905_ecustom--PrincipalBorrowed_c20220630__us-gaap--LineOfCreditFacilityAxis__custom--WifeOfChairmanMember_pp0p0" title="Principal Borrowed"&gt;2,826,570&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_901_ecustom--AccruedInterest_c20220630__us-gaap--LineOfCreditFacilityAxis__custom--WifeOfChairmanMember_pp0p0" title="Accrued Interest"&gt;197,420&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90B_ecustom--TotalOutstanding_c20220630__us-gaap--LineOfCreditFacilityAxis__custom--WifeOfChairmanMember_pp0p0" title="Total Outstanding"&gt;3,023,990&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90C_ecustom--Security1_c20220101__20220630__us-gaap--LineOfCreditFacilityAxis__custom--WifeOfChairmanMember" title="Security"&gt;General
    Security over Assets&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_902_ecustom--Purpose1_c20220101__20220630__us-gaap--LineOfCreditFacilityAxis__custom--WifeOfChairmanMember" title="Purpose"&gt;General
    Corporate Requirements&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$
    &lt;span id="xdx_90C_ecustom--BorrowingLimit_c20220630_pp0p0" title="Borrowing Limit"&gt;14,300,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$
    &lt;span id="xdx_902_ecustom--PrincipalBorrowed_iI_pp0p0_c20220630_z2E6OXZMPoqg" title="Principal Borrowed"&gt;13,126,570&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$
    &lt;span id="xdx_902_ecustom--AccruedInterest_c20220630_pp0p0" title="Accrued Interest"&gt;1,960,468&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$
    &lt;span id="xdx_903_ecustom--TotalOutstanding_c20220630_pp0p0" title="Total Outstanding"&gt;15,087,038&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of December&#160;31, 2021, the Company had two lines of credit as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Creditor&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 8%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Interest
    Rate&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Borrowing
    Limit&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Repayment
    Terms&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Principal
    Borrowed&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Accrued
    Interest&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total
    Outstanding&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Security&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 15%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Purpose&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Chairman
    and CEO &lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90A_ecustom--InterestRate_c20210101__20211231__us-gaap--LineOfCreditFacilityAxis__custom--ChairmanAndCEOMember" title="Interest Rate"&gt;1%
    per Month&lt;/span&gt; &lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$
    &lt;span id="xdx_908_ecustom--BorrowingLimit_c20211231__us-gaap--LineOfCreditFacilityAxis__custom--ChairmanAndCEOMember_pp0p0" title="Borrowing Limit"&gt;10,300,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90D_ecustom--RepaymentTerms1_c20210101__20211231__us-gaap--LineOfCreditFacilityAxis__custom--ChairmanAndCEOMember" title="Repayment Terms"&gt;Due
    on Demand&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$
    &lt;span id="xdx_900_ecustom--PrincipalBorrowed_c20211231__us-gaap--LineOfCreditFacilityAxis__custom--ChairmanAndCEOMember_pp0p0" title="Principal Borrowed"&gt;10,220,700&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$
    &lt;span id="xdx_900_ecustom--AccruedInterest_c20211231__us-gaap--LineOfCreditFacilityAxis__custom--ChairmanAndCEOMember_pp0p0" title="Accrued Interest"&gt;1,208,582&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$
    &lt;span id="xdx_907_ecustom--TotalOutstanding_c20211231__us-gaap--LineOfCreditFacilityAxis__custom--ChairmanAndCEOMember_pp0p0" title="Total Outstanding"&gt;11,429,282&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_901_ecustom--Security1_c20210101__20211231__us-gaap--LineOfCreditFacilityAxis__custom--ChairmanAndCEOMember" title="Security"&gt;General
    Security over Assets&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_905_ecustom--Purpose1_c20210101__20211231__us-gaap--LineOfCreditFacilityAxis__custom--ChairmanAndCEOMember" title="Purpose"&gt;General
    Corporate Requirements&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Wife
    of Chairman&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_909_ecustom--InterestRate_c20210101__20211231__us-gaap--LineOfCreditFacilityAxis__custom--WifeOfChairmanMember" title="Interest Rate"&gt;1%
    per Month&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90B_ecustom--BorrowingLimit_c20211231__us-gaap--LineOfCreditFacilityAxis__custom--WifeOfChairmanMember_pp0p0" title="Borrowing Limit"&gt;4,000,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_900_ecustom--RepaymentTerms1_c20210101__20211231__us-gaap--LineOfCreditFacilityAxis__custom--WifeOfChairmanMember" title="Repayment Terms"&gt;Due
    on Demand&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_906_ecustom--PrincipalBorrowed_c20211231__us-gaap--LineOfCreditFacilityAxis__custom--WifeOfChairmanMember_pp0p0" title="Principal Borrowed"&gt;2,467,705&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_904_ecustom--AccruedInterest_c20211231__us-gaap--LineOfCreditFacilityAxis__custom--WifeOfChairmanMember_pp0p0" title="Accrued Interest"&gt;111,846&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90C_ecustom--TotalOutstanding_c20211231__us-gaap--LineOfCreditFacilityAxis__custom--WifeOfChairmanMember_pp0p0" title="Total Outstanding"&gt;2,579,551&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_900_ecustom--Security1_c20210101__20211231__us-gaap--LineOfCreditFacilityAxis__custom--WifeOfChairmanMember" title="Security"&gt;General
    Security over Assets&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_906_ecustom--Purpose1_c20210101__20211231__us-gaap--LineOfCreditFacilityAxis__custom--WifeOfChairmanMember" title="Purpose"&gt;General
    Corporate Requirements&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$
    &lt;span id="xdx_90F_ecustom--BorrowingLimit_c20211231_pp0p0" title="Borrowing Limit"&gt;14,300,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$
    &lt;span id="xdx_90F_ecustom--PrincipalBorrowed_c20211231_pp0p0" title="Principal Borrowed"&gt;12,688,405&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;span id="xdx_90F_ecustom--AccruedInterest_c20211231_pp0p0" title="Accrued Interest"&gt;
    1,320,428&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$
    &lt;span id="xdx_900_ecustom--TotalOutstanding_c20211231_pp0p0" title="Total Outstanding"&gt;14,008,833&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p id="xdx_8A2_zUIZZ25eBE04" style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;


















</ALRT:LineOfCreditTextBlock>
    <us-gaap:ScheduleOfLineOfCreditFacilitiesTextBlock contextRef="From2022-01-01to2022-06-30">&lt;table cellpadding="0" cellspacing="0" id="xdx_89D_eus-gaap--ScheduleOfLineOfCreditFacilitiesTextBlock_zKMNFGvRVN99" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Lines of credit (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -7.6pt; padding-left: 17.05pt"&gt;&lt;span id="xdx_8B1_zATBTdZKmVW4" style="display: none"&gt;Schedule of lines of credit activity&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right" title="Advances received on lines of credit"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;Lines of Credit&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Total&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 70%; padding-left: 5.4pt"&gt;Balance, December&#160;31, 2020&lt;/td&gt;&lt;td style="width: 10%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--LongTermLineOfCredit_iS_pp0p0_c20210101__20211231_zRhtx1Ez1L94" style="width: 18%; text-align: right" title="Balance at beginning"&gt;11,914,092&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -7.6pt; padding-left: 17.05pt"&gt;Advances received on lines of credit&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--LineOfCreditFacilityPeriodicPaymentPrincipal_c20210101__20211231_pp0p0" style="text-align: right" title="Advances received on lines of credit"&gt;1,149,279&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; text-indent: -7.6pt; padding-left: 17.05pt"&gt;Interest incurred on lines of credit&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--LineOfCreditFacilityPeriodicPaymentInterest_c20210101__20211231_pp0p0" style="text-align: right" title="Interest incurred on lines of credit"&gt;1,402,187&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; text-indent: -7.6pt; padding-left: 17.05pt"&gt;Repayment of interest on lines of credit&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_ecustom--RepaymentOfInterestOnLinesOfCredit_c20210101__20211231_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Repayment of interest on lines of credit"&gt;(456,725&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 5.4pt"&gt;Balance, December&#160;31, 2021&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--LongTermLineOfCredit_iS_pp0p0_c20220101__20220630_ziT29OeiKi7k" style="text-align: right" title="Balance at beginning"&gt;14,008,833&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -7.6pt; padding-left: 17.05pt"&gt;Advances received on lines of credit&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--LineOfCreditFacilityPeriodicPaymentPrincipal_c20220101__20220630_pp0p0" style="text-align: right" title="Advances received on lines of credit"&gt;438,165&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; text-indent: -7.6pt; padding-left: 17.05pt"&gt;Interest incurred on lines of credit&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--LineOfCreditFacilityPeriodicPaymentInterest_c20220101__20220630_pp0p0" style="text-align: right" title="Interest incurred on lines of credit"&gt;777,515&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; text-indent: -7.6pt; padding-left: 17.05pt"&gt;Repayment of interest on lines of credit&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_ecustom--RepaymentOfInterestOnLinesOfCredit_c20220101__20220630_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Repayment of interest on lines of credit"&gt;(137,475&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt; padding-left: 5.4pt"&gt;Balance, June&#160;30, 2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--LongTermLineOfCredit_iE_pp0p0_c20220101__20220630_zBhbtCvA0bAh" style="border-bottom: Black 1pt solid; text-align: right" title="Balance at ending"&gt;15,087,038&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfLineOfCreditFacilitiesTextBlock>
    <us-gaap:LongTermLineOfCredit contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">11914092</us-gaap:LongTermLineOfCredit>
    <us-gaap:LineOfCreditFacilityPeriodicPaymentPrincipal
      contextRef="From2021-01-012021-12-31"
      decimals="0"
      unitRef="USD">1149279</us-gaap:LineOfCreditFacilityPeriodicPaymentPrincipal>
    <us-gaap:LineOfCreditFacilityPeriodicPaymentInterest
      contextRef="From2021-01-012021-12-31"
      decimals="0"
      unitRef="USD">1402187</us-gaap:LineOfCreditFacilityPeriodicPaymentInterest>
    <ALRT:RepaymentOfInterestOnLinesOfCredit
      contextRef="From2021-01-012021-12-31"
      decimals="0"
      unitRef="USD">-456725</ALRT:RepaymentOfInterestOnLinesOfCredit>
    <us-gaap:LongTermLineOfCredit contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">14008833</us-gaap:LongTermLineOfCredit>
    <us-gaap:LineOfCreditFacilityPeriodicPaymentPrincipal
      contextRef="From2022-01-01to2022-06-30"
      decimals="0"
      unitRef="USD">438165</us-gaap:LineOfCreditFacilityPeriodicPaymentPrincipal>
    <us-gaap:LineOfCreditFacilityPeriodicPaymentInterest
      contextRef="From2022-01-01to2022-06-30"
      decimals="0"
      unitRef="USD">777515</us-gaap:LineOfCreditFacilityPeriodicPaymentInterest>
    <ALRT:RepaymentOfInterestOnLinesOfCredit
      contextRef="From2022-01-01to2022-06-30"
      decimals="0"
      unitRef="USD">-137475</ALRT:RepaymentOfInterestOnLinesOfCredit>
    <us-gaap:LongTermLineOfCredit contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">15087038</us-gaap:LongTermLineOfCredit>
    <ALRT:ScheduledOfLineOfCreditTableTextBlock contextRef="From2022-01-01to2022-06-30">&lt;table cellpadding="0" cellspacing="0" id="xdx_89B_ecustom--ScheduledOfLineOfCreditTableTextBlock_zRahJRFE61N8" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Lines of credit (Details 1)"&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span id="xdx_8BF_zBK8AxfWWqua" style="display: none"&gt;Schedule of lines of credit&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Creditor&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 8%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Interest
    Rate&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Borrowing
    Limit&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Repayment
    Terms&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Principal
    Borrowed&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Accrued
    Interest&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total
    Outstanding&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Security&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 15%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Purpose&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Chairman
    and CEO &lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90E_ecustom--InterestRate_c20220101__20220630__us-gaap--LineOfCreditFacilityAxis__custom--ChairmanAndCEOMember" title="Interest Rate"&gt;1%
    per Month&lt;/span&gt; &lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$
    &lt;span id="xdx_90B_ecustom--BorrowingLimit_c20220630__us-gaap--LineOfCreditFacilityAxis__custom--ChairmanAndCEOMember_pp0p0" title="Borrowing Limit"&gt;10,300,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_901_ecustom--RepaymentTerms1_c20220101__20220630__us-gaap--LineOfCreditFacilityAxis__custom--ChairmanAndCEOMember" title="Repayment Terms"&gt;Due
    on Demand&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$
    &lt;span id="xdx_90F_ecustom--PrincipalBorrowed_c20220630__us-gaap--LineOfCreditFacilityAxis__custom--ChairmanAndCEOMember_pp0p0" title="Principal Borrowed"&gt;10,300,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$
    &lt;span id="xdx_90D_ecustom--AccruedInterest_c20220630__us-gaap--LineOfCreditFacilityAxis__custom--ChairmanAndCEOMember_pp0p0" title="Accrued Interest"&gt;1,763,048&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$
    &lt;span id="xdx_904_ecustom--TotalOutstanding_c20220630__us-gaap--LineOfCreditFacilityAxis__custom--ChairmanAndCEOMember_pp0p0" title="Total Outstanding"&gt;12,063,048&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90C_ecustom--Security1_c20220101__20220630__us-gaap--LineOfCreditFacilityAxis__custom--ChairmanAndCEOMember" title="Security"&gt;General
    Security over Assets&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_909_ecustom--Purpose1_c20220101__20220630__us-gaap--LineOfCreditFacilityAxis__custom--ChairmanAndCEOMember" title="Purpose"&gt;General
    Corporate Requirements&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Wife
    of Chairman&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_905_ecustom--InterestRate_c20220101__20220630__us-gaap--LineOfCreditFacilityAxis__custom--WifeOfChairmanMember" title="Interest Rate"&gt;1%
    per Month&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90A_ecustom--BorrowingLimit_c20220630__us-gaap--LineOfCreditFacilityAxis__custom--WifeOfChairmanMember_pp0p0" title="Borrowing Limit"&gt;4,000,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90D_ecustom--RepaymentTerms1_c20220101__20220630__us-gaap--LineOfCreditFacilityAxis__custom--WifeOfChairmanMember" title="Repayment Terms"&gt;Due
    on Demand&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_905_ecustom--PrincipalBorrowed_c20220630__us-gaap--LineOfCreditFacilityAxis__custom--WifeOfChairmanMember_pp0p0" title="Principal Borrowed"&gt;2,826,570&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_901_ecustom--AccruedInterest_c20220630__us-gaap--LineOfCreditFacilityAxis__custom--WifeOfChairmanMember_pp0p0" title="Accrued Interest"&gt;197,420&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90B_ecustom--TotalOutstanding_c20220630__us-gaap--LineOfCreditFacilityAxis__custom--WifeOfChairmanMember_pp0p0" title="Total Outstanding"&gt;3,023,990&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90C_ecustom--Security1_c20220101__20220630__us-gaap--LineOfCreditFacilityAxis__custom--WifeOfChairmanMember" title="Security"&gt;General
    Security over Assets&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_902_ecustom--Purpose1_c20220101__20220630__us-gaap--LineOfCreditFacilityAxis__custom--WifeOfChairmanMember" title="Purpose"&gt;General
    Corporate Requirements&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$
    &lt;span id="xdx_90C_ecustom--BorrowingLimit_c20220630_pp0p0" title="Borrowing Limit"&gt;14,300,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$
    &lt;span id="xdx_902_ecustom--PrincipalBorrowed_iI_pp0p0_c20220630_z2E6OXZMPoqg" title="Principal Borrowed"&gt;13,126,570&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$
    &lt;span id="xdx_902_ecustom--AccruedInterest_c20220630_pp0p0" title="Accrued Interest"&gt;1,960,468&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$
    &lt;span id="xdx_903_ecustom--TotalOutstanding_c20220630_pp0p0" title="Total Outstanding"&gt;15,087,038&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of December&#160;31, 2021, the Company had two lines of credit as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Creditor&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 8%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Interest
    Rate&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Borrowing
    Limit&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Repayment
    Terms&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Principal
    Borrowed&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Accrued
    Interest&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total
    Outstanding&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Security&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; width: 15%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Purpose&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Chairman
    and CEO &lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90A_ecustom--InterestRate_c20210101__20211231__us-gaap--LineOfCreditFacilityAxis__custom--ChairmanAndCEOMember" title="Interest Rate"&gt;1%
    per Month&lt;/span&gt; &lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$
    &lt;span id="xdx_908_ecustom--BorrowingLimit_c20211231__us-gaap--LineOfCreditFacilityAxis__custom--ChairmanAndCEOMember_pp0p0" title="Borrowing Limit"&gt;10,300,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90D_ecustom--RepaymentTerms1_c20210101__20211231__us-gaap--LineOfCreditFacilityAxis__custom--ChairmanAndCEOMember" title="Repayment Terms"&gt;Due
    on Demand&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$
    &lt;span id="xdx_900_ecustom--PrincipalBorrowed_c20211231__us-gaap--LineOfCreditFacilityAxis__custom--ChairmanAndCEOMember_pp0p0" title="Principal Borrowed"&gt;10,220,700&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$
    &lt;span id="xdx_900_ecustom--AccruedInterest_c20211231__us-gaap--LineOfCreditFacilityAxis__custom--ChairmanAndCEOMember_pp0p0" title="Accrued Interest"&gt;1,208,582&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$
    &lt;span id="xdx_907_ecustom--TotalOutstanding_c20211231__us-gaap--LineOfCreditFacilityAxis__custom--ChairmanAndCEOMember_pp0p0" title="Total Outstanding"&gt;11,429,282&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_901_ecustom--Security1_c20210101__20211231__us-gaap--LineOfCreditFacilityAxis__custom--ChairmanAndCEOMember" title="Security"&gt;General
    Security over Assets&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_905_ecustom--Purpose1_c20210101__20211231__us-gaap--LineOfCreditFacilityAxis__custom--ChairmanAndCEOMember" title="Purpose"&gt;General
    Corporate Requirements&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Wife
    of Chairman&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_909_ecustom--InterestRate_c20210101__20211231__us-gaap--LineOfCreditFacilityAxis__custom--WifeOfChairmanMember" title="Interest Rate"&gt;1%
    per Month&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90B_ecustom--BorrowingLimit_c20211231__us-gaap--LineOfCreditFacilityAxis__custom--WifeOfChairmanMember_pp0p0" title="Borrowing Limit"&gt;4,000,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_900_ecustom--RepaymentTerms1_c20210101__20211231__us-gaap--LineOfCreditFacilityAxis__custom--WifeOfChairmanMember" title="Repayment Terms"&gt;Due
    on Demand&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_906_ecustom--PrincipalBorrowed_c20211231__us-gaap--LineOfCreditFacilityAxis__custom--WifeOfChairmanMember_pp0p0" title="Principal Borrowed"&gt;2,467,705&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_904_ecustom--AccruedInterest_c20211231__us-gaap--LineOfCreditFacilityAxis__custom--WifeOfChairmanMember_pp0p0" title="Accrued Interest"&gt;111,846&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90C_ecustom--TotalOutstanding_c20211231__us-gaap--LineOfCreditFacilityAxis__custom--WifeOfChairmanMember_pp0p0" title="Total Outstanding"&gt;2,579,551&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_900_ecustom--Security1_c20210101__20211231__us-gaap--LineOfCreditFacilityAxis__custom--WifeOfChairmanMember" title="Security"&gt;General
    Security over Assets&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_906_ecustom--Purpose1_c20210101__20211231__us-gaap--LineOfCreditFacilityAxis__custom--WifeOfChairmanMember" title="Purpose"&gt;General
    Corporate Requirements&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$
    &lt;span id="xdx_90F_ecustom--BorrowingLimit_c20211231_pp0p0" title="Borrowing Limit"&gt;14,300,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$
    &lt;span id="xdx_90F_ecustom--PrincipalBorrowed_c20211231_pp0p0" title="Principal Borrowed"&gt;12,688,405&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;span id="xdx_90F_ecustom--AccruedInterest_c20211231_pp0p0" title="Accrued Interest"&gt;
    1,320,428&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: -2.8pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$
    &lt;span id="xdx_900_ecustom--TotalOutstanding_c20211231_pp0p0" title="Total Outstanding"&gt;14,008,833&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
</ALRT:ScheduledOfLineOfCreditTableTextBlock>
    <ALRT:InterestRate contextRef="From2022-01-012022-06-30_custom_ChairmanAndCEOMember">1%
    per Month</ALRT:InterestRate>
    <ALRT:BorrowingLimit
      contextRef="AsOf2022-06-30_custom_ChairmanAndCEOMember"
      decimals="0"
      unitRef="USD">10300000</ALRT:BorrowingLimit>
    <ALRT:RepaymentTerms1 contextRef="From2022-01-012022-06-30_custom_ChairmanAndCEOMember">Due
    on Demand</ALRT:RepaymentTerms1>
    <ALRT:PrincipalBorrowed
      contextRef="AsOf2022-06-30_custom_ChairmanAndCEOMember"
      decimals="0"
      unitRef="USD">10300000</ALRT:PrincipalBorrowed>
    <ALRT:AccruedInterest
      contextRef="AsOf2022-06-30_custom_ChairmanAndCEOMember"
      decimals="0"
      unitRef="USD">1763048</ALRT:AccruedInterest>
    <ALRT:TotalOutstanding
      contextRef="AsOf2022-06-30_custom_ChairmanAndCEOMember"
      decimals="0"
      unitRef="USD">12063048</ALRT:TotalOutstanding>
    <ALRT:Security1 contextRef="From2022-01-012022-06-30_custom_ChairmanAndCEOMember">General
    Security over Assets</ALRT:Security1>
    <ALRT:Purpose1 contextRef="From2022-01-012022-06-30_custom_ChairmanAndCEOMember">General
    Corporate Requirements</ALRT:Purpose1>
    <ALRT:InterestRate contextRef="From2022-01-012022-06-30_custom_WifeOfChairmanMember">1%
    per Month</ALRT:InterestRate>
    <ALRT:BorrowingLimit
      contextRef="AsOf2022-06-30_custom_WifeOfChairmanMember"
      decimals="0"
      unitRef="USD">4000000</ALRT:BorrowingLimit>
    <ALRT:RepaymentTerms1 contextRef="From2022-01-012022-06-30_custom_WifeOfChairmanMember">Due
    on Demand</ALRT:RepaymentTerms1>
    <ALRT:PrincipalBorrowed
      contextRef="AsOf2022-06-30_custom_WifeOfChairmanMember"
      decimals="0"
      unitRef="USD">2826570</ALRT:PrincipalBorrowed>
    <ALRT:AccruedInterest
      contextRef="AsOf2022-06-30_custom_WifeOfChairmanMember"
      decimals="0"
      unitRef="USD">197420</ALRT:AccruedInterest>
    <ALRT:TotalOutstanding
      contextRef="AsOf2022-06-30_custom_WifeOfChairmanMember"
      decimals="0"
      unitRef="USD">3023990</ALRT:TotalOutstanding>
    <ALRT:Security1 contextRef="From2022-01-012022-06-30_custom_WifeOfChairmanMember">General
    Security over Assets</ALRT:Security1>
    <ALRT:Purpose1 contextRef="From2022-01-012022-06-30_custom_WifeOfChairmanMember">General
    Corporate Requirements</ALRT:Purpose1>
    <ALRT:BorrowingLimit contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">14300000</ALRT:BorrowingLimit>
    <ALRT:PrincipalBorrowed contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">13126570</ALRT:PrincipalBorrowed>
    <ALRT:AccruedInterest contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">1960468</ALRT:AccruedInterest>
    <ALRT:TotalOutstanding contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">15087038</ALRT:TotalOutstanding>
    <ALRT:InterestRate contextRef="From2021-01-012021-12-31_custom_ChairmanAndCEOMember">1%
    per Month</ALRT:InterestRate>
    <ALRT:BorrowingLimit
      contextRef="AsOf2021-12-31_custom_ChairmanAndCEOMember"
      decimals="0"
      unitRef="USD">10300000</ALRT:BorrowingLimit>
    <ALRT:RepaymentTerms1 contextRef="From2021-01-012021-12-31_custom_ChairmanAndCEOMember">Due
    on Demand</ALRT:RepaymentTerms1>
    <ALRT:PrincipalBorrowed
      contextRef="AsOf2021-12-31_custom_ChairmanAndCEOMember"
      decimals="0"
      unitRef="USD">10220700</ALRT:PrincipalBorrowed>
    <ALRT:AccruedInterest
      contextRef="AsOf2021-12-31_custom_ChairmanAndCEOMember"
      decimals="0"
      unitRef="USD">1208582</ALRT:AccruedInterest>
    <ALRT:TotalOutstanding
      contextRef="AsOf2021-12-31_custom_ChairmanAndCEOMember"
      decimals="0"
      unitRef="USD">11429282</ALRT:TotalOutstanding>
    <ALRT:Security1 contextRef="From2021-01-012021-12-31_custom_ChairmanAndCEOMember">General
    Security over Assets</ALRT:Security1>
    <ALRT:Purpose1 contextRef="From2021-01-012021-12-31_custom_ChairmanAndCEOMember">General
    Corporate Requirements</ALRT:Purpose1>
    <ALRT:InterestRate contextRef="From2021-01-012021-12-31_custom_WifeOfChairmanMember">1%
    per Month</ALRT:InterestRate>
    <ALRT:BorrowingLimit
      contextRef="AsOf2021-12-31_custom_WifeOfChairmanMember"
      decimals="0"
      unitRef="USD">4000000</ALRT:BorrowingLimit>
    <ALRT:RepaymentTerms1 contextRef="From2021-01-012021-12-31_custom_WifeOfChairmanMember">Due
    on Demand</ALRT:RepaymentTerms1>
    <ALRT:PrincipalBorrowed
      contextRef="AsOf2021-12-31_custom_WifeOfChairmanMember"
      decimals="0"
      unitRef="USD">2467705</ALRT:PrincipalBorrowed>
    <ALRT:AccruedInterest
      contextRef="AsOf2021-12-31_custom_WifeOfChairmanMember"
      decimals="0"
      unitRef="USD">111846</ALRT:AccruedInterest>
    <ALRT:TotalOutstanding
      contextRef="AsOf2021-12-31_custom_WifeOfChairmanMember"
      decimals="0"
      unitRef="USD">2579551</ALRT:TotalOutstanding>
    <ALRT:Security1 contextRef="From2021-01-012021-12-31_custom_WifeOfChairmanMember">General
    Security over Assets</ALRT:Security1>
    <ALRT:Purpose1 contextRef="From2021-01-012021-12-31_custom_WifeOfChairmanMember">General
    Corporate Requirements</ALRT:Purpose1>
    <ALRT:BorrowingLimit contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">14300000</ALRT:BorrowingLimit>
    <ALRT:PrincipalBorrowed contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">12688405</ALRT:PrincipalBorrowed>
    <ALRT:AccruedInterest contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">1320428</ALRT:AccruedInterest>
    <ALRT:TotalOutstanding contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">14008833</ALRT:TotalOutstanding>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="From2022-01-01to2022-06-30">&lt;p id="xdx_80C_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_zWejA8MeCBsl" style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;6.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;span id="xdx_823_z5o6392NDyMk"&gt;Capital
stock&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 18pt"/&gt;&lt;td style="width: 17.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;a)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Authorized
                                            capital stock&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify; text-indent: -0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 35.45pt"/&gt;&lt;td style="width: 18.55pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;i)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Common
                                            Stock&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;10,000,000,000
shares of common stock with a par value of $0.001 per share.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 35.45pt"/&gt;&lt;td style="width: 18.55pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;ii)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Preferred
                                            Stock &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;500,000,000
shares of preferred stock with a par value of $0.001 per share.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;Issued
capital stock&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;During
the period ended June&#160;30, 2022:&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 35.3pt"/&gt;&lt;td style="width: 18pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;i)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
                                            January 18, 2022, the Company issued a prospectus whereby it distributed 101,025,592 subscription
                                            rights to its shareholders to purchase shares of common stock of the Company at a price of
                                            $0.05 per share. The rights were set to expire on February 18, 2022, subsequently extended
                                            to March&#160;15, 2022. On such case-by-case basis, the Company allowed for the exercise
                                            of any such shares until April&#160;1, 2022. Management may, at its discretion, allocate
                                            unexercised subscription rights to non-shareholders within 150 days (August&#160;12, 2022)
                                            following the expiration date of March&#160;15, 2022. On March&#160;21, 2022, the Company
                                            recognized share subscriptions receivable of $25 pursuant to its registration statement and
                                            issued a total of 500 shares of common stock for gross proceeds of $25. The subscription
                                            rights were cancelled on July 7, 2022 (note 11(a)).&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 35.45pt"/&gt;&lt;td style="width: 18.55pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;ii)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
                                            Company issued four parties an aggregate 9,250,000 shares of common stock at a fair value
                                            of $0.04 per share for a total of $370,000 in exchange for the retirement of $125,000 of
                                            accounts payable and $245,000 for bonuses issued.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




























&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;During
the year ended December&#160;31, 2021:&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 35.45pt"/&gt;&lt;td style="width: 18.55pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;iii)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
                                            January 4, 2021, 1,000 shares of common stock were cancelled by a shareholder; no consideration
                                            was exchanged.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify; text-indent: -18.55pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 35.45pt"/&gt;&lt;td style="width: 18.55pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;iv)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
                                            April 12, 2021, the Company elected to extend the initial 90-day period (April&#160;22, 2021)
                                            by an additional 100-day period related to the closing of the rights offering. The Company
                                            had until July&#160;31, 2021 to sell the remaining 113,025,592 shares of common stock. The
                                            Company further extended the offering period to October 29, 2021. The Company filed a post-effective
                                            amendment to further extend the rights offering from October 29, 2021 to March 15, 2022.
                                            On such case-by-case basis, the Company allowed for the exercise of any such shares until
                                            April&#160;1, 2022. Management may, at its discretion, allocate unexercised subscription
                                            rights to non-shareholders within 150 days (August 12, 2022) following the expiration date
                                            of March&#160;15, 2022. The subscription rights were cancelled on July 7, 2022 (note 11(a)).&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify; text-indent: -18.55pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 35.45pt"/&gt;&lt;td style="width: 18.55pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;v)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
                                            Company collected subscriptions of $1,124,832 pursuant to its registration statement and
                                            issued a total of 26,496,635 shares of common stock for gross proceeds of $1,324,832; $200,000
                                            of the proceeds had been collected during the year ended December&#160;31, 2020 and recognized
                                            as obligation to issue shares.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify; text-indent: -18.55pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 35.45pt"/&gt;&lt;td style="width: 18.55pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;vi)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
                                            Company received proceeds of $12,000 pursuant to the exercise of options to acquire 800,000
                                            shares of common stock at a price of $0.015 per share.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-indent: -18.55pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 35.45pt"/&gt;&lt;td style="width: 18.55pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;vii)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
                                            Company entered into two shares for debt agreements with two creditors to issue an aggregate
                                            4,400,000 shares of common stock at a fair value of $0.057 per share for a purchase price
                                            of $250,800 in exchange for the retirement of $217,186 of liabilities comprised of: &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify; text-indent: -0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 71.45pt"/&gt;&lt;td style="width: 18pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Accounts
                                            payable	-	$ 194,186&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 71.45pt"/&gt;&lt;td style="width: 18pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Promissory
                                            notes &#x2013; Principal 	-	$ 20,000&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 71.45pt"/&gt;&lt;td style="width: 18pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Line
                                            of credit &#x2013; Accrued interest	-	$ 3,000&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify; text-indent: 13.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company recognized loss on debt settlement of $33,614. The Company also issued commitment letters to two creditors offering them an aggregate
20,000,000 shares of common stock in exchange for the extinguishment of $1,511,377 in promissory notes and interest payable prior to
December&#160;31, 2021 (note&#160;8). These offer letters expired on December&#160;31, 2021 without the parties executing any settlements.
On March&#160;18, 2022, the Company extended the offer letters from December&#160;31, 2021 to December&#160;31, 2022 for the settlement
of $1,541,000 in promissory notes and interest payable. As of the date of these condensed consolidated financial statements, the offer
letters have not been executed.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;


















</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <ALRT:AdditionalPaidInCapitalTextBlock contextRef="From2022-01-01to2022-06-30">&lt;p id="xdx_802_ecustom--AdditionalPaidInCapitalTextBlock_znlk1pU4dip9" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;7.
&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;span id="xdx_823_zUDSEonENrri"&gt;Additional paid-in capital&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Stock
options&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;A
summary of stock option activity is as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_892_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_zUoiYiGi2vq5" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Additional paid-in capital (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span id="xdx_8B1_zKthe3E0mds9" style="display: none"&gt;Schedule of share-based compensation, stock options, activity&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Six
                                            Months Ended&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;June&#160;30,
    2022&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Year
                                            Ended&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;December&#160;31,
    2021&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Number
    of Options&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Weighted
    Average Exercise Price&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Number
    of Options&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Weighted
    Average Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 45%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Outstanding,
    beginning of period&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20220101__20220630_zV1DYlxCfDN8" style="width: 16%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Outstanding, beginning of period"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;5,497,001,500&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 3%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20220101__20220630_zQXpNrvOIiRh" style="width: 8%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Average Exercise Price, beginning"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.006&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20210101__20211231_zAwiiG38tZ2b" style="width: 16%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Outstanding, beginning of period"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;5,362,701,500&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 3%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20210101__20211231_zO1LKcElzOu7" style="width: 9%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Average Exercise Price, beginning"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.004&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Granted&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_c20220101__20220630_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Granted"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0655"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20220101__20220630_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Granted, per share"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0657"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_c20210101__20211231_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Granted"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;165,000,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20210101__20211231_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Granted, per share"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.050&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Exercised
    &lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_di_c20220101__20220630_zrvMVZcthA6b" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercised"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0663"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_iN_di_c20220101__20220630_zxzdztcQw2U7" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercised per share"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0665"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_di_c20210101__20211231_z3u32gzrfZC7" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercised"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(800,000)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_iN_di_c20210101__20211231_zi9SZEmKkBQk" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercised per share"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(0.015)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Cancelled&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--ShareBasedCompensationArrangementbyShareBasedPaymentAwardOptionsCancelations_iN_di_c20220101__20220630_zhCh96P9e14d" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cancelled"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(90,000,000)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--CancelledPerShares_iN_di_c20220101__20220630_zjhNUX9qAFAj" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cancelled per share"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(0.041)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--ShareBasedCompensationArrangementbyShareBasedPaymentAwardOptionsCancelations_iN_di_c20210101__20211231_znFABDdf4dOh" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cancelled"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(29,900,000)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--CancelledPerShares_iN_di_c20210101__20211231_zFFfX3awkha1" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cancelled per share"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(0.034)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Outstanding,
    end of period&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20220101__20220630_zbKFTwrihlcl" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Outstanding, end of period"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;5,407,001,500&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20220101__20220630_zc8T3dYSe4N4" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Average Exercise price, ending"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.005&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20210101__20211231_zbgPrtK7TVQf" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Outstanding, end of period"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;5,497,001,500&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20210101__20211231_zgkryhDzsGA6" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Average Exercise price, ending"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.006&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Exercisable,
    end of period&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_c20220630_pdd" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercisable, end of period"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;5,223,701,500&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_c20220630_pdd" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercisable, end of period"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.004&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_c20211231_pdd" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercisable, end of period"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;5,221,701,500&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_c20211231_pdd" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercisable, end of period"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.004&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p id="xdx_8AF_z8qgwZeEZTPb" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;During
the period ended June&#160;30, 2022:&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"&gt;On
March 18, 2022, the Company modified 70,000,000 options previously granted to a number of advisors and independent contractors by extending
the vesting period under vesting terms, which have not been met, from September&#160;30, 2021 and December&#160;31, 2021 to December&#160;31,
2022, and from June&#160;30, 2022 to June&#160;30, 2023.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"&gt;On
March 18, 2022, the Company amended 2,500,000 options previously granted to an individual on October&#160;4, 2021 by vesting 1,000,000
options with performance conditions and cancelling the remaining 1,500,000 options. During the period ended June&#160;30, 2022, $59,639
related to the 1,000,000 options that vested immediately was recorded.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"&gt;Effective
March 18, 2022, the Company cancelled 20,000,000 stock options exercisable at $0.015, 10,000,000 stock options exercisable at $0.035
and 28,500,000 exercisable at $0.05 related to the termination of certain contractors.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"&gt;On
April 27, 2022, the Company provided termination notice to a contractor. As a result, the contractor&#x2019;s 30,000,000 stock options
exercisable at $0.05 were cancelled, unvested, effective June&#160;30, 2022.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"&gt;During
the period ended June&#160;30, 2022, the Company recorded a total of $518,659 in compensation expense related to the vesting of stock
options granted in 2021, including the $59,639 from the modification of vesting terms of 1,000,000 options.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




























&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"&gt;&lt;b&gt;During
the year ended December&#160;31, 2021:&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"&gt;On
January 28, 2021, the Company granted the option to acquire an aggregate 32,000,000 shares of common stock at a price of $0.05 per share
to six individuals. All of the options will vest according to performance or time-based conditions. Options to acquire 22,000,000 shares
of common stock will expire December&#160;31, 2025, and options to acquire 10,000,000 shares of common stock will expire May&#160;17,
2024. As at June&#160;30, 2022, 2,000,000 (December&#160;31, 2021&#160;- 1,000,000) options have vested to date. The fair value of the
options granted totals $1,706,244, of which $573,292 relates to stock options that have time-based vesting conditions and $1,132,952
relates to stock options that have performance vesting conditions. During the period ended June&#160;30, 2022, $98,726 (December&#160;31,
2021 - $248,189) related to stock options with time-based vesting conditions and $56,648 (December&#160;31, 2021 - $nil) related to stock
options with performance-based vesting conditions was recognized. The remaining fair value of $1,302,681 has not been recorded.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"&gt;On
February 22, 2021, the Company granted the option to acquire an aggregate 5,000,000 shares of common stock at a price of $0.05 per share.
These options were granted to three individuals and have an expiry date of May 17, 2024. None of these options have vested to date. The
fair value of the options granted totaled $225,141. During the period ended June&#160;30, 2022, $34,638 (December&#160;31, 2021 - $57,730)
related to stock options with time-based vesting conditions was recognized. The remaining fair value of $132,773 has not been recorded.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"&gt;On
April 14, 2021, the Company&#x2019;s Board of Directors approved the grant of the option to acquire an aggregate 28,500,000 shares of
common stock at a price of $0.05 per share until December&#160;31, 2025 to five individuals. All of the options will vest according to
performance or time-based conditions; 200,000 options have vested to date. The fair value of the options granted totaled $1,565,812,
of which $351,621 related to stock options that have time-based vesting conditions and $1,214,191 related to stock options that have
performance vesting conditions. During the period ended June&#160;30, 2022, $54,558 (December&#160;31, 2021 - $88,540) related to the
stock options with time-based vesting conditions was recognized. The remaining fair value of $1,422,714 has not been recorded.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"&gt;On
May 12, 2021, the Company&#x2019;s Board of Directors amended the option to acquire 2,000,000 shares, previously granted on January 28,
2021 to a consultant, to increase the option by 1,000,000 to provide the optionee the option to acquire an aggregate 3,000,000 shares
of common stock at a price of $0.05 per share until December&#160;31, 2025. All other terms of the January 28, 2021 grant remain the
same and the options are subject to performance vesting conditions. The fair value of the additional 1,000,000 amended options granted
totaled $54,940 was not recorded, as it cannot be determined that it is more likely than not that the performance condition will be met.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"&gt;On
May 31, 2021, the Company granted one consultant the option to acquire 5,000,000 shares of common stock of the Company at a price of
$0.05 per share until December&#160;31, 2025 subject to performance vesting conditions. The fair value of the options granted totaled
$254,708 was not recorded, as it cannot be determined that it is more likely than not that the performance condition will be met.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




























&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"&gt;On
June 27, 2021, the Company cancelled 7,400,000 stock options with an average exercise price of $0.033.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"&gt;On
June 27, 2021, the Company&#x2019;s Board of Directors approved the grant of the option to acquire an aggregate 21,000,000 shares of common
stock at a price of $0.05 per share until June&#160;30, 2026 to four individuals. All of the options will vest according to performance
or time-based conditions. The fair value of the options granted totaled $1,374,208, of which $26,175 related to stock options with time-based
vesting conditions and $1,348,033 related to stock options with performance vesting conditions. During the period ended June&#160;30,
2022, $9,812 (December&#160;31, 2021 - $9,816) related to the stock options with time-based vesting conditions was recognized. The remaining
fair value of $1,354,580 has not been recorded.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"&gt;On
June&#160;30, 2021, the Company amended the option to acquire 4,365,001,300 shares of common stock granted on July&#160;1, 2016 by extending
the expiry date from July&#160;1, 2021 to April&#160;12, 2024. The options were granted in connection with lines of credit provided by
the Chairman and his spouse, which are currently outstanding (note&#160;5). All of the options had vested in previous years. The fair
value of the amendments totaled $1,287,834 and was recorded during the year ended December&#160;31, 2021 in interest expense.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"&gt;Effective
July 22, 2021, the Company cancelled 22,500,000 stock options exercisable at $0.035 related to the termination of certain contractors
and advisors.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"&gt;On
August 27, 2021, the Company granted a member of the Board of Directors the option to acquire 5,000,000 shares of common stock at a price
of $0.05 per share until June&#160;30, 2026. The fair value of the options granted totaling $304,692 was fully recorded at grant.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"&gt;On
October 4, 2021, the Company granted two individuals the option to acquire an aggregate 17,500,000 options at an exercise price of $0.05
per share until September&#160;30, 2026; 15,000,000 of the options will vest according to time-based conditions and 2,500,000 will vest
according to performance conditions. &lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On March 18, 2022,
the Company cancelled 1,500,000 options and vested 1,000,000 options with performance vesting conditions. &lt;span style="background-color: white"&gt;As
at June&#160;30, 2022, 1,000,000 (December&#160;31, 2021&#160;- nil) options have vested to date. The fair value of the options granted
totaled $1,043,690, of which $894,592 related to stock options that have time-based vesting conditions and $149,098 related to stock
options that have performance vesting conditions. During the period ended June&#160;30, 2022, $204,638 (December&#160;31, 2021 - $101,758)
related to stock options with time-based vesting conditions and $59,639 (December&#160;31, 2021 - $nil) related to stock options with
performance-based vesting conditions was recognized. The remaining fair value of $677,655 has not been recorded.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"&gt;On
December 10, 2021, the Company granted one creditor the option to acquire 40,000,000 shares of common stock of the Company at a price
of $0.05 per share until December&#160;31, 2026 in connection with receiving line of credit financing (note&#160;5). The fair value of
the options granted totaled $2,137,286 and was fully recorded upon the Company entering into the financing agreement with the creditor.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;






























&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"&gt;On
December 10, 2021, the Company granted one consultant the option to acquire 10,000,000 shares of common stock of the Company at a price
of $0.05 per share until December&#160;31, 2026 subject to performance vesting conditions. The fair value of the options granted totaled
$534,321 was not recorded, as it cannot be determined that it is more likely than not that the performance condition will be met.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"&gt;During
the year ended December&#160;31, 2021, the Company recorded a further $167,373 in compensation expense related to the vesting of stock
options granted in previous years.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Outstanding:&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"&gt;The
options outstanding at June&#160;30, 2022 and December&#160;31, 2021 were as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_894_ecustom--ScheduleofOptionsOutstandingTableTextBlock_z6jbF1ydVQfd" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Additional paid-in capital (Details 1)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span id="xdx_8B7_zW1FlOVS0Zvl" style="display: none"&gt;Schedule of Options Outstanding&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="5" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;June&#160;30,
    2022&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="5" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;December&#160;31,
    2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Expiry
    Date&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Options&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Exercise
    Price&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Intrinsic
    Value&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Options&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Exercise
    Price&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Intrinsic
    Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="width: 34%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 13%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 3%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 7%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 3%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 7%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 13%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 3%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 7%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 3%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 7%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;November
    27, 2022&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options1Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;5,600,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--ExercisePrices_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options1Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.015&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--IntrinsicValue_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options1Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.044&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options1Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;5,600,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options1Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.015&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options1Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.045&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;January
    31, 2023&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options2Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;20,500,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--ExercisePrices_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options2Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.015&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--IntrinsicValue_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options2Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.044&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options2Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;40,500,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options2Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.015&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options2Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.045&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;June
    13, 2023&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options3Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;5,000,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--ExercisePrices_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options3Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.015&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--IntrinsicValue_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options3Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.044&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options3Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;5,000,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options3Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.015&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options3Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.045&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;March
    14, 2024&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options4Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;6,650,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--ExercisePrices_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options4Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.035&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--IntrinsicValue_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options4Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.024&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options4Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;6,650,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options4Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.035&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options4Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;April
    12, 2024&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options5Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;4,925,001,500&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--ExercisePrices_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options5Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.002&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--IntrinsicValue_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options5Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.057&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options5Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;4,925,001,500&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options5Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.002&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options5Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.058&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;April
    12, 2024&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options6Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3,350,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--ExercisePrices_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options6Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.015&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--IntrinsicValue_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options6Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.044&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options6Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3,350,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options6Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.015&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options6Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.045&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;April
    12, 2024&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options7Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;200,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--ExercisePrices_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options7Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.030&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--IntrinsicValue_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options7Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.029&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options7Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;200,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options7Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.030&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options7Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.030&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;May
    6, 2024&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options8Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;13,000,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--ExercisePrices_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options8Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.035&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--IntrinsicValue_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options8Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.024&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options8Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;13,000,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options8Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.035&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options8Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;May
    17, 2024&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options9Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;57,000,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--ExercisePrices_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options9Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.050&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--IntrinsicValue_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options9Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.009&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options9Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;77,000,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options9Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.050&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options9Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.010&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;May
    17, 2024&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options10Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;19,400,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--ExercisePrices_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options10Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.035&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--IntrinsicValue_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options10Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.024&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options10Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;19,400,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options10Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.035&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options10Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;June
    17, 2024&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options11Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0854"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--ExercisePrices_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options11Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0856"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--IntrinsicValue_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options11Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0858"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options11Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;5,000,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options11Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.050&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options11Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.010&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;August
    16, 2024&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options12Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0866"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--ExercisePrices_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options12Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0868"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--IntrinsicValue_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options12Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0870"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options12Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,500,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options12Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.050&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options12Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.010&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;September
    6, 2024&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options13Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0878"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--ExercisePrices_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options13Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0880"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--IntrinsicValue_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options13Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0882"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options13Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,000,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options13Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.050&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options13Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.010&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;October
    3, 2024&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options14Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3,500,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--ExercisePrices_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options14Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.035&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--IntrinsicValue_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options14Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.024&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options14Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3,500,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options14Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.035&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options14Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;October
    24, 2024&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options15Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,000,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--ExercisePrices_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options15Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.035&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--IntrinsicValue_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options15Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.024&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options15Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,000,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options15Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.035&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options15Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;December
    11, 2024&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options16Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;120,000,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--ExercisePrices_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options16Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.015&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--IntrinsicValue_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options16Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.044&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options16Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;120,000,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options16Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.015&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options16Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.045&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;April
    1, 2025&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options17Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;10,000,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--ExercisePrices_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options17Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.035&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--IntrinsicValue_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options17Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.024&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options17Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;10,000,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options17Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.035&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options17Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;May
    31, 2025&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options18Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;10,000,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--ExercisePrices_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options18Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.035&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--IntrinsicValue_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options18Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.024&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options18Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;20,000,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options18Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.035&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options18Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;May
    31, 2025&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options19Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;57,300,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--ExercisePrices_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options19Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.050&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--IntrinsicValue_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options19Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.009&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options19Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;87,300,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options19Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.050&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options19Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.010&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;December&#160;31,
    2025&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options20Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;56,500,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--ExercisePrices_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options20Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.050&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--IntrinsicValue_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options20Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.009&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options20Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;56,500,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options20Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.050&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options20Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.010&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;June&#160;30,
    2026&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options21Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;26,000,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--ExercisePrices_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options21Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.050&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--IntrinsicValue_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options21Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.009&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options21Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;26,000,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options21Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.050&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options21Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.010&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;September
    30, 2026&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options22Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;16,000,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--ExercisePrices_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options22Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.050&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--IntrinsicValue_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options22Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.009&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options22Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;17,500,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options22Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.050&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options22Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.010&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;December&#160;31,
    2026&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options23Member_pdd" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;50,000,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--ExercisePrices_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options23Member_pdd" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.050&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--IntrinsicValue_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options23Member_pdd" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.009&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options23Member_pdd" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;50,000,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options23Member_pdd" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.050&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options23Member_pdd" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.010&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220630_pdd" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;5,407,001,500&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--ExercisePrices_c20220101__20220630_pdd" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.005&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--IntrinsicValue_c20220101__20220630_pdd" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.053&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231_pdd" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;5,497,001,500&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--ExercisePrices_c20210101__20211231_pdd" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.006&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--IntrinsicValue_c20210101__20211231_pdd" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.054&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Weighted
    Average Remaining Contractual Life&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_905_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20220101__20220630_zWiLVbV9cCZ4" title="Weighted Average Remaining Contractual Life"&gt;1.87&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20210101__20211231_zlPBtc7FoC4l" title="Weighted Average Remaining Contractual Life"&gt;2.37&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_8AD_z30Vgv9DjIIb" style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;


























&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
fair value of the stock options granted and vested was allocated as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_897_eus-gaap--ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_zAieNWJFwSL5" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Additional paid-in capital (Details 2)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -7.1pt; padding-left: 14.2pt"&gt;&lt;span id="xdx_8BF_zkr2h51EzkZg" style="display: none"&gt;Schedule of Fair Value of Stock Options Granted-Allocation&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49A_20220401__20220630_zqv7fsuHb40a" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_497_20210401__20210630_z53lf9cfitN5" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49F_20220101__20220630_zkOtOGVIv4O9" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49F_20210101__20210630_zsj8W9Hjt4Ok" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Three Months Ended&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;June&#160;30, 2022&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Three Months Ended&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;June&#160;30, 2021&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Six Months Ended&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;June&#160;30, 2022&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Six Months Ended&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;June&#160;30, 2021&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--InterestExpenseDebt_maTz8pZ_zawqV4y5I0T2" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 40%; text-align: left; text-indent: -7.1pt; padding-left: 14.2pt"&gt;Interest expense&lt;/td&gt;&lt;td style="width: 3%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1039"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 3%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;1,287,834&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 3%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1041"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 3%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;1,287,834&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_maTz8pZ_ztudKj64f4a1" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -7.1pt; padding-left: 14.2pt"&gt;Product development expense&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;56,418&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;61,697&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;118,586&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;97,842&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--ProfessionalAndContractServicesExpense_maTz8pZ_zmwPAzZlOCmb" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; text-indent: -7.1pt; padding-left: 14.2pt"&gt;Professional expense&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;8,957&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;28,070&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;17,916&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;43,295&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--OtherSellingGeneralAndAdministrativeExpense_maTz8pZ_zQ9KPUtr4fm9" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; text-indent: -7.1pt; padding-left: 14.2pt"&gt;Selling, general and administrative expenses&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;133,495&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1055"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;382,157&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1057"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -13.5pt; padding-left: 0.25in"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--Total_iT_pp0p0_mtTz8pZ_zfGCw9vnMgVd" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="display: none; padding-bottom: 1pt; text-indent: -7.1pt; padding-left: 14.2pt"&gt;&#160;Fair value of the stock options granted&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;198,870&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,377,601&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;518,659&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,428,971&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A8_zzuQzAPfNN7b" style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company uses the fair value method for determining stock-based compensation for all options granted during the fiscal periods. The fair
value was determined using the Black-Scholes option pricing model based on the following weighted average assumptions:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_895_eus-gaap--ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_zR1Dx1NDg6Dg" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Additional paid-in capital (Details 3)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -6.25pt; padding-left: 6.25pt"&gt;&lt;span id="xdx_8BD_zcSjjppCVuK6" style="display: none"&gt;Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 12pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-size: 12pt; text-align: center"&gt;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;June&#160;30,&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2022&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;December&#160;31,&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;2021&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 56%; text-align: left; text-indent: -6.25pt; padding-left: 6.25pt"&gt;Risk-free interest rate&lt;/td&gt;&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_c20210101__20211231_zYqUjZP2qKDk" title="Risk-free interest rate"&gt;0.87&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -6.25pt; padding-left: 6.25pt"&gt;Expected life&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_905_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20210101__20211231_zhNNsFBDHCw7" title="Expected life"&gt;4.8&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; text-indent: -6.25pt; padding-left: 6.25pt"&gt;Expected dividends&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend_pp0p0_dp_c20210101__20211231_zeoyAzkgLNxk" title="Expected dividends"&gt;0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -6.25pt; padding-left: 6.25pt"&gt;Expected volatility&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp_c20210101__20211231_z8ssnjE7yBK7" title="Expected volatility"&gt;278&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; text-indent: -6.25pt; padding-left: 6.25pt"&gt;Forfeiture rate&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageIntrinsicValue_dp_c20210101__20211231_zGhyd9Bp1Apf" title="Forfeiture rate"&gt;0&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AF_zL5lfXIuQ7Bc" style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"&gt;There
were no options granted during the six months ended June&#160;30, 2022. The weighted average fair value for the options granted during
the year ended December&#160;31, 2021 was &lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20210101__20211231_zHfs39Bauv87" title="Weighted average fair value options granted"&gt;0.06&lt;/span&gt;&lt;span style="background-color: white"&gt;.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




















</ALRT:AdditionalPaidInCapitalTextBlock>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock contextRef="From2022-01-01to2022-06-30">&lt;table cellpadding="0" cellspacing="0" id="xdx_892_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_zUoiYiGi2vq5" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Additional paid-in capital (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span id="xdx_8B1_zKthe3E0mds9" style="display: none"&gt;Schedule of share-based compensation, stock options, activity&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Six
                                            Months Ended&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;June&#160;30,
    2022&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Year
                                            Ended&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;December&#160;31,
    2021&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Number
    of Options&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Weighted
    Average Exercise Price&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Number
    of Options&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Weighted
    Average Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 45%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Outstanding,
    beginning of period&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20220101__20220630_zV1DYlxCfDN8" style="width: 16%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Outstanding, beginning of period"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;5,497,001,500&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 3%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20220101__20220630_zQXpNrvOIiRh" style="width: 8%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Average Exercise Price, beginning"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.006&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20210101__20211231_zAwiiG38tZ2b" style="width: 16%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Outstanding, beginning of period"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;5,362,701,500&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 3%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20210101__20211231_zO1LKcElzOu7" style="width: 9%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Average Exercise Price, beginning"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.004&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Granted&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_c20220101__20220630_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Granted"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0655"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20220101__20220630_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Granted, per share"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0657"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_c20210101__20211231_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Granted"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;165,000,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20210101__20211231_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Granted, per share"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.050&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Exercised
    &lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_di_c20220101__20220630_zrvMVZcthA6b" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercised"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0663"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_iN_di_c20220101__20220630_zxzdztcQw2U7" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercised per share"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0665"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_di_c20210101__20211231_z3u32gzrfZC7" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercised"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(800,000)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_iN_di_c20210101__20211231_zi9SZEmKkBQk" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercised per share"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(0.015)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Cancelled&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--ShareBasedCompensationArrangementbyShareBasedPaymentAwardOptionsCancelations_iN_di_c20220101__20220630_zhCh96P9e14d" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cancelled"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(90,000,000)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--CancelledPerShares_iN_di_c20220101__20220630_zjhNUX9qAFAj" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cancelled per share"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(0.041)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--ShareBasedCompensationArrangementbyShareBasedPaymentAwardOptionsCancelations_iN_di_c20210101__20211231_znFABDdf4dOh" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cancelled"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(29,900,000)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--CancelledPerShares_iN_di_c20210101__20211231_zFFfX3awkha1" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cancelled per share"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(0.034)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Outstanding,
    end of period&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20220101__20220630_zbKFTwrihlcl" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Outstanding, end of period"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;5,407,001,500&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20220101__20220630_zc8T3dYSe4N4" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Average Exercise price, ending"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.005&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20210101__20211231_zbgPrtK7TVQf" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Outstanding, end of period"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;5,497,001,500&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20210101__20211231_zgkryhDzsGA6" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Average Exercise price, ending"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.006&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Exercisable,
    end of period&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_c20220630_pdd" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercisable, end of period"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;5,223,701,500&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_c20220630_pdd" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercisable, end of period"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.004&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_c20211231_pdd" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercisable, end of period"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;5,221,701,500&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_c20211231_pdd" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercisable, end of period"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.004&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="AsOf2021-12-31" decimals="INF" unitRef="Shares">5497001500</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2021-12-31"
      decimals="INF"
      unitRef="USDPShares">0.006</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="AsOf2020-12-31" decimals="INF" unitRef="Shares">5362701500</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2020-12-31"
      decimals="INF"
      unitRef="USDPShares">0.004</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
      contextRef="From2021-01-012021-12-31"
      decimals="INF"
      unitRef="Shares">165000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="From2021-01-012021-12-31"
      decimals="INF"
      unitRef="USDPShares">0.050</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="From2021-01-012021-12-31"
      decimals="INF"
      unitRef="Shares">800000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="From2021-01-012021-12-31"
      decimals="INF"
      unitRef="USDPShares">0.015</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <ALRT:ShareBasedCompensationArrangementbyShareBasedPaymentAwardOptionsCancelations
      contextRef="From2022-01-01to2022-06-30"
      decimals="INF"
      unitRef="Shares">90000000</ALRT:ShareBasedCompensationArrangementbyShareBasedPaymentAwardOptionsCancelations>
    <ALRT:CancelledPerShares
      contextRef="From2022-01-01to2022-06-30"
      decimals="INF"
      unitRef="USDPShares">0.041</ALRT:CancelledPerShares>
    <ALRT:ShareBasedCompensationArrangementbyShareBasedPaymentAwardOptionsCancelations
      contextRef="From2021-01-012021-12-31"
      decimals="INF"
      unitRef="Shares">29900000</ALRT:ShareBasedCompensationArrangementbyShareBasedPaymentAwardOptionsCancelations>
    <ALRT:CancelledPerShares
      contextRef="From2021-01-012021-12-31"
      decimals="INF"
      unitRef="USDPShares">0.034</ALRT:CancelledPerShares>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="AsOf2022-06-30" decimals="INF" unitRef="Shares">5407001500</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2022-06-30"
      decimals="INF"
      unitRef="USDPShares">0.005</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="AsOf2021-12-31" decimals="INF" unitRef="Shares">5497001500</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2021-12-31"
      decimals="INF"
      unitRef="USDPShares">0.006</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber contextRef="AsOf2022-06-30" decimals="INF" unitRef="Shares">5223701500</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
      contextRef="AsOf2022-06-30"
      decimals="INF"
      unitRef="USDPShares">0.004</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber contextRef="AsOf2021-12-31" decimals="INF" unitRef="Shares">5221701500</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
      contextRef="AsOf2021-12-31"
      decimals="INF"
      unitRef="USDPShares">0.004</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice>
    <ALRT:ScheduleofOptionsOutstandingTableTextBlock contextRef="From2022-01-01to2022-06-30">&lt;table cellpadding="0" cellspacing="0" id="xdx_894_ecustom--ScheduleofOptionsOutstandingTableTextBlock_z6jbF1ydVQfd" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Additional paid-in capital (Details 1)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span id="xdx_8B7_zW1FlOVS0Zvl" style="display: none"&gt;Schedule of Options Outstanding&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="5" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;June&#160;30,
    2022&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="5" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;December&#160;31,
    2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Expiry
    Date&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Options&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Exercise
    Price&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Intrinsic
    Value&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Options&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Exercise
    Price&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Intrinsic
    Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="width: 34%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 13%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 3%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 7%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 3%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 7%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 13%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 3%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 7%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 3%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 7%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;November
    27, 2022&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options1Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;5,600,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--ExercisePrices_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options1Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.015&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--IntrinsicValue_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options1Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.044&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options1Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;5,600,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options1Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.015&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options1Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.045&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;January
    31, 2023&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options2Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;20,500,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--ExercisePrices_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options2Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.015&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--IntrinsicValue_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options2Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.044&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options2Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;40,500,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options2Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.015&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options2Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.045&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;June
    13, 2023&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options3Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;5,000,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--ExercisePrices_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options3Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.015&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--IntrinsicValue_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options3Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.044&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options3Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;5,000,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options3Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.015&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options3Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.045&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;March
    14, 2024&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options4Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;6,650,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--ExercisePrices_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options4Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.035&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--IntrinsicValue_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options4Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.024&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options4Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;6,650,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options4Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.035&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options4Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;April
    12, 2024&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options5Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;4,925,001,500&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--ExercisePrices_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options5Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.002&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--IntrinsicValue_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options5Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.057&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options5Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;4,925,001,500&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options5Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.002&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options5Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.058&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;April
    12, 2024&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options6Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3,350,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--ExercisePrices_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options6Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.015&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--IntrinsicValue_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options6Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.044&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options6Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3,350,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options6Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.015&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options6Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.045&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;April
    12, 2024&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options7Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;200,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--ExercisePrices_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options7Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.030&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--IntrinsicValue_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options7Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.029&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options7Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;200,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options7Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.030&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options7Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.030&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;May
    6, 2024&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options8Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;13,000,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--ExercisePrices_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options8Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.035&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--IntrinsicValue_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options8Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.024&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options8Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;13,000,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options8Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.035&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options8Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;May
    17, 2024&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options9Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;57,000,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--ExercisePrices_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options9Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.050&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--IntrinsicValue_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options9Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.009&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options9Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;77,000,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options9Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.050&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options9Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.010&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;May
    17, 2024&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options10Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;19,400,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--ExercisePrices_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options10Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.035&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--IntrinsicValue_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options10Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.024&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options10Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;19,400,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options10Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.035&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options10Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;June
    17, 2024&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options11Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0854"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--ExercisePrices_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options11Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0856"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--IntrinsicValue_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options11Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0858"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options11Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;5,000,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options11Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.050&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options11Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.010&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;August
    16, 2024&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options12Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0866"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--ExercisePrices_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options12Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0868"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--IntrinsicValue_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options12Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0870"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options12Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,500,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options12Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.050&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options12Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.010&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;September
    6, 2024&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options13Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0878"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--ExercisePrices_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options13Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0880"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--IntrinsicValue_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options13Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0882"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options13Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,000,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options13Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.050&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options13Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.010&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;October
    3, 2024&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options14Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3,500,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--ExercisePrices_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options14Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.035&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--IntrinsicValue_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options14Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.024&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options14Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3,500,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options14Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.035&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options14Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;October
    24, 2024&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options15Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,000,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--ExercisePrices_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options15Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.035&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--IntrinsicValue_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options15Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.024&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options15Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,000,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options15Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.035&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options15Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;December
    11, 2024&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options16Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;120,000,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--ExercisePrices_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options16Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.015&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--IntrinsicValue_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options16Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.044&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options16Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;120,000,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options16Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.015&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options16Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.045&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;April
    1, 2025&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options17Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;10,000,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--ExercisePrices_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options17Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.035&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--IntrinsicValue_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options17Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.024&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options17Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;10,000,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options17Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.035&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options17Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;May
    31, 2025&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options18Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;10,000,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--ExercisePrices_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options18Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.035&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--IntrinsicValue_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options18Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.024&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options18Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;20,000,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options18Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.035&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options18Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;May
    31, 2025&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options19Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;57,300,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--ExercisePrices_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options19Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.050&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--IntrinsicValue_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options19Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.009&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options19Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;87,300,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options19Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.050&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options19Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.010&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;December&#160;31,
    2025&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options20Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;56,500,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--ExercisePrices_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options20Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.050&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--IntrinsicValue_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options20Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.009&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options20Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;56,500,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options20Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.050&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options20Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.010&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;June&#160;30,
    2026&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options21Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;26,000,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--ExercisePrices_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options21Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.050&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--IntrinsicValue_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options21Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.009&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options21Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;26,000,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options21Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.050&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options21Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.010&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;September
    30, 2026&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options22Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;16,000,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--ExercisePrices_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options22Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.050&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--IntrinsicValue_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options22Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.009&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options22Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;17,500,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options22Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.050&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options22Member_pdd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.010&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;December&#160;31,
    2026&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options23Member_pdd" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;50,000,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--ExercisePrices_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options23Member_pdd" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.050&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--IntrinsicValue_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__custom--Options23Member_pdd" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.009&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options23Member_pdd" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;50,000,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--ExercisePrices_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options23Member_pdd" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.050&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--IntrinsicValue_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--Options23Member_pdd" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.010&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20220101__20220630_pdd" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;5,407,001,500&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--ExercisePrices_c20220101__20220630_pdd" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.005&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--IntrinsicValue_c20220101__20220630_pdd" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.053&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--OpenOptionContractsWrittenNumbersOfShare_c20210101__20211231_pdd" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Options"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;5,497,001,500&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--ExercisePrices_c20210101__20211231_pdd" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Exercise Price"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.006&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--IntrinsicValue_c20210101__20211231_pdd" style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intrinsic Value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.054&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Weighted
    Average Remaining Contractual Life&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_905_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20220101__20220630_zWiLVbV9cCZ4" title="Weighted Average Remaining Contractual Life"&gt;1.87&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20210101__20211231_zlPBtc7FoC4l" title="Weighted Average Remaining Contractual Life"&gt;2.37&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</ALRT:ScheduleofOptionsOutstandingTableTextBlock>
    <ALRT:OpenOptionContractsWrittenNumbersOfShare
      contextRef="From2022-01-012022-06-30_custom_Options1Member"
      decimals="INF"
      unitRef="Shares">5600000</ALRT:OpenOptionContractsWrittenNumbersOfShare>
    <ALRT:ExercisePrices
      contextRef="From2022-01-012022-06-30_custom_Options1Member"
      decimals="INF"
      unitRef="USDPShares">0.015</ALRT:ExercisePrices>
    <ALRT:IntrinsicValue
      contextRef="From2022-01-012022-06-30_custom_Options1Member"
      decimals="INF"
      unitRef="USDPShares">0.044</ALRT:IntrinsicValue>
    <ALRT:OpenOptionContractsWrittenNumbersOfShare
      contextRef="From2021-01-012021-12-31_custom_Options1Member"
      decimals="INF"
      unitRef="Shares">5600000</ALRT:OpenOptionContractsWrittenNumbersOfShare>
    <ALRT:ExercisePrices
      contextRef="From2021-01-012021-12-31_custom_Options1Member"
      decimals="INF"
      unitRef="USDPShares">0.015</ALRT:ExercisePrices>
    <ALRT:IntrinsicValue
      contextRef="From2021-01-012021-12-31_custom_Options1Member"
      decimals="INF"
      unitRef="USDPShares">0.045</ALRT:IntrinsicValue>
    <ALRT:OpenOptionContractsWrittenNumbersOfShare
      contextRef="From2022-01-012022-06-30_custom_Options2Member"
      decimals="INF"
      unitRef="Shares">20500000</ALRT:OpenOptionContractsWrittenNumbersOfShare>
    <ALRT:ExercisePrices
      contextRef="From2022-01-012022-06-30_custom_Options2Member"
      decimals="INF"
      unitRef="USDPShares">0.015</ALRT:ExercisePrices>
    <ALRT:IntrinsicValue
      contextRef="From2022-01-012022-06-30_custom_Options2Member"
      decimals="INF"
      unitRef="USDPShares">0.044</ALRT:IntrinsicValue>
    <ALRT:OpenOptionContractsWrittenNumbersOfShare
      contextRef="From2021-01-012021-12-31_custom_Options2Member"
      decimals="INF"
      unitRef="Shares">40500000</ALRT:OpenOptionContractsWrittenNumbersOfShare>
    <ALRT:ExercisePrices
      contextRef="From2021-01-012021-12-31_custom_Options2Member"
      decimals="INF"
      unitRef="USDPShares">0.015</ALRT:ExercisePrices>
    <ALRT:IntrinsicValue
      contextRef="From2021-01-012021-12-31_custom_Options2Member"
      decimals="INF"
      unitRef="USDPShares">0.045</ALRT:IntrinsicValue>
    <ALRT:OpenOptionContractsWrittenNumbersOfShare
      contextRef="From2022-01-012022-06-30_custom_Options3Member"
      decimals="INF"
      unitRef="Shares">5000000</ALRT:OpenOptionContractsWrittenNumbersOfShare>
    <ALRT:ExercisePrices
      contextRef="From2022-01-012022-06-30_custom_Options3Member"
      decimals="INF"
      unitRef="USDPShares">0.015</ALRT:ExercisePrices>
    <ALRT:IntrinsicValue
      contextRef="From2022-01-012022-06-30_custom_Options3Member"
      decimals="INF"
      unitRef="USDPShares">0.044</ALRT:IntrinsicValue>
    <ALRT:OpenOptionContractsWrittenNumbersOfShare
      contextRef="From2021-01-012021-12-31_custom_Options3Member"
      decimals="INF"
      unitRef="Shares">5000000</ALRT:OpenOptionContractsWrittenNumbersOfShare>
    <ALRT:ExercisePrices
      contextRef="From2021-01-012021-12-31_custom_Options3Member"
      decimals="INF"
      unitRef="USDPShares">0.015</ALRT:ExercisePrices>
    <ALRT:IntrinsicValue
      contextRef="From2021-01-012021-12-31_custom_Options3Member"
      decimals="INF"
      unitRef="USDPShares">0.045</ALRT:IntrinsicValue>
    <ALRT:OpenOptionContractsWrittenNumbersOfShare
      contextRef="From2022-01-012022-06-30_custom_Options4Member"
      decimals="INF"
      unitRef="Shares">6650000</ALRT:OpenOptionContractsWrittenNumbersOfShare>
    <ALRT:ExercisePrices
      contextRef="From2022-01-012022-06-30_custom_Options4Member"
      decimals="INF"
      unitRef="USDPShares">0.035</ALRT:ExercisePrices>
    <ALRT:IntrinsicValue
      contextRef="From2022-01-012022-06-30_custom_Options4Member"
      decimals="INF"
      unitRef="USDPShares">0.024</ALRT:IntrinsicValue>
    <ALRT:OpenOptionContractsWrittenNumbersOfShare
      contextRef="From2021-01-012021-12-31_custom_Options4Member"
      decimals="INF"
      unitRef="Shares">6650000</ALRT:OpenOptionContractsWrittenNumbersOfShare>
    <ALRT:ExercisePrices
      contextRef="From2021-01-012021-12-31_custom_Options4Member"
      decimals="INF"
      unitRef="USDPShares">0.035</ALRT:ExercisePrices>
    <ALRT:IntrinsicValue
      contextRef="From2021-01-012021-12-31_custom_Options4Member"
      decimals="INF"
      unitRef="USDPShares">0.025</ALRT:IntrinsicValue>
    <ALRT:OpenOptionContractsWrittenNumbersOfShare
      contextRef="From2022-01-012022-06-30_custom_Options5Member"
      decimals="INF"
      unitRef="Shares">4925001500</ALRT:OpenOptionContractsWrittenNumbersOfShare>
    <ALRT:ExercisePrices
      contextRef="From2022-01-012022-06-30_custom_Options5Member"
      decimals="INF"
      unitRef="USDPShares">0.002</ALRT:ExercisePrices>
    <ALRT:IntrinsicValue
      contextRef="From2022-01-012022-06-30_custom_Options5Member"
      decimals="INF"
      unitRef="USDPShares">0.057</ALRT:IntrinsicValue>
    <ALRT:OpenOptionContractsWrittenNumbersOfShare
      contextRef="From2021-01-012021-12-31_custom_Options5Member"
      decimals="INF"
      unitRef="Shares">4925001500</ALRT:OpenOptionContractsWrittenNumbersOfShare>
    <ALRT:ExercisePrices
      contextRef="From2021-01-012021-12-31_custom_Options5Member"
      decimals="INF"
      unitRef="USDPShares">0.002</ALRT:ExercisePrices>
    <ALRT:IntrinsicValue
      contextRef="From2021-01-012021-12-31_custom_Options5Member"
      decimals="INF"
      unitRef="USDPShares">0.058</ALRT:IntrinsicValue>
    <ALRT:OpenOptionContractsWrittenNumbersOfShare
      contextRef="From2022-01-012022-06-30_custom_Options6Member"
      decimals="INF"
      unitRef="Shares">3350000</ALRT:OpenOptionContractsWrittenNumbersOfShare>
    <ALRT:ExercisePrices
      contextRef="From2022-01-012022-06-30_custom_Options6Member"
      decimals="INF"
      unitRef="USDPShares">0.015</ALRT:ExercisePrices>
    <ALRT:IntrinsicValue
      contextRef="From2022-01-012022-06-30_custom_Options6Member"
      decimals="INF"
      unitRef="USDPShares">0.044</ALRT:IntrinsicValue>
    <ALRT:OpenOptionContractsWrittenNumbersOfShare
      contextRef="From2021-01-012021-12-31_custom_Options6Member"
      decimals="INF"
      unitRef="Shares">3350000</ALRT:OpenOptionContractsWrittenNumbersOfShare>
    <ALRT:ExercisePrices
      contextRef="From2021-01-012021-12-31_custom_Options6Member"
      decimals="INF"
      unitRef="USDPShares">0.015</ALRT:ExercisePrices>
    <ALRT:IntrinsicValue
      contextRef="From2021-01-012021-12-31_custom_Options6Member"
      decimals="INF"
      unitRef="USDPShares">0.045</ALRT:IntrinsicValue>
    <ALRT:OpenOptionContractsWrittenNumbersOfShare
      contextRef="From2022-01-012022-06-30_custom_Options7Member"
      decimals="INF"
      unitRef="Shares">200000</ALRT:OpenOptionContractsWrittenNumbersOfShare>
    <ALRT:ExercisePrices
      contextRef="From2022-01-012022-06-30_custom_Options7Member"
      decimals="INF"
      unitRef="USDPShares">0.030</ALRT:ExercisePrices>
    <ALRT:IntrinsicValue
      contextRef="From2022-01-012022-06-30_custom_Options7Member"
      decimals="INF"
      unitRef="USDPShares">0.029</ALRT:IntrinsicValue>
    <ALRT:OpenOptionContractsWrittenNumbersOfShare
      contextRef="From2021-01-012021-12-31_custom_Options7Member"
      decimals="INF"
      unitRef="Shares">200000</ALRT:OpenOptionContractsWrittenNumbersOfShare>
    <ALRT:ExercisePrices
      contextRef="From2021-01-012021-12-31_custom_Options7Member"
      decimals="INF"
      unitRef="USDPShares">0.030</ALRT:ExercisePrices>
    <ALRT:IntrinsicValue
      contextRef="From2021-01-012021-12-31_custom_Options7Member"
      decimals="INF"
      unitRef="USDPShares">0.030</ALRT:IntrinsicValue>
    <ALRT:OpenOptionContractsWrittenNumbersOfShare
      contextRef="From2022-01-012022-06-30_custom_Options8Member"
      decimals="INF"
      unitRef="Shares">13000000</ALRT:OpenOptionContractsWrittenNumbersOfShare>
    <ALRT:ExercisePrices
      contextRef="From2022-01-012022-06-30_custom_Options8Member"
      decimals="INF"
      unitRef="USDPShares">0.035</ALRT:ExercisePrices>
    <ALRT:IntrinsicValue
      contextRef="From2022-01-012022-06-30_custom_Options8Member"
      decimals="INF"
      unitRef="USDPShares">0.024</ALRT:IntrinsicValue>
    <ALRT:OpenOptionContractsWrittenNumbersOfShare
      contextRef="From2021-01-012021-12-31_custom_Options8Member"
      decimals="INF"
      unitRef="Shares">13000000</ALRT:OpenOptionContractsWrittenNumbersOfShare>
    <ALRT:ExercisePrices
      contextRef="From2021-01-012021-12-31_custom_Options8Member"
      decimals="INF"
      unitRef="USDPShares">0.035</ALRT:ExercisePrices>
    <ALRT:IntrinsicValue
      contextRef="From2021-01-012021-12-31_custom_Options8Member"
      decimals="INF"
      unitRef="USDPShares">0.025</ALRT:IntrinsicValue>
    <ALRT:OpenOptionContractsWrittenNumbersOfShare
      contextRef="From2022-01-012022-06-30_custom_Options9Member"
      decimals="INF"
      unitRef="Shares">57000000</ALRT:OpenOptionContractsWrittenNumbersOfShare>
    <ALRT:ExercisePrices
      contextRef="From2022-01-012022-06-30_custom_Options9Member"
      decimals="INF"
      unitRef="USDPShares">0.050</ALRT:ExercisePrices>
    <ALRT:IntrinsicValue
      contextRef="From2022-01-012022-06-30_custom_Options9Member"
      decimals="INF"
      unitRef="USDPShares">0.009</ALRT:IntrinsicValue>
    <ALRT:OpenOptionContractsWrittenNumbersOfShare
      contextRef="From2021-01-012021-12-31_custom_Options9Member"
      decimals="INF"
      unitRef="Shares">77000000</ALRT:OpenOptionContractsWrittenNumbersOfShare>
    <ALRT:ExercisePrices
      contextRef="From2021-01-012021-12-31_custom_Options9Member"
      decimals="INF"
      unitRef="USDPShares">0.050</ALRT:ExercisePrices>
    <ALRT:IntrinsicValue
      contextRef="From2021-01-012021-12-31_custom_Options9Member"
      decimals="INF"
      unitRef="USDPShares">0.010</ALRT:IntrinsicValue>
    <ALRT:OpenOptionContractsWrittenNumbersOfShare
      contextRef="From2022-01-012022-06-30_custom_Options10Member"
      decimals="INF"
      unitRef="Shares">19400000</ALRT:OpenOptionContractsWrittenNumbersOfShare>
    <ALRT:ExercisePrices
      contextRef="From2022-01-012022-06-30_custom_Options10Member"
      decimals="INF"
      unitRef="USDPShares">0.035</ALRT:ExercisePrices>
    <ALRT:IntrinsicValue
      contextRef="From2022-01-012022-06-30_custom_Options10Member"
      decimals="INF"
      unitRef="USDPShares">0.024</ALRT:IntrinsicValue>
    <ALRT:OpenOptionContractsWrittenNumbersOfShare
      contextRef="From2021-01-012021-12-31_custom_Options10Member"
      decimals="INF"
      unitRef="Shares">19400000</ALRT:OpenOptionContractsWrittenNumbersOfShare>
    <ALRT:ExercisePrices
      contextRef="From2021-01-012021-12-31_custom_Options10Member"
      decimals="INF"
      unitRef="USDPShares">0.035</ALRT:ExercisePrices>
    <ALRT:IntrinsicValue
      contextRef="From2021-01-012021-12-31_custom_Options10Member"
      decimals="INF"
      unitRef="USDPShares">0.025</ALRT:IntrinsicValue>
    <ALRT:OpenOptionContractsWrittenNumbersOfShare
      contextRef="From2021-01-012021-12-31_custom_Options11Member"
      decimals="INF"
      unitRef="Shares">5000000</ALRT:OpenOptionContractsWrittenNumbersOfShare>
    <ALRT:ExercisePrices
      contextRef="From2021-01-012021-12-31_custom_Options11Member"
      decimals="INF"
      unitRef="USDPShares">0.050</ALRT:ExercisePrices>
    <ALRT:IntrinsicValue
      contextRef="From2021-01-012021-12-31_custom_Options11Member"
      decimals="INF"
      unitRef="USDPShares">0.010</ALRT:IntrinsicValue>
    <ALRT:OpenOptionContractsWrittenNumbersOfShare
      contextRef="From2021-01-012021-12-31_custom_Options12Member"
      decimals="INF"
      unitRef="Shares">2500000</ALRT:OpenOptionContractsWrittenNumbersOfShare>
    <ALRT:ExercisePrices
      contextRef="From2021-01-012021-12-31_custom_Options12Member"
      decimals="INF"
      unitRef="USDPShares">0.050</ALRT:ExercisePrices>
    <ALRT:IntrinsicValue
      contextRef="From2021-01-012021-12-31_custom_Options12Member"
      decimals="INF"
      unitRef="USDPShares">0.010</ALRT:IntrinsicValue>
    <ALRT:OpenOptionContractsWrittenNumbersOfShare
      contextRef="From2021-01-012021-12-31_custom_Options13Member"
      decimals="INF"
      unitRef="Shares">1000000</ALRT:OpenOptionContractsWrittenNumbersOfShare>
    <ALRT:ExercisePrices
      contextRef="From2021-01-012021-12-31_custom_Options13Member"
      decimals="INF"
      unitRef="USDPShares">0.050</ALRT:ExercisePrices>
    <ALRT:IntrinsicValue
      contextRef="From2021-01-012021-12-31_custom_Options13Member"
      decimals="INF"
      unitRef="USDPShares">0.010</ALRT:IntrinsicValue>
    <ALRT:OpenOptionContractsWrittenNumbersOfShare
      contextRef="From2022-01-012022-06-30_custom_Options14Member"
      decimals="INF"
      unitRef="Shares">3500000</ALRT:OpenOptionContractsWrittenNumbersOfShare>
    <ALRT:ExercisePrices
      contextRef="From2022-01-012022-06-30_custom_Options14Member"
      decimals="INF"
      unitRef="USDPShares">0.035</ALRT:ExercisePrices>
    <ALRT:IntrinsicValue
      contextRef="From2022-01-012022-06-30_custom_Options14Member"
      decimals="INF"
      unitRef="USDPShares">0.024</ALRT:IntrinsicValue>
    <ALRT:OpenOptionContractsWrittenNumbersOfShare
      contextRef="From2021-01-012021-12-31_custom_Options14Member"
      decimals="INF"
      unitRef="Shares">3500000</ALRT:OpenOptionContractsWrittenNumbersOfShare>
    <ALRT:ExercisePrices
      contextRef="From2021-01-012021-12-31_custom_Options14Member"
      decimals="INF"
      unitRef="USDPShares">0.035</ALRT:ExercisePrices>
    <ALRT:IntrinsicValue
      contextRef="From2021-01-012021-12-31_custom_Options14Member"
      decimals="INF"
      unitRef="USDPShares">0.025</ALRT:IntrinsicValue>
    <ALRT:OpenOptionContractsWrittenNumbersOfShare
      contextRef="From2022-01-012022-06-30_custom_Options15Member"
      decimals="INF"
      unitRef="Shares">2000000</ALRT:OpenOptionContractsWrittenNumbersOfShare>
    <ALRT:ExercisePrices
      contextRef="From2022-01-012022-06-30_custom_Options15Member"
      decimals="INF"
      unitRef="USDPShares">0.035</ALRT:ExercisePrices>
    <ALRT:IntrinsicValue
      contextRef="From2022-01-012022-06-30_custom_Options15Member"
      decimals="INF"
      unitRef="USDPShares">0.024</ALRT:IntrinsicValue>
    <ALRT:OpenOptionContractsWrittenNumbersOfShare
      contextRef="From2021-01-012021-12-31_custom_Options15Member"
      decimals="INF"
      unitRef="Shares">2000000</ALRT:OpenOptionContractsWrittenNumbersOfShare>
    <ALRT:ExercisePrices
      contextRef="From2021-01-012021-12-31_custom_Options15Member"
      decimals="INF"
      unitRef="USDPShares">0.035</ALRT:ExercisePrices>
    <ALRT:IntrinsicValue
      contextRef="From2021-01-012021-12-31_custom_Options15Member"
      decimals="INF"
      unitRef="USDPShares">0.025</ALRT:IntrinsicValue>
    <ALRT:OpenOptionContractsWrittenNumbersOfShare
      contextRef="From2022-01-012022-06-30_custom_Options16Member"
      decimals="INF"
      unitRef="Shares">120000000</ALRT:OpenOptionContractsWrittenNumbersOfShare>
    <ALRT:ExercisePrices
      contextRef="From2022-01-012022-06-30_custom_Options16Member"
      decimals="INF"
      unitRef="USDPShares">0.015</ALRT:ExercisePrices>
    <ALRT:IntrinsicValue
      contextRef="From2022-01-012022-06-30_custom_Options16Member"
      decimals="INF"
      unitRef="USDPShares">0.044</ALRT:IntrinsicValue>
    <ALRT:OpenOptionContractsWrittenNumbersOfShare
      contextRef="From2021-01-012021-12-31_custom_Options16Member"
      decimals="INF"
      unitRef="Shares">120000000</ALRT:OpenOptionContractsWrittenNumbersOfShare>
    <ALRT:ExercisePrices
      contextRef="From2021-01-012021-12-31_custom_Options16Member"
      decimals="INF"
      unitRef="USDPShares">0.015</ALRT:ExercisePrices>
    <ALRT:IntrinsicValue
      contextRef="From2021-01-012021-12-31_custom_Options16Member"
      decimals="INF"
      unitRef="USDPShares">0.045</ALRT:IntrinsicValue>
    <ALRT:OpenOptionContractsWrittenNumbersOfShare
      contextRef="From2022-01-012022-06-30_custom_Options17Member"
      decimals="INF"
      unitRef="Shares">10000000</ALRT:OpenOptionContractsWrittenNumbersOfShare>
    <ALRT:ExercisePrices
      contextRef="From2022-01-012022-06-30_custom_Options17Member"
      decimals="INF"
      unitRef="USDPShares">0.035</ALRT:ExercisePrices>
    <ALRT:IntrinsicValue
      contextRef="From2022-01-012022-06-30_custom_Options17Member"
      decimals="INF"
      unitRef="USDPShares">0.024</ALRT:IntrinsicValue>
    <ALRT:OpenOptionContractsWrittenNumbersOfShare
      contextRef="From2021-01-012021-12-31_custom_Options17Member"
      decimals="INF"
      unitRef="Shares">10000000</ALRT:OpenOptionContractsWrittenNumbersOfShare>
    <ALRT:ExercisePrices
      contextRef="From2021-01-012021-12-31_custom_Options17Member"
      decimals="INF"
      unitRef="USDPShares">0.035</ALRT:ExercisePrices>
    <ALRT:IntrinsicValue
      contextRef="From2021-01-012021-12-31_custom_Options17Member"
      decimals="INF"
      unitRef="USDPShares">0.025</ALRT:IntrinsicValue>
    <ALRT:OpenOptionContractsWrittenNumbersOfShare
      contextRef="From2022-01-012022-06-30_custom_Options18Member"
      decimals="INF"
      unitRef="Shares">10000000</ALRT:OpenOptionContractsWrittenNumbersOfShare>
    <ALRT:ExercisePrices
      contextRef="From2022-01-012022-06-30_custom_Options18Member"
      decimals="INF"
      unitRef="USDPShares">0.035</ALRT:ExercisePrices>
    <ALRT:IntrinsicValue
      contextRef="From2022-01-012022-06-30_custom_Options18Member"
      decimals="INF"
      unitRef="USDPShares">0.024</ALRT:IntrinsicValue>
    <ALRT:OpenOptionContractsWrittenNumbersOfShare
      contextRef="From2021-01-012021-12-31_custom_Options18Member"
      decimals="INF"
      unitRef="Shares">20000000</ALRT:OpenOptionContractsWrittenNumbersOfShare>
    <ALRT:ExercisePrices
      contextRef="From2021-01-012021-12-31_custom_Options18Member"
      decimals="INF"
      unitRef="USDPShares">0.035</ALRT:ExercisePrices>
    <ALRT:IntrinsicValue
      contextRef="From2021-01-012021-12-31_custom_Options18Member"
      decimals="INF"
      unitRef="USDPShares">0.025</ALRT:IntrinsicValue>
    <ALRT:OpenOptionContractsWrittenNumbersOfShare
      contextRef="From2022-01-012022-06-30_custom_Options19Member"
      decimals="INF"
      unitRef="Shares">57300000</ALRT:OpenOptionContractsWrittenNumbersOfShare>
    <ALRT:ExercisePrices
      contextRef="From2022-01-012022-06-30_custom_Options19Member"
      decimals="INF"
      unitRef="USDPShares">0.050</ALRT:ExercisePrices>
    <ALRT:IntrinsicValue
      contextRef="From2022-01-012022-06-30_custom_Options19Member"
      decimals="INF"
      unitRef="USDPShares">0.009</ALRT:IntrinsicValue>
    <ALRT:OpenOptionContractsWrittenNumbersOfShare
      contextRef="From2021-01-012021-12-31_custom_Options19Member"
      decimals="INF"
      unitRef="Shares">87300000</ALRT:OpenOptionContractsWrittenNumbersOfShare>
    <ALRT:ExercisePrices
      contextRef="From2021-01-012021-12-31_custom_Options19Member"
      decimals="INF"
      unitRef="USDPShares">0.050</ALRT:ExercisePrices>
    <ALRT:IntrinsicValue
      contextRef="From2021-01-012021-12-31_custom_Options19Member"
      decimals="INF"
      unitRef="USDPShares">0.010</ALRT:IntrinsicValue>
    <ALRT:OpenOptionContractsWrittenNumbersOfShare
      contextRef="From2022-01-012022-06-30_custom_Options20Member"
      decimals="INF"
      unitRef="Shares">56500000</ALRT:OpenOptionContractsWrittenNumbersOfShare>
    <ALRT:ExercisePrices
      contextRef="From2022-01-012022-06-30_custom_Options20Member"
      decimals="INF"
      unitRef="USDPShares">0.050</ALRT:ExercisePrices>
    <ALRT:IntrinsicValue
      contextRef="From2022-01-012022-06-30_custom_Options20Member"
      decimals="INF"
      unitRef="USDPShares">0.009</ALRT:IntrinsicValue>
    <ALRT:OpenOptionContractsWrittenNumbersOfShare
      contextRef="From2021-01-012021-12-31_custom_Options20Member"
      decimals="INF"
      unitRef="Shares">56500000</ALRT:OpenOptionContractsWrittenNumbersOfShare>
    <ALRT:ExercisePrices
      contextRef="From2021-01-012021-12-31_custom_Options20Member"
      decimals="INF"
      unitRef="USDPShares">0.050</ALRT:ExercisePrices>
    <ALRT:IntrinsicValue
      contextRef="From2021-01-012021-12-31_custom_Options20Member"
      decimals="INF"
      unitRef="USDPShares">0.010</ALRT:IntrinsicValue>
    <ALRT:OpenOptionContractsWrittenNumbersOfShare
      contextRef="From2022-01-012022-06-30_custom_Options21Member"
      decimals="INF"
      unitRef="Shares">26000000</ALRT:OpenOptionContractsWrittenNumbersOfShare>
    <ALRT:ExercisePrices
      contextRef="From2022-01-012022-06-30_custom_Options21Member"
      decimals="INF"
      unitRef="USDPShares">0.050</ALRT:ExercisePrices>
    <ALRT:IntrinsicValue
      contextRef="From2022-01-012022-06-30_custom_Options21Member"
      decimals="INF"
      unitRef="USDPShares">0.009</ALRT:IntrinsicValue>
    <ALRT:OpenOptionContractsWrittenNumbersOfShare
      contextRef="From2021-01-012021-12-31_custom_Options21Member"
      decimals="INF"
      unitRef="Shares">26000000</ALRT:OpenOptionContractsWrittenNumbersOfShare>
    <ALRT:ExercisePrices
      contextRef="From2021-01-012021-12-31_custom_Options21Member"
      decimals="INF"
      unitRef="USDPShares">0.050</ALRT:ExercisePrices>
    <ALRT:IntrinsicValue
      contextRef="From2021-01-012021-12-31_custom_Options21Member"
      decimals="INF"
      unitRef="USDPShares">0.010</ALRT:IntrinsicValue>
    <ALRT:OpenOptionContractsWrittenNumbersOfShare
      contextRef="From2022-01-012022-06-30_custom_Options22Member"
      decimals="INF"
      unitRef="Shares">16000000</ALRT:OpenOptionContractsWrittenNumbersOfShare>
    <ALRT:ExercisePrices
      contextRef="From2022-01-012022-06-30_custom_Options22Member"
      decimals="INF"
      unitRef="USDPShares">0.050</ALRT:ExercisePrices>
    <ALRT:IntrinsicValue
      contextRef="From2022-01-012022-06-30_custom_Options22Member"
      decimals="INF"
      unitRef="USDPShares">0.009</ALRT:IntrinsicValue>
    <ALRT:OpenOptionContractsWrittenNumbersOfShare
      contextRef="From2021-01-012021-12-31_custom_Options22Member"
      decimals="INF"
      unitRef="Shares">17500000</ALRT:OpenOptionContractsWrittenNumbersOfShare>
    <ALRT:ExercisePrices
      contextRef="From2021-01-012021-12-31_custom_Options22Member"
      decimals="INF"
      unitRef="USDPShares">0.050</ALRT:ExercisePrices>
    <ALRT:IntrinsicValue
      contextRef="From2021-01-012021-12-31_custom_Options22Member"
      decimals="INF"
      unitRef="USDPShares">0.010</ALRT:IntrinsicValue>
    <ALRT:OpenOptionContractsWrittenNumbersOfShare
      contextRef="From2022-01-012022-06-30_custom_Options23Member"
      decimals="INF"
      unitRef="Shares">50000000</ALRT:OpenOptionContractsWrittenNumbersOfShare>
    <ALRT:ExercisePrices
      contextRef="From2022-01-012022-06-30_custom_Options23Member"
      decimals="INF"
      unitRef="USDPShares">0.050</ALRT:ExercisePrices>
    <ALRT:IntrinsicValue
      contextRef="From2022-01-012022-06-30_custom_Options23Member"
      decimals="INF"
      unitRef="USDPShares">0.009</ALRT:IntrinsicValue>
    <ALRT:OpenOptionContractsWrittenNumbersOfShare
      contextRef="From2021-01-012021-12-31_custom_Options23Member"
      decimals="INF"
      unitRef="Shares">50000000</ALRT:OpenOptionContractsWrittenNumbersOfShare>
    <ALRT:ExercisePrices
      contextRef="From2021-01-012021-12-31_custom_Options23Member"
      decimals="INF"
      unitRef="USDPShares">0.050</ALRT:ExercisePrices>
    <ALRT:IntrinsicValue
      contextRef="From2021-01-012021-12-31_custom_Options23Member"
      decimals="INF"
      unitRef="USDPShares">0.010</ALRT:IntrinsicValue>
    <ALRT:OpenOptionContractsWrittenNumbersOfShare
      contextRef="From2022-01-01to2022-06-30"
      decimals="INF"
      unitRef="Shares">5407001500</ALRT:OpenOptionContractsWrittenNumbersOfShare>
    <ALRT:ExercisePrices
      contextRef="From2022-01-01to2022-06-30"
      decimals="INF"
      unitRef="USDPShares">0.005</ALRT:ExercisePrices>
    <ALRT:IntrinsicValue
      contextRef="From2022-01-01to2022-06-30"
      decimals="INF"
      unitRef="USDPShares">0.053</ALRT:IntrinsicValue>
    <ALRT:OpenOptionContractsWrittenNumbersOfShare
      contextRef="From2021-01-012021-12-31"
      decimals="INF"
      unitRef="Shares">5497001500</ALRT:OpenOptionContractsWrittenNumbersOfShare>
    <ALRT:ExercisePrices
      contextRef="From2021-01-012021-12-31"
      decimals="INF"
      unitRef="USDPShares">0.006</ALRT:ExercisePrices>
    <ALRT:IntrinsicValue
      contextRef="From2021-01-012021-12-31"
      decimals="INF"
      unitRef="USDPShares">0.054</ALRT:IntrinsicValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="From2022-01-01to2022-06-30">P1Y10M13D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="From2021-01-012021-12-31">P2Y4M13D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock contextRef="From2022-01-01to2022-06-30">&lt;table cellpadding="0" cellspacing="0" id="xdx_897_eus-gaap--ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_zAieNWJFwSL5" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Additional paid-in capital (Details 2)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -7.1pt; padding-left: 14.2pt"&gt;&lt;span id="xdx_8BF_zkr2h51EzkZg" style="display: none"&gt;Schedule of Fair Value of Stock Options Granted-Allocation&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49A_20220401__20220630_zqv7fsuHb40a" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_497_20210401__20210630_z53lf9cfitN5" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49F_20220101__20220630_zkOtOGVIv4O9" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49F_20210101__20210630_zsj8W9Hjt4Ok" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Three Months Ended&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;June&#160;30, 2022&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Three Months Ended&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;June&#160;30, 2021&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Six Months Ended&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;June&#160;30, 2022&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Six Months Ended&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;June&#160;30, 2021&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--InterestExpenseDebt_maTz8pZ_zawqV4y5I0T2" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 40%; text-align: left; text-indent: -7.1pt; padding-left: 14.2pt"&gt;Interest expense&lt;/td&gt;&lt;td style="width: 3%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1039"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 3%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;1,287,834&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 3%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1041"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 3%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;1,287,834&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_maTz8pZ_ztudKj64f4a1" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -7.1pt; padding-left: 14.2pt"&gt;Product development expense&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;56,418&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;61,697&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;118,586&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;97,842&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--ProfessionalAndContractServicesExpense_maTz8pZ_zmwPAzZlOCmb" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; text-indent: -7.1pt; padding-left: 14.2pt"&gt;Professional expense&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;8,957&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;28,070&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;17,916&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;43,295&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--OtherSellingGeneralAndAdministrativeExpense_maTz8pZ_zQ9KPUtr4fm9" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; text-indent: -7.1pt; padding-left: 14.2pt"&gt;Selling, general and administrative expenses&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;133,495&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1055"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;382,157&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1057"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -13.5pt; padding-left: 0.25in"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--Total_iT_pp0p0_mtTz8pZ_zfGCw9vnMgVd" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="display: none; padding-bottom: 1pt; text-indent: -7.1pt; padding-left: 14.2pt"&gt;&#160;Fair value of the stock options granted&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;198,870&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,377,601&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;518,659&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,428,971&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock>
    <us-gaap:InterestExpenseDebt
      contextRef="From2021-04-012021-06-30"
      decimals="0"
      unitRef="USD">1287834</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt
      contextRef="From2021-01-012021-06-30"
      decimals="0"
      unitRef="USD">1287834</us-gaap:InterestExpenseDebt>
    <us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
      contextRef="From2022-04-012022-06-30"
      decimals="0"
      unitRef="USD">56418</us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost>
    <us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
      contextRef="From2021-04-012021-06-30"
      decimals="0"
      unitRef="USD">61697</us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost>
    <us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
      contextRef="From2022-01-01to2022-06-30"
      decimals="0"
      unitRef="USD">118586</us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost>
    <us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
      contextRef="From2021-01-012021-06-30"
      decimals="0"
      unitRef="USD">97842</us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost>
    <us-gaap:ProfessionalAndContractServicesExpense
      contextRef="From2022-04-012022-06-30"
      decimals="0"
      unitRef="USD">8957</us-gaap:ProfessionalAndContractServicesExpense>
    <us-gaap:ProfessionalAndContractServicesExpense
      contextRef="From2021-04-012021-06-30"
      decimals="0"
      unitRef="USD">28070</us-gaap:ProfessionalAndContractServicesExpense>
    <us-gaap:ProfessionalAndContractServicesExpense
      contextRef="From2022-01-01to2022-06-30"
      decimals="0"
      unitRef="USD">17916</us-gaap:ProfessionalAndContractServicesExpense>
    <us-gaap:ProfessionalAndContractServicesExpense
      contextRef="From2021-01-012021-06-30"
      decimals="0"
      unitRef="USD">43295</us-gaap:ProfessionalAndContractServicesExpense>
    <us-gaap:OtherSellingGeneralAndAdministrativeExpense
      contextRef="From2022-04-012022-06-30"
      decimals="0"
      unitRef="USD">133495</us-gaap:OtherSellingGeneralAndAdministrativeExpense>
    <us-gaap:OtherSellingGeneralAndAdministrativeExpense
      contextRef="From2022-01-01to2022-06-30"
      decimals="0"
      unitRef="USD">382157</us-gaap:OtherSellingGeneralAndAdministrativeExpense>
    <ALRT:Total
      contextRef="From2022-04-012022-06-30"
      decimals="0"
      unitRef="USD">198870</ALRT:Total>
    <ALRT:Total
      contextRef="From2021-04-012021-06-30"
      decimals="0"
      unitRef="USD">1377601</ALRT:Total>
    <ALRT:Total
      contextRef="From2022-01-01to2022-06-30"
      decimals="0"
      unitRef="USD">518659</ALRT:Total>
    <ALRT:Total
      contextRef="From2021-01-012021-06-30"
      decimals="0"
      unitRef="USD">1428971</ALRT:Total>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock contextRef="From2022-01-01to2022-06-30">&lt;table cellpadding="0" cellspacing="0" id="xdx_895_eus-gaap--ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_zR1Dx1NDg6Dg" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Additional paid-in capital (Details 3)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -6.25pt; padding-left: 6.25pt"&gt;&lt;span id="xdx_8BD_zcSjjppCVuK6" style="display: none"&gt;Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 12pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-size: 12pt; text-align: center"&gt;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;June&#160;30,&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2022&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;December&#160;31,&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;2021&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 56%; text-align: left; text-indent: -6.25pt; padding-left: 6.25pt"&gt;Risk-free interest rate&lt;/td&gt;&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_c20210101__20211231_zYqUjZP2qKDk" title="Risk-free interest rate"&gt;0.87&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -6.25pt; padding-left: 6.25pt"&gt;Expected life&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_905_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20210101__20211231_zhNNsFBDHCw7" title="Expected life"&gt;4.8&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; text-indent: -6.25pt; padding-left: 6.25pt"&gt;Expected dividends&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend_pp0p0_dp_c20210101__20211231_zeoyAzkgLNxk" title="Expected dividends"&gt;0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -6.25pt; padding-left: 6.25pt"&gt;Expected volatility&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp_c20210101__20211231_z8ssnjE7yBK7" title="Expected volatility"&gt;278&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; text-indent: -6.25pt; padding-left: 6.25pt"&gt;Forfeiture rate&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageIntrinsicValue_dp_c20210101__20211231_zGhyd9Bp1Apf" title="Forfeiture rate"&gt;0&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="From2021-01-012021-12-31"
      decimals="INF"
      unitRef="Pure">0.0087</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="From2021-01-012021-12-31">P4Y9M18D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend
      contextRef="From2021-01-012021-12-31"
      decimals="0"
      unitRef="USD">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="From2021-01-012021-12-31"
      decimals="INF"
      unitRef="Pure">2.78</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageIntrinsicValue
      contextRef="From2021-01-012021-12-31"
      decimals="INF"
      unitRef="USDPShares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="From2021-01-012021-12-31"
      decimals="INF"
      unitRef="USDPShares">0.06</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock contextRef="From2022-01-01to2022-06-30">&lt;p id="xdx_800_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_zPp4n3aZk1B9" style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;8.&lt;/b&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;b&gt;&lt;span id="xdx_829_zExiT1eJebji"&gt;Related
party transactions and balances&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_882_eus-gaap--ScheduleOfRelatedPartyTransactionsTableTextBlock_zfWfVwVtCy5e" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Related party transactions and balances (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -7.1pt; padding-left: 14.2pt"&gt;&lt;span id="xdx_8BE_zR7Yvg3k2MDe" style="display: none"&gt;Schedule of related party transactions&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_491_20220401__20220630_zn6ultEjUn36" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49B_20210401__20210630_zdsHow6FYqQb" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_492_20220101__20220630_z9fB57JuG5Mf" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_490_20210101__20210630_z0WMvSSbdky9" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Three Months Ended&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;June&#160;30, 2022&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Three Months Ended&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;June&#160;30, 2021&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Six Months Ended&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;June&#160;30, 2022&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Six Months Ended&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;June&#160;30, 2021&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_ecustom--RelatedPartyTransactionIncludedWithinInterestExpense_iB" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;Related party transactions included within interest expense:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_ecustom--InterestExpenseOnPromissoryNotesIssuedToRelativesOfChairmanAndChiefExecutiveOfficerOfCompany_i_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 40%; text-align: left; text-indent: -7.1pt; padding-left: 14.2pt"&gt;Interest expenses on promissory notes issued to relatives of the Chairman and Chief Executive Officer of the Company&lt;/td&gt;&lt;td style="width: 3%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;83,457&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 3%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;78,981&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 3%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;162,749&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 3%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;157,963&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--InterestExpenseOnLinesOfCreditPayableToChairmanAndChiefExecutiveOfficerOfCompanyAndHisSpouse_i_pp0p0" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -7.1pt; padding-left: 14.2pt"&gt;Interest expense on lines of credit payable to the Chairman and Chief Executive Officer of the Company and his spouse&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;392,593&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;355,715&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;777,515&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;670,452&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--InterestExpenseRelatedToModificationOfStockOptionsHeldByChairmanAndChiefExecutiveOfficerOfCompanyAndHisSpouseRelatedToFinancingProvided_zKTIh7876p1i" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; text-indent: -7.1pt; padding-left: 14.2pt"&gt;Interest expense related to the modification of stock options held by the Chairman and Chief Executive Officer of the Company and his spouse related to financing provided&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1105"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,287,834&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1107"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,287,834&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_ecustom--RelatedPartyTransactionsIncludingWithinSellingGeneralAndAdministrationExpenses_iB" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;Related party transactions including within selling, general and administrative expenses:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_ecustom--ConsultingFeesToChairmanAndChiefExecutiveOfficerOfCompanyAccruedOnLineOfCreditAvailableToCompany_z2C54136v8zh" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -7.1pt; padding-left: 14.2pt"&gt;Consulting fees to the Chairman and Chief Executive Officer of the Company accrued on the line of credit available to the Company&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;62,400&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;62,400&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;124,800&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;124,800&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--ConsultingFeesToDirectorOfCompanySettledWithIssuanceOfCommonStock_ztxkHOeK1iGi" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; text-indent: -7.1pt; padding-left: 14.2pt"&gt;Consulting fees to a director of the Company settled with issuance of common stock&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;40,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1121"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;40,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1123"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--SalaryForServicesAsVpCorporateAndDirectorOfSingaporeSubsidiaryToSpouseOfChairmanAndChiefExecutiveOfficerOfCompany_i_pp0p0" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -7.1pt; padding-left: 14.2pt"&gt;Salary for services as VP Corporate and director of the Singapore subsidiary to the spouse of the Chairman and Chief Executive Officer of the Company&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;10,890&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;11,254&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;21,981&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;11,254&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_ecustom--LossOnSettlementOfDebtToRelativeOfChairmanAndChiefExecutiveOfficerOfCompany_zKseanDzvHkb" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; text-indent: -7.1pt; padding-left: 14.2pt"&gt;Loss on settlement of debt to a relative of the Chairman and Chief Executive Officer of the Company&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1130"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;16,800&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1132"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;16,800&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--RentPaidToCompanyControlledBySpouseOfChairmanAndImmediateFamilyMembers_i_pp0p0" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; text-indent: -7.1pt; padding-left: 14.2pt"&gt;Rent paid to a company controlled by the spouse of the Chairman and immediate family members&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;8,006&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1136"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;20,206&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1138"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"&gt;Interest
on promissory notes payable to related parties, management compensation and compensation paid to a relative of a director have been recorded
at the exchange amount, which is the amount agreed to by the parties. &lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"&gt;The
Company also issued commitment letters to two creditors who are relatives of the Chairman and Chief Executive Officer of the Company
offering them an aggregate 20,000,000 shares of common stock in exchange for the extinguishment of $1,511,377 in promissory notes and
interest payable prior to December&#160;31, 2021 (note&#160;6(b)(vii)). These offer letters expired on December&#160;31, 2021 without
the parties executing any settlements. On March 18, 2022, the Company extended the offer letters from December&#160;31, 2021 to December&#160;31,
2022 for the settlement of $1,541,000 in promissory notes and interest payable. &lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of the date of these condensed consolidated financial statements, the offer letters have not been executed.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;






















&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
June 3, 2022, the Company issued an aggregate of 1,000,000 shares of common stock at a fair value of $0.04 per share for the settlement
of $40,000 for a bonus issued and recognized in consulting fees &lt;span style="background-color: white"&gt;(note&#160;6(b)(ii))&lt;/span&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
July 7, 2022, the Company granted the Chairman and Chief Executive Officer the option to acquire 115,500,000 shares of common stock of
the Company at a price of $0.05 per share until December&#160;31, &lt;span style="background-color: white"&gt;2026 &lt;/span&gt;(note 11(a)).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock contextRef="From2022-01-01to2022-06-30">&lt;table cellpadding="0" cellspacing="0" id="xdx_882_eus-gaap--ScheduleOfRelatedPartyTransactionsTableTextBlock_zfWfVwVtCy5e" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Related party transactions and balances (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -7.1pt; padding-left: 14.2pt"&gt;&lt;span id="xdx_8BE_zR7Yvg3k2MDe" style="display: none"&gt;Schedule of related party transactions&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_491_20220401__20220630_zn6ultEjUn36" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49B_20210401__20210630_zdsHow6FYqQb" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_492_20220101__20220630_z9fB57JuG5Mf" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_490_20210101__20210630_z0WMvSSbdky9" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Three Months Ended&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;June&#160;30, 2022&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Three Months Ended&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;June&#160;30, 2021&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Six Months Ended&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;June&#160;30, 2022&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Six Months Ended&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;June&#160;30, 2021&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_ecustom--RelatedPartyTransactionIncludedWithinInterestExpense_iB" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;Related party transactions included within interest expense:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_ecustom--InterestExpenseOnPromissoryNotesIssuedToRelativesOfChairmanAndChiefExecutiveOfficerOfCompany_i_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 40%; text-align: left; text-indent: -7.1pt; padding-left: 14.2pt"&gt;Interest expenses on promissory notes issued to relatives of the Chairman and Chief Executive Officer of the Company&lt;/td&gt;&lt;td style="width: 3%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;83,457&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 3%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;78,981&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 3%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;162,749&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 3%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;157,963&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--InterestExpenseOnLinesOfCreditPayableToChairmanAndChiefExecutiveOfficerOfCompanyAndHisSpouse_i_pp0p0" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -7.1pt; padding-left: 14.2pt"&gt;Interest expense on lines of credit payable to the Chairman and Chief Executive Officer of the Company and his spouse&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;392,593&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;355,715&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;777,515&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;670,452&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--InterestExpenseRelatedToModificationOfStockOptionsHeldByChairmanAndChiefExecutiveOfficerOfCompanyAndHisSpouseRelatedToFinancingProvided_zKTIh7876p1i" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; text-indent: -7.1pt; padding-left: 14.2pt"&gt;Interest expense related to the modification of stock options held by the Chairman and Chief Executive Officer of the Company and his spouse related to financing provided&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1105"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,287,834&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1107"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,287,834&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_ecustom--RelatedPartyTransactionsIncludingWithinSellingGeneralAndAdministrationExpenses_iB" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;Related party transactions including within selling, general and administrative expenses:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_ecustom--ConsultingFeesToChairmanAndChiefExecutiveOfficerOfCompanyAccruedOnLineOfCreditAvailableToCompany_z2C54136v8zh" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -7.1pt; padding-left: 14.2pt"&gt;Consulting fees to the Chairman and Chief Executive Officer of the Company accrued on the line of credit available to the Company&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;62,400&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;62,400&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;124,800&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;124,800&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--ConsultingFeesToDirectorOfCompanySettledWithIssuanceOfCommonStock_ztxkHOeK1iGi" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; text-indent: -7.1pt; padding-left: 14.2pt"&gt;Consulting fees to a director of the Company settled with issuance of common stock&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;40,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1121"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;40,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1123"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--SalaryForServicesAsVpCorporateAndDirectorOfSingaporeSubsidiaryToSpouseOfChairmanAndChiefExecutiveOfficerOfCompany_i_pp0p0" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -7.1pt; padding-left: 14.2pt"&gt;Salary for services as VP Corporate and director of the Singapore subsidiary to the spouse of the Chairman and Chief Executive Officer of the Company&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;10,890&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;11,254&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;21,981&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;11,254&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_ecustom--LossOnSettlementOfDebtToRelativeOfChairmanAndChiefExecutiveOfficerOfCompany_zKseanDzvHkb" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; text-indent: -7.1pt; padding-left: 14.2pt"&gt;Loss on settlement of debt to a relative of the Chairman and Chief Executive Officer of the Company&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1130"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;16,800&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1132"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;16,800&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--RentPaidToCompanyControlledBySpouseOfChairmanAndImmediateFamilyMembers_i_pp0p0" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; text-indent: -7.1pt; padding-left: 14.2pt"&gt;Rent paid to a company controlled by the spouse of the Chairman and immediate family members&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;8,006&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1136"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;20,206&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1138"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock>
    <ALRT:InterestExpenseOnPromissoryNotesIssuedToRelativesOfChairmanAndChiefExecutiveOfficerOfCompany
      contextRef="From2022-04-012022-06-30"
      decimals="0"
      unitRef="USD">83457</ALRT:InterestExpenseOnPromissoryNotesIssuedToRelativesOfChairmanAndChiefExecutiveOfficerOfCompany>
    <ALRT:InterestExpenseOnPromissoryNotesIssuedToRelativesOfChairmanAndChiefExecutiveOfficerOfCompany
      contextRef="From2021-04-012021-06-30"
      decimals="0"
      unitRef="USD">78981</ALRT:InterestExpenseOnPromissoryNotesIssuedToRelativesOfChairmanAndChiefExecutiveOfficerOfCompany>
    <ALRT:InterestExpenseOnPromissoryNotesIssuedToRelativesOfChairmanAndChiefExecutiveOfficerOfCompany
      contextRef="From2022-01-01to2022-06-30"
      decimals="0"
      unitRef="USD">162749</ALRT:InterestExpenseOnPromissoryNotesIssuedToRelativesOfChairmanAndChiefExecutiveOfficerOfCompany>
    <ALRT:InterestExpenseOnPromissoryNotesIssuedToRelativesOfChairmanAndChiefExecutiveOfficerOfCompany
      contextRef="From2021-01-012021-06-30"
      decimals="0"
      unitRef="USD">157963</ALRT:InterestExpenseOnPromissoryNotesIssuedToRelativesOfChairmanAndChiefExecutiveOfficerOfCompany>
    <ALRT:InterestExpenseOnLinesOfCreditPayableToChairmanAndChiefExecutiveOfficerOfCompanyAndHisSpouse
      contextRef="From2022-04-012022-06-30"
      decimals="0"
      unitRef="USD">392593</ALRT:InterestExpenseOnLinesOfCreditPayableToChairmanAndChiefExecutiveOfficerOfCompanyAndHisSpouse>
    <ALRT:InterestExpenseOnLinesOfCreditPayableToChairmanAndChiefExecutiveOfficerOfCompanyAndHisSpouse
      contextRef="From2021-04-012021-06-30"
      decimals="0"
      unitRef="USD">355715</ALRT:InterestExpenseOnLinesOfCreditPayableToChairmanAndChiefExecutiveOfficerOfCompanyAndHisSpouse>
    <ALRT:InterestExpenseOnLinesOfCreditPayableToChairmanAndChiefExecutiveOfficerOfCompanyAndHisSpouse
      contextRef="From2022-01-01to2022-06-30"
      decimals="0"
      unitRef="USD">777515</ALRT:InterestExpenseOnLinesOfCreditPayableToChairmanAndChiefExecutiveOfficerOfCompanyAndHisSpouse>
    <ALRT:InterestExpenseOnLinesOfCreditPayableToChairmanAndChiefExecutiveOfficerOfCompanyAndHisSpouse
      contextRef="From2021-01-012021-06-30"
      decimals="0"
      unitRef="USD">670452</ALRT:InterestExpenseOnLinesOfCreditPayableToChairmanAndChiefExecutiveOfficerOfCompanyAndHisSpouse>
    <ALRT:InterestExpenseRelatedToModificationOfStockOptionsHeldByChairmanAndChiefExecutiveOfficerOfCompanyAndHisSpouseRelatedToFinancingProvided
      contextRef="From2021-04-012021-06-30"
      decimals="0"
      unitRef="USD">1287834</ALRT:InterestExpenseRelatedToModificationOfStockOptionsHeldByChairmanAndChiefExecutiveOfficerOfCompanyAndHisSpouseRelatedToFinancingProvided>
    <ALRT:InterestExpenseRelatedToModificationOfStockOptionsHeldByChairmanAndChiefExecutiveOfficerOfCompanyAndHisSpouseRelatedToFinancingProvided
      contextRef="From2021-01-012021-06-30"
      decimals="0"
      unitRef="USD">1287834</ALRT:InterestExpenseRelatedToModificationOfStockOptionsHeldByChairmanAndChiefExecutiveOfficerOfCompanyAndHisSpouseRelatedToFinancingProvided>
    <ALRT:ConsultingFeesToChairmanAndChiefExecutiveOfficerOfCompanyAccruedOnLineOfCreditAvailableToCompany
      contextRef="From2022-04-012022-06-30"
      decimals="0"
      unitRef="USD">62400</ALRT:ConsultingFeesToChairmanAndChiefExecutiveOfficerOfCompanyAccruedOnLineOfCreditAvailableToCompany>
    <ALRT:ConsultingFeesToChairmanAndChiefExecutiveOfficerOfCompanyAccruedOnLineOfCreditAvailableToCompany
      contextRef="From2021-04-012021-06-30"
      decimals="0"
      unitRef="USD">62400</ALRT:ConsultingFeesToChairmanAndChiefExecutiveOfficerOfCompanyAccruedOnLineOfCreditAvailableToCompany>
    <ALRT:ConsultingFeesToChairmanAndChiefExecutiveOfficerOfCompanyAccruedOnLineOfCreditAvailableToCompany
      contextRef="From2022-01-01to2022-06-30"
      decimals="0"
      unitRef="USD">124800</ALRT:ConsultingFeesToChairmanAndChiefExecutiveOfficerOfCompanyAccruedOnLineOfCreditAvailableToCompany>
    <ALRT:ConsultingFeesToChairmanAndChiefExecutiveOfficerOfCompanyAccruedOnLineOfCreditAvailableToCompany
      contextRef="From2021-01-012021-06-30"
      decimals="0"
      unitRef="USD">124800</ALRT:ConsultingFeesToChairmanAndChiefExecutiveOfficerOfCompanyAccruedOnLineOfCreditAvailableToCompany>
    <ALRT:ConsultingFeesToDirectorOfCompanySettledWithIssuanceOfCommonStock
      contextRef="From2022-04-012022-06-30"
      decimals="0"
      unitRef="USD">40000</ALRT:ConsultingFeesToDirectorOfCompanySettledWithIssuanceOfCommonStock>
    <ALRT:ConsultingFeesToDirectorOfCompanySettledWithIssuanceOfCommonStock
      contextRef="From2022-01-01to2022-06-30"
      decimals="0"
      unitRef="USD">40000</ALRT:ConsultingFeesToDirectorOfCompanySettledWithIssuanceOfCommonStock>
    <ALRT:SalaryForServicesAsVpCorporateAndDirectorOfSingaporeSubsidiaryToSpouseOfChairmanAndChiefExecutiveOfficerOfCompany
      contextRef="From2022-04-012022-06-30"
      decimals="0"
      unitRef="USD">10890</ALRT:SalaryForServicesAsVpCorporateAndDirectorOfSingaporeSubsidiaryToSpouseOfChairmanAndChiefExecutiveOfficerOfCompany>
    <ALRT:SalaryForServicesAsVpCorporateAndDirectorOfSingaporeSubsidiaryToSpouseOfChairmanAndChiefExecutiveOfficerOfCompany
      contextRef="From2021-04-012021-06-30"
      decimals="0"
      unitRef="USD">11254</ALRT:SalaryForServicesAsVpCorporateAndDirectorOfSingaporeSubsidiaryToSpouseOfChairmanAndChiefExecutiveOfficerOfCompany>
    <ALRT:SalaryForServicesAsVpCorporateAndDirectorOfSingaporeSubsidiaryToSpouseOfChairmanAndChiefExecutiveOfficerOfCompany
      contextRef="From2022-01-01to2022-06-30"
      decimals="0"
      unitRef="USD">21981</ALRT:SalaryForServicesAsVpCorporateAndDirectorOfSingaporeSubsidiaryToSpouseOfChairmanAndChiefExecutiveOfficerOfCompany>
    <ALRT:SalaryForServicesAsVpCorporateAndDirectorOfSingaporeSubsidiaryToSpouseOfChairmanAndChiefExecutiveOfficerOfCompany
      contextRef="From2021-01-012021-06-30"
      decimals="0"
      unitRef="USD">11254</ALRT:SalaryForServicesAsVpCorporateAndDirectorOfSingaporeSubsidiaryToSpouseOfChairmanAndChiefExecutiveOfficerOfCompany>
    <ALRT:LossOnSettlementOfDebtToRelativeOfChairmanAndChiefExecutiveOfficerOfCompany
      contextRef="From2021-04-012021-06-30"
      decimals="0"
      unitRef="USD">16800</ALRT:LossOnSettlementOfDebtToRelativeOfChairmanAndChiefExecutiveOfficerOfCompany>
    <ALRT:LossOnSettlementOfDebtToRelativeOfChairmanAndChiefExecutiveOfficerOfCompany
      contextRef="From2021-01-012021-06-30"
      decimals="0"
      unitRef="USD">16800</ALRT:LossOnSettlementOfDebtToRelativeOfChairmanAndChiefExecutiveOfficerOfCompany>
    <ALRT:RentPaidToCompanyControlledBySpouseOfChairmanAndImmediateFamilyMembers
      contextRef="From2022-04-012022-06-30"
      decimals="0"
      unitRef="USD">8006</ALRT:RentPaidToCompanyControlledBySpouseOfChairmanAndImmediateFamilyMembers>
    <ALRT:RentPaidToCompanyControlledBySpouseOfChairmanAndImmediateFamilyMembers
      contextRef="From2022-01-01to2022-06-30"
      decimals="0"
      unitRef="USD">20206</ALRT:RentPaidToCompanyControlledBySpouseOfChairmanAndImmediateFamilyMembers>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="From2022-01-01to2022-06-30">&lt;p id="xdx_80B_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_z9RkJqzrBGYf" style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;9.&lt;/b&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;b&gt;&lt;span id="xdx_828_zh4z5znECrec"&gt;Commitments
and contingencies&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 18.9pt"/&gt;&lt;td style="width: 18pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;a)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Contingencies
                                            &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 36.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company has had three judgments against it relating to overdue promissory notes and accrued interest, and a fourth creditor has demanded
repayment of an overdue promissory note and accrued interest. To date, the Company has not repaid any of these promissory notes and related
accrued interest and could be subject to further action. The legal liability, totaling $1,271,981, of these promissory notes and related
accrued interest have been fully recognized and recorded by the Company. The Company has accrued interest of $291,457 related to one
of these promissory notes.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
December 22, 2020, a default judgment was entered against the Company in regard to one of the above noted judgments totaling $551,576,
consisting of the principal amount of $300,000 and accrued interest of $251,576, as of the date of the Civil Summons.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"/&gt;&lt;td style="width: 0.75in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;b)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Commitments
                                            &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"/&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;i)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Management
                                            contract&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company has a consulting arrangement with Mr. Sidney Chan, Chief Executive Officer and Chairman of the Board of Directors of the Company.
Under the terms of the contract, Mr. Chan will be paid $240,000 per annum for services as Chief Executive Officer. The contract can be
terminated at any time with thirty days&#x2019; notice and the payment of two years&#x2019; annual salary. Should the contract be terminated,
all debts owed to Mr. Chan and his spouse must be immediately repaid. The initial term of the contract is for one year and automatically
renews for continuous one-year terms. Also, under the terms of the contract are the following:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.75in"/&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Incentive
                                            revenue bonus&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Mr.
Chan will be entitled to a 1% net sales commission from the sales of any of the Company&#x2019;s products at any time during his life,
regardless if Mr. Chan is still under contract with the Company.&lt;/span&gt;&lt;/p&gt;




























&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.75in"/&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Sale
                                            of business&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;If
more than 50% of the Company&#x2019;s stock or assets are sold, Mr. Chan will be compensated for entering into non-compete agreements
based on the selling price of the Company or its assets as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 1in"/&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;i.&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2%
                                            of sales price up to $24,999,999 plus&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 1in"/&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;ii.&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3%
                                            of sales price between $25,000,000 and $49,999,999 plus&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 1in"/&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;iii.&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;4%
                                            of sales price between $50,000,000 and $199,999,999 plus&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 1in"/&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;iv.&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;5%
                                            of sales price in excess of $200,000,000.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
August 4, 2022, ALR Singapore entered into an Employment Agreement with the Chairman and Chief Executive Officer (the &#x201c;Employment
Agreement&#x201d;) with an effective date of July 1, 2022 (note 11(c)).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"/&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;ii)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Manufacturing
                                            and Supply Agreement&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
June&#160;28, 2022, ALR Singapore entered into a Manufacturing and Supply Agreement (the &#x201c;&lt;b&gt;Supply Agreement&lt;/b&gt;&#x201d;) with
Infinovo Medical Co., Ltd. (&#x201c;&lt;b&gt;Infinovo&lt;/b&gt;&#x201d;). Pursuant to the Supply Agreement, Infinovo will manufacture and supply certain
continuous glucose monitoring components necessary to the Company&#x2019;s diabetes management platform for animal health, known as &#x201c;&lt;b&gt;GluCurve&lt;/b&gt;&#x201d;.
The term of the Supply Agreement continues for three years from August&#160;1, 2022, unless earlier terminated in accordance with the
terms of the Supply Agreement. The Supply Agreement, however, will not become effective unless (i) ALR Singapore enters into a binding
distribution agreement for the sale and distribution of GluCurve by July&#160;31, 2022, and (ii) ALR Singapore and Infinovo enter into
a quality agreement by July&#160;31, 2022. There can be no assurance that the two conditions to effectiveness of the Supply Agreement
will be satisfied. If the conditions are met and the agreement becomes effective, the Supply Agreement will automatically renew for additional
one year terms unless ALR Singapore or Infinovo provides written notice of its intent to terminate the Supply Agreement. The Supply Agreement
provides for customary reasons to terminate the Supply Agreement for cause with immediate effect.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
closing conditions for the Supply Agreement between ALR Singapore and Infinovo were not met and the Supply Agreement has now terminated
(note 11(d)).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




















</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:SegmentReportingDisclosureTextBlock contextRef="From2022-01-01to2022-06-30">&lt;p id="xdx_808_eus-gaap--SegmentReportingDisclosureTextBlock_zrJlnRpXAbuj" style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;10.&lt;/b&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;b&gt;&lt;span id="xdx_82D_zd8aEXD4TcMj"&gt;Operating
segments&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company has one operating segment, development of diabetes hardware and software. The Company&#x2019;s geographical segments are summarized
as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_898_eus-gaap--ScheduleOfSegmentReportingInformationBySegmentTextBlock_z19IF7i0tr1f" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Operating segments (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10.05pt"&gt;&lt;span id="xdx_8B5_zSQc2FjcK0qd" style="display: none"&gt;Schedule of Operating Segments&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;June 30,&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2022&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;December&#160;31,&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2021&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-left: 5.4pt"&gt;Current and Total Assets&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 56%; padding-left: 10.05pt"&gt;Other&lt;/td&gt;&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--Assets_c20220630__srt--StatementGeographicalAxis__custom--OtherMember_pp0p0" style="width: 12%; text-align: right" title="Current and Total Assets"&gt;15,327&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--Assets_c20211231__srt--StatementGeographicalAxis__custom--OtherMember_pp0p0" style="width: 12%; text-align: right" title="Current and Total Assets"&gt;9,547&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10.05pt"&gt;Singapore&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--Assets_c20220630__srt--StatementGeographicalAxis__country--SG_pp0p0" style="text-align: right" title="Current and Total Assets"&gt;3,777&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--Assets_c20211231__srt--StatementGeographicalAxis__country--SG_pp0p0" style="text-align: right" title="Current and Total Assets"&gt;110,527&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 10.05pt"&gt;United States&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--Assets_c20220630__srt--StatementGeographicalAxis__country--US_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Current and Total Assets"&gt;77,223&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--Assets_c20211231__srt--StatementGeographicalAxis__country--US_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Current and Total Assets"&gt;73,143&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt; text-indent: -6.25pt; padding-left: 6.25pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--Assets_c20220630_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Current and Total Assets"&gt;96,327&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--Assets_c20211231_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Current and Total Assets"&gt;193,217&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Six Months &lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Ended June&#160;30, 2022&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Six Months &lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Ended June&#160;30, 2021&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-indent: -6.25pt; padding-left: 6.25pt"&gt;Revenue&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10.05pt"&gt;Other&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--Revenues_c20220101__20220630__srt--StatementGeographicalAxis__custom--OtherMember_pp0p0" style="text-align: right" title="Revenue"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1191"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--Revenues_c20210101__20210630__srt--StatementGeographicalAxis__custom--OtherMember_pp0p0" style="text-align: right" title="Revenue"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1193"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 56%; padding-left: 10.05pt"&gt;Singapore&lt;/td&gt;&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--Revenues_c20220101__20220630__srt--StatementGeographicalAxis__country--SG_pp0p0" style="width: 12%; text-align: right" title="Revenue"&gt;2,023&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--Revenues_c20210101__20210630__srt--StatementGeographicalAxis__country--SG_pp0p0" style="width: 12%; text-align: right" title="Revenue"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1197"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 10.05pt"&gt;United States&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--Revenues_c20220101__20220630__srt--StatementGeographicalAxis__country--US_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Revenue"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1199"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--Revenues_c20210101__20210630__srt--StatementGeographicalAxis__country--US_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Revenue"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1201"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt; text-indent: -6.25pt; padding-left: 6.25pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--Revenues_c20220101__20220630_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Revenue"&gt;2,023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--Revenues_c20210101__20210630_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Revenue"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1205"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -6.25pt; padding-left: 6.25pt"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left; text-indent: -6.25pt; padding-left: 6.25pt"&gt;Net Loss&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10.05pt"&gt;Other&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--NetIncomeLoss_c20220101__20220630__srt--StatementGeographicalAxis__custom--OtherMember_pp0p0" style="text-align: right" title="Net Loss"&gt;(1,457&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--NetIncomeLoss_c20210101__20210630__srt--StatementGeographicalAxis__custom--OtherMember_pp0p0" style="text-align: right" title="Net Loss"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1209"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10.05pt"&gt;Singapore&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--NetIncomeLoss_c20220101__20220630__srt--StatementGeographicalAxis__country--SG_pp0p0" style="text-align: right" title="Net Loss"&gt;(141,861&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--NetIncomeLoss_c20210101__20210630__srt--StatementGeographicalAxis__country--SG_pp0p0" style="text-align: right" title="Net Loss"&gt;(77,666&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 10.05pt"&gt;United States&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--NetIncomeLoss_c20220101__20220630__srt--StatementGeographicalAxis__country--US_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Net Loss"&gt;(2,749,297&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--NetIncomeLoss_c20210101__20210630__srt--StatementGeographicalAxis__country--US_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Net Loss"&gt;(3,259,787&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt; text-indent: -6.25pt; padding-left: 6.25pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--NetIncomeLoss_c20220101__20220630_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Net Loss"&gt;(2,892,615&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--NetIncomeLoss_c20210101__20210630_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Net Loss"&gt;(3,337,453&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A0_zkH6IA2PGSQg" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock contextRef="From2022-01-01to2022-06-30">&lt;table cellpadding="0" cellspacing="0" id="xdx_898_eus-gaap--ScheduleOfSegmentReportingInformationBySegmentTextBlock_z19IF7i0tr1f" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Operating segments (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10.05pt"&gt;&lt;span id="xdx_8B5_zSQc2FjcK0qd" style="display: none"&gt;Schedule of Operating Segments&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;June 30,&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2022&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;December&#160;31,&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2021&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-left: 5.4pt"&gt;Current and Total Assets&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 56%; padding-left: 10.05pt"&gt;Other&lt;/td&gt;&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--Assets_c20220630__srt--StatementGeographicalAxis__custom--OtherMember_pp0p0" style="width: 12%; text-align: right" title="Current and Total Assets"&gt;15,327&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--Assets_c20211231__srt--StatementGeographicalAxis__custom--OtherMember_pp0p0" style="width: 12%; text-align: right" title="Current and Total Assets"&gt;9,547&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10.05pt"&gt;Singapore&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--Assets_c20220630__srt--StatementGeographicalAxis__country--SG_pp0p0" style="text-align: right" title="Current and Total Assets"&gt;3,777&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--Assets_c20211231__srt--StatementGeographicalAxis__country--SG_pp0p0" style="text-align: right" title="Current and Total Assets"&gt;110,527&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 10.05pt"&gt;United States&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--Assets_c20220630__srt--StatementGeographicalAxis__country--US_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Current and Total Assets"&gt;77,223&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--Assets_c20211231__srt--StatementGeographicalAxis__country--US_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Current and Total Assets"&gt;73,143&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt; text-indent: -6.25pt; padding-left: 6.25pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--Assets_c20220630_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Current and Total Assets"&gt;96,327&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--Assets_c20211231_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Current and Total Assets"&gt;193,217&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Six Months &lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Ended June&#160;30, 2022&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Six Months &lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Ended June&#160;30, 2021&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-indent: -6.25pt; padding-left: 6.25pt"&gt;Revenue&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10.05pt"&gt;Other&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--Revenues_c20220101__20220630__srt--StatementGeographicalAxis__custom--OtherMember_pp0p0" style="text-align: right" title="Revenue"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1191"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--Revenues_c20210101__20210630__srt--StatementGeographicalAxis__custom--OtherMember_pp0p0" style="text-align: right" title="Revenue"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1193"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 56%; padding-left: 10.05pt"&gt;Singapore&lt;/td&gt;&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--Revenues_c20220101__20220630__srt--StatementGeographicalAxis__country--SG_pp0p0" style="width: 12%; text-align: right" title="Revenue"&gt;2,023&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--Revenues_c20210101__20210630__srt--StatementGeographicalAxis__country--SG_pp0p0" style="width: 12%; text-align: right" title="Revenue"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1197"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 10.05pt"&gt;United States&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--Revenues_c20220101__20220630__srt--StatementGeographicalAxis__country--US_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Revenue"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1199"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--Revenues_c20210101__20210630__srt--StatementGeographicalAxis__country--US_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Revenue"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1201"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt; text-indent: -6.25pt; padding-left: 6.25pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--Revenues_c20220101__20220630_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Revenue"&gt;2,023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--Revenues_c20210101__20210630_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Revenue"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1205"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -6.25pt; padding-left: 6.25pt"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left; text-indent: -6.25pt; padding-left: 6.25pt"&gt;Net Loss&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10.05pt"&gt;Other&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--NetIncomeLoss_c20220101__20220630__srt--StatementGeographicalAxis__custom--OtherMember_pp0p0" style="text-align: right" title="Net Loss"&gt;(1,457&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--NetIncomeLoss_c20210101__20210630__srt--StatementGeographicalAxis__custom--OtherMember_pp0p0" style="text-align: right" title="Net Loss"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1209"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10.05pt"&gt;Singapore&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--NetIncomeLoss_c20220101__20220630__srt--StatementGeographicalAxis__country--SG_pp0p0" style="text-align: right" title="Net Loss"&gt;(141,861&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--NetIncomeLoss_c20210101__20210630__srt--StatementGeographicalAxis__country--SG_pp0p0" style="text-align: right" title="Net Loss"&gt;(77,666&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 10.05pt"&gt;United States&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--NetIncomeLoss_c20220101__20220630__srt--StatementGeographicalAxis__country--US_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Net Loss"&gt;(2,749,297&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--NetIncomeLoss_c20210101__20210630__srt--StatementGeographicalAxis__country--US_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Net Loss"&gt;(3,259,787&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt; text-indent: -6.25pt; padding-left: 6.25pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--NetIncomeLoss_c20220101__20220630_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Net Loss"&gt;(2,892,615&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--NetIncomeLoss_c20210101__20210630_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Net Loss"&gt;(3,337,453&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
    <us-gaap:Assets
      contextRef="AsOf2022-06-30_custom_OtherMember"
      decimals="0"
      unitRef="USD">15327</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="AsOf2021-12-31_custom_OtherMember"
      decimals="0"
      unitRef="USD">9547</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="AsOf2022-06-30_country_SG"
      decimals="0"
      unitRef="USD">3777</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="AsOf2021-12-31_country_SG"
      decimals="0"
      unitRef="USD">110527</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="AsOf2022-06-30_country_US"
      decimals="0"
      unitRef="USD">77223</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="AsOf2021-12-31_country_US"
      decimals="0"
      unitRef="USD">73143</us-gaap:Assets>
    <us-gaap:Assets contextRef="AsOf2022-06-30" decimals="0" unitRef="USD">96327</us-gaap:Assets>
    <us-gaap:Assets contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">193217</us-gaap:Assets>
    <us-gaap:Revenues
      contextRef="From2022-01-012022-06-30_country_SG"
      decimals="0"
      unitRef="USD">2023</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2022-01-01to2022-06-30"
      decimals="0"
      unitRef="USD">2023</us-gaap:Revenues>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-01-012022-06-30_custom_OtherMember"
      decimals="0"
      unitRef="USD">-1457</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-01-012022-06-30_country_SG"
      decimals="0"
      unitRef="USD">-141861</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-01-012021-06-30_country_SG"
      decimals="0"
      unitRef="USD">-77666</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-01-012022-06-30_country_US"
      decimals="0"
      unitRef="USD">-2749297</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-01-012021-06-30_country_US"
      decimals="0"
      unitRef="USD">-3259787</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-01-01to2022-06-30"
      decimals="0"
      unitRef="USD">-2892615</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-01-012021-06-30"
      decimals="0"
      unitRef="USD">-3337453</us-gaap:NetIncomeLoss>
    <us-gaap:SubsequentEventsTextBlock contextRef="From2022-01-01to2022-06-30">&lt;p id="xdx_806_eus-gaap--SubsequentEventsTextBlock_zStQ919zb3lk" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;11.&lt;/b&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;b&gt;&lt;span id="xdx_828_zEfaV68VRSG"&gt;Subsequent
events&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"/&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;a)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
                                            July 7, 2022, the Company granted the Chairman and Chief Executive Officer the option to
                                            acquire 115,500,000 shares of common stock of the Company at a price of $0.05 per share until
                                            December&#160;31, &lt;span style="background-color: white"&gt;2026. The Company canceled the &lt;/span&gt;subscription
                                            rights to distribute 101,025,092 shares of common stock at a price of $0.05 pursuant to the
                                            prospectus (note 6(b)(i)).&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt/12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"/&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;b)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
                                            July 12, 2022, ALR Singapore received advances from a relative of the Chairman aggregating
                                            SGD$500,000, with interest of $150 per day outstanding payable upon maturity or early payment,
                                            which will mature and be repayable on August&#160;31, 2022. The principal amount of SGD$500,000
                                            was repaid on July 18, 2022.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"/&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;c)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
                                            August 4, 2022, ALR Singapore entered into an Employment Agreement with the Chairman and
                                            Chief Executive Officer with an effective date of July 1, 2022 (note 9(b)(i)). The terms
                                            of the Employment Agreement were materially the same as the Services Agreement between the
                                            Company and the Chief Executive Officer, except as follows: &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;






























&lt;table cellpadding="0" cellspacing="0" style="font: 12pt/13.7pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"/&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
                                            incentive compensation whereby Mr. Chan will earn a 1% commission from the sale of Company
                                            products has been amended to be in perpetuity and assignable. Previously, the commission
                                            was based on the lifetime of Mr. Chan, and&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt/13.7pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"/&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Mr.
                                            Chan has relinquished his right to certain compensation on the sale of the business or assets
                                            of the Company or its affiliates. &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/13.7pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
connection with entering into the Employment Agreement with ALR Singapore:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/13.7pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt/13.7pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"/&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Mr.
                                            Chan has been issued a bonus of $150,000 as consideration for the advancements to the GluCurve
                                            business unit;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt/13.7pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"/&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;the
                                            services agreement between the Company and Mr. Chan has terminated, and&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt/13.7pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"/&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Mr.
                                            Chan will continue to act as Chief Executive Officer, Chief Financial Officer, Chief Accounting
                                            Officer and Treasurer of the Company.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 11pt/13.7pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify; text-indent: -0.25in; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/13.7pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;This
Employment Agreement is executed and the Services Agreement is being terminated in connection with the Redomicile Agreement.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"/&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;d)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
                                            closing conditions for the Supply Agreement between ALR Singapore and Infinovo were not met
                                            and the Supply Agreement has now terminated. The parties are now working on completing a
                                            new agreement whereby the closing condition for ALR Singapore to enter into a binding sales
                                            and distribution agreement for the GluCurve would be August 31, 2022. Should the parties
                                            enter into a new manufacturing and supply agreement, it will not become effective unless
                                            ALR Singapore enters into a binding distribution agreement for the sale and distribution
                                            of GluCurve by August 31, 2022. There can be no assurance that the parties will enter in
                                            such new agreement or that this condition to effectiveness of the new agreement will be satisfied
                                            (note 9(b)(ii)).&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

</us-gaap:SubsequentEventsTextBlock>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>51
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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MB:0$]J'[2NBZ"\BH3^0W_FQ%QJV@75UG<MHT1+O(.&X=<EP\I92<]^R)+$*
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MVV >ULS#4YCW=N?PJ.X\%-7 '-68HU,P[W:VYNCM3N[[HS <]GJO.%LB>\'
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MP4P5U=>RZD;R??DY:,6EY%EYN6-1S H%@/]O.)>/-RI \\UR_A]02P,$%
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M<K*M1;9+%9S[!VAH6[WA(4 J*XUVCG /'<9Q&$='),RPA,8!L3.(>@;1RQA
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M)>F^_!R<[3SV6H_OO4&%OU9LAGS'1I[C>0/Z_ X!W^CSOX, NFL!N , 'G8
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M1TC4)_/U@^*E.0U?<J5X86XS@J%M]0+X?<4AUN9!&^C^/7+[-U!+ P04
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MQQBY \OQP,?#3!77COW0M9RETT!>GGKHL:1#E;MK>FB!.W+\L 4#Z"Q]AQQ
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MX]&MPV.%V[2TO '?2P.V_0LK&.[GEW\!4$L#!!0    ( !5T#U73Q8!80P,
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M&W"/X<<2%T?E: +&"PN^W0MM,%Q%S_\#4$L#!!0    ( !5T#U6'(H4<A0(
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M__L=*5EU&L<9EL& J2-Y=\^]\N9;J1YT!6#(KN9"+[S*F.8R"'1>04WUA6Q
MX$DI54T-DFH3Z$8!+1Q3S8,X#*=!39GPEG.W=ZN6<]D:S@3<*J+;NJ9J?PU<
M;A=>Y!TV[MBF,G8C6,X;NH$5F-^;6X54,$@I6 U",RF(@G+A7467UXF][RY\
M8;#51]_$6K*6\L$2GXJ%%UI P"$W5@+%Y1%N@',K"&'\W<OT!I66\?C[(/TG
M9SO:LJ8:;B3_@Q6F6GB91PHH:<O-G=S^#+T]$RLOEUR[?[+M[B8SC^2M-K+N
MF1%!S42WTEWOAR.&+'R!(>X98H>[4^10_D@-7<Z5W!)E;Z,T^^%,==P(C@D;
ME)51>,J0SRSO@%,#!6FH,GMB%!6:.G]I0D6!!G,J<M#D^WNZYJ!_F <&M5K>
M(.\U7'<:XA<T3,EG*4RER4=10/&4/T"T ^3X /DZ/BOPEU9<D''HDSB,XS/R
MQH,+QD[>^!47W#H7W!^[X,^KM4:?Y.:O4W9W8I/38FTU7>J&YK#PL%PTJ$?P
MEN_?1=/PPQG0R0 Z.2=]N<+J+%H.1)98&R_%\!3JLW)/H_YWRD;WE0)X$FV"
ML8(A5N25"Q%9L=TY_K/'T>@[XGZC,SG-1,Y;R[EEIF(":0-HIB&PPS:GX7+T
MZ9L=3;!W-$K63&NI]D1(@WM(M"C%R,X?V%BT=8ZI@-Q4E&&[$*Y^;BH&)?FX
M@[RUE\AO9<ER4,-=63=4[$DV]I-)2M+,GV41B::QGR8S$DU2?S8=/X-D$=FX
M.96Y@H(9M'5O"]0B^J\@[-6*::(;V:*2\2SV)[,Q&4\F?AI-2)JF_@37:1HB
MV/@YJD-F]!!J63#40UWS1578RO('(ILN$!5P["[[_POLD>Z2"6Q93&QLU!Z9
M#?;[=UD<Q1](Y,=9ZF?CY/G.ZTEC)?99@X\*^G_CDPT(4)0[-+3 ]LQLNW"X
M#^ES.;I!&?A&6/X2,&AO"5&>*YMWZ%&[;9/@* ?H(V7\21;T;)A/21@>EBA.
M_.SK>@H?)053^&[*9P@T&,/[^G%58)\'AT'6-<+JHIR$?H@:#EY^2HY6^*A@
M)>%$06R#8?9]H9I\N44MJI'H0'!.^1;#"B%2/ <<(=::%<Q*Z4WM\^ --1B%
M?C9#KV!*3!(21UTI.FKTJ]2N#W36XTQB+'<!:]-YZ] $WJ)_2,FIB\Y3$M-3
MV")G1:<P[YER[(9*<AN1OIC..(+5->:)]6Y):\;WI(9Z#4J3#,,S'33&H1\?
MD:<>J^!HX*A!;=Q8I1%-*TPW>PR[P^1VU0TL7Z]W8]]GJC8,BXQ#B:SA13KQ
MB.I&J8XPLG'CRUH:'(;<9X73)RA[ <]+B1VY)ZR"89Y=_@-02P,$%     @
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M,M$:$'AOUAAW2FC/#5B,BX';"^/.#-DY=AE)W3B.":6^VV-QYTFD!A(R,]R
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M_49R]94HG$RF6!"!V JI0R. 2JQWXPQ1+"L.>ET=,&X6!<(T0VM&Z!JEC*;
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MJ>Y?,]RHE@JX-E#?5XS)QXEVT#9IR5]02P,$%     @ %70/5;@GJH2* @
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M4@.VPXR>2% F@/87DHK83LP!W:,;_P902P,$%     @ %70/55G513V. P
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M.4['@JY_'6YW^=,/#R!$N-T%;WGC-MOJEGSN$;[[F MU_@U$1@)8*?+];YQ
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M!Z$GX/LUQ_-7=[2!YI^"^?]02P,$%     @ %70/54<.Q!9? P  M0H  !D
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M*"#C3"5="E5IPS*M:3J'E>N[TTD0+NS#)?RPW177I.&:]',-@5W!..,PG X
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M=4BJ!HKGY3ECRY4^M92/B3Y7HC &>CWFFJL>F*-+<U)=_0M02P,$%     @
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M:_P0@'8%N+]4>.O;B>LUW:<E_P-02P,$%     @ %70/5=J>/RW* @  )0D
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M"CG#]#*5[QA@2D&>SZF\.^J-,M"\C,+?4$L#!!0    ( !5T#U6L"J)9XP(
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M3HM4WK+UW[!)R"OY(I:*ZB]:U[&."HX*(5FV 2L%69+7W_3;IA"[ .\ @&P
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M5(. [<@;VY$;M@UA)H> [<AQ-YE].YE=9?)A?0EN1\#M")O;$2JWL=34[9W
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M\1()V,ZM.WR[)L:^-OB'P4E>W"/#Y('S1[/XG,TMQR0$.:3*(%!].<(2\MP
MZ33^:S&M+J1QO+P_HW^JN6LN#U3"DN?_LDSMYQ:Q4 9;>LC55W[Z"UH^@<%+
M>2[K7W1J;/W80NE!*EZTSCJ#@I7-E3ZU.EPX:)QQ![=U</L._D\<O-;!>VD$
MOW7P7QHA:!UJZG;#O19N115-9H*?D##6&LW<U.K7WEHO5IIS<J^$?LJTGTKN
MLHR9BM$<591E'UB)4EHQI==O5Z HRR5RWZ$/Z-O]"KW]\]W,5CJJ\;73-L*B
MB>#^)(*'OO!2[25:EQED(_ZK:?]PPM_6;#O*[IGRPIT$_/M0WB#/>8]<QW5'
M\EF^W!V/T?F]Z.M?CGXEAM?5WZOQO.?KOVGKOVSJ/U;I!LL?QS*?M%M9T13F
MEOYF21!'L)(W?^#0^3@F\VN"K5X3;/U*8%<%\;N"^%/HR>=2@495")YT+Y P
M5H9)A/'\T%@%&IRPQC$-Y9A@ET3$\V?V\5+<5XJW?C[>E61!)UDP*=E&\.R0
M*MT?CKKO5;J+3:K7@ 47602AC\DUY^70*L1A'/64&5IA3 (27INMAV9Q1'QW
MG';8T0Z?H[T%*9N7=X)O. A.XJ!'9#DT<HD3.3VZ0RL<Q;C/=FCE>VX<C+.-
M.K;1)-M[/4NP<O<>[: $H1G3,D,TTRV1226H&3?.(L@Q%:)AZI[G7V35Z#"9
MQ,N/^FH8SB,N[LN^_OUP5V*23DSRJY^P3Y0)=*3Y 1#?(K4'I&>0]!'QRK0)
MB7:"ZB_46!]?D.'K'1/2/T3+$3,OBD(']P[;T"[ ) SBGH0C<+Y+X@CWSIM]
M,205(';U="I1R@^E:OIEM]L-P'?UW-?;7^#;)1[97^F!N9EO_X=OINTO5.R8
MUBZ'K0[EW$3Z7(AF@FT6BE?UB/; E1[XZMN]'OI!& /]?,NY.B],@.YO1/(#
M4$L#!!0    ( !5T#U7C-M=1H0(  ,X&   9    >&PO=V]R:W-H965T<R]S
M:&5E=#,W+GAM;(U5;6_:,!#^*Z>LFEII)2]0"!U$*F73]J$2:M7MLQM?B%4G
MSFP#1=J/GU\@HU*:E@_$9]\]SW,7WV6V$_)9E8@:7BI>JWE0:MU<AZ'*2ZR(
M&H@&:W-2"%D1;4RY#E4CD5 75/$PB:)Q6!%6!]G,[:UD-A,;S5F-*PEJ4U5$
M[A?(Q6X>Q,%QXYZM2VTWPFS6D#4^H'YL5M)888M"686U8J(&B<4\N(FO%ZGU
M=PZ_&.[4R1IL)D]"/%OC)YT'D16$''-M$8AY;/$6.;= 1L:? V;04MK T_41
M_;O+W>3R1!3>"OZ;45W.@S0 B@79<'TO=C_PD,^5Q<L%5^X?=MYW. T@WR@M
MJD.P45"QVC_)RZ$.IP'#-P*20T#B='LBIW))-,EF4NQ 6F^#9A<N51=MQ+':
MOI0'+<TI,W$ZNZ&4V?(0#@UA])+5D).&:6.?+U$3QA4,+V:A-EPV(LP/N N/
MF[R!&R=P)VI=*OA64Z2O 4(CLE6:')4NDE[$)>8#&,9?((F2&!X?EG!^=@%G
M$((JB4350S%LBS%T%,/WB[$Z%./6%Z.K !YKU(UEF^E:-23'>6"Z1:'<8I!]
M_A2/HZ\]2D>MTE$?>G;/U/-E(1&!U1H-O@9)-';)]$!3!V1;=)M%@RA*Q]-7
MOUFX[9!SU<JYZI7S[:4Q7884."LZ1?2'CV"/1"J80N7O3)P")?N^5SINE8T_
MIHRR+:-84P5_X:Q+HL<9G]:INRB3EGKR,>JMX$0SSO2^B]>#Q-$)<3*8I-W<
M:<N=]G*;B54@TQN)[E[8G-]H%"\B?3?Y\&3&5"C7;I(JR,6FUG[<M+OML+[Q
M,^J_NY_T=T2N6:V 8V%"H\'$W [IIZ<WM&C<Q'H2VLP_MRS-!P>E=3#GA1#Z
M:%B"]A.6_0-02P,$%     @ %70/5=ZQNT@S @  P 0  !D   !X;"]W;W)K
M<VAE971S+W-H965T,S@N>&ULA91M;],P$,>_BA40 @GJ-.VZJ:21^@""%T/5
M)MCK:W))K#EVL-UD?'O\D(:"MO(F\=EW/__O<I>TE^I1UXB&/#5<Z%54&],N
M*=5YC0WHB6Q1V)-2J@:,-55%=:L0"A_4<)K$\8(VP$24I7YOK[)4'@UG O>*
MZ&/3@/JU02[[532-3AMWK*J-VZ!9VD*%]VB^MWME+3I2"M:@T$P*HK!<1>OI
M<C-W_M[A!\->GZV)R^0@Y:,SOA:K*':"D&-N' 'LJ\,M<NY 5L;/@1F-5[K
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M4CPUCS'0"(06P.];CH>_\D4[J.X>E_\#4$L#!!0    ( !5T#U4*UQ=N$@4
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M&4U>:6_ZTP_8[/\B"R<DS(:$.9 P%PA62X-!F08#%7TZVR6)F#&R:#_%7&1
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M!^ !0Z*H/@</SJ-P>TZ%W:]'D]]02P,$%     @ %70/59>*NQS     $P(
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M&HT!  !/&   &@   'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR96QSS=E-CH)
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M;64O=&AE;64Q+GAM;%!+ 0(4 Q0    ( !5T#U6VGD/S>04   $=   8
M          " @0X(  !X;"]W;W)K<VAE971S+W-H965T,2YX;6Q02P$"% ,4
M    "  5= ]5LS7[I*($  "X$0  &               @(&]#0  >&PO=V]R
M:W-H965T<R]S:&5E=#(N>&UL4$L! A0#%     @ %70/5;Y>1!;V @  WPD
M !@              ("!E1(  'AL+W=O<FMS:&5E=',O<VAE970S+GAM;%!+
M 0(4 Q0    ( !5T#U5Y1R/)(@8  +\<   8              " @<$5  !X
M;"]W;W)K<VAE971S+W-H965T-"YX;6Q02P$"% ,4    "  5= ]59KKVD?D%
M  !R%P  &               @($9'   >&PO=V]R:W-H965T<R]S:&5E=#4N
M>&UL4$L! A0#%     @ %70/53TTLE;B!P  7!(  !@              ("!
M2"(  'AL+W=O<FMS:&5E=',O<VAE970V+GAM;%!+ 0(4 Q0    ( !5T#U5%
M<YH;P 0  '$+   8              " @6 J  !X;"]W;W)K<VAE971S+W-H
M965T-RYX;6Q02P$"% ,4    "  5= ]5B6Y@+98"  !$!@  &
M    @(%6+P  >&PO=V]R:W-H965T<R]S:&5E=#@N>&UL4$L! A0#%     @
M%70/53*SY///!P  *AD  !@              ("!(C(  'AL+W=O<FMS:&5E
M=',O<VAE970Y+GAM;%!+ 0(4 Q0    ( !5T#U4W,':\T@0  #P-   9
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M970Q-"YX;6Q02P$"% ,4    "  5= ]5T\6 6$,#   \!P  &0
M    @($!8@  >&PO=V]R:W-H965T<R]S:&5E=#$U+GAM;%!+ 0(4 Q0    (
M !5T#U5]#IMF)P8  )8.   9              " @7ME  !X;"]W;W)K<VAE
M971S+W-H965T,38N>&UL4$L! A0#%     @ %70/58<BA1R% @  Y 4  !D
M             ("!V6L  'AL+W=O<FMS:&5E=',O<VAE970Q-RYX;6Q02P$"
M% ,4    "  5= ]5F+"5/\L%  !V%   &0              @(&5;@  >&PO
M=V]R:W-H965T<R]S:&5E=#$X+GAM;%!+ 0(4 Q0    ( !5T#U7/NQ\B]P,
M $4+   9              " @9=T  !X;"]W;W)K<VAE971S+W-H965T,3DN
M>&UL4$L! A0#%     @ %70/56\J08(2!@  ,1,  !D              ("!
MQ7@  'AL+W=O<FMS:&5E=',O<VAE970R,"YX;6Q02P$"% ,4    "  5= ]5
M?8<*82T$  #;"@  &0              @($.?P  >&PO=V]R:W-H965T<R]S
M:&5E=#(Q+GAM;%!+ 0(4 Q0    ( !5T#U7LGR9=[ (  (D&   9
M      " @7*#  !X;"]W;W)K<VAE971S+W-H965T,C(N>&UL4$L! A0#%
M  @ %70/50X0VU$; P  L D  !D              ("!E88  'AL+W=O<FMS
M:&5E=',O<VAE970R,RYX;6Q02P$"% ,4    "  5= ]5N">JA(H"   #!P
M&0              @('GB0  >&PO=V]R:W-H965T<R]S:&5E=#(T+GAM;%!+
M 0(4 Q0    ( !5T#U7GZ)?SU0(  ( '   9              " @:B,  !X
M;"]W;W)K<VAE971S+W-H965T,C4N>&UL4$L! A0#%     @ %70/55G513V.
M P  "@L  !D              ("!M(\  'AL+W=O<FMS:&5E=',O<VAE970R
M-BYX;6Q02P$"% ,4    "  5= ]5<*/'Z><#   U$   &0
M@(%YDP  >&PO=V]R:W-H965T<R]S:&5E=#(W+GAM;%!+ 0(4 Q0    ( !5T
M#U5'#L067P,  +4*   9              " @9>7  !X;"]W;W)K<VAE971S
M+W-H965T,C@N>&UL4$L! A0#%     @ %70/5:9QND(' P  %@D  !D
M         ("!+9L  'AL+W=O<FMS:&5E=',O<VAE970R.2YX;6Q02P$"% ,4
M    "  5= ]5$;KVY78"  !F!@  &0              @(%KG@  >&PO=V]R
M:W-H965T<R]S:&5E=#,P+GAM;%!+ 0(4 Q0    ( !5T#U7:GC\MR@(  "4)
M   9              " @1BA  !X;"]W;W)K<VAE971S+W-H965T,S$N>&UL
M4$L! A0#%     @ %70/5:P*HEGC @  ?P@  !D              ("!&:0
M 'AL+W=O<FMS:&5E=',O<VAE970S,BYX;6Q02P$"% ,4    "  5= ]53=<)
ML[\$   G&   &0              @($SIP  >&PO=V]R:W-H965T<R]S:&5E
M=#,S+GAM;%!+ 0(4 Q0    ( !5T#U5I"=MGB@,  *,-   9
M  " @2FL  !X;"]W;W)K<VAE971S+W-H965T,S0N>&UL4$L! A0#%     @
M%70/5>[^:#T-"@  YV$  !D              ("!ZJ\  'AL+W=O<FMS:&5E
M=',O<VAE970S-2YX;6Q02P$"% ,4    "  5= ]5?,-[VW,#  !2#   &0
M            @($NN@  >&PO=V]R:W-H965T<R]S:&5E=#,V+GAM;%!+ 0(4
M Q0    ( !5T#U7C-M=1H0(  ,X&   9              " @=B]  !X;"]W
M;W)K<VAE971S+W-H965T,S<N>&UL4$L! A0#%     @ %70/5=ZQNT@S @
MP 0  !D              ("!L,   'AL+W=O<FMS:&5E=',O<VAE970S."YX
M;6Q02P$"% ,4    "  5= ]5TU"08_X$  "'%   &0              @($:
MPP  >&PO=V]R:W-H965T<R]S:&5E=#,Y+GAM;%!+ 0(4 Q0    ( !5T#U4*
MUQ=N$@4  (PE   9              " @4_(  !X;"]W;W)K<VAE971S+W-H
M965T-# N>&UL4$L! A0#%     @ %70/5;R%+@HE P  2A(   T
M     ( !F,T  'AL+W-T>6QE<RYX;6Q02P$"% ,4    "  5= ]5EXJ[',
M   3 @  "P              @ 'HT   7W)E;',O+G)E;'-02P$"% ,4
M"  5= ]5_:GQB80#   G&P  #P              @ '1T0  >&PO=V]R:V)O
M;VLN>&UL4$L! A0#%     @ %70/53QA]1J- 0  3Q@  !H
M ( !@M4  'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR96QS4$L! A0#%     @
M%70/59C$(26B 0  IA@  !,              ( !1]<  %M#;VYT96YT7U1Y
><&5S72YX;6Q02P4&     #  ,  '#0  &MD

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.2.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>86</ContextCount>
  <ElementCount>192</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>30</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>4</UnitCount>
  <MyReports>
    <Report instance="sfsalr10q081122.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://alrt.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="sfsalr10q081122.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>00000002 - Statement - Condensed Consolidated Balance Sheets (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://alrt.com/role/BalanceSheets</Role>
      <ShortName>Condensed Consolidated Balance Sheets (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="sfsalr10q081122.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>00000003 - Statement - Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://alrt.com/role/BalanceSheetsParenthetical</Role>
      <ShortName>Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="sfsalr10q081122.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>00000004 - Statement - Condensed Consolidated Statements of Operations (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://alrt.com/role/StatementsOfOperations</Role>
      <ShortName>Condensed Consolidated Statements of Operations (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="sfsalr10q081122.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>00000005 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://alrt.com/role/StatementsOfCashFlows</Role>
      <ShortName>Condensed Consolidated Statements of Cash Flows (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="sfsalr10q081122.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>00000006 - Disclosure - Basis of presentation, nature of operations and going concern</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://alrt.com/role/BasisOfPresentationNatureOfOperationsAndGoingConcern</Role>
      <ShortName>Basis of presentation, nature of operations and going concern</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="sfsalr10q081122.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>00000007 - Disclosure - Significant accounting policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://alrt.com/role/SignificantAccountingPolicies</Role>
      <ShortName>Significant accounting policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="sfsalr10q081122.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>00000008 - Disclosure - Accounts payable and accrued liabilities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://alrt.com/role/AccountsPayableAndAccruedLiabilities</Role>
      <ShortName>Accounts payable and accrued liabilities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="sfsalr10q081122.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>00000009 - Disclosure - Interest, advances and promissory notes payable</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayable</Role>
      <ShortName>Interest, advances and promissory notes payable</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="sfsalr10q081122.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>00000010 - Disclosure - Lines of credit</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://alrt.com/role/LinesOfCredit</Role>
      <ShortName>Lines of credit</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="sfsalr10q081122.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>00000011 - Disclosure - Capital stock</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://alrt.com/role/CapitalStock</Role>
      <ShortName>Capital stock</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="sfsalr10q081122.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>00000012 - Disclosure - Additional paid-in capital</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://alrt.com/role/AdditionalPaid-inCapital</Role>
      <ShortName>Additional paid-in capital</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="sfsalr10q081122.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>00000013 - Disclosure - Related party transactions and balances</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://alrt.com/role/RelatedPartyTransactionsAndBalances</Role>
      <ShortName>Related party transactions and balances</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="sfsalr10q081122.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>00000014 - Disclosure - Commitments and contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://alrt.com/role/CommitmentsAndContingencies</Role>
      <ShortName>Commitments and contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="sfsalr10q081122.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>00000015 - Disclosure - Operating segments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://alrt.com/role/OperatingSegments</Role>
      <ShortName>Operating segments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="sfsalr10q081122.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>00000016 - Disclosure - Subsequent events</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://alrt.com/role/SubsequentEvents</Role>
      <ShortName>Subsequent events</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="sfsalr10q081122.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>00000017 - Disclosure - Accounts payable and accrued liabilities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://alrt.com/role/AccountsPayableAndAccruedLiabilitiesTables</Role>
      <ShortName>Accounts payable and accrued liabilities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://alrt.com/role/AccountsPayableAndAccruedLiabilities</ParentRole>
      <Position>17</Position>
    </Report>
    <Report instance="sfsalr10q081122.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>00000018 - Disclosure - Interest, advances and promissory notes payable (Tables)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableTables</Role>
      <ShortName>Interest, advances and promissory notes payable (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayable</ParentRole>
      <Position>18</Position>
    </Report>
    <Report instance="sfsalr10q081122.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>00000019 - Disclosure - Lines of credit (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://alrt.com/role/LinesOfCreditTables</Role>
      <ShortName>Lines of credit (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://alrt.com/role/LinesOfCredit</ParentRole>
      <Position>19</Position>
    </Report>
    <Report instance="sfsalr10q081122.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>00000020 - Disclosure - Additional paid-in capital (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://alrt.com/role/AdditionalPaid-inCapitalTables</Role>
      <ShortName>Additional paid-in capital (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://alrt.com/role/AdditionalPaid-inCapital</ParentRole>
      <Position>20</Position>
    </Report>
    <Report instance="sfsalr10q081122.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>00000021 - Disclosure - Related party transactions and balances (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://alrt.com/role/RelatedPartyTransactionsAndBalancesTables</Role>
      <ShortName>Related party transactions and balances (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://alrt.com/role/RelatedPartyTransactionsAndBalances</ParentRole>
      <Position>21</Position>
    </Report>
    <Report instance="sfsalr10q081122.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>00000022 - Disclosure - Operating segments (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://alrt.com/role/OperatingSegmentsTables</Role>
      <ShortName>Operating segments (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://alrt.com/role/OperatingSegments</ParentRole>
      <Position>22</Position>
    </Report>
    <Report instance="sfsalr10q081122.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>00000023 - Disclosure - Basis of presentation, nature of operations and going concern (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://alrt.com/role/BasisOfPresentationNatureOfOperationsAndGoingConcernDetailsNarrative</Role>
      <ShortName>Basis of presentation, nature of operations and going concern (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://alrt.com/role/BasisOfPresentationNatureOfOperationsAndGoingConcern</ParentRole>
      <Position>23</Position>
    </Report>
    <Report instance="sfsalr10q081122.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>00000024 - Disclosure - Accounts payable and accrued liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://alrt.com/role/AccountsPayableAndAccruedLiabilitiesDetails</Role>
      <ShortName>Accounts payable and accrued liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://alrt.com/role/AccountsPayableAndAccruedLiabilitiesTables</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="sfsalr10q081122.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>00000025 - Disclosure - Interest, advances and promissory notes payable (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails</Role>
      <ShortName>Interest, advances and promissory notes payable (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableTables</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="sfsalr10q081122.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>00000026 - Disclosure - Interest, advances and promissory notes payable (Details 1)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails1</Role>
      <ShortName>Interest, advances and promissory notes payable (Details 1)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableTables</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="sfsalr10q081122.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>00000027 - Disclosure - Interest, advances and promissory notes payable (Details 2)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails2</Role>
      <ShortName>Interest, advances and promissory notes payable (Details 2)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableTables</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="sfsalr10q081122.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>00000028 - Disclosure - Interest, advances and promissory notes payable (Details 3)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails3</Role>
      <ShortName>Interest, advances and promissory notes payable (Details 3)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableTables</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="sfsalr10q081122.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>00000029 - Disclosure - Interest, advances and promissory notes payable (Details 4)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails4</Role>
      <ShortName>Interest, advances and promissory notes payable (Details 4)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableTables</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="sfsalr10q081122.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>00000030 - Disclosure - Interest, advances and promissory notes payable (Details 5)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails5</Role>
      <ShortName>Interest, advances and promissory notes payable (Details 5)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableTables</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="sfsalr10q081122.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>00000031 - Disclosure - Interest, advances and promissory notes payable (Details Narrative)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetailsNarrative</Role>
      <ShortName>Interest, advances and promissory notes payable (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableTables</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="sfsalr10q081122.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>00000032 - Disclosure - Lines of credit (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://alrt.com/role/LinesOfCreditDetails</Role>
      <ShortName>Lines of credit (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://alrt.com/role/LinesOfCreditTables</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="sfsalr10q081122.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>00000033 - Disclosure - Lines of credit (Details 1)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://alrt.com/role/LinesOfCreditDetails1</Role>
      <ShortName>Lines of credit (Details 1)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://alrt.com/role/LinesOfCreditTables</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="sfsalr10q081122.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>00000034 - Disclosure - Additional paid-in capital (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://alrt.com/role/AdditionalPaid-inCapitalDetails</Role>
      <ShortName>Additional paid-in capital (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://alrt.com/role/AdditionalPaid-inCapitalTables</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="sfsalr10q081122.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>00000035 - Disclosure - Additional paid-in capital (Details 1)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://alrt.com/role/AdditionalPaid-inCapitalDetails1</Role>
      <ShortName>Additional paid-in capital (Details 1)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://alrt.com/role/AdditionalPaid-inCapitalTables</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="sfsalr10q081122.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>00000036 - Disclosure - Additional paid-in capital (Details 2)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://alrt.com/role/AdditionalPaid-inCapitalDetails2</Role>
      <ShortName>Additional paid-in capital (Details 2)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://alrt.com/role/AdditionalPaid-inCapitalTables</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="sfsalr10q081122.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>00000037 - Disclosure - Additional paid-in capital (Details 3)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://alrt.com/role/AdditionalPaid-inCapitalDetails3</Role>
      <ShortName>Additional paid-in capital (Details 3)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://alrt.com/role/AdditionalPaid-inCapitalTables</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="sfsalr10q081122.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>00000038 - Disclosure - Additional paid-in capital (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://alrt.com/role/AdditionalPaid-inCapitalDetailsNarrative</Role>
      <ShortName>Additional paid-in capital (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://alrt.com/role/AdditionalPaid-inCapitalTables</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="sfsalr10q081122.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>00000039 - Disclosure - Related party transactions and balances (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://alrt.com/role/RelatedPartyTransactionsAndBalancesDetails</Role>
      <ShortName>Related party transactions and balances (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://alrt.com/role/RelatedPartyTransactionsAndBalancesTables</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="sfsalr10q081122.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>00000040 - Disclosure - Operating segments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://alrt.com/role/OperatingSegmentsDetails</Role>
      <ShortName>Operating segments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://alrt.com/role/OperatingSegmentsTables</ParentRole>
      <Position>40</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-Q" original="sfsalr10q081122.htm">sfsalr10q081122.htm</File>
    <File>alrt-20220630.xsd</File>
    <File>alrt-20220630_cal.xml</File>
    <File>alrt-20220630_def.xml</File>
    <File>alrt-20220630_lab.xml</File>
    <File>alrt-20220630_pre.xml</File>
    <File>sfsalr10q081122ex31_1.htm</File>
    <File>sfsalr10q081122ex32_1.htm</File>
  </InputFiles>
  <SupplementalFiles>
    <File>image_001.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="241">http://fasb.org/us-gaap/2022</BaseTaxonomy>
    <BaseTaxonomy items="27">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>56
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "sfsalr10q081122.htm": {
   "axisCustom": 0,
   "axisStandard": 4,
   "contextCount": 86,
   "dts": {
    "calculationLink": {
     "local": [
      "alrt-20220630_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "alrt-20220630_def.xml"
     ]
    },
    "inline": {
     "local": [
      "sfsalr10q081122.htm"
     ]
    },
    "labelLink": {
     "local": [
      "alrt-20220630_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "alrt-20220630_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "alrt-20220630.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd",
      "https://xbrl.sec.gov/country/2022/country-2022.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd"
     ]
    }
   },
   "elementCount": 298,
   "entityCount": 1,
   "hidden": {
    "http://alrt.com/20220630": 23,
    "http://fasb.org/us-gaap/2022": 29,
    "http://xbrl.sec.gov/dei/2022": 7,
    "total": 59
   },
   "keyCustom": 71,
   "keyStandard": 121,
   "memberCustom": 28,
   "memberStandard": 2,
   "nsprefix": "ALRT",
   "nsuri": "http://alrt.com/20220630",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "baseRef": "sfsalr10q081122.htm",
      "contextRef": "From2022-01-01to2022-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "00000001 - Document - Cover",
     "role": "http://alrt.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "baseRef": "sfsalr10q081122.htm",
      "contextRef": "From2022-01-01to2022-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "sfsalr10q081122.htm",
      "contextRef": "From2022-01-01to2022-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ALRT:LineOfCreditTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000010 - Disclosure - Lines of credit",
     "role": "http://alrt.com/role/LinesOfCredit",
     "shortName": "Lines of credit",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "sfsalr10q081122.htm",
      "contextRef": "From2022-01-01to2022-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ALRT:LineOfCreditTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "sfsalr10q081122.htm",
      "contextRef": "From2022-01-01to2022-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000011 - Disclosure - Capital stock",
     "role": "http://alrt.com/role/CapitalStock",
     "shortName": "Capital stock",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "sfsalr10q081122.htm",
      "contextRef": "From2022-01-01to2022-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "sfsalr10q081122.htm",
      "contextRef": "From2022-01-01to2022-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ALRT:AdditionalPaidInCapitalTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000012 - Disclosure - Additional paid-in capital",
     "role": "http://alrt.com/role/AdditionalPaid-inCapital",
     "shortName": "Additional paid-in capital",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "sfsalr10q081122.htm",
      "contextRef": "From2022-01-01to2022-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ALRT:AdditionalPaidInCapitalTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "sfsalr10q081122.htm",
      "contextRef": "From2022-01-01to2022-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000013 - Disclosure - Related party transactions and balances",
     "role": "http://alrt.com/role/RelatedPartyTransactionsAndBalances",
     "shortName": "Related party transactions and balances",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "sfsalr10q081122.htm",
      "contextRef": "From2022-01-01to2022-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "sfsalr10q081122.htm",
      "contextRef": "From2022-01-01to2022-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000014 - Disclosure - Commitments and contingencies",
     "role": "http://alrt.com/role/CommitmentsAndContingencies",
     "shortName": "Commitments and contingencies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "sfsalr10q081122.htm",
      "contextRef": "From2022-01-01to2022-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "sfsalr10q081122.htm",
      "contextRef": "From2022-01-01to2022-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000015 - Disclosure - Operating segments",
     "role": "http://alrt.com/role/OperatingSegments",
     "shortName": "Operating segments",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "sfsalr10q081122.htm",
      "contextRef": "From2022-01-01to2022-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "sfsalr10q081122.htm",
      "contextRef": "From2022-01-01to2022-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000016 - Disclosure - Subsequent events",
     "role": "http://alrt.com/role/SubsequentEvents",
     "shortName": "Subsequent events",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "sfsalr10q081122.htm",
      "contextRef": "From2022-01-01to2022-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "sfsalr10q081122.htm",
      "contextRef": "From2022-01-01to2022-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000017 - Disclosure - Accounts payable and accrued liabilities (Tables)",
     "role": "http://alrt.com/role/AccountsPayableAndAccruedLiabilitiesTables",
     "shortName": "Accounts payable and accrued liabilities (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "sfsalr10q081122.htm",
      "contextRef": "From2022-01-01to2022-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "ALRT:InterestAdvancesAndPromissoryNotesPayableTextBlock",
       "body",
       "html"
      ],
      "baseRef": "sfsalr10q081122.htm",
      "contextRef": "From2022-01-01to2022-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ALRT:SummaryOfActivitiesOfPromissoryNotesPayableTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000018 - Disclosure - Interest, advances and promissory notes payable (Tables)",
     "role": "http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableTables",
     "shortName": "Interest, advances and promissory notes payable (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ALRT:InterestAdvancesAndPromissoryNotesPayableTextBlock",
       "body",
       "html"
      ],
      "baseRef": "sfsalr10q081122.htm",
      "contextRef": "From2022-01-01to2022-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ALRT:SummaryOfActivitiesOfPromissoryNotesPayableTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "ALRT:LineOfCreditTextBlock",
       "body",
       "html"
      ],
      "baseRef": "sfsalr10q081122.htm",
      "contextRef": "From2022-01-01to2022-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfLineOfCreditFacilitiesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000019 - Disclosure - Lines of credit (Tables)",
     "role": "http://alrt.com/role/LinesOfCreditTables",
     "shortName": "Lines of credit (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ALRT:LineOfCreditTextBlock",
       "body",
       "html"
      ],
      "baseRef": "sfsalr10q081122.htm",
      "contextRef": "From2022-01-01to2022-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfLineOfCreditFacilitiesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "sfsalr10q081122.htm",
      "contextRef": "AsOf2022-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:Cash",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "00000002 - Statement - Condensed Consolidated Balance Sheets (Unaudited)",
     "role": "http://alrt.com/role/BalanceSheets",
     "shortName": "Condensed Consolidated Balance Sheets (Unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "sfsalr10q081122.htm",
      "contextRef": "AsOf2022-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:Cash",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "ALRT:AdditionalPaidInCapitalTextBlock",
       "body",
       "html"
      ],
      "baseRef": "sfsalr10q081122.htm",
      "contextRef": "From2022-01-01to2022-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000020 - Disclosure - Additional paid-in capital (Tables)",
     "role": "http://alrt.com/role/AdditionalPaid-inCapitalTables",
     "shortName": "Additional paid-in capital (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ALRT:AdditionalPaidInCapitalTextBlock",
       "body",
       "html"
      ],
      "baseRef": "sfsalr10q081122.htm",
      "contextRef": "From2022-01-01to2022-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "sfsalr10q081122.htm",
      "contextRef": "From2022-01-01to2022-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000021 - Disclosure - Related party transactions and balances (Tables)",
     "role": "http://alrt.com/role/RelatedPartyTransactionsAndBalancesTables",
     "shortName": "Related party transactions and balances (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "sfsalr10q081122.htm",
      "contextRef": "From2022-01-01to2022-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "sfsalr10q081122.htm",
      "contextRef": "From2022-01-01to2022-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000022 - Disclosure - Operating segments (Tables)",
     "role": "http://alrt.com/role/OperatingSegmentsTables",
     "shortName": "Operating segments (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "sfsalr10q081122.htm",
      "contextRef": "From2022-01-01to2022-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock",
       "body",
       "html"
      ],
      "baseRef": "sfsalr10q081122.htm",
      "contextRef": "From2022-01-01to2022-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000023 - Disclosure - Basis of presentation, nature of operations and going concern (Details Narrative)",
     "role": "http://alrt.com/role/BasisOfPresentationNatureOfOperationsAndGoingConcernDetailsNarrative",
     "shortName": "Basis of presentation, nature of operations and going concern (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock",
       "body",
       "html"
      ],
      "baseRef": "sfsalr10q081122.htm",
      "contextRef": "From2022-01-01to2022-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
       "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "sfsalr10q081122.htm",
      "contextRef": "AsOf2022-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:AccountsPayableCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000024 - Disclosure - Accounts payable and accrued liabilities (Details)",
     "role": "http://alrt.com/role/AccountsPayableAndAccruedLiabilitiesDetails",
     "shortName": "Accounts payable and accrued liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
       "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "sfsalr10q081122.htm",
      "contextRef": "AsOf2022-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:AccountsPayableCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "ALRT:SummaryOfActivitiesOfPromissoryNotesPayableTableTextBlock",
       "ALRT:InterestAdvancesAndPromissoryNotesPayableTextBlock",
       "body",
       "html"
      ],
      "baseRef": "sfsalr10q081122.htm",
      "contextRef": "AsOf2021-12-31_custom_RelatedPartyMember",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:NotesPayableRelatedPartiesClassifiedCurrent",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000025 - Disclosure - Interest, advances and promissory notes payable (Details)",
     "role": "http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails",
     "shortName": "Interest, advances and promissory notes payable (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "ALRT:SummaryOfActivitiesOfPromissoryNotesPayableTableTextBlock",
       "ALRT:InterestAdvancesAndPromissoryNotesPayableTextBlock",
       "body",
       "html"
      ],
      "baseRef": "sfsalr10q081122.htm",
      "contextRef": "AsOf2020-12-31_custom_RelatedPartyMember",
      "decimals": "0",
      "lang": null,
      "name": "us-gaap:NotesPayableRelatedPartiesClassifiedCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "ALRT:ScheduleofPromissoryNotesPayableRelativesofBoardofDirectorsTableTextBlock",
       "ALRT:InterestAdvancesAndPromissoryNotesPayableTextBlock",
       "body",
       "html"
      ],
      "baseRef": "sfsalr10q081122.htm",
      "contextRef": "AsOf2022-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "ALRT:NotePayablewithInterestat1PercentInterestperMonth",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000026 - Disclosure - Interest, advances and promissory notes payable (Details 1)",
     "role": "http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails1",
     "shortName": "Interest, advances and promissory notes payable (Details 1)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "ALRT:ScheduleofPromissoryNotesPayableRelativesofBoardofDirectorsTableTextBlock",
       "ALRT:InterestAdvancesAndPromissoryNotesPayableTextBlock",
       "body",
       "html"
      ],
      "baseRef": "sfsalr10q081122.htm",
      "contextRef": "AsOf2022-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "ALRT:NotePayablewithInterestat1PercentInterestperMonth",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "sfsalr10q081122.htm",
      "contextRef": "From2022-01-01to2022-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:IncreaseDecreaseInInterestPayableNet",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000027 - Disclosure - Interest, advances and promissory notes payable (Details 2)",
     "role": "http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails2",
     "shortName": "Interest, advances and promissory notes payable (Details 2)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "ALRT:ScheduleofPromissoryNotesPayableToUnrelatedPartiesTableTextBlock",
       "ALRT:InterestAdvancesAndPromissoryNotesPayableTextBlock",
       "body",
       "html"
      ],
      "baseRef": "sfsalr10q081122.htm",
      "contextRef": "From2021-01-012021-12-31_custom_UnRelatedPartyMember",
      "decimals": "0",
      "lang": null,
      "name": "us-gaap:IncreaseDecreaseInInterestPayableNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ALRT:ScheduleofActivityofPromissoryNotestoUnrelatedPatiesTableTextBlock",
       "ALRT:InterestAdvancesAndPromissoryNotesPayableTextBlock",
       "body",
       "html"
      ],
      "baseRef": "sfsalr10q081122.htm",
      "contextRef": "AsOf2022-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "ALRT:I.InterestAt1PerMonthRepayableOnMarch312009DueOnDemand",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000028 - Disclosure - Interest, advances and promissory notes payable (Details 3)",
     "role": "http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails3",
     "shortName": "Interest, advances and promissory notes payable (Details 3)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ALRT:ScheduleofActivityofPromissoryNotestoUnrelatedPatiesTableTextBlock",
       "ALRT:InterestAdvancesAndPromissoryNotesPayableTextBlock",
       "body",
       "html"
      ],
      "baseRef": "sfsalr10q081122.htm",
      "contextRef": "AsOf2022-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "ALRT:I.InterestAt1PerMonthRepayableOnMarch312009DueOnDemand",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:InterestAndOtherIncomeTableTextBlock",
       "ALRT:InterestAdvancesAndPromissoryNotesPayableTextBlock",
       "body",
       "html"
      ],
      "baseRef": "sfsalr10q081122.htm",
      "contextRef": "AsOf2021-12-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:InterestPayableCurrentAndNoncurrent",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000029 - Disclosure - Interest, advances and promissory notes payable (Details 4)",
     "role": "http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails4",
     "shortName": "Interest, advances and promissory notes payable (Details 4)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:InterestAndOtherIncomeTableTextBlock",
       "ALRT:InterestAdvancesAndPromissoryNotesPayableTextBlock",
       "body",
       "html"
      ],
      "baseRef": "sfsalr10q081122.htm",
      "contextRef": "AsOf2020-12-31",
      "decimals": "0",
      "lang": null,
      "name": "us-gaap:InterestPayableCurrentAndNoncurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "sfsalr10q081122.htm",
      "contextRef": "AsOf2022-06-30",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:PreferredStockSharesAuthorized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "00000003 - Statement - Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical)",
     "role": "http://alrt.com/role/BalanceSheetsParenthetical",
     "shortName": "Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "sfsalr10q081122.htm",
      "contextRef": "AsOf2022-06-30",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:PreferredStockSharesAuthorized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Shares",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "ALRT:ScheduledOfInterestPayableDueToRelatedTableTextBlock",
       "ALRT:InterestAdvancesAndPromissoryNotesPayableTextBlock",
       "body",
       "html"
      ],
      "baseRef": "sfsalr10q081122.htm",
      "contextRef": "AsOf2022-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "ALRT:InterestPayableRelativesOfDirectors",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000030 - Disclosure - Interest, advances and promissory notes payable (Details 5)",
     "role": "http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails5",
     "shortName": "Interest, advances and promissory notes payable (Details 5)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "ALRT:ScheduledOfInterestPayableDueToRelatedTableTextBlock",
       "ALRT:InterestAdvancesAndPromissoryNotesPayableTextBlock",
       "body",
       "html"
      ],
      "baseRef": "sfsalr10q081122.htm",
      "contextRef": "AsOf2022-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "ALRT:InterestPayableRelativesOfDirectors",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "sfsalr10q081122.htm",
      "contextRef": "From2022-04-012022-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:InterestExpense",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000031 - Disclosure - Interest, advances and promissory notes payable (Details Narrative)",
     "role": "http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetailsNarrative",
     "shortName": "Interest, advances and promissory notes payable (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "ALRT:InterestAdvancesAndPromissoryNotesPayableTextBlock",
       "body",
       "html"
      ],
      "baseRef": "sfsalr10q081122.htm",
      "contextRef": "From2022-01-01to2022-06-30",
      "decimals": "0",
      "lang": null,
      "name": "us-gaap:InterestExpenseRelatedParty",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfLineOfCreditFacilitiesTextBlock",
       "ALRT:LineOfCreditTextBlock",
       "body",
       "html"
      ],
      "baseRef": "sfsalr10q081122.htm",
      "contextRef": "AsOf2021-12-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:LongTermLineOfCredit",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000032 - Disclosure - Lines of credit (Details)",
     "role": "http://alrt.com/role/LinesOfCreditDetails",
     "shortName": "Lines of credit (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfLineOfCreditFacilitiesTextBlock",
       "ALRT:LineOfCreditTextBlock",
       "body",
       "html"
      ],
      "baseRef": "sfsalr10q081122.htm",
      "contextRef": "AsOf2020-12-31",
      "decimals": "0",
      "lang": null,
      "name": "us-gaap:LongTermLineOfCredit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "ALRT:ScheduledOfLineOfCreditTableTextBlock",
       "ALRT:LineOfCreditTextBlock",
       "body",
       "html"
      ],
      "baseRef": "sfsalr10q081122.htm",
      "contextRef": "AsOf2022-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "ALRT:BorrowingLimit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000033 - Disclosure - Lines of credit (Details 1)",
     "role": "http://alrt.com/role/LinesOfCreditDetails1",
     "shortName": "Lines of credit (Details 1)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "ALRT:ScheduledOfLineOfCreditTableTextBlock",
       "ALRT:LineOfCreditTextBlock",
       "body",
       "html"
      ],
      "baseRef": "sfsalr10q081122.htm",
      "contextRef": "AsOf2022-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "ALRT:BorrowingLimit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ALRT:AdditionalPaidInCapitalTextBlock",
       "body",
       "html"
      ],
      "baseRef": "sfsalr10q081122.htm",
      "contextRef": "AsOf2021-12-31",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unitRef": "Shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000034 - Disclosure - Additional paid-in capital (Details)",
     "role": "http://alrt.com/role/AdditionalPaid-inCapitalDetails",
     "shortName": "Additional paid-in capital (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ALRT:AdditionalPaidInCapitalTextBlock",
       "body",
       "html"
      ],
      "baseRef": "sfsalr10q081122.htm",
      "contextRef": "AsOf2020-12-31",
      "decimals": "INF",
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Shares",
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ALRT:ScheduleofOptionsOutstandingTableTextBlock",
       "ALRT:AdditionalPaidInCapitalTextBlock",
       "body",
       "html"
      ],
      "baseRef": "sfsalr10q081122.htm",
      "contextRef": "From2022-01-01to2022-06-30",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "ALRT:OpenOptionContractsWrittenNumbersOfShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000035 - Disclosure - Additional paid-in capital (Details 1)",
     "role": "http://alrt.com/role/AdditionalPaid-inCapitalDetails1",
     "shortName": "Additional paid-in capital (Details 1)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ALRT:ScheduleofOptionsOutstandingTableTextBlock",
       "ALRT:AdditionalPaidInCapitalTextBlock",
       "body",
       "html"
      ],
      "baseRef": "sfsalr10q081122.htm",
      "contextRef": "From2022-01-01to2022-06-30",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "ALRT:OpenOptionContractsWrittenNumbersOfShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Shares",
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
       "ALRT:AdditionalPaidInCapitalTextBlock",
       "body",
       "html"
      ],
      "baseRef": "sfsalr10q081122.htm",
      "contextRef": "From2021-04-012021-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:InterestExpenseDebt",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000036 - Disclosure - Additional paid-in capital (Details 2)",
     "role": "http://alrt.com/role/AdditionalPaid-inCapitalDetails2",
     "shortName": "Additional paid-in capital (Details 2)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
       "ALRT:AdditionalPaidInCapitalTextBlock",
       "body",
       "html"
      ],
      "baseRef": "sfsalr10q081122.htm",
      "contextRef": "From2021-04-012021-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:InterestExpenseDebt",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "ALRT:AdditionalPaidInCapitalTextBlock",
       "body",
       "html"
      ],
      "baseRef": "sfsalr10q081122.htm",
      "contextRef": "From2021-01-012021-12-31",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Pure",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000037 - Disclosure - Additional paid-in capital (Details 3)",
     "role": "http://alrt.com/role/AdditionalPaid-inCapitalDetails3",
     "shortName": "Additional paid-in capital (Details 3)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "ALRT:AdditionalPaidInCapitalTextBlock",
       "body",
       "html"
      ],
      "baseRef": "sfsalr10q081122.htm",
      "contextRef": "From2021-01-012021-12-31",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Pure",
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "ALRT:AdditionalPaidInCapitalTextBlock",
       "body",
       "html"
      ],
      "baseRef": "sfsalr10q081122.htm",
      "contextRef": "From2021-01-012021-12-31",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USDPShares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000038 - Disclosure - Additional paid-in capital (Details Narrative)",
     "role": "http://alrt.com/role/AdditionalPaid-inCapitalDetailsNarrative",
     "shortName": "Additional paid-in capital (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "ALRT:AdditionalPaidInCapitalTextBlock",
       "body",
       "html"
      ],
      "baseRef": "sfsalr10q081122.htm",
      "contextRef": "From2021-01-012021-12-31",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USDPShares",
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock",
       "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "sfsalr10q081122.htm",
      "contextRef": "From2022-04-012022-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "ALRT:InterestExpenseOnPromissoryNotesIssuedToRelativesOfChairmanAndChiefExecutiveOfficerOfCompany",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000039 - Disclosure - Related party transactions and balances (Details)",
     "role": "http://alrt.com/role/RelatedPartyTransactionsAndBalancesDetails",
     "shortName": "Related party transactions and balances (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock",
       "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "sfsalr10q081122.htm",
      "contextRef": "From2022-04-012022-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "ALRT:InterestExpenseOnPromissoryNotesIssuedToRelativesOfChairmanAndChiefExecutiveOfficerOfCompany",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "sfsalr10q081122.htm",
      "contextRef": "From2022-04-012022-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "00000004 - Statement - Condensed Consolidated Statements of Operations (Unaudited)",
     "role": "http://alrt.com/role/StatementsOfOperations",
     "shortName": "Condensed Consolidated Statements of Operations (Unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "sfsalr10q081122.htm",
      "contextRef": "From2022-04-012022-06-30",
      "decimals": "0",
      "lang": null,
      "name": "us-gaap:CostOfRevenue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "sfsalr10q081122.htm",
      "contextRef": "AsOf2022-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:Assets",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000040 - Disclosure - Operating segments (Details)",
     "role": "http://alrt.com/role/OperatingSegmentsDetails",
     "shortName": "Operating segments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "sfsalr10q081122.htm",
      "contextRef": "AsOf2021-12-31_custom_OtherMember",
      "decimals": "0",
      "lang": null,
      "name": "us-gaap:Assets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "sfsalr10q081122.htm",
      "contextRef": "From2022-01-01to2022-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "00000005 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)",
     "role": "http://alrt.com/role/StatementsOfCashFlows",
     "shortName": "Condensed Consolidated Statements of Cash Flows (Unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "sfsalr10q081122.htm",
      "contextRef": "From2022-01-01to2022-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "sfsalr10q081122.htm",
      "contextRef": "From2022-01-01to2022-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000006 - Disclosure - Basis of presentation, nature of operations and going concern",
     "role": "http://alrt.com/role/BasisOfPresentationNatureOfOperationsAndGoingConcern",
     "shortName": "Basis of presentation, nature of operations and going concern",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "sfsalr10q081122.htm",
      "contextRef": "From2022-01-01to2022-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "sfsalr10q081122.htm",
      "contextRef": "From2022-01-01to2022-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000007 - Disclosure - Significant accounting policies",
     "role": "http://alrt.com/role/SignificantAccountingPolicies",
     "shortName": "Significant accounting policies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "sfsalr10q081122.htm",
      "contextRef": "From2022-01-01to2022-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "sfsalr10q081122.htm",
      "contextRef": "From2022-01-01to2022-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000008 - Disclosure - Accounts payable and accrued liabilities",
     "role": "http://alrt.com/role/AccountsPayableAndAccruedLiabilities",
     "shortName": "Accounts payable and accrued liabilities",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "sfsalr10q081122.htm",
      "contextRef": "From2022-01-01to2022-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "sfsalr10q081122.htm",
      "contextRef": "From2022-01-01to2022-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ALRT:InterestAdvancesAndPromissoryNotesPayableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000009 - Disclosure - Interest, advances and promissory notes payable",
     "role": "http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayable",
     "shortName": "Interest, advances and promissory notes payable",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "sfsalr10q081122.htm",
      "contextRef": "From2022-01-01to2022-06-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ALRT:InterestAdvancesAndPromissoryNotesPayableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 30,
   "tag": {
    "ALRT_AccruedInterest": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Accrued Interest"
       }
      }
     },
     "localname": "AccruedInterest",
     "nsuri": "http://alrt.com/20220630",
     "presentation": [
      "http://alrt.com/role/LinesOfCreditDetails1"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ALRT_AdditionalPaidInCapitalTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "AdditionalPaidInCapitalTextBlock",
        "verboseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalTextBlock",
     "nsuri": "http://alrt.com/20220630",
     "presentation": [
      "http://alrt.com/role/AdditionalPaid-inCapital"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ALRT_BonusesSettledByIssuanceOfShares": {
     "auth_ref": [],
     "calculation": {
      "http://alrt.com/role/StatementsOfCashFlows": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Bonuses settled by issuance of shares"
       }
      }
     },
     "localname": "BonusesSettledByIssuanceOfShares",
     "nsuri": "http://alrt.com/20220630",
     "presentation": [
      "http://alrt.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ALRT_BorrowingLimit": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Borrowing Limit"
       }
      }
     },
     "localname": "BorrowingLimit",
     "nsuri": "http://alrt.com/20220630",
     "presentation": [
      "http://alrt.com/role/LinesOfCreditDetails1"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ALRT_CancelledPerShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "CancelledPerShares",
        "negatedLabel": "Cancelled per share"
       }
      }
     },
     "localname": "CancelledPerShares",
     "nsuri": "http://alrt.com/20220630",
     "presentation": [
      "http://alrt.com/role/AdditionalPaid-inCapitalDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "ALRT_ChairmanAndCEOMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Chairman And C E O [Member]"
       }
      }
     },
     "localname": "ChairmanAndCEOMember",
     "nsuri": "http://alrt.com/20220630",
     "presentation": [
      "http://alrt.com/role/LinesOfCreditDetails1"
     ],
     "xbrltype": "domainItemType"
    },
    "ALRT_ConsultingFeesToChairmanAndChiefExecutiveOfficerOfCompanyAccruedOnLineOfCreditAvailableToCompany": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Consulting fees to the Chairman and Chief Executive Officer of the Company accrued on the line of credit available to the Company"
       }
      }
     },
     "localname": "ConsultingFeesToChairmanAndChiefExecutiveOfficerOfCompanyAccruedOnLineOfCreditAvailableToCompany",
     "nsuri": "http://alrt.com/20220630",
     "presentation": [
      "http://alrt.com/role/RelatedPartyTransactionsAndBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ALRT_ConsultingFeesToDirectorOfCompanySettledWithIssuanceOfCommonStock": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Consulting fees to a director of the Company settled with issuance of common stock"
       }
      }
     },
     "localname": "ConsultingFeesToDirectorOfCompanySettledWithIssuanceOfCommonStock",
     "nsuri": "http://alrt.com/20220630",
     "presentation": [
      "http://alrt.com/role/RelatedPartyTransactionsAndBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ALRT_DisclosureAdditionalPaidinCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Paid-in Capital"
       }
      }
     },
     "localname": "DisclosureAdditionalPaidinCapitalAbstract",
     "nsuri": "http://alrt.com/20220630",
     "xbrltype": "stringItemType"
    },
    "ALRT_DisclosureInterestAdvancesAndPromissoryNotesPayableAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest Advances And Promissory Notes Payable"
       }
      }
     },
     "localname": "DisclosureInterestAdvancesAndPromissoryNotesPayableAbstract",
     "nsuri": "http://alrt.com/20220630",
     "xbrltype": "stringItemType"
    },
    "ALRT_DisclosureLinesOfCreditAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lines Of Credit"
       }
      }
     },
     "localname": "DisclosureLinesOfCreditAbstract",
     "nsuri": "http://alrt.com/20220630",
     "xbrltype": "stringItemType"
    },
    "ALRT_ExercisePrices": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercise Price"
       }
      }
     },
     "localname": "ExercisePrices",
     "nsuri": "http://alrt.com/20220630",
     "presentation": [
      "http://alrt.com/role/AdditionalPaid-inCapitalDetails1"
     ],
     "xbrltype": "perShareItemType"
    },
    "ALRT_ExtinguishedThroughIssuanceOfSharesOfCommonStock": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Extinguished through issuance of shares of common stock (note 6)"
       }
      }
     },
     "localname": "ExtinguishedThroughIssuanceOfSharesOfCommonStock",
     "nsuri": "http://alrt.com/20220630",
     "presentation": [
      "http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails2"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ALRT_I.InterestAt1PerMonthRepayableOnMarch312009DueOnDemand": {
     "auth_ref": [],
     "calculation": {
      "http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails3": {
       "order": 1.0,
       "parentTag": "ALRT_TotalPromissoryNotesPayableToUnrelatedParties",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "I.InterestAt1PerMonthRepayableOnMarch312009DueOnDemand",
        "verboseLabel": "i.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Interest at 1% per month"
       }
      }
     },
     "localname": "I.InterestAt1PerMonthRepayableOnMarch312009DueOnDemand",
     "nsuri": "http://alrt.com/20220630",
     "presentation": [
      "http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails3"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ALRT_Iii.InterestAt0.625PerMonthWith50000RepayableOnOctober5200440000RepayableOnDecember312004And60000RepayableOnJuly282006AllDueOnDemand": {
     "auth_ref": [],
     "calculation": {
      "http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails3": {
       "order": 2.0,
       "parentTag": "ALRT_TotalPromissoryNotesPayableToUnrelatedParties",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "ii.\u00a0\u00a0\u00a0\u00a0\u00a0 Interest at 0.667% per month"
       }
      }
     },
     "localname": "Iii.InterestAt0.625PerMonthWith50000RepayableOnOctober5200440000RepayableOnDecember312004And60000RepayableOnJuly282006AllDueOnDemand",
     "nsuri": "http://alrt.com/20220630",
     "presentation": [
      "http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails3"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ALRT_InterestAdvancesAndPromissoryNotesPayableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest, advances and promissory notes payable"
       }
      }
     },
     "localname": "InterestAdvancesAndPromissoryNotesPayableTextBlock",
     "nsuri": "http://alrt.com/20220630",
     "presentation": [
      "http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayable"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ALRT_InterestAt1.25PerMonth": {
     "auth_ref": [],
     "calculation": {
      "http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails1": {
       "order": 2.0,
       "parentTag": "ALRT_PromissoryNotesRelatedParty",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "ii.\u00a0\u00a0\u00a0\u00a0\u00a0 Interest at 1.25% per month"
       }
      }
     },
     "localname": "InterestAt1.25PerMonth",
     "nsuri": "http://alrt.com/20220630",
     "presentation": [
      "http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails1"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ALRT_InterestExpenseIncurredonPromissoryNotesandOtherPayables": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cost of borrowed funds accounted for as interest that was charged against earnings during the period.",
        "label": "Interest incurred on promissory notes payable"
       }
      }
     },
     "localname": "InterestExpenseIncurredonPromissoryNotesandOtherPayables",
     "nsuri": "http://alrt.com/20220630",
     "presentation": [
      "http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails4"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ALRT_InterestExpenseOnLinesOfCredit": {
     "auth_ref": [],
     "calculation": {
      "http://alrt.com/role/StatementsOfCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest expense on lines of credit"
       }
      }
     },
     "localname": "InterestExpenseOnLinesOfCredit",
     "nsuri": "http://alrt.com/20220630",
     "presentation": [
      "http://alrt.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ALRT_InterestExpenseOnLinesOfCreditPayableToChairmanAndChiefExecutiveOfficerOfCompanyAndHisSpouse": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest expense on lines of credit payable to the Chairman and Chief Executive Officer of the Company and his spouse"
       }
      }
     },
     "localname": "InterestExpenseOnLinesOfCreditPayableToChairmanAndChiefExecutiveOfficerOfCompanyAndHisSpouse",
     "nsuri": "http://alrt.com/20220630",
     "presentation": [
      "http://alrt.com/role/RelatedPartyTransactionsAndBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ALRT_InterestExpenseOnPromissoryNotesIssuedToRelativesOfChairmanAndChiefExecutiveOfficerOfCompany": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest expenses on promissory notes issued to relatives of the Chairman and Chief Executive Officer of the Company"
       }
      }
     },
     "localname": "InterestExpenseOnPromissoryNotesIssuedToRelativesOfChairmanAndChiefExecutiveOfficerOfCompany",
     "nsuri": "http://alrt.com/20220630",
     "presentation": [
      "http://alrt.com/role/RelatedPartyTransactionsAndBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ALRT_InterestExpenseRelatedToModificationOfStockOptionsHeldByChairmanAndChiefExecutiveOfficerOfCompanyAndHisSpouseRelatedToFinancingProvided": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest expense related to the modification of stock options held by the Chairman and Chief Executive Officer of the Company and his spouse related to financing provided"
       }
      }
     },
     "localname": "InterestExpenseRelatedToModificationOfStockOptionsHeldByChairmanAndChiefExecutiveOfficerOfCompanyAndHisSpouseRelatedToFinancingProvided",
     "nsuri": "http://alrt.com/20220630",
     "presentation": [
      "http://alrt.com/role/RelatedPartyTransactionsAndBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ALRT_InterestPayableCurrentAndNoncurrents": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "InterestPayableCurrentAndNoncurrents",
        "verboseLabel": "Interest payable"
       }
      }
     },
     "localname": "InterestPayableCurrentAndNoncurrents",
     "nsuri": "http://alrt.com/20220630",
     "presentation": [
      "http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails5"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ALRT_InterestPayableRelativesOfDirectors": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of [accrued] interest payable to relatives of directors on all forms of debt, including trade payables, that has been incurred and is unpaid.",
        "label": "Related parties"
       }
      }
     },
     "localname": "InterestPayableRelativesOfDirectors",
     "nsuri": "http://alrt.com/20220630",
     "presentation": [
      "http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails5"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ALRT_InterestPayableRetiredThroughIssuanceOfShares": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest payable retired through issuance of shares"
       }
      }
     },
     "localname": "InterestPayableRetiredThroughIssuanceOfShares",
     "nsuri": "http://alrt.com/20220630",
     "presentation": [
      "http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails4"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ALRT_InterestPayabletoNonrelatedParties": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of [accrued] interest payable to non-related parties on all forms of debt, including trade payables, that has been incurred and is unpaid.",
        "label": "Unrelated parties"
       }
      }
     },
     "localname": "InterestPayabletoNonrelatedParties",
     "nsuri": "http://alrt.com/20220630",
     "presentation": [
      "http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails5"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ALRT_InterestRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest Rate"
       }
      }
     },
     "localname": "InterestRate",
     "nsuri": "http://alrt.com/20220630",
     "presentation": [
      "http://alrt.com/role/LinesOfCreditDetails1"
     ],
     "xbrltype": "stringItemType"
    },
    "ALRT_IntrinsicValue": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Intrinsic Value"
       }
      }
     },
     "localname": "IntrinsicValue",
     "nsuri": "http://alrt.com/20220630",
     "presentation": [
      "http://alrt.com/role/AdditionalPaid-inCapitalDetails1"
     ],
     "xbrltype": "perShareItemType"
    },
    "ALRT_Iv.InterestAt0.5PerMonth": {
     "auth_ref": [],
     "calculation": {
      "http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails1": {
       "order": 4.0,
       "parentTag": "ALRT_PromissoryNotesRelatedParty",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "iv.\u00a0\u00a0\u00a0\u00a0 Interest at 0.5% per month"
       }
      }
     },
     "localname": "Iv.InterestAt0.5PerMonth",
     "nsuri": "http://alrt.com/20220630",
     "presentation": [
      "http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails1"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ALRT_LineOfCreditTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lines of credit"
       }
      }
     },
     "localname": "LineOfCreditTextBlock",
     "nsuri": "http://alrt.com/20220630",
     "presentation": [
      "http://alrt.com/role/LinesOfCredit"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ALRT_LinesOfCreditFromRelatedParties": {
     "auth_ref": [],
     "calculation": {
      "http://alrt.com/role/BalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Lines of credit from related parties"
       }
      }
     },
     "localname": "LinesOfCreditFromRelatedParties",
     "nsuri": "http://alrt.com/20220630",
     "presentation": [
      "http://alrt.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ALRT_LossOnSettlementOfDebt": {
     "auth_ref": [],
     "calculation": {
      "http://alrt.com/role/StatementsOfCashFlows": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "LossOnSettlementOfDebt",
        "negatedLabel": "Loss on settlement of debt"
       }
      }
     },
     "localname": "LossOnSettlementOfDebt",
     "nsuri": "http://alrt.com/20220630",
     "presentation": [
      "http://alrt.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ALRT_LossOnSettlementOfDebtToRelativeOfChairmanAndChiefExecutiveOfficerOfCompany": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Loss on settlement of debt to a relative of the Chairman and Chief Executive Officer of the Company"
       }
      }
     },
     "localname": "LossOnSettlementOfDebtToRelativeOfChairmanAndChiefExecutiveOfficerOfCompany",
     "nsuri": "http://alrt.com/20220630",
     "presentation": [
      "http://alrt.com/role/RelatedPartyTransactionsAndBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ALRT_LossPerShareBasicAndDiluted": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Loss per share, basic and diluted"
       }
      }
     },
     "localname": "LossPerShareBasicAndDiluted",
     "nsuri": "http://alrt.com/20220630",
     "presentation": [
      "http://alrt.com/role/StatementsOfOperations"
     ],
     "xbrltype": "perShareItemType"
    },
    "ALRT_NoncashImputedInterestExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://alrt.com/role/StatementsOfCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-cash imputed interest expenses"
       }
      }
     },
     "localname": "NoncashImputedInterestExpenses",
     "nsuri": "http://alrt.com/20220630",
     "presentation": [
      "http://alrt.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ALRT_Noninterestbearing": {
     "auth_ref": [],
     "calculation": {
      "http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails3": {
       "order": 4.0,
       "parentTag": "ALRT_TotalPromissoryNotesPayableToUnrelatedParties",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "iv.\u00a0\u00a0\u00a0\u00a0 Non-interest-bearing"
       }
      }
     },
     "localname": "Noninterestbearing",
     "nsuri": "http://alrt.com/20220630",
     "presentation": [
      "http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails3"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ALRT_NotePayableInterestattheUSBankPrimeRatePlus1PercentperMonth": {
     "auth_ref": [],
     "calculation": {
      "http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails1": {
       "order": 3.0,
       "parentTag": "ALRT_PromissoryNotesRelatedParty",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Including the current and noncurrent portions, aggregate carrying amount of all types of notes payable, as of the balance sheet date, with initial maturities beyond one year or beyond the normal operating cycle, if longer",
        "label": "iii.\u00a0\u00a0\u00a0 Interest at the U.S. bank prime rate plus 1%"
       }
      }
     },
     "localname": "NotePayableInterestattheUSBankPrimeRatePlus1PercentperMonth",
     "nsuri": "http://alrt.com/20220630",
     "presentation": [
      "http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails1"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ALRT_NotePayablewithInterestat1PercentInterestperMonth": {
     "auth_ref": [],
     "calculation": {
      "http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails1": {
       "order": 1.0,
       "parentTag": "ALRT_PromissoryNotesRelatedParty",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Including the current and noncurrent portions, aggregate carrying amount of all types of notes payable, as of the balance sheet date, with initial maturities beyond one year or beyond the normal operating cycle, if longer",
        "label": "i.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Interest at 1% per month"
       }
      }
     },
     "localname": "NotePayablewithInterestat1PercentInterestperMonth",
     "nsuri": "http://alrt.com/20220630",
     "presentation": [
      "http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails1"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ALRT_OpenOptionContractsWrittenNumbersOfShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Options"
       }
      }
     },
     "localname": "OpenOptionContractsWrittenNumbersOfShare",
     "nsuri": "http://alrt.com/20220630",
     "presentation": [
      "http://alrt.com/role/AdditionalPaid-inCapitalDetails1"
     ],
     "xbrltype": "sharesItemType"
    },
    "ALRT_Options10Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Options 10 [Member]"
       }
      }
     },
     "localname": "Options10Member",
     "nsuri": "http://alrt.com/20220630",
     "presentation": [
      "http://alrt.com/role/AdditionalPaid-inCapitalDetails1"
     ],
     "xbrltype": "domainItemType"
    },
    "ALRT_Options11Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Options 11 [Member]"
       }
      }
     },
     "localname": "Options11Member",
     "nsuri": "http://alrt.com/20220630",
     "presentation": [
      "http://alrt.com/role/AdditionalPaid-inCapitalDetails1"
     ],
     "xbrltype": "domainItemType"
    },
    "ALRT_Options12Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Options 12 [Member]"
       }
      }
     },
     "localname": "Options12Member",
     "nsuri": "http://alrt.com/20220630",
     "presentation": [
      "http://alrt.com/role/AdditionalPaid-inCapitalDetails1"
     ],
     "xbrltype": "domainItemType"
    },
    "ALRT_Options13Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Options 13 [Member]"
       }
      }
     },
     "localname": "Options13Member",
     "nsuri": "http://alrt.com/20220630",
     "presentation": [
      "http://alrt.com/role/AdditionalPaid-inCapitalDetails1"
     ],
     "xbrltype": "domainItemType"
    },
    "ALRT_Options14Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Options 14 [Member]"
       }
      }
     },
     "localname": "Options14Member",
     "nsuri": "http://alrt.com/20220630",
     "presentation": [
      "http://alrt.com/role/AdditionalPaid-inCapitalDetails1"
     ],
     "xbrltype": "domainItemType"
    },
    "ALRT_Options15Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Options 15 [Member]"
       }
      }
     },
     "localname": "Options15Member",
     "nsuri": "http://alrt.com/20220630",
     "presentation": [
      "http://alrt.com/role/AdditionalPaid-inCapitalDetails1"
     ],
     "xbrltype": "domainItemType"
    },
    "ALRT_Options16Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Options 16 [Member]"
       }
      }
     },
     "localname": "Options16Member",
     "nsuri": "http://alrt.com/20220630",
     "presentation": [
      "http://alrt.com/role/AdditionalPaid-inCapitalDetails1"
     ],
     "xbrltype": "domainItemType"
    },
    "ALRT_Options17Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Options 17 [Member]"
       }
      }
     },
     "localname": "Options17Member",
     "nsuri": "http://alrt.com/20220630",
     "presentation": [
      "http://alrt.com/role/AdditionalPaid-inCapitalDetails1"
     ],
     "xbrltype": "domainItemType"
    },
    "ALRT_Options18Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Options 18 [Member]"
       }
      }
     },
     "localname": "Options18Member",
     "nsuri": "http://alrt.com/20220630",
     "presentation": [
      "http://alrt.com/role/AdditionalPaid-inCapitalDetails1"
     ],
     "xbrltype": "domainItemType"
    },
    "ALRT_Options19Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Options 19 [Member]"
       }
      }
     },
     "localname": "Options19Member",
     "nsuri": "http://alrt.com/20220630",
     "presentation": [
      "http://alrt.com/role/AdditionalPaid-inCapitalDetails1"
     ],
     "xbrltype": "domainItemType"
    },
    "ALRT_Options1Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Options 1 [Member]"
       }
      }
     },
     "localname": "Options1Member",
     "nsuri": "http://alrt.com/20220630",
     "presentation": [
      "http://alrt.com/role/AdditionalPaid-inCapitalDetails1"
     ],
     "xbrltype": "domainItemType"
    },
    "ALRT_Options20Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Options 20 [Member]"
       }
      }
     },
     "localname": "Options20Member",
     "nsuri": "http://alrt.com/20220630",
     "presentation": [
      "http://alrt.com/role/AdditionalPaid-inCapitalDetails1"
     ],
     "xbrltype": "domainItemType"
    },
    "ALRT_Options21Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Options 21 [Member]"
       }
      }
     },
     "localname": "Options21Member",
     "nsuri": "http://alrt.com/20220630",
     "presentation": [
      "http://alrt.com/role/AdditionalPaid-inCapitalDetails1"
     ],
     "xbrltype": "domainItemType"
    },
    "ALRT_Options22Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Options 22 [Member]"
       }
      }
     },
     "localname": "Options22Member",
     "nsuri": "http://alrt.com/20220630",
     "presentation": [
      "http://alrt.com/role/AdditionalPaid-inCapitalDetails1"
     ],
     "xbrltype": "domainItemType"
    },
    "ALRT_Options23Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Options 23 [Member]"
       }
      }
     },
     "localname": "Options23Member",
     "nsuri": "http://alrt.com/20220630",
     "presentation": [
      "http://alrt.com/role/AdditionalPaid-inCapitalDetails1"
     ],
     "xbrltype": "domainItemType"
    },
    "ALRT_Options2Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Options 2 [Member]"
       }
      }
     },
     "localname": "Options2Member",
     "nsuri": "http://alrt.com/20220630",
     "presentation": [
      "http://alrt.com/role/AdditionalPaid-inCapitalDetails1"
     ],
     "xbrltype": "domainItemType"
    },
    "ALRT_Options3Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Options 3 [Member]"
       }
      }
     },
     "localname": "Options3Member",
     "nsuri": "http://alrt.com/20220630",
     "presentation": [
      "http://alrt.com/role/AdditionalPaid-inCapitalDetails1"
     ],
     "xbrltype": "domainItemType"
    },
    "ALRT_Options4Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Options 4 [Member]"
       }
      }
     },
     "localname": "Options4Member",
     "nsuri": "http://alrt.com/20220630",
     "presentation": [
      "http://alrt.com/role/AdditionalPaid-inCapitalDetails1"
     ],
     "xbrltype": "domainItemType"
    },
    "ALRT_Options5Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Options 5 [Member]"
       }
      }
     },
     "localname": "Options5Member",
     "nsuri": "http://alrt.com/20220630",
     "presentation": [
      "http://alrt.com/role/AdditionalPaid-inCapitalDetails1"
     ],
     "xbrltype": "domainItemType"
    },
    "ALRT_Options6Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Options 6 [Member]"
       }
      }
     },
     "localname": "Options6Member",
     "nsuri": "http://alrt.com/20220630",
     "presentation": [
      "http://alrt.com/role/AdditionalPaid-inCapitalDetails1"
     ],
     "xbrltype": "domainItemType"
    },
    "ALRT_Options7Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Options 7 [Member]"
       }
      }
     },
     "localname": "Options7Member",
     "nsuri": "http://alrt.com/20220630",
     "presentation": [
      "http://alrt.com/role/AdditionalPaid-inCapitalDetails1"
     ],
     "xbrltype": "domainItemType"
    },
    "ALRT_Options8Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Options 8 [Member]"
       }
      }
     },
     "localname": "Options8Member",
     "nsuri": "http://alrt.com/20220630",
     "presentation": [
      "http://alrt.com/role/AdditionalPaid-inCapitalDetails1"
     ],
     "xbrltype": "domainItemType"
    },
    "ALRT_Options9Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Options 9 [Member]"
       }
      }
     },
     "localname": "Options9Member",
     "nsuri": "http://alrt.com/20220630",
     "presentation": [
      "http://alrt.com/role/AdditionalPaid-inCapitalDetails1"
     ],
     "xbrltype": "domainItemType"
    },
    "ALRT_OtherMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other [Member]"
       }
      }
     },
     "localname": "OtherMember",
     "nsuri": "http://alrt.com/20220630",
     "presentation": [
      "http://alrt.com/role/OperatingSegmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ALRT_PrincipalBorrowed": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Principal Borrowed"
       }
      }
     },
     "localname": "PrincipalBorrowed",
     "nsuri": "http://alrt.com/20220630",
     "presentation": [
      "http://alrt.com/role/BasisOfPresentationNatureOfOperationsAndGoingConcernDetailsNarrative",
      "http://alrt.com/role/LinesOfCreditDetails1"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ALRT_PromissoryNoteReceived": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Promissory note received"
       }
      }
     },
     "localname": "PromissoryNoteReceived",
     "nsuri": "http://alrt.com/20220630",
     "presentation": [
      "http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails2"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ALRT_PromissoryNotesPayableSecuredByGuaranteeFromChiefExecutiveOfficerBearingInterestAt1PerMonth": {
     "auth_ref": [],
     "calculation": {
      "http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails3": {
       "order": 6.0,
       "parentTag": "ALRT_TotalPromissoryNotesPayableToUnrelatedParties",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Promissory notes payable, secured by a guarantee from the Chief Executive Officer, bearing interest at 1% per month, past maturity"
       }
      }
     },
     "localname": "PromissoryNotesPayableSecuredByGuaranteeFromChiefExecutiveOfficerBearingInterestAt1PerMonth",
     "nsuri": "http://alrt.com/20220630",
     "presentation": [
      "http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails3"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ALRT_PromissoryNotesPayableToRelatedParties": {
     "auth_ref": [],
     "calculation": {
      "http://alrt.com/role/BalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Promissory notes payable to related parties"
       }
      }
     },
     "localname": "PromissoryNotesPayableToRelatedParties",
     "nsuri": "http://alrt.com/20220630",
     "presentation": [
      "http://alrt.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ALRT_PromissoryNotesPayableToRelativesOfDirectorsCollateralizedByAGeneralSecurityAgreementOnAllTheAssetsOfTheCompanyDueOnDemandAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Promissory notes payable to relatives of directors collateralized by a general security agreement over all the assets of the Company, past maturity:"
       }
      }
     },
     "localname": "PromissoryNotesPayableToRelativesOfDirectorsCollateralizedByAGeneralSecurityAgreementOnAllTheAssetsOfTheCompanyDueOnDemandAbstract",
     "nsuri": "http://alrt.com/20220630",
     "presentation": [
      "http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails1"
     ],
     "xbrltype": "stringItemType"
    },
    "ALRT_PromissoryNotesPayableUnrelatedLender": {
     "auth_ref": [],
     "calculation": {
      "http://alrt.com/role/BalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Promissory notes payable to unrelated parties"
       }
      }
     },
     "localname": "PromissoryNotesPayableUnrelatedLender",
     "nsuri": "http://alrt.com/20220630",
     "presentation": [
      "http://alrt.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ALRT_PromissoryNotesPayableUnsecuredtoRelativesofaDirectorBearingInterestat1PercentperMonth": {
     "auth_ref": [],
     "calculation": {
      "http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails1": {
       "order": 6.0,
       "parentTag": "ALRT_PromissoryNotesRelatedParty",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Including the current and noncurrent portions, aggregate carrying amount of all types of notes payable, as of the balance sheet date, with initial maturities beyond one year or beyond the normal operating cycle, if longer",
        "label": "Promissory notes payable, unsecured, to relatives of a director, bearing interest at 1% per month, past maturity"
       }
      }
     },
     "localname": "PromissoryNotesPayableUnsecuredtoRelativesofaDirectorBearingInterestat1PercentperMonth",
     "nsuri": "http://alrt.com/20220630",
     "presentation": [
      "http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails1"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ALRT_PromissoryNotesRelatedParty": {
     "auth_ref": [],
     "calculation": {
      "http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Including the current and noncurrent portions, aggregate carrying amount of all types of notes payable, as of the balance sheet date, with initial maturities beyond one year or beyond the normal operating cycle, if longer",
        "label": "PromissoryNotesRelatedParty",
        "totalLabel": "Total Promissory Notes Payable to Related Parties"
       }
      }
     },
     "localname": "PromissoryNotesRelatedParty",
     "nsuri": "http://alrt.com/20220630",
     "presentation": [
      "http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails1"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ALRT_Purpose1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Purpose"
       }
      }
     },
     "localname": "Purpose1",
     "nsuri": "http://alrt.com/20220630",
     "presentation": [
      "http://alrt.com/role/LinesOfCreditDetails1"
     ],
     "xbrltype": "stringItemType"
    },
    "ALRT_ReclassifiedFromPromissoryNotesPayable": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Reclassified from promissory notes payable"
       }
      }
     },
     "localname": "ReclassifiedFromPromissoryNotesPayable",
     "nsuri": "http://alrt.com/20220630",
     "presentation": [
      "http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails4"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ALRT_RelatedPartyMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party [Member]"
       }
      }
     },
     "localname": "RelatedPartyMember",
     "nsuri": "http://alrt.com/20220630",
     "presentation": [
      "http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ALRT_RelatedPartyTransactionIncludedWithinInterestExpense": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related party transactions included within interest expense:"
       }
      }
     },
     "localname": "RelatedPartyTransactionIncludedWithinInterestExpense",
     "nsuri": "http://alrt.com/20220630",
     "presentation": [
      "http://alrt.com/role/RelatedPartyTransactionsAndBalancesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ALRT_RelatedPartyTransactionsIncludingWithinSellingGeneralAndAdministrationExpenses": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related party transactions including within selling, general and administrative expenses:"
       }
      }
     },
     "localname": "RelatedPartyTransactionsIncludingWithinSellingGeneralAndAdministrationExpenses",
     "nsuri": "http://alrt.com/20220630",
     "presentation": [
      "http://alrt.com/role/RelatedPartyTransactionsAndBalancesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ALRT_RentPaidToCompanyControlledBySpouseOfChairmanAndImmediateFamilyMembers": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Rent paid to a company controlled by the spouse of the Chairman and immediate family members"
       }
      }
     },
     "localname": "RentPaidToCompanyControlledBySpouseOfChairmanAndImmediateFamilyMembers",
     "nsuri": "http://alrt.com/20220630",
     "presentation": [
      "http://alrt.com/role/RelatedPartyTransactionsAndBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ALRT_RepaymentOfInterestOnLinesOfCredit": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Repayment of interest on lines of credit"
       }
      }
     },
     "localname": "RepaymentOfInterestOnLinesOfCredit",
     "nsuri": "http://alrt.com/20220630",
     "presentation": [
      "http://alrt.com/role/LinesOfCreditDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ALRT_RepaymentOfLinesOfCreditInterest": {
     "auth_ref": [],
     "calculation": {
      "http://alrt.com/role/StatementsOfCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "RepaymentOfLinesOfCreditInterest",
        "negatedLabel": "Repayment of lines of credit interest"
       }
      }
     },
     "localname": "RepaymentOfLinesOfCreditInterest",
     "nsuri": "http://alrt.com/20220630",
     "presentation": [
      "http://alrt.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ALRT_RepaymentTerms1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Repayment Terms"
       }
      }
     },
     "localname": "RepaymentTerms1",
     "nsuri": "http://alrt.com/20220630",
     "presentation": [
      "http://alrt.com/role/LinesOfCreditDetails1"
     ],
     "xbrltype": "stringItemType"
    },
    "ALRT_SalaryForServicesAsVpCorporateAndDirectorOfSingaporeSubsidiaryToSpouseOfChairmanAndChiefExecutiveOfficerOfCompany": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Salary for services as VP Corporate and director of the Singapore subsidiary to the spouse of the Chairman and Chief Executive Officer of the Company"
       }
      }
     },
     "localname": "SalaryForServicesAsVpCorporateAndDirectorOfSingaporeSubsidiaryToSpouseOfChairmanAndChiefExecutiveOfficerOfCompany",
     "nsuri": "http://alrt.com/20220630",
     "presentation": [
      "http://alrt.com/role/RelatedPartyTransactionsAndBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ALRT_ScheduledOfInterestPayableDueToRelatedTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Interest payable due to related and non-related parties"
       }
      }
     },
     "localname": "ScheduledOfInterestPayableDueToRelatedTableTextBlock",
     "nsuri": "http://alrt.com/20220630",
     "presentation": [
      "http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ALRT_ScheduledOfLineOfCreditTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of lines of credit"
       }
      }
     },
     "localname": "ScheduledOfLineOfCreditTableTextBlock",
     "nsuri": "http://alrt.com/20220630",
     "presentation": [
      "http://alrt.com/role/LinesOfCreditTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ALRT_ScheduleofActivityofPromissoryNotestoUnrelatedPatiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of activity of promissory notes payable to unrelated parties"
       }
      }
     },
     "localname": "ScheduleofActivityofPromissoryNotestoUnrelatedPatiesTableTextBlock",
     "nsuri": "http://alrt.com/20220630",
     "presentation": [
      "http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ALRT_ScheduleofOptionsOutstandingTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Options Outstanding"
       }
      }
     },
     "localname": "ScheduleofOptionsOutstandingTableTextBlock",
     "nsuri": "http://alrt.com/20220630",
     "presentation": [
      "http://alrt.com/role/AdditionalPaid-inCapitalTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ALRT_ScheduleofPromissoryNotesPayableRelativesofBoardofDirectorsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of activity of promissory notes payable to related parties"
       }
      }
     },
     "localname": "ScheduleofPromissoryNotesPayableRelativesofBoardofDirectorsTableTextBlock",
     "nsuri": "http://alrt.com/20220630",
     "presentation": [
      "http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ALRT_ScheduleofPromissoryNotesPayableToUnrelatedPartiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Promissory Notes Payable to Unrelated Parties"
       }
      }
     },
     "localname": "ScheduleofPromissoryNotesPayableToUnrelatedPartiesTableTextBlock",
     "nsuri": "http://alrt.com/20220630",
     "presentation": [
      "http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ALRT_Security1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security"
       }
      }
     },
     "localname": "Security1",
     "nsuri": "http://alrt.com/20220630",
     "presentation": [
      "http://alrt.com/role/LinesOfCreditDetails1"
     ],
     "xbrltype": "stringItemType"
    },
    "ALRT_ShareBasedCompensationArrangementbyShareBasedPaymentAwardOptionsCancelations": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares under options that were cancelled during the reporting period.",
        "label": "ShareBasedCompensationArrangementbyShareBasedPaymentAwardOptionsCancelations",
        "negatedLabel": "Cancelled"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementbyShareBasedPaymentAwardOptionsCancelations",
     "nsuri": "http://alrt.com/20220630",
     "presentation": [
      "http://alrt.com/role/AdditionalPaid-inCapitalDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "ALRT_StockbasedCompensationProfessionalFees": {
     "auth_ref": [],
     "calculation": {
      "http://alrt.com/role/StatementsOfCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock-based compensation-professional fees"
       }
      }
     },
     "localname": "StockbasedCompensationProfessionalFees",
     "nsuri": "http://alrt.com/20220630",
     "presentation": [
      "http://alrt.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ALRT_StockbasedCompensationgeneralSellingAndAdministration": {
     "auth_ref": [],
     "calculation": {
      "http://alrt.com/role/StatementsOfCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock-based compensation-selling, general and administrative"
       }
      }
     },
     "localname": "StockbasedCompensationgeneralSellingAndAdministration",
     "nsuri": "http://alrt.com/20220630",
     "presentation": [
      "http://alrt.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ALRT_StockbasedCompensationinterest": {
     "auth_ref": [],
     "calculation": {
      "http://alrt.com/role/StatementsOfCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock-based compensation-interest"
       }
      }
     },
     "localname": "StockbasedCompensationinterest",
     "nsuri": "http://alrt.com/20220630",
     "presentation": [
      "http://alrt.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ALRT_StockbasedCompensationproductDevelopmentCosts": {
     "auth_ref": [],
     "calculation": {
      "http://alrt.com/role/StatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "StockbasedCompensationproductDevelopmentCosts",
        "negatedLabel": "Stock-based compensation-product development costs"
       }
      }
     },
     "localname": "StockbasedCompensationproductDevelopmentCosts",
     "nsuri": "http://alrt.com/20220630",
     "presentation": [
      "http://alrt.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ALRT_SummaryOfActivitiesOfPromissoryNotesPayableTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Summary of activities of promissory notes payable"
       }
      }
     },
     "localname": "SummaryOfActivitiesOfPromissoryNotesPayableTableTextBlock",
     "nsuri": "http://alrt.com/20220630",
     "presentation": [
      "http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ALRT_Total": {
     "auth_ref": [],
     "calculation": {
      "http://alrt.com/role/AdditionalPaid-inCapitalDetails2": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Total",
        "totalLabel": "Fair value of the stock options granted"
       }
      }
     },
     "localname": "Total",
     "nsuri": "http://alrt.com/20220630",
     "presentation": [
      "http://alrt.com/role/AdditionalPaid-inCapitalDetails2"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ALRT_TotalOutstanding": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Outstanding"
       }
      }
     },
     "localname": "TotalOutstanding",
     "nsuri": "http://alrt.com/20220630",
     "presentation": [
      "http://alrt.com/role/LinesOfCreditDetails1"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ALRT_TotalPromissoryNotesPayableToUnrelatedParties": {
     "auth_ref": [],
     "calculation": {
      "http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails3": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "TotalPromissoryNotesPayableToUnrelatedParties",
        "totalLabel": "Total Promissory Notes Payable to Unrelated Parties"
       }
      }
     },
     "localname": "TotalPromissoryNotesPayableToUnrelatedParties",
     "nsuri": "http://alrt.com/20220630",
     "presentation": [
      "http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails3"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ALRT_TransferredFromPromissoryNotesPayablePursuantToPrivateTransaction.": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Transferred from promissory notes payable pursuant to private transaction"
       }
      }
     },
     "localname": "TransferredFromPromissoryNotesPayablePursuantToPrivateTransaction.",
     "nsuri": "http://alrt.com/20220630",
     "presentation": [
      "http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails",
      "http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails2"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ALRT_UnRelatedPartyMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Un Related Party [Member]"
       }
      }
     },
     "localname": "UnRelatedPartyMember",
     "nsuri": "http://alrt.com/20220630",
     "presentation": [
      "http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails2"
     ],
     "xbrltype": "domainItemType"
    },
    "ALRT_UnsecuredPromissoryNotesPayableToRelativesOfChairmanWithFixedAmountsOfInterestDueAugust312022": {
     "auth_ref": [],
     "calculation": {
      "http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails1": {
       "order": 5.0,
       "parentTag": "ALRT_PromissoryNotesRelatedParty",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Unsecured promissory notes payable to relatives of the Chairman with fixed amounts of interest due August 31, 2022"
       }
      }
     },
     "localname": "UnsecuredPromissoryNotesPayableToRelativesOfChairmanWithFixedAmountsOfInterestDueAugust312022",
     "nsuri": "http://alrt.com/20220630",
     "presentation": [
      "http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails1"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ALRT_UnsecuredPromissoryNotesPayableToUnrelatedLendersAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Unsecured promissory notes payable to unrelated lenders, past maturity:"
       }
      }
     },
     "localname": "UnsecuredPromissoryNotesPayableToUnrelatedLendersAbstract",
     "nsuri": "http://alrt.com/20220630",
     "presentation": [
      "http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails3"
     ],
     "xbrltype": "stringItemType"
    },
    "ALRT_UnsecuredPromissoryNotesPayableToUnrelatedLendersWithFixedAmountsOfInterestDue": {
     "auth_ref": [],
     "calculation": {
      "http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails3": {
       "order": 5.0,
       "parentTag": "ALRT_TotalPromissoryNotesPayableToUnrelatedParties",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Unsecured promissory notes payable to unrelated lenders with fixed amounts of interest due August 31, 2022"
       }
      }
     },
     "localname": "UnsecuredPromissoryNotesPayableToUnrelatedLendersWithFixedAmountsOfInterestDue",
     "nsuri": "http://alrt.com/20220630",
     "presentation": [
      "http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails3"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ALRT_Vi.InterestAt0.667PerMonthWith125000DueJanuary152011": {
     "auth_ref": [],
     "calculation": {
      "http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails3": {
       "order": 3.0,
       "parentTag": "ALRT_TotalPromissoryNotesPayableToUnrelatedParties",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "iii.\u00a0\u00a0\u00a0 Interest at 0.625% per month"
       }
      }
     },
     "localname": "Vi.InterestAt0.667PerMonthWith125000DueJanuary152011",
     "nsuri": "http://alrt.com/20220630",
     "presentation": [
      "http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails3"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ALRT_WeightedAverageNumberOfSharesOfCommonStockOutstandingBasicAndDiluted": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted average number of shares of common stock outstanding, basic and diluted"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOfCommonStockOutstandingBasicAndDiluted",
     "nsuri": "http://alrt.com/20220630",
     "presentation": [
      "http://alrt.com/role/StatementsOfOperations"
     ],
     "xbrltype": "sharesItemType"
    },
    "ALRT_WifeOfChairmanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Wife Of Chairman [Member]"
       }
      }
     },
     "localname": "WifeOfChairmanMember",
     "nsuri": "http://alrt.com/20220630",
     "presentation": [
      "http://alrt.com/role/LinesOfCreditDetails1"
     ],
     "xbrltype": "domainItemType"
    },
    "ALRT_WorkingCapitalDeficit": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Working capital deficit"
       }
      }
     },
     "localname": "WorkingCapitalDeficit",
     "nsuri": "http://alrt.com/20220630",
     "presentation": [
      "http://alrt.com/role/BasisOfPresentationNatureOfOperationsAndGoingConcernDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "country_SG": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "SINGAPORE"
       }
      }
     },
     "localname": "SG",
     "nsuri": "http://xbrl.sec.gov/country/2022",
     "presentation": [
      "http://alrt.com/role/OperatingSegmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "country_US": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "UNITED STATES"
       }
      }
     },
     "localname": "US",
     "nsuri": "http://xbrl.sec.gov/country/2022",
     "presentation": [
      "http://alrt.com/role/OperatingSegmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of changes contained within amended document.",
        "label": "Amendment Description"
       }
      }
     },
     "localname": "AmendmentDescription",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://alrt.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://alrt.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AnnualInformationForm": {
     "auth_ref": [
      "r278"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.",
        "label": "Annual Information Form"
       }
      }
     },
     "localname": "AnnualInformationForm",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://alrt.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditedAnnualFinancialStatements": {
     "auth_ref": [
      "r278"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.",
        "label": "Audited Annual Financial Statements"
       }
      }
     },
     "localname": "AuditedAnnualFinancialStatements",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://alrt.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://alrt.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CountryRegion": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Region code of country",
        "label": "Country Region"
       }
      }
     },
     "localname": "CountryRegion",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://alrt.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://alrt.com/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAccountingStandard": {
     "auth_ref": [
      "r277"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.",
        "label": "Document Accounting Standard"
       }
      }
     },
     "localname": "DocumentAccountingStandard",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://alrt.com/role/Cover"
     ],
     "xbrltype": "accountingStandardItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r275",
      "r277",
      "r278"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://alrt.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://alrt.com/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://alrt.com/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://alrt.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentPeriodStartDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.",
        "label": "Document Period Start Date"
       }
      }
     },
     "localname": "DocumentPeriodStartDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://alrt.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r276"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://alrt.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentRegistrationStatement": {
     "auth_ref": [
      "r264"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a registration statement.",
        "label": "Document Registration Statement"
       }
      }
     },
     "localname": "DocumentRegistrationStatement",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://alrt.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentShellCompanyEventDate": {
     "auth_ref": [
      "r277"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date of event requiring a shell company report.",
        "label": "Document Shell Company Event Date"
       }
      }
     },
     "localname": "DocumentShellCompanyEventDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://alrt.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentShellCompanyReport": {
     "auth_ref": [
      "r277"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.",
        "label": "Document Shell Company Report"
       }
      }
     },
     "localname": "DocumentShellCompanyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://alrt.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r279"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://alrt.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://alrt.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r267"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated by Reference [Text Block]"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://alrt.com/role/Cover"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://alrt.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://alrt.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine3": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 3 such as an Office Park",
        "label": "Entity Address, Address Line Three"
       }
      }
     },
     "localname": "EntityAddressAddressLine3",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://alrt.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://alrt.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://alrt.com/role/Cover"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://alrt.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://alrt.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "auth_ref": [
      "r270"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not.  Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.",
        "label": "Entity Bankruptcy Proceedings, Reporting Current"
       }
      }
     },
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://alrt.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r266"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://alrt.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://alrt.com/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://alrt.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r266"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://alrt.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r283"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Elected Not To Use the Extended Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://alrt.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://alrt.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r266"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://alrt.com/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://alrt.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r280"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://alrt.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPrimarySicNumber": {
     "auth_ref": [
      "r278"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.",
        "label": "Entity Primary SIC Number"
       }
      }
     },
     "localname": "EntityPrimarySicNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://alrt.com/role/Cover"
     ],
     "xbrltype": "sicNumberItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://alrt.com/role/Cover"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r266"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://alrt.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r266"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://alrt.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r266"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://alrt.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r266"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://alrt.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://alrt.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [
      "r281"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://alrt.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_Extension": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Extension number for local phone number.",
        "label": "Extension"
       }
      }
     },
     "localname": "Extension",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://alrt.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://alrt.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_NoTradingSymbolFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a security having no trading symbol.",
        "label": "No Trading Symbol Flag"
       }
      }
     },
     "localname": "NoTradingSymbolFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://alrt.com/role/Cover"
     ],
     "xbrltype": "trueItemType"
    },
    "dei_OtherReportingStandardItemNumber": {
     "auth_ref": [
      "r277"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.",
        "label": "Other Reporting Standard Item Number"
       }
      }
     },
     "localname": "OtherReportingStandardItemNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://alrt.com/role/Cover"
     ],
     "xbrltype": "otherReportingStandardItemNumberItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r271"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://alrt.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r272"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://alrt.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r265"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://alrt.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_Security12gTitle": {
     "auth_ref": [
      "r269"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(g) registered security.",
        "label": "Title of 12(g) Security"
       }
      }
     },
     "localname": "Security12gTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://alrt.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r268"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://alrt.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SecurityReportingObligation": {
     "auth_ref": [
      "r273"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.",
        "label": "Security Reporting Obligation"
       }
      }
     },
     "localname": "SecurityReportingObligation",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://alrt.com/role/Cover"
     ],
     "xbrltype": "securityReportingObligationItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r274"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://alrt.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://alrt.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r282"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://alrt.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "srt_SegmentGeographicalDomain": {
     "auth_ref": [
      "r104",
      "r105",
      "r171",
      "r172",
      "r244",
      "r254",
      "r255",
      "r256",
      "r257",
      "r258",
      "r259",
      "r260",
      "r261",
      "r262"
     ],
     "localname": "SegmentGeographicalDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://alrt.com/role/OperatingSegmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_StatementGeographicalAxis": {
     "auth_ref": [
      "r104",
      "r105",
      "r171",
      "r172",
      "r244",
      "r252",
      "r254",
      "r255",
      "r256",
      "r257",
      "r258",
      "r259",
      "r260",
      "r261",
      "r262"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Axis]"
       }
      }
     },
     "localname": "StatementGeographicalAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://alrt.com/role/OperatingSegmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r22"
     ],
     "calculation": {
      "http://alrt.com/role/AccountsPayableAndAccruedLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://alrt.com/role/BalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.",
        "label": "Accounts payable and accrued liabilities",
        "totalLabel": "Accounts payable and accrued liabilities"
       }
      }
     },
     "localname": "AccountsPayableAndAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/AccountsPayableAndAccruedLiabilitiesDetails",
      "http://alrt.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock": {
     "auth_ref": [
      "r19"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.",
        "label": "Accounts Payable and Accrued Liabilities Disclosure [Text Block]",
        "verboseLabel": "Accounts payable and accrued liabilities"
       }
      }
     },
     "localname": "AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/AccountsPayableAndAccruedLiabilities"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r18",
      "r219"
     ],
     "calculation": {
      "http://alrt.com/role/AccountsPayableAndAccruedLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts payable"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/AccountsPayableAndAccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r24"
     ],
     "calculation": {
      "http://alrt.com/role/AccountsPayableAndAccruedLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued liabilities"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/AccountsPayableAndAccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r12",
      "r29",
      "r30",
      "r31",
      "r237",
      "r246",
      "r247"
     ],
     "calculation": {
      "http://alrt.com/role/BalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated other comprehensive loss\u00a0\u2013 cumulative translation differences"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapital": {
     "auth_ref": [
      "r10",
      "r219"
     ],
     "calculation": {
      "http://alrt.com/role/BalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.",
        "label": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapital",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r4",
      "r64",
      "r87",
      "r92",
      "r99",
      "r110",
      "r120",
      "r121",
      "r122",
      "r123",
      "r124",
      "r125",
      "r126",
      "r127",
      "r128",
      "r129",
      "r130",
      "r191",
      "r195",
      "r205",
      "r217",
      "r219",
      "r224",
      "r235"
     ],
     "calculation": {
      "http://alrt.com/role/BalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Current and Total Assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/BalanceSheets",
      "http://alrt.com/role/OperatingSegmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/BalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current assets:"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/BalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock": {
     "auth_ref": [
      "r1",
      "r67",
      "r80"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the business description and basis of presentation concepts. Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Basis of presentation, nature of operations and going concern"
       }
      }
     },
     "localname": "BusinessDescriptionAndBasisOfPresentationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/BasisOfPresentationNatureOfOperationsAndGoingConcern"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Cash": {
     "auth_ref": [
      "r3",
      "r219",
      "r248",
      "r249"
     ],
     "calculation": {
      "http://alrt.com/role/BalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash"
       }
      }
     },
     "localname": "Cash",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r54",
      "r59",
      "r60"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents",
        "periodStartLabel": "Cash, beginning of period"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": {
     "auth_ref": [
      "r54",
      "r59",
      "r60"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations",
        "periodEndLabel": "Cash, end of period"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r54",
      "r206"
     ],
     "calculation": {
      "http://alrt.com/role/StatementsOfCashFlows": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Change in cash"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r114",
      "r115",
      "r116",
      "r117",
      "r253"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/CommitmentsAndContingencies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r9"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common shares, par value"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/BalanceSheetsParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r9"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common shares, authorized"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/BalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r9"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common shares, Issued"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/BalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r9",
      "r168"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common shares, outstanding"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/BalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r9",
      "r219"
     ],
     "calculation": {
      "http://alrt.com/role/BalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r36",
      "r38",
      "r39",
      "r45",
      "r231",
      "r242"
     ],
     "calculation": {
      "http://alrt.com/role/StatementsOfOperations": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "Comprehensive loss for the period"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/StatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfRevenue": {
     "auth_ref": [
      "r47",
      "r64",
      "r110",
      "r120",
      "r121",
      "r122",
      "r124",
      "r125",
      "r126",
      "r127",
      "r128",
      "r129",
      "r130",
      "r205"
     ],
     "calculation": {
      "http://alrt.com/role/StatementsOfOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate cost of goods produced and sold and services rendered during the reporting period.",
        "label": "Cost of Revenue",
        "negatedLabel": "Cost of revenue"
       }
      }
     },
     "localname": "CostOfRevenue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/StatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r5",
      "r6",
      "r7",
      "r63",
      "r66",
      "r131",
      "r132",
      "r133",
      "r134",
      "r135",
      "r136",
      "r137",
      "r138",
      "r139",
      "r140",
      "r141",
      "r142",
      "r143",
      "r144",
      "r145",
      "r146",
      "r147",
      "r149",
      "r150",
      "r151",
      "r152",
      "r210",
      "r225",
      "r226",
      "r234"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails",
      "http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails2"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r25",
      "r63",
      "r66",
      "r131",
      "r132",
      "r133",
      "r134",
      "r135",
      "r136",
      "r137",
      "r138",
      "r139",
      "r140",
      "r141",
      "r142",
      "r143",
      "r144",
      "r145",
      "r146",
      "r147",
      "r149",
      "r150",
      "r151",
      "r152",
      "r210"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities."
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails",
      "http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails2"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DeferredRevenueCurrent": {
     "auth_ref": [
      "r6"
     ],
     "calculation": {
      "http://alrt.com/role/AccountsPayableAndAccruedLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current.",
        "label": "Deferred revenue"
       }
      }
     },
     "localname": "DeferredRevenueCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/AccountsPayableAndAccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeContractTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset."
       }
      }
     },
     "localname": "DerivativeContractTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/AdditionalPaid-inCapitalDetails1"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DerivativeInstrumentRiskAxis": {
     "auth_ref": [
      "r28",
      "r199",
      "r200",
      "r201",
      "r202"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of derivative contract.",
        "label": "Derivative Instrument [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentRiskAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/AdditionalPaid-inCapitalDetails1"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r206"
     ],
     "calculation": {
      "http://alrt.com/role/StatementsOfCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Effect of foreign exchange on cash"
       }
      }
     },
     "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Abstract]"
       }
      }
     },
     "localname": "EquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_GainsLossesOnExtinguishmentOfDebt": {
     "auth_ref": [
      "r57",
      "r153",
      "r154"
     ],
     "calculation": {
      "http://alrt.com/role/StatementsOfOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.",
        "label": "Loss on settlement of debt"
       }
      }
     },
     "localname": "GainsLossesOnExtinguishmentOfDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/StatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GrossProfit": {
     "auth_ref": [
      "r46",
      "r64",
      "r87",
      "r91",
      "r95",
      "r98",
      "r101",
      "r110",
      "r120",
      "r121",
      "r122",
      "r124",
      "r125",
      "r126",
      "r127",
      "r128",
      "r129",
      "r130",
      "r205"
     ],
     "calculation": {
      "http://alrt.com/role/StatementsOfOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.",
        "label": "Gross Profit",
        "totalLabel": "Gross margin"
       }
      }
     },
     "localname": "GrossProfit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/StatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "auth_ref": [
      "r43",
      "r87",
      "r91",
      "r95",
      "r98",
      "r101",
      "r223",
      "r229",
      "r233",
      "r243"
     ],
     "calculation": {
      "http://alrt.com/role/StatementsOfOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "totalLabel": "Loss before other items"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/StatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": {
     "auth_ref": [
      "r56"
     ],
     "calculation": {
      "http://alrt.com/role/StatementsOfCashFlows": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.",
        "label": "Increase in accounts payable and accrued liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInInterestPayableNet": {
     "auth_ref": [
      "r56"
     ],
     "calculation": {
      "http://alrt.com/role/StatementsOfCashFlows": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in interest payable, which represents the amount owed to note holders, bond holders, and other parties for interest earned on loans or credit extended to the reporting entity.",
        "label": "Increase in interest payable",
        "verboseLabel": "Reclassified to interest payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInInterestPayableNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails2",
      "http://alrt.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Changes in operating assets and liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInPrepaidExpense": {
     "auth_ref": [
      "r56"
     ],
     "calculation": {
      "http://alrt.com/role/StatementsOfCashFlows": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods.",
        "label": "Increase (Decrease) in Prepaid Expense",
        "negatedLabel": "Decrease (increase) in prepaid expenses"
       }
      }
     },
     "localname": "IncreaseDecreaseInPrepaidExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestAndOtherIncomeTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of interest income and income classified as other.",
        "label": "Schedule of interest payable activity"
       }
      }
     },
     "localname": "InterestAndOtherIncomeTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InterestExpense": {
     "auth_ref": [
      "r41",
      "r86",
      "r208",
      "r209",
      "r232"
     ],
     "calculation": {
      "http://alrt.com/role/StatementsOfOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.",
        "label": "Interest expense",
        "negatedLabel": "Interest expense"
       }
      }
     },
     "localname": "InterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetailsNarrative",
      "http://alrt.com/role/StatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpenseDebt": {
     "auth_ref": [
      "r50",
      "r145",
      "r148",
      "r151",
      "r152"
     ],
     "calculation": {
      "http://alrt.com/role/AdditionalPaid-inCapitalDetails2": {
       "order": 1.0,
       "parentTag": "ALRT_Total",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense for debt.",
        "label": "Interest Expense, Debt",
        "verboseLabel": "Interest expense"
       }
      }
     },
     "localname": "InterestExpenseDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/AdditionalPaid-inCapitalDetails2"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpenseRelatedParty": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of interest expense incurred on a debt or other obligation to related party.",
        "label": "Interest on other"
       }
      }
     },
     "localname": "InterestExpenseRelatedParty",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPayableCurrent": {
     "auth_ref": [
      "r24"
     ],
     "calculation": {
      "http://alrt.com/role/BalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of [accrued] interest payable on all forms of debt, including trade payables, that has been incurred and is unpaid. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Interest payable"
       }
      }
     },
     "localname": "InterestPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPayableCurrentAndNoncurrent": {
     "auth_ref": [
      "r228",
      "r240"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of interest payable on debt, including, but not limited to, trade payables.",
        "label": "Interest Payable",
        "periodEndLabel": "Ending Balance",
        "periodStartLabel": "Beginning Balance"
       }
      }
     },
     "localname": "InterestPayableCurrentAndNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails4"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r23",
      "r64",
      "r93",
      "r110",
      "r120",
      "r121",
      "r122",
      "r124",
      "r125",
      "r126",
      "r127",
      "r128",
      "r129",
      "r130",
      "r192",
      "r195",
      "r196",
      "r205",
      "r217",
      "r218"
     ],
     "calculation": {
      "http://alrt.com/role/BalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r15",
      "r64",
      "r110",
      "r205",
      "r219",
      "r227",
      "r239"
     ],
     "calculation": {
      "http://alrt.com/role/BalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities and stockholders\u2019 deficit"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Stockholders\u2019 Deficit"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/BalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current liabilities:"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/BalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCreditFacilityAxis": {
     "auth_ref": [
      "r20",
      "r63"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name of lender, which may be a single entity (for example, but not limited to, a bank, pension fund, venture capital firm) or a group of entities that participate in the line of credit.",
        "label": "Lender Name [Axis]"
       }
      }
     },
     "localname": "LineOfCreditFacilityAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/LinesOfCreditDetails1"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCreditFacilityLenderDomain": {
     "auth_ref": [
      "r20",
      "r63"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the lender, which may be a single entity (for example, a bank, pension fund, venture capital firm) or a group of entities that participate in the line of credit, including a letter of credit facility."
       }
      }
     },
     "localname": "LineOfCreditFacilityLenderDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/LinesOfCreditDetails1"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LineOfCreditFacilityLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Line of Credit Facility [Line Items]"
       }
      }
     },
     "localname": "LineOfCreditFacilityLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/LinesOfCreditDetails1"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCreditFacilityPeriodicPaymentInterest": {
     "auth_ref": [
      "r20"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the required periodic payment applied to interest.",
        "label": "Interest incurred on lines of credit"
       }
      }
     },
     "localname": "LineOfCreditFacilityPeriodicPaymentInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/LinesOfCreditDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityPeriodicPaymentPrincipal": {
     "auth_ref": [
      "r20"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the required periodic payment applied to principal.",
        "label": "Advances received on lines of credit"
       }
      }
     },
     "localname": "LineOfCreditFacilityPeriodicPaymentPrincipal",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/LinesOfCreditDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityTable": {
     "auth_ref": [
      "r20",
      "r63"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to short-term or long-term contractual arrangements with lenders, including letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line.",
        "label": "Line of Credit Facility [Table]"
       }
      }
     },
     "localname": "LineOfCreditFacilityTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/LinesOfCreditDetails1"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongTermLineOfCredit": {
     "auth_ref": [
      "r25",
      "r118",
      "r119"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The carrying value as of the balance sheet date of the noncurrent portion of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.",
        "label": "Long-Term Line of Credit, Noncurrent",
        "periodEndLabel": "Balance at ending",
        "periodStartLabel": "Balance at beginning"
       }
      }
     },
     "localname": "LongTermLineOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/LinesOfCreditDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r54"
     ],
     "calculation": {
      "http://alrt.com/role/StatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash provided by financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "FINANCING ACTIVITIES"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r54",
      "r55",
      "r58"
     ],
     "calculation": {
      "http://alrt.com/role/StatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash used in operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "OPERATING ACTIVITIES"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r0",
      "r35",
      "r37",
      "r40",
      "r44",
      "r58",
      "r64",
      "r68",
      "r69",
      "r70",
      "r71",
      "r72",
      "r73",
      "r74",
      "r77",
      "r87",
      "r91",
      "r95",
      "r98",
      "r101",
      "r110",
      "r120",
      "r121",
      "r122",
      "r124",
      "r125",
      "r126",
      "r127",
      "r128",
      "r129",
      "r130",
      "r204",
      "r205",
      "r230",
      "r241"
     ],
     "calculation": {
      "http://alrt.com/role/StatementsOfOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Loss",
        "totalLabel": "Net Loss"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/OperatingSegmentsDetails",
      "http://alrt.com/role/StatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": {
     "auth_ref": [
      "r69",
      "r70",
      "r71",
      "r72",
      "r75",
      "r76",
      "r78",
      "r79",
      "r87",
      "r91",
      "r95",
      "r98",
      "r101"
     ],
     "calculation": {
      "http://alrt.com/role/StatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.",
        "label": "Net Income (Loss) Available to Common Stockholders, Basic",
        "negatedLabel": "Net loss"
       }
      }
     },
     "localname": "NetIncomeLossAvailableToCommonStockholdersBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NonoperatingIncomeExpense": {
     "auth_ref": [
      "r49"
     ],
     "calculation": {
      "http://alrt.com/role/StatementsOfOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).",
        "label": "Nonoperating Income (Expense)",
        "totalLabel": "Total Other Items"
       }
      }
     },
     "localname": "NonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/StatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NonoperatingIncomeExpenseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Items"
       }
      }
     },
     "localname": "NonoperatingIncomeExpenseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/StatementsOfOperations"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NotesPayable": {
     "auth_ref": [
      "r7",
      "r226",
      "r236"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Including the current and noncurrent portions, aggregate carrying amount of all types of notes payable, as of the balance sheet date, with initial maturities beyond one year or beyond the normal operating cycle, if longer.",
        "label": "Notes Payable",
        "periodEndLabel": "Balance at ending",
        "periodStartLabel": "Balance at beginning"
       }
      }
     },
     "localname": "NotesPayable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails2"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NotesPayableRelatedPartiesClassifiedCurrent": {
     "auth_ref": [
      "r17",
      "r65",
      "r214"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount for notes payable (written promise to pay), due to related parties. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Notes Payable, Related Parties, Current",
        "periodEndLabel": "Carrying value at ending",
        "periodStartLabel": "Carrying value at beginning"
       }
      }
     },
     "localname": "NotesPayableRelatedPartiesClassifiedCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OffsettingAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Offsetting Assets [Line Items]"
       }
      }
     },
     "localname": "OffsettingAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/AdditionalPaid-inCapitalDetails1"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OffsettingAssetsTable": {
     "auth_ref": [
      "r26",
      "r27"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about derivative and financial assets that are subject to offsetting, including enforceable master netting arrangements.",
        "label": "Offsetting Assets [Table]"
       }
      }
     },
     "localname": "OffsettingAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/AdditionalPaid-inCapitalDetails1"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Expenses"
       }
      }
     },
     "localname": "OperatingExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/StatementsOfOperations"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r87",
      "r91",
      "r95",
      "r98",
      "r101"
     ],
     "calculation": {
      "http://alrt.com/role/StatementsOfOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "negatedTotalLabel": "Operating Loss"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/StatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax": {
     "auth_ref": [
      "r29",
      "r32",
      "r33",
      "r34",
      "r207"
     ],
     "calculation": {
      "http://alrt.com/role/StatementsOfOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of reclassification adjustment from accumulated other comprehensive income for translation gain (loss) realized upon the sale or liquidation of an investment in a foreign entity and foreign currency hedges that are designated and qualified as hedging instruments for hedges of the foreign currency exposure of a net investment in a foreign operation.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Reclassification Adjustment from AOCI, Realized upon Sale or Liquidation, Net of Tax",
        "negatedLabel": "Exchange difference on translating foreign operations"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/StatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxAttributableToParentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other comprehensive loss"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxAttributableToParentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/StatementsOfOperations"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherSellingGeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r48"
     ],
     "calculation": {
      "http://alrt.com/role/AdditionalPaid-inCapitalDetails2": {
       "order": 4.0,
       "parentTag": "ALRT_Total",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of selling, general and administrative expense classified as other.",
        "label": "Other Selling, General and Administrative Expense",
        "verboseLabel": "Selling, general and administrative expenses"
       }
      }
     },
     "localname": "OtherSellingGeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/AdditionalPaid-inCapitalDetails2"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PayablesAndAccrualsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Payables and Accruals [Abstract]"
       }
      }
     },
     "localname": "PayablesAndAccrualsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r8",
      "r155"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred shares, par value"
       }
      }
     },
     "localname": "PreferredStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/BalanceSheetsParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r8"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred shares, authorized"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/BalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesIssued": {
     "auth_ref": [
      "r8",
      "r155"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.",
        "label": "Preferred shares, issued"
       }
      }
     },
     "localname": "PreferredStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/BalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "auth_ref": [
      "r8"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.",
        "label": "Preferred shares, outstanding"
       }
      }
     },
     "localname": "PreferredStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/BalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockValue": {
     "auth_ref": [
      "r8",
      "r219"
     ],
     "calculation": {
      "http://alrt.com/role/BalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Preferred Stock, Value"
       }
      }
     },
     "localname": "PreferredStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseCurrent": {
     "auth_ref": [
      "r2",
      "r16",
      "r111",
      "r112"
     ],
     "calculation": {
      "http://alrt.com/role/BalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.",
        "label": "Prepaid expenses"
       }
      }
     },
     "localname": "PrepaidExpenseCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromConvertibleDebt": {
     "auth_ref": [
      "r52"
     ],
     "calculation": {
      "http://alrt.com/role/StatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.",
        "label": "Proceeds from promissory notes"
       }
      }
     },
     "localname": "ProceedsFromConvertibleDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfCommonStock": {
     "auth_ref": [
      "r51"
     ],
     "calculation": {
      "http://alrt.com/role/StatementsOfCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from the additional capital contribution to the entity.",
        "label": "Proceeds from sales of shares of common stock"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromLinesOfCredit": {
     "auth_ref": [
      "r52",
      "r63"
     ],
     "calculation": {
      "http://alrt.com/role/StatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from contractual arrangement with the lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.",
        "label": "Proceeds from lines of credit"
       }
      }
     },
     "localname": "ProceedsFromLinesOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProfessionalAndContractServicesExpense": {
     "auth_ref": [],
     "calculation": {
      "http://alrt.com/role/AdditionalPaid-inCapitalDetails2": {
       "order": 3.0,
       "parentTag": "ALRT_Total",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Professional and contract service expense includes cost reimbursements for support services related to contracted projects, outsourced management, technical and staff support.",
        "label": "Professional expense"
       }
      }
     },
     "localname": "ProfessionalAndContractServicesExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/AdditionalPaid-inCapitalDetails2"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProfessionalFees": {
     "auth_ref": [
      "r250",
      "r251"
     ],
     "calculation": {
      "http://alrt.com/role/StatementsOfOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer.",
        "label": "Professional fees"
       }
      }
     },
     "localname": "ProfessionalFees",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/StatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProfitLoss": {
     "auth_ref": [
      "r0",
      "r35",
      "r37",
      "r40",
      "r53",
      "r64",
      "r68",
      "r73",
      "r74",
      "r87",
      "r91",
      "r95",
      "r98",
      "r101",
      "r110",
      "r120",
      "r121",
      "r122",
      "r124",
      "r125",
      "r126",
      "r127",
      "r128",
      "r129",
      "r130",
      "r190",
      "r193",
      "r194",
      "r197",
      "r198",
      "r204",
      "r205",
      "r233"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.",
        "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest",
        "negatedLabel": "Net loss"
       }
      }
     },
     "localname": "ProfitLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/BasisOfPresentationNatureOfOperationsAndGoingConcernDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RelatedPartyTransactionsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transactions [Abstract]"
       }
      }
     },
     "localname": "RelatedPartyTransactionsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": {
     "auth_ref": [
      "r211",
      "r212",
      "r213",
      "r215",
      "r216"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.",
        "label": "Related party transactions and balances"
       }
      }
     },
     "localname": "RelatedPartyTransactionsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/RelatedPartyTransactionsAndBalances"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "auth_ref": [
      "r189",
      "r222",
      "r263"
     ],
     "calculation": {
      "http://alrt.com/role/StatementsOfOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.",
        "label": "Product development costs"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/StatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost": {
     "auth_ref": [
      "r189"
     ],
     "calculation": {
      "http://alrt.com/role/AdditionalPaid-inCapitalDetails2": {
       "order": 2.0,
       "parentTag": "ALRT_Total",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The costs incurred in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, excluding in-process research and development acquired in a business combination consummated during the period. Excludes software research and development, which has a separate concept.",
        "label": "Product development expense"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/AdditionalPaid-inCapitalDetails2"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r11",
      "r169",
      "r219",
      "r238",
      "r245",
      "r247"
     ],
     "calculation": {
      "http://alrt.com/role/BalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Accumulated deficit",
        "negatedLabel": "Accumulated deficit"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/BalanceSheets",
      "http://alrt.com/role/BasisOfPresentationNatureOfOperationsAndGoingConcernDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Revenues": {
     "auth_ref": [
      "r42",
      "r64",
      "r84",
      "r85",
      "r90",
      "r96",
      "r97",
      "r103",
      "r104",
      "r107",
      "r110",
      "r120",
      "r121",
      "r122",
      "r124",
      "r125",
      "r126",
      "r127",
      "r128",
      "r129",
      "r130",
      "r205",
      "r233"
     ],
     "calculation": {
      "http://alrt.com/role/StatementsOfOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).",
        "label": "Revenue"
       }
      }
     },
     "localname": "Revenues",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/OperatingSegmentsDetails",
      "http://alrt.com/role/StatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Revenues from External Customers and Long-Lived Assets [Line Items]"
       }
      }
     },
     "localname": "RevenuesFromExternalCustomersAndLongLivedAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/OperatingSegmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses.",
        "label": "Schedule of accounts payable and accrued liabilities"
       }
      }
     },
     "localname": "ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/AccountsPayableAndAccruedLiabilitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock": {
     "auth_ref": [
      "r188"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.",
        "label": "Schedule of Fair Value of Stock Options Granted-Allocation"
       }
      }
     },
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/AdditionalPaid-inCapitalTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock": {
     "auth_ref": [
      "r20"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of short-term or long-term contractual arrangements with lenders, including letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line.",
        "label": "Schedule of lines of credit activity"
       }
      }
     },
     "localname": "ScheduleOfLineOfCreditFacilitiesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/LinesOfCreditTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of related party transactions. Examples of related party transactions include, but are not limited to, transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners and (d) affiliates.",
        "label": "Schedule of related party transactions"
       }
      }
     },
     "localname": "ScheduleOfRelatedPartyTransactionsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/RelatedPartyTransactionsAndBalancesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable": {
     "auth_ref": [
      "r42",
      "r106"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of material long-lived assets (excluding financial instruments, customer relationships with financial institutions, mortgage and other servicing rights, deferred policy acquisition costs, and deferred taxes assets) located in identified geographic areas and/or the amount of revenue from external customers attributed to that country from which revenue is material. An entity may also provide subtotals of geographic information about groups of countries.",
        "label": "Schedule of Revenues from External Customers and Long-Lived Assets [Table]"
       }
      }
     },
     "localname": "ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/OperatingSegmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": {
     "auth_ref": [
      "r87",
      "r88",
      "r94",
      "r113"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Operating Segments"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/OperatingSegmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "auth_ref": [
      "r173",
      "r179",
      "r181"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.",
        "label": "Schedule of share-based compensation, stock options, activity"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/AdditionalPaid-inCapitalTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": {
     "auth_ref": [
      "r183"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.",
        "label": "Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions"
       }
      }
     },
     "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/AdditionalPaid-inCapitalTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShortTermDebtTable": {
     "auth_ref": [
      "r21"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to borrowings under which repayment was required in less than twelve months (or normal operating cycle, if longer) after its issuance. It may include: (1) description of the short-term debt arrangement; (2) identification of the lender or type of lender; (3) repayment terms; (4) weighted average interest rate; (5) carrying amount of funds borrowed under the specified short-term debt arrangement as of the balance sheet date and measures of the maximum and average amount outstanding during the period; (6) description of the refinancing of a short-term obligation when that obligation is excluded from current liabilities in the balance sheet; and (7) amount of a short-term obligation that has been excluded from current liabilities in the balance sheet because of a refinancing of the obligation.",
        "label": "Schedule of Short-Term Debt [Table]"
       }
      }
     },
     "localname": "ScheduleOfShortTermDebtTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails",
      "http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails2"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting [Abstract]"
       }
      }
     },
     "localname": "SegmentReportingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "auth_ref": [
      "r81",
      "r82",
      "r83",
      "r87",
      "r89",
      "r95",
      "r99",
      "r100",
      "r101",
      "r102",
      "r103",
      "r106",
      "r107",
      "r108"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.",
        "label": "Operating segments"
       }
      }
     },
     "localname": "SegmentReportingDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/OperatingSegments"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r48"
     ],
     "calculation": {
      "http://alrt.com/role/StatementsOfOperations": {
       "order": 3.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.",
        "label": "Selling, general and administrative expenses"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/StatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agreed-upon price for the exchange of the underlying asset relating to the share-based payment award.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Exercise Price",
        "verboseLabel": "Exercisable, end of period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/AdditionalPaid-inCapitalDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": {
     "auth_ref": [
      "r185"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.",
        "label": "Expected volatility"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/AdditionalPaid-inCapitalDetails3"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": {
     "auth_ref": [
      "r187"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.",
        "label": "Risk-free interest rate"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/AdditionalPaid-inCapitalDetails3"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend": {
     "auth_ref": [
      "r186"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of the weighted average expected dividend for an entity using a valuation technique with different dividend rates during the contractual term.",
        "label": "Expected dividends"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/AdditionalPaid-inCapitalDetails3"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": {
     "auth_ref": [
      "r176"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.",
        "label": "Exercisable, end of period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/AdditionalPaid-inCapitalDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageIntrinsicValue": {
     "auth_ref": [
      "r180"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The combined weighted average of the accumulated differences between the fair values on underlying shares and exercises prices to acquire such shares as of the grant date on options that were either forfeited or lapsed.",
        "label": "Forfeiture rate"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/AdditionalPaid-inCapitalDetails3"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod": {
     "auth_ref": [
      "r177"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net number of share options (or share units) granted during the period.",
        "label": "Granted"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/AdditionalPaid-inCapitalDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r180"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.",
        "label": "Weighted average fair value options granted"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/AdditionalPaid-inCapitalDetailsNarrative"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "auth_ref": [
      "r174",
      "r175"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options outstanding, including both vested and non-vested options.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number",
        "periodEndLabel": "Outstanding, end of period",
        "periodStartLabel": "Outstanding, beginning of period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/AdditionalPaid-inCapitalDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r174",
      "r175"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "periodEndLabel": "Average Exercise price, ending",
        "periodStartLabel": "Average Exercise Price, beginning"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/AdditionalPaid-inCapitalDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r178"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price",
        "negatedLabel": "Exercised per share"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/AdditionalPaid-inCapitalDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r177"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.",
        "label": "Granted, per share"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/AdditionalPaid-inCapitalDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "auth_ref": [
      "r184"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Expected life"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/AdditionalPaid-inCapitalDetails3"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": {
     "auth_ref": [
      "r182"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Weighted Average Remaining Contractual Life"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/AdditionalPaid-inCapitalDetails1"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShortTermDebtLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Short-Term Debt [Line Items]"
       }
      }
     },
     "localname": "ShortTermDebtLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails",
      "http://alrt.com/role/InterestAdvancesAndPromissoryNotesPayableDetails2"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r61",
      "r67"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.",
        "label": "Significant accounting policies"
       }
      }
     },
     "localname": "SignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/SignificantAccountingPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "auth_ref": [
      "r8",
      "r9",
      "r168",
      "r169",
      "r178"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of share options (or share units) exercised during the current period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period",
        "negatedLabel": "Exercised"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/AdditionalPaid-inCapitalDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r9",
      "r13",
      "r14",
      "r64",
      "r109",
      "r110",
      "r205",
      "r219"
     ],
     "calculation": {
      "http://alrt.com/role/BalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "totalLabel": "Total stockholders\u2019 deficit"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/BalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders\u2019 Deficit"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/BalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "auth_ref": [
      "r62",
      "r156",
      "r157",
      "r158",
      "r159",
      "r160",
      "r161",
      "r162",
      "r163",
      "r164",
      "r165",
      "r166",
      "r167",
      "r169",
      "r170",
      "r203"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.",
        "label": "Capital stock"
       }
      }
     },
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/CapitalStock"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SubsequentEventsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events [Abstract]"
       }
      }
     },
     "localname": "SubsequentEventsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventsTextBlock": {
     "auth_ref": [
      "r220",
      "r221"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.",
        "label": "Subsequent events"
       }
      }
     },
     "localname": "SubsequentEventsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://alrt.com/role/SubsequentEvents"
     ],
     "xbrltype": "textBlockItemType"
    }
   },
   "unitCount": 4
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "205",
   "URI": "https://asc.fasb.org/topic&trid=2122149"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "34",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8981-108599"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "280",
   "URI": "https://asc.fasb.org/topic&trid=2134510"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Topic": "340",
   "URI": "https://asc.fasb.org/extlink&oid=126905020&loc=d3e5879-108316"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "340",
   "URI": "https://asc.fasb.org/extlink&oid=6387103&loc=d3e6435-108320"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "https://asc.fasb.org/topic&trid=2144648"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "https://asc.fasb.org/topic&trid=2127136"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=99376301&loc=d3e1314-112600"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=99376301&loc=d3e1336-112600"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6036836-161870"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126972273&loc=d3e12317-112629"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126972273&loc=d3e12355-112629"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(7))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496180-112644"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a)(5))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "https://asc.fasb.org/topic&trid=2208762"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "730",
   "URI": "https://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a),20,24)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=SL126733271-114008"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=116633155&loc=d3e31531-110899"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "850",
   "URI": "https://asc.fasb.org/topic&trid=2122745"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19,20)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "855",
   "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "855",
   "URI": "https://asc.fasb.org/topic&trid=2122774"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "730",
   "Topic": "912",
   "URI": "https://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "940",
   "URI": "https://asc.fasb.org/extlink&oid=126941158&loc=d3e41242-110953"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.15(5))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(15))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.9)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.15(a))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(8))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "210",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=118262064&loc=SL116631418-115840"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "210",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=118262064&loc=SL116631419-115840"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "220",
   "Subparagraph": "(k)",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=124433917&loc=SL114874205-224268"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07.2(a),(b),(c),(d))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=120401555&loc=SL114874292-224272"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Topic": "948",
   "URI": "https://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "440",
   "Subparagraph": "(a)",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "985",
   "URI": "https://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756"
  },
  "r264": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12"
  },
  "r265": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r266": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r267": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r268": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r269": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "g"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=51824906&loc=SL20225877-175312"
  },
  "r270": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12, 13, 15d"
  },
  "r271": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r272": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r273": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "15",
   "Subsection": "d"
  },
  "r274": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r275": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310"
  },
  "r276": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a"
  },
  "r277": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f"
  },
  "r278": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f"
  },
  "r279": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313"
  },
  "r280": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r281": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r282": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  },
  "r283": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e637-108580"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e681-108580"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669686-108580"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e689-108580"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e709-108580"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL34724391-108580"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e557-108580"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(18))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(210.5-03(11))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(1))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(10))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1,2)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.8)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3000-108585"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18726-107790"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(f))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(k)(1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "https://asc.fasb.org/topic&trid=2122369"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1377-109256"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "275",
   "URI": "https://asc.fasb.org/topic&trid=2134479"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8657-108599"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "26",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8844-108599"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>57
<FILENAME>0001903596-22-000530-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001903596-22-000530-xbrl.zip
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M/FC1"])6#"_.>Q*%?GC7_G=0[>#9MD(2R;KB.04/N*PU@HI#%H@9.2ZYYQZ
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M/2A/&Y5>7]QO':JVKNI;F]&26F-5@>!GPF=KZG)<:MK]UO&-F#8\ZDQOJ4E
M(4\DF&V\YPE\A^!G;)D7VU9VB+A?$P>4@WX'[7=#S'@K61UQ5 6L[+<X_.$2
M=/#'R^ ^?G"P,7<M/WMQ>-]<E1N=P9'BKB4/9,AK^KOT8S]P],>#Z$K?!A$K
M&!#2(_1?4(^RJS!9W<,USTC'X-JV;$OQ^F_!R9E],%+62C.HAVVO*9MAMI'N
M\9A_7%]2"$)!'NP]F1)J.P,+($C',ZB,F 3*/5!_[&KA/'R-BI5%H?B^?>PY
MM;#O?EDJ:[E[^"8OET9#DA>C4LM[CZ&@C=S8-L@#+>P:V<0*'HQ/3#Q[XJ:
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M,JI* 5KPQL$+A3\"AO1NHT)*6?OC^-RO_$LKGC>-Z8C^5XV%FNA:]L5JM I
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M"IEH%;BB_"\TM=#218^<(<W4;_8!%52W%>2MJ6P7FF2O,I,K?NLKVI]AV*"
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M;QS2^)G W.L;J;=F:?].H-F['*D?"LR38IQZ)5;6+P4V^\-J#^+G5 -(Q4L
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M%A])0G\H?[[V'F'T!A!)S ]AOCYU;)5*[TR#O84H3(*+>!SJOK8E^+CMH.R
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M91R8L6W=P<P+8QA<>(B\D90N?3_?Y70XYM2#OM:O)ZZUQ@&8.=<D5Z(ZU75
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MK][Q7-277EJAI6GCE5*-K/ >*96HN1@@HP^;V4>K@F5 N:,V4P_9CO00WS;
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MK_]LB- Z-](Y^E7M=--M.-*+80;MTFH7[J@5*)HA+X"5'=P?4FIM/=)307+
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M>D6%49+_DKVH)[R0C;/T#K,-A>19(_(!+^B[/[0DBU<0V.&G# "Y>/:W)!2
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M]:X_L:IP-@H"CK">AWP[K,*K1I#NSR@))RU8N.J"2%="J#P*S='JMS8E%PD
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MCXS9C?MG).XH>7-]2D^OB$3/QVM,]^ JC:0)![VA+8%2K^G*3NA)AZ9WFEH
M\!9321V)KUS-%^*1LD>^7YB3I-+[>)9&C,PR0229\)$S*W!M<2OA>E%8&@8E
MQFYF:/1D1: .-,=Q,PNEK&Z(N,1-P^M@8E3V0$] -) .@/4>Q4.)FIQ7'OTN
M"8=Z5R4<2HPYB ?%#X?*1+9M635*2BKIA>8D"EHFC#ZZCJC)_9F+X=K?'E6/
MQ$M@27:=_EBUPEC]25J2"K+H9U9$#-U]V'.11X^6ZR4[SHQM3W,G8Q,#/#.
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M27CM<_^?B*,LN4!RS?!#*QJ52BD(1D<QZ2_B_XE4,/Z7_P=02P,$%     @
M%70/5;JSN *\#   T0T   T   !I;6%G95\P,#$N:G!GG99Y/)1MV\?/R3Z%
M)F7),C=C7T+6&.:6#))$,5),XDZX$6*49;*UN,N$1+K'3LDR5"1+LF<IRPB5
MR S9HK&/:<SU3/?G>=_W\]R?]X_G>8[K<_US'<=U7N?W.(_?<5S0*/0%[#Z*
MM<4"& P&SG$O 'T"E@ N(" HP \7%!3<"8?O%)'<+2(L+"*[3QPAB4(J*2H@
M%>25-8RTE=7TU>05="QT]0^9FIN;*QTX8FN)MC$R,S?]N0@,OG.GB+"(S.[=
M,J:J"JJF_[%!KP%"$#B ;SPP!; # >-!P* V@ 0 Q@?[R\ _#;:#AY>/7T!0
M"+Z3&U"]&^R \?#LX.7AX^/EY7JCN7[ B^#;(Z]KP2_FZ"F@$+SW8&Q*GB#J
M<%7S/J<!AJ+>^9 X(;BXA*34?B5E%54U=7T#0R/C0R:61ZRPUC:V1T^><G;!
MN9YV\_+^[8+/15^_T,MAX82(*U?C$Q*OW[AY*RDU[5[Z_8S,!UGY!85%Q8\>
MESQY^NQY=<V+VI=U+:UM[1V=;[JZ!ZE#[X='1C]\G*31IZ:_SLS.S2^OK*ZM
M;VPRMU@_N6" !_8_]O]R(;A<.WAY>7@%?G+!=A!^!B!X^>1U^?=8. IX!HLI
M'(P5W'LX):^J60BEY\38=SYD "ZNJ#^IM/P3[2^R?P\L[K\B^U^P_^/Z"';Q
MP+B'QX, &+#AIYI_#?X?WGH7EL5)07JMAGEP6^F WU3N^IW1PCL,>5_\MD0G
M]P>>NY%+T1F!P)3G$&9ALHD<R$9#X"YY9CL8R=H7@FT@'S\CM_C[4S):K^QA
M8YHI2S6_KD]0-3\):"0P2V@]))'9?K>Y$7[IA2YSG,?C/X8X*CRK%4NO@IF)
M% BT6-)^E-"CAX=GWL0+W"GE.I6KB^1\84BVIJ@X!/K#9U:1DQX]C$]M3R/2
M6@:ZPK0?1/IUJ(VN>PWILDA3_C-)BQRQ!0B,<K3L#N$#7N6CB[N^8!C(KYC]
M'PO%DN/--I)4*RRDS-4::JELK1(/-]OI/KYZ=-"U\+O&Q@:37C3"[2H(R!=#
MH D!@66#Q5>&$$C1<(4 Q9KCO/KKK$9^DKWI'>21*(/A,&%"BVUTR9CT'_&F
M)2%Y$;+& +Z@D<C$0$!!D;B^JK*Z[[.+'C,S+DFUA">664XSP[?6Q9 /I$4$
M9/L^.)O@\H9G;/\JAGEZ_" $<JG$B9L08&8MQ1A#X(VV+00JOG,?CR3CW%4?
MR9YX5\H1)]QNFM6?V*1A.,JDO[TU>_)+\I/9,H-2M$X?ZSX$]BLRY<LTO3M+
M/YC"6C(_A#('WAZ#9^$['!!N1YL^(LY,M+,M?;AQL3(QZ0MR$LOA&;0>E%E"
MHC=)[O*>2\LY1,?O>+3_5?&"R<\696&F1.5S1FH"ZO3W#L$N:"6*_63?'C<_
MA.ZHC&(W)OG@)>MU5I+2<2V/7R)GDL,T&E'-6>G;">/VO;KQ,@\M/A)@_<OC
M#2?_9?^-G>U7T:\4&(U+&4$'K90&P5-C)>M>T:"B*P2VFK /)VX#L]DZ?'EL
MS^:U&0A,^D3T<.+M(1"#@@#M(@02R71MEK#1-I,$@5NEX[\P<25,PI':]X$&
MTK8%+\!3;)E05Z<4:T3T3)'0[]<6SC/3Z+[3-I[O"U-M)=45/G78B?7#:AIQ
M=DW#Z$.YT<_:W5(:A@[P>U6?LD+\B,KU9F6G_\$H:-X(9VF:*][5W!Q1'\<N
MK[3 4*30Y.KRQTS3T^^UY>873KSP"8P73I2+_UA;I><;0K7VV$.6ZML<?(ZC
M>0RLV6N?H9X\^>JI]<N7%ZY(FL+(G37^R/;P*F;XUZ'9KW:H@T:9YU.>CJ)D
MM^?;,Y+R&(M-&^CA5'NE@H/Z-U]KR*1UQ%2?.9$=).-^)"NZ*77XL=W6.WX+
M5+%Y>K.*P$YKFMG5$Y1=EF3L]OWZ1BVJ0VV;.P$WUK2L7S^/F2ZAG)'EN_*:
M<>"Y)'(M4)2]CIGT2#9QR0PSB/%Z:%!R."J[JZ(^*C$_2>/Q\G$?FD@3! 0W
M$P*7$#5CQ]$W,>.!$+C6Q=:8D8MKW$D7:=HNH-FL/<[1F>M9_<+P#G28TM'(
M82@G0D!(](^R<EF"A?05*@1J&^C+QL@[8=2SE?52[_VS>0WQ<$V*N/;:PH4?
MSITRBU'>,3Q!4_YOO5)H*4JWDNIT?O,<3;:@E!XH/]_P_/ZPM_#>-UYA9LV2
M!BN<%T5V^?Z$+._72S7W<E68&55LK)H3>2D3-0MQ)>9+TQ;^X.>'G?.2.X=L
MH5]'9I9?7?X>5P>!= (A]Q@$-%O[KB&_BTC&N&(2(X4]C5>Z6W0: KBJ=.%J
MVX/$+OT:VX\;Y/Q=V7[2N@7CKT2YZKN%W([J8K<3G%O82&[0'@QK*VTK::E4
MB'W,PFKOJ=CI"1GBE$0A!$8(W)[DWRD<B>Q$;O'-8=8_0V!M_W+WMR*&,-+5
M @)RR]S$8-)M/=1SI,,N6SD6?O#$FJ]"X(YBCG1U\6'48)DS":OT#N/6^N&8
MIE]4"'=//H,"/1ND@PX5O:)48PH*I()YFW;\</5;ZS:3>+P?@=_WYFLZ/+Y?
MI*6Z@6_R08,]S16UTO6L)EBK9P,N<GC;EKY:<;/"9EZ@_V/$;]3R]-A=\K^&
M+L2ZJ.;7)H00Q;B-.V>>N$3A)&C,7&6A:$1VVK;#]GLN1V+4=_=3,8B"6<IU
M_,KQ-1+K*P18NJ5/*G"3&>RT1A3G91/GMM]\:391##%5QZI:YL];X2;4)G!\
M_25CW=6/\, )$V)"VBAM+*JPF=SR>1LZ6IH5>0Q3-36;SFUE@#L#YM"7RK8)
M+C<L!PZL'WKS(0!Q"=,0*=KVQ27QBG5'.?%WPRQ>[=X;BQ*29C?@&'3.:^?#
MZ,%*.8?04(/%H1'<+@_?L3??(E-#+EZG15[0"D+?K9)4-E*W8:O;FW0$.#C5
M5+XXVQ.JWM'D='6D6KN9M"L15MRDE6R3N2NGNU[)N!.KUPZ!ZC!MEB#WF"8V
MN%V2HCG8)Y_J*X<S.SV:2A3SH'/KRZL% JO#$.! @,1X\I'43!:ZO'"]\O[J
MXGE#G:VT'455KU&RZOM<85,FAB6&M\K<_"Y%__"UI/]HK65CK:(M? C"V_<D
M[B_6J='WR*_S>N.Z?R^[[3A4JM;*,[I)"6 :4;;K6U=F5UY=H'Y2%8WXE+(E
M0^I.O_CYK-00\Q/G2+D7IQ&YA7O+DTLI8O^M:)WRGO%&CC1#8 O!;824!YC,
MBOD&E>8)L8R6+/B<CZU__E.]K;ASC9%>^QHAL/,=AB4Q 8$=ULQ31__\\V&E
M7)75%0Q;FSM?9O%$MA!RTAT9%Z.@?;M:XZ$!=3_U38)=;3<239?ELWRD6-%_
M&Y.,6=DY2%RHY\8;T-._$?]6])<'F?S)U3$2$<WW=*ABO-[$0A7FR*$2WQ=9
MV#RM1#:_=.9Q6=&Y^#'<4#^QLX&X)#I]5J(]2( 8X(O_).[XE=5U?-VQMRH,
M-6]"ZL@W>!CN&?H&;>1;C%_8J,EJ;ZO92#/O2$5[BU$5UZ3H9J5SLD@KZG-I
MWBJJUGU!W)\B9=&V2_[3%04?&ZF3^-M-+_0IWQ[.Z1&]"_QUO[K^0#Z>)<+#
MTJJ;LV.M]N)4DQW^M<[Q1Z(<()!*+(% 71-K-X6\\(34HA^]C]'#L1U/@<!9
M;MJP!F'.W6SND$TE%!)'C" P<,?=.;2/=I[[CU2X(TDUE]>KVG;J2[@4)3O*
MKH#YK$U.H?&](F/CT:U"<U?#Q97<2>MIO.4 3F@EECX!CY)Z_"GBNCO.A5JA
M)3YL5JFYG*ZYV(PRC\>0(X7W.MW[D_R:JX^[:!6:0&S8Q0;W,,.T(G=W-W<.
M6Q\A+MCY7<0D-(U)10L51Q2T9FL^;TBS&+H_;CDU=N%S555]3EXS6V/\8GEC
MZ71E;Y#$I[>$25FG\7&5+%\MLI.^U 7C6;XH%EJ:=EN4^2A,F\WOQPI,RCP5
MC%A58<N_4H5 'L$) J\O%'!V3^PE]M>7$+_HX:B7G7\01@GFWA!(,&I'KAV8
MQS-WO9]@_])??4<#WY3A.+CTC1YYX@FU[93NF+$4Y6S^O2<O-?CZ#C%;"^?=
M:LC%R@\]@R,&>J?;$!GJAIOM5QP904F86?>A)H94Z5R=&K8TJ1+1(ABG@Q5T
M3&&>9 T.G!9D]"'9ID.:89NU_6L?ELHJ5G^QB^BYHO791E8@V#4+FTC7$G-^
M,53V7-96Y45TZ[9L96NM>5LPWMKQC/J[8:^7)X\U1EO:QRW9G2[W.+6K_WB]
MA]X8PF4VOPK1RS[RK*Z)@2T(\ E2:ELJK3'."#7J-8$S*$S+*$<('%XJXHZ\
MMWC[ ;?#!4F5[X(F%\EO;\1>[CG#_?S,'4FT4\4PGDQ2J#NJ^CAPB<:M@+M\
M>QU_14(?_@%02P,$%     @ %70/50DZ^8!L'P$ #4L- !,   !S9G-A;'(Q
M,'$P.#$Q,C(N:'1M['W[<Z+8\^COJ<K_P,W=O;5;13* [YG9W#)J,F82==3,
MZ]:W+(2CDB X/)+H7W_['$!105%!,6$_G]TDRJ/?W:=/G^[/__=U*%//2-,E
M5?GOC+U@SBBD"*HH*?W_SDRC=YX_^[^7IR>?!P9<!]<J^G]G \,8??SPX>7E
MY>(E=:%J_0]LH5#X\(JO.;,N^OCJ>1W',.R'G_=W+6& AORYI.@&KPAH>I,L
M*4_^S\??3B_M:K(T=RG^Q'E)ZL/2H^%;<7:#^^+L!^O+N4L-STLSUJ6&<ZFD
MJVF.S:V"P[IB>L.KW[4LAADP1#^OFG>SRPWOZV>7?C T7M%[JC;D#> A?E+F
MG.'.N:SK(><Z$N8>!']?]-7GM<_)GZ=8YSE+S)G'%'_=Y?4IQ46T0&[GG? %
MW,%QSH4:ZOD^-OL!OG4N-/7S/L^/IA?W>+U++K2_F'LJ?*:I,M(]KR;?S%TN
M&MJY,1XAW1L4^/H#_AK?PYPS[#DW)8N@FHJAC;UQM;^<>Y6N&<M P8=S%Q7O
MFNWI5;RL&1>".B17,-D4<T94$O$B_*3P/Y\-R9#1Y></UD_X=H@,GL+WGZ,_
MIO3\WUE)50RD&.=M0..,$JR__CLST*OQP=+<#_B^#_9C/_^O\W/J6D*R^)%J
M(>,35>.'Z"/U*KY^HJIE\DN'X:XZ#ZV_N?)-L=B 'Q@\ZOP\Z-VI5 >CV7'0
MZSCH;?",=-&ZBV78;6[/9#H(Y!%@A_]7%*#>N 1DT7BYJHCH]2L:=QBP64P^
MMQEJF8+KN<4A4D3XU[B6^7ZGQ\LZVN11K.M1)5/3\(,D7>#E7XC7*HI8Y@W4
ML;Z^:S&O]Q(SN?_VWW^;O()QO:*L"N9P[AW7\(G>V9"YF;SO,QM(DU31>NJW
M39Z9Q>)6[K =VZI:#X>/-GD&UVD-> T!0AWB1*R'Z.2S39Y3QK T[&>EED#:
M[>&%3L/44"?M?LH(/K&?T57%,?XI2L^4;HQE]-^9*.DCF1]_I!150<0^2*\?
ML2XC#1L)\I<DBD@A)@/_"1?6@"N:)%C6X-5H8DM\K:E#S&MLY1C64*W?L^=@
M=2@%8(57(>FCIZZ<7<Z4Y?.'N5>$\]8Y33J[)*H4R8O\].SL\OR<Y< I1O)6
M']4[N^2B(JBO8IY=?@OSC9+XWQE(-B=A>89HP4N6+)(WT4C5# @_6P9O8#A^
M(3U"0-AE0*KP)(T7#.D9 <MY&ZYU@%R36U3%?IP=DGQL0/R"X %BRU"%I^^\
M;#K.UP:VJ-=[*P L0.AH*I)U+9@5B _TCXHD@^/6X%&7#D3.ZT,$B;4D?1FD
M0N@@-=$S4DRDGWGQ$9B8!CY:OWD1B4V%3Z1U$+%K( J?1B55-^H]&ZXM"97F
M#@/6&FJETZ&#=:.INM[0U)YD;$NK\(4J %#K*!6^7-WPL%:^ \"07E<JK]CT
MFI(^P%ZAWBNCKC>HW)1^/I:++;#Q 76='V +J="!K1L#I)74X4A# Z3HX$VJ
M"BQR$(;_6M60U%<LUR*,VWCI;3VDJ(CD+YFLPIM(D'E=EWJ20/XNBH^F;A"'
M#;@5ZZ5J$_&R-$'BPTA56KR,ZMJ=!.L]D5Q>0T"7-O^ZG09P;/C6X@B(LEH#
M.38\6X47OQ^)$\9Y$Q&3!6A"@.PC!6(0N85D&80<\"^*0TF1=(BV\==;PIX.
M3R57P"[A^ GI6RLCE\Z&"^:5JIA@,F"U9<A(O!I7==W$N<%ZSUJ];4G-3,A@
M8AVH*Q:4NYLT+I./(')4!81$'4-14I5G!(%Z5T:^8*ZG83Y\NUOI]9  Q*N\
M"@,>%*D)R[:Z4N+U ?ZW@I-A8!(40V^"C$(0;X#TPA>@8_,?N*[<$KE")EP!
M>5!T))@0N ,?AI*NJ]JXIAI(;_!C'MC05IL(6\AG\(Z]TH"7M"&O_)",P;7T
MBL3B$*<BX9NJK9YE$Q7-/EC.%&LE'H,O 5(A+@&"8?:@:!@W)-XA142:OA*M
M35!)9\(/4XA5N5HTBT5-P^*(-?MJ/+L$4,0?%5]X3:R/\(7Z#5QHZ%7%6HYO
M:P"R&;?X.98N>N3TC;#[ 2Y_ 'PM@C'A^ZCRBC1!TE$#]-![-1$(\X70O1$>
M]MCC8?^!Q+*I@6NVL+">3[ZTL700V9Y]V50LV><@%BT'LYFP.4CL3!TPMO#
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MK_O@^3[[;2.2:EZ&0C=XS<"%F9<S=)PGS;Y;N@U9U9R7,[QGKQ?G;G$^GP/
M^= FJ3^=9\5]^7,V<V2TM8[0&)<S!*:OL+\)FTA'*(#S1')+4B1$<G8QCY9(
MK%,^'061?!<IQT6N1:.6CI=1\UUI'#&5V6VHS.Z'RNQ;HO+F#CI2*MMFE3EV
ML\I$:5:GON<8!7#.]T3OH&U&.,L+.X7; $&W,QT'(]],)5$?)])<7]A?B0#,
MZTB6!,FP8*5$:8BK=/'1<&>MA;-O5:"<1LX-%5\E_>S2S@,MHOKY@^=3W1!]
M\ 8IWOK@89H3IA^*Z6$XF#E9B<3!)!(2"[.PI]6'=XHX8?JAS$*<$T.)A!S>
M+.PC<[,0&#XH[XC97LB^U^ P87P2(*X/$!,I>:=!8L+X)%!<'R@F4O)&@T6_
MZ.'(DJXQ][GKC+"[HK!2?QOJ=2<IN Y/0Z)D7/.") /P+B7S0CDQQ0%,<2(K
M[\$@^YJ*'U+/5=[Z+MCOA7)B*@*8BD16WH.I\,W\))[B\*8B?K&H=_XGD95#
MFXI]9(%\347B*1)3$=14)++R'DS%VN8%;X/Q9:#1,SG7.4L%-B7]R<7\>823
MA<=&CB61EL2A;&Q;N/<F+5P,I.5H;4LB+8EM"6Y;4N]-6E(QD):CM2V)M"2V
M);AM2;\W:4G'0%J.UK8DTI+8EN"V)?/>I"43 VDY6MN22$MB6X+;ENQ[DY9L
M#*3E:&U+(BV);0EN6W+O35IR,9"6H[4MB;0DMB6X;<F_-VG)QT!:CM:V)-*2
MV);@MJ7PWJ2E$ -I.5K;DDA+8ELVJ)UCWINX.!@GUF6KZKE$7A+[LHE]>7_E
MEG&HMSQ>^Y+(2V)?-K$O[Z[DDHU#S>7QVI=$7A+[LHE]>7=EEVP<ZBZ/U[XD
M\I+8ETWLR[LKO70P3NS+5O8ED9?$OFQB7]Y=^24;A_K+X[4OB;PD]F43^_+N
M2C#9.-1@'J]]2>0EL2^;V)=W5X;)QJ$.\WCM2R(OB7W9Q+Z\NU),-@ZUF,=K
M7Q)Y2>S+)O;EW95CLG&HQSQ>^Y+(2V)?-NE/]^[J,;DXU&,>K7U)Y"6Q+QO9
MEW=7C\G%H1[S>.U+(B^)?=G$OKR[>DPN#O68QVM?$GE)[,LF]N7=U6-R<:C'
M/%[[DLA+8E_\Q]C5C0'2CEM"=,WXV#* 4/C>&Z3V-7XTD 1>=HO&#,U]B\6^
M)M9Y#Q1*^+M'_D8Z.VA1?U53,;1QIW7S1OEJ(_BQ=?->-#;AZ!O5T8?6&^?H
M0^N=Z6C"T:/5T;7K["1B2A;6"POK1$".;B4=O8!X6) D@DMLQH+-2$0BL1+>
M5B*)(1,KD8C$.[02IB)9\O#0*B_Q>XAXW=30I:2K:8[- <7*SL.<K^9?@9_F
M\_S6@->0[OL*FPCDHJW? ? U?-XC2L\@:,NTQ??6S"'2>$/5EN5L QHLPNCU
M5-=+RTA1AY*R[K7KZ;+X7J\'.]_/42$ 01OPFC4L&\&O 1GV^8/T^A'P4$U-
M0#K^B'PR0+Q(E.[S!X /?N+_??Y?Y^?4M81D\2/5-&5TWN#[B#H_O_P,UU"Z
M,9;!R QYK2\IYX8Z^DBQ(^,397_050U8'-F?O4BB,8#?&>;OL[F[NZH&[[7N
MOI)YX8E*761&!J6KLB1^HNROG6=95["S[WN@3N>Z-$'D/?!H?<0KSK/)ESU^
M*,GCCU0;3)-.U= +U52'O$);']!4"[2T-_\@!C_I__QO-LM\^OP!/_#2(HK]
M7Q=1/LQ1A9!LY'X[/ P#N^;=%L$^4DR$\(]VA^X3A2W7.2]+??A3 *N+U[OA
M0?RY>_E0J[8KY=.35KO8KH!GZ%X>&0*M2NFA66U7*ZW3DV*M3%5^EKX4:S<5
MJE2_OZ^V6M5Z[0BQ^L'K TGI&ZI"GYZ4+TH7%,=DTH6P,=F_^&?C1>?K>O,>
MH"2/Q);_57SM%!BF@T0DG9^758$4.;3'(]01<&@*41S;Z9#?LA T3H3;=EK^
M4TV_<$_P/+#JBJH0#R@)E!UX-%%O<25BJ+,P]XQ2>!PYP@L_NM]W=LDRY]^(
MIY@]<\;\8Y,#@^_*"'@HR_"Y *+]WQF@CO\>\:+H_#V/ ;<> Y>7F[HN095E
M?J0#0,YOEB__;&C."YZ19N#(V)$M<(:.O_]LB,Y5]L-3?X<L=(OBEEL0MV\F
MQ,1(D\=--%(UPTORSB@(P#$LSCW4]";*NFMK<>RIVI W_CN37HV/7565$0_+
M!A-YR>D"H&>7_^_G_P216$/T)78A%S:UOST4F^U*\^X7U:PTZLTV]5 K5YI4
MNTZ!ZVB#>[! 85-4O4FQF7_$?ZGZ-=7^4J%FKF7F58JE-OZ:+:32%!@/<MWL
M#8U*LUH''P1O*%.+;$XML+E!5BL5:RT3C,G6+13<0^&;0N&QB%>,<-] Y,=C
M! &WXL7J.6#/+F\?:A4JQ= 41Y:T@5@._]$V4\3HK)); B-]2UR1=IX?N8?]
M+%W6FR AB3@<'&G@QO^S0'+_]W\6[51I,?K1>$67<%VGOS_J3%JYH<X^-U(O
MMX]3/RY*^DCF 5(P#N$8*]LA]7A9]_1(B[!B'A1RZ?2G3=U2N&1O-XNU5A4[
M&\<)-1Z:K8=BK>WR0VX79,$1S _Y*]8'$G5=QCXXC/EBK*0.AY*.DZRG)ST)
MPEC%)+G71<4IVHI3(=G1:[BR1B[T5I@G_O6I_,K<IL005@Z+KR099[@FS:;?
MS!)B 3J.B9>4^"TB+=8T45_2#;!.1@V8YBT1_(/1>S%_--54&(M)K_>2N@*J
M72E]J=7OZC?8HE1KI8OM1:00)QY(E_]47GG!.#W!5*#4'J5-L:=XG=)'2, [
M+B(E :,,G1(&9/WRKQ6>'+$NQ,UB+NI"?DX7JHJ@:N"=>>RGR8Y5R=J;*JFB
MCVJ\*C5)>E7O)T+F;"YTQ<S5<83PD3)'(Z0)O!Y*I'&N(P%O3AEHI*G/6)[F
MUT4!,#F[5- S+_)O1[L(AJ<GJD:IN#*)>C0U21<E 6./U4URDX/"EVE]7I$F
MY.\@6A8GA-^$XF7F%*_-OU;M;6>!\&15?)(Q*_RST?[3T]C0O)$/ &>7^?PY
MW);),[FWHRW5B^9%Z^+TI#(<R>H8U&4>=:JF7B2>)VH%R,XI0%$4-:3K]H\[
M24&LC_"_-!O"745\_"6%)OP>+S^[S*49AKI"O(F1H5HC35+Z.E76I&?DHPE+
MRX[2&A0Y;Q1+3'6@]\K:#Q0EBMS99<N4#$2E&&9/*Y&#FUD;_1+\6M?:ZHOB
MS0#F)37\-6AS725L^L_>?';9E(3!4%5$'^+3R[M?GBI#7']=:T P!%[>)TH3
MO]51]:GXZVJ0"QNEA?>?77XO!M6/@A<^#16"._FW-/*/.<<W7[X/RY.N49+#
MQF;N[6>77 I\W]MQ?#:2$"CV*&S0!&G$RQ1Z18*)#X]#I @^$#\$OI)-O/E'
M3:01T%1$B4?<6UX"&XFBAGA_!="J ^-'.\5_K75#4 #W^\XN_\DSZ7]]1-Y_
M0_Y.%7BY,5"5E9DUO=LV4A7Y:^WK]DO!&=R+[SR[S&32YZG,+OXL;AK;1C(:
M811/3ZS<IELW>6 :4<ZP5W![5\U# 5=51!ST W6[8TH8(.$)O^>)>AD@LHZ&
M_U"2KIOPZS_LO]2 URF<9Q8I7I8IC6QDZ/#SCREI\*&A4EUD7P#/:R%K_<VF
M\(K;VL &PXN?67D5!KS21U11,"C1Q+$E_OST9*0A 1'FLAQ%-G]UZA^XNP?_
MZJ8PH/2!BC-CE%51"S?Q!GFB*Z'VPL_#1#+CY&8;XG]IBE=$ZA_.PJB+$%#3
M[#X"O/AZ?"G)IV,P[ ?A+1R=0(%?)O.Z01482N3'^@6U-L5:,C4-[K<V?N"A
M.&0P=6\3\?.FR_9;W?35K]P"HW'BYUQZ/1]((BS7/E+P)D["%9T, W;A\A<N
MDK.%S HW_A_UD_H?JE:'7_XG9-5/%,2E("[1P^($DC24# -D#VR78&BJ@O=0
MY3&1N1'$5_"-:J=Y[:04HGZ@+J7#:@3,6P\N'-,4>D;:F*IBH\H+)#HI\P9_
M>H*W4A95;O9*USM&IJ:;&"BX!M>F4FDF@_6OB?JF;"WT6^=MZI]6BX(P[\+^
MUAA()/T\PNEGEVI2;LT\/0E)-2W IU!;S\'ZJO_KJ5?7"^G:*7$P;6PU\]:K
MOE%NM=K=5BJS@5JQGFKU,U&JO2H5""0/)E<#=\$+ B@5UAB1B(F&+;GGIWAG
M_]SC"Q!6GM*'H)#P(LVQR*<G@CH$],87 #0B (BH)REDPU['>O%__G<>1.F3
M+QCV]\O?D"_83\X%WF#9%YV>8$VPKUP"DK)A=)XH*99>LUSWG//RK!?4/R5"
M78B?_OT84V%(JC)WK92RWYOFPBY0O"/"7G1)*W8^6M"*R738\'C6" 4$)GL@
MKJ3R85-A:WZ$7L :A!_OH)C.(TXI+17<:"5@6%_5QBOK::WK+;92SAVA[1I;
MAR.)QQ'L9WOM'<^!>W996_!8MLP=LFIM(T-PC/+4LGW_=,E(E2S?OR<"K\Y4
M$^BN3%U2D.ZSC!T6?NM&#<*Y6R[*>G\/>#:I]8^K<<*1"/[XOS,N[(1:687(
MV+"C;EAK^D:9\SFUHU:HP]=4^]:['BKJ!E' _[=@75!V;D[9*Z!!\/[^C::^
M& /;#'DK_=7D>BC^3C>_97('J+1> >[Z8FO[AW09XTSR',^. N)M%OKZ !9Y
MCA&B_N%U:R5NU4:N7N]:.:-?E19.SBSMMK+S/@R_9J4TUW[I/^Y>6M\RU?X>
MY-8-#\1<=;\]9)+4?4^)ISUL1!8;C;MJJ7AU5SD]J=?N?N&C#Z5ZLU%O%ML5
MJMIJ/52:K8_OB>AA F?79F)EM8\G@.I:#30HU31P^T:25H9/$2\,',6VMIUP
MKHO-?=(I0>9U'9%4'-B&H:I0.(ULC&E</VW?(L.+=(,:D9RP0#)(^ SAQR53
M4)G?GB'/:QFJ\&0U*ZG/H.I(5=LZY-E,9])]T,OE:ZW\>EVPSY 1);TF;P28
M%K5ZU://YJS(K#ML_IS-S%L.()NH&B(2) C6SBC[%_V_LVKM^HS"[3S((YQ.
M*YD,2Q>R63J?GAZQ<  D33VZBVZO&R*W+6X4S;X)G& SUCG,B[GXVQ;/0S04
M<;4+\6PG,M=PQ(U;+!N*Q,F,>IJ@>2YC5#[! _Z82!'PC19>)!)?YKG#F"PA
M_2P?[,[_+N:'Y_-=MD! #+[R6.F" #F(./&[$[L[S7 6P>UJB'\Z[R)06,!I
M1'!TBVTLX7>+66@M:_;AJ>^:IR<>IX2.KDZS;4<;UQ!HU-J56OL8.]PXHO:&
M -]FWPDC5P)PNYI$4U^0_(QP] $ \(I^'NG&DRM-M,]C\XUBLTU5+RPXKJNU
M8JU4+=Z!*N*F-<4V:6RT?*Q^SR?\PSCB'E$>[N#=#T*AS;RS*H2ZN50UT)!B
M+U:2R'YQ/MQMQI*JB$C1D4C!;R00M#<]%%X1)%ZVP)AVL]0#P9C[>\_A5XQS
MV]'SZHJ7@5>(:@T0,G3J'U/A35&";_X]H,JE$]Y@WLP4!R\3ZR-D'<F,"Y<R
M"9>6N53B]0%U+:LO<>%2]IUQJ:8:<+VA4NN<DXMQ%ASQX%?NG?'K3<1W84=S
MG'>D%.)K[GF%[Q/IGV:-RY(NF*1!#JDQ+BJ\/-8E8M46(CJL6J3:DUS81+HI
M+_JHU:%>M!SEWIO-2W3(0X=2D>O0-WQB0 (O@@\<8$V #V3G;ZQ-LHH[BNM4
ML:N:!G7/:T_(L #! W</J2*I?&R8E:C(P50D';F*@*<P-%76B7HT-%5 (M:(
M1/03T4^H'G^J'PK2@S2XM3+UU0NJWOY2:;[!#'VB0T=.]569_A!?<X?ZO&QY
M:W*(];#NNA ;\B="?SBA+T8N]7A)1EWS@J%JB< G G_H#&#45']0K&)RA+L+
MM'C9*A>MD#I1W(W$U"1#PF/;$D5(%.%-I_'*J,>3!/;#"+?Y0(JD:BX-2'Q!
MH@*'58%,Y"I 1M135<4JI)=4)1'Z1.@/*_39R(6^\CJ0NM*ZJK2(*YV8V% ]
MD?5#E[I^EBY;\#;>,,F\9)\3Y7L23';#P]EOJ)UK ET"70)= ET"W5Z.-G+)
MT<;D:.-6N[6G)]6+@&>J8J8F <_5!1"2X(C,':MSBR:S=%2<(?*V)AA>/KJ#
M;R,"M_0-*RDADZ_:KMR3O="%+E6AKE;PV,AZK5RIM2IE2V6"_@.WM>IWU7*Q
M72F[1+35A@_N\1'69<C=6AHK88VWQXGL;.W!@ S0F]7'V#Z:NB'UQOMG?JQ
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M(H8TMB#&V\5Z0Q?,+SB)MA13ZK LUYE\^RYFQ^83DEY3X#7,(4 \)I=\G*D
M=4Y-U80*I"64B\EG"V1CUI,MF-LZBVB9,9?AV^1D4Y@![30C6LAW\!J=81FV
M8_V633&=R:22G30S/ZKFEUGU;$QB\1GH' :8G8+.6J"/\S6CUZ]<\ZG00;<"
M][4BX>*\SVO<2L?Y9AA FK 2_G>6._.YT2>\B7-4#&Z\);U2]_#Y0*<J(/KB
M@@.GX@[_K:D@BV$IAEX ?L,D14!1F=\H")ZCFDI0:C%F]TTVK=F8< B*3<7Q
M@,J&QI; P*\U.6$]*<!8"V1@W]G0U&<)U.UJ_ ">MJI,1U06!4-ZE@P)Z7,G
M]\=WM5'&+ J3 8K-G(M5J;EZH](LMJNU&ZI8:E>_5]NP0(AC^B=>T'B+SY5?
M1ZKB,R_)5K,'5RW$ )B'-)UDF^>.D0M_^,ZD,OY1J++,GV=QFZ,X?L&4':IE
MLG_O)C:X2Y6[T\/"\_-_^QBL^<M8#R@\4OW.U9QW;F"3OCGK.1%UH__@+8A6
M$FEI#^:-4CZTN0'!2_.#T-UWIHM3*$&PZ_+@,_"I!%BFD7/'(TT53<$HHV<D
MJR.\2"NINJ$O:W^F\?/A*JO5M"=Y7TTD-EE5$>S."7JD_8N#W[F-(#!BBB%<
M "A&;<57;.UMQ(K]=6IE\W0FOTVKN_VXQ4@)&O[)FT*.SJ>Y':GIK=7I=5K=
M1PH$A7(+D>F%144LBD-)D7!4B+^>S@HAFGU]_X?]^7"72H^>8C/*R5>==0LE
MFK)1)'50O N[Y\C'/FTLAVNX$;5_3^4YFLVL[Z5R,+T.V'HAO=&$E!W+"KTY
M"6NO'M)U^(V7KQ'2YQ5I^.WF=M!MLH-,1.=\HG.14ZRH'J 5.PU:I'ODLZ]R
M=(%]0YXP$/U""VS3*9HK;-/0-% +B=4:*MF3O^8U\_Z!J]65(7<KAMEI.2)U
M=%"(C=W-AF=W8Z03#IFCU066YO(0"*:VF:*W7AU*,W58&'E75^XDA1QUT9 H
M+:C#RZ18>?UR6ZA]X^/HJ!;G>.+&?S+&AAPQ)?@<4)I6$SIJSY3+Y>C,5MVB
M#ZZ&6Q N-#7,YA@ZG8EF->;R27AJ/*\/JL,1+M-=0-B*%D<C9L3,5%&_R]Y4
MORG<#S/, 56[Z1]@<8[1H"0+#TI:4,A#!HBK21Q!L@08@;P&[G(TEUM?%1U#
M/=R"@KMD1WSHEV5H)K.^?\PV"EF>*>25JIB 5(N,%!6OQE5=-WE%0,Y14"^5
M'/3ORE]_ULT[?6_M<C?13ALE>TRJ2'7'E&1C-6O&<$#Q6D?R_:DHE\[03( 3
M07%/?&1"#,"]-28W?YZRKK2F,WAGTX5KMJ*X=P6&F2M-^S),#V_CDSM</T?X
MX S-'_F*REM(HG,=NPTAW77GO*K H@.6CV5D_7357)3XD63P\JS@@F&O8N0T
M[+WQ$FFEKD,<1TW'RU&\#@JBD_RY+/%=22:E(W&L;8@7-.L';BS+2T-#(UX2
M7;-JYS=7E?QMX?>WIV']?IMQ[=&840=ZZA_)QN=?+$ C"Y6]+076[.BOHW7D
MF6((8P/TT5Y1+K%?\[T3W<+?),W0++/-**?U"IE=J9!%00 -,O0&/\85('A/
M3A T$XEW,U,XGS-+_>DQC7SZX8N:B9&!=^7,;&T%%>5MY.!:@IVU1VKAMT];
MOZD$!F%*Y)NE7)K.9F*\9M@73</+@.?HW%86,E#F;86..YD-&_4:6LB"=YM<
M_>';-6NTHG6Z.\_"<>OV-!5GZ_8B&8^_?Y>_+"\S-/+2R%R.3G.A]3[PIES"
MLO",#9?%??+BUTPM&1L9FY5:=JLC%;,1SMAW8!]RWVMU)H/K26NH_9!2+]M4
MQ4;O0US%\61'Q]3)=HX[#3!%\9CMTOJZ[X!\WENU;8[)T6PJM&Z>A^B ="3<
M"W_5FL] 6,#FX]02*7$PL7$P^?4.YMKJ#N-[9D]\$,;IMG0_FH2YK1+R0;WK
M:JU8*R4']<*0&<XE,R L D*BCLV7=Q&7H4XZD[)8,.K<38,9Q6F;VI8-!P>J
M!TC$HWC+\2:^Y(UZ,9D&4K/98RO=VHYLX=42,RR=RZQWM5M63WHJ74E5B"+!
M@M79^YZIG7"O2#]'6NX%/1YZJ\93UT;P'TG756UL]2F+C]0LD#7RW$TA3:=V
MEIS#%POD4U%7?[BJB)MHQ(^M'?TY)7?R.'-;ET0?*A7#_/W[MEF^CI\7FF*#
M?<^"$Z+V56:_JL?K.G)'OGN)#R#GMG%)D6]?ADZV\,YMYQ@ZQVVS:[GRJ#;K
MXXUF]7.N4^KS/HDQ?]9JDW(_W8BVB'C'+-2\H])YV=)'[_%1QYS/".X3/9D;
MN6=,9LA$RJH0#P^QJ2R=3ZT_MY#L9[S;U,%VZ:;9?@;V(-/]#/[IKEK+5AJ5
M2CSWQ!?W,T8VIK@*ON=@^4;V-+9*BGNP.FIWDBED:"87VH#9M^Y3=F1<F,XE
MFZ/SV?6-(1+G\FZ=BWNSO-+K(0&67)57@=23-WD#U14LR_C?RA]3>H:07C'T
M)BS!-$DPD(B_*"KB_ >N*Z?+&.)\D)3O-;J9QRM^FV/)>W,^%AWP>@7W<H?G
M4LBF"#YU@MW2VS5>$<A Y.X)!]&)<]HT[5C(;))V3%S$NW41[B+<G0Q! VF2
M*B[7$ JRB7GF-CF6&9JM88C[*''?7QOE0;7]N$V%?A0[,]:Y*UQOY?8*!SHI
MLU_>[*]K(9.E"]P1GL") 3_"2XFS#)U.1W.:OQB6?<'F LS$3WZLMYNY2:[%
M1;-CM6-XB:&FJ2[J2XJ"DQD09XX(MX\ZZHA.%>8ENZC7>T2>6>X\Q6Z]-F8S
M8%0B2;LF_ O"/V8W_F6S-%N(_!3 7/^$<&S4U(*7)7VDZKQ\ ]9G1"9_ZIA,
MDF(BT2Y\515BTBJ=R4L^]?Q3S Z_C<)<.(=BQY B'M2"A3&E-4+AWY#?GKJR
MX_HX3Q<*Q[\^?@=\WKEL(4MG4^MCM%V,8C()]?#0O=5YJ-ED'FH$\U"SR3S4
M9![JQD#7L,:?GH#*^XQ\O)ZJ^VSX8UR1N58U0 5,U^) .VIN0AQES4J+)P[)
M8-=8^^3HH;."NIHYA+N$P+E7I O\".?E-!.=+<2[5Z:.:VOU,ERD22,<*T*\
MBN<B03C:T) ..DVBU3:\Z4K&Q7#8-CN+XCQNPSE=%&_^L,ZD]2/]RCV-:M7[
MV1"]PQMK]L*]#[;ZO]:+IQ3A<IW)Z&?V?L+?W=74U-DEP?_T!*^/722@@1&&
MJ9%NGNIT24":^/15'&\!=P6D*5,1B*^?"%^3K/]=<!E)F0]#'DW=D'KC,*&W
M_#(2!HHJJWT)[H5EW 7U#_85>&N4 ]2ZER4K$,9L(!^RG_ZE7GC<;$]0M9&J
M$7]H@C_12'PL\R^DUAG_3D)A_$<-/?,BC\L'[GE-&%ADX](TQ1;RN0NJKIR>
MW/-CZV,V2UP1."3\"/OM\V_CJ9<!A*QC2GU1X$_=[.J2*/':F*8 )VH.I5:?
M:ACH@KHS1$!MAA:^L 72QL-#D1LY^O1DALUGR<8?/ZHH&+"ZO,0(3>_$P+O\
M:(' SFX'>XE7,)7*$M]%)/YHJ;))5NHET!T-T80_-#4'GF-YX&W6.X@R :@4
MAA5 +<I=B-7YQ<7(T4CI<>N8+=H4F[,"K'G)( L;JP&Y"@:0*O8U9'5TQ=:P
M(<-'P,%[I/6!X?BC)E*U/DCCA/!Y456;2%2'DB#!4M"^9_I MX2?GKQ(QL!#
M56YFJD*#H$Z%G+(7PY0L#4D,UAW;IQIH I5DZ+94GWMJ9)LJ([ +_$R$^>DG
MIR?"3' 7%=2Y:$X_*0T^);T],-%PB>Q(Q0'ZT$+9T'A%MS-<L/BR#)$*)!F9
M&KZ0',3 NX?D"3-FD&*0W"=0NT=3DW11LAX!5\_TESP3'^ZP#1H X+($;7C8
M"A8XQ;PZO)4W0(U'\#0, ,C T/)_0+='7'MEJ%;$CI,-DJ71.C(P.L W^$)#
MDF+9.H="L'*798L$%.$NX8MB)RT<>5LG+_-TAD=88#BWDW=TD4524WN6GC$-
M 37)&%M-^/S$ )-QSN)>>$ OD"9@ #)ZE70#KC"LC(NL@HGKDSC"\"(Q;3N;
MV71+QP'- 3ZM8H-O),WG6(XET/@>=601'D0(0 2A,G3"%Q C> X ZOT H( D
M$":-J2%.'5 8)AK[/NP T3DP\1Q^4ET<'-%$1%5-A/6DYBB5KYNBZO:%X!KL
M-N@NIXP!]P::, +B4F =?IWW,ZF6H]$@BZ.1+ DXOX&E6M)=0HQ#;UZ"5UA'
M*@DP-H=<XDICI;$RPO! ($Z?4K'<XL>/L![ RMF/G=BZ>.CE'(,MEB.R]2\]
M(^P I_*AH?YT]MPL&X<9 "OA(75]GJ9ZDMU9?IX4Q+# %[;6> @:IK&&! 0A
M/H9?0W],"1MP>*<)]ZJ8&@Z"2_F_HW%:Q^URP0R?GCB:#YKJC$9%EJ.:Z983
M:%%.G.52)]K68Y!]GK@_#0V0HH.L60+,8QU7*=%YA, 3-PE7Z(9=U2#R!H^]
MFRPCP5KWC/ I3B*P5)$M81W135E2*%'5<>J.%S$UB+#J9K^/=%N58(U$MD1P
MXA+W4'DB6J6AH0K1->B6!')'CH6 <$X!,G 31=W$BHST"XCSW0$I=B?HR5+9
M(3@-DLE21Z $!MY4D:QTMXA&LFKIXA*IR,MN9+,$;@!1#7!.I9O[( +_@>5B
M*C>!I3Z^* "3=837+W8*:I/="E 5X&07(;L'MA67DF:[FDADC\05]K!/6,#
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MI$;,VI9T"8#]2I6,Y\8?"O:FZ2P>X6<<7EIW>:\W5%P#YY2DX46-)!#>Z<B
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MGW,'A\88#JX-,96RE (8W!?Y=LI"*$RM:H- P'F.Q@DF+.2]_3A@QCA 5E3
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M%BH6B7@]EFH4:7L]MO; J12\(@O/.PFOR-+CWHQ7)$+FQ/)DDHU8&6Y3NM@
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MZ"J@BRRH#D<<(<8$'PXX(T8Z43K $V\TU6-/@1?,XVG[>S-,#0OE:>!_OU"
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MTL4HF%WE-@^:^)(33D4)*>Y/*2_WZC'(8H(I74X7#%7JN $&@'M%5MVUZA)
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M+VX@F.;YYUX"1@4 %=U<.]VPN;95#'A3YAJ=1/)CD0)JC4S,M6V4$>F::^L
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M3$1L\D4*83<RL:UW3FRFBL1"BDTV$]MZ]\1FEDC<= B[K>FBI!\ZS_@7.U;
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M(G1 "?'K^KW9;(NOH\1GJY0#2M*J!BC@<(IR-$&)@7) R:Z/IRBYP*XC8/F
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MGWHE;^@[WWNDJ3<ZSC-F=5IK4C:?D7+EC%0H_ X=QHABF<_^-7)A;=!+4"R
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M:^T#88[,2#4I'0*$=%<>$.B[Y-!=D"T5T87ICP (G"'O"U>;C4T!EKLIG 0
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M9/@J<YE<+NG>RO<01L,QE8>-EFPSE$W(ND !$N0J@%[)41X%E0R(;O9!X<S
MAVV"G>] @R3<KAE-X9B[ZU.,K=!;G.LS+WU@0LD&/#@UC0TT0L8Z.G[5(2<*
M6J/X 6B-!++^L0EM20W*U"UZ-1+'T=&2G/?N3>%M7=3!YCX 6Y%LSMTV#:KE
MV_QXT9[1;&@]JV % >:WSA^A)%GX&Y\FP 3R,NAW?==2NK+M9<JW/&^C^80]
M@&-*3-[ 7YL;FTF)H@?Q \@BR>;Z2P*PVI"S'D;9Y>CN<S_>M?A@Q"L:_=S4
MAF]Q3U='TXCIG:U'T4?FO9&E>!"(A2E@I0]@[R0DN^!3)X]NO-$4SV4.O4^
M+?HQJ0=2,3_KP&W",4;0D^DET\4YTY<T!#\I_^Z;9QY,2MY[W[*_1#9/2:!?
M980DR?#]E!7T@S-%OJ0H.A+(\]VR&,'SD@&P'5!<8'*D(=!R%6R\4=]63.O;
MYE'?5DSKVQ*86A'.&SFW3.COQJ/Z\?GF:?;(8K-';-.UE/$$$CPQ/]OJLRDD
M/.T_-H7$S\$/YC)='@E<*#Q!Q'MP3IUB$E04^IW31B9*B31GY,?EC,06!D3O
M$[R]07-L$Q 72<BZF")B\_&>'5^Z$BJ5XX,?B^T',@59D&=HP,J QTQ$2YI[
M("'!D6+Q PD)BW- OW*LDYS)<XL%5V(=GFDL>)957OW($8\VH(;/3JBRU]!4
M@PP%Z"JVS"[T7#8V&/1C0@CQ#;Z^.H(PY_);5&3#5=9Q-M22NM G%&\GG8!G
ML?2)A>))J%S\+@Z/V;NA&EW3<C965R"[Y-BDQX1=U8^U1U>C-\PP]3XEO981
MBPT%O]8P#.+)!2O@;Q+F_[$YAF>OISF0_!N(7L<4B,'@JAWX1X]0Y0,*$V6U
MIQF:[4! 8D#HC.A%TB6RFHG+)!=:KMHA#B:@ Y@WO US4LT6W3I>L 0CX#P-
MNGV"\T3T >%.LK1F<5&1J1$ \K$2-#S%@%PT&U%),>6X!Z=L6CZ26*04%JM5
M;4(>@*C,%B2S<>W5M&P^.H*_$X2)IS]2B2X#EFM?'B))^8CH %IK"Z[A:#H0
M*9V"AZE,?TQO*,)_Y\^29T\R+VB'&!!48RI'4#Z7\1[&=\$J,Y3&+6XH4RGH
M#,,#.EVJ*G5 ?]$&4%KG/XKXQ0R!>,RX9F6[LF7)]'>;8"KH)+X<V=L8Y&4J
ME#L6K_.E!$ 0R\W;%96R(,L<XYCB@-+KX0EK(! $V;9="].#$4J9?L6/(XSA
MJYKT3O?&:+L0F8P>8%>FQ]*6%<PK=3@3L^T)IAN: ZL<\7NCZT..9&^[?.NI
M!>,]B&^:--]03;/_HM455OU,I5U/?J #Z;+6H_O;H61E.Z/UG>$E[<J:[K(P
M*Z="HB%8<OCX _H&,&K^4H\Z!9\V$5<Z0J#DF4I(>"X803%='0[,=G7'FTRP
MIP,N<Q5$\ C(\:<+P)DJ.-J_3;D%0/NK*S7-5G33!@J@Q[5#?VK)@-FO"V?!
MS?0WTW:2N9IO$>R88.+@8I\(&!+PD*[&VI-O10#$RM0A@)@7QD4%SAF'VT*-
M"DLJN\)X.E.;V%^U_.D#(%.N'EN(+3PR,\: 4Y#O! GH#SE+&^J80"ENQ$(2
MDC[G)C0($)=MUK=$MD;FG%+G&WLF;N26\9A'.2H]YS<V+;=12,_Y!YSSB6F1
M93MHO&V^$7E^4=I'KO!IJ)"QCGAO5(F.S$":1SI%95(V12X^^O7Q;)!T^E-/
M?ZY9.>E"%KR0!!;"!JWT)C;_F7>^2"Z3K20*BR1Q$TIPTM9WGEJR 0GB.'=R
M!\6YYZ!E\H5$U;,G;D+?F5,2/+4$WKD'(PV@YKV'^4RNG"A62-R$OC,#)'AJ
M\[Y@/PVL<!P/"?-^K]@'/&$S3FD5"YEL^6<#@Z1;, W+IGN1[L6,]F*N=54?
M%NI+G=TM%3.YPH_-;?_9J_\& BO=AH1O0XH:M6B;*IW-]YU-BN_U1544D:J'
M<)J]:Q.>C@ZU"/) UG0,R&,>/7PQ@@*+N>%8*!.MOQ&\\AL.!SQ>@1-N)+:Z
MPJHE;%?I"@Z=/\"_:-"%S!"(#;2@V5W6DXPUOQWI+;0I'!A!I0[@RD1+CV0Z
MNJ+U90P#=+U&0Y ];)E/1!7H8EFIS^I*S/HTWL RPV<%X&B*8[.E]WI01B'K
M^E#09=>@\X=BI#W=W7$MN@T,6BJ^&9OD[0T43K,2D*"P%$M,^(@PY9HFMPC,
MOV'J+I8VX ,[>R?8+6/?I6<O[!-9IQ]RT!WZBMRW0E\KI>AK\T!?*Z7H:PLN
M &% :Y:&]+*ZPM.AL#,NU6\5C==#[IG8O=.DIV,9\ZAX3:_+L66<N=;JBJK9
MBHMMAUAFFB'K0UO#:\)T+5X\Q?X9]+N#7^I>?3*K9V5]5\-5KO1N8(V0Z- P
ME&O(+OT]%J;"DEB/) /-'$@Z65T)BF7IQ>B,-.)TNA9AV7/3 +K![P E*B,\
M=35ZSV!A;HL0@^'W6PPP&5HX6"KK/ I7SM5F8W-U9:]:/9]_$=ABD-F6;AFH
MT[$S8V6/?BUJ/!4)L43$-3*;*H%860V%BU3[PMZ,C)SO7;7#?LLJ'UF#>B \
M^F[30OKD31QA"K)M$X=..Y3!"66L T*5338@[^5$/\8*[$CQ&U-+.Z KLH$X
M1_EC;0K7C'N0<X*9FL;J2I=JHJ8%XI1SK*< >J6.])6.15#)I=\/9$LSZ;)-
M++6$ L\>+XG%A3X!6^@:G3ER+&B#)BM"]S5'0=$LQ>W1[80&*!E0&G47U RZ
M(Z'A9)L!Z$*QIP [ 86V33RJ8 &4FYFR31>G,>:FAP&R/S@ N66Z;.L5V;*&
M\.5 UET2VOC1_:(J)9X:?3,4IM)5J)3:!+D/K&YPE!ZV UP^;0K;6$6J68(A
MPY0S88( M$:W=8\D8-*7T35#E2P6_4)!,,S$A;L*REB=X2;  +IPOWGRLB</
MZ9D#Z)L 0UI,C6;3")]H*F<2LHRP[1@4@[]#Q,3<,'"G"AV3E2*C9L/(WKN4
M^D M/6ZX49K5M1>4<8@Y$2)T^!H$2)?N$))>B/)#:!)L'KS.V:",!F7;E-J\
M0GC_^O:N5%!.;4*8%<R+M!L$68@((LX"?O;6Q1V['REA)V09-9>@P0UBA\$
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MMR_H?:OLRO6SB__]7Z:V_G]02P,$%     @ %70/5<S0%5@H!P  OC4  !D
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M%]YH5)@*6:L_8![X8ZDB-1(T:D_Z*U\ _AFXAZMJ'\[S)XCU@C69$ZODT/_
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M  !I;6%G95\P,#$N:G!G4$L! A0#%     @ %70/50DZ^8!L'P$ #4L- !,
M             ( !.:$  '-F<V%L<C$P<3 X,3$R,BYH=&U02P$"% ,4
M"  5= ]5S- 56"@'  "^-0  &0              @ '6P $ <V9S86QR,3!Q
M,#@Q,3(R97@S,5\Q+FAT;5!+ 0(4 Q0    ( !5T#U7,XXZ+F 0  #P7   9
M              "  37( 0!S9G-A;'(Q,'$P.#$Q,C)E>#,R7S$N:'1M4$L%
3!@     )  D 50(   3- 0    $!

end
</TEXT>
</DOCUMENT>
</SUBMISSION>
